Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABCA9	EST640918	ENSG00000154258	"ATP binding cassette subfamily A member 9"	Q8IUA7	17	68974488-69061064	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 42.5"	"Cell type enhanced"	"Detected in many"	22	"Ito cells: 26.4;Leydig cells: 89.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"ASC diff: 14.5;ASC TERT1: 31.1;HSkMC: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052113, HPA054823"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA052113: AB_2732573, HPA054823: AB_2682615"	"unprognostic (3.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.51e-4)"	"unprognostic (1.83e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.77e-6)"	"unprognostic (5.32e-4)"	"unprognostic (7.22e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-3)"	42.5	4.2	1.2	5.5	2.8	1.7	14.1	2.7	2.6	13.4	17.4	2.6	6.8	1.7	15.5	11.8	25.5	8.8	7.2	15.0	2.1	1.9	2.5	7.6	5.6	2.1	7.8	2.0	25.2	2.3	1.7	2.8	1.1	4.4	13.9	3.8	4.1	5.7	4.7	12.4	5.4	3.7	11.9	3.8	1.6	4.8	10.9	2.1	1.0	7.6	9.9	2.5	20.4	18.7	1.8	0.9	2.9	0.8	1.2	1.3	0.0	0.2	0.4	0.5	0.6	14.5	31.1	0.5	0.3	0.3	0.0	0.2	0.4	0.4	0.4	0.1	0.5	0.3	0.4	0.3	0.5	0.2	0.2	0.4	0.5	1.3	0.4	1.6	0.6	0.9	11.1	0.4	2.3	0.2	0.6	3.1	0.4	0.5	1.1	0.2	0.2	0.2	1.4	0.3	0.1	0.3	1.5	0.1	0.2	0.1	1.3	0.6	0.5	0.4	0.3	0.3	0.4	0.3	0.5	1.3	0.9	0.4	1.7	0.3	1.0	0.3	0.3	0.3	0.3	1.5	1.7	0.8	1.4	1.3	0.6	1.3	1.1	0.8	0.5	0.9	1.8	1.3	1.3	2.9	1.2	0.5	0.7	0.4	0.0	1.2	2.8	2.7	2.6	2.1	1.9	7.8	2.0	4.4	2.1	0.0	1.0	0.0	0.2	1.5	5.4	2.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.4	0.0	0.0	0.0	10.6	0.1	0.0	9.9	0.2	0.0	0.0	26.4	1.8	2.1	89.2	0.6	0.0	0.0	0.0	12.1	0.3	0.0	14.5	0.0	6.1	12.9	1.4	1.2	0.6	1.4	0.0	0.0	0.0	0.1
AC010422.5		ENSG00000269590			19	12664828-12669397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"	33	"Club cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 14.1;RT4: 7.4;U-138 MG: 5.3"									HPA065685	Uncertain		Approved	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Nuclear membrane, Endoplasmic reticulum"		"HPA065685: AB_2685531"																		4.5	8.7	3.7	5.1	3.8	3.1	7.5	5.1	8.3	5.6	5.8	3.6	5.9	11.3	4.5	6.7	6.9	5.4	7.8	5.5	4.2	4.1	6.0	8.3	8.0	13.1	3.5	2.4	6.4	13.2	2.3	3.8	7.5	2.2	6.9	2.8	3.3	8.2	6.2	10.9	6.0	5.9	4.6	3.7	4.1	3.8	4.5	2.6	2.7	10.4	6.9	3.9	4.7	7.1	1.2	0.0	6.7	0.2	0.0	0.2	0.5	2.1	0.0	0.0	3.3	0.0	0.8	1.0	0.0	0.0	0.0	0.7	0.0	1.4	0.0	2.3	0.0	0.4	1.3	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.4	1.3	0.2	0.0	0.0	0.1	0.3	3.8	0.0	14.1	3.5	0.4	0.9	0.0	0.0	1.4	0.0	0.0	1.1	7.4	2.1	1.9	0.0	1.7	0.3	0.0	2.4	0.7	0.0	5.3	0.1	1.9	2.2	2.3	3.1	1.4	4.7	0.8	2.1	2.0	0.2	1.8	0.1	0.1	0.0	1.2	0.0	0.2	0.0	0.8	0.0	0.1	6.7	0.0	0.2	0.0	0.1	0.5	3.7	3.8	5.1	4.4	4.2	4.1	3.5	2.4	2.2	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC068631.2		ENSG00000283149			3	186581995-186597103	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 17.4"	"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA010814	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010814: AB_1078691"																		1.9	1.3		3.1		6.3	2.7		1.2	0.0	4.7			2.9	1.3	8.3	0.7	0.1	1.9	0.4			1.3	5.3	0.5	1.5			0.2	2.8	0.0		1.6		0.0	2.3		0.6	0.5	0.0	0.0	1.5	0.3		2.1	1.7	0.2			2.9		1.2	0.0		9.0	17.4	9.7	8.7	10.7	11.9	6.6	12.7	10.1	12.9	16.1	10.9	5.1	4.2	24.0	6.7	9.9	6.8	35.5	6.2	8.0	29.8	16.1	15.7	9.5	13.0	9.1	13.0	6.5	0.2	8.0	18.2	37.2	13.0	15.6	5.5	5.7	5.5	11.6	20.7	8.0	6.3	3.9	4.5	31.8	4.4	28.0	8.0	5.3	4.0	32.0	0.0	5.3	12.9	11.3	10.3	23.0	1.0	1.9	10.7	22.9	7.3	15.2	15.6	20.2	3.4	6.7	8.0	5.9	22.5	13.5	27.2	22.8	10.1	12.5	13.9	7.6	6.7	9.7	11.9	8.7	8.5	9.0	7.5	10.1	10.5	5.5	4.9	9.5	1.8	10.7	7.2	17.4	8.8	6.6											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC135050.2		ENSG00000255439			16	31083439-31094956	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042720	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.84e-8)"	"unprognostic (4.96e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.29e-4)"	4.5	2.6	1.6	4.8	1.7	3.0	6.4	1.9	2.6	5.4	3.9	3.3	3.2	3.3	5.1	5.9	3.7	4.0	4.9	3.7	1.8	1.8	6.9	47.1	3.6	3.7	2.4	1.1	5.6	14.1	4.6	3.1	4.8	2.3	4.8	2.2	4.4	8.3	3.8	2.0	7.8	6.0	6.3	1.8	4.3	3.5	3.6	1.5	3.0	5.7	2.4	2.6	6.5	3.9	2.3	2.6	2.9	2.7	1.4	3.8	2.0	1.2	1.2	0.0	1.2	2.7	3.6	0.3	3.7	0.9	0.0	0.5	0.6	0.7	0.7	1.9	0.3	0.0	0.5	0.0	0.4	0.0	0.4	1.7	1.5	1.2	0.5	0.0	0.0	1.5	1.0	0.6	0.6	0.0	0.6	0.0	1.1	0.0	1.5	0.3	1.2	1.0	3.1	0.3	0.1	1.6	2.9	0.2	1.1	0.0	0.8	1.0	0.9	1.8	1.0	1.9	0.0	0.0	0.4	0.0	1.2	0.0	3.2	0.9	3.6	0.8	0.0	2.9	0.9	0.4	0.8	1.6	2.9	2.7	1.6	3.5	2.3	3.4	3.8	2.3	1.8	2.1	2.8	1.5	1.4	2.7	2.6	3.4	2.0	1.6	1.7	1.9	2.6	1.8	1.8	2.4	1.1	2.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC138811.2		ENSG00000260342			16	18788063-18801519	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"blood: 51.6;testis: 43.2"	"Cell type enhanced"	"Detected in some"	24	"Alveolar cells type 2: 3.5;Ciliated cells: 9.4;Club cells: 4.5;granulocytes: 2.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 28.6;HDLM-2: 34.8"									HPA045307	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045307: AB_10961042"	"unprognostic (1.03e-2)"	"unprognostic (8.89e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.18e-4)"	"unprognostic (2.92e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.95e-2)"	5.0	5.8	7.8	7.0	12.6	4.6	4.4	9.4	17.0	3.8	13.5	6.3	2.3	1.9	4.2	3.1	5.6	3.5	3.8	4.8	6.9	4.8	6.4	12.1	4.3	4.0	6.6	10.6	4.1	9.3	10.8	3.6	4.0	17.1	3.6	4.1	9.6	4.1	4.1	12.0	4.0	5.9	5.5	7.0	6.0	14.6	43.2	4.0	7.5	4.5	1.6	4.1	4.7	3.9	29.2	51.6	29.0	25.8	37.2	49.0	48.3	11.6	2.3	2.0	12.2	0.7	0.3	0.4	12.6	0.7	1.2	1.6	8.3	14.9	3.1	28.6	2.9	3.1	13.9	4.4	1.8	3.6	34.8	1.3	3.3	5.3	2.2	0.0	15.8	8.2	0.7	0.4	4.2	0.0	1.2	0.7	1.5	6.7	12.1	1.3	0.0	5.5	0.2	1.1	0.7	0.3	21.1	4.5	1.6	0.8	7.0	6.4	0.7	16.3	4.3	1.1	1.1	7.8	0.3	13.1	5.7	8.9	5.6	13.0	3.3	16.5	7.2	8.1	1.9	13.2	29.0	25.8	15.0	43.5	18.0	34.2	29.0	34.9	41.5	24.5	29.2	29.8	32.9	20.1	37.2	22.9	51.6	49.0	48.3	7.8	12.6	9.4	17.0	6.9	4.8	6.6	10.6	17.1	4.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	9.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC245033.1		ENSG00000260836			15	82536788-82573194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	5	"brain: 11.3"	"Group enriched"	"Detected in some"	240	"Alveolar cells type 1: 29.8;Alveolar cells type 2: 42.6;Ciliated cells: 20.1;Club cells: 15.9;granulocytes: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 19.0"									HPA055060	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum"	"Nucleoli, Cytosol"	"HPA055060: AB_2682686"									"unprognostic (2.91e-2)"									1.5	0.9	5.3	0.9	7.1	0.9	1.3	6.1	11.3	0.9	1.0	1.4	0.0	0.9	0.9	0.9	1.5	0.9	0.9	1.3	3.9	1.6	0.9	1.0	1.1	0.9	3.2	6.1	0.9	1.0	0.9	2.0	1.0	7.3	1.1	1.1	1.9	0.9	0.9	2.0	0.9	1.4	0.9	2.4	1.1	0.9	1.4	1.7	0.0	1.0	0.0	1.0	1.7	0.8	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.7	0.7	19.0	0.3	0.0	0.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.1	6.1	11.3	3.9	1.6	3.2	6.1	7.3	1.7	29.8	42.6	0.0	0.0	0.0	0.0	0.0	0.0	20.1	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAM9	"CORD9, KIAA0021, MCMP, MDC9, Mltng"	ENSG00000168615	"ADAM metallopeptidase domain 9"	Q13443	8	38996869-39105144	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 140.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 11.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004000			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted - unknown location"	NA	NA		640000	Vesicles	"Endoplasmic reticulum"	"HPA004000: AB_1844584"	"prognostic unfavorable (1.14e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (5.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.80e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.23e-2)"	36.7	25.0	14.7	21.7	13.6	10.4	17.1	20.9	14.4	21.8	24.4	13.2	21.8	19.4	24.9	19.8	24.1	15.5	31.7	28.5	12.5	10.1	29.4	11.6	39.2	20.3	19.2	12.9	17.6	11.1	37.5	10.4	30.1	15.8	23.8	23.8	15.4	44.5	21.4	18.3	12.8	25.4	32.8	22.0	25.7	33.2	13.7	12.7	2.4	24.0	14.9	11.7	34.8	19.2	0.6	8.1	3.4	11.4	3.1	0.8	2.8	41.2	29.9	11.8	7.2	19.2	61.9	15.4	56.1	61.4	31.5	29.5	14.2	30.0	2.1	21.2	38.6	32.2	17.7	5.0	39.6	61.1	2.0	5.1	2.2	20.8	12.2	38.8	1.6	4.8	47.5	23.5	31.0	35.3	60.1	42.9	3.6	4.3	14.1	65.5	4.0	1.6	1.0	1.7	29.5	9.7	1.4	21.4	7.2	51.2	11.8	1.6	2.4	14.9	18.0	13.6	13.3	14.5	3.0	73.6	24.1	23.2	45.5	25.6	4.5	6.9	2.3	40.0	2.7	16.4	1.4	11.4	2.2	0.6	6.1	0.3	0.1	0.3	0.8	8.1	0.6	0.1	0.6	3.4	3.1	2.6	2.7	0.4	2.8	14.7	13.6	20.9	14.4	12.5	10.1	19.2	12.9	15.8	12.7	44.7	35.4	8.2	50.9	31.9	18.5	45.6	25.5	14.7	39.8	33.2	19.6	17.9	3.3	80.4	10.3	23.6	20.8	0.0	100.4	80.2	38.5	85.4	4.7	6.7	104.9	4.8	10.3	26.4	54.2	5.1	26.4	39.7	20.3	22.6	26.3	15.2	140.3	25.9	23.3	36.6	23.8	12.9	32.5	4.3	2.0	18.7	28.7	4.1	25.8	75.5
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 51.4"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 62.4;Ductal cells: 67.2;Endothelial cells: 76.0;Glandular cells: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 9.4;RPTEC TERT1: 11.2;SH-SY5Y: 52.5;SuSa: 17.3;WM-115: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	No	NA			Vesicles	"Endoplasmic reticulum"	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	51.4	4.7	5.6	12.0	11.5	0.5	15.2	3.9	8.0	10.4	10.4	2.8	7.2	1.6	13.9	5.6	6.8	7.7	8.2	29.6	5.7	2.7	9.0	3.1	11.5	7.7	6.8	0.3	17.4	9.9	17.2	2.4	30.5	12.4	7.4	3.2	0.7	3.5	4.3	10.8	2.6	3.2	12.2	12.6	4.4	4.6	3.1	5.9	0.0	6.4	3.7	1.6	19.6	29.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	5.6	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	3.6	1.0	0.0	0.0	0.2	0.0	9.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.0	0.4	0.0	0.0	1.0	0.0	11.2	0.1	0.0	52.5	0.0	0.0	0.0	17.3	0.0	0.2	2.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	11.5	3.9	8.0	5.7	2.7	6.8	0.3	12.4	5.9	3.0	4.5	0.0	62.4	15.5	0.0	5.9	5.1	0.0	4.5	36.6	2.0	0.6	0.0	67.2	0.8	76.0	0.0	0.0	2.9	0.5	35.3	51.3	0.0	0.0	5.8	0.0	1.2	23.4	0.3	0.0	2.3	3.0	25.3	0.0	1.4	0.0	27.6	0.0	2.1	6.3	0.0	0.0	38.9	0.3	0.2	11.8	1.4	0.0	0.4	26.6
AGPAT1	LPAAT-alpha	ENSG00000204310	"1-acylglycerol-3-phosphate O-acyltransferase 1"	Q99943	6	32168212-32178096	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048478, HPA073355"	Approved		Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA			"Endoplasmic reticulum"	"Rods & Rings"	"HPA048478: AB_2680411, HPA073355: AB_2686596"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.35e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (4.79e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.92e-3)"	"unprognostic (7.00e-2)"	11.7	32.3	21.5	8.3	33.1	7.4	12.1	18.7	32.4	26.9	22.1	19.6	19.6	32.0	25.1	53.3	13.8	26.9	22.3	19.4	22.8	21.1	26.4	20.3	24.3	10.7	20.3	23.6	33.1	18.5	1.3	16.6	18.5	22.4	18.5	24.8	17.5	17.4	19.5	25.5	9.1	46.9	17.9	18.6	11.7	27.8	27.7	17.4	12.1	33.4	9.0	14.6	19.3	12.7	6.7	13.8	13.2	9.6	8.9	10.1	5.7	0.0	0.1	13.5	0.0	35.3	23.8	12.5	0.0	0.0	0.0	0.0	27.5	0.0	0.0	11.6	33.7	9.5	3.3	29.1	9.6	0.0	0.0	22.5	0.0	0.0	29.0	0.0	0.0	27.3	13.3	12.4	0.0	12.6	29.0	8.2	23.0	17.3	17.7	29.2	7.3	0.0	6.3	0.0	0.0	4.2	0.1	0.0	0.1	8.8	0.0	0.0	0.0	13.4	4.3	15.1	14.6	16.9	0.0	5.8	0.0	5.0	0.0	0.0	10.6	10.1	4.4	17.4	0.0	0.0	2.7	5.7	13.2	9.2	9.6	8.7	6.7	5.8	10.1	10.3	5.9	5.0	7.3	11.0	8.9	6.6	13.8	7.8	5.7	21.5	33.1	18.7	32.4	22.8	21.1	20.3	23.6	22.4	17.4	14.9	18.1	19.4	9.5	8.0	26.4	3.1	12.7	12.0	7.9	34.9	11.8	28.8	5.0	16.4	52.8	13.5	30.7	0.0	12.4	25.8	14.4	11.5	12.7	27.1	22.0	30.2	28.3	18.4	17.4	64.8	12.4	17.4	8.5	5.4	24.1	34.1	13.6	21.0	20.1	22.3	17.0	0.0	20.8	45.5	20.6	3.1	12.8	12.1	20.4	10.5
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 160.2;gallbladder: 147.0;seminal vesicle: 159.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 1045.3;Mucus-secreting cells: 2788.2;Paneth cells: 1013.4;Undifferentiated cells: 1404.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"OE19: 672.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		22000	"Endoplasmic reticulum"		"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	0.9	0.9	0.9	23.0	0.9	0.0	5.3	0.9	0.9	52.8	58.8	1.3	160.2	36.5	4.8	51.9	4.0	23.7	147.0	0.9	0.9	0.9	3.3	0.9	19.0	0.0	0.8	0.0	4.0	59.2	0.0	11.3	1.6	0.1	18.8	97.7	0.0	70.0	159.4	0.9	1.1	62.2	3.3	0.8	0.9	107.6	0.9	0.0	0.1	1.1	20.0	97.7	13.2	3.7	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	0.0	0.0	0.0	0.2	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	672.3	5.3	0.0	0.0	0.1	21.3	12.6	0.0	0.0	0.0	3.4	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.9	0.9	0.9	0.9	0.9	0.8	0.0	0.1	0.0	47.6	221.9	2.2	104.9	2.5	0.0	0.0	351.6	1045.3	577.8	76.8	0.0	4.6	0.0	37.7	2.8	0.1	824.5	0.0	764.4	3.5	4.2	606.7	44.8	0.6	180.1	0.0	501.7	0.0	0.6	0.0	0.3	2.7	3.3	1.8	2788.2	0.0	180.9	1013.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	2.7	0.7	1404.9	754.7
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859405-16881987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 40.5;intestine: 99.1"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 1287.5;Club cells: 422.0;Enterocytes: 526.8;Mucus-secreting cells: 499.0;Paneth cells: 524.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 104.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"OE19: 27.2;T-47d: 86.4"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		31000	"Endoplasmic reticulum"	Vesicles	"HPA053942: AB_2682317"	"unprognostic (2.18e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.49e-1)"		"unprognostic (1.46e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.57e-1)"	0.6	0.0	0.6	7.5	0.7	0.0	13.1	0.7	0.6	4.4	45.8	0.6	0.6	29.2	1.2	5.4	0.9	40.5	11.8	0.6	0.6	0.3	1.5	0.6	26.3	0.6	0.6	0.6	5.1	1.9	0.0	12.9	2.8	1.9	1.1	38.9	0.6	9.4	0.6	0.6	0.3	99.1	1.2	0.8	0.6	17.1	1.0	0.6	0.6	1.4	1.9	3.9	4.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	27.2	0.0	0.0	0.0	0.5	2.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	86.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.6	0.6	0.3	0.6	0.6	1.9	0.6	309.7	310.7	0.0	9.4	2.4	0.0	0.0	35.7	1287.5	422.0	27.9	0.0	1.4	1.7	20.8	0.0	0.0	526.8	0.0	65.4	1.2	0.2	4.4	19.7	0.0	0.5	0.0	108.2	0.0	0.0	0.0	0.3	0.7	0.0	1.0	499.0	0.0	10.6	524.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.5	1.8	0.0	345.5	94.0
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 145.9;tongue: 74.5"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 239.5;Exocrine glandular cells: 290.3;Hepatocytes: 511.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"ASC diff: 185.8;Hep G2: 315.1;OE19: 134.5"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	52.0	3.8	2.1	3.4	4.1	1.4	36.0	2.6	2.7	2.2	3.2	2.6	1.2	6.2	1.4	4.0	19.2	1.7	16.1	22.1	2.6	2.6	32.0	145.9	11.2	2.5	5.4	1.4	3.8	4.9	0.6	4.1	0.7	6.6	5.1	3.2	3.8	13.1	3.4	17.1	4.7	4.6	4.8	6.8	0.9	21.9	5.2	3.2	0.0	11.5	74.5	5.0	17.4	10.8	0.0	0.9	4.2	0.1	0.3	1.7	0.8	0.0	25.5	0.1	25.7	185.8	22.4	0.0	0.8	5.7	0.3	0.2	0.4	0.0	0.0	0.3	5.7	4.4	0.2	0.0	1.3	0.1	0.0	0.0	0.7	4.1	315.1	1.8	0.1	0.0	11.4	1.6	2.6	1.6	0.0	0.6	0.1	5.4	0.0	4.4	0.1	0.0	0.0	0.0	134.5	0.0	0.0	0.0	0.2	1.4	4.8	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.4	5.0	2.2	0.1	5.9	0.2	0.1	0.0	0.0	7.9	0.7	0.0	4.2	0.1	1.1	1.7	0.0	0.1	0.0	0.7	0.4	0.2	0.0	0.3	1.5	0.9	0.3	0.0	0.9	0.4	0.8	2.1	4.1	2.6	2.7	2.6	2.6	5.4	1.4	6.6	3.2	62.5	27.2	1.5	11.8	18.8	2.5	2.4	239.5	96.4	128.5	59.3	0.0	0.0	11.6	33.9	14.9	17.8	9.3	70.0	290.3	0.0	13.4	11.4	4.6	511.8	0.3	0.0	1.7	26.4	14.5	8.0	140.4	3.8	101.3	8.2	1.7	47.9	184.6	0.9	138.6	40.8	4.3	0.0	14.4	1.7	0.7	17.9	0.1	0.9	2.6	140.8
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 71.9;liver: 122.7;tongue: 111.8"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 135.0;Hepatocytes: 341.7;Pancreatic endocrine cells: 140.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"	"Group enriched"	"Detected in some"	4	"A549: 130.6;ASC diff: 162.1;Hep G2: 243.7;OE19: 168.2;RT4: 74.6"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	60.4	4.0	1.8	2.0	3.3	0.0	71.9	2.5	2.1	1.3	2.9	1.0	1.2	5.5	1.0	3.0	17.4	1.5	19.4	9.3	1.7	2.3	4.8	122.7	5.9	1.1	4.7	0.9	1.9	2.4	0.0	1.8	0.1	4.2	8.1	2.4	2.0	12.0	2.4	19.8	4.2	2.4	4.4	3.9	0.6	26.2	2.3	2.6	0.1	4.2	111.8	5.5	25.3	11.9	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	130.6	0.1	13.8	162.1	5.6	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.7	0.9	0.6	3.6	0.0	0.6	0.0	0.0	0.0	0.0	36.8	243.7	0.3	0.0	0.0	14.5	8.2	0.6	0.6	0.0	0.0	0.0	5.0	0.0	1.3	0.2	0.0	0.0	0.0	168.2	0.0	0.0	0.0	2.1	1.2	74.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.1	4.8	0.0	0.0	0.0	0.0	1.7	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.8	3.3	2.5	2.1	1.7	2.3	4.7	0.9	4.2	2.6	11.9	3.2	0.0	3.2	10.5	1.8	3.7	135.0	18.7	19.4	0.0	0.0	0.0	0.0	12.3	18.3	8.7	9.3	0.0	93.5	0.1	15.0	4.5	0.0	341.7	0.1	3.2	1.7	12.3	13.7	5.6	73.4	1.1	8.5	1.0	2.8	33.8	140.7	7.0	73.9	2.6	2.6	0.0	7.6	0.3	0.3	11.8	0.0	1.3	7.4	79.1
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.1;intestine: 52.3"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 261.7;Exocrine glandular cells: 644.1;Pancreatic endocrine cells: 362.8;Proximal tubular cells: 434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 50.1;gdT-cell: 26.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 115.0;ASC diff: 66.2;Hep G2: 48.3;OE19: 226.4;RT4: 45.4"									"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		11000000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	16.6	6.6	3.2	3.2	3.9	3.5	12.8	3.2	3.9	3.2	17.3	3.2	3.2	52.3	3.2	3.2	6.0	4.5	32.2	4.8	4.4	1.0	20.1	34.4	5.5	3.2	3.2	3.2	3.2	4.2	1.8	3.2	3.2	4.2	3.2	11.4	3.2	4.4	3.2	13.0	2.6	31.1	4.2	3.2	3.2	28.6	3.2	3.2	3.2	3.2	3.2	3.2	12.3	3.2	0.1	9.6	50.1	0.7	4.6	26.7	9.7	0.0	115.0	0.0	33.6	66.2	23.8	0.0	0.0	1.6	0.0	0.1	3.4	1.9	0.0	6.2	1.5	3.4	0.9	0.1	2.3	0.0	0.2	0.0	0.2	35.6	48.3	0.3	0.0	0.0	13.2	4.7	1.5	0.0	1.9	2.2	0.2	0.7	0.0	3.0	0.2	0.7	0.1	0.0	226.4	0.3	0.2	0.7	3.4	11.3	45.4	0.0	0.2	16.5	0.0	0.0	0.0	0.0	0.0	16.0	0.3	0.3	6.9	0.2	0.0	0.0	0.0	3.8	4.5	0.3	50.1	0.7	1.1	26.7	0.2	1.7	0.0	5.0	4.8	0.5	0.1	3.2	2.4	1.9	4.6	0.3	9.6	4.9	9.7	3.2	3.9	3.2	3.9	4.4	1.0	3.2	3.2	4.2	3.2	41.7	4.0	1.5	1.1	10.6	1.7	3.6	0.0	88.3	61.4	34.9	0.0	0.1	36.5	85.3	2.9	61.2	261.7	0.0	644.1	0.0	13.8	0.7	5.7	0.0	1.6	1.6	18.4	0.0	0.0	2.1	72.5	19.0	20.3	5.4	31.0	121.7	362.8	121.1	100.4	434.1	3.6	25.8	8.0	0.3	0.7	9.4	0.0	0.0	103.0	27.3
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 127.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 437.4"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;gdT-cell: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.2;T-cells: 1.1"	"Group enriched"	"Detected in some"	4	"HDLM-2: 11.6;OE19: 5.1"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		1800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	1.1	0.1	0.0	1.5	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.5	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.1	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	45.9	2.7	1.2	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	23.3	0.6	0.0	0.0	0.0	0.0	437.4	0.0	0.0	0.0	14.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1
AL035078.4		ENSG00000285283	"Reticulocalbin-1 "	Q15293	11	31812391-32104665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.2"	"Cell type enriched"	"Detected in single"	4	"Ciliated cells: 1.4"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 63.7;RH-30: 39.5;RT4: 43.1"									HPA038474	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA		2300000	"Endoplasmic reticulum"		"HPA038474: AB_10672595"																		4.7	0.9	1.6	7.5	2.4	0.0	0.3	16.2	3.2	0.3	5.9	1.7	0.3	0.9	3.8	0.3	1.7	4.3	0.3	0.3	3.1		0.4	2.8	1.4	0.3	2.2	1.9	6.1	0.3	0.0	1.8	1.6	3.0	0.3	0.8	6.9	0.3	0.3	3.3	0.0	2.4	4.6	3.6	0.5	2.2	0.3	1.0	0.3	0.5	0.3	0.7	1.9	0.3	0.6	5.3	0.4	3.5	3.2	2.1	1.7	7.4	12.4	12.0	11.5	3.4	2.1	6.7	63.7	21.2	11.2	10.4	6.0	9.6	0.0	21.0	24.0	16.2	6.5	9.0	7.2	12.3	5.0	1.5	3.6	9.0	0.7	0.0	3.1	1.5	10.6	1.4	12.3	8.1	3.9	15.8	2.0	1.2	3.9	0.1	2.6	4.9	0.0	5.1	0.0	0.1	2.7	39.5	1.6	0.0	43.1	5.0	1.9	12.4	0.8	7.6	3.1	9.1	0.1	37.7	28.7	12.1	17.3	24.3	0.0	0.0	0.1	30.4	1.2	13.1	0.0	3.5	0.0	2.1	3.4	1.9	0.6	0.2	1.8	5.3	0.1	0.3	0.9	0.4	3.2	2.0	0.6	0.0	1.7											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL136454.1		ENSG00000231767			1	192716132-192716653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 13.4;Club cells: 30.7;Distal tubular cells: 36.5;granulocytes: 33.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 7.5;SK-MEL-30: 6.6;THP-1: 7.8"									"HPA041344, HPA049132, HPA054087"	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.09e-2)"	"unprognostic (7.80e-3)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (3.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.62e-2)"	1.7	0.9	0.3	2.3	0.6	1.9	2.6	0.9	0.9	1.3	0.7	0.0	3.9	2.8	1.8	2.5	0.8	0.7	1.8	0.8	0.5		1.2	0.4	1.3	3.3	1.7	0.2	2.6	7.3	0.0	0.0	0.6	0.8	1.5	0.0	0.4	5.9	4.2	3.4	0.1	1.6	0.6	0.7	3.0	1.2	0.4	1.0	0.2	0.6	2.5	0.8	3.0	2.3	6.1	2.6	1.3	1.9	4.5	7.4	6.4	1.7	0.7	0.5	1.1	0.5	0.0	4.4	0.2	1.0	0.0	0.6	0.0	1.3	0.4	4.4	0.0	0.3	1.8	0.3	0.5	0.0	1.4	0.9	0.8	0.9	3.3	0.4	1.2	2.3	0.5	0.8	0.3	0.0	0.1	0.3	0.4	0.2	1.3	0.0	0.9	1.5	7.5	1.9	0.2	0.4	1.7	0.5	1.0	0.6	2.2	1.4	2.7	0.3	2.7	6.6	0.2	1.7	7.8	0.9	1.1	2.1	1.4	4.0	2.6	1.8	1.5	1.4	1.2	0.2	1.3	1.4	0.7	3.2	1.9	4.6	6.1	5.7	3.5	2.6	5.8	7.4	7.0	0.4	4.5	1.4	2.4	3.6	6.4											8.9	8.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	30.7	1.8	0.0	0.0	36.5	1.4	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.8	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL162231.1		ENSG00000187186			9	34664163-34666112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 68.6"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 34.9;Distal tubular cells: 21.6;Proximal tubular cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 28.3"					"Low region specificity"	"Detected in all"			HPA069617	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Nucleoli, Endoplasmic reticulum"	"HPA069617: AB_2686161"	"unprognostic (8.20e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (2.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.39e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.00e-2)"	3.0	6.9	12.1	2.1	21.6	1.8	2.9	6.9	20.2	2.3	1.8	1.9	1.1	2.8	4.0	13.9	1.8	1.8	2.2	9.1	11.8	9.5	4.9	2.5	2.2	1.4	9.6	12.2	7.8	6.2	3.4	13.1	2.3	7.0	3.7	1.2	1.8	4.6	2.1	21.9	2.2	2.0	3.8	5.0	1.0	1.4	68.6	5.3	0.6	3.5	2.0	0.7	1.5	2.5	4.0	11.8	12.0	2.5	3.5	2.9	1.6	0.3	6.0	5.6	7.2	4.6	2.3	5.0	4.8	1.4	3.0	3.5	1.0	2.4	0.0	0.6	3.2	6.0	1.4	3.6	1.7	0.5	12.9	0.6	0.0	28.3	1.7	1.1	2.6	4.5	2.4	2.0	1.8	1.9	4.2	0.8	7.4	3.2	7.4	2.2	0.0	0.5	2.6	4.6	5.3	1.6	0.0	5.3	0.9	5.4	0.0	5.8	9.3	3.4	1.1	8.0	3.3	2.8	7.4	1.1	10.7	14.8	3.4	1.1	7.9	2.6	1.0	13.2	1.5	14.6	12.0	2.5	2.6	1.8	1.3	1.7	4.0	2.3	1.0	0.8	1.6	2.9	1.5	3.5	3.5	0.8	11.8	2.0	1.6	12.1	21.6	6.9	20.2	11.8	9.5	9.6	12.2	7.0	5.3	8.9	9.5	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.5	34.9	0.0	11.6	21.6	12.0	0.0	0.0	0.0	0.0	9.4	10.4	0.0	0.0	2.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	9.0	0.0	0.0	10.8	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0
AL645922.1		ENSG00000244255			6	31927698-31952048	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	7	"liver: 115.5"	"Group enriched"	"Detected in some"	8	"Ciliated cells: 9.4;Club cells: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.3;Hep G2: 1.6;Karpas-707: 2.4;U-266/84: 1.0"									"HPA000951, HPA001817, HPA001832"	Approved		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"		NA	NA			"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"							"unprognostic (7.68e-2)"							"unprognostic (1.86e-2)"				5.3	0.9	0.6	2.9	0.7	0.3	3.9	0.6	0.7	0.7	3.7	0.3	0.0	0.8	0.9	3.0	0.9	1.1	0.8	4.4	0.7	0.6	10.8	115.5	15.8	9.7	0.7	0.0	1.5	0.7	0.3	0.7	5.0	0.6	0.8	0.6	1.1	0.8	0.3	0.8	0.7	4.3	1.5	0.8	9.7	1.3	1.3	0.0	0.3	0.7	0.0	1.3	1.5	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.6	0.7	0.7	0.6	0.7	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL669918.1		ENSG00000250264			6	32813767-32838822	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 17.2;HDLM-2: 11.4;HEL: 12.4"									HPA001312	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Nuclear speckles, Endoplasmic reticulum"		"HPA001312: AB_1080206"	"unprognostic (6.13e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.62e-1)"		"unprognostic (9.88e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	6.5	3.6	2.8	25.5	3.1	3.8	3.6	3.1	3.3	4.8	7.7	3.5	1.0	5.7	4.6	2.5	4.8	3.6	5.7	3.5	2.1	2.6	5.3	10.0	8.5	12.6	3.2	2.8	4.7	2.1	1.7	5.0	2.4	3.6	3.8	3.1	3.6	7.0	1.4	2.5	3.3	15.1	2.7	2.8	18.1	12.3	2.5	3.1	14.0	7.5	3.2	10.6	3.8	3.9	8.6	5.5	8.1	4.8	2.3	4.6	5.1	2.1	3.2	0.0	0.7	1.6	1.7	0.5	0.6	0.3	0.0	0.6	0.0	3.3	17.2	2.0	0.2	0.2	7.8	1.6	1.7	0.6	11.4	0.2	12.4	2.1	0.3	0.5	0.0	0.5	0.0	0.9	0.5	0.2	0.0	0.0	1.9	3.1	2.9	0.2	0.6	1.4	0.9	0.2	0.0	2.9	6.0	0.6	5.5	0.0	0.0	0.3	0.3	0.5	5.3	1.4	0.0	5.1	1.3	0.0	1.3	1.9	0.4	0.7	1.4	2.8	7.6	0.7	3.6	0.4	1.6	3.1	6.1	3.5	3.2	3.4	8.0	2.8	3.9	5.5	8.6	2.1	4.6	8.1	2.3	4.8	5.2	4.2	5.1	2.8	3.1	3.1	3.3	2.1	2.6	3.2	2.8	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421412	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 3075.8"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 49859.9"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enriched"	"Detected in some"	39	"Hep G2: 315.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000		"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.0	4.9	3075.8	0.1	0.1	0.1	0.1	0.1	38.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.0	0.0	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.1	315.9	0.0	8.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.5	0.0	2.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	683.8	0.0	0.0	0.0	0.1	12066.1	0.0	0.0	36.6	0.0	0.8	61.3	4.3	2.0	0.0	0.0	1612.0	237.4	2.3	0.2	0.1	0.0	49859.9	8.2	0.0	1.7	1417.3	1529.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	261.7	0.0	0.0	442.7	0.0	0.0	0.4	0.2	0.2	0.1	17.7	22.3	0.0	0.0
ALG1	"CDG1K, HMAT1, HMT-1, Mat-1"	ENSG00000033011	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase"	Q9BT22	16	5033960-5087379	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA060392	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: AB_2684273"	"unprognostic (1.66e-2)"	"unprognostic (5.18e-1)"	"prognostic favorable (5.79e-4)"	"unprognostic (1.55e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.58e-3)"	"unprognostic (3.86e-2)"	11.0	22.2	8.7	10.8	12.8	6.6	12.8	9.3	18.8	13.7	16.4	14.9	10.1	14.7	12.1	17.0	11.7	12.4	14.3	8.1	8.8	10.4	18.9	31.6	9.9	12.7	10.5	6.5	10.1	27.9	21.5	13.6	10.7	14.6	10.8	17.2	15.5	20.6	12.0	7.3	9.1	12.8	12.1	9.4	16.2	16.5	19.4	11.4	16.0	15.0	8.7	14.5	12.1	8.7	20.7	24.3	7.8	23.3	20.9	26.5	31.7	6.5	17.8	4.5	8.4	17.2	10.3	8.3	14.7	20.7	19.2	19.3	14.7	24.2	13.9	12.7	18.7	8.0	17.6	12.3	14.5	13.1	11.4	13.9	7.8	14.8	30.3	14.1	13.6	13.7	12.4	11.0	15.1	9.6	7.6	11.4	11.3	9.7	18.2	14.2	17.7	8.7	16.7	17.0	11.9	10.2	16.2	6.2	38.7	12.0	7.1	7.6	7.7	15.7	24.6	8.4	6.3	16.0	11.1	10.9	9.0	8.3	45.5	12.3	13.3	16.0	9.4	7.4	14.6	12.7	3.3	23.3	7.8	26.5	21.6	23.1	19.8	22.9	25.4	24.3	20.7	21.0	23.7	1.5	20.9	21.2	21.2	21.6	31.7	8.7	12.8	9.3	18.8	8.8	10.4	10.5	6.5	14.6	11.4	14.9	6.7	14.0	2.8	2.2	7.1	0.6	12.7	12.0	7.9	7.0	11.8	13.9	3.3	15.9	8.2	4.5	8.4	0.0	24.6	16.8	7.2	3.4	1.1	15.5	19.6	3.2	12.9	9.2	8.2	23.0	8.9	5.9	10.1	6.4	17.7	7.2	18.4	10.5	6.3	8.7	5.0	6.5	1.4	25.9	17.2	1.4	7.1	8.7	18.0	3.5
ALG10	"ALG10A, DIE2, FLJ14751"	ENSG00000139133	"ALG10, alpha-1,2-glucosyltransferase"	Q5BKT4	12	34022281-34029694	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.88e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.29e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.45e-2)"	6.2	7.0	2.7	5.4	5.9	6.9	6.9	4.0	5.5	5.3	4.6	3.8	3.6	3.4	10.3	5.5	6.0	6.2	3.7	4.6	2.6	2.9	4.6	5.7	5.4	6.7	4.1	1.7	7.1	7.8	7.5	6.1	7.2	3.5	5.8	4.1	8.7	9.0	4.4	4.6	5.1	5.0	4.0	3.5	6.1	5.1	8.0	3.6	17.2	6.2	3.0	9.8	5.8	4.8	2.7	1.8	4.5	2.7	2.1	3.8	1.6	4.5	5.4	3.5	5.8	4.2	3.3	12.4	4.4	4.1	4.8	8.6	7.9	11.0	6.9	6.5	2.2	7.1	6.9	6.6	5.6	6.5	11.0	6.3	6.4	5.7	3.1	1.7	9.2	6.7	3.6	3.3	10.1	7.7	2.3	3.2	6.2	9.6	11.7	3.9	6.2	5.9	5.1	13.1	2.7	6.8	5.3	12.7	7.0	2.6	6.8	3.1	2.5	7.7	3.3	5.5	10.5	7.9	2.5	6.8	6.6	9.8	8.8	5.5	6.4	11.5	13.3	4.6	3.7	5.2	0.0	2.7	4.5	1.9	1.2	3.0	2.5	2.6	1.1	1.8	2.7	3.1	3.8	0.4	2.1	1.2	1.8	3.0	1.6	2.7	5.9	4.0	5.5	2.6	2.9	4.1	1.7	3.5	3.6	6.0	0.3	3.0	2.5	1.3	3.5	0.8	2.5	4.0	3.4	5.2	3.9	6.4	1.7	1.9	0.6	2.1	1.0	0.0	3.3	4.7	2.1	0.6	1.1	2.4	2.9	1.6	1.2	0.6	2.7	0.0	1.4	2.1	0.0	4.6	1.9	3.7	2.6	0.0	1.1	1.1	4.1	0.0	1.0	7.5	3.0	2.4	2.6	4.3	1.7	1.4
ALG10B	KCR1	ENSG00000175548	"ALG10B, alpha-1,2-glucosyltransferase"	Q5I7T1	12	38316578-38329728	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (4.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.43e-2)"	"unprognostic (8.58e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	8.2	8.5	4.3	4.9	7.0	6.6	9.1	5.3	7.2	6.1	4.4	5.4	9.5	4.2	8.5	6.7	6.9	6.4	6.0	5.8	5.0	2.7	5.9	6.6	6.5	7.3	6.6	4.8	8.7	9.6	8.7	7.8	11.6	4.3	6.1	4.5	10.5	9.3	9.7	5.8	7.7	6.5	4.6	4.5	7.5	6.4	8.9	5.0	10.5	7.4	5.6	6.6	7.7	6.8	3.6	2.6	2.0	2.0	1.4	4.1	1.2	5.0	4.7	6.2	6.2	3.1	5.8	6.4	4.0	2.1	5.4	4.8	1.7	15.3	7.7	7.0	2.0	4.0	5.3	5.4	4.4	7.8	5.1	6.9	8.1	8.1	3.4	3.4	10.8	5.7	3.2	5.8	7.6	5.6	4.8	3.9	9.8	9.1	4.7	4.5	3.8	7.2	8.6	7.8	0.5	4.7	2.4	13.3	6.1	4.6	6.3	1.8	6.4	7.0	2.4	4.8	6.9	10.7	4.4	3.3	5.7	6.6	5.0	5.0	3.7	9.5	12.3	4.8	7.6	7.1	1.2	1.5	2.0	1.1	2.0	2.2	1.8	1.1	1.8	1.1	3.6	2.2	2.7	0.6	1.4	1.4	2.6	4.1	1.2	4.3	7.0	5.3	7.2	5.0	2.7	6.6	4.8	4.3	5.0	6.0	11.5	0.5	3.5	1.8	12.9	3.0	0.0	6.7	9.1	3.5	31.4	15.2	6.6	3.6	0.2	4.9	1.2	0.0	5.0	8.2	3.5	2.4	1.1	5.9	4.2	9.5	0.0	6.2	1.5	1.5	3.7	1.9	1.7	0.0	2.5	8.9	3.5	2.0	5.3	2.2	12.4	6.5	1.4	8.3	3.4	1.6	6.8	1.3	2.5	2.3
ALG12	"CDG1G, ECM39"	ENSG00000182858	"ALG12, alpha-1,6-mannosyltransferase"	Q9BV10	22	49900229-49918458	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003076, HPA051665"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003076: AB_2666777, HPA051665: AB_2681566"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.39e-3)"	"prognostic favorable (6.09e-4)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.60e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.32e-2)"	9.8	13.3	9.6	11.3	11.2	8.5	9.9	16.0	12.7	10.9	11.7	16.2	15.7	18.0	13.2	11.5	12.1	11.4	11.0	12.0	10.0	5.8	14.1	22.8	10.8	9.2	11.6	7.9	11.8	17.5	14.7	10.6	11.3	10.9	13.5	7.1	12.2	19.4	10.2	8.7	11.5	14.8	7.7	8.9	11.5	14.5	6.5	14.9	12.6	24.5	10.5	12.8	12.1	10.3	7.6	7.8	17.7	9.4	16.1	12.7	7.9	7.0	7.1	7.5	12.5	14.5	6.8	8.4	7.4	6.7	8.8	7.1	11.6	10.2	3.8	6.8	6.6	9.6	12.9	9.2	8.8	4.4	6.0	13.5	3.5	11.9	11.7	16.4	8.7	7.7	10.2	9.1	8.6	12.4	9.7	8.4	8.7	4.3	9.6	4.6	16.1	8.4	7.1	7.2	9.4	6.6	14.2	9.5	10.0	9.2	8.1	5.1	8.4	11.8	22.5	9.2	10.6	9.2	7.8	6.5	9.8	7.5	6.8	5.6	8.5	3.9	5.0	10.9	6.7	9.3	17.7	8.8	7.4	12.4	8.2	12.7	5.3	9.8	12.2	7.7	7.6	8.3	9.3	6.9	16.1	9.4	7.8	12.3	7.9	9.6	11.2	16.0	12.7	10.0	5.8	11.6	7.9	10.9	14.9	8.9	1.9	8.1	9.0	3.7	5.4	1.2	2.5	5.3	7.9	17.4	2.0	17.2	3.3	14.4	4.7	6.9	15.5	0.0	11.7	19.0	7.8	8.8	8.1	11.9	15.8	3.2	6.4	7.4	8.6	3.0	8.1	6.1	10.1	10.8	11.2	3.4	10.1	7.0	7.8	5.5	5.1	0.0	3.3	8.6	9.4	5.3	22.0	12.9	13.7	8.1
ALG1L2		ENSG00000251287	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like 2"	C9J202	3	130081831-130113227	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 4.0;lymphoid tissue: 3.5"	"Cell type enhanced"	"Detected in some"	5	"Basal glandular cells: 4.9;Cone photoreceptor cells: 3.9;Horizontal cells: 4.8;Muller glia cells: 4.8"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	4	"plasmacytoid DC: 4.0"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 4.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.6;HDLM-2: 1.9;HEL: 1.8;Karpas-707: 1.4;REH: 2.9"									HPA060392	Uncertain		Uncertain	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: AB_2684273"	"unprognostic (1.05e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.44e-3)"	"unprognostic (8.15e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.38e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.28e-3)"	0.0	0.0		0.8		1.2	0.0		0.0	0.0	0.0			0.8	0.0	0.0	0.3	0.3	0.0	0.0			0.0	0.0	0.0	0.0			0.2	0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0	0.9	0.0	0.0		3.5	0.3	0.0			0.0		0.0	0.1		0.7	4.0	0.0	0.3	0.0	0.9	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	1.4	0.0	0.0	0.0	0.5	0.1	0.9	0.0	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.6	0.3	0.3	0.4	0.1	0.0	0.0	0.0	4.0	0.9	0.1											0.0	1.6	0.8	4.9	0.0	1.9	0.2	0.0	1.4	1.2	1.8	3.9	0.2	1.7	0.0	0.4	0.0	0.9	0.0	0.0	0.2	0.6	1.8	0.0	0.2	0.2	4.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	4.8	0.0	0.0	2.5	0.3	3.0	0.0	0.1	0.5	0.1	0.0	0.0	0.5	0.6	1.4
ALG6		ENSG00000088035	"ALG6, alpha-1,3-glucosyltransferase"	Q9Y672	1	63367590-63438562	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062536, HPA076130"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA062536: AB_2684792, HPA076130: "	"unprognostic (1.21e-1)"	"unprognostic (5.60e-3)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (2.07e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (1.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.41e-1)"	9.7	13.7	9.3	13.5	13.5	8.8	11.6	12.2	12.6	9.9	11.8	10.1	9.0	12.1	11.0	14.3	16.7	9.6	9.1	9.9	11.2	7.1	10.3	14.6	10.0	13.4	8.2	11.1	10.8	11.5	10.6	10.0	14.1	11.6	8.9	14.0	10.2	12.9	11.9	8.0	13.7	13.5	7.5	10.5	14.5	10.0	6.9	8.7	25.9	9.7	8.5	21.7	10.0	11.6	7.5	7.9	24.2	7.4	7.4	10.6	5.6	5.3	4.8	8.5	7.7	10.2	8.8	11.2	6.3	2.2	3.3	3.8	5.6	5.4	13.9	15.2	5.2	14.6	10.3	12.4	10.1	6.0	15.6	9.8	10.7	5.5	4.6	5.0	12.7	9.3	7.3	6.1	8.1	3.0	6.1	12.5	14.2	11.3	11.2	7.7	7.0	12.2	10.7	26.0	14.6	7.2	12.5	12.0	16.4	9.5	7.4	7.9	4.3	16.8	17.5	16.5	16.3	9.7	7.2	6.8	5.5	5.5	11.6	8.1	9.5	13.3	11.5	5.3	12.7	18.4	24.2	7.4	13.6	8.8	6.6	10.6	7.5	7.2	8.5	7.9	5.6	8.7	9.1	4.3	7.4	6.4	6.5	9.4	5.6	9.3	13.5	12.2	12.6	11.2	7.1	8.2	11.1	11.6	8.7	8.9	3.7	7.5	8.0	9.7	5.6	2.8	10.2	4.0	7.9	3.5	3.9	39.5	1.7	10.5	1.9	5.8	5.8	0.0	7.8	23.6	8.2	5.4	9.2	9.2	13.7	6.4	4.1	8.0	5.9	1.7	6.4	7.5	15.1	0.0	7.8	4.9	6.5	0.0	4.6	5.9	5.1	6.5	5.1	12.1	15.9	9.7	22.4	13.8	9.3	6.4
ALG9	DIBD1	ENSG00000086848	"ALG9, alpha-1,2-mannosyltransferase"	Q9H6U8	11	111782195-111871581	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038575	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038575: AB_10672718"	"unprognostic (1.48e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.34e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.07e-3)"	"unprognostic (5.11e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (9.15e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.10e-2)"	19.9	13.5	11.8	11.4	17.9	9.0	16.8	19.3	19.3	16.9	13.7	15.6	15.7	16.2	19.1	15.7	13.8	12.5	14.0	14.3	11.6	13.7	13.7	17.7	12.3	13.5	12.2	11.2	19.2	29.9	21.0	16.5	20.3	14.6	14.7	14.9	17.5	34.3	20.1	11.7	17.3	13.2	15.8	13.2	13.0	14.1	25.0	9.8	15.3	17.4	10.9	15.2	13.8	14.2	7.8	9.5	7.0	7.9	7.1	12.2	6.5	9.9	10.1	19.8	19.4	12.3	11.8	15.0	13.0	10.6	10.8	11.7	17.2	17.0	16.1	18.5	14.6	13.6	18.7	10.3	15.7	15.2	12.4	8.1	12.2	5.9	12.6	14.3	13.7	8.5	10.2	10.6	11.2	11.1	15.5	10.3	12.5	12.2	25.2	17.6	7.3	13.7	12.2	6.5	13.9	11.2	12.6	17.6	31.3	11.8	8.9	9.7	16.7	11.4	17.5	7.0	14.4	18.9	5.6	10.2	22.7	16.0	11.0	14.0	8.2	6.1	15.1	9.4	17.1	15.3	6.7	5.8	7.0	8.5	7.9	9.4	7.8	8.0	8.8	9.5	6.6	12.2	7.3	2.3	7.1	6.9	9.4	7.7	6.5	11.8	17.9	19.3	19.3	11.6	13.7	12.2	11.2	14.6	9.8	0.0	4.1	2.9	1.2	1.8	9.4	5.0	2.5	1.4	4.5	7.0	7.9	3.0	3.3	6.3	4.3	2.1	3.2	0.0	6.1	11.4	2.8	1.2	0.0	5.8	2.7	14.3	4.1	2.5	1.2	3.5	4.4	2.3	0.0	3.6	3.4	5.4	5.9	3.5	3.5	2.2	10.3	6.5	4.1	3.7	5.5	1.4	7.6	2.5	3.9	0.6
ALKBH1	"ABH, alkB, ALKBH, hABH"	ENSG00000100601	"AlkB homolog 1, histone H2A dioxygenase"	Q13686	14	77672404-77708020	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, RNA repair, Translation regulation"	"Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044087, HPA060061"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Endoplasmic reticulum"	"HPA044087: AB_2678803, HPA060061: "	"unprognostic (1.92e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.45e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.65e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.44e-2)"	8.2	8.5	6.2	6.7	8.6	2.7	9.7	9.6	8.8	9.7	9.1	8.2	4.5	6.5	7.0	5.9	7.1	8.0	5.8	11.1	5.4	5.7	7.9	9.4	5.9	8.3	6.5	3.7	8.3	7.9	8.4	11.2	10.2	6.4	9.3	9.1	9.9	7.2	8.7	16.5	8.2	6.7	7.8	5.5	8.3	7.8	9.9	6.6	12.7	8.8	6.5	10.3	8.5	9.4	5.4	4.9	11.4	5.7	5.2	5.3	3.2	5.3	8.0	6.5	4.4	7.0	7.7	8.2	5.6	7.3	12.4	14.0	8.1	3.3	8.3	3.2	5.1	5.8	4.9	14.2	6.1	14.7	5.6	5.6	4.4	4.7	6.8	9.9	4.6	2.9	6.5	10.1	7.3	11.6	5.5	10.1	6.5	6.8	4.8	6.6	8.5	6.2	6.0	7.2	8.1	10.3	6.2	6.6	5.5	7.1	4.8	8.4	6.3	4.6	4.8	6.1	5.6	11.8	4.8	4.6	5.2	5.3	5.7	4.5	6.0	9.5	8.1	3.5	6.7	5.1	11.4	5.0	2.2	5.0	5.7	4.3	5.4	4.7	5.0	4.9	4.9	5.0	3.9	1.4	5.2	3.8	2.6	5.3	3.2	6.2	8.6	9.6	8.8	5.4	5.7	6.5	3.7	6.4	6.6	0.0	4.6	3.7	4.9	7.4	4.0	6.5	0.0	5.3	3.4	1.8	2.0	8.9	8.3	5.3	3.3	4.1	4.2	0.0	6.1	6.7	6.0	3.8	9.2	3.0	6.5	0.0	2.4	3.1	4.6	3.1	6.1	5.6	5.0	5.4	4.6	7.3	5.7	0.0	4.9	5.1	4.9	6.5	5.2	15.8	14.9	4.6	10.2	4.4	4.2	3.0
AMFR	"gp78, RNF45"	ENSG00000159461	"Autocrine motility factor receptor"	Q9UKV5	16	56361452-56425538	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 124.0;Hepatocytes: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026381, HPA029018, HPA077835"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"		"CAB026381: , HPA029018: AB_2672869, HPA077835: AB_2686856"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.16e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.28e-1)"	13.9	25.9	21.3	10.6	23.8	14.1	28.7	12.6	25.0	17.2	21.0	24.5	18.5	21.6	16.6	25.2	20.8	15.3	13.7	17.6	20.6	20.2	35.2	50.0	13.3	19.3	22.3	14.3	20.5	14.0	33.3	13.0	41.6	18.9	14.9	11.8	23.8	12.6	18.6	71.6	11.9	18.8	16.0	25.0	14.3	12.2	36.8	17.5	14.6	18.6	10.1	19.3	15.5	16.9	18.3	10.6	21.4	13.1	11.7	9.7	4.0	17.7	24.8	10.8	19.9	33.9	19.1	9.5	19.2	23.8	26.1	20.5	22.0	16.9	46.3	22.2	25.9	15.4	16.6	16.6	14.9	24.9	10.3	17.0	14.0	10.2	23.6	29.7	10.8	16.2	22.1	21.7	20.8	24.9	18.5	15.2	13.6	14.5	6.4	18.9	11.2	16.2	11.6	5.1	9.2	17.0	18.4	21.9	17.4	16.1	18.6	10.9	8.3	45.1	15.8	14.5	11.1	47.6	11.4	19.6	24.6	13.5	12.4	12.9	13.8	12.1	24.6	17.9	7.9	11.2	21.4	8.5	10.9	6.9	9.9	9.7	18.3	8.7	7.1	7.8	15.6	9.1	9.5	10.5	11.7	13.1	10.6	9.0	4.0	21.3	23.8	12.6	25.0	20.6	20.2	22.3	14.3	18.9	17.5	8.9	7.0	28.6	15.3	22.9	17.3	18.2	30.6	1.4	9.1	94.2	37.3	20.9	21.6	18.1	124.0	20.4	37.5	0.0	37.1	5.8	28.2	27.6	8.1	146.0	15.4	30.2	23.8	39.3	62.3	81.3	38.0	22.3	28.7	15.4	25.9	45.2	27.4	21.0	32.2	42.8	41.0	12.9	26.9	32.0	10.8	18.2	20.4	15.2	19.8	17.2
ANKLE2	"KIAA0692, Lem4, LEMD7"	ENSG00000176915	"Ankyrin repeat and LEM domain containing 2"	Q86XL3	12	132725503-132761888	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 154.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003602, HPA074838"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Endoplasmic reticulum, Plasma membrane"		"HPA003602: AB_1858349, HPA074838: "	"unprognostic (4.43e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (3.97e-6)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (6.10e-2)"	"prognostic unfavorable (1.90e-8)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.92e-3)"	"unprognostic (2.09e-1)"	20.1	26.4	14.9	21.3	17.6	27.2	21.8	23.3	20.4	15.6	15.4	19.6	15.1	14.6	18.9	16.8	23.7	18.6	17.0	16.5	12.4	10.7	16.3	16.3	21.6	24.1	16.0	11.3	20.7	18.1	17.2	22.3	18.3	15.2	17.2	13.9	16.7	19.1	15.7	19.9	27.3	22.8	18.5	13.4	27.4	16.8	43.7	14.1	31.4	17.4	15.8	27.9	16.4	28.6	4.8	3.3	7.7	2.2	4.7	5.5	1.4	19.7	18.5	19.4	12.0	11.3	17.8	24.3	24.2	18.1	24.3	18.7	21.1	13.6	15.6	12.7	21.2	16.3	23.9	16.9	22.1	23.3	6.6	21.0	19.8	31.1	9.9	12.6	21.2	14.0	16.5	22.6	23.1	17.2	45.1	17.3	12.9	17.8	6.1	24.8	14.2	19.8	35.2	16.4	9.8	17.8	22.8	12.7	6.5	17.5	25.9	23.9	14.7	31.2	13.2	10.6	19.0	23.2	15.4	24.7	29.3	21.1	15.5	26.9	11.5	11.3	19.1	22.7	14.2	16.4	1.4	2.2	7.7	3.6	2.1	4.8	4.8	5.3	5.5	3.3	4.3	5.0	4.1	1.3	4.7	2.2	3.2	4.7	1.4	14.9	17.6	23.3	20.4	12.4	10.7	16.0	11.3	15.2	14.1	68.5	24.5	25.4	82.7	59.8	30.8	22.9	28.1	20.1	55.7	29.6	43.2	25.0	1.7	29.1	63.9	32.7	20.2	0.0	28.1	29.6	26.8	92.4	18.4	12.1	17.7	30.2	20.0	19.0	15.1	14.0	23.3	33.1	32.1	42.3	16.9	24.7	66.6	20.9	26.5	6.4	38.7	25.8	34.8	131.6	52.4	63.7	30.6	37.3	18.6	154.8
ANKRD16	DKFZP434N1511	ENSG00000134461	"Ankyrin repeat domain 16"	Q6P6B7	10	5861617-5889906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037920, HPA037921"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA037920: AB_10671381, HPA037921: AB_2675740"	"unprognostic (1.90e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (1.06e-2)"	"unprognostic (7.64e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.93e-2)"	6.2	7.2	9.8	7.1	13.9	3.9	8.4	12.9	16.6	10.9	7.3	10.0	7.9	7.3	12.7	11.6	6.3	13.6	10.8	5.7	8.6	7.7	6.2	7.3	4.9	6.5	7.8	7.8	14.7	12.6	10.0	7.2	4.0	8.0	8.4	6.0	9.3	8.3	7.7	6.6	14.8	5.3	9.3	6.3	6.3	10.0	13.6	11.2	7.3	7.1	5.4	7.2	7.7	7.7	2.6	2.7	1.4	1.1	2.1	2.2	0.8	7.5	9.1	4.2	8.7	4.5	3.3	6.3	2.3	1.8	4.2	3.7	11.1	4.0	8.1	3.3	3.9	1.6	7.9	5.2	6.0	1.9	2.8	8.0	5.0	4.2	10.1	5.7	3.1	3.6	5.1	4.6	3.8	3.0	3.4	4.6	8.5	6.7	2.5	2.9	10.4	11.4	5.3	3.5	10.2	6.5	8.7	2.8	16.3	4.7	4.9	2.6	5.7	4.8	6.0	5.3	3.6	8.4	6.3	2.9	2.5	3.2	5.5	3.2	13.9	6.3	5.3	5.2	3.0	2.7	1.4	1.1	0.3	0.9	0.5	0.8	2.0	0.7	1.3	1.3	2.6	2.2	0.9	1.1	2.1	0.8	2.7	1.2	0.8	9.8	13.9	12.9	16.6	8.6	7.7	7.8	7.8	8.0	11.2	3.0	2.2	0.8	6.0	4.1	13.2	2.0	10.2	0.0	2.3	3.5	5.9	3.9	11.6	1.8	6.8	2.7	4.0	0.0	1.9	2.6	5.1	4.5	0.0	3.4	2.8	25.4	4.1	2.5	0.6	11.0	5.2	1.6	3.3	4.6	2.0	7.0	0.8	0.0	3.5	6.7	13.5	0.0	3.1	8.9	8.0	5.0	1.3	1.5	5.4	3.2
AP001781.2		ENSG00000258529			11	111786286-111879425	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 6.0;HeLa: 4.7;U-698: 4.5"									HPA038575	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038575: AB_10672718"																		2.2	0.2	1.7	2.8	2.2	2.9	2.5	0.4	2.7	0.4	3.6	1.9	1.0	2.9	2.0	2.1	0.9	0.9	2.0	0.9	3.0		1.2	0.7	2.6	4.1	1.3	1.1	1.5	1.2	1.7	0.4	0.4	2.2	1.2	2.5	1.5	2.8	0.2	1.2	4.1	0.6	1.3	2.2	3.6	2.1	5.6	1.5	5.7	1.3	0.7	3.7	0.2	0.0	1.6	2.0	1.3	1.6	1.7	3.6	2.9	0.3	0.1	1.3	1.3	0.0	1.8	0.4	1.8	0.1	0.3	0.0	6.0	0.0	0.2	0.9	0.0	1.6	2.3	0.0	0.0	1.3	0.5	0.0	3.4	4.7	0.4	0.0	0.0	0.8	2.5	2.2	1.7	3.4	1.0	0.0	2.0	0.3	2.2	0.0	0.0	1.3	2.6	0.5	0.0	0.0	0.0	0.0	1.7	1.0	1.9	0.0	0.0	1.7	0.0	0.0	0.0	1.2	1.3	0.2	2.4	0.7	1.2	0.0	1.7	1.3	4.5	0.7	3.1	0.4	1.0	1.0	1.3	3.3	1.6	2.2	1.4	2.6	2.1	1.6	1.6	3.6	1.5	0.1	1.7	1.3	2.0	0.9	2.9											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARHGAP5	"GFI2, p190-B, p190BRhoGAP, RhoGAP5"	ENSG00000100852	"Rho GTPase activating protein 5"	Q13017	14	32076114-32159728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 267.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046993, HPA056507"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA046993: AB_2679895, HPA056507: AB_2683158"	"unprognostic (1.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.97e-8)"	"unprognostic (9.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.00e-2)"	11.3	13.1	29.8	8.4	26.1	4.0	13.0	39.1	29.2	14.2	14.6	11.5	7.9	16.0	13.2	11.9	31.5	11.1	15.3	28.0	29.5	19.6	20.8	14.5	12.8	5.9	26.8	23.4	23.3	13.5	21.8	27.6	16.9	24.2	14.7	12.3	9.2	26.0	14.5	11.5	14.0	17.3	13.4	26.6	18.7	13.3	20.4	30.6	8.8	32.5	7.7	8.0	15.6	25.8	7.3	9.0	1.5	1.8	6.8	7.4	2.3	19.0	15.5	15.5	22.7	20.4	14.3	8.9	11.9	14.7	7.2	10.9	19.7	18.7	5.6	10.6	15.0	12.2	20.3	14.7	12.8	14.2	5.6	8.6	8.5	9.6	28.8	13.9	5.1	5.1	15.9	26.0	6.8	25.5	17.9	8.8	10.7	7.5	16.8	11.7	10.0	11.2	0.2	7.7	21.2	18.7	12.2	19.0	1.1	15.9	50.9	24.0	9.4	31.9	17.2	24.1	18.0	17.8	0.3	14.2	13.4	20.3	11.1	8.7	6.4	12.5	0.8	6.8	5.5	36.6	1.5	1.8	0.0	4.0	0.8	4.8	7.3	7.0	3.7	6.1	7.1	7.4	4.3	0.6	6.8	1.3	9.0	5.7	2.3	29.8	26.1	39.1	29.2	29.5	19.6	26.8	23.4	24.2	30.6	178.6	60.0	8.7	112.0	83.7	78.5	267.9	53.5	62.9	76.2	55.8	108.0	20.8	46.4	45.5	30.6	29.2	76.6	46.7	40.4	10.4	47.7	94.2	4.7	45.6	15.8	62.0	59.4	36.8	15.2	47.7	96.7	33.3	64.1	19.8	49.4	93.1	55.1	77.2	94.4	48.0	87.6	58.2	56.6	94.1	58.3	61.5	11.2	20.3	44.5	133.8
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901300-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.6"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 860.1;Smooth muscle cells: 627.3;Syncytiotrophoblasts: 769.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	43.3	5.6	7.8	13.8	9.9	4.2	22.6	3.3	11.5	27.5	14.0	9.5	4.4	6.8	29.4	10.4	14.0	15.6	27.2	16.0	5.9	5.1	14.6	5.7	14.6	14.4	11.8	6.5	18.6	4.3	14.7	11.4	22.4	9.4	16.6	8.2	6.9	14.5	7.3	88.6	15.0	12.1	29.4	10.4	12.7	9.4	7.7	10.5	8.6	7.5	11.7	18.0	22.5	17.1	21.2	1.0	4.3	3.6	5.7	14.7	2.6	0.8	0.3	2.3	5.9	5.2	14.0	0.4	16.9	45.7	12.1	9.5	20.5	0.9	1.4	4.1	16.2	1.7	5.6	8.1	2.5	14.6	5.3	2.4	0.8	4.1	5.1	9.7	0.2	10.1	17.6	1.3	7.1	8.1	10.4	1.4	2.9	0.7	2.3	3.9	2.9	5.5	0.4	0.4	3.9	5.4	6.7	3.9	0.4	7.9	9.2	1.3	1.7	7.5	4.1	4.9	5.5	3.5	0.2	1.3	6.7	9.1	10.1	4.2	0.1	0.0	4.4	5.8	0.3	2.1	4.3	0.6	0.4	7.3	1.4	0.9	19.0	10.5	6.3	1.0	21.2	6.9	4.5	1.2	5.7	3.6	0.5	14.7	2.6	7.8	9.9	3.3	11.5	5.9	5.1	11.8	6.5	9.4	10.5	122.1	57.7	77.2	286.1	860.1	43.7	59.7	12.7	50.9	120.6	48.8	0.0	138.5	84.6	43.9	23.9	62.4	4.7	23.3	12.8	104.6	292.5	224.3	23.2	5.1	46.6	69.9	34.9	106.8	33.2	10.0	140.4	39.6	131.6	60.5	13.2	19.3	30.6	20.9	57.0	145.5	2.8	129.4	627.3	5.7	0.5	417.5	769.7	77.6	30.2	122.9
ARL6IP1	"AIP1, ARL6IP, ARMER, KIAA0069, SPG61"	ENSG00000170540	"ADP ribosylation factor like GTPase 6 interacting protein 1"	Q15041	16	18791667-18801678	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA045307	Uncertain		Approved	"Endoplasmic reticulum"		NA	Yes			"Endoplasmic reticulum"		"HPA045307: AB_10961042"	"unprognostic (2.42e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (6.32e-3)"	"unprognostic (5.36e-3)"	29.6	40.9	75.9	16.5	62.0	40.2	26.2	76.5	93.0	19.5	31.5	28.6	13.8	31.4	16.7	29.7	19.8	20.5	30.2	8.8	65.7	70.1	35.1	80.7	18.0	27.0	65.2	44.6	24.7	18.6	45.1	13.4	20.3	68.6	18.1	29.0	40.9	18.6	17.4	8.3	14.8	27.5	16.0	43.0	20.4	27.8	28.1	20.4	33.1	26.2	11.3	24.9	27.8	14.2	41.2	57.2	40.1	32.4	44.1	67.7	63.0	48.3	44.2	58.8	45.9	21.1	13.6	52.6	28.3	27.3	44.0	35.2	27.1	117.2	42.3	51.9	27.1	29.6	53.1	42.1	19.9	51.2	54.1	19.0	30.0	27.3	73.7	16.8	42.4	32.1	11.3	19.4	30.4	31.9	32.6	43.9	25.0	32.7	44.1	84.6	43.8	29.8	32.1	72.2	42.4	15.1	50.8	73.8	35.9	47.2	27.3	35.8	40.7	62.2	39.0	27.9	41.4	80.0	42.9	24.2	28.9	27.2	20.5	50.5	15.0	26.6	51.0	25.8	29.0	55.8	40.1	32.4	20.9	48.7	30.0	44.7	41.2	43.2	52.4	32.0	38.3	38.5	45.8	27.7	44.1	30.9	57.2	67.7	63.0	75.9	62.0	76.5	93.0	65.7	70.1	65.2	44.6	68.6	20.4	62.5	47.7	99.8	227.5	331.0	171.8	27.4	341.4	91.0	61.4	272.2	123.7	218.9	147.6	292.3	62.1	144.0	214.0	677.5	180.9	329.7	163.0	191.1	134.8	383.9	223.1	84.2	140.0	177.4	230.1	29.6	78.6	248.9	190.6	385.9	155.5	189.5	210.1	217.5	104.3	161.1	161.3	90.5	101.1	73.5	56.8	285.4	273.1	186.2	246.9	307.2
ARL6IP5	"DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b"	ENSG00000144746	"ADP ribosylation factor like GTPase 6 interacting protein 5"	O75915	3	69084944-69106066	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015540, CAB019321"	Supported		Approved	"Endoplasmic reticulum"		NA	NA		19000000	"Endoplasmic reticulum"		"CAB019321: , HPA015540: AB_1852061"	"unprognostic (8.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.60e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.31e-2)"	53.2	53.2	44.0	37.4	48.5	21.3	51.5	32.9	62.1	48.1	31.9	41.5	16.8	21.1	33.8	40.0	38.5	34.5	37.3	76.0	42.9	51.0	43.3	28.4	44.9	43.7	53.1	30.7	28.9	23.3	18.3	36.3	50.6	81.7	49.2	31.8	32.1	54.9	35.6	69.3	18.5	30.3	37.0	51.6	40.7	27.9	21.4	46.1	32.5	39.9	32.7	45.2	46.9	30.2	57.3	40.4	91.5	57.5	41.4	74.8	114.8	15.2	10.6	13.1	9.6	68.3	64.0	16.6	15.8	35.8	12.3	14.5	5.3	37.4	3.0	5.3	27.1	23.1	12.2	10.7	18.2	10.6	59.8	10.0	10.5	18.0	8.1	17.6	8.9	52.1	46.0	32.9	11.3	14.4	43.7	37.6	10.1	4.6	28.7	29.8	8.8	9.7	11.8	3.4	35.6	10.0	8.6	12.0	28.0	60.7	25.7	3.3	8.7	15.7	17.1	20.6	13.5	11.3	14.3	36.7	8.2	6.5	20.7	17.1	25.8	36.1	5.6	27.2	22.4	13.2	81.4	57.5	91.5	52.3	51.4	40.1	57.3	73.9	66.5	40.4	43.9	63.1	66.2	24.0	41.4	43.0	25.6	74.8	114.8	44.0	48.5	32.9	62.1	42.9	51.0	53.1	30.7	81.7	46.1	163.8	103.0	121.2	73.7	64.7	192.5	338.6	84.1	117.8	116.0	89.0	176.7	275.4	21.6	231.6	8.1	130.0	85.8	70.0	188.9	320.0	170.5	132.5	322.8	62.5	267.8	116.0	40.4	118.4	223.5	12.7	191.8	306.3	258.1	527.6	54.0	207.9	194.4	84.2	246.1	66.8	224.8	187.5	100.4	8.1	2.5	64.5	149.2	256.0	66.9	73.3
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 154.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 660.0"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 36.9;myeloid DC: 21.7"	"Group enriched"	"Detected in many"	52	"dendritic cells: 21.7;monocytes: 36.9"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 107.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA		4700000	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	0.2	0.0	0.3	1.4	0.1	1.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.1	0.1	3.4	0.2	0.2	0.0	0.2	154.1	0.5	4.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.9	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	21.7	0.5	36.9	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	36.9	0.2	0.0	3.8	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	9.5	0.3	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.0	9.0	14.0	0.0	0.0	0.0	0.0	152.8	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.3	0.0	0.0	23.3	0.0	0.1	0.0	0.1	2.3	660.0	6.9	0.0	6.8	16.0	35.5	0.4	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.5	0.0	0.0
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 462.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		900000	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	104.6	60.4	27.3	15.0	29.5	4.8	84.3	35.2	31.3	22.3	23.8	10.6	18.3	14.0	16.8	17.8	22.4	16.5	19.1	33.9	26.1	22.4	19.0	23.0	22.5	10.9	21.1	22.2	20.5	13.8	12.5	15.7	14.7	20.5	17.3	26.8	23.6	28.8	23.4	103.1	12.0	13.9	26.1	16.7	12.8	30.5	6.4	19.6	2.9	31.7	36.0	13.7	30.0	25.4	3.3	21.0	15.9	5.2	4.9	3.4	2.3	49.9	72.6	10.2	6.2	45.7	43.5	3.5	89.7	83.3	38.4	40.3	12.4	66.6	3.8	6.2	52.5	30.9	18.7	6.3	31.3	65.7	1.4	6.4	8.9	44.1	33.9	29.3	1.3	1.4	35.7	7.0	21.3	27.3	75.4	16.2	2.0	2.4	3.6	33.8	10.6	0.3	1.8	5.8	48.4	42.8	2.4	11.0	0.8	23.4	41.4	10.6	3.6	27.8	13.1	11.1	5.8	5.3	2.4	50.8	38.9	20.0	35.5	31.6	2.3	2.9	0.1	102.4	0.8	26.0	1.1	5.2	0.1	1.6	1.9	3.1	3.3	2.3	1.6	6.1	3.3	3.4	1.6	15.9	4.9	1.0	21.0	2.3	2.3	27.3	29.5	35.2	31.3	26.1	22.4	21.1	22.2	20.5	19.6	181.7	183.4	8.3	108.3	41.8	126.7	192.2	22.9	57.6	137.6	82.0	276.9	97.4	13.3	97.2	1.6	71.6	39.8	0.0	158.3	85.9	64.5	113.1	8.1	51.6	62.4	120.8	111.8	38.6	25.4	0.5	65.6	43.4	40.5	13.6	178.8	462.0	186.9	24.6	54.1	31.9	150.0	45.3	73.9	2.6	16.8	44.0	40.2	10.0	58.7	212.3
ASTE1	HT001	ENSG00000034533	"Asteroid homolog 1"	Q2TB18	3	131013875-131027649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037010, HPA037011"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA037010: AB_10673629, HPA037011: AB_10696929"	"unprognostic (7.42e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (2.27e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-2)"	10.1	9.2	6.8	11.7	9.5	10.2	10.3	9.3	9.4	11.9	14.3	13.1	7.1	10.4	12.4	11.4	7.7	9.3	9.4	6.1	8.5	7.1	7.2	10.9	7.4	11.9	11.3	9.7	11.1	12.9	10.7	14.0	8.0	8.8	7.9	10.8	8.2	7.2	8.2	4.9	7.4	16.6	8.9	9.7	12.0	8.7	12.1	8.0	17.7	12.9	6.9	13.8	8.3	7.8	9.8	9.1	25.1	12.1	17.6	19.9	7.0	10.2	7.4	4.9	5.0	8.8	9.3	2.2	5.8	5.1	7.1	7.3	12.2	4.3	11.3	8.9	5.6	6.0	11.4	9.7	4.8	10.7	6.1	5.8	6.7	4.0	5.6	8.9	10.4	4.0	6.1	6.6	5.7	5.4	6.1	5.9	9.5	5.8	5.8	7.3	7.0	9.0	5.3	4.5	12.2	7.5	9.8	6.9	9.9	5.8	6.4	8.4	7.7	10.9	2.6	7.9	5.0	6.7	7.2	4.1	8.0	5.4	13.3	4.6	7.4	6.5	15.2	6.2	9.0	4.0	25.1	8.4	16.9	13.8	9.5	14.5	9.6	15.2	12.0	9.1	9.8	19.9	14.5	6.1	17.6	12.1	6.6	16.7	7.0	6.8	9.5	9.3	9.4	8.5	7.1	11.3	9.7	8.8	8.0	11.9	4.3	4.2	3.5	2.9	9.1	1.7	2.5	1.4	7.9	3.5	13.7	5.1	5.0	4.4	25.5	5.8	9.3	0.0	5.1	4.2	3.7	2.4	8.1	4.4	4.2	3.2	6.4	5.5	2.2	9.3	6.6	5.9	1.7	2.8	4.7	6.9	2.8	5.8	4.6	3.7	12.7	0.0	5.1	1.8	5.1	1.3	3.3	11.5	6.6	2.5
ATL2	ARL6IP2	ENSG00000119787	"Atlastin GTPase 2"	Q8NHH9	2	38294880-38377285	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029108, HPA075302"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029108: AB_10670557, HPA075302: AB_2732289"	"unprognostic (5.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.86e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.84e-1)"	11.9	19.1	14.2	15.2	28.0	15.7	23.4	29.4	17.1	18.2	31.0	7.2	12.3	19.0	21.8	12.3	25.8	18.3	15.5	11.5	12.9	7.9	16.6	25.0	15.0	9.9	10.2	15.9	24.2	14.3	8.8	15.6	10.1	9.8	19.6	15.5	14.0	29.2	19.5	32.8	29.7	23.7	35.3	8.3	13.8	22.9	9.9	12.1	17.9	32.2	24.8	19.0	28.5	20.7	5.4	3.8	13.0	3.8	3.5	6.0	3.5	34.0	17.4	20.6	15.1	19.0	12.2	26.3	12.6	11.1	15.4	15.3	19.7	26.5	28.9	14.2	8.0	18.5	40.9	25.5	12.6	23.7	29.2	22.2	16.9	12.3	27.1	10.7	20.8	15.5	8.6	30.2	13.6	19.4	9.1	14.1	9.5	28.3	15.1	11.9	12.5	21.9	19.3	29.2	36.5	11.9	19.5	23.9	17.6	11.8	18.7	10.7	18.7	15.4	16.6	15.3	17.2	8.8	12.1	8.8	15.2	21.3	14.4	23.9	20.7	18.3	32.3	9.7	20.6	18.3	1.3	3.3	13.0	3.3	2.9	4.7	4.1	4.3	3.5	3.8	5.4	6.0	4.9	4.4	3.5	3.8	2.8	4.6	3.5	14.2	28.0	29.4	17.1	12.9	7.9	10.2	15.9	9.8	12.1	11.9	23.0	18.6	28.2	32.6	19.7	6.7	12.7	14.7	34.2	7.0	13.7	13.6	6.6	8.9	19.2	15.5	11.8	0.0	4.3	12.2	12.2	21.6	4.6	28.0	9.3	20.6	6.3	12.9	7.0	16.1	13.3	7.4	11.8	5.4	11.5	9.5	4.6	10.5	15.6	10.2	18.8	32.3	14.4	17.0	19.0	40.9	12.2	10.0	12.7	29.4
ATL3	DKFZP564J0863	ENSG00000184743	"Atlastin GTPase 3"	Q6DD88	11	63624087-63671921	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 242.0;Late spermatids: 574.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065702, HPA076616"			Enhanced	"Endoplasmic reticulum"		NA	NA		1600000	"Endoplasmic reticulum"		"HPA065702: AB_2685536, HPA076616: AB_2732318"	"unprognostic (4.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (4.52e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-3)"	40.3	17.7	7.9	11.8	10.4	8.2	28.3	5.6	7.4	20.9	15.0	12.4	14.0	6.7	22.5	15.7	23.4	14.5	15.1	9.7	7.0	5.0	15.0	23.6	15.9	24.7	10.9	5.4	22.3	18.4	12.9	8.8	11.8	9.8	17.9	11.7	14.0	17.5	15.4	7.6	20.3	11.0	35.6	12.8	12.0	14.1	43.3	10.7	11.0	18.9	14.2	13.0	32.2	22.3	6.2	9.6	6.6	13.7	7.4	11.8	8.1	13.3	12.9	3.6	8.9	19.3	26.3	0.0	15.9	18.9	16.0	11.0	10.3	21.0	7.8	16.5	27.4	12.3	8.6	6.8	10.7	23.1	11.6	1.8	7.9	14.5	0.0	12.7	15.6	12.0	16.7	18.0	20.5	13.4	10.7	17.2	9.1	8.8	21.9	18.5	14.5	5.7	9.8	4.6	4.4	10.2	12.3	9.1	11.7	13.3	9.6	2.0	5.5	47.6	11.4	15.3	5.0	21.0	6.0	23.7	33.7	16.1	32.9	11.1	6.2	8.5	15.8	18.1	10.5	20.4	6.6	9.1	4.0	10.8	12.4	11.8	6.2	9.0	8.7	9.6	5.2	7.5	10.1	3.9	7.4	13.7	4.8	9.9	8.1	7.9	10.4	5.6	7.4	7.0	5.0	10.9	5.4	9.8	10.7	41.7	22.7	18.0	39.1	38.8	4.3	7.8	30.6	13.4	21.6	31.4	0.0	5.8	1.7	37.0	242.0	45.4	28.8	23.3	43.5	16.5	29.6	47.3	16.2	46.1	35.2	4.8	10.3	47.9	54.0	574.9	50.3	34.8	40.5	40.5	18.4	12.4	59.3	22.9	63.3	18.2	7.0	71.1	60.4	25.8	27.3	35.5	3.3	23.5	15.9	44.8
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904509	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"skeletal muscle: 456.3;tongue: 209.0"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 13.7;Late spermatids: 2.9;Rod photoreceptor cells: 4.6;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 19.8"	"Region enriched"	"Detected in single"	8	"thalamus: 14.3"	"Not detected"	"Not detected"			"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	7.6	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	1.1	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.6	0.1	12.6	7.0	0.3	456.3	0.2	0.2	0.1	0.1	0.1	0.1	0.9	0.0	0.0	4.2	209.0	6.5	0.2	0.1	1.6	3.1	0.7	0.2	4.7	1.5	0.6	4.8	5.2	9.6	5.8	0.4	1.6	8.9	2.3	1.3	0.4	0.4	2.9	4.4	7.6	2.7	0.4	3.2	5.1	2.4	0.1	0.7	3.8	19.8	2.7	11.8	9.0	0.2	1.1	2.6	4.1	1.1	0.6	0.5	4.9	0.2	14.3	5.2	6.5	0.3	9.7	10.9	6.1	9.7	1.8	7.4	16.9	6.8	5.7	0.0	0.6	6.2	4.9	3.3	4.5	3.4	3.7	3.4	2.7	2.0	3.0	6.3	5.6	2.8	9.5	5.8	7.4	5.9	15.0	2.9	0.0	0.1	0.7	1.0	0.0	1.3	1.6	1.1	1.0	0.0	0.8	1.4	1.3	0.0	4.7	0.2	3.1	1.5	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.3	0.0	0.0	0.0	0.0	13.7	0.3	0.0	0.1	1.0	0.0	0.5	0.0	0.2	0.1	0.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.3	2.9	0.3	0.0	0.0	0.0	0.1	0.5	0.2	0.3	0.0	0.0	4.6	0.0	0.0	1.8	3.0	0.1	0.6	0.0	0.6	0.0
AVL9	KIAA0241	ENSG00000105778	"AVL9 cell migration associated"	Q8NBF6	7	32495426-32588721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050957	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA050957: AB_2681289"	"unprognostic (2.33e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.14e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.05e-1)"	12.0	15.8	17.4	16.7	22.9	12.2	15.6	24.1	25.7	14.2	22.5	12.9	14.0	18.8	13.1	18.6	12.4	12.9	11.6	8.8	16.6	20.0	15.6	11.9	12.0	14.1	14.5	15.1	13.8	15.9	12.7	15.9	16.3	17.3	14.4	26.2	15.4	15.2	12.8	12.6	11.6	19.9	12.2	11.5	14.3	17.4	10.0	10.3	21.3	19.3	6.6	15.8	12.9	11.0	12.5	9.9	27.4	10.7	5.1	10.9	9.4	9.4	8.3	8.7	11.7	5.3	7.6	6.1	8.5	11.3	8.4	11.3	6.5	12.7	11.9	0.1	7.4	32.5	7.8	8.3	8.4	14.3	5.1	5.1	8.9	5.7	7.0	19.4	15.1	11.7	8.2	8.3	10.7	12.3	9.3	12.4	9.6	21.7	11.0	26.3	9.7	6.1	12.7	9.8	13.1	7.4	5.9	9.7	9.0	8.9	16.0	18.8	12.0	7.1	17.7	7.6	12.2	12.6	13.9	9.4	8.8	10.4	6.9	7.4	25.5	22.1	19.0	17.3	14.4	19.1	12.8	10.7	15.5	10.6	8.4	9.1	9.9	8.8	9.9	8.2	12.5	10.9	9.5	27.4	5.1	7.9	9.9	8.0	9.4	17.4	22.9	24.1	25.7	16.6	20.0	14.5	15.1	17.3	10.3	6.0	9.4	15.9	9.1	10.2	32.8	6.1	12.7	14.7	11.4	12.2	58.9	13.5	3.3	11.2	4.6	9.5	26.2	0.0	15.0	11.6	9.3	16.4	17.3	11.1	13.1	30.2	21.5	11.6	28.6	1.8	9.5	14.6	11.8	5.4	28.5	13.8	20.1	28.1	8.9	13.1	38.6	6.5	10.0	8.1	7.5	9.3	14.6	16.2	24.7	20.1
BAZ1A	"ACF1, hACF1, WALp1, WCRF180"	ENSG00000198604	"Bromodomain adjacent to zinc finger domain 1A"	Q9NRL2	14	34752731-34875647	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 380.8;Early spermatids: 560.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 22.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 22.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA002730	Supported		Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA002730: AB_1078269"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.31e-7)"	"unprognostic (2.44e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.37e-2)"	15.2	5.3	3.8	23.8	4.6	39.3	9.8	1.6	3.1	9.3	14.0	3.0	9.9	6.0	6.8	5.8	14.8	7.6	8.3	9.4	3.7	2.6	7.5	11.7	23.7	21.9	8.2	1.1	11.7	6.7	6.2	6.6	13.4	5.1	10.1	8.0	3.3	10.7	8.2	9.0	14.4	17.6	7.0	6.6	34.7	7.6	17.4	5.3	33.2	8.4	15.1	19.4	14.7	18.6	3.6	3.0	22.0	4.7	2.0	2.9	1.0	16.6	8.9	14.9	11.4	6.5	7.6	18.5	13.5	7.4	12.7	12.8	8.7	12.1	33.4	10.7	9.6	7.0	17.4	25.4	8.8	22.2	12.0	10.9	21.7	8.1	24.2	7.7	35.8	26.3	7.0	9.1	13.7	18.4	5.1	18.4	15.2	20.0	8.6	10.6	19.0	34.0	11.2	7.2	13.2	12.5	26.1	15.5	9.3	7.9	16.2	19.0	15.6	18.4	25.3	7.3	5.3	12.9	24.9	16.1	11.8	8.7	12.6	13.6	4.8	4.7	28.6	3.8	16.8	13.4	3.9	4.3	5.1	2.6	4.5	1.9	3.3	2.7	2.9	2.4	3.6	2.7	2.2	22.0	2.0	4.7	3.0	2.8	1.0	3.8	4.6	1.6	3.1	3.7	2.6	8.2	1.1	5.1	5.3	56.6	74.6	62.4	190.4	380.8	2.3	11.6	25.5	73.6	58.0	15.7	2.0	59.9	0.0	79.3	560.7	61.8	66.5	23.3	65.2	94.9	81.7	165.1	101.3	28.0	79.6	0.0	29.2	25.8	88.6	290.9	37.4	126.2	69.2	144.3	45.8	2.8	92.7	70.2	12.7	10.3	2.0	6.5	117.4	223.9	39.1	340.5	164.7	97.6	50.3	278.3
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724746	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"		NA	NA		6800000	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	60.7	43.4	38.3	20.3	38.8	27.4	71.3	22.2	48.1	28.7	31.8	27.1	27.5	28.8	30.2	48.6	42.4	31.0	26.8	26.7	34.1	36.5	41.6	52.4	42.2	50.0	38.1	26.0	29.1	67.6	36.0	27.4	43.6	44.5	34.3	36.6	30.7	44.5	37.7	15.6	37.3	37.8	32.4	33.6	36.7	24.8	31.6	21.1	25.4	53.1	27.2	37.1	38.1	30.8	72.7	109.7	104.4	97.5	68.2	89.8	150.4	55.1	52.0	14.4	72.3	64.2	19.5	33.5	26.8	30.8	31.9	41.1	41.9	40.5	32.3	122.4	43.4	42.5	55.9	36.0	56.3	26.7	15.9	53.7	20.4	41.2	36.0	31.5	33.1	44.2	26.0	48.9	31.1	36.6	33.6	39.0	19.1	27.6	58.9	35.7	57.7	21.2	45.1	16.5	74.8	53.8	23.2	16.1	72.4	50.0	60.5	18.9	26.8	12.0	59.6	40.2	23.7	21.8	37.4	40.7	28.1	27.7	38.0	53.7	60.5	116.6	42.9	54.8	44.9	24.6	80.3	80.6	77.5	89.0	86.1	79.5	71.2	89.8	88.1	69.9	72.7	79.4	86.4	104.4	68.2	97.5	109.7	72.4	150.4	38.3	38.8	22.2	48.1	34.1	36.5	38.1	26.0	44.5	21.1	104.2	111.8	94.7	188.6	125.9	40.7	56.9	135.0	112.4	95.5	122.1	43.2	414.9	31.5	221.9	4.3	139.7	190.7	23.3	182.9	352.4	105.7	160.9	92.5	177.7	341.5	30.2	99.2	204.4	127.2	16.4	97.5	153.8	151.8	150.5	117.5	122.3	207.2	171.9	93.0	136.1	33.7	155.2	85.4	143.9	179.9	114.0	450.0	97.8	147.8	228.6
BGN	"DSPG1, SLRR1A"	ENSG00000182492	Biglycan	P21810	X	153494939-153509554	"Disease related genes, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Peritubular cells: 735.8;Sertoli cells: 1461.7;Smooth muscle cells: 411.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 46.6;BJ hTERT+: 60.2;fHDF/TERT166: 84.0;HSkMC: 44.1;hTEC/SVTERT24-B: 35.7;HUVEC TERT2: 84.3;U-138 MG: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003157, CAB003678"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		2500000	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB003678: AB_425325, HPA003157: AB_1078282"	"unprognostic (1.74e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.60e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (6.00e-8)"	"unprognostic (7.05e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.57e-3)"	41.1	39.7	8.1	23.2	14.6	0.4	20.2	5.6	14.3	76.7	12.0	18.7	16.7	6.0	63.4	31.7	21.1	23.6	86.7	133.0	8.9	5.2	67.6	78.1	77.6	29.4	8.9	16.3	39.6	16.8	5.1	26.7	131.1	15.0	33.6	7.0	48.3	20.4	38.2	17.0	31.0	8.6	56.9	5.9	101.3	10.0	28.0	15.8	3.9	45.3	29.9	14.6	34.5	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	4.9	11.0	0.1	46.6	60.2	8.6	2.8	5.8	0.0	0.0	8.6	84.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	4.2	0.0	0.0	44.1	0.3	35.7	1.6	4.4	84.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.8	0.1	0.0	17.8	38.3	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	14.6	5.6	14.3	8.9	5.2	8.9	16.3	15.0	15.8	3.0	9.3	0.0	1.0	92.5	0.0	6.7	5.1	2.7	4.5	8.7	0.0	13.9	1.7	2.4	1.4	48.7	0.0	0.0	0.2	33.9	142.9	2.3	3.5	1.0	4.0	3.2	0.0	198.2	3.1	4.0	137.0	6.2	33.7	3.6	0.0	0.0	1.8	0.0	735.8	0.3	0.1	1461.7	411.6	0.6	1.1	47.3	47.6	4.9	0.0	1.4
BNIP1	"Nip1, SEC20"	ENSG00000113734	"BCL2 interacting protein 1"	Q12981	5	173144442-173164387	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008009, HPA008149"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA008009: AB_1078291, HPA008149: AB_2667993"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.40e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.07e-2)"	12.0	14.5	13.3	9.5	14.5	34.0	13.7	10.1	16.9	10.5	11.1	13.4	9.0	10.2	10.2	15.0	11.4	10.8	9.4	13.0	12.2	14.9	14.5	14.1	10.1	10.9	13.7	12.0	11.3	22.5	13.6	14.7	13.1	17.5	10.6	13.4	10.8	12.4	9.6	20.9	9.0	9.8	10.8	11.8	11.8	11.5	28.1	9.3	14.4	13.1	9.3	12.4	9.9	10.1	9.9	12.7	3.4	9.3	9.6	14.6	8.5	10.8	9.7	11.6	14.3	7.2	16.8	12.9	9.2	14.5	19.6	19.8	16.7	15.0	11.6	10.9	13.6	20.6	8.6	15.0	26.0	20.1	19.0	12.1	10.4	6.4	8.7	19.0	16.6	13.1	9.4	13.2	18.1	22.9	9.3	14.9	17.0	10.0	14.1	15.9	25.2	18.4	14.7	5.1	13.2	11.6	12.2	9.4	14.2	11.2	6.6	14.7	9.1	8.1	10.4	19.7	8.5	17.5	13.4	11.8	17.0	12.7	14.5	18.5	10.8	12.6	17.8	15.7	17.1	10.9	0.0	8.5	3.4	14.6	9.3	12.4	9.0	12.8	10.5	10.3	9.9	11.0	10.8	0.3	9.6	7.2	12.7	11.1	8.5	13.3	14.5	10.1	16.9	12.2	14.9	13.7	12.0	17.5	9.3	3.0	10.7	5.6	9.0	10.3	13.2	4.5	7.6	10.7	6.8	5.2	3.9	18.5	23.2	12.5	2.2	6.5	7.4	0.0	10.8	15.9	8.2	11.0	1.1	5.7	13.4	9.5	6.9	5.5	6.9	4.8	8.1	9.1	3.3	11.8	10.8	9.8	8.4	7.8	11.0	13.0	9.6	0.0	6.1	19.2	12.5	9.5	25.2	10.4	10.1	7.8
BTG4	"APRO3, PC3B"	ENSG00000137707	"BTG anti-proliferation factor 4"	Q9NY30	11	111467526-111512354	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 24.8"	"Group enriched"	"Detected in some"	6	"Early spermatids: 46.0;Late spermatids: 57.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.4;Karpas-707: 8.6;U-266/70: 6.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057157			Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"		"HPA057157: AB_2683354"		"unprognostic (1.58e-1)"		"unprognostic (2.68e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.80e-4)"		"unprognostic (1.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.39e-2)"					"unprognostic (1.31e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.2	0.0	0.2	0.4	6.4	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.7	1.6	0.1	0.0	0.0	1.0	0.0	8.6	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.4	0.0	0.4	6.0	2.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.7	3.4	0.0	0.0	0.0	0.0	0.0	46.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	8.2	1.2	0.0	0.0	0.0	0.0	0.0
C11orf58	SMAP	ENSG00000110696	"Chromosome 11 open reading frame 58"	O00193	11	16613132-16756881	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036591, HPA076406"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA036591: AB_10669909, HPA076406: AB_2686798"	"unprognostic (8.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (1.30e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.45e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-1)"	44.5	47.1	34.7	37.8	49.0	34.7	40.5	59.7	43.0	40.3	42.1	32.3	29.7	27.3	54.1	35.3	51.6	36.3	34.0	55.1	32.4	33.3	42.6	56.4	41.6	43.0	36.5	38.9	54.2	39.6	35.8	53.7	58.9	35.7	42.0	23.6	30.6	40.1	36.3	69.5	36.4	28.4	43.0	38.9	41.1	35.1	27.5	33.9	50.6	47.6	32.6	36.5	52.0	39.2	97.7	91.8	87.4	74.8	67.4	91.1	123.2	66.2	53.4	63.9	31.5	35.6	32.5	45.0	66.0	34.4	44.0	40.3	50.5	63.0	57.3	53.1	40.0	49.6	38.8	43.0	31.1	47.7	75.2	46.0	50.6	46.1	45.6	44.1	72.4	45.6	32.1	43.6	26.1	57.7	36.2	30.7	36.5	63.3	40.0	37.7	38.8	77.6	35.3	47.3	31.9	30.5	63.2	64.5	30.1	34.1	38.0	43.9	45.0	57.7	43.9	78.4	39.6	39.0	50.3	57.2	55.2	45.2	66.0	62.3	26.8	99.0	79.7	48.1	42.3	50.4	78.3	65.8	87.4	72.2	72.9	83.0	97.7	80.2	75.8	71.4	89.3	91.1	78.9	31.3	67.4	74.8	91.8	81.5	123.2	34.7	49.0	59.7	43.0	32.4	33.3	36.5	38.9	35.7	33.9	229.3	197.2	206.1	231.6	228.4	159.6	184.4	135.0	259.6	228.6	190.1	141.4	273.3	363.1	215.1	28.5	242.4	57.2	116.8	199.0	283.9	266.4	215.5	227.9	146.0	198.9	135.1	152.8	152.9	158.4	25.1	190.7	234.1	217.6	267.9	113.4	201.7	195.9	92.6	192.0	246.7	201.4	155.2	279.5	283.4	219.5	241.8	379.3	210.4	107.6	232.0
C16orf95		ENSG00000260456	"Chromosome 16 open reading frame 95"	Q9H693	16	87083562-87317420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 47.2"	"Group enriched"	"Detected in many"	9	"Early spermatids: 56.7;Erythroid cells: 23.3;Late spermatids: 77.4;Sertoli cells: 25.8;Spermatocytes: 52.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA040850, HPA067924"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA040850: AB_10794882, HPA067924: AB_2685924"	"unprognostic (3.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.23e-1)"	1.5	1.7	1.7	1.0	2.6	2.2	0.8	1.5	2.0	0.5	1.0	1.5	1.2	1.2	0.7	1.2	0.5	0.8	1.2	1.0	1.7	1.4	1.1	2.6	0.7	0.9	1.9	0.9	0.7	2.1	1.0	0.9	0.5	1.8	0.6	0.6	0.9	1.1	1.2	3.0	0.5	1.2	1.2	1.3	0.7	1.1	47.2	1.1	1.2	0.7	0.6	0.9	0.7	0.4	3.4	6.0	1.1	6.0	1.5	5.7	3.2	3.2	9.1	3.2	3.8	3.7	2.2	5.4	3.0	1.2	3.0	2.3	4.4	5.2	8.1	8.6	0.6	3.3	2.7	2.9	2.0	1.4	3.9	5.3	7.6	3.2	5.9	3.2	0.8	1.5	3.8	0.7	3.4	1.1	1.5	2.8	6.0	6.7	4.1	3.6	8.4	2.8	6.9	2.9	2.0	5.5	6.4	1.4	4.6	1.7	1.3	4.0	3.3	7.4	0.4	2.5	1.2	4.5	3.6	3.3	5.5	2.4	3.2	2.8	12.6	10.2	15.4	7.4	7.6	3.7	0.0	4.9	1.1	4.9	4.8	3.6	3.4	4.3	4.5	4.5	2.9	3.5	5.7	0.8	1.5	6.0	6.0	5.1	3.2	1.7	2.6	1.5	2.0	1.7	1.4	1.9	0.9	1.8	1.1	0.0	1.0	2.2	0.4	1.4	2.3	2.0	2.5	1.4	0.0	0.0	2.0	1.9	1.7	2.8	56.7	0.6	4.9	23.3	3.0	2.7	1.1	0.4	0.0	4.2	2.5	1.6	0.0	2.5	1.5	77.4	3.1	1.6	0.0	3.6	2.5	2.4	3.6	2.9	4.9	2.4	2.0	25.8	0.5	52.2	4.3	0.5	0.9	1.5	5.3	0.3
C19orf71	LOC100128569	ENSG00000183397	"Chromosome 19 open reading frame 71"	A6NCJ1	19	3539154-3544030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 88.8"	"Group enriched"	"Detected in some"	58	"Early spermatids: 515.2;Late spermatids: 237.4"	"Cancer enriched"	"Detected in all"	5	"melanoma: 23.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HeLa: 27.3;SK-MEL-30: 16.6;WM-115: 59.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048654	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Endoplasmic reticulum"	"HPA048654: AB_2680480"	"unprognostic (1.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.74e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.13e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (2.02e-5)"	"unprognostic (5.52e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.97e-3)"	1.6	2.3	1.6	4.1	2.2	5.1	1.6	9.8	2.2	1.7	1.6	2.0	1.6	4.7	2.5	1.9	1.6	2.6	1.6	1.6	1.6	1.3	3.5	1.6	2.1	4.9	1.8	1.9	2.8	4.2	0.0	4.5	1.6	1.7	2.2	0.0	1.6	7.6	1.6	1.6	7.4	3.9	1.6	1.6	5.2	3.2	88.8	1.8	1.6	6.3	1.6	1.6	1.7	1.6	0.3	0.5	0.0	0.2	0.0	0.7	0.1	5.3	4.4	1.4	2.0	0.0	0.0	2.9	3.4	0.0	0.0	0.0	2.7	1.6	0.9	2.6	0.0	7.4	4.8	0.0	0.2	0.0	5.4	2.6	0.7	27.3	0.8	0.0	0.7	3.4	0.0	0.0	0.1	0.0	1.6	0.0	2.5	3.7	4.9	0.0	3.8	1.1	1.7	1.2	0.1	1.3	1.8	2.1	5.0	0.0	2.1	3.4	3.1	5.9	3.0	16.6	0.7	3.3	1.7	4.5	2.7	3.6	8.2	3.1	3.9	1.0	1.4	8.1	3.2	59.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.2	0.5	0.0	0.1	1.6	2.2	9.8	2.2	1.6	1.3	1.8	1.9	1.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	515.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	237.4	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	6.5	0.0	2.8	1.5	0.0	0.1	0.0	0.0	0.0
C20orf196	FLJ25067	ENSG00000171984	"Chromosome 20 open reading frame 196"	Q8IYI0	20	5750393-5863912	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"T-cells: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 31.0;U-698: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040749	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Endoplasmic reticulum, Golgi apparatus, Vesicles"		"HPA040749: AB_10673093"	"unprognostic (2.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (4.05e-5)"	5.4	13.9	7.1	15.5	7.3	17.8	8.1	10.6	8.7	6.8	7.9	9.2	12.6	11.9	7.7	8.7	7.4	6.7	8.0	12.3	7.0	7.0	6.9	4.1	9.3	17.6	8.9	6.7	7.7	11.1	2.8	10.6	5.1	6.9	8.7	7.4	10.9	19.1	12.9	15.1	5.6	13.7	6.7	7.1	14.2	6.2	4.2	7.8	20.4	9.6	9.4	16.8	6.4	6.6	21.7	10.9	15.6	10.8	16.2	22.7	10.2	4.8	6.1	3.1	1.4	1.9	1.6	1.3	1.4	2.4	2.0	2.8	2.8	5.5	19.1	3.7	1.4	1.5	2.3	2.0	3.6	2.2	5.7	2.3	6.9	0.9	10.3	4.2	8.3	3.3	2.4	5.2	2.9	2.0	1.8	3.9	5.5	9.7	7.7	3.5	2.1	11.7	31.0	3.6	6.4	3.3	9.6	4.1	8.6	2.9	2.4	4.9	4.6	2.9	2.8	5.6	1.6	2.2	8.8	2.3	2.2	3.1	1.9	3.0	5.3	8.8	25.3	1.0	8.7	3.7	11.2	8.7	15.6	17.0	10.4	13.2	19.7	19.5	16.7	9.2	21.7	18.8	13.4	3.9	16.2	10.8	10.9	22.7	10.2	7.1	7.3	10.6	8.7	7.0	7.0	8.9	6.7	6.9	7.8	3.0	5.5	7.5	7.2	3.3	6.3	0.0	7.6	1.4	0.0	0.0	2.0	6.1	0.0	0.0	0.1	4.2	5.8	0.0	0.0	6.0	3.2	8.1	1.1	0.8	15.0	3.2	12.1	3.7	10.3	0.5	1.7	7.3	5.0	0.0	11.4	7.7	0.0	6.8	2.1	0.0	5.0	0.0	2.5	4.8	12.2	3.8	4.9	18.7	7.3	10.1
C22orf39	MGC74441	ENSG00000242259	"Chromosome 22 open reading frame 39"	Q6P5X5	22	19351368-19448232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073701			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA073701: AB_2686627"	"unprognostic (4.97e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.95e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.45e-3)"	"unprognostic (5.34e-3)"	"prognostic favorable (1.44e-4)"	"unprognostic (6.51e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.32e-2)"	18.2	19.5	27.0	11.9	22.6	11.4	20.1	21.9	24.4	13.1	19.6	14.0	13.9	11.3	13.8	13.9	14.4	13.6	13.1	29.9	23.7	19.6	15.6	10.3	12.5	14.1	23.5	18.3	16.4	27.3	17.4	16.5	12.6	16.2	19.6	13.5	13.7	15.4	18.5	69.5	14.6	12.0	21.3	19.2	13.6	13.1	11.7	14.1	12.9	22.1	18.4	14.7	13.7	13.7	23.5	27.6	48.8	22.4	21.3	23.7	19.9	10.6	7.1	12.3	8.7	14.9	10.4	7.8	3.8	4.0	11.0	12.3	10.4	3.4	11.3	5.1	4.3	7.3	10.5	14.8	8.0	11.3	12.4	35.5	13.2	14.1	18.1	12.8	18.5	15.3	9.9	12.8	6.7	15.0	10.1	11.0	23.5	44.8	17.2	6.9	8.3	15.3	15.3	4.5	26.1	10.4	18.9	16.8	6.9	12.4	8.8	15.9	7.0	8.5	5.8	12.6	12.1	9.7	11.6	8.0	8.4	16.3	4.3	6.2	17.4	7.5	16.1	7.1	9.5	7.8	24.3	21.6	48.8	19.3	22.4	17.7	23.5	20.9	15.6	18.5	23.2	22.3	18.4	29.4	21.3	18.9	27.6	23.7	19.9	27.0	22.6	21.9	24.4	23.7	19.6	23.5	18.3	16.2	14.1	20.8	30.2	29.0	23.3	21.6	27.3	86.7	25.5	45.5	42.1	34.9	15.7	47.2	91.2	36.1	13.9	32.2	49.1	23.3	67.6	38.3	31.6	33.0	26.5	27.0	56.0	17.5	43.4	28.3	31.9	10.2	32.5	31.1	37.1	60.5	40.1	27.8	49.4	34.5	31.8	43.3	16.4	45.3	42.2	56.4	60.9	28.4	42.1	39.5	51.9	24.7
C2orf76	"AIM29, LOC130355, MGC104437"	ENSG00000186132	"Chromosome 2 open reading frame 76"	Q3KRA6	2	119302225-119366828	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 66.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044977, HPA055362"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044977: AB_10961918, HPA055362: AB_2682794"	"unprognostic (4.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.16e-8)"	"unprognostic (3.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.19e-2)"	13.7	14.9	17.6	6.8	17.4	6.2	16.9	10.1	17.6	10.0	9.5	11.9	17.0	4.6	12.7	33.1	11.8	15.2	9.1	11.3	15.9	13.8	14.3	9.9	19.5	9.7	19.5	13.0	13.5	20.6	10.6	14.7	7.8	23.0	11.9	8.6	9.6	10.8	11.9	7.4	14.5	6.2	14.0	20.3	8.7	9.5	18.3	15.3	7.9	15.1	10.2	9.4	10.0	9.3	14.8	15.7	27.7	16.3	23.4	15.8	9.3	9.4	9.0	13.0	8.3	18.8	23.2	7.5	13.4	9.6	8.8	9.6	5.7	6.4	11.4	23.9	14.0	10.2	4.4	5.7	8.5	8.6	9.8	19.4	22.0	6.9	7.4	13.1	8.2	14.3	12.0	14.5	12.3	8.2	11.3	12.6	8.9	6.9	11.3	12.9	14.3	8.6	15.6	7.1	7.5	7.2	5.3	2.7	16.1	19.2	10.3	8.5	9.7	9.7	14.0	18.0	12.9	7.6	29.5	11.6	10.2	7.9	8.5	7.1	7.5	12.2	12.3	10.3	6.2	11.4	17.4	16.3	15.4	15.8	14.5	14.1	14.8	12.4	14.4	15.7	11.2	11.3	15.6	27.7	23.4	8.9	14.7	12.1	9.3	17.6	17.4	10.1	17.6	15.9	13.8	19.5	13.0	23.0	15.3	6.0	10.7	8.0	14.8	22.1	2.7	14.9	12.7	38.8	13.6	14.0	0.0	22.7	66.3	12.0	4.8	18.6	8.4	23.3	15.4	27.7	18.3	10.6	21.9	10.5	23.6	1.6	10.5	16.5	20.3	3.4	17.8	14.4	42.2	17.2	10.6	8.6	15.0	7.0	15.9	35.2	3.8	6.5	18.6	18.0	20.4	31.1	17.3	16.7	10.3	10.3
C4orf3	HCVFTP1	ENSG00000164096	"Chromosome 4 open reading frame 3"	Q8WVX3	4	119296419-119304445	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Proximal tubular cells: 865.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA026907	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA026907: AB_10600760"	"unprognostic (2.97e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.85e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.04e-1)"	"unprognostic (8.85e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (8.32e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.59e-1)"	51.6	41.9	46.2	39.1	47.2	19.0	31.7	18.2	41.1	46.1	33.5	41.1	25.6	41.3	39.4	49.0	101.3	33.8	37.0	43.4	46.5	45.4	55.8	63.4	33.6	32.2	61.2	31.6	45.1	32.7	19.6	34.7	36.6	47.3	38.7	20.3	33.4	42.6	34.1	70.5	37.7	45.0	41.5	68.7	38.0	26.9	19.4	35.8	30.3	44.2	42.3	39.3	50.0	59.8	60.4	66.8	112.7	53.3	38.0	48.6	65.5	69.1	8.0	23.3	19.3	32.7	24.9	19.0	30.6	8.3	9.0	16.7	8.5	23.1	47.6	23.7	29.2	16.8	13.6	10.3	25.3	14.1	31.9	10.2	19.7	18.5	29.9	9.8	32.3	21.6	26.0	21.2	12.9	5.6	42.0	15.0	13.7	17.5	19.9	33.0	19.9	20.9	30.2	11.8	26.9	8.2	15.0	31.2	12.1	17.0	15.8	14.7	23.8	23.2	30.8	15.9	23.9	16.5	16.9	29.5	33.3	19.8	20.1	12.4	33.6	34.4	22.1	62.6	13.4	18.8	69.3	50.7	60.4	40.1	53.3	38.7	60.4	47.8	45.0	42.7	46.4	48.4	46.9	112.7	38.0	49.0	66.8	48.6	65.5	46.2	47.2	18.2	41.1	46.5	45.4	61.2	31.6	47.3	35.8	145.9	143.1	236.2	239.8	280.2	80.9	421.0	165.6	215.5	144.5	211.1	23.6	289.6	325.0	242.8	18.7	229.5	160.4	23.3	156.7	297.9	248.2	254.6	179.3	378.8	279.6	144.6	65.7	200.7	283.9	15.8	155.1	255.4	189.0	413.8	155.2	139.4	215.9	181.4	202.6	865.1	58.0	194.1	282.9	205.3	54.1	303.0	372.8	183.3	101.9	339.6
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 77.9"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 68.3;Horizontal cells: 235.2;Intestinal endocrine cells: 205.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 77.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 31.2;U-87 MG: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064258, HPA068138, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA064258: AB_2685229, HPA068138: , HPA071902: "	"unprognostic (1.09e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.78e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.47e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (5.31e-3)"	"unprognostic (5.03e-6)"	"unprognostic (6.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (6.25e-2)"	2.2	5.3	7.6	1.0	12.2	0.7	0.9	77.9	19.7	0.8	1.5	1.8	0.0	3.9	1.2	2.8	0.7	2.2	0.8	1.1	5.7	5.1	0.7	0.5	0.7	1.3	3.9	7.3	1.1	3.0	0.7	1.5	0.6	7.2	0.8	1.7	1.2	0.9	0.8	1.3	0.7	2.8	0.9	3.3	1.3	7.7	1.9	2.8	0.0	0.7	0.0	1.0	0.8	0.3	2.8	0.8	1.9	1.1	0.8	0.8	0.4	0.0	0.1	0.0	3.9	0.1	0.3	0.0	1.6	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	2.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.1	0.9	0.0	0.2	0.4	0.0	0.1	0.0	0.1	31.2	0.0	0.0	0.0	0.2	0.1	0.0	1.2	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.0	17.6	0.0	0.4	1.9	0.4	0.7	0.5	0.5	0.8	2.8	0.5	0.3	0.4	1.7	0.6	0.7	1.6	0.8	1.1	0.8	0.6	0.4	7.6	12.2	77.9	17.4	5.7	5.1	3.9	7.3	7.2	2.8	6.0	2.7	1.3	1.4	0.6	68.3	2.2	0.0	6.7	2.3	1.8	15.7	0.0	0.0	0.6	22.1	4.2	0.0	0.0	0.3	0.1	2.1	0.8	1.1	0.0	0.5	235.2	205.4	1.8	1.3	17.9	1.1	2.1	0.0	1.0	1.1	2.9	1.9	0.0	0.4	2.0	6.2	0.0	4.2	4.1	5.1	0.1	0.2	4.3	0.8	0.9
CALR	"cC1qR, CRT, FLJ26680, RO, SSA"	ENSG00000179218	Calreticulin	P27797	19	12938578-12944489	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 1318.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001513, HPA002242, CAB019952, CAB079775"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		450000000	"Endoplasmic reticulum"		"CAB001513: , CAB019952: AB_2069792, CAB079775: AB_303403, HPA002242: AB_1078384"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.27e-2)"	67.5	55.5	31.9	58.9	36.1	86.4	64.6	20.9	38.9	50.2	52.3	42.5	65.7	44.1	61.6	108.4	65.2	49.1	67.5	62.5	31.6	35.2	81.9	302.6	61.8	83.6	33.5	33.4	59.6	124.3	56.4	60.3	98.0	35.7	53.1	60.0	43.2	121.0	68.6	25.1	34.2	53.8	56.9	42.1	66.6	49.7	65.0	32.7	61.6	250.6	55.0	65.2	39.4	68.0	25.1	57.2	16.1	38.6	26.3	48.4	16.2	118.3	46.8	64.3	140.1	81.3	73.4	58.9	158.3	130.0	95.4	139.0	71.5	95.3	76.0	146.2	183.6	85.6	47.2	70.3	100.9	96.7	56.5	40.1	63.3	57.0	108.7	192.1	254.0	85.9	68.0	46.8	88.4	74.9	126.5	114.8	52.2	54.1	38.6	77.4	81.7	70.4	166.1	57.2	66.7	66.4	54.6	54.5	92.0	83.8	67.8	24.5	52.3	98.1	54.0	32.3	79.5	72.2	105.4	99.3	79.7	50.2	113.4	70.7	48.2	42.9	76.4	112.3	110.8	87.6	16.1	19.5	10.1	48.4	38.6	34.3	25.1	29.2	36.7	20.4	22.4	21.6	39.2	6.6	26.3	30.8	57.2	21.5	16.2	31.9	36.1	20.9	38.9	31.6	35.2	33.5	33.4	35.7	32.7	137.0	125.9	216.1	284.2	232.4	67.7	39.5	168.2	151.3	164.9	211.1	119.8	557.7	54.7	494.3	20.8	202.2	487.4	140.2	249.9	1318.6	319.8	346.7	204.2	513.5	724.5	33.4	339.2	328.4	165.0	18.8	295.1	261.1	202.4	256.1	263.3	298.5	397.7	287.1	292.4	139.9	115.0	200.5	213.6	255.0	394.6	186.7	806.5	193.7	294.0	285.1
CALU		ENSG00000128595	Calumenin	O43852	7	128739292-128771807	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 431.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 156.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006018	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		15000000	"Endoplasmic reticulum"		"HPA006018: AB_1845934"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.52e-3)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.30e-11)"	"unprognostic (3.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.60e-5)"	33.6	20.7	10.2	30.8	13.6	6.2	27.6	7.8	13.0	33.6	35.0	13.9	34.0	8.4	57.0	29.4	29.7	27.3	24.0	60.0	10.5	9.0	23.6	38.3	31.4	17.0	14.0	9.8	28.5	21.5	18.6	19.7	104.6	14.4	29.9	21.1	18.7	26.9	40.2	26.5	12.5	16.6	78.1	17.4	26.6	25.6	14.3	10.8	8.1	25.5	16.7	13.4	57.0	27.6	14.0	19.5	13.4	22.9	13.7	18.5	16.4	16.4	13.9	32.5	10.4	90.8	88.3	17.9	113.8	99.3	41.9	55.3	18.0	25.6	8.2	20.7	156.9	48.5	9.6	16.8	22.3	63.2	5.0	11.7	9.0	20.8	19.9	41.6	12.8	16.8	59.4	16.5	57.7	22.5	57.4	37.9	8.0	15.3	11.9	81.1	9.4	9.4	7.5	21.9	15.6	14.0	7.7	23.5	12.8	17.4	9.2	3.4	19.5	36.7	33.9	45.9	62.4	7.2	10.1	50.8	116.1	15.0	96.8	50.3	19.2	23.7	15.2	120.9	16.2	118.3	11.2	21.7	13.4	18.5	22.9	17.0	14.0	12.7	13.8	18.6	10.0	11.3	13.4	2.8	13.7	18.2	19.5	13.6	16.4	10.2	13.6	7.8	13.0	10.5	9.0	14.0	9.8	14.4	10.8	20.8	32.6	29.2	53.7	72.2	27.3	197.2	22.9	49.5	37.5	24.4	17.7	103.1	14.9	67.6	7.8	81.7	12.2	0.0	52.9	431.1	239.3	93.2	58.8	48.7	119.8	27.0	18.9	138.7	55.3	4.7	92.9	49.6	114.7	20.8	39.1	30.4	58.9	7.0	111.7	16.5	11.7	58.2	119.2	21.2	38.7	67.1	203.2	20.3	23.0	60.8
CANX	"CNX, IP90, P90"	ENSG00000127022	Calnexin	P27824	5	179678628-179730925	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004738, HPA009433, HPA009696"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		82000000	"Endoplasmic reticulum"		"CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379"	"unprognostic (6.56e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.15e-1)"	49.3	35.4	40.0	35.8	40.9	57.6	37.8	27.3	49.1	93.0	33.6	37.1	48.3	44.0	42.7	115.4	31.6	31.7	30.0	51.3	36.9	50.9	61.6	120.8	34.7	30.1	47.5	27.9	41.0	78.2	13.7	33.0	70.5	44.9	33.5	55.1	32.2	121.5	48.5	28.5	23.4	68.5	60.5	48.8	38.2	31.7	34.3	30.0	31.0	113.4	25.9	29.9	41.4	47.6	10.1	26.3	25.9	28.9	18.7	22.6	30.0	8.4	23.8	20.2	12.3	43.5	32.3	10.2	43.5	47.8	50.3	42.7	20.7	19.5	63.9	61.1	34.8	25.6	5.8	31.7	23.7	57.5	16.4	9.6	10.3	59.3	13.4	59.3	19.6	9.7	6.3	43.6	27.0	78.5	15.4	20.8	4.9	8.1	24.9	5.5	7.8	9.9	0.3	4.1	3.6	1.4	10.3	14.7	7.0	37.0	24.9	10.2	2.4	12.2	5.2	109.0	25.3	41.2	8.7	38.6	11.5	19.2	13.0	33.7	7.6	26.2	16.1	17.4	12.8	11.2	25.9	28.9	8.8	17.7	21.2	22.6	10.1	13.9	16.3	26.3	7.7	9.5	10.6	6.1	18.7	18.0	25.3	10.1	30.0	40.0	40.9	27.3	33.3	36.9	50.9	47.5	27.9	44.9	30.0	184.6	236.5	93.5	89.0	131.9	112.0	432.6	180.9	323.9	284.4	172.7	149.2	138.7	41.4	148.7	197.6	180.1	166.6	46.7	132.3	187.5	146.3	221.3	188.7	393.6	206.3	151.0	170.9	163.9	186.1	659.2	147.3	192.4	167.0	120.8	179.5	201.8	157.0	97.9	179.6	160.8	108.3	90.5	152.7	141.2	80.8	141.4	204.7	88.6	178.9	131.5
CAPZA2	"CAPPA2, CAPZ"	ENSG00000198898	"Capping actin protein of muscle Z-line alpha subunit 2"	P47755	7	116811070-116922049	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007470, HPA007643"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		No	No		19000000	"Endoplasmic reticulum"	Cytosol	"HPA007470: AB_1845985, HPA007643: AB_2667886"	"unprognostic (1.37e-2)"	"unprognostic (2.25e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.58e-2)"	32.4	17.7	23.6	15.8	22.6	33.6	18.5	17.6	30.2	17.7	26.3	10.7	13.5	16.9	20.6	16.4	25.9	14.9	17.6	36.4	26.7	20.6	40.9	29.2	23.2	16.6	22.1	15.9	17.3	13.8	12.9	16.4	26.1	27.1	21.8	20.6	11.8	14.4	18.3	47.1	11.6	30.6	30.3	19.6	26.0	17.8	12.4	13.7	17.7	24.5	21.0	14.0	31.5	15.0	6.6	14.8	32.0	22.8	7.1	7.8	17.7	13.1	8.9	8.7	11.3	16.6	17.6	4.8	13.1	18.4	13.1	15.0	6.5	16.9	9.0	21.4	18.4	16.8	8.2	8.9	10.7	20.4	9.7	7.1	13.5	8.9	10.8	10.2	8.9	18.2	14.1	12.0	10.7	10.1	15.9	27.6	5.7	8.9	15.6	25.7	6.4	11.6	15.1	12.8	13.5	7.8	8.3	11.7	17.7	30.5	11.2	9.2	10.5	12.1	45.7	12.4	11.5	6.4	10.4	10.2	21.1	6.7	16.6	12.2	12.3	9.0	17.1	12.5	12.7	14.9	19.9	16.4	19.2	5.5	20.1	6.1	6.6	6.5	5.7	14.8	6.0	6.4	6.5	32.0	7.1	22.8	8.2	7.8	17.7	23.6	22.6	17.6	30.2	26.7	20.6	22.1	15.9	27.1	13.7	68.5	67.4	96.3	183.9	215.9	99.6	196.7	68.8	42.8	60.3	162.3	25.5	129.4	437.7	161.9	6.6	193.4	141.9	93.5	141.3	163.7	177.2	113.8	124.6	101.1	274.2	101.7	116.2	221.6	215.0	12.9	69.0	242.4	172.1	184.0	86.3	127.8	150.8	154.3	104.3	362.3	90.2	90.5	201.3	35.1	43.4	191.2	120.5	90.6	83.0	173.2
CAST		ENSG00000153113	Calpastatin	P20810	5	96525267-96779595	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 201.9"	"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 948.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009491, HPA036881, HPA036882, HPA075906"	Enhanced		Enhanced	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		18000000	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"CAB009491: AB_2259755, HPA036881: AB_2675359, HPA036882: AB_2675360, HPA075906: "	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.94e-2)"	"unprognostic (6.11e-3)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (4.98e-4)"	38.3	20.7	10.4	25.0	16.3	22.1	32.0	8.7	21.7	38.0	44.6	10.5	18.6	25.6	24.8	25.9	87.4	19.5	25.5	98.5	11.9	10.6	27.2	38.2	29.5	21.1	14.3	12.5	26.9	14.8	22.3	25.3	52.6	24.8	30.0	34.5	12.7	38.7	23.2	201.9	40.7	56.3	36.2	18.7	21.7	22.2	21.2	15.6	10.1	25.6	51.2	34.1	42.2	57.0	24.5	32.7	12.4	48.0	18.3	26.6	27.2	48.5	40.0	6.8	17.7	41.1	76.6	24.0	34.6	49.0	27.7	36.1	9.9	29.6	7.0	32.7	46.9	41.3	82.6	12.9	47.1	33.5	45.1	12.2	9.0	42.4	11.7	31.6	5.9	15.7	34.6	43.6	39.7	64.9	38.7	30.9	5.4	7.5	22.7	33.7	15.3	2.9	0.2	5.3	13.2	14.9	2.7	23.0	12.0	55.0	20.5	28.7	6.9	35.3	19.4	22.6	16.2	11.8	6.4	41.1	37.8	16.1	25.2	34.9	7.6	20.2	3.3	42.9	3.2	10.4	2.5	48.0	7.0	26.6	29.0	25.2	24.5	23.9	26.5	32.7	22.7	12.2	16.3	12.4	18.3	32.2	9.0	24.2	27.2	10.4	16.3	8.7	21.7	11.9	10.6	14.3	12.5	24.8	15.6	375.2	182.6	82.4	358.6	212.9	34.7	740.0	140.1	410.9	277.5	102.9	17.7	150.3	112.7	215.3	948.1	166.8	282.7	280.4	218.0	79.9	187.6	259.7	169.0	148.0	103.8	12.7	136.3	108.6	206.2	312.7	159.3	211.5	124.9	235.4	207.6	36.8	240.8	170.9	137.6	98.2	16.9	90.5	162.6	20.9	10.1	220.1	117.7	139.5	143.0	490.4
CCDC47	GK001	ENSG00000108588	"Coiled-coil domain containing 47"	Q96A33	17	63745250-63776351	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029674, HPA072573, HPA075958"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: "	"unprognostic (6.33e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.16e-1)"	26.2	42.1	26.7	18.7	43.3	11.4	26.7	32.4	31.3	24.4	38.2	23.0	29.2	39.9	20.6	26.3	28.9	21.2	22.8	42.4	26.5	24.0	40.0	71.8	27.4	13.9	29.4	24.8	27.0	30.5	49.3	28.5	49.9	26.4	29.3	38.4	17.7	30.0	29.7	71.9	23.5	44.0	20.7	31.5	26.8	35.9	15.1	34.7	13.3	29.4	24.3	18.1	29.8	24.5	19.9	41.9	37.4	30.8	20.8	25.7	24.2	38.6	36.7	22.8	20.0	32.3	21.5	44.6	39.6	25.7	27.1	32.1	32.4	35.3	30.5	21.2	27.6	31.4	31.8	27.6	24.2	48.1	10.7	28.1	43.9	30.3	31.6	31.0	35.0	23.1	22.6	34.2	37.3	32.2	19.2	22.5	15.3	48.8	26.8	22.0	31.2	26.8	12.9	19.9	48.6	37.4	24.9	44.5	41.9	32.5	44.1	21.0	28.6	26.5	68.0	31.7	30.3	44.8	19.1	28.7	50.8	32.5	36.8	45.4	26.8	31.8	31.5	29.6	22.4	40.9	22.2	30.7	37.4	22.1	30.8	25.7	19.9	21.9	20.3	41.9	16.0	22.9	20.2	24.5	20.8	30.4	27.9	23.4	24.2	26.7	43.3	32.4	31.3	26.5	24.0	29.4	24.8	26.4	34.7	134.0	106.5	47.7	83.7	89.5	39.7	111.9	63.7	88.3	134.2	57.6	13.7	93.7	8.3	87.2	11.3	69.1	81.5	46.7	91.7	81.3	51.1	84.9	42.9	81.9	52.3	54.0	50.2	59.5	48.5	10.0	44.3	53.4	37.1	57.7	79.0	57.4	77.1	56.1	52.6	28.2	22.6	71.1	79.8	53.4	31.7	79.4	120.5	30.6	79.3	73.5
CCPG1	"CPR8, KIAA1254"	ENSG00000260916	"Cell cycle progression 1"	Q9ULG6	15	55340032-55408510	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 52.9;neutrophil: 59.9"	"Group enriched"	"Detected in all"	7	"granulocytes: 59.9;monocytes: 15.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 50.3;Karpas-707: 73.3;U-266/84: 51.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009432, HPA026861"	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA009432: AB_2668242, HPA026861: AB_1846192"	"unprognostic (3.14e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (5.07e-4)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (1.15e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.72e-2)"	22.4	20.3	21.1	11.2	34.8	29.5	20.2	27.6	27.7	32.1	16.0	9.9	28.2	11.9	16.0	19.4	12.7	11.7	26.6	29.7	21.2	26.1	27.5	56.2	23.3	19.8	21.8	18.5	17.4	41.6	37.7	56.3	13.4	21.7	21.0	16.5	13.5	33.1	27.4	44.2	7.8	16.9	16.7	23.2	19.5	22.2	13.8	19.7	5.2	41.9	12.9	11.3	20.0	16.7	3.7	5.5	59.9	15.4	4.9	5.6	5.6	2.9	10.5	2.3	5.2	38.7	13.2	3.4	6.3	12.1	3.8	5.8	3.1	5.0	4.4	21.8	20.9	7.4	4.0	2.0	5.3	3.1	11.5	3.1	5.8	13.3	2.7	50.3	8.1	18.4	11.0	12.9	7.9	7.7	31.0	13.8	0.2	9.8	73.3	11.8	4.0	0.0	4.0	1.4	11.5	2.8	1.3	3.8	17.4	7.9	2.1	3.0	4.7	7.4	4.2	32.0	7.9	6.7	17.9	13.9	11.2	2.4	8.4	4.2	14.1	51.7	2.7	20.9	16.3	8.8	34.6	11.5	52.9	5.6	10.1	4.8	3.7	3.6	4.3	5.5	2.8	3.1	4.3	59.9	4.9	15.4	0.9	4.4	5.6	21.1	34.8	27.6	27.7	21.2	26.1	21.8	18.5	21.7	19.7	107.2	100.3	14.1	26.7	13.7	62.1	11.7	48.4	104.4	112.6	83.7	88.4	24.4	5.0	45.7	107.6	39.4	20.9	23.3	127.8	18.8	46.4	51.8	36.0	85.4	45.5	81.0	16.0	63.8	57.2	149.5	52.3	56.5	45.5	79.4	25.9	77.3	67.8	45.6	109.6	32.8	123.2	51.8	41.2	37.2	43.4	14.4	20.6	34.9	15.8	18.6
CCR10	GPR2	ENSG00000184451	"C-C motif chemokine receptor 10"	P46092	17	42678889-42683917	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.1"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 12.0;Sertoli cells: 19.4;Smooth muscle cells: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 31.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 10.9;T-cells: 31.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.8;RPMI-8226: 6.4;U-266/70: 18.1;U-266/84: 8.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB011684, HPA048007, HPA069188"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB011684: AB_731502, HPA048007: AB_2680232, HPA069188: AB_2686100"	"unprognostic (3.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.18e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-11)"	"unprognostic (2.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-1)"	10.0	5.4	5.7	4.8	5.3	0.7	3.0	7.3	7.3	3.9	9.7	0.9	1.5	5.1	5.8	1.4	1.5	4.5	1.5	2.5	3.5	5.0	1.6	0.5	2.2	12.5	1.9	5.0	5.2	2.6	0.4	14.0	2.3	4.1	2.1	1.0	1.1	4.0	2.0	9.1	1.1	8.7	1.8	4.4	4.3	5.0	2.2	1.2	0.5	1.5	0.3	3.6	1.0	2.0	2.3	10.9	0.1	0.3	0.0	31.1	0.7	0.5	0.8	1.1	5.0	0.3	0.8	1.2	2.5	0.5	0.2	0.4	0.7	0.3	0.1	0.3	0.3	2.2	0.9	0.0	0.1	0.2	2.3	1.2	0.0	3.2	0.4	0.7	0.0	0.3	0.8	0.0	0.4	0.0	0.9	0.2	0.3	2.6	8.8	0.0	0.3	0.1	2.4	0.6	0.0	1.2	0.6	0.2	6.4	1.1	0.0	0.8	1.1	0.7	0.0	0.2	0.5	0.8	0.9	2.4	2.9	0.6	0.9	0.3	18.1	8.2	2.6	1.4	0.7	0.9	0.0	0.3	0.1	0.2	0.0	0.1	2.3	5.2	2.6	0.2	2.1	0.6	0.8	0.0	0.0	0.1	10.9	31.1	0.7	5.7	5.3	7.3	7.3	3.5	5.0	1.9	5.0	4.1	1.2	0.0	0.0	0.0	0.2	0.7	12.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.3	0.4	1.4	0.0	0.0	0.5	0.2	2.3	0.3	0.0	0.0	1.7	1.6	1.7	1.3	1.8	1.8	5.2	1.2	5.0	5.4	0.1	2.0	0.2	0.0	2.5	0.6	3.1	19.4	10.3	0.7	0.7	0.3	0.0	0.5	0.4	0.1
CD1D		ENSG00000158473	"CD1d molecule"	P15813	1	158179947-158184896	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.5;lymphoid tissue: 17.8"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 27.5;Kupffer cells: 52.9;Macrophages: 34.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	6	"classical monocyte: 49.5;intermediate monocyte: 22.4;myeloid DC: 49.5"	"Group enriched"	"Detected in many"	8	"dendritic cells: 49.5;monocytes: 49.5"	"Cell line enriched"	"Detected in some"	4	"JURKAT: 45.7"					"Low region specificity"	"Detected in all"			"CAB016107, HPA072662"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		720000	"Endoplasmic reticulum"		"CAB016107: AB_626960, HPA072662: AB_2686545"	"unprognostic (8.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (9.31e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.38e-1)"	1.5	1.2	0.0	8.6	0.0	2.6	1.2	0.0	0.0	0.8	2.5			9.5	1.5	0.0	0.4	1.4	2.0	1.4	0.0	0.1	1.6	10.5	2.3	5.5	0.2		0.3	0.7	0.0	0.6	0.0		1.4	3.7		0.7	0.3	0.6	0.0	12.2	2.2	0.4	17.8	1.4	1.4			1.8		3.4	1.6	0.5	6.3	49.5	2.5	49.5	0.1	0.1	23.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	2.9	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.0	8.5	0.1	0.0	3.2	0.4	0.0	0.6	0.0	0.0	45.7	0.0	0.0	0.0	0.0	11.2	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.3	0.0	3.1	0.4	0.0	49.5	0.1	0.0	22.4	0.1	6.3	0.0	0.0	49.5	4.7	0.0	0.0	2.5	0.1	3.6	0.5	0.0	23.5											0.0	5.1	27.5	0.4	0.2	0.4	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	1.2	2.2	0.0	0.0	0.1	0.2	0.0	1.1	5.3	11.3	1.6	2.4	4.3	52.9	0.9	0.0	34.3	0.0	10.0	2.0	0.3	0.0	3.7	0.0	0.0	0.1	0.0	0.5	0.5	0.9	0.1	0.1	0.0	3.9	0.0
CD3D	T3D	ENSG00000167286	"CD3d molecule"	P04234	11	118338954-118342744	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 108.7;lymphoid tissue: 181.4"	"Cell type enriched"	"Detected in many"	12	"T-cells: 532.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	53	"gdT-cell: 105.6;MAIT T-cell: 68.6;memory CD4 T-cell: 88.1;memory CD8 T-cell: 97.6;naive CD4 T-cell: 78.8;naive CD8 T-cell: 98.6;T-reg: 108.7"	"Lineage enriched"	"Detected in many"	63	"T-cells: 108.7"	"Cell line enhanced"	"Detected in some"		"JURKAT: 69.9;MOLT-4: 149.5;NB-4: 27.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB013055, HPA071778"	Enhanced		Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB013055: , HPA071778: "	"prognostic favorable (3.00e-4)"	"prognostic favorable (8.46e-5)"	"unprognostic (1.05e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (6.00e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (9.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.66e-2)"	"prognostic favorable (6.16e-4)"	2.6	0.8	0.5	17.4	0.7	4.8	1.7	0.5	0.7	1.3	4.1	0.7	0.8	4.1	1.2	1.6	3.2	1.9	2.9	1.0	0.7	0.4	2.6	1.9	6.1	40.8	0.9	0.5	1.0	1.2	0.0	0.7	0.8	0.7	2.2	4.3	1.1	9.0	0.8	0.7	1.3	19.3	1.0	1.5	28.6	4.4	0.8	0.5	181.4	2.7	2.8	32.6	5.7	2.4	0.5	0.3	1.7	0.3	0.2	108.7	64.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.9	5.7	0.0	0.0	0.0	149.5	27.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.2	105.6	0.2	68.6	0.5	88.1	97.6	0.3	0.2	78.8	98.6	1.7	0.2	0.3	0.3	108.7	64.9	0.5	0.7	0.5	0.7	0.7	0.4	0.9	0.5	0.7	0.5	6.0	45.4	3.0	0.3	13.6	0.0	2.5	0.0	2.7	4.5	3.5	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	5.1	0.1	11.6	2.0	0.6	0.0	1.2	9.8	7.6	0.4	0.0	6.1	11.8	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	5.6	0.0	0.0	10.3	0.2	532.0	0.3	0.0
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304545-118316175	"CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 294.2"	"Cell type enriched"	"Detected in some"	31	"T-cells: 377.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	36	"gdT-cell: 59.5;MAIT T-cell: 50.2;memory CD4 T-cell: 50.7;memory CD8 T-cell: 55.7;naive CD4 T-cell: 61.3;naive CD8 T-cell: 62.0;NK-cell: 21.8;T-reg: 46.8"	"Group enriched"	"Detected in many"	29	"NK-cells: 21.8;T-cells: 62.0"	"Group enriched"	"Detected in some"	67	"JURKAT: 80.1;MOLT-4: 108.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Endoplasmic reticulum, Plasma membrane"		"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favorable (1.72e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	3.9	1.0	0.5	16.7	0.7	6.8	1.9	0.5	0.7	2.1	4.7	0.9	0.7	4.4	2.0	1.4	3.3	3.0	4.0	1.4	0.5	0.5	3.3	2.6	7.3	40.9	1.3	0.6	1.5	1.3	0.0	0.9	1.2	0.9	2.6	3.9	1.9	6.4	1.1	0.8	1.3	21.1	1.1	1.9	34.5	4.6	1.2	0.5	294.2	3.4	2.1	37.8	6.3	3.0	0.2	0.9	1.4	0.2	21.8	62.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.1	0.1	0.3	0.0	0.0	108.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	1.4	0.0	0.1	0.0	1.3	0.2	0.2	59.5	0.1	50.2	0.1	50.7	55.7	0.1	0.2	61.3	62.0	1.4	21.8	0.2	0.9	46.8	32.9	0.5	0.7	0.5	0.7	0.5	0.5	1.3	0.6	0.9	0.5	0.0	11.3	4.5	0.3	4.6	0.0	0.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.1	6.5	0.2	0.0	0.0	0.0	0.0	1.0	0.1	7.0	0.8	0.3	0.0	0.0	12.3	7.3	0.0	0.0	2.5	11.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.5	0.0	0.0	4.6	0.2	377.3	0.2	0.3
CDS2		ENSG00000101290	"CDP-diacylglycerol synthase 2"	O95674	20	5126786-5197887	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019698	Approved		Approved	"Endoplasmic reticulum"		No	No		200000	"Endoplasmic reticulum"		"HPA019698: AB_1846464"	"unprognostic (4.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.53e-9)"	"unprognostic (8.89e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.44e-1)"	14.8	16.1	22.2	9.9	25.5	12.1	12.1	36.0	34.5	12.7	11.8	21.4	6.7	5.9	12.9	9.8	10.5	12.5	10.0	26.6	22.0	34.0	16.9	14.2	14.5	10.9	26.7	24.0	10.9	7.2	20.6	15.6	11.1	28.3	15.9	12.3	19.8	8.0	19.7	9.4	6.2	9.9	20.2	16.2	9.8	10.6	13.0	12.5	8.1	14.2	4.6	13.6	11.6	8.2	7.6	7.9	28.3	9.7	6.5	11.1	11.7	9.6	10.8	10.8	5.6	6.4	5.9	4.9	5.3	10.9	8.8	12.7	6.6	9.5	7.3	2.7	9.9	16.0	13.8	8.8	11.1	9.3	7.7	3.0	8.4	3.1	10.1	6.0	5.4	3.2	5.1	6.2	11.5	4.5	7.8	11.7	10.1	4.0	9.5	8.2	1.7	10.8	2.0	5.2	4.7	3.3	9.3	8.7	3.3	5.6	9.4	4.5	6.3	5.9	10.1	13.6	13.7	6.2	2.5	8.5	6.3	5.0	5.6	5.3	8.3	60.6	6.1	2.8	4.3	3.8	24.1	9.7	11.5	10.0	8.0	10.6	7.6	10.2	11.1	7.9	7.4	8.0	7.8	28.3	6.5	7.3	6.3	11.1	11.7	22.2	25.5	36.0	31.6	22.0	34.0	26.7	24.0	28.3	12.5	17.9	14.9	30.8	25.7	15.7	61.3	45.6	25.5	9.4	11.4	31.4	90.3	19.1	5.0	29.0	54.7	32.9	11.8	0.0	19.9	30.4	16.4	18.4	20.7	17.5	51.1	41.3	10.3	27.0	37.0	25.0	15.0	23.1	30.4	28.9	11.5	22.0	25.6	14.8	23.3	13.5	58.9	19.4	53.6	21.6	29.8	13.4	13.6	30.2	12.8	26.9
CERS1	"LAG1, LASS1, UOG1"	ENSG00000223802	"Ceramide synthase 1"	P27544	19	18868545-18896727	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 86.3"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 85.2"	"Cancer enhanced"	"Detected in many"		"glioma: 13.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.7;EFO-21: 13.0;HEK 293: 18.1;NB-4: 19.4;NTERA-2: 13.3"									HPA045724	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA045724: AB_10969762"	"unprognostic (8.25e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.04e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.49e-1)"	2.4	4.7	28.9	2.3	32.9	1.7	1.7	12.5	86.3	2.2	2.1	40.5	0.0	1.6	2.0	2.1	2.5	2.1	3.9	3.4	29.5	23.2	1.6	1.6	1.9	1.6	31.9	20.5	4.3	2.4	1.7	3.2	1.9	33.8	2.0	1.8	1.8	2.3	2.1	17.8	2.0	1.9	3.0	37.8	1.7	1.8	15.7	22.2	0.0	2.4	0.0	1.6	2.6	0.4	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.1	1.8	10.9	17.7	0.6	0.2	0.3	1.2	0.1	3.1	2.2	8.7	0.6	0.0	13.0	0.8	2.5	0.1	8.0	0.3	1.2	0.0	18.1	0.1	0.4	6.5	1.4	1.8	0.2	0.6	0.1	1.0	0.3	3.5	0.7	0.1	1.1	0.1	2.1	4.5	0.1	19.4	13.3	0.0	0.3	0.0	0.3	0.3	2.4	0.0	9.3	9.3	0.4	0.0	7.9	3.7	3.0	10.8	0.3	0.0	2.5	1.7	2.5	0.3	0.2	0.0	0.0	0.6	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	28.9	32.9	12.5	35.7	29.5	23.2	31.9	20.5	33.8	22.2	0.0	0.0	0.0	0.1	0.5	2.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	18.9	0.4	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	85.2	1.1	0.0	1.7	0.0	0.0	9.2	0.0	0.0	1.1	0.0	1.2	0.0	0.3	0.9	2.7	0.4	0.2	0.0	0.0	0.0
CERS2	"FLJ10243, LASS2, SP260"	ENSG00000143418	"Ceramide synthase 2"	Q96G23	1	150960583-150975004	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 142.3"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027262, HPA078737"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA		24000	"Nuclear membrane, Endoplasmic reticulum"		"HPA027262: AB_1852717, HPA078737: "	"unprognostic (1.01e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	19.4	65.5	17.0	10.5	36.1	13.9	22.6	9.6	21.3	19.8	21.1	59.3	22.1	19.6	16.9	19.0	12.5	21.1	21.6	14.4	23.0	16.1	60.9	142.3	28.6	14.0	50.1	14.5	21.8	29.7	28.7	17.6	24.0	25.5	18.5	18.8	16.5	12.3	19.2	7.1	9.1	33.3	21.2	63.7	13.2	23.4	10.2	38.7	10.2	35.5	8.8	14.0	17.5	25.6	12.3	23.5	56.6	27.0	19.3	33.6	26.2	25.5	28.0	23.6	50.6	70.5	43.3	17.7	26.1	38.4	49.9	34.3	29.3	45.3	22.5	43.7	41.1	31.2	29.2	32.7	27.9	41.0	30.5	26.7	31.0	19.6	35.4	51.0	35.2	38.4	39.4	36.0	44.0	54.9	60.5	31.1	32.5	33.2	51.5	62.2	38.5	23.0	20.3	36.1	85.2	50.0	26.3	16.0	35.8	54.0	21.7	21.8	34.0	28.8	51.3	29.9	30.7	61.0	53.4	24.1	36.1	16.3	32.6	46.0	33.4	37.5	141.2	40.6	15.1	36.6	56.6	27.0	44.0	28.0	14.6	33.6	12.3	25.7	28.4	23.4	11.4	22.9	22.2	29.2	19.3	10.2	23.5	28.8	26.2	17.0	36.1	9.6	21.3	23.0	16.1	50.1	14.5	25.5	38.7	62.5	51.6	17.2	31.4	21.4	7.0	2.2	101.9	21.4	14.8	50.6	3.9	65.8	11.6	88.6	6.4	42.6	55.1	0.0	80.3	35.9	56.4	34.0	35.8	187.2	49.9	3.2	23.6	32.5	43.8	3.8	52.0	30.4	35.4	20.8	32.1	25.3	90.5	30.8	37.8	65.4	8.2	38.8	25.5	11.8	5.2	13.7	45.3	37.6	28.9	27.6
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 355.0"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 565.6;Hepatocytes: 2145.0"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	18	"classical monocyte: 32.6;myeloid DC: 32.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 32.9;monocytes: 32.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 96.2;THP-1: 103.6"	"Not detected"	"Not detected"							"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	27.1	1.7	0.3	0.5	0.4	2.1	24.7	0.4	0.6	3.1	8.9	0.5	1.5	2.4	7.3	2.1	4.5	6.7	57.7	8.1	0.3	0.0	0.7	355.0	19.8	2.3	0.3	0.6	3.9	1.3	0.0	0.8	1.1	0.6	11.2	1.0	3.8	3.9	4.0	1.6	1.4	3.5	10.2	0.7	4.4	7.0	1.0	0.3	0.4	1.7	2.3	1.5	8.2	16.1	0.2	32.9	0.2	32.6	0.1	1.6	12.1	0.0	0.6	0.0	0.0	14.4	0.0	0.4	0.0	0.0	0.0	0.0	6.7	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	20.8	0.0	0.0	32.6	0.1	1.3	1.8	0.5	0.2	0.2	1.6	32.9	0.2	0.2	0.4	0.2	0.1	0.4	1.7	0.1	12.1	0.3	0.4	0.4	0.6	0.3	0.0	0.3	0.6	0.6	0.3	14.9	74.9	21.0	2.5	14.8	0.0	0.6	565.6	202.1	28.4	15.7	0.0	0.4	0.0	16.2	77.2	1.5	0.0	70.0	17.2	0.8	45.8	1.1	5.8	2145.0	18.9	0.0	36.2	43.0	88.2	134.3	17.3	20.4	37.1	0.0	0.0	8.3	0.9	0.2	93.0	0.5	0.5	0.0	7.2	0.9	1.0	10.2	0.7	20.3	0.0	1.7
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"esophagus: 46.7;intestine: 146.9;liver: 78.6"	"Group enriched"	"Detected in many"	4	"Enterocytes: 912.6;Hepatocytes: 449.6;Paneth cells: 448.9;Undifferentiated cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA018897	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		7500000	"Golgi apparatus"	"Endoplasmic reticulum, Cytosol"	"HPA018897: AB_1846558"	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	5.8	15.3	8.5	8.8	11.7	2.4	5.1	13.0	15.9	9.5	42.3	12.1	11.2	146.9	7.0	11.9	46.7	6.1	14.5	15.2	7.4	6.6	22.5	78.6	6.7	4.6	8.2	10.7	8.4	12.0	10.0	6.8	7.3	10.3	9.7	42.6	13.0	12.7	7.9	11.6	8.9	117.3	10.4	5.6	7.8	10.9	8.5	8.2	9.0	11.7	14.1	12.1	7.6	11.6	6.9	8.9	5.0	10.6	7.9	10.7	5.2	6.9	9.1	9.6	12.8	9.5	8.9	7.3	7.9	12.8	9.3	11.9	9.8	11.5	8.1	7.9	10.3	7.0	18.0	7.0	19.9	7.3	7.2	9.7	7.9	5.2	18.4	13.4	10.4	14.0	12.9	37.7	13.2	22.1	11.5	6.9	5.7	11.1	6.0	15.7	4.4	9.3	8.7	5.2	7.5	9.2	11.0	9.7	9.5	26.4	12.1	6.2	8.2	25.8	6.5	6.7	3.9	11.2	12.9	8.5	12.3	6.5	7.6	5.9	12.0	14.3	9.6	18.9	8.2	9.2	4.7	10.4	4.7	10.1	7.8	9.2	6.1	7.7	10.7	8.9	6.9	9.5	8.6	5.0	7.9	10.6	7.7	6.8	5.2	8.5	11.7	13.0	15.9	7.4	6.6	8.2	10.7	10.3	8.2	29.8	24.0	25.9	13.7	17.3	28.5	25.4	137.6	42.8	12.5	50.6	19.6	13.0	31.5	21.9	1.5	9.8	912.6	0.0	29.5	5.6	12.7	14.5	27.6	449.6	16.6	27.0	23.2	25.2	27.6	1.3	17.3	13.9	10.1	5.4	141.3	17.6	37.9	448.9	17.0	124.1	22.7	32.3	11.3	42.6	10.2	17.9	11.3	18.7	459.3	15.2
CES3	"ES31, FLJ21736"	ENSG00000172828	"Carboxylesterase 3"	Q6UWW8	16	66961237-66975148	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8;liver: 26.7"	"Group enriched"	"Detected in many"	5	"Enterocytes: 66.2;Hepatocytes: 40.9;Intestinal endocrine cells: 18.9;Mucus-secreting cells: 31.1;Paneth cells: 60.4;Undifferentiated cells: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.1;Daudi: 8.9;JURKAT: 14.6;U-937: 7.6"					"Not detected"	"Not detected"			"HPA041008, HPA041307"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		1200000	"Nuclear membrane, Endoplasmic reticulum"		"HPA041008: AB_2677247, HPA041307: AB_2677400"	"unprognostic (3.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.84e-4)"	"prognostic favorable (7.26e-5)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-2)"	0.5	0.1	0.8	13.3	1.3	0.2	1.0	1.6	1.3	0.6	40.7	0.7	1.4	16.8	0.4	0.7	2.2	1.5	3.0	0.7	1.5	1.0	6.8	26.7	0.9	0.2	0.8	1.1	0.5	7.8	0.0	1.1	0.4	2.2	0.4	17.9	1.1	5.9	0.6	12.9	0.5	41.8	0.5	0.9	0.2	4.6	0.9	0.6	0.5	0.4	2.4	0.5	0.4	0.3	0.7	0.6	2.7	0.6	0.3	0.9	0.2	0.4	3.2	0.4	8.1	0.3	0.2	1.3	0.3	0.2	0.4	0.5	0.5	4.0	8.9	2.7	0.0	0.2	0.7	1.2	0.6	0.1	1.5	6.0	4.4	1.3	2.6	0.1	1.0	0.7	0.3	1.0	0.9	0.2	0.3	0.0	14.6	2.8	1.9	0.3	1.2	1.5	1.6	1.4	2.7	0.5	1.4	0.7	1.4	0.1	0.5	0.4	0.9	0.2	6.1	0.2	0.7	5.4	6.8	0.4	0.4	2.6	0.7	0.2	1.0	3.6	1.3	0.3	7.6	0.2	0.6	0.6	2.7	0.3	0.3	0.5	0.5	0.6	0.4	0.6	0.7	0.9	0.6	2.0	0.3	0.4	0.3	0.9	0.2	0.8	1.3	1.6	1.3	1.5	1.0	0.8	1.1	2.2	0.6	3.0	7.0	0.8	0.0	0.5	0.0	1.0	5.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	66.2	0.0	0.8	0.0	0.0	0.2	1.1	40.9	0.2	0.0	18.9	0.0	3.2	2.6	0.0	1.4	0.0	0.0	31.1	0.2	1.0	60.4	1.1	8.2	0.0	0.0	0.0	0.6	1.3	0.3	0.0	0.0	31.9	0.1
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 461.5"	"Group enriched"	"Detected in many"	8	"Ductal cells: 523.0;Exocrine glandular cells: 173.6;Hepatocytes: 158.3;Pancreatic endocrine cells: 492.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 6.1;ASC TERT1: 6.0;CAPAN-2: 7.1;EFO-21: 5.3;fHDF/TERT166: 11.6;HSkMC: 19.1"									"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	180000000000	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	9.3	1.0	0.3	4.1	0.4	0.3	2.4	0.2	0.4	1.3	9.0	0.4	0.9	3.2	0.5	3.7	2.2	4.0	8.9	3.3	0.2	0.0	16.1	461.5	2.5	2.1	0.7	0.1	2.8	5.8	0.4	1.0	4.0	1.0	4.0	1.6	2.6	3.1	0.3	0.5	0.5	4.7	2.6	0.6	0.8	4.1	1.4	0.3	0.3	1.8	0.5	1.7	1.6	0.4	0.1	1.6	0.0	0.8	0.0	0.2	0.0	0.0	1.8	0.1	0.1	6.1	6.0	0.0	0.0	0.3	1.6	0.6	0.0	7.1	0.1	5.3	11.6	0.3	0.0	0.0	1.9	1.4	0.4	0.3	0.4	0.3	0.6	0.0	0.7	0.1	19.1	0.1	0.9	0.6	0.6	0.2	0.1	0.2	0.7	0.1	0.1	0.1	0.4	0.3	0.0	0.1	0.2	0.4	0.2	1.7	0.0	0.0	0.0	0.6	1.2	0.2	0.0	0.0	0.2	0.0	0.2	0.5	0.3	0.4	0.6	1.9	0.5	3.2	0.6	0.5	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.3	0.4	0.2	0.3	0.2	0.0	0.7	0.1	1.0	0.3	0.0	20.0	14.0	0.7	0.7	0.1	0.4	20.4	24.1	40.9	5.2	0.0	0.0	3.3	523.0	0.0	2.4	5.0	0.0	173.6	0.1	6.0	9.0	0.0	158.3	0.8	0.0	2.4	11.6	13.2	0.0	2.6	1.2	0.0	31.5	6.7	0.8	492.1	11.8	0.0	11.2	0.7	0.0	3.8	0.1	0.0	1.6	1.4	1.9	11.2	1.8
CHKA	"CHK, CKI"	ENSG00000110721	"Choline kinase alpha"	P35790	11	68052859-68121444	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 282.2;Late spermatids: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024153, CAB072803"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB072803: , HPA024153: AB_1846664"	"unprognostic (5.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (2.36e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (5.00e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.73e-2)"	8.9	15.5	18.1	6.4	19.5	25.5	18.6	10.2	19.3	10.8	18.2	30.9	28.8	19.0	5.8	19.2	3.9	6.5	10.7	5.4	18.7	15.4	8.0	17.4	11.4	7.5	26.5	12.5	10.4	29.3	9.2	10.0	5.0	21.5	13.5	11.8	17.4	36.9	37.4	3.9	4.2	22.8	8.2	20.9	13.5	18.8	55.9	22.7	3.1	19.9	2.2	5.2	8.7	4.7	1.3	1.5	9.5	2.5	1.6	0.7	0.4	8.0	7.0	8.2	7.9	2.8	1.9	8.3	2.6	4.2	7.2	4.7	30.1	22.8	6.2	9.6	3.7	7.8	5.4	11.5	1.8	5.5	2.8	4.1	7.7	9.2	34.8	7.9	8.1	4.3	3.8	3.1	3.3	1.6	4.1	4.1	4.0	7.2	10.8	3.8	6.2	4.3	22.1	13.2	27.3	4.8	7.0	8.7	17.4	6.1	9.1	6.1	6.5	4.9	25.1	57.8	7.1	10.6	11.2	2.3	4.6	5.8	10.9	3.3	12.7	13.0	10.8	5.0	10.7	4.2	0.0	1.4	9.5	0.2	2.5	0.0	1.3	0.1	0.4	1.5	0.6	0.7	0.5	0.8	1.6	1.5	1.2	0.3	0.4	18.1	19.5	10.2	19.3	18.7	15.4	26.5	12.5	21.5	22.7	41.7	30.1	4.5	14.6	14.1	10.2	2.2	33.1	17.4	14.8	3.5	31.4	6.1	11.6	8.8	282.2	8.5	26.2	0.0	16.5	3.2	9.5	16.9	18.5	16.9	14.9	54.0	26.9	9.2	22.6	221.9	5.8	13.0	21.9	9.0	14.3	20.0	14.9	20.1	2.5	3.7	25.8	0.0	10.3	56.6	19.2	9.2	10.9	2.9	21.7	33.5
CHRNB4		ENSG00000117971	"Cholinergic receptor nicotinic beta 4 subunit"	P30926	15	78624119-78727754	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"adrenal gland: 6.6;lymphoid tissue: 18.5;retina: 10.6;testis: 10.7"	"Group enriched"	"Detected in some"	21	"Early spermatids: 41.7;Late spermatids: 39.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"SCLC-21H: 20.7;SH-SY5Y: 26.9"	"Group enriched"	"Detected in some"	5	"olfactory region: 6.5;pons and medulla: 1.4;thalamus: 4.6"	"Low region specificity"	"Detected in many"			HPA059484			Approved	"Endoplasmic reticulum,Cell Junctions"		NA	NA			"Endoplasmic reticulum"	"Cell Junctions"	"HPA059484: "	"unprognostic (4.74e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.77e-5)"	"unprognostic (8.15e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-4)"	"unprognostic (7.00e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.76e-2)"	0.2	6.6	2.7	3.9	0.8	0.7	0.2	0.5	0.4	0.6	2.3	0.2	0.0	0.2	0.8	0.7	1.4	0.1	0.1	0.8	1.0	0.3	0.5	0.1	0.1	2.9	0.2	0.0	0.3	0.2	0.0	1.6	0.0	1.3	0.2	1.1	10.6	2.2	2.4	0.6	0.3	1.0	0.9	1.0	1.0	0.8	10.7	0.1	18.5	0.4	0.3	1.1	0.5	0.5	1.5	0.4	1.4	0.8	1.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	26.9	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.3	0.5	0.2	0.6	0.9	0.5	0.6	0.2	1.5	0.8	0.8	1.4	1.0	0.4	0.4	0.3	0.0	2.7	0.8	0.5	0.4	1.0	0.3	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.4	0.1	0.0	0.0	0.0	1.6	1.9	0.0	0.0	0.0	0.0	0.1
CISD2	"ERIS, Miner1, NAF-1, WFS2, ZCD2"	ENSG00000145354	"CDGSH iron sulfur domain 2"	Q8N5K1	4	102868974-102892807	"Disease related genes, Predicted membrane proteins"	Autophagy		"Deafness, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015914	Approved		Supported	"Endoplasmic reticulum"		NA	NA		80000	"Endoplasmic reticulum"		"HPA015914: AB_1846794"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.48e-3)"	"unprognostic (9.12e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	8.1	13.8	14.8	13.5	11.3	13.7	11.2	14.5	16.1	13.5	8.3	9.3	9.3	5.0	9.4	14.4	8.5	8.2	11.5	10.6	14.5	17.7	19.8	40.5	8.0	12.8	17.9	8.2	8.2	29.7	13.3	10.7	9.5	15.6	7.8	10.7	9.4	16.3	10.5	4.9	7.7	12.5	8.0	16.7	13.0	7.0	7.6	8.4	11.2	21.2	5.6	8.9	6.8	9.3	5.1	6.9	11.0	5.7	7.9	6.6	4.2	10.6	3.6	3.8	4.8	9.6	10.5	2.4	8.4	3.1	3.6	5.5	4.1	18.0	7.8	7.4	7.8	8.6	5.3	18.3	6.6	16.5	6.8	2.8	6.6	2.5	4.2	7.0	11.9	10.7	3.9	10.1	15.1	11.9	3.4	6.4	4.3	14.5	14.0	9.6	2.9	10.3	3.5	7.5	3.6	2.7	4.3	3.9	14.1	8.7	3.4	8.9	5.3	4.9	8.5	7.8	4.6	5.6	2.5	2.8	10.6	11.8	14.3	5.0	10.8	14.6	15.8	7.6	3.7	8.1	7.2	5.6	11.0	5.4	5.1	5.8	5.1	5.5	5.6	5.3	4.0	3.8	4.9	4.1	7.9	5.7	6.9	6.6	4.2	14.8	11.3	14.5	16.1	14.5	17.7	17.9	8.2	15.6	8.4	23.8	25.0	53.7	38.3	76.1	29.8	24.8	48.4	17.4	23.9	73.3	19.6	67.4	61.3	82.9	9.3	26.3	58.3	210.2	67.5	102.3	44.1	55.3	57.6	142.1	102.4	28.6	41.2	19.0	73.8	4.2	22.2	68.4	65.8	85.6	58.6	24.6	77.7	83.4	31.8	182.4	24.3	32.3	31.1	25.1	30.9	78.7	47.5	45.7	58.6	44.3
CLCC1	MCLC	ENSG00000121940	"Chloride channel CLIC like 1"	Q96S66	1	108929508-108963457	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009087, HPA013210"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA009087: AB_1078532, HPA013210: AB_1846895"	"unprognostic (2.95e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.68e-3)"	"unprognostic (9.65e-2)"	17.4	19.5	17.5	13.2	24.8	7.1	19.1	22.8	26.1	19.0	16.4	28.4	22.9	15.6	22.1	31.2	12.2	16.9	15.8	20.2	19.5	15.2	12.2	23.5	15.1	10.9	24.4	16.3	23.3	28.5	26.6	24.4	20.0	20.5	23.1	15.3	17.7	21.8	24.1	29.3	16.1	14.8	19.3	21.5	13.7	17.9	8.3	24.3	5.1	21.7	10.4	12.9	17.1	16.0	7.7	9.5	9.0	15.4	7.1	9.4	5.5	23.8	10.4	13.5	23.3	18.8	17.1	17.5	19.9	16.4	14.1	15.3	11.2	10.0	5.7	21.4	15.7	9.2	9.2	12.2	7.5	18.1	18.1	10.9	14.1	13.0	10.3	15.1	13.9	15.6	12.5	11.3	16.3	13.4	14.5	12.9	6.7	17.0	23.3	10.3	9.5	1.3	5.5	10.2	8.4	9.4	12.9	6.9	13.6	11.8	14.2	8.1	12.4	23.3	25.2	18.0	10.8	7.9	9.5	13.9	18.9	15.1	18.0	19.5	17.0	13.9	8.8	23.0	11.3	40.6	4.1	9.2	9.0	9.1	11.1	9.4	7.7	7.7	7.2	8.0	5.9	8.7	7.9	1.6	7.1	15.4	9.5	9.2	5.5	17.5	24.8	22.8	26.1	19.5	15.2	24.4	16.3	20.5	24.3	23.8	18.1	4.5	11.7	3.3	13.1	4.5	15.3	18.7	19.4	10.4	27.5	24.4	0.0	15.5	6.1	7.1	5.7	0.0	18.3	10.5	14.6	15.9	11.5	19.2	11.6	20.6	3.5	10.4	4.3	2.1	18.4	5.7	8.5	11.8	8.8	14.5	17.7	0.0	17.7	5.6	15.6	19.4	8.0	4.2	4.6	5.5	15.4	6.4	10.1	8.9
CLEC14A	C14orf27	ENSG00000176435	"C-type lectin domain containing 14A"	Q86T13	14	38254103-38256369	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 63.2"	"Group enriched"	"Detected in some"	45	"Endothelial cells: 217.3;Ito cells: 286.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"myeloid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 17.4;HUVEC TERT2: 94.4;TIME: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039468, HPA048119"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		3600000	"Endoplasmic reticulum, Golgi apparatus"		"HPA039468: AB_2676524, HPA048119: AB_2680270"	"unprognostic (4.02e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.20e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.13e-6)"	"unprognostic (2.55e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.28e-2)"	32.2	3.9	3.2	6.8	4.3	0.0	47.8	2.3	3.9	14.5	9.3	3.4	5.9	5.9	18.4	13.3	9.3	9.9	13.6	23.7	3.8	3.4	6.8	11.4	63.2	7.9	4.9	2.2	7.6	3.3	5.0	2.8	15.0	4.4	11.8	4.4	10.8	5.5	6.5	36.5	6.5	7.4	12.1	3.9	9.0	5.9	6.8	2.2	1.4	14.0	21.1	3.8	9.4	14.8	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	4.3	2.3	3.9	3.8	3.4	4.9	2.2	4.4	2.2	0.0	5.6	2.9	0.3	3.1	0.0	5.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.0	217.3	0.0	0.0	0.2	0.1	2.7	0.2	1.1	0.8	0.3	0.0	0.0	286.7	5.6	1.0	0.6	0.7	5.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.5	0.0	4.1	0.6	0.2	2.8	0.1	0.0	0.0	0.0
CLGN		ENSG00000153132	Calmegin	O14967	4	140388455-140427968	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.3;pituitary gland: 23.6;testis: 52.6"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 243.4;Early spermatids: 78.2;Muller glia cells: 200.1;Spermatocytes: 280.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 21.7;U-251 MG: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020709, HPA048761, HPA058627"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782"	"unprognostic (6.74e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.01e-1)"	0.4	3.6	2.1	0.7	3.7	1.2	1.6	5.9	3.5	0.8	1.4	0.5	0.0	0.4	1.0	1.6	0.9	7.0	0.4	40.3	0.9	3.4	0.4	3.7	0.5	0.5	1.4	1.6	1.8	1.6	0.2	23.6	0.3	8.6	11.9	0.8	2.4	0.6	0.6	0.4	0.3	0.8	0.9	0.8	0.3	1.6	52.6	0.3	3.1	1.5	0.0	0.8	0.6	0.4	0.5	1.0	3.4	1.1	0.0	0.0	0.1	0.0	4.0	4.2	2.7	1.7	8.8	1.0	0.0	3.7	4.0	7.5	0.1	0.3	0.0	11.5	0.4	3.5	0.1	2.9	0.0	6.6	0.2	3.4	1.1	4.0	2.9	17.5	14.6	0.2	1.0	16.1	0.4	0.4	21.7	0.1	3.9	0.7	0.0	0.0	0.2	18.3	0.2	4.8	0.1	11.4	12.2	0.0	0.1	0.0	0.1	6.8	12.3	2.5	1.6	0.7	1.6	0.8	2.2	0.0	11.0	2.0	4.0	28.9	5.8	12.6	7.9	17.7	0.6	1.2	3.4	1.1	1.5	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	5.9	3.5	0.9	3.4	1.4	1.6	8.6	0.3	0.0	2.1	0.0	1.0	0.0	8.5	243.4	0.0	28.1	4.5	0.0	3.9	0.3	0.0	0.9	78.2	1.1	0.0	23.3	3.7	0.1	0.5	35.3	0.0	2.6	0.1	23.8	5.1	0.0	0.0	42.6	4.6	0.0	1.7	0.0	0.0	200.1	1.4	0.0	4.2	0.0	11.8	0.0	0.3	280.7	9.8	0.1	0.2	0.0	0.4	0.9
CLN6	"FLJ20561, HsT18960, nclf"	ENSG00000128973	"CLN6, transmembrane ER protein"	Q9NWW5	15	68206992-68257211	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 161.8;Hofbauer cells: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066046, HPA066759"	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	"Nucleoli, Vesicles"	"HPA066046: AB_2685604, HPA066759: "	"unprognostic (1.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.78e-2)"	21.2	17.8	11.6	16.5	11.8	29.8	13.9	14.9	20.7	14.4	20.2	13.2	11.6	17.1	11.7	14.3	16.7	12.0	17.1	10.4	11.7	10.8	22.0	29.5	18.8	27.0	11.1	12.2	12.4	19.7	11.7	11.5	18.6	14.3	13.4	18.0	28.6	16.0	17.9	16.3	17.0	18.5	12.4	11.6	26.5	15.7	13.8	9.7	27.7	14.5	18.2	21.7	11.0	10.9	2.9	4.6	9.4	13.4	1.8	4.1	2.7	11.5	28.8	7.5	10.6	4.7	3.8	18.2	11.0	5.3	13.6	11.2	22.2	18.8	18.0	5.5	6.5	10.1	21.5	21.6	10.7	5.4	11.9	26.4	25.9	21.1	16.5	9.6	29.1	18.5	6.7	3.6	10.9	7.5	2.8	9.0	10.3	17.0	36.5	10.4	31.6	13.2	20.9	18.1	20.5	12.3	12.9	23.1	24.5	11.3	30.2	15.5	6.4	12.4	19.4	10.6	5.9	10.4	29.1	5.9	15.3	18.2	11.3	38.9	26.7	29.0	14.7	9.6	35.4	14.8	0.0	7.3	0.4	2.8	11.5	3.8	2.9	2.1	4.1	4.6	2.3	2.7	1.2	9.4	1.8	13.4	3.8	1.9	2.7	11.6	11.8	14.9	20.7	11.7	10.8	11.1	12.2	14.3	9.7	8.9	5.8	12.7	17.8	17.9	161.8	19.9	0.0	0.0	4.5	5.2	15.7	29.2	0.0	3.1	0.2	12.9	13.6	23.3	1.6	44.9	15.2	12.6	9.2	17.7	76.0	20.6	14.6	14.1	18.0	1.3	8.3	11.9	18.6	7.2	15.3	16.9	3.1	20.9	7.8	1.3	31.0	6.5	8.0	0.9	16.8	12.3	18.2	10.9	30.5	14.5
CLPTM1L	"CRR9, FLJ14400"	ENSG00000049656	"CLPTM1 like"	Q96KA5	5	1317744-1345099	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 83.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014791	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA014791: AB_1847250"	"unprognostic (2.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (3.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.47e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.77e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.17e-2)"	15.8	14.1	10.6	20.5	12.4	13.5	16.3	6.7	16.9	13.8	19.0	11.1	12.1	24.6	12.0	10.6	15.7	11.7	20.7	13.1	11.3	12.2	29.4	56.1	20.0	17.6	14.8	8.3	11.3	57.6	10.0	14.6	15.8	11.6	13.9	11.0	13.1	33.3	14.5	8.3	12.3	23.6	12.1	9.2	22.5	25.6	20.0	9.8	37.2	30.9	11.3	21.1	13.8	9.8	10.4	12.3	12.3	9.6	12.8	9.7	5.2	12.7	21.7	7.4	20.0	12.1	5.2	19.6	13.1	8.7	11.8	11.7	23.6	20.4	12.2	40.5	12.2	26.3	11.2	10.0	10.9	5.4	49.6	27.5	6.4	50.7	15.6	13.6	16.8	16.5	8.3	12.5	10.9	10.2	8.7	9.6	28.1	14.5	41.9	8.9	20.9	18.5	22.1	13.7	14.2	23.6	15.7	12.1	37.4	9.2	12.2	7.8	15.5	22.9	19.9	9.9	6.5	33.5	25.3	7.1	14.2	40.8	9.8	18.8	75.8	83.6	19.7	10.6	25.4	16.1	4.6	6.7	12.3	7.9	6.2	9.3	9.7	8.4	7.8	6.0	10.4	8.0	9.6	5.2	12.8	9.6	12.3	9.7	5.2	10.6	12.4	6.7	16.9	11.3	12.2	14.8	8.3	11.6	9.8	53.6	65.0	17.1	16.0	19.8	9.7	11.3	50.9	32.1	38.7	27.9	13.7	9.6	5.0	15.2	2.0	19.5	35.1	23.3	27.7	17.2	13.6	39.9	24.3	114.3	20.9	20.6	42.9	25.8	37.2	2.6	16.1	17.0	15.1	6.4	46.8	21.2	37.1	28.5	18.0	58.6	10.5	12.9	13.3	18.9	35.7	20.6	9.2	18.1	32.0	28.8
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15665031	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 204.4"	"Cell type enriched"	"Detected in some"	15	"Proximal tubular cells: 679.1"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 5.0"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.6;hTERT-HME1: 6.1;RPTEC TERT1: 9.8;SuSa: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.1	0.2	0.3	0.1	0.4	0.0	0.3	0.1	0.2	0.2	0.2	0.5	0.1	0.1	0.2	1.6	0.2	0.4	0.6	0.2	0.5	0.4	204.4	11.5	0.6	0.1	0.3	0.1	0.8	1.2	4.0	0.2	0.7	5.0	0.3	0.0	11.3	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	2.4	0.3	0.1	0.2	0.7	0.1	0.1	0.4	0.2	0.9	0.6	0.0	0.5	0.0	3.0	0.4	3.0	2.1	1.5	0.6	0.8	1.2	1.0	0.1	0.0	0.1	0.1	0.2	0.5	0.3	2.1	0.1	0.2	10.6	0.9	2.5	0.0	0.4	1.4	0.3	0.0	1.0	1.6	0.0	0.0	0.2	2.4	0.4	6.1	0.7	0.0	2.4	0.7	0.6	0.3	3.5	0.2	0.4	3.5	0.9	3.1	0.3	0.5	1.3	9.8	0.2	1.4	1.3	0.8	0.2	2.0	6.5	1.0	0.3	0.1	0.2	0.5	0.4	0.0	0.5	0.3	0.4	0.9	0.1	0.1	0.0	0.5	0.0	0.6	0.2	1.3	0.4	0.8	0.5	0.6	0.9	3.0	0.9	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.4	0.1	0.2	0.5	0.4	0.3	0.1	5.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	26.2	0.0	1.9	46.4	19.8	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	679.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0
CLUL1		ENSG00000079101	"Clusterin like 1"	Q15846	18	596988-650334	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 45.2"	"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 335.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 24.6"					"Not detected"	"Not detected"			"CAB025264, HPA075240"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Endoplasmic reticulum"	"Plasma membrane"	"CAB025264: , HPA075240: AB_2732286"	"unprognostic (1.75e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.81e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.97e-3)"	"unprognostic (8.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.37e-2)"	0.5	1.4	5.0	0.5	3.8	4.3	3.1	4.5	6.6	2.1	1.0	1.4	1.0	0.6	1.9	0.7	1.6	2.4	2.5	0.4	5.9	6.4	7.5	0.7	1.8	0.8	4.9	2.0	7.4	1.6	2.5	6.1	0.7	5.1	12.0	0.0	45.2	3.1	1.6	0.1	0.8	1.7	0.4	5.3	0.1	3.9	3.4	2.8	0.3	9.4	0.1	0.4	2.1	0.3	1.0	1.3	2.1	0.3	0.1	2.0	0.5	2.6	3.9	7.5	5.1	0.0	0.0	4.5	2.9	0.2	0.0	0.0	3.1	1.5	3.1	0.7	0.0	2.7	1.1	0.0	0.4	0.0	2.5	7.0	5.2	2.1	24.6	0.0	1.7	1.0	0.2	0.0	0.0	0.0	1.3	0.3	7.7	7.3	9.1	0.0	0.8	3.1	5.6	0.5	3.2	1.8	6.3	3.5	11.0	0.8	0.8	6.6	4.6	2.9	1.8	2.2	6.3	2.4	0.8	0.6	3.0	4.4	2.1	1.4	5.2	9.1	6.5	2.4	3.4	2.6	0.9	0.3	0.2	0.2	0.0	0.1	1.0	0.4	0.2	0.5	0.1	0.1	0.8	2.1	0.1	0.0	1.3	2.0	0.5	5.0	3.8	4.5	5.7	5.9	6.4	4.9	2.0	5.1	2.8	0.0	1.6	0.0	3.4	0.0	23.9	0.1	0.0	4.0	2.3	0.0	19.6	0.4	1.7	0.2	0.4	0.2	0.0	0.0	0.2	0.1	0.1	8.5	0.0	0.0	0.2	15.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	46.9	0.0	0.0	1.1	0.3	335.8	6.5	0.0	8.4	4.5	0.1	0.3	0.0	0.0	1.4
COL10A1		ENSG00000123500	"Collagen type X alpha 1 chain"	Q03692	6	116118923-116158747	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.2;retina: 32.7"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 1.1;Club cells: 1.2;Horizontal cells: 1.6;Muller glia cells: 2.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 51.9"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enriched"	"Detected in some"	6	"hTEC/SVTERT24-B: 30.1"	"Region enhanced"	"Detected in single"		"amygdala: 1.0"	"Low region specificity"	"Detected in single"			HPA053268			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000	"Endoplasmic reticulum"		"HPA053268: "	"unprognostic (3.83e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.20e-2)"	"unprognostic (7.45e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.38e-11)"	"unprognostic (2.16e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.06e-3)"	0.9	0.1	0.4	0.8	0.7	0.1	0.3	0.3	1.4	1.4	0.3	0.9	0.3	0.0	0.6	0.3	0.5	0.0	12.2	0.3	0.6	0.2	0.8	0.7	3.5	0.4	0.3	0.6	5.4	4.2	0.5	0.9	0.3	3.2	2.6	0.0	32.7	6.5	0.9	0.3	0.7	0.3	0.5	0.3	2.9	0.2	0.5	0.3	0.8	1.4	0.3	2.0	0.3	0.3	0.6	0.3	2.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	2.2	0.3	4.6	0.0	0.0	0.1	0.0	0.7	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	30.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	4.9	0.1	0.3	0.4	0.0	0.0	0.1	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.3	1.4	0.6	0.2	0.3	0.6	3.2	0.3	0.0	1.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0
COL11A1	"CO11A1, COLL6, STL2"	ENSG00000060718	"Collagen type XI alpha 1 chain"	P12107	1	102876467-103108872	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 33.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 12.1;Melanocytes: 10.1;Muller glia cells: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 38.5;BJ: 13.5;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;HBF TERT88: 16.3;HSkMC: 48.5;SuSa: 21.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA058335			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		270000	"Endoplasmic reticulum"		"HPA058335: AB_2683682"	"unprognostic (2.60e-3)"	"unprognostic (6.61e-4)"	"unprognostic (9.58e-2)"	"unprognostic (5.06e-5)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.01e-12)"	"unprognostic (1.27e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	1.2	1.8	8.6	1.3	9.1	0.8	1.5	2.0	7.9	2.3	1.1	4.1	0.0	1.0	1.8	1.0	0.8	0.8	5.9	0.8	8.3	8.6	1.0	0.8	1.2	0.9	8.1	5.9	1.2	1.9	1.0	5.5	33.3	11.1	1.1	1.4	5.9	3.3	2.2	0.9	2.4	0.9	1.3	9.0	2.2	0.9	4.7	5.8	0.0	0.9	0.6	0.8	1.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	38.5	0.0	1.5	2.1	0.0	13.5	5.2	7.8	28.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	48.5	0.0	0.3	0.0	5.9	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	2.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.2	9.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.6	9.1	2.0	7.9	8.3	8.6	8.1	5.9	11.1	5.8	0.0	2.1	0.0	0.0	1.5	0.6	0.4	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.5	2.1	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.1	0.6	10.1	0.0	0.0	27.8	0.1	0.0	0.0	0.0	1.7	0.0	1.9	0.5	0.4	1.0	0.2	0.0	0.0	0.0
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	22	"Fibroblasts: 113.2;Leydig cells: 302.6;Peritubular cells: 454.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;NK-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 13.3;BJ hTERT+: 27.8;HDLM-2: 11.8;K-562: 9.0;U-2197: 23.0;U-87 MG: 10.5;WM-115: 15.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		23000000	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (3.08e-4)"	36.1	17.6	0.5	12.7	0.7	0.0	21.4	0.4	0.7	22.4	19.7	1.4	5.0	3.0	42.4	22.0	26.6	9.0	25.2	41.2	0.5	0.7	8.7	1.0	5.6	11.7	1.6	0.8	28.9	13.7	4.5	3.4	66.9	2.1	16.6	4.0	11.4	23.4	6.2	12.8	6.7	11.1	27.3	1.3	3.9	14.8	22.8	0.4	5.1	10.5	21.7	8.6	21.3	8.8	0.6	0.1	0.0	0.4	1.7	1.7	0.2	0.0	0.0	0.0	0.0	2.4	1.3	0.0	13.3	27.8	0.7	0.2	0.0	0.0	0.1	0.4	2.8	0.1	0.0	0.0	0.0	0.1	11.8	0.0	0.1	6.7	0.0	0.5	0.2	1.3	3.9	0.0	3.0	0.1	0.0	0.0	0.0	9.0	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	7.4	0.1	0.0	0.0	0.0	0.0	0.4	2.0	3.5	0.1	0.1	0.3	0.0	0.0	0.3	23.0	0.2	0.1	0.0	0.0	10.5	0.1	15.6	0.0	0.3	0.0	1.7	0.4	0.1	0.6	0.4	0.5	0.1	0.1	0.1	0.3	0.0	1.7	0.2	0.0	0.4	0.2	0.5	0.7	0.4	0.7	0.5	0.7	1.6	0.8	2.1	0.4	0.0	0.0	0.0	0.1	17.3	0.0	5.6	0.0	0.0	0.0	0.0	0.0	3.1	0.0	2.1	5.2	71.7	0.0	0.0	0.7	3.0	113.2	0.8	0.0	0.0	7.0	0.0	0.0	0.0	0.3	11.0	302.6	1.0	16.9	1.0	0.0	0.0	0.8	0.0	454.3	0.0	0.0	12.9	16.5	1.7	1.4	14.3	6.4	0.0	0.0	0.1
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50183289-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 415.7"	"Cell type enhanced"	"Detected in many"	22	"Fibroblasts: 2038.6;Ito cells: 615.0;Leydig cells: 514.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 91.8;BJ: 176.2;fHDF/TERT166: 266.1;HHSteC: 71.8;HSkMC: 134.8;U-138 MG: 143.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA011795, HPA012111"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		58000000	"Endoplasmic reticulum, Vesicles"		"HPA011795: AB_1847088, HPA012111: "	"unprognostic (1.61e-1)"	"unprognostic (3.60e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (7.19e-12)"	"unprognostic (2.74e-2)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.87e-3)"	30.2	5.7	0.7	28.2	4.0	0.1	31.7	0.6	0.9	415.7	25.7	1.6	23.9	3.0	121.8	70.9	17.4	33.0	110.3	43.9	0.7	0.1	7.5	4.6	18.8	38.5	0.7	1.2	73.6	10.5	1.0	10.7	89.1	2.2	31.5	4.0	9.2	9.1	21.0	11.0	35.5	10.6	88.0	1.3	13.7	15.0	44.6	0.7	7.7	6.7	15.5	8.7	67.3	49.7	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.2	0.9	0.1	37.7	91.8	1.6	176.2	47.9	43.9	27.6	3.5	0.8	0.0	0.4	266.1	0.3	0.5	0.4	0.1	7.9	0.2	0.3	0.0	4.4	0.2	71.8	0.0	0.0	134.8	2.6	53.7	0.2	7.3	0.0	0.2	0.1	0.0	22.1	0.4	0.0	0.0	0.9	0.6	0.5	0.3	0.1	0.1	0.2	0.0	0.1	0.5	0.3	0.2	0.0	13.7	2.2	0.0	0.0	143.2	31.3	21.4	0.8	0.1	0.3	0.0	10.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.0	0.6	0.9	0.7	0.1	0.7	1.2	2.2	0.7	8.9	14.4	0.5	11.0	166.9	0.0	4.8	0.0	5.3	12.5	7.0	0.0	29.5	0.0	11.2	0.9	5.1	0.0	0.0	3.7	26.1	2038.6	12.1	2.3	1.9	59.9	0.0	2.9	615.0	0.8	4.5	514.8	7.7	178.8	0.0	2.2	2.8	25.7	0.0	252.1	0.5	0.1	77.6	273.4	4.2	1.7	142.9	93.5	0.5	1.3	7.5
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394561-94431232	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 244.6"	"Cell type enhanced"	"Detected in many"	15	"Fibroblasts: 1445.8;Ito cells: 427.2;Leydig cells: 918.4;Peritubular cells: 470.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 154.3;ASC TERT1: 185.1;BJ: 151.4;BJ hTERT+: 111.2;fHDF/TERT166: 512.4;HSkMC: 160.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000000	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: AB_2684116"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	44.7	9.8	1.2	34.9	4.3	0.0	33.4	1.7	2.4	244.6	26.5	2.1	54.1	3.8	166.9	139.1	28.2	36.6	101.4	45.1	1.3	0.8	10.2	4.1	37.1	20.4	1.8	2.8	68.3	10.9	1.8	6.0	70.6	3.8	40.3	10.1	23.0	17.5	28.0	12.1	35.6	15.2	100.7	3.2	16.4	16.1	49.7	1.1	5.6	14.7	42.7	12.6	62.4	55.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	57.1	154.3	185.1	0.0	151.4	111.2	24.9	33.3	0.0	0.1	0.0	0.1	512.4	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	160.7	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.5	63.6	0.0	39.4	4.2	0.0	0.0	0.0	15.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.3	1.7	2.4	1.3	0.8	1.8	2.8	3.8	1.1	3.0	17.5	0.0	0.5	198.1	0.1	13.3	0.0	1.4	5.7	1.8	0.0	23.0	0.0	2.8	7.1	30.1	0.0	0.0	0.2	19.3	1445.8	1.2	9.3	1.1	95.1	0.0	0.0	427.2	1.0	22.0	918.4	12.0	226.0	4.6	0.0	3.0	8.5	0.0	470.9	0.3	0.3	297.5	291.6	5.1	3.2	163.7	59.2	0.0	0.0	0.7
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914006	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 46.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 30.8;Late spermatids: 25.2;Muller glia cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.9;RT4: 10.2;SCLC-21H: 6.9;U-2 OS: 5.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	12.0	0.2	1.3	1.1	0.0	0.1	6.8	1.1	1.3	0.7	1.4	10.8	0.3	2.4	1.9	0.2	0.5	0.4	0.2	0.3	0.8	2.8	0.1	0.1	0.5	0.3	0.0	0.3	0.2	1.7	46.5	0.0	1.9	4.7	0.1	1.6	0.8	5.1	0.5	0.1	0.4	2.2	1.8	0.3	3.7	0.8	0.1	1.4	0.3	0.7	1.7	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	10.2	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.8	0.3	0.3	0.8	0.3	0.0	1.9	0.1	0.0	0.0	0.0	2.8	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	30.8	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	25.2	0.3	0.0	0.0	1.0	0.0	26.2	2.1	0.0	0.0	0.0	1.1	0.0	0.3	1.1	0.8	0.0	0.0	0.0	0.0	1.3
COL25A1		ENSG00000188517	"Collagen type XXV alpha 1 chain"	Q9BXS0	4	108808725-109302752	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Heparin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.4;retina: 22.1;testis: 23.6"	"Group enriched"	"Detected in some"	16	"Early spermatids: 89.3;Late spermatids: 22.6;Rod photoreceptor cells: 75.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HeLa: 31.5"	"Low region specificity"	"Detected in many"							HPA029107			Approved	"Endoplasmic reticulum,Vesicles,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Endoplasmic reticulum"	"HPA029107: AB_10600802"	"unprognostic (1.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.87e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.62e-3)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.82e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	9.0	0.8	6.7	0.2	4.4	0.0	5.1	0.8	3.4	1.6	0.9	0.4	0.9	4.0	2.1	3.5	0.8	1.4	3.1	2.0	4.7	2.1	2.9	3.2	0.9	0.1	0.8	0.0	1.6	0.9	3.9	17.4	0.4	2.5	0.9	0.4	22.1	6.7	1.4	1.4	1.1	3.1	1.5	0.9	1.0	0.9	23.6	1.5	0.0	3.7	0.1	0.0	1.6	3.4	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.9	0.0	0.1	0.0	2.3	4.2	31.5	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.2	4.0	0.0	0.5	0.0	1.2	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.4	0.8	3.4	4.7	2.1	0.8	0.0	2.5	1.5	0.0	0.0	0.0	0.0	0.0	1.9	0.8	0.0	0.0	1.2	1.8	3.9	0.0	0.0	0.0	89.3	0.7	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.6	0.0	1.3	0.0	22.6	0.6	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	75.2	0.0	3.4	3.2	1.5	0.1	0.0	0.0	0.0	0.0
COL3A1	EDS4A	ENSG00000168542	"Collagen type III alpha 1 chain"	P02461	2	188974320-189012746	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 304.2;endometrium 1: 208.0"	"Cell type enriched"	"Detected in many"	4	"Fibroblasts: 1855.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 81.7;ASC diff: 151.5;ASC TERT1: 263.7;fHDF/TERT166: 106.1;HHSteC: 104.2;HSkMC: 196.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA007583, CAB016766, CAB059993"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		16000000	"Endoplasmic reticulum"		"CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (3.59e-10)"	"unprognostic (1.70e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.17e-3)"	41.7	9.7	0.7	34.1	3.4	0.0	29.7	0.8	1.2	304.2	41.3	1.3	23.8	3.9	208.0	82.0	31.3	32.3	116.3	41.0	1.0	0.3	14.4	12.1	32.9	39.3	1.3	1.1	54.9	14.4	1.7	2.3	161.2	3.2	27.4	18.3	32.0	15.1	22.4	14.5	28.3	24.2	114.1	1.7	29.5	25.3	45.5	0.7	9.5	12.8	44.8	15.4	64.8	51.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.7	3.1	151.5	263.7	0.0	32.9	29.3	14.4	12.9	0.4	0.0	0.0	0.0	106.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	13.9	0.0	104.2	0.1	0.0	196.1	0.0	17.5	2.8	0.0	0.7	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.4	0.0	1.2	0.8	0.0	0.0	60.2	0.0	0.0	0.0	0.1	1.7	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.4	0.8	1.2	1.0	0.3	1.3	1.1	3.2	0.7	3.0	20.2	0.0	0.4	152.4	0.0	9.8	0.0	2.7	2.3	0.0	0.0	40.3	0.0	2.5	21.6	52.5	0.0	0.0	0.0	34.9	1855.8	0.5	5.8	0.9	81.7	0.0	5.8	358.5	0.8	11.8	299.1	3.8	163.6	0.0	0.0	0.0	6.1	0.0	221.7	0.0	0.0	446.3	215.4	1.1	1.0	136.1	105.6	0.0	0.0	0.3
COL4A3		ENSG00000169031	"Collagen type IV alpha 3 chain"	Q01955	2	227164565-227314792	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Alport syndrome, Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 27.9"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 157.8;Cone photoreceptor cells: 375.0;Muller glia cells: 214.6"	"Group enriched"	"Detected in some"	6	"lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 3.8;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 15.4;hTERT-RPE1: 13.4;Karpas-707: 9.0;RPTEC TERT1: 10.1;U-266/70: 8.3"	"Not detected"	"Not detected"							HPA042064	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA042064: AB_10794410"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.28e-6)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (2.51e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	0.7	9.5	0.9	5.4	2.9	0.3	0.9	1.4	2.9	0.7	0.7	1.7	12.0	0.7	1.5	15.3	1.1	1.5	5.3	6.7	1.6	1.2	27.9	0.7	15.0	3.6	2.4	0.0	3.6	4.4	0.2	16.7	0.2	7.5	4.9	1.0	20.9	1.1	11.2	17.8	0.6	5.0	2.9	3.1	6.1	1.5	1.5	3.4	0.0	16.2	9.4	5.8	1.8	1.2	3.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.2	1.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	1.1	0.0	9.0	0.0	0.4	0.0	0.1	1.3	0.0	0.0	0.0	0.0	2.8	10.1	2.0	0.4	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	8.3	2.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	3.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.9	1.4	2.9	1.6	1.2	2.4	0.0	7.5	3.4	157.8	24.8	4.7	0.0	0.1	58.0	1.7	0.0	0.0	17.0	40.1	375.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.8	0.0	1.7	0.0	0.0	214.6	0.9	0.0	11.3	1.0	11.5	12.9	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0
COL4A6		ENSG00000197565	"Collagen type IV alpha 6 chain"	Q14031	X	108155607-108439497	"Disease related genes, Predicted secreted proteins"	"Cell adhesion"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 60.9"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 19.4;Cardiomyocytes: 9.2;Muller glia cells: 7.7;Peritubular cells: 8.5;Smooth muscle cells: 8.0;Urothelial cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.4;HeLa: 16.2;HHSteC: 24.9;hTERT-HME1: 18.2;HUVEC TERT2: 16.8;TIME: 37.6"	"Low region specificity"	"Detected in single"							HPA065393			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA			"Endoplasmic reticulum"		"HPA065393: AB_2685483"	"unprognostic (8.47e-3)"	"unprognostic (4.50e-3)"	"unprognostic (9.75e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.51e-1)"	2.1	0.4	0.4	0.8	0.5	0.0	1.7	0.2	0.4	12.1	1.0	1.3	8.0	0.7	22.9	17.1	25.0	11.3	35.8	3.6	0.6	0.6	3.0	0.3	2.1	0.0	1.0	0.9	6.4	0.3	7.6	11.3	1.9	0.9	16.5	1.3	8.3	1.4	15.6	1.0	4.1	1.8	60.9	1.4	1.1	10.4	2.1	0.7	0.2	0.6	1.4	0.5	24.7	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.4	4.0	0.0	10.1	0.7	0.0	0.0	0.7	0.1	0.1	7.1	0.0	0.0	0.0	0.0	1.6	2.3	4.1	18.4	0.3	0.1	3.5	0.3	16.2	0.1	24.9	0.0	0.0	1.0	11.4	2.6	18.2	0.0	16.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.6	0.0	1.5	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.9	0.0	0.0	7.8	0.3	0.0	37.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.4	0.6	0.6	1.0	0.9	0.9	0.7	0.0	0.0	0.0	19.4	5.7	0.0	9.2	0.0	2.7	2.3	1.8	0.0	0.1	1.7	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.9	3.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.7	0.1	0.0	8.5	0.0	0.2	0.0	8.0	0.3	0.2	3.1	0.0	0.0	0.0	10.6
COL6A3		ENSG00000163359	"Collagen type VI alpha 3 chain"	P12111	2	237324003-237414375	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Congenital muscular dystrophy, Disease mutation, Dystonia, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Fibroblasts: 396.3;Leydig cells: 291.6;Peritubular cells: 97.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 206.4;ASC TERT1: 265.7;BJ hTERT+: 77.0;HSkMC: 168.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.6"	"Not detected"	"Not detected"			"HPA010007, HPA010080"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		990000000	"Endoplasmic reticulum"	Vesicles	"HPA010007: , HPA010080: AB_1078550"	"unprognostic (8.94e-2)"	"unprognostic (7.24e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.20e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (5.57e-11)"	"unprognostic (1.54e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.84e-3)"	95.3	2.7	0.4	22.2	1.2	0.0	48.6	0.4	0.6	104.9	29.9	1.0	27.6	3.9	101.6	70.1	31.9	33.2	47.9	33.0	0.6	0.4	6.8	3.0	24.8	32.7	0.8	0.3	61.9	12.9	2.5	1.3	35.6	1.7	47.2	9.9	1.0	17.1	16.3	31.8	10.8	17.7	73.0	0.7	17.2	16.5	25.8	0.1	4.2	18.5	22.5	8.3	74.8	39.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	206.4	265.7	3.7	48.7	77.0	10.2	11.6	0.0	0.0	0.2	0.0	48.4	4.1	0.0	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.0	41.9	0.0	0.0	168.7	0.0	36.3	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	1.1	2.7	1.6	8.3	0.0	0.0	0.0	52.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.4	1.2	0.4	0.6	0.6	0.4	0.8	0.3	1.7	0.1	0.0	17.5	0.0	0.5	54.3	0.8	5.8	2.5	1.4	6.8	0.0	0.0	4.8	0.0	0.9	4.6	4.7	0.0	0.0	0.0	4.6	396.3	0.8	1.1	1.5	7.1	0.0	0.0	41.7	1.0	4.0	291.6	4.3	69.2	2.8	0.0	0.5	3.9	0.0	97.2	0.0	2.5	32.3	52.3	1.2	1.0	53.8	4.8	2.9	0.0	0.8
COL7A1	"EBD1, EBDCT, EBR1"	ENSG00000114270	"Collagen type VII alpha 1 chain"	Q02388	3	48564073-48595267	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 59.2"	"Cell type enhanced"	"Detected in many"	13	"Basal glandular cells: 22.7;Basal keratinocytes: 64.5;Suprabasal keratinocytes: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	19	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 20.8;HaCaT: 20.0;HBEC3-KT: 31.9;HDLM-2: 30.1;HeLa: 39.2;SiHa: 26.2"	"Region enhanced"	"Detected in single"		"cerebellum: 0.7"	"Not detected"	"Not detected"			"CAB016357, HPA018877, HPA042420"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Endoplasmic reticulum"	Vesicles	"CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990"	"unprognostic (2.69e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (6.31e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.86e-2)"	1.3	1.0	0.6	2.6	3.3	0.4	2.5	8.2	3.6	11.7	1.3	0.8	5.2	1.4	8.0	11.9	11.3	2.5	4.5	1.6	2.3	4.4	3.4	1.2	0.9	1.0	1.5	1.0	1.8	0.5	0.4	1.1	2.2	4.8	17.1	0.9	2.6	7.3	10.8	2.3	59.2	1.8	2.9	3.2	4.3	1.2	1.6	0.7	0.5	0.4	13.5	4.8	3.3	14.2	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	8.0	0.3	0.1	3.0	4.1	10.0	20.8	13.1	5.5	3.3	0.1	0.1	0.0	0.6	4.7	5.0	20.0	0.0	31.9	1.0	30.1	0.1	0.0	39.2	1.3	8.4	0.0	0.1	6.6	19.1	11.1	8.7	7.5	0.0	0.2	0.1	0.2	0.6	0.1	0.0	0.2	1.0	0.4	0.4	0.1	0.7	0.0	3.0	0.0	0.0	0.0	26.2	0.0	0.2	1.2	0.4	0.1	0.0	1.8	1.0	1.0	15.5	0.6	0.5	0.0	16.0	0.1	0.9	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	8.2	3.6	2.3	4.4	1.5	1.0	4.8	0.7	0.0	0.0	0.5	22.7	64.5	15.5	5.3	0.0	0.0	13.6	10.4	9.8	1.0	0.0	0.6	11.6	0.8	0.2	0.0	0.6	0.8	2.6	2.0	0.0	0.4	1.5	7.9	1.7	0.0	0.3	3.8	4.6	0.7	8.5	0.0	0.2	2.3	9.3	0.0	5.3	0.0	11.7	0.0	8.5	2.8	0.9	21.1	1.0	0.0	0.0	4.6
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941607-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 139.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 779.9;Syncytiotrophoblasts: 542.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 118.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"		NA	NA		560000	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favorable (5.67e-4)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	18.6	49.0	29.4	14.3	28.8	24.3	27.8	19.6	32.9	22.4	23.4	42.4	36.1	21.0	19.8	33.8	58.1	19.4	36.8	28.1	28.9	22.3	31.1	139.3	30.9	17.0	29.0	18.4	36.3	27.2	14.1	12.7	59.0	23.3	25.7	8.9	24.9	67.3	30.9	21.5	27.7	28.6	15.5	41.0	17.8	24.8	18.2	23.7	11.5	19.2	44.0	32.0	36.3	28.0	11.2	55.1	10.9	60.0	12.9	15.6	28.0	19.1	19.7	2.3	19.5	22.2	19.8	0.8	21.8	27.4	18.7	21.4	16.7	22.4	7.7	9.7	31.1	7.4	26.3	3.7	23.3	5.0	16.7	24.9	13.8	10.5	39.0	41.5	23.0	5.5	25.2	28.9	16.2	16.1	18.0	17.5	12.5	55.7	16.5	15.0	118.8	9.0	41.3	4.8	52.7	6.7	13.6	19.5	10.6	19.7	60.8	9.5	8.4	7.2	61.7	18.0	1.3	13.3	64.7	20.9	33.4	12.8	10.9	16.3	6.1	2.6	6.3	36.0	31.0	23.0	10.2	60.0	10.9	15.6	39.9	12.8	11.2	10.8	12.6	47.7	10.7	9.6	10.6	2.4	12.9	26.6	55.1	13.3	28.0	29.4	28.8	19.6	32.9	28.9	22.3	29.0	18.4	23.3	23.7	116.1	64.8	45.5	189.7	90.7	68.3	29.9	109.5	88.3	85.3	144.8	9.8	779.9	271.9	173.4	3.6	68.7	98.5	0.0	167.1	75.3	99.4	123.4	70.4	231.9	281.1	23.8	81.1	74.9	149.0	7.4	124.3	142.1	227.7	154.1	89.3	151.7	163.3	110.1	169.0	60.7	34.5	135.8	91.5	4.4	5.3	107.9	542.4	36.6	110.1	180.5
COQ10A	FLJ32452	ENSG00000135469	"Coenzyme Q10A"	Q96MF6	12	56266858-56270966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 43.5;skeletal muscle: 103.7;tongue: 46.1"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068931			Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"HPA068931: AB_2686061"	"unprognostic (4.55e-2)"	"unprognostic (4.88e-3)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (8.99e-3)"	"unprognostic (2.77e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.09e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (5.03e-2)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.07e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.15e-1)"	2.9	12.4	5.0	2.3	6.8	2.2	3.1	7.6	7.3	3.7	2.9	4.8	5.9	1.9	3.6	7.7	4.3	5.2	3.2	43.5	4.5	5.4	7.2	12.8	3.5	3.4	5.6	3.9	4.5	5.5	6.0	9.9	1.7	4.8	4.1	2.7	14.0	6.5	5.6	103.7	2.2	2.9	3.7	3.6	3.8	2.6	2.4	3.0	4.9	5.4	46.1	6.2	2.7	3.3	11.7	6.8	8.0	1.1	5.0	8.6	3.6	2.5	10.3	10.0	6.5	5.7	5.8	4.2	3.6	8.6	12.7	12.7	8.0	3.8	14.7	8.2	9.0	3.6	2.4	11.5	2.0	7.6	2.3	12.8	6.8	9.4	8.3	7.8	5.4	4.2	6.0	3.4	9.4	3.7	8.0	6.6	10.4	4.5	6.1	11.8	3.3	7.7	19.3	8.5	1.8	6.0	16.6	10.9	9.7	7.0	1.5	14.5	15.6	12.3	2.6	3.8	7.7	4.0	6.0	4.7	2.4	7.1	6.7	3.6	12.8	13.7	7.2	7.1	5.1	1.8	8.0	1.0	0.9	7.7	1.1	7.9	11.7	7.1	8.2	1.7	6.7	8.6	8.4	0.4	5.0	0.8	6.8	4.6	3.6	5.0	6.8	7.6	7.3	4.5	5.4	5.6	3.9	4.8	3.0	3.0	7.4	6.1	12.1	11.8	17.4	115.4	7.6	12.0	4.5	10.4	15.7	5.0	44.7	2.4	0.1	9.6	2.1	0.0	4.0	5.9	8.0	4.7	4.6	14.0	4.4	30.2	15.5	2.5	1.6	1.4	7.8	2.5	11.8	1.8	2.8	21.7	2.5	3.4	15.9	11.0	30.0	38.8	18.9	1.7	17.7	9.3	2.5	13.4	4.5	4.3
CPVL		ENSG00000106066	"Carboxypeptidase, vitellogenic like"	Q9H3G5	7	28995231-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.9;lymphoid tissue: 84.0"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 263.6;Kupffer cells: 230.2;Macrophages: 292.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 95.8;intermediate monocyte: 81.6;myeloid DC: 111.9"	"Group enriched"	"Detected in many"	52	"dendritic cells: 111.9;monocytes: 95.8"	"Cell line enriched"	"Detected in many"	4	"RPTEC TERT1: 131.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		510000	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140"	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavorable (4.99e-4)"	19.0	6.2	4.0	15.0	9.1	11.9	7.7	11.6	3.4	9.1	10.0	7.7	4.2	7.6	6.9	20.4	6.4	7.2	10.2	30.2	6.1	4.4	39.1	12.3	13.5	30.5	6.6	2.3	10.1	8.5	0.2	6.1	31.3	20.1	8.4	6.0	15.8	3.5	5.2	7.9	5.1	13.3	8.1	9.7	84.0	4.7	10.6	4.2	29.7	51.9	5.0	8.1	11.0	15.7	0.1	111.9	1.9	95.8	0.5	0.3	74.4	0.2	0.0	3.3	0.0	0.0	0.0	31.5	0.0	0.0	0.3	0.0	9.5	0.0	0.0	15.0	0.1	15.6	0.5	8.4	0.6	0.1	0.0	7.8	10.6	0.1	22.8	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	0.1	4.4	7.1	0.0	0.2	0.0	9.8	0.0	5.2	0.0	2.6	0.0	0.0	0.0	131.9	3.6	1.9	1.5	8.6	20.6	15.9	16.8	2.4	7.9	0.0	0.0	0.1	0.0	1.9	2.9	31.7	0.1	0.0	3.9	3.3	1.0	95.8	0.4	0.2	81.6	0.3	0.1	0.1	0.1	111.9	0.1	0.1	0.1	1.9	0.5	26.0	2.9	0.1	74.4	4.0	9.1	11.6	3.4	6.1	4.4	6.6	2.3	20.1	4.2	6.0	20.2	17.9	1.1	11.1	0.0	63.1	7.6	2.7	4.5	68.0	0.0	103.1	29.9	0.5	15.2	12.6	0.0	0.0	14.2	103.4	14.2	0.2	4.7	0.5	263.6	0.0	1.7	6.7	230.2	6.4	8.6	292.5	10.1	4.6	0.8	0.2	1.2	0.0	2.8	23.9	0.3	0.0	5.7	15.2	103.9	7.8	99.1	0.9	0.9	0.9
CREB3L2	"BBF2H7, TCAG_1951439"	ENSG00000182158	"CAMP responsive element binding protein 3 like 2"	Q70SY1	7	137874979-138002067	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.6"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 120.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015068, HPA015534"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"		"HPA015068: AB_1847224, HPA015534: AB_2669210"	"unprognostic (8.50e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.50e-1)"	"unprognostic (4.77e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.48e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.32e-2)"	14.9	19.8	4.7	17.1	9.8	10.8	15.7	1.9	6.0	25.4	16.7	11.4	18.7	11.6	28.2	25.5	12.8	16.2	16.2	20.4	5.6	4.3	17.0	11.7	14.6	15.2	11.8	3.7	25.9	16.0	38.4	28.8	81.6	9.8	15.9	9.5	24.9	26.5	23.3	5.0	6.9	17.5	17.7	6.2	12.1	14.1	9.8	9.1	7.0	35.8	10.9	18.1	21.3	15.7	4.6	12.4	7.4	5.6	6.5	11.8	3.2	4.0	6.3	12.0	0.2	20.5	20.4	9.0	20.4	33.0	14.3	14.5	8.6	3.7	0.8	5.5	22.1	7.8	2.2	7.0	14.9	28.0	5.9	3.5	25.7	8.6	20.5	13.6	7.7	36.9	8.4	9.5	18.0	21.1	14.7	18.8	2.1	13.2	12.0	16.7	7.3	2.4	9.5	4.3	5.6	4.5	5.4	6.5	6.8	11.2	4.2	3.1	7.2	6.6	17.1	9.1	7.3	2.5	5.8	20.0	19.2	2.9	23.1	7.4	14.2	4.9	5.3	23.0	21.8	42.5	7.4	5.6	5.9	8.2	2.9	10.6	4.0	6.0	8.6	5.8	4.6	2.2	3.8	2.1	6.5	1.5	12.4	11.8	3.2	4.7	9.8	1.9	6.0	5.6	4.3	11.8	3.7	9.8	9.1	6.0	20.4	20.6	8.1	10.9	7.2	14.1	20.4	10.7	18.2	22.7	9.8	50.6	11.6	9.3	48.0	20.2	32.0	0.0	15.3	76.5	40.4	27.0	48.5	24.5	49.4	14.3	15.1	30.1	33.2	14.1	57.2	25.1	25.3	10.0	17.0	6.7	15.1	17.3	96.9	9.1	12.4	38.8	42.4	1.1	4.3	6.1	120.8	27.3	14.9	17.2
CSGALNACT2	"GALNACT-2, GALNACT2, MGC40204, PRO0082"	ENSG00000169826	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2"	Q8N6G5	10	43138486-43185308	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.6"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 62.0;Macrophages: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031540	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031540: AB_10599943"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.85e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.43e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.05e-3)"	18.3	8.2	9.0	16.4	13.0	80.6	11.5	10.0	10.9	11.4	12.5	17.6	4.8	6.8	14.7	7.5	9.8	12.8	18.4	11.5	10.0	9.0	8.2	11.3	24.0	25.7	11.0	6.2	16.2	6.3	7.8	15.0	18.3	11.5	10.4	8.9	19.8	7.9	8.6	12.5	8.1	9.6	15.7	14.4	21.1	8.7	6.7	9.6	24.3	9.2	6.6	12.2	17.8	11.0	2.5	11.6	15.2	16.3	8.7	6.3	5.1	4.9	3.3	6.2	5.9	9.7	16.4	1.5	18.1	24.4	8.0	12.5	1.1	5.1	8.2	4.5	16.3	3.8	4.6	5.1	6.8	13.1	9.8	3.8	4.3	3.1	3.4	21.2	9.9	9.0	16.3	7.5	17.8	37.3	10.1	10.2	12.5	1.8	24.7	16.3	2.6	7.5	5.9	2.7	1.7	4.3	4.7	6.2	3.4	7.1	2.6	5.6	11.1	4.7	4.8	11.3	5.6	6.4	8.2	15.0	6.9	10.9	21.5	12.1	6.4	8.9	4.4	14.6	24.3	3.2	10.7	9.8	15.2	6.3	11.4	5.5	2.5	4.9	4.9	11.6	2.2	5.8	4.8	9.0	8.7	16.3	3.4	5.6	5.1	9.0	13.0	10.0	10.9	10.0	9.0	11.0	6.2	11.5	9.6	14.9	16.0	7.2	10.1	15.8	11.9	9.2	2.5	6.7	14.8	10.4	9.8	1.9	0.0	5.4	2.1	14.0	1.4	0.0	6.0	5.6	26.7	10.2	46.2	10.4	15.8	7.9	8.6	14.1	62.0	0.4	15.8	59.7	8.5	7.2	2.1	4.4	9.8	1.7	11.7	3.4	8.3	25.8	25.1	11.7	17.2	10.7	1.3	32.8	1.6	6.0
CTAGE5	"cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, MEA6, MGEA, MGEA11, MGEA6"	ENSG00000150527	"CTAGE family member 5, ER export factor"	"O15320, Q96PC5"	14	39230231-39388513	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 72.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 43.4"									"HPA000387, HPA000922, HPA054066, HPA055459"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819"	"unprognostic (2.62e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-4)"	"unprognostic (3.21e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.93e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.97e-2)"	9.3	16.9	7.3	11.4	7.3	7.3	7.9	5.1	7.9	12.1	22.8	5.8	13.5	28.5	8.5	17.9	18.5	8.4	15.1	7.5	6.4	5.9	34.7	52.2	10.6	9.0	7.8	6.5	8.6	20.6	22.9	20.6	6.0	21.1	8.9	12.6	6.0	22.3	17.0	17.4	6.4	52.4	6.9	9.7	9.7	16.0	8.7	8.6	10.1	17.0	15.9	7.0	8.3	10.9	8.7	12.5	24.5	13.5	9.8	11.6	8.4	7.7	8.6	3.6	6.4	7.4	8.4	5.1	4.6	4.8	3.3	3.4	6.7	43.4	9.3	14.3	5.1	6.7	11.8	4.4	5.1	3.9	7.2	3.7	5.8	4.2	35.8	17.4	7.8	10.8	5.1	29.5	3.2	24.6	20.9	5.3	11.0	5.5	23.9	4.9	7.4	4.9	6.3	4.2	29.6	7.2	5.1	6.4	11.6	15.1	8.4	3.1	1.8	10.6	11.3	6.9	4.8	10.9	8.4	8.3	5.0	3.3	3.6	3.0	13.7	11.7	9.2	2.8	4.9	4.1	22.5	11.8	17.6	11.6	12.3	10.5	8.5	8.9	10.8	12.5	8.7	11.0	10.2	24.5	9.8	13.5	8.7	8.1	8.4	7.3	7.3	5.1	7.9	6.4	5.9	7.8	6.5	21.1	8.6	35.7	36.1	11.6	6.2	3.8	11.5	0.0	43.3	72.3	29.6	0.0	31.4	4.5	0.0	0.0	4.3	3.1	34.6	0.0	0.0	4.0	5.3	11.6	24.4	38.4	6.8	7.9	31.2	11.1	12.4	2.2	11.8	7.6	5.0	0.0	21.2	4.3	0.0	20.1	11.0	0.0	13.0	0.0	3.1	17.9	13.4	3.0	5.8	13.8	14.3	12.8
CYB5B	CYB5-M	ENSG00000103018	"Cytochrome b5 type B"	O43169	16	69424525-69466266	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 130.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007893	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite,Cytosol"		NA	NA		1600000	"Endoplasmic reticulum"	"Centriolar satellite, Cytosol"	"HPA007893: AB_1847369"	"unprognostic (1.13e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (2.87e-3)"	"unprognostic (4.35e-3)"	"unprognostic (3.87e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.30e-2)"	21.3	130.7	29.6	15.4	33.1	5.9	17.1	12.0	37.9	16.6	29.0	22.8	12.6	21.9	20.5	24.6	21.4	19.2	14.7	18.0	23.1	22.0	26.9	26.5	18.3	20.1	21.6	24.4	19.9	12.8	26.3	16.2	24.6	34.3	17.1	38.2	20.2	14.8	16.7	19.9	16.0	31.2	19.9	20.8	20.7	15.4	14.0	16.0	26.0	19.9	17.6	23.5	24.3	16.0	24.8	44.2	35.8	28.3	32.3	46.0	32.4	29.6	94.4	38.9	24.0	18.0	24.0	16.6	26.6	37.1	44.6	42.2	65.8	36.4	27.1	26.8	25.7	36.3	35.3	37.0	38.5	50.8	14.4	14.1	13.0	17.0	76.7	26.6	26.8	29.0	20.6	19.4	52.8	25.3	18.9	42.0	31.3	21.0	13.1	27.3	38.6	43.9	32.6	28.8	27.6	12.9	41.6	21.5	29.7	59.5	34.0	22.8	11.7	70.8	13.6	22.5	20.9	26.3	21.5	18.9	25.7	21.2	17.0	23.4	15.9	35.1	82.9	26.5	22.3	29.7	35.8	20.3	24.3	39.3	28.3	32.2	24.8	29.6	30.8	24.8	22.6	24.6	29.2	6.1	32.3	20.1	44.2	46.0	32.4	29.6	33.1	12.0	37.9	23.1	22.0	21.6	24.4	34.3	16.0	41.7	38.5	39.4	44.1	44.3	21.6	21.7	25.5	52.2	42.1	59.3	5.9	140.9	66.3	51.1	13.9	49.6	69.8	23.3	62.0	75.3	41.2	33.1	58.9	43.3	55.7	28.6	22.5	36.2	27.6	17.2	41.1	44.4	59.1	64.9	68.4	45.7	54.3	63.1	41.8	46.7	30.4	45.3	42.2	31.1	48.5	36.9	50.0	71.0	55.0	45.3
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011032, HPA042299"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Endoplasmic reticulum, Plasma membrane"		"HPA011032: , HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favorable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favorable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	13.1	17.3	18.7	5.1	26.4	3.6	15.0	20.6	27.5	15.0	8.1	21.8	14.6	13.3	13.9	27.1	9.8	17.4	14.5	10.3	17.8	21.6	22.9	25.3	8.6	7.4	19.7	26.1	19.5	17.0	28.5	18.5	9.9	19.1	12.0	6.8	17.3	17.5	16.8	12.2	11.7	10.3	7.8	21.7	7.9	12.3	54.1	17.1	4.8	20.6	7.1	6.8	12.0	8.6	9.4	13.0	14.7	12.7	5.9	12.5	9.0	7.9	10.7	6.2	6.5	40.1	11.8	2.6	7.7	16.7	5.7	5.8	3.1	5.3	2.6	7.0	8.9	4.8	11.3	2.6	3.6	2.3	8.5	12.9	2.4	6.7	5.3	7.3	1.0	4.9	15.4	8.6	3.1	6.2	11.9	10.2	5.8	2.5	15.8	4.3	9.8	3.7	1.6	2.2	6.8	5.8	4.5	5.5	6.3	13.1	4.2	5.0	4.2	8.7	5.1	11.4	7.2	13.5	1.6	13.7	8.3	2.1	7.6	4.0	3.0	2.3	2.0	10.2	2.2	3.2	0.6	12.7	14.7	7.2	10.4	8.1	9.4	11.4	8.8	12.0	9.4	10.8	9.7	11.7	5.9	9.4	13.0	12.5	9.0	18.7	26.4	20.6	27.5	17.8	21.6	19.7	26.1	19.1	17.1	11.9	9.3	19.5	18.9	47.7	26.3	8.5	56.0	45.5	11.4	29.6	55.0	44.7	44.7	26.6	19.7	31.6	18.6	0.0	23.9	24.3	20.3	8.4	10.5	31.1	17.8	38.1	13.3	29.4	21.3	23.3	26.7	17.5	13.5	14.4	13.8	34.2	24.3	17.3	26.9	34.9	30.0	0.0	21.2	83.1	23.6	37.5	32.3	15.2	15.8	7.8
CYB5R3	DIA1	ENSG00000100243	"Cytochrome b5 reductase 3"	P00387	22	42617840-42649568	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 117.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001566	Approved		Supported	"Endoplasmic reticulum"		NA	NA		67000000	"Endoplasmic reticulum"		"HPA001566: AB_1078601"	"unprognostic (4.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.45e-1)"	"unprognostic (8.22e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.24e-2)"	79.7	57.1	33.2	22.8	32.6	19.3	86.8	19.5	33.1	52.4	31.9	37.6	51.8	25.9	51.9	35.0	39.1	39.3	38.6	86.4	31.3	24.1	43.3	78.2	43.5	30.3	31.8	25.4	58.8	21.9	15.1	27.2	32.1	33.9	40.6	21.3	37.9	29.3	96.4	34.4	43.1	32.5	55.5	36.3	20.2	33.7	44.0	25.9	14.1	30.1	28.4	23.2	43.4	53.5	28.6	37.6	70.3	39.7	14.2	22.3	19.7	16.5	10.6	17.5	10.8	117.8	93.7	10.3	48.8	45.3	36.5	32.6	13.9	13.0	7.8	21.8	90.2	15.8	15.3	11.7	24.1	18.8	8.4	26.2	11.1	18.4	26.8	30.0	15.5	20.8	56.4	19.1	26.2	17.4	26.7	30.1	10.1	9.6	40.9	49.5	18.3	15.2	14.3	7.0	17.3	19.6	11.2	21.3	17.4	28.0	12.2	7.8	10.1	16.1	15.6	17.8	13.5	12.4	15.0	46.1	39.6	24.7	26.6	18.3	10.9	11.7	9.6	46.1	9.0	32.5	26.3	25.7	70.3	19.7	32.4	19.9	28.6	19.1	21.6	37.6	26.4	13.6	14.3	13.4	14.2	39.7	34.3	22.3	19.7	33.2	32.6	19.5	33.1	31.3	24.1	31.8	25.4	33.9	25.9	80.4	44.4	45.6	76.5	97.8	15.9	86.2	112.1	24.1	47.8	57.6	3.9	94.2	41.4	197.4	3.7	128.1	83.6	116.8	93.8	165.0	171.8	78.6	62.2	149.9	98.1	15.9	80.4	125.8	48.8	6.9	235.1	65.2	167.0	156.9	41.0	91.8	117.8	80.6	263.8	100.0	17.3	187.5	253.9	15.8	48.1	98.5	98.6	40.1	48.2	75.8
CYFIP2	PIR121	ENSG00000055163	"Cytoplasmic FMR1 interacting protein 2"	Q96F07	5	157266079-157395595	"Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.8;brain: 44.2;kidney: 69.7"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 150.1;Distal tubular cells: 147.6;Horizontal cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 52.0;JURKAT: 35.9;MOLT-4: 49.3;U-266/70: 38.4;U-698: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB055519, HPA068106, HPA071459"	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"CAB055519: , HPA068106: AB_2685955, HPA071459: AB_2686400"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (3.76e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (3.81e-2)"	"prognostic favorable (3.21e-12)"	"unprognostic (2.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.49e-2)"	1.9	6.6	28.6	13.4	31.7	22.8	1.7	39.1	44.2	1.8	4.3	7.7	1.6	3.1	3.5	12.3	2.1	4.9	4.7	5.1	28.7	20.4	69.7	8.2	5.9	25.9	16.2	27.2	2.7	3.6	30.6	13.2	4.4	15.8	3.2	5.0	4.7	2.2	3.5	3.1	1.8	6.4	2.9	7.9	15.8	9.5	2.6	8.9	28.5	5.4	0.0	25.7	6.0	1.7	13.7	15.6	30.1	42.8	17.4	32.1	22.9	0.0	8.1	12.5	7.0	0.2	0.3	20.0	1.4	2.5	0.6	1.8	1.5	0.1	52.0	3.6	0.8	1.8	0.1	9.9	6.7	1.5	11.8	15.6	6.6	10.6	6.0	1.0	6.9	18.4	1.4	2.7	2.0	0.1	4.9	2.1	35.9	0.1	20.9	1.7	1.9	49.3	1.3	5.5	0.1	2.1	12.2	0.3	24.8	6.6	7.4	18.1	7.2	0.1	7.1	1.1	12.7	4.8	0.2	2.9	0.4	5.3	1.7	1.3	38.4	9.6	36.6	5.5	8.3	2.9	17.4	4.3	30.1	32.1	20.0	22.9	13.7	23.3	27.7	6.2	13.4	24.7	28.1	14.4	17.4	42.8	15.6	18.4	22.9	28.6	31.7	39.1	38.3	28.7	20.4	16.2	27.2	15.8	8.9	3.0	24.0	31.6	2.0	1.0	56.1	15.1	10.2	6.7	11.4	150.1	15.7	28.2	147.6	8.4	15.2	2.7	5.3	0.0	1.4	38.9	2.1	1.2	2.3	30.8	4.7	85.8	13.8	7.4	5.4	14.9	1.7	6.2	6.8	13.6	5.6	10.9	2.5	9.9	6.3	46.6	33.3	0.0	7.1	2.3	11.5	1.3	17.6	48.4	8.8	1.4
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"liver: 802.4"	"Cell type enriched"	"Detected in many"	65	"Hepatocytes: 5979.1"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.9;myeloid DC: 9.1"	"Group enriched"	"Detected in many"	17	"dendritic cells: 9.1;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.8	0.2	1.3	0.1	0.1	0.1	0.3	802.4	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.1	1.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.0	9.1	0.0	0.3	0.2	3.9	0.3	0.1	0.0	0.3	0.9	3.2	1.8	0.7	1.4	4.0	0.0	0.3	0.0	2.4	1.3	0.2	0.4	0.0	9.8	0.0	0.2	0.3	0.2	1.4	1.5	0.1	1.1	0.5	7.6	8.1	0.9	0.2	0.0	0.6	1.7	0.0	2.8	0.5	0.4	0.9	0.6	0.5	20.6	5.6	3.7	0.4	0.3	5.5	0.0	1.8	0.0	0.0	0.0	3.7	0.0	0.6	0.1	0.2	0.8	0.0	1.3	0.4	2.0	0.9	2.0	0.8	2.8	1.3	6.4	0.1	0.0	0.0	0.0	0.1	0.0	3.9	0.0	1.7	1.0	9.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.6	21.0	0.2	2.1	4.5	2.2	50.9	2.7	2.3	0.0	2.0	0.0	0.0	0.3	1.3	0.4	0.0	23.3	1.2	0.1	0.4	0.5	1.1	5979.1	0.0	7.9	0.0	68.2	91.8	1.9	1.4	0.0	0.0	0.0	0.0	1.0	2.6	0.0	2.5	0.0	5.2	0.0	0.5	3.6	2.2	6.6	0.1	8.7	0.0	0.0
CYP2S1		ENSG00000167600	"Cytochrome P450 family 2 subfamily S member 1"	Q96SQ9	19	41193049-41207539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.1;gallbladder: 29.1;intestine: 62.7;stomach 1: 45.9"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 16.5;Enterocytes: 23.2;Mucus-secreting cells: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.5;myeloid DC: 33.1"	"Group enriched"	"Detected in many"	121	"dendritic cells: 33.1;monocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"A549: 31.3;CACO-2: 16.1;HaCaT: 16.8;NTERA-2: 23.7;OE19: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA049227, HPA069248"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049227: AB_2680681, HPA069248: AB_2732128"	"unprognostic (1.49e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	1.2	0.8	0.8	2.3	1.0	0.5	0.6	0.1	1.0	1.7	18.3	1.2	0.5	37.6	0.3	0.9	10.1	2.4	29.1	1.0	1.4	1.6	0.9	2.1	3.8	3.3	5.6	0.4	0.8	0.6	0.0	0.9	1.6	4.5	0.9	7.2	1.1	3.8	0.3	0.1	2.0	62.7	0.6	1.1	4.0	45.9	0.5	1.2	2.6	0.4	15.8	21.0	3.2	2.7	0.0	33.1	0.0	9.5	0.0	0.1	3.9	1.2	31.3	0.0	0.0	0.0	0.0	1.5	0.2	0.2	0.3	0.0	16.1	4.5	0.0	3.7	0.2	0.0	16.8	5.5	8.5	0.1	0.0	0.1	4.2	1.7	5.8	6.6	0.0	0.1	0.2	0.4	0.4	0.2	0.0	0.2	1.4	1.9	0.1	0.0	0.6	0.1	0.0	23.7	51.4	4.1	0.0	0.0	0.3	0.5	6.7	0.0	0.2	3.1	0.0	0.0	9.7	4.1	1.6	3.6	0.0	1.3	0.6	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	9.5	0.0	0.0	2.3	0.1	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	3.9	0.8	1.0	0.1	1.0	1.4	1.6	5.6	0.4	4.5	1.2	0.0	8.6	0.0	1.6	2.3	0.0	0.8	0.0	8.1	7.9	1.8	0.0	16.5	0.0	0.8	0.3	0.0	23.2	0.0	0.9	0.6	1.3	0.4	1.1	0.0	12.8	0.0	0.0	0.6	4.7	0.0	0.0	11.5	0.0	8.2	29.0	0.0	13.8	14.8	0.0	0.0	0.0	0.0	0.3	0.1	0.4	2.5	8.6	0.0	13.9	0.1
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112151-92142952	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 62.5;Alveolar cells type 2: 133.7;Club cells: 77.3;Early spermatids: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 96.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"	10.3	27.0	16.7	8.1	22.1	10.5	15.5	13.3	32.0	11.8	21.1	32.9	6.3	33.1	9.1	15.3	23.4	7.1	10.3	9.9	18.6	20.8	18.6	80.9	22.2	5.0	17.2	13.7	21.0	20.2	32.4	11.9	8.8	47.1	18.2	16.9	17.1	11.0	7.7	4.3	12.8	28.8	8.3	43.7	7.3	18.1	35.7	19.5	2.3	14.1	18.7	10.0	9.0	13.2	14.2	14.1	3.5	13.9	6.7	10.7	7.1	21.4	10.5	26.6	17.0	18.7	30.7	3.8	7.3	22.1	9.5	26.0	25.3	39.3	18.7	11.6	12.6	96.2	18.8	23.1	46.1	11.1	7.8	16.4	5.4	11.2	19.0	25.6	11.0	8.1	22.2	21.0	37.1	39.0	8.4	9.7	3.8	20.2	43.2	11.1	22.0	2.3	10.2	19.8	8.8	10.5	7.6	5.5	42.2	43.0	36.4	18.7	12.5	15.5	30.9	22.6	12.6	11.2	13.2	11.5	13.0	14.6	18.8	9.5	14.7	13.1	17.1	10.0	14.6	16.6	1.8	9.7	3.5	10.7	13.9	7.1	14.2	7.6	8.4	14.1	10.7	7.2	9.2	1.5	6.7	8.3	12.4	5.8	7.1	16.7	22.1	13.3	32.0	18.6	20.8	17.2	13.7	47.1	19.5	62.5	133.7	7.5	1.0	2.3	2.1	1.2	7.6	28.1	77.3	1.8	2.0	1.3	1.7	9.2	70.7	2.1	14.4	23.3	17.0	0.8	1.8	1.3	27.7	4.2	1.3	0.0	10.4	8.6	6.6	27.7	3.4	2.1	0.0	1.0	12.0	1.9	12.3	10.4	1.4	1.7	1.8	0.0	2.8	3.2	1.5	4.6	3.7	1.0	11.5	2.1
CYTL1	"C17, C4orf4"	ENSG00000170891	"Cytokine like 1"	Q9NRR1	4	5014586-5019472	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.2"	"Cell type enhanced"	"Detected in some"	12	"Endothelial cells: 8.3;Fibroblasts: 15.8;granulocytes: 9.2;Hofbauer cells: 12.7;Macrophages: 5.9;Melanocytes: 8.5"	"Cancer enhanced"	"Detected in many"		"glioma: 21.0;melanoma: 20.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 18.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 18.8"	"Cell line enhanced"	"Detected in some"		"HEL: 42.6;HUVEC TERT2: 34.2;NB-4: 83.4;WM-115: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067201			Supported	"Nuclear membrane,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Nuclear membrane, Endoplasmic reticulum"		"HPA067201: AB_2732760"	"unprognostic (2.35e-2)"	"unprognostic (9.01e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (7.43e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.25e-4)"	5.2	2.3	6.5	2.0	6.0	10.8	6.4	0.7	4.2	11.0	4.9	9.2	4.9	1.0	10.1	2.8	5.3	7.3	4.6	4.4	5.4	4.4	1.2	0.8	17.1	9.4	6.2	2.1	2.5	1.1	1.7	1.6	42.2	4.7	10.5	1.8	4.5	4.0	14.2	0.8	3.3	2.1	4.2	11.0	1.1	4.9	2.2	8.4	0.5	5.7	3.6	4.8	13.2	7.4	0.0	0.3	1.9	1.0	18.8	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.6	0.0	0.0	34.2	0.0	0.0	1.7	0.0	0.0	0.0	83.4	0.1	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	5.2	0.0	0.0	0.0	11.7	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	20.2	1.9	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.1	18.8	0.0	0.3	0.0	0.6	6.5	6.0	0.7	4.2	5.4	4.4	6.2	2.1	4.7	8.4	0.0	0.3	0.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	8.3	0.0	0.0	0.0	0.1	15.8	0.5	9.2	0.0	12.7	0.0	0.0	1.3	0.0	0.0	0.0	5.9	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.5	0.0	0.0	0.6
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636360-133659344	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 86.6;brain: 36.2;liver: 35.6"	"Cell type enriched"	"Detected in single"	43	"Ito cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	45	"pons and medulla: 36.2"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Cell line enriched"	"Detected in single"	340	"SH-SY5Y: 206.1"	"Region enriched"	"Detected in some"	6	"pons and medulla: 23.2"	"Region enriched"	"Detected in single"	38	"pons and medulla: 25.1"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		2000000000	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	0.7	86.6	0.1	0.3	0.1	0.0	0.0	0.1	0.8	0.3	0.0	1.9	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.5	35.6	0.3	0.6	0.0	0.0	0.1	1.3	0.0	0.6	0.4	36.2	0.8	0.0	1.0	0.2	5.9	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.2	206.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDOST	"GATD6, KIAA0115, OST, OST48, WBP1"	ENSG00000244038	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit"	P39656	1	20651767-20661544	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009746, HPA046841, HPA052867"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		3300000	"Endoplasmic reticulum"		"CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977"	"unprognostic (8.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (2.70e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (9.05e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.07e-1)"	25.7	42.7	17.0	28.7	21.6	37.1	42.5	13.9	26.7	32.8	35.3	16.4	52.0	27.3	37.1	54.7	33.2	32.7	40.0	53.2	13.9	15.7	36.0	59.8	37.2	84.7	16.5	18.3	42.4	146.9	25.4	37.2	71.6	16.1	24.9	39.1	29.5	51.3	58.3	25.5	25.1	35.6	32.2	12.8	49.8	36.5	35.1	15.0	32.5	51.5	28.7	34.5	26.7	30.0	45.6	80.1	50.1	57.1	49.7	58.9	80.7	46.3	29.8	26.0	77.0	51.8	54.2	54.3	39.1	78.7	63.7	65.8	39.6	97.2	38.6	65.3	63.4	35.0	40.3	35.8	47.9	47.2	30.5	36.8	33.3	19.4	52.0	77.2	51.8	86.3	55.5	53.5	53.3	64.5	76.8	72.7	25.9	16.1	64.3	38.2	35.5	24.5	42.8	26.8	74.4	31.6	21.6	34.9	68.4	52.0	20.5	18.9	33.0	42.2	43.0	58.1	39.2	34.4	80.3	37.3	36.8	38.7	63.4	36.0	76.3	82.0	25.9	60.6	69.2	49.3	44.7	55.7	50.1	55.7	57.1	58.9	45.6	48.2	51.3	80.1	39.6	44.1	46.6	14.2	49.7	48.5	65.4	49.2	80.7	17.0	21.6	13.9	26.7	13.9	15.7	16.5	18.3	16.1	15.0	32.8	59.5	70.0	69.0	44.6	15.7	18.9	58.6	75.0	70.5	33.2	27.5	298.3	33.2	141.7	21.4	50.9	44.9	23.3	130.8	225.3	93.6	64.6	76.3	67.1	126.3	15.9	69.0	62.0	66.8	12.2	69.0	83.0	81.0	115.4	106.2	51.5	92.2	91.2	57.3	44.9	19.3	45.3	41.9	107.7	187.2	46.9	292.5	81.2	128.2	58.0
DDRGK1	"C20orf116, dJ1187M17.3, UFBP1"	ENSG00000198171	"DDRGK domain containing 1"	Q96HY6	20	3190350-3204685	"Predicted intracellular proteins"	"Ubl conjugation pathway"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013373, HPA013705"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"HPA013373: AB_2091955, HPA013705: AB_2668872"	"unprognostic (2.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.10e-3)"	"unprognostic (8.16e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.01e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.90e-2)"	29.5	47.3	28.5	18.6	45.7	17.8	20.5	33.4	38.2	22.1	23.9	29.8	23.7	35.3	21.5	17.8	21.1	21.0	24.3	17.7	27.0	21.8	28.5	54.0	27.0	17.5	47.9	22.9	23.9	43.6	37.5	17.7	31.3	30.9	27.3	16.6	20.6	48.5	29.3	29.5	22.2	31.9	17.1	36.8	20.2	31.5	14.7	39.3	12.6	34.0	14.2	16.2	20.8	29.4	15.1	32.0	24.4	20.2	12.3	21.0	12.9	29.9	37.8	9.4	17.4	21.3	8.1	13.5	19.1	9.2	11.8	13.0	29.7	21.9	18.0	15.7	10.6	22.8	33.7	9.6	28.6	4.4	12.2	18.0	15.2	12.6	51.5	29.2	17.1	16.5	12.7	28.1	22.6	16.2	13.1	10.8	13.0	21.1	21.7	7.5	16.4	11.7	32.0	11.6	20.6	17.5	15.5	8.3	27.3	19.2	28.3	20.8	12.8	19.6	55.7	17.8	5.9	23.6	10.5	16.2	19.1	8.5	13.4	29.1	16.2	18.2	7.6	5.3	14.5	11.1	11.7	20.2	24.4	19.6	13.3	19.5	15.1	20.9	21.0	20.5	15.1	18.7	18.2	5.4	12.3	12.1	32.0	18.6	12.9	28.5	45.7	33.4	38.2	27.0	21.8	47.9	22.9	30.9	39.3	41.7	48.8	26.8	54.1	23.4	43.2	27.9	104.4	44.2	40.9	66.3	60.9	110.7	16.6	129.1	42.5	50.1	133.4	0.0	154.4	53.3	42.9	64.4	27.6	109.1	106.6	49.3	51.3	39.3	55.8	12.9	51.8	50.8	37.1	61.3	57.4	61.1	136.8	122.8	64.7	61.9	91.7	64.7	41.2	35.6	20.7	33.9	122.1	30.5	77.9	57.1
DERL1	"DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577"	ENSG00000136986	"Derlin 1"	Q9BUN8	8	123013164-123042423	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 135.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016562, CAB037269"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB037269: AB_609868, HPA016562: AB_1847611"	"prognostic unfavorable (2.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	31.2	34.3	12.7	24.5	14.6	43.4	31.6	18.6	19.5	17.3	23.9	16.6	21.4	22.9	21.3	17.0	23.4	17.5	20.2	23.8	11.7	12.4	25.4	73.3	23.4	42.3	14.1	11.5	23.5	33.6	11.7	23.0	25.0	14.9	16.4	21.5	17.9	21.9	24.4	48.0	16.3	32.6	16.9	14.4	35.3	18.1	22.4	13.0	17.9	25.2	20.9	31.2	23.3	18.3	34.0	26.6	32.8	35.1	34.6	47.3	35.1	20.5	15.3	9.2	11.9	16.6	12.6	7.6	17.3	11.8	11.6	14.3	9.7	20.7	23.8	21.7	14.2	13.5	17.3	8.6	11.2	16.4	27.6	9.6	24.8	10.7	8.1	15.2	9.6	18.6	11.3	14.7	12.6	15.2	10.5	10.2	9.8	14.8	31.8	12.9	41.0	10.5	6.0	6.9	26.6	13.7	10.9	7.6	39.9	29.3	14.8	10.0	14.7	17.5	135.8	11.0	10.4	16.0	8.7	11.8	13.8	26.0	12.1	16.2	40.1	67.1	21.4	22.7	12.1	12.9	27.3	28.8	32.8	45.1	35.1	47.3	34.0	30.6	37.1	23.4	26.2	21.6	33.3	19.8	34.6	34.2	26.6	36.6	35.1	12.7	14.6	18.6	19.5	11.7	12.4	14.1	11.5	14.9	13.0	29.8	23.4	47.9	34.8	37.5	21.5	25.5	12.7	10.7	21.6	27.9	19.6	36.4	8.3	77.0	57.1	33.4	43.9	46.7	65.5	54.9	36.5	51.0	42.6	68.3	62.7	17.5	29.2	42.4	44.8	14.7	22.7	41.9	57.3	51.3	45.8	25.2	57.9	42.1	24.1	23.1	22.1	45.3	37.1	43.5	36.8	44.4	65.2	61.8	30.5	53.3
DERL2	"CGI-101, derlin-2, F-LAN-1, F-LANa, FLANa"	ENSG00000072849	"Derlin 2"	Q9GZP9	17	5471251-5486811	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 180.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB037287, HPA048957, HPA056551"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB037287: AB_1078641, HPA048957: AB_2680570, HPA056551: AB_2683171"	"unprognostic (2.54e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.83e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.91e-2)"	12.2	18.9	8.8	11.6	10.7	22.4	13.5	8.1	9.7	11.9	10.7	10.5	17.0	10.9	12.4	23.6	13.4	11.5	13.2	9.6	10.6	6.8	18.1	28.7	12.8	18.8	12.5	4.4	13.1	49.1	12.2	14.7	16.6	11.5	11.0	9.5	10.7	30.3	19.4	9.5	9.5	15.9	11.3	11.0	14.9	13.5	21.0	11.3	11.4	22.1	7.6	16.7	13.8	10.5	33.4	36.6	39.3	36.3	29.5	40.6	53.3	16.8	21.9	10.3	17.4	17.8	13.4	13.3	24.0	19.7	16.6	20.3	14.9	15.2	11.7	21.9	15.3	18.7	18.9	7.1	13.9	16.7	15.5	15.0	5.7	14.3	16.0	24.5	4.2	14.0	12.4	11.6	22.4	19.5	14.7	17.1	12.2	6.2	20.6	22.4	8.8	9.0	6.5	10.0	11.1	8.7	11.0	14.7	8.6	17.8	8.7	4.4	12.8	14.7	10.2	25.2	11.9	13.5	6.3	12.9	19.7	13.3	12.0	22.9	14.4	15.9	10.4	20.6	10.6	15.5	31.4	34.4	39.3	36.5	36.3	37.8	33.4	35.4	38.6	25.7	29.3	28.1	34.8	32.3	29.5	27.8	36.6	40.6	53.3	8.8	10.7	8.1	9.7	10.6	6.8	12.5	4.4	11.5	11.3	11.9	25.8	37.1	44.0	30.5	17.1	26.9	33.1	36.1	26.1	41.8	21.6	60.0	13.3	71.9	180.2	34.2	29.0	23.3	78.4	83.8	58.7	59.6	47.4	52.3	67.1	11.1	17.7	27.6	34.8	40.2	40.6	40.1	43.9	79.4	23.7	29.0	76.1	28.1	33.2	37.4	20.7	58.2	30.9	77.5	49.8	27.1	80.4	41.7	25.9	52.1
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"intestine: 161.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 291.1;Paneth cells: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 15.8;PC-3: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	11.8	18.5	3.6	5.7	4.7	6.4	6.8	6.6	5.6	3.3	60.2	4.0	6.4	44.7	3.9	3.6	5.5	3.1	7.9	6.3	3.7	2.7	6.7	14.4	3.8	3.1	4.1	2.7	3.3	3.9	5.0	4.0	4.3	3.6	3.4	6.3	4.1	5.9	4.3	10.0	4.8	161.0	3.6	2.6	5.3	5.7	10.7	4.2	5.1	3.8	6.2	5.0	4.7	3.4	0.7	2.2	2.8	2.0	0.3	1.7	0.8	3.8	4.2	2.0	3.6	3.2	1.3	2.3	2.8	2.7	2.6	1.8	9.7	2.6	1.5	10.7	1.7	1.3	3.3	1.6	3.8	0.6	2.8	4.0	2.8	3.4	15.8	2.3	0.7	2.9	1.8	2.9	1.7	1.9	1.8	2.0	4.9	2.2	3.6	1.7	3.2	4.8	3.1	0.9	9.2	17.6	6.3	0.8	2.5	2.4	2.1	2.0	3.4	3.6	4.4	1.8	0.8	2.5	2.7	1.6	1.4	4.9	2.8	2.2	2.1	0.4	0.6	1.5	4.9	2.3	0.0	2.0	2.8	1.2	1.3	1.7	0.7	0.9	1.1	2.2	0.5	0.7	0.3	2.3	0.3	1.7	1.1	0.7	0.8	3.6	4.7	6.6	5.6	3.7	2.7	4.1	2.7	3.6	4.2	14.9	21.3	6.5	9.8	7.1	24.2	17.9	15.3	4.0	7.9	17.4	27.5	10.2	1.7	6.8	13.4	13.5	291.1	0.0	10.4	8.3	7.1	8.8	6.9	49.5	16.5	17.5	22.4	10.4	25.4	16.4	6.4	15.0	5.0	1.0	70.1	18.1	11.4	112.2	6.3	6.8	21.9	0.0	10.5	25.1	15.9	8.2	13.7	8.5	84.8	18.4
DHCR7	SLOS	ENSG00000172893	"7-dehydrocholesterol reductase"	Q9UBM7	11	71428193-71452868	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.8"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 43.9;Hepatocytes: 67.2;Syncytiotrophoblasts: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044280	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044280: AB_10794893"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-3)"	"unprognostic (8.57e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.45e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (5.67e-4)"	8.0	40.1	12.1	5.6	14.5	19.0	16.8	5.3	22.8	5.5	9.3	27.9	8.8	20.8	4.0	27.3	14.6	5.2	5.8	10.7	13.7	13.2	7.1	64.8	12.0	2.7	20.6	12.3	21.5	7.3	14.0	7.0	3.7	23.4	10.0	6.6	16.6	10.0	3.9	5.4	22.9	15.8	4.5	20.5	5.9	8.5	17.7	15.5	2.8	5.4	12.1	7.7	4.3	7.4	6.3	6.2	3.5	1.9	4.6	12.1	5.7	21.2	19.3	18.9	20.9	8.9	13.8	5.9	8.8	23.5	7.5	20.5	71.9	70.0	14.9	14.0	8.4	67.3	41.0	22.5	47.6	7.9	5.6	16.9	5.7	16.3	30.7	22.8	10.6	2.7	15.9	21.1	28.2	19.4	6.2	11.1	19.5	26.6	31.8	7.5	57.2	8.7	12.0	27.1	21.1	11.5	7.9	26.6	64.0	28.2	32.2	25.7	9.6	8.4	27.8	20.0	9.6	26.9	5.8	10.4	2.0	11.4	0.6	10.5	10.5	12.7	15.9	6.0	18.9	8.5	3.5	1.9	1.7	9.7	1.2	11.8	6.3	8.2	9.0	2.5	5.4	10.5	12.1	1.0	4.6	1.2	6.2	5.1	5.7	12.1	14.5	5.3	22.8	13.7	13.2	20.6	12.3	23.4	15.5	3.0	12.6	6.7	7.1	0.7	6.8	11.3	10.2	5.3	9.1	21.0	11.8	13.8	6.6	29.1	0.1	6.6	7.8	0.0	43.9	21.8	9.3	14.2	0.0	67.2	9.8	0.0	9.1	6.2	3.7	0.0	7.8	3.0	5.0	9.0	11.8	20.9	19.8	7.0	4.6	2.9	8.0	12.9	2.5	0.6	5.9	1.0	45.3	10.2	14.5	7.1
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 117.7;Syncytiotrophoblasts: 99.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	25.3	5.7	8.2	16.5	13.6	19.9	12.0	1.6	4.6	17.8	18.5	2.9	15.1	5.5	10.7	9.1	16.3	10.4	12.6	13.0	6.6	3.0	6.1	15.7	16.8	6.9	4.1	4.4	14.2	6.6	8.7	5.5	37.2	7.1	16.0	11.4	4.7	9.4	17.2	19.9	9.3	12.0	18.5	7.3	9.8	9.9	12.3	5.1	9.4	7.5	12.0	4.9	19.8	26.9	2.7	4.3	5.7	5.8	1.4	2.8	1.0	0.0	4.0	1.9	3.9	11.1	18.5	0.0	7.0	7.4	3.8	8.0	3.3	7.6	11.3	5.6	6.0	7.2	0.0	10.4	1.1	4.9	0.3	5.9	0.0	4.9	3.6	9.3	14.6	5.2	9.3	3.7	5.0	15.8	5.1	7.3	8.5	0.0	9.4	7.0	3.2	5.5	6.0	15.4	0.0	5.9	0.0	10.5	0.0	2.1	6.0	0.0	4.0	0.0	2.0	5.6	12.5	1.7	8.0	9.1	8.1	3.7	6.7	4.5	0.1	0.0	9.5	6.8	14.9	4.7	0.0	5.8	5.7	2.3	5.4	1.8	2.7	2.4	2.8	4.3	2.4	1.6	1.5	0.6	1.4	4.5	4.1	1.3	1.0	8.2	13.6	1.6	4.6	6.6	3.0	4.1	4.4	7.1	5.1	29.8	42.7	10.6	4.8	9.6	5.7	19.0	7.6	42.8	18.2	19.2	0.0	41.5	6.6	16.9	60.0	25.2	23.6	0.0	20.1	14.6	25.5	6.7	7.0	23.1	17.8	0.0	23.6	8.0	30.6	117.7	41.7	21.4	8.5	6.4	27.6	12.5	26.4	35.1	19.1	6.1	14.0	25.8	18.6	4.9	12.2	15.9	99.0	12.5	28.1	4.8
DIP2B	"FLJ34278, KIAA1463"	ENSG00000066084	"Disco interacting protein 2 homolog B"	Q9P265	12	50504985-50748667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038472, HPA046133, HPA056045"	Enhanced		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA038472: AB_2676033, HPA046133: AB_2679551, HPA056045: AB_2683019"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.70e-3)"	8.6	12.2	20.3	11.2	33.0	14.3	14.2	37.7	25.6	10.0	12.4	35.9	5.3	8.3	8.6	5.1	17.1	6.3	9.5	7.6	24.5	17.2	8.4	14.7	9.0	11.9	35.2	17.4	13.2	10.2	21.4	8.9	13.9	24.8	9.3	14.6	9.0	11.1	6.2	6.7	22.6	8.3	9.7	35.6	18.4	9.3	9.9	34.4	11.4	11.2	6.4	15.1	9.0	10.4	3.9	2.5	7.7	5.6	0.9	3.1	1.2	13.7	8.6	13.0	9.1	7.5	7.3	18.0	7.9	9.4	7.8	5.9	15.3	7.8	9.3	9.6	8.8	8.0	14.5	20.8	15.2	9.2	10.7	7.4	14.7	7.3	19.4	11.7	17.6	9.0	8.2	13.2	8.7	12.7	13.6	14.7	8.6	20.3	9.0	6.8	11.0	13.6	8.9	7.4	8.0	15.0	15.9	12.7	4.5	8.8	11.0	12.2	8.5	19.8	11.8	12.2	15.8	16.6	12.4	14.8	6.3	7.4	5.7	6.5	6.5	10.7	11.0	8.8	8.2	8.6	1.7	2.0	4.3	0.7	2.3	1.2	2.5	1.8	0.7	2.5	3.9	3.1	2.5	7.7	0.9	5.6	0.7	1.6	1.2	20.3	33.0	37.7	23.2	24.5	17.2	35.2	17.4	24.8	34.4	6.0	8.0	14.5	21.8	48.8	26.2	8.5	15.3	4.0	4.5	8.7	60.9	11.0	0.0	8.9	1.4	14.6	15.5	0.0	14.9	15.4	8.7	29.0	10.4	16.6	16.5	11.1	30.1	14.7	25.2	2.2	9.5	12.8	15.1	7.2	20.1	15.6	16.0	14.4	9.6	4.5	31.3	0.0	6.8	11.2	18.4	58.5	31.8	6.9	10.2	19.5
DLGAP3	"DAP3, SAPAP3"	ENSG00000116544	"DLG associated protein 3"	O95886	1	34865436-34929585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 28.7"	"Cell type enhanced"	"Detected in some"	11	"Early spermatids: 11.5;Hofbauer cells: 7.8;Horizontal cells: 20.6;Late spermatids: 13.7"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 1.0;glioma: 1.5;ovarian cancer: 1.9;testis cancer: 5.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 9.6;NTERA-2: 5.2;SCLC-21H: 15.5;SH-SY5Y: 3.0"	"Group enriched"	"Detected in all"	4	"amygdala: 128.4;basal ganglia: 124.0;cerebral cortex: 122.6;hippocampal formation: 84.0;thalamus: 55.9"	"Low region specificity"	"Detected in all"			"HPA026445, HPA027304"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody"		NA	NA			"Endoplasmic reticulum"	"Plasma membrane, Midbody"	"HPA026445: AB_1847733, HPA027304: "	"unprognostic (8.63e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.77e-7)"	"unprognostic (4.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.21e-1)"	1.3	1.5	17.4	1.8	20.0	2.8	1.1	14.6	28.7	0.9	1.2	3.3	0.0	1.4	1.0	1.0	0.9	1.0	1.1	1.0	17.7	5.5	1.3	1.0	1.1	1.4	5.4	9.6	1.0	2.2	1.0	1.9	1.0	2.3	1.0	1.0	0.7	1.1	1.5	1.0	1.1	1.3	1.0	1.1	2.5	1.3	6.7	5.0	0.0	1.0	0.0	1.2	1.0	0.0	0.3	3.2	0.4	2.3	0.1	0.8	0.9	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	9.6	0.2	0.0	1.2	0.0	1.6	0.0	0.0	0.2	0.2	0.7	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.6	0.0	0.0	5.2	0.0	0.0	0.5	0.0	0.2	0.0	0.5	15.5	3.0	0.1	0.1	0.0	0.2	0.3	0.1	0.1	0.1	1.7	0.0	0.0	0.2	0.3	1.9	0.1	0.1	0.1	0.4	2.3	0.0	0.2	1.4	0.8	0.3	0.5	0.5	3.2	0.3	0.2	0.8	0.0	0.1	0.1	0.9	0.7	0.9	17.4	20.0	14.6	22.4	17.7	5.5	5.4	9.6	2.3	5.0	0.0	0.0	0.0	0.6	0.2	4.0	1.1	0.0	0.0	0.0	1.8	3.9	0.1	3.3	0.4	11.5	0.1	0.8	0.0	0.5	0.2	0.2	0.2	0.0	0.0	7.8	20.6	1.2	0.0	7.3	13.7	0.9	1.0	0.0	0.0	0.2	1.3	0.3	0.0	0.0	0.7	2.2	0.0	0.1	2.7	3.4	0.3	0.0	0.8	0.7	0.1
DNAJB11	"EDJ, ERdj3, HEDJ"	ENSG00000090520	"DnaJ heat shock protein family (Hsp40) member B11"	Q9UBS4	3	186567403-186585800	"Predicted intracellular proteins"		Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA010814, HPA017051"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		18000	"Endoplasmic reticulum"		"HPA010814: AB_1078691, HPA017051: AB_1847792"	"unprognostic (4.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.86e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.44e-9)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-1)"	18.8	16.4	14.0	27.7	21.2	26.4	22.3	12.4	14.4	18.7	21.6	15.9	21.5	19.7	20.0	28.1	19.9	18.1	18.2	27.3	14.7	14.9	29.5	83.5	21.7	31.5	17.4	10.2	13.9	67.4	20.6	18.0	26.2	19.6	14.4	22.7	13.3	37.2	18.4	13.2	13.9	25.4	17.3	17.4	25.6	21.3	16.1	19.6	17.9	47.6	15.7	20.3	19.0	26.0	19.3	42.2	19.0	21.6	22.6	23.7	16.8	33.2	13.1	19.3	33.4	15.9	12.3	33.2	37.7	21.6	31.2	33.0	40.4	22.2	24.3	76.4	24.7	45.3	31.0	22.0	19.5	32.9	27.2	19.4	21.5	13.0	29.8	37.0	25.2	34.0	10.9	19.9	17.5	30.8	17.2	26.0	13.4	11.9	58.6	20.6	25.3	16.9	20.7	18.9	45.7	17.7	17.0	21.9	40.8	23.3	14.4	16.7	23.3	24.2	40.5	26.1	24.8	46.6	38.5	19.6	17.4	22.5	22.5	53.4	46.8	34.4	38.4	23.0	30.8	37.3	16.6	18.3	19.0	23.7	21.6	19.9	19.3	12.2	19.2	22.9	11.5	11.8	16.0	8.4	22.6	15.8	42.2	16.7	16.8	14.0	21.2	12.4	14.4	14.7	14.9	17.4	10.2	19.6	19.6	17.9	18.1	40.2	176.4	129.0	21.7	133.1	73.9	14.7	21.6	14.0	17.7	80.7	3.3	86.5	28.0	75.2	81.9	46.7	74.8	136.3	69.6	91.0	55.2	85.7	131.5	22.3	136.1	66.3	76.0	7.2	29.1	64.3	97.8	20.8	37.6	45.1	80.8	43.8	24.4	17.2	21.3	64.7	67.3	102.4	77.5	98.1	163.2	65.0	43.1	144.4
DNAJB12	"DJ10, FLJ20027"	ENSG00000148719	"DnaJ heat shock protein family (Hsp40) member B12"	Q9NXW2	10	72332830-72355230	"Predicted membrane proteins, Transporters"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 160.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010642, HPA072702"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nuclear membrane"	"HPA010642: AB_1078692, HPA072702: "	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.73e-2)"	"unprognostic (5.60e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.87e-1)"	24.9	31.7	18.6	20.1	20.6	27.2	32.6	24.0	28.3	24.1	21.8	29.9	26.4	25.0	26.8	31.0	23.8	21.1	28.7	25.3	18.0	17.3	25.6	34.3	26.8	27.5	19.9	19.4	25.4	33.1	38.4	26.2	36.0	20.2	24.5	17.5	27.5	32.4	44.8	40.3	28.6	27.4	22.8	22.3	26.9	24.3	29.2	18.2	20.8	25.5	25.8	23.5	21.1	21.2	7.6	15.5	23.3	19.8	8.3	8.7	9.9	15.6	16.3	10.3	17.2	13.5	13.8	13.0	15.8	27.4	21.8	20.3	19.1	27.4	11.6	12.8	19.0	13.6	26.4	9.5	14.2	11.5	12.6	13.0	6.2	9.7	12.3	29.8	12.6	23.8	17.7	29.5	19.2	24.4	19.7	15.1	11.2	9.7	17.5	18.0	15.2	10.7	10.7	4.8	12.0	4.8	9.9	7.8	8.0	16.0	9.2	7.1	10.2	8.6	32.0	15.4	5.8	12.2	14.4	16.9	10.9	15.0	12.2	19.8	14.8	11.0	6.8	18.0	13.9	7.4	9.1	18.1	11.0	8.7	19.8	7.8	7.6	8.6	6.5	15.5	7.3	7.2	7.1	23.3	8.3	16.8	10.5	8.7	9.9	18.6	20.6	24.0	28.3	18.0	17.3	19.9	19.4	20.2	18.2	26.8	27.7	36.1	25.5	11.8	32.1	20.2	53.5	20.1	22.7	22.7	21.6	34.5	10.0	30.2	95.9	21.5	37.6	46.7	56.5	35.4	21.6	25.1	39.3	26.0	34.3	28.6	28.3	17.8	36.2	160.7	33.6	33.3	10.1	33.3	24.0	31.9	29.4	31.7	32.9	30.0	34.0	51.8	25.0	20.2	9.0	13.6	56.9	20.3	21.7	29.8
DNAJB9	MDG1	ENSG00000128590	"DnaJ heat shock protein family (Hsp40) member B9"	Q9UBS3	7	108569568-108574850	"Predicted intracellular proteins"	"Unfolded protein response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Melanocytes: 322.2;Syncytiotrophoblasts: 476.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 34.1;Karpas-707: 31.1;U-266/70: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040967, HPA041553"	Supported		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA040967: AB_10794430, HPA041553: AB_10794300"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.75e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.76e-2)"	13.7	28.9	11.6	9.7	14.1	16.7	14.6	8.6	15.4	18.2	11.1	10.0	33.7	11.1	12.6	31.4	8.7	12.8	10.8	24.2	11.6	18.7	29.2	54.3	16.1	13.3	14.0	11.4	14.6	47.9	6.9	31.0	51.2	15.7	14.2	9.6	10.1	32.2	29.5	29.4	7.6	10.8	10.7	14.7	10.8	11.9	18.5	10.6	5.4	37.4	7.2	14.2	18.1	13.5	10.0	30.1	25.8	7.7	9.9	24.0	11.4	2.5	2.9	4.0	4.6	11.2	8.1	8.9	9.4	11.4	5.2	6.3	2.9	4.9	3.4	10.5	2.9	16.4	3.1	4.5	2.3	5.4	3.6	2.4	1.8	2.1	9.0	34.1	2.7	3.6	5.7	18.0	3.0	16.9	11.8	5.4	2.0	2.6	31.1	8.1	3.7	2.5	3.1	4.0	3.0	1.6	1.6	4.1	17.7	4.3	1.6	2.8	5.9	3.5	15.8	17.3	11.8	2.9	3.7	6.2	5.5	2.6	6.8	3.3	54.8	17.5	3.9	4.8	3.5	5.0	25.8	7.7	3.5	14.1	5.8	24.0	10.0	15.4	14.1	5.7	8.1	8.9	10.2	2.1	9.9	6.2	30.1	8.9	11.4	11.6	14.1	8.6	15.4	11.6	18.7	14.0	11.4	15.7	10.6	3.0	24.5	55.9	74.7	164.9	35.2	49.9	33.1	12.0	26.1	50.6	7.9	92.1	41.4	36.7	250.3	25.6	26.9	46.7	40.0	74.4	81.3	107.9	93.2	138.2	37.2	19.1	63.8	27.0	30.2	167.7	35.4	38.7	322.2	17.2	22.8	79.9	42.7	35.1	43.5	139.7	27.0	38.8	75.0	129.5	59.0	138.6	476.2	51.1	13.6	74.9
DNAJC1	"DNAJL1, ERdj1, MTJ1"	ENSG00000136770	"DnaJ heat shock protein family (Hsp40) member C1"	Q96KC8	10	21756537-22003769	"Predicted membrane proteins, Transcription factors"		"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013432	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013432: AB_1847797"	"unprognostic (7.00e-2)"	"unprognostic (9.81e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.36e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (4.44e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.22e-2)"	14.8	16.0	8.6	13.5	13.4	11.1	14.6	8.3	11.2	14.5	17.8	9.6	16.2	19.9	15.5	14.0	14.1	10.9	16.4	14.2	10.2	7.2	22.1	41.3	20.5	9.5	13.5	6.8	13.4	33.7	27.1	34.3	16.6	13.8	29.2	13.6	12.6	28.5	14.3	10.6	11.6	18.5	22.8	15.0	13.7	19.9	7.7	13.9	12.2	21.8	11.6	11.5	25.9	28.8	6.5	21.5	5.4	15.2	17.9	21.1	7.7	12.7	8.3	18.7	6.9	17.6	12.5	8.1	17.4	7.6	7.3	11.5	11.4	11.3	5.6	7.7	10.6	10.9	12.3	4.2	8.7	4.0	29.4	14.1	13.4	6.8	6.8	42.7	1.0	5.7	12.7	16.2	8.6	9.9	10.7	9.5	5.6	14.0	32.4	8.1	13.0	3.1	4.3	2.4	11.1	7.0	4.6	6.5	20.6	10.0	3.0	3.9	6.0	12.8	21.5	12.6	21.5	6.8	14.4	14.5	7.1	15.6	11.9	9.8	10.4	3.2	3.9	10.6	42.7	4.2	5.4	9.2	3.6	20.9	8.7	21.1	4.9	12.0	16.6	8.3	6.5	7.8	9.9	5.2	17.9	15.2	21.5	8.4	7.7	8.6	13.4	8.3	11.2	10.2	7.2	13.5	6.8	13.8	13.9	32.8	26.9	21.2	53.6	34.5	28.0	12.9	56.0	21.4	22.7	29.6	43.2	13.3	23.2	67.3	35.8	46.6	45.3	23.3	64.6	86.2	53.4	72.0	40.5	79.1	47.8	36.5	36.8	46.6	37.7	15.6	87.8	31.8	64.1	40.5	54.8	41.6	73.1	46.5	62.9	69.2	144.0	58.2	37.3	70.7	72.9	38.6	29.5	94.8	50.0	63.1
DNAJC3	"ERdj6, HP58, P58, P58IPK, PRKRI"	ENSG00000102580	"DnaJ heat shock protein family (Hsp40) member C3"	Q13217	13	95677139-95794989	"Disease related genes, Predicted intracellular proteins"	"Antiviral defense, Stress response, Translation regulation, Unfolded protein response"	"Chaperone, Repressor"	"Deafness, Diabetes mellitus, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039336, HPA041326"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		2900000	"Endoplasmic reticulum"		"HPA039336: AB_2676451, HPA041326: AB_2677412"	"unprognostic (1.44e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.12e-2)"	"prognostic favorable (3.47e-5)"	"unprognostic (8.18e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.19e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.30e-3)"	"unprognostic (8.18e-2)"	19.1	16.1	11.2	13.5	14.5	24.5	25.4	8.5	12.3	24.4	15.5	10.0	35.5	14.7	18.5	25.9	13.9	15.8	14.0	16.6	9.8	9.8	22.1	61.9	18.7	19.0	12.8	9.0	15.0	44.8	14.8	33.9	31.6	13.8	22.8	17.1	10.8	43.3	34.0	10.3	11.6	22.0	14.2	17.5	17.2	17.9	8.6	12.9	8.9	40.7	10.4	12.8	19.1	19.2	4.5	18.0	32.5	13.0	8.9	10.6	5.6	12.2	7.0	5.6	16.1	23.4	11.7	16.9	17.4	15.8	8.0	7.4	8.7	26.0	11.3	16.6	17.4	11.4	12.6	7.3	13.2	12.4	10.9	3.3	15.5	10.0	13.9	32.3	18.8	20.6	13.9	14.2	11.8	27.4	14.8	17.4	5.1	5.2	0.1	13.5	5.0	6.3	6.8	4.2	28.8	5.5	6.5	9.8	8.6	17.8	15.3	3.2	6.2	12.3	29.6	8.5	13.5	14.7	20.9	19.7	15.7	5.4	10.4	8.9	24.2	10.5	5.2	26.4	11.4	21.5	21.9	10.6	32.5	10.2	12.5	10.6	4.5	8.5	8.5	6.8	3.8	6.1	8.2	30.6	8.9	13.0	18.0	5.1	5.6	11.2	14.5	8.5	12.3	9.8	9.8	12.8	9.0	13.8	12.9	74.5	58.8	47.9	69.5	83.6	21.8	45.1	71.4	64.3	56.9	45.4	25.5	47.0	18.3	87.5	152.1	55.4	52.5	23.3	103.7	111.5	93.0	145.2	65.8	125.0	73.0	23.8	40.2	63.3	61.2	22.1	66.4	81.8	113.1	51.3	45.2	44.2	87.6	42.4	71.1	57.9	16.8	90.5	89.1	33.5	81.0	81.2	158.7	51.7	36.6	100.0
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 23.0;placenta: 63.1"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 876.9;Distal tubular cells: 616.8;Syncytiotrophoblasts: 1451.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Hep G2: 90.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6"	HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.1	3.2	0.2	4.4	0.1	0.3	0.2	2.0	0.2	0.1	0.7	0.0	0.2	0.1	0.3	0.3	0.2	0.1	0.2	2.5	0.6	23.0	0.7	0.2	0.2	1.1	0.6	1.9	0.5	0.1	0.0	63.1	0.9	0.2	0.1	0.0	0.8	1.5	0.1	0.2	0.2	0.1	0.5	0.2	0.2	1.1	0.8	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	8.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.6	0.5	0.0	4.0	0.0	0.3	1.8	10.1	0.2	0.0	0.2	1.8	0.0	0.7	90.8	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.2	0.2	0.4	3.7	0.0	0.0	0.0	0.0	2.3	0.1	0.3	0.6	0.7	0.3	0.2	0.1	0.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	0.2	2.0	2.5	0.6	1.1	0.6	0.9	0.8	0.0	0.0	0.0	0.6	0.6	0.0	1.8	0.0	0.0	0.0	10.4	0.0	876.9	616.8	0.1	0.0	0.0	0.0	0.0	0.0	57.4	0.2	0.3	0.0	0.8	72.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	0.0	0.0	0.0	0.7	8.3	0.0	1451.1	0.0	0.0	0.9
DYNC1I2	"DIC74, DNCI2"	ENSG00000077380	"Dynein cytoplasmic 1 intermediate chain 2"	Q13409	2	171687409-171748420	"Predicted intracellular proteins"	"Host-virus interaction, Transport"	"Motor protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033836, HPA040619, HPA053987"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol"		NA	NA		33000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Microtubules"	"CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.19e-1)"	"prognostic favorable (8.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.42e-2)"	33.4	32.9	39.6	22.5	53.2	10.8	35.5	30.1	50.0	36.1	33.0	50.0	20.1	28.8	43.1	29.3	37.5	26.5	32.0	34.3	45.2	38.3	43.5	21.8	27.3	18.5	59.3	37.9	40.6	23.3	35.8	29.9	40.2	58.7	33.7	35.8	15.1	28.3	34.7	41.3	27.9	27.7	43.7	92.7	25.8	26.5	28.6	49.2	27.9	31.2	23.5	24.3	36.7	31.8	23.5	35.3	51.7	30.8	18.9	19.9	11.5	20.0	12.9	40.1	14.7	37.2	35.9	22.7	35.2	27.5	29.7	32.4	22.4	20.0	18.4	31.0	41.8	40.7	20.4	31.5	33.8	39.0	6.9	14.2	16.1	16.6	25.3	18.6	18.3	17.3	27.8	32.2	36.7	23.7	41.6	52.0	18.0	25.3	5.1	58.6	12.6	15.6	14.9	18.5	29.5	13.2	15.8	36.1	13.3	39.5	32.3	25.1	28.3	19.5	15.7	20.9	31.9	15.3	17.9	56.3	45.3	22.5	18.0	21.0	6.3	12.0	14.9	30.8	14.9	33.1	51.7	30.8	14.7	16.9	30.1	18.0	23.1	19.5	19.6	21.4	23.5	17.6	16.7	1.8	18.9	29.4	35.3	19.9	11.5	39.6	53.2	30.1	45.7	45.2	38.3	59.3	37.9	58.7	49.2	184.6	55.8	68.6	52.1	45.0	68.0	67.4	196.1	111.1	96.7	160.5	60.9	85.6	111.0	177.4	58.5	118.7	140.2	70.0	139.8	89.1	77.0	39.2	96.2	130.7	90.2	76.3	80.9	188.4	142.1	30.8	119.0	94.7	33.7	151.5	111.3	91.1	161.5	106.7	129.7	165.2	120.2	109.9	79.3	209.8	92.5	52.4	96.7	52.4	94.0	47.0
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"Emopamil binding protein (sterol isomerase)"	Q15125	X	48521158-48528716	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease mutation, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell type enhanced"	"Detected in all"	7	"Hepatocytes: 389.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003130	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	3.7	33.2	5.3	4.3	5.7	10.5	10.5	10.1	6.3	8.6	19.6	2.8	3.4	17.2	4.0	3.7	20.6	3.9	4.5	21.7	4.7	4.3	12.8	74.1	14.9	13.0	3.5	8.0	4.8	11.7	6.0	3.7	4.2	8.8	8.6	15.7	5.2	8.7	4.8	3.5	9.1	30.0	5.6	7.0	7.9	8.1	5.4	2.8	9.0	4.6	9.8	10.4	5.0	10.0	17.1	22.9	21.5	12.6	13.3	29.9	18.1	33.6	7.1	18.9	11.3	10.5	7.8	6.1	8.6	7.2	11.5	16.6	14.1	56.2	18.2	6.1	6.0	11.3	37.9	31.6	46.7	8.7	14.0	15.8	9.2	9.5	12.1	7.7	33.8	22.8	7.6	17.0	15.3	11.4	2.9	7.6	12.9	11.7	17.3	9.4	14.7	18.8	20.7	19.0	9.7	23.4	13.0	1.9	51.6	28.1	6.0	16.1	8.1	31.8	16.4	4.5	12.6	18.0	8.1	8.0	5.9	10.0	22.7	9.4	7.4	11.6	18.4	13.7	34.1	5.6	17.4	8.9	21.5	29.9	11.7	25.1	17.1	22.2	27.5	12.3	12.6	20.1	25.5	1.8	13.3	12.6	22.9	22.4	18.1	5.3	5.7	10.1	6.3	4.7	4.3	3.5	8.0	8.8	2.8	29.8	39.6	41.7	45.2	33.0	23.7	36.3	81.5	22.7	21.6	50.6	7.9	40.6	33.2	80.2	5.4	24.3	135.6	46.7	207.1	93.9	32.6	42.4	40.3	389.0	57.0	7.9	28.8	28.8	26.6	7.8	12.4	34.4	35.4	47.7	72.4	13.4	126.3	129.8	13.8	76.4	15.9	12.9	20.6	8.6	20.0	39.6	31.4	74.7	134.2	61.7
EBPL	EBRP	ENSG00000123179	"Emopamil binding protein like"	Q9BY08	13	49660723-49691475	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 285.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA049891	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049891: AB_2680937"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (7.18e-8)"	"unprognostic (1.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	10.2	32.6	5.8	13.4	5.7	11.1	17.1	4.5	8.6	21.5	13.9	4.7	8.8	10.1	21.1	7.0	32.9	13.0	7.2	6.8	4.8	7.1	12.8	64.8	14.5	17.9	6.1	5.0	21.8	46.4	6.6	5.9	7.3	9.4	22.4	11.7	8.2	21.0	14.6	4.9	15.5	8.8	13.5	6.0	13.7	13.6	8.4	3.7	11.1	22.2	21.8	19.7	14.7	22.6	7.0	6.7	9.3	4.8	5.5	10.4	1.7	14.3	11.6	7.5	30.8	9.5	23.1	12.2	14.9	11.1	11.4	8.3	22.4	21.0	17.6	6.9	8.1	9.8	30.3	13.7	15.9	15.5	13.9	39.0	15.2	8.1	31.8	26.8	22.1	11.4	26.9	33.0	8.3	23.5	17.5	18.5	20.9	10.8	7.7	14.0	9.6	8.6	41.9	24.5	51.4	24.3	18.1	4.3	28.3	22.8	4.8	6.5	17.0	5.8	20.9	6.8	8.0	18.0	17.9	9.1	7.8	7.9	6.6	12.4	4.8	11.9	14.8	3.4	22.1	7.2	2.8	4.0	1.1	3.4	4.7	10.0	5.8	7.3	7.2	6.7	7.0	10.4	5.8	9.3	5.5	4.8	4.5	4.9	1.7	5.8	5.7	4.5	8.6	4.8	7.1	6.1	5.0	9.4	3.7	32.8	17.2	59.6	137.3	96.5	6.8	3.8	76.5	5.3	14.8	22.7	7.9	26.0	34.9	55.4	11.6	57.3	12.7	0.0	44.5	33.3	44.2	104.1	18.4	285.3	33.1	1.6	26.8	65.7	45.6	8.4	87.2	31.9	43.9	3.6	79.1	13.6	42.9	21.0	65.7	52.5	8.0	19.4	53.6	31.6	14.1	135.1	12.7	39.8	112.1	100.9
EDEM1	"EDEM, KIAA0212"	ENSG00000134109	"ER degradation enhancing alpha-mannosidase like protein 1"	Q92611	3	5187646-5219957	"Plasma proteins, Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.5;lymphoid tissue: 89.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 96.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029565	Uncertain		Enhanced	"Endoplasmic reticulum,Aggresome"		NA	NA			"Endoplasmic reticulum"	Aggresome	"HPA029565: AB_10602032"	"unprognostic (3.03e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-3)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	6.5	7.6	5.3	13.1	6.7	26.3	7.0	4.8	6.3	6.7	7.6	4.5	5.1	5.9	8.4	6.4	10.5	7.0	6.2	4.8	4.3	3.1	6.6	57.5	14.2	16.9	3.9	5.0	8.6	20.3	10.2	6.5	14.2	4.2	6.6	7.6	5.5	9.7	5.7	3.7	10.1	11.8	5.4	3.7	15.4	7.8	7.8	4.0	89.4	7.8	5.5	23.5	8.8	8.1	9.9	10.3	4.3	5.8	2.9	8.9	2.8	4.7	4.8	3.0	3.0	4.0	9.0	9.7	7.8	10.6	5.4	7.1	2.2	6.3	25.5	4.2	7.7	11.8	3.7	3.3	10.7	8.3	48.9	1.9	8.7	4.5	4.9	18.8	10.2	25.5	8.1	13.1	11.5	12.7	7.3	10.7	33.3	2.2	35.3	6.6	2.8	20.5	3.9	1.5	2.2	3.6	29.9	5.4	23.4	6.2	10.0	0.4	4.0	5.6	8.1	11.5	2.8	4.1	32.9	10.4	10.4	7.3	8.8	8.9	20.8	12.6	43.9	17.3	9.9	8.6	3.5	3.8	4.0	5.8	5.0	8.4	9.9	8.8	6.5	4.6	6.8	7.9	6.2	4.3	2.9	5.8	10.3	8.9	2.8	5.3	6.7	4.8	6.3	4.3	3.1	3.9	5.0	4.2	4.0	56.6	96.8	35.0	6.3	18.3	4.1	2.8	17.8	6.7	20.5	15.7	9.8	8.0	0.0	6.0	9.1	11.3	14.8	0.0	10.5	26.0	8.7	10.9	23.1	65.7	15.8	1.6	8.1	14.7	33.3	37.6	7.8	35.8	15.1	47.7	22.7	3.5	14.0	0.0	8.5	7.0	3.5	0.0	12.2	6.7	2.0	23.8	34.2	21.4	10.1	16.1
EDEM3	C1orf22	ENSG00000116406	"ER degradation enhancing alpha-mannosidase like protein 3"	Q9BZQ6	1	184690231-184754913	"Enzymes, Predicted intracellular proteins"	"Unfolded protein response"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025754, HPA025755, HPA027297"	Approved		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA025754: AB_1845638, HPA025755: AB_1845639, HPA027297: AB_2672205"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.63e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.01e-1)"	12.5	12.6	10.8	11.3	13.8	6.4	11.1	15.2	11.8	13.2	17.6	7.5	10.8	16.0	11.7	7.7	10.9	10.2	10.4	10.4	9.1	8.2	9.6	27.8	13.3	8.9	13.5	8.4	8.8	27.3	18.4	26.4	17.9	10.6	12.3	21.3	7.6	18.3	14.3	20.8	7.1	14.4	10.6	13.3	9.5	31.3	6.2	11.5	15.8	11.5	6.3	10.6	11.6	16.1	2.7	5.9	7.4	6.8	4.0	6.3	3.4	6.6	5.0	7.0	6.1	25.4	26.2	11.3	13.5	9.4	5.2	5.4	2.6	19.3	4.6	14.8	10.2	5.2	9.1	6.6	7.0	7.6	4.5	5.4	6.1	5.3	3.7	9.8	15.9	9.0	14.9	8.7	12.5	11.2	9.7	13.8	12.5	16.0	21.7	9.8	5.5	12.7	8.3	9.7	15.1	4.7	5.6	5.3	15.8	7.5	4.7	7.8	11.1	6.6	11.5	9.3	12.1	10.8	25.0	16.2	7.4	3.4	15.7	11.3	33.3	12.8	6.2	9.9	18.2	16.2	7.4	6.8	4.1	2.9	6.7	5.1	2.7	4.5	3.5	5.9	2.0	6.3	3.3	6.9	4.0	6.3	3.0	3.0	3.4	10.8	13.8	15.2	11.8	9.1	8.2	13.5	8.4	10.6	11.5	17.9	13.4	12.2	6.8	14.8	27.8	13.7	10.2	22.7	23.9	14.0	23.6	10.6	0.0	11.1	14.7	22.4	27.1	0.0	30.7	9.0	21.5	26.1	20.7	38.0	11.5	20.6	29.4	20.9	41.6	5.6	19.0	19.1	18.6	4.6	60.6	8.0	21.3	21.0	17.0	8.1	14.2	19.4	14.1	14.3	8.1	17.9	16.2	13.1	29.1	15.2
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24, autophagy associated transmembrane protein"	O14681	11	125569216-125584687	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 164.6"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 494.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	13.4	10.2	13.3	8.9	16.2	4.6	16.7	11.2	22.1	12.7	17.0	14.4	13.8	11.3	13.6	12.9	22.7	12.1	15.8	16.4	10.6	10.7	14.6	55.5	12.1	11.2	12.0	11.1	13.1	34.2	164.6	9.2	11.9	11.0	13.7	18.9	13.2	20.9	14.3	26.5	17.2	16.1	15.9	9.2	10.5	17.7	10.4	10.5	9.9	12.0	14.2	13.0	16.2	12.9	8.5	15.5	5.4	7.3	6.5	10.0	4.9	24.5	18.7	21.4	25.8	35.2	26.8	26.8	25.2	19.1	17.4	15.7	28.4	49.7	24.7	42.9	23.7	18.5	28.4	32.5	53.0	22.6	6.5	20.6	117.9	13.4	26.6	26.2	26.6	12.8	25.0	48.6	26.1	38.7	17.2	36.7	13.5	53.5	10.1	24.4	17.3	12.1	13.6	28.2	63.6	20.5	17.8	25.3	21.0	29.0	44.0	20.0	19.2	29.5	35.2	9.5	37.0	71.9	26.5	30.5	22.4	15.2	15.7	20.4	6.3	12.7	32.2	9.8	40.8	29.8	4.1	7.3	5.4	8.2	7.0	8.1	8.5	6.5	10.0	11.6	7.3	9.4	7.6	0.9	6.5	5.1	15.5	9.0	4.9	13.3	16.2	11.2	22.1	10.6	10.7	12.0	11.1	11.0	10.5	29.8	34.7	29.8	114.2	107.2	57.4	55.7	129.9	9.4	27.3	104.7	35.3	140.6	122.7	154.4	19.7	84.2	53.8	0.0	158.4	174.0	83.1	141.9	27.6	494.9	92.4	77.9	94.5	65.1	44.4	33.9	66.2	50.8	86.0	34.3	100.9	68.5	153.1	52.6	67.8	102.8	30.5	45.3	89.6	92.8	109.0	158.6	117.2	35.1	116.3	136.4
EIF2S2	"EIF2, EIF2beta, PPP1R67"	ENSG00000125977	"Eukaryotic translation initiation factor 2 subunit beta"	P20042	20	34088298-34112332	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034415, HPA041262, HPA041332"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"CAB034415: AB_2095998, HPA041262: AB_2677381, HPA041332: AB_2677417"	"unprognostic (5.76e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (9.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (9.64e-10)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.12e-2)"	25.9	30.1	32.8	23.3	40.7	21.4	38.1	20.2	37.7	21.1	24.3	10.9	27.1	21.2	21.2	22.4	36.3	17.0	18.3	36.3	30.1	20.4	22.0	40.1	27.2	37.7	40.0	26.2	19.9	45.4	18.7	22.4	29.9	35.8	20.4	24.7	7.4	26.3	25.5	101.8	21.2	20.4	37.0	50.2	23.0	28.1	19.6	35.6	18.2	24.1	32.7	30.1	25.0	30.7	38.8	48.5	28.1	39.3	32.4	42.4	27.3	39.3	26.5	20.1	24.2	19.7	30.0	38.4	36.1	34.6	36.0	36.4	93.1	27.8	35.4	26.6	32.6	40.1	37.3	32.6	59.3	43.8	11.3	17.8	70.1	21.8	47.5	51.0	44.8	22.9	30.6	50.7	35.6	53.3	24.7	37.6	52.5	41.1	33.9	29.6	25.3	41.5	37.5	19.5	45.8	48.5	23.9	34.3	32.7	28.4	33.0	20.5	14.0	40.0	24.3	74.0	24.4	36.7	53.1	25.3	41.2	25.4	25.8	33.8	31.8	28.0	36.9	38.7	34.9	29.8	21.2	37.0	28.1	26.9	39.3	32.9	38.8	38.2	37.6	34.7	31.8	36.4	36.5	21.9	32.4	35.6	48.5	42.4	27.3	32.8	40.7	20.2	37.7	30.1	20.4	40.0	26.2	35.8	35.6	157.8	148.8	160.1	252.4	160.3	53.2	134.4	252.3	164.6	154.7	132.6	29.5	312.1	260.2	306.9	265.0	180.9	122.1	397.1	456.4	341.9	160.2	180.5	139.9	436.7	212.4	39.7	121.7	263.9	224.1	127.6	117.1	190.4	113.1	327.4	153.0	65.4	448.4	141.1	121.6	191.6	90.0	109.9	93.7	435.4	188.7	152.4	536.6	139.5	166.4	296.5
ELOVL1	Ssc1	ENSG00000066322	"ELOVL fatty acid elongase 1"	Q9BW60	1	43363397-43368074	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 101.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033426, HPA056557"	Enhanced		Supported	"Endoplasmic reticulum"		NA	Yes			"Endoplasmic reticulum"		"CAB033426: AB_2099896, HPA056557: AB_2683173"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (8.00e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.00e-2)"	21.2	15.6	16.2	15.3	25.3	18.3	24.1	6.8	32.5	16.1	23.6	101.5	11.7	20.7	14.1	13.0	46.6	15.1	17.3	11.5	30.3	18.3	26.6	23.8	22.9	22.7	51.4	14.1	9.3	18.3	16.7	8.4	20.9	45.6	21.6	20.1	8.6	20.6	21.6	6.8	54.0	21.7	20.7	99.5	17.2	22.8	8.4	37.2	7.2	23.9	15.6	21.7	20.4	22.6	30.9	61.1	46.9	54.8	30.5	32.3	48.8	23.8	26.9	5.2	10.3	35.6	33.5	16.3	28.3	35.7	36.1	29.1	23.8	41.9	16.5	22.0	44.3	31.2	27.5	18.4	34.8	22.2	21.2	12.4	21.4	18.6	17.2	30.9	18.4	22.9	25.6	39.6	42.6	47.1	27.1	36.1	6.5	14.8	12.6	41.3	17.6	4.3	15.5	7.6	31.1	27.9	9.7	13.9	20.1	45.5	29.1	6.4	6.7	16.7	59.7	23.8	16.2	28.1	18.4	29.8	30.6	19.4	37.0	35.8	6.3	6.8	7.9	29.8	18.9	27.5	29.0	54.8	46.9	32.3	50.6	28.6	30.9	30.7	31.4	61.1	25.5	20.1	28.1	38.2	30.5	48.1	42.9	31.4	48.8	16.2	25.3	6.8	32.5	30.3	18.3	51.4	14.1	45.6	37.2	17.9	8.4	18.1	20.4	13.9	5.4	3.6	45.9	5.3	7.9	38.4	9.8	79.2	6.6	86.7	2.5	28.7	74.3	70.0	86.6	103.3	20.2	33.0	20.7	13.7	66.2	3.2	18.4	23.4	47.0	3.4	18.7	37.1	11.8	129.8	30.5	12.4	99.9	40.7	24.1	21.3	8.4	19.4	15.3	6.7	8.6	27.0	80.2	24.6	36.9	43.7
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 250.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	75.7	48.7	17.9	24.2	22.0	33.9	78.8	13.3	22.1	18.2	13.9	38.3	91.2	9.7	15.7	18.0	10.8	16.5	18.0	14.6	18.3	17.5	13.5	36.8	24.4	33.6	41.1	12.3	13.1	5.7	8.1	11.6	13.6	26.4	45.2	6.7	16.1	9.4	88.4	3.6	11.4	17.3	18.0	46.4	18.5	9.5	34.8	29.1	28.7	17.6	5.6	33.6	16.6	19.4	23.8	18.1	60.7	11.3	8.4	25.3	10.4	25.3	18.5	32.5	59.3	86.2	50.1	13.8	29.6	33.3	23.9	33.6	16.4	29.4	28.8	21.5	30.7	37.6	15.0	32.0	27.1	35.9	24.2	22.5	28.4	17.3	22.8	47.4	22.4	20.8	46.2	21.3	23.9	30.1	24.2	26.5	57.5	35.4	16.8	17.2	2.7	66.5	19.9	17.5	0.9	14.2	26.0	22.3	10.0	45.0	15.2	30.3	20.8	24.5	12.8	24.8	22.1	29.2	21.0	25.1	26.3	23.4	46.8	38.9	14.1	13.0	21.9	13.7	32.6	18.6	9.0	11.3	40.7	8.8	8.1	14.2	21.6	14.7	10.6	18.1	23.8	7.2	6.7	60.7	8.4	9.6	4.8	25.3	10.4	17.9	22.0	13.3	20.2	18.3	17.5	41.1	12.3	26.4	29.1	74.5	46.1	107.2	78.7	46.5	7.7	20.2	22.9	49.5	31.8	12.2	2.0	21.5	13.3	32.0	79.1	51.7	5.1	0.0	31.8	46.1	52.2	250.9	98.0	83.9	32.1	7.9	24.0	41.1	61.4	135.1	19.2	53.0	45.5	16.2	0.6	75.7	19.7	0.6	30.1	34.2	5.2	64.7	88.4	20.7	10.4	53.2	26.1	87.3	4.3	62.0
EMD	"LEMD5, STA"	ENSG00000102119	Emerin	P50402	X	154379197-154381523	"Disease related genes, Predicted membrane proteins"		Actin-binding	"Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000609, CAB001545, CAB002029, CAB058694, CAB062552"	Supported		Enhanced	"Nuclear membrane,Endoplasmic reticulum"		NA	NA		520000	"Nuclear membrane"	"Endoplasmic reticulum"	"CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: AB_2665587, CAB062552: AB_2665586, HPA000609: AB_1078736"	"unprognostic (2.92e-1)"	"unprognostic (6.59e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.99e-1)"	25.0	17.5	14.0	17.6	16.0	21.0	26.5	15.8	21.8	24.8	21.3	13.7	22.3	14.0	32.3	25.7	22.9	27.2	28.7	29.5	13.1	14.1	18.2	21.2	22.0	37.4	13.3	16.5	35.9	29.4	20.5	22.8	15.4	11.9	25.5	11.4	20.7	24.5	29.1	62.0	18.1	13.7	40.4	13.1	17.6	20.1	16.1	9.7	16.6	28.1	24.4	18.3	31.7	20.6	23.2	30.5	24.5	19.7	14.7	26.9	15.8	30.6	11.6	8.0	8.8	7.3	14.6	14.4	15.1	16.2	19.3	20.3	10.3	6.0	24.4	23.0	15.5	40.7	17.1	15.3	18.7	8.2	14.3	33.4	11.4	17.0	6.0	19.8	11.0	12.6	12.8	14.9	17.2	21.5	13.0	13.4	10.4	9.4	10.5	13.1	13.0	19.2	20.2	13.4	17.9	36.2	16.0	12.0	23.3	10.4	5.9	10.2	12.6	7.8	13.1	18.4	8.1	9.2	8.3	12.1	9.6	18.3	21.6	21.6	34.4	25.5	44.0	11.7	18.6	10.4	16.6	16.9	24.5	26.9	19.7	25.0	22.5	25.7	25.7	13.5	23.2	23.1	22.4	18.1	14.7	14.0	30.5	23.9	15.8	14.0	16.0	15.8	21.8	13.1	14.1	13.3	16.5	11.9	9.7	29.8	39.9	28.9	65.6	63.7	31.2	18.5	30.6	20.1	30.7	26.2	11.8	50.6	59.7	39.0	13.8	27.2	18.0	0.0	47.4	56.3	49.5	56.7	53.2	33.5	46.5	28.6	23.0	27.0	17.1	11.2	37.7	46.4	64.1	59.5	33.9	40.7	39.0	28.8	42.1	35.0	29.9	25.8	51.0	10.7	34.1	67.2	104.6	47.8	27.5	59.3
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 74.7"	"Cell type enhanced"	"Detected in some"	14	"Cone photoreceptor cells: 9.8;Early spermatids: 30.2;Late spermatids: 26.8;Muller glia cells: 16.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Region enhanced"	"Detected in all"		"cerebellum: 74.7"	"Group enriched"	"Detected in some"	33	"neutrophil: 15.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 15.4;granulocytes: 15.9"	"Group enriched"	"Detected in some"	4	"HDLM-2: 34.7;HMC-1: 20.6;RPTEC TERT1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	2.0	1.5	9.0	1.8	16.6	1.5	5.5	74.7	23.6	3.6	3.4	3.4	3.1	2.8	4.1	2.0	3.8	2.8	3.3	1.1	9.4	5.3	2.3	2.9	1.0	3.3	2.8	7.0	1.7	1.1	0.6	3.8	0.9	7.1	3.3	1.4	1.9	3.9	5.1	7.4	6.0	1.7	1.7	6.0	3.4	1.3	16.7	6.0	0.0	11.6	2.9	3.3	4.5	2.6	0.0	15.4	15.9	0.0	0.0	0.4	0.1	0.0	0.0	4.8	0.0	0.1	0.0	0.1	3.6	0.0	0.2	0.0	0.0	0.0	0.6	1.0	1.9	0.3	0.0	3.2	0.0	0.7	34.7	0.4	2.6	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.2	2.6	0.1	0.1	0.1	1.4	0.6	0.0	0.0	0.5	0.1	9.4	0.0	0.6	0.1	0.0	0.0	0.0	0.7	0.1	0.4	0.2	0.6	2.0	0.3	4.3	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	15.4	0.0	0.1	9.0	16.6	74.7	19.0	9.4	5.3	2.8	7.0	7.1	6.0	0.0	0.0	0.9	0.0	3.3	1.2	1.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.8	30.2	0.6	0.0	0.0	0.3	0.0	0.2	0.1	0.0	5.8	0.4	0.0	0.0	0.0	0.0	26.8	0.6	0.0	1.7	0.0	0.0	16.2	0.6	0.0	0.0	0.0	0.9	0.0	0.8	0.4	0.9	5.1	0.0	0.0	0.0	0.1
ERLIN1	"C10orf69, Erlin-1, KE04, SPFH1, SPG62"	ENSG00000107566	"ER lipid raft associated 1"	O75477	10	100150094-100188334	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011252	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA011252: AB_1853965"	"unprognostic (3.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (1.26e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	12.9	8.0	5.4	6.9	10.1	23.2	13.9	6.7	6.1	11.3	18.6	5.7	7.0	13.8	11.9	6.6	17.9	11.2	6.8	6.8	6.2	3.7	12.3	81.4	8.7	10.1	7.3	3.8	13.9	17.7	5.9	8.8	24.2	4.7	9.2	13.5	8.2	9.8	5.7	5.5	10.8	18.9	7.7	4.1	9.7	12.7	17.4	5.4	8.6	11.8	10.3	14.3	14.7	14.6	6.2	12.6	18.2	16.0	7.5	9.0	7.0	23.5	23.4	12.0	21.8	28.9	28.4	24.5	37.5	34.8	31.0	35.8	15.7	27.5	10.5	15.2	34.7	25.4	24.6	10.7	22.1	43.0	6.3	9.5	9.0	10.5	19.8	12.0	31.5	10.0	16.1	13.4	27.1	32.9	29.2	22.4	10.8	8.9	6.4	32.6	9.5	8.1	11.5	8.5	15.8	9.8	6.9	19.7	7.6	13.3	9.4	4.9	7.9	21.3	6.0	13.2	14.4	15.0	26.1	25.3	31.1	23.9	18.5	39.4	5.0	8.4	14.3	27.3	49.9	15.3	4.3	16.0	18.2	8.5	11.7	7.6	6.2	6.6	7.0	12.6	5.5	6.8	9.0	11.6	7.5	8.6	2.9	3.8	7.0	5.4	10.1	6.7	6.1	6.2	3.7	7.3	3.8	4.7	5.4	0.0	8.6	8.0	9.7	14.1	4.7	3.7	2.5	34.8	12.5	14.0	5.9	17.0	0.0	8.5	15.7	14.3	24.4	23.3	9.6	54.3	14.0	10.1	8.1	68.9	12.5	3.2	12.7	11.1	15.9	10.0	14.1	7.2	10.1	10.0	23.4	5.6	8.4	17.5	7.4	10.3	5.3	0.0	6.6	35.7	16.8	17.8	20.7	5.0	23.6	11.9
ERLIN2	"C8orf2, Erlin-2, NET32, SPFH2, SPG18"	ENSG00000147475	"ER lipid raft associated 2"	O94905	8	37736599-37759101	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002025, CAB014894"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB014894: , HPA002025: AB_1080077"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (6.67e-6)"	"unprognostic (4.78e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.33e-1)"	14.5	17.7	15.6	9.5	17.6	8.9	17.5	11.0	13.8	16.6	16.2	21.4	26.9	11.8	18.1	23.1	19.5	21.8	20.6	11.9	13.1	11.3	28.5	31.1	12.0	16.5	13.2	16.0	22.3	45.7	34.2	12.9	26.8	15.2	21.2	17.9	23.3	23.2	18.9	13.0	12.4	19.1	22.8	15.3	12.0	16.6	15.9	12.5	13.8	32.4	14.8	14.0	20.5	13.5	4.9	8.7	14.8	9.8	2.8	5.8	3.5	16.3	17.1	18.7	12.5	20.9	15.6	19.6	24.5	23.3	13.8	15.0	8.6	20.7	8.0	41.4	27.0	13.5	17.0	14.1	21.2	22.9	4.5	10.5	11.4	10.9	9.5	13.9	7.3	16.4	19.1	21.3	20.6	21.7	17.9	14.4	7.7	21.2	7.6	20.9	8.1	10.5	5.8	18.9	22.0	7.2	7.4	13.2	5.8	16.7	17.8	3.5	9.1	15.9	4.8	14.5	23.7	26.7	11.0	12.9	13.2	11.8	24.6	13.1	10.2	16.6	10.0	23.7	11.9	18.0	1.7	7.5	14.8	5.2	7.5	4.3	4.9	3.5	4.2	6.0	2.8	5.4	4.8	9.6	2.8	9.8	8.7	5.8	3.5	15.6	17.6	11.0	13.8	13.1	11.3	13.2	16.0	15.2	12.5	11.9	14.7	6.5	9.1	8.7	24.5	28.3	33.1	52.2	20.5	31.4	19.6	15.2	8.3	18.0	17.6	10.5	17.4	0.0	19.3	19.3	14.4	18.4	3.5	34.7	17.8	15.9	10.9	15.4	21.0	11.9	10.9	14.6	13.5	7.2	23.9	21.9	17.5	17.3	16.6	17.4	17.9	19.4	8.5	42.7	17.2	6.5	13.2	7.0	25.9	10.5
ESYT1	"FAM62A, KIAA0747, MBC2"	ENSG00000139641	"Extended synaptotagmin 1"	Q9BSJ8	12	56118250-56144671	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016858, HPA076926"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		2600000	"Endoplasmic reticulum"		"HPA016858: AB_1848404, HPA076926: AB_2686819"	"unprognostic (5.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.04e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.98e-2)"	49.8	25.9	10.8	17.6	11.5	7.8	40.3	14.3	16.5	22.8	25.1	15.9	13.7	8.3	33.7	16.4	21.7	24.4	21.1	15.2	10.1	11.3	17.8	27.6	21.8	20.2	11.3	10.8	28.9	25.8	24.7	8.6	19.1	28.1	25.4	18.4	15.9	18.4	24.7	23.4	15.7	18.5	36.6	9.2	23.6	19.1	19.7	12.7	24.3	17.9	18.1	23.5	27.1	22.0	11.7	15.2	70.9	13.4	13.6	29.2	26.3	22.7	16.8	13.8	34.8	20.4	15.3	11.8	25.8	28.3	30.2	21.1	15.4	25.0	8.7	20.6	43.2	11.2	25.9	16.1	25.9	27.1	12.4	11.8	52.7	13.1	12.2	28.3	41.1	83.5	17.3	27.4	32.5	18.2	32.3	25.5	8.4	32.3	58.2	26.9	16.9	14.6	24.0	17.4	9.3	22.4	22.5	19.0	22.6	25.1	19.3	11.6	12.1	38.3	11.5	17.2	16.4	24.5	27.0	33.9	23.5	21.6	13.2	18.3	13.9	20.7	12.7	21.9	17.1	24.5	63.2	6.2	70.9	23.4	12.0	29.2	11.7	24.2	23.7	15.2	9.5	19.5	22.5	1.7	13.6	13.4	5.1	23.9	26.3	10.8	11.5	14.3	16.5	10.1	11.3	11.3	10.8	28.1	12.7	8.9	9.4	28.3	15.0	14.4	4.9	7.2	10.2	2.7	10.3	29.6	9.8	25.2	0.0	30.2	1.6	24.5	2.3	0.0	22.8	13.7	14.6	18.2	61.2	28.0	40.0	0.0	24.2	27.0	18.1	1.9	16.1	21.3	33.7	60.5	11.2	5.8	24.0	0.0	23.7	4.2	5.8	51.8	24.5	3.7	2.6	10.5	31.7	34.6	9.2	13.7
FAF2	"ETEA, KIAA0887, UBXD8, UBXN3B"	ENSG00000113194	"Fas associated factor family member 2"	Q96CS3	5	176447628-176510074	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065968, HPA071246, HPA073828"	Approved		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Lipid droplets"	"Endoplasmic reticulum"	"HPA065968: AB_2685589, HPA071246: AB_2732176, HPA073828: AB_2686636"	"unprognostic (6.25e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.02e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (1.79e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (6.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.74e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.48e-1)"	21.1	27.7	17.5	16.5	28.5	21.7	20.8	25.4	28.3	21.5	19.2	24.4	17.4	17.2	22.3	21.5	23.0	21.0	18.0	15.1	16.8	18.9	20.5	34.2	17.8	17.2	16.4	15.9	29.3	25.9	32.4	31.5	32.0	25.5	22.3	23.1	24.6	20.1	18.6	15.3	25.5	22.6	22.2	14.5	21.0	18.8	31.9	14.2	30.0	23.1	15.2	24.3	20.7	17.5	7.2	10.9	10.0	14.9	12.4	13.1	7.5	13.7	15.7	15.6	17.3	22.2	17.7	21.4	18.1	20.8	20.7	22.4	20.4	25.0	12.1	20.5	19.1	37.7	21.4	22.3	45.9	28.7	48.1	12.3	7.9	16.1	9.9	22.6	17.1	10.4	23.3	20.2	25.3	21.1	13.4	17.1	13.8	11.3	16.6	19.7	22.9	14.9	9.1	12.6	15.0	13.4	14.8	13.6	13.4	17.5	18.3	13.9	14.8	22.1	19.2	20.0	14.0	22.5	13.7	19.1	28.5	15.5	15.6	24.1	14.2	15.2	15.8	18.0	12.3	24.8	10.0	9.2	6.1	10.0	7.6	12.2	7.2	8.2	10.5	10.9	7.0	10.7	9.5	7.8	12.4	14.9	7.5	13.1	7.5	17.5	28.5	25.4	28.3	16.8	18.9	16.4	15.9	25.5	14.2	26.8	43.3	7.2	26.4	4.7	42.5	12.5	17.8	38.8	34.2	17.4	43.2	29.9	10.0	28.6	8.7	24.9	14.4	0.0	32.2	33.2	25.2	27.7	30.2	21.9	19.6	14.3	19.1	25.8	12.7	3.6	28.1	13.8	11.8	21.6	16.4	44.7	43.0	8.6	29.4	7.7	28.0	25.8	18.9	48.6	53.9	7.4	48.4	13.8	15.7	25.7
FAM234B	KIAA1467	ENSG00000084444	"Family with sequence similarity 234 member B"	A2RU67	12	13044284-13142521	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 17.4;Erythroid cells: 23.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 16.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010803, HPA010850"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010803: AB_1079200, HPA010850: AB_2732402"	"unprognostic (1.85e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.03e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.06e-3)"	"unprognostic (7.62e-2)"	4.4	3.6	9.6	2.3	17.5	3.5	21.2	21.3	28.5	3.4	1.6	4.4	4.2	2.6	3.6	4.4	2.8	4.0	2.4	1.9	10.8	12.4	7.3	3.0	3.6	2.1	9.1	16.7	3.5	3.4	4.8	5.2	7.1	13.6	8.1	1.9	3.4	3.4	5.0	2.8	15.5	2.5	3.2	5.1	2.9	1.7	6.8	5.0	0.5	10.9	0.1	2.2	3.6	2.8	6.8	4.3	1.9	6.9	2.7	4.5	1.4	2.9	3.0	9.2	6.5	7.3	7.1	7.2	2.0	2.3	4.5	8.9	3.1	4.4	12.0	2.5	2.4	7.9	4.5	11.5	2.2	9.5	1.4	6.4	7.1	3.3	2.5	3.9	6.2	4.1	5.4	4.7	6.5	5.0	6.8	5.9	8.4	1.8	4.4	4.9	9.8	5.2	4.0	12.1	2.3	1.7	6.8	12.0	1.3	2.8	7.2	12.9	4.2	4.4	2.9	3.5	16.5	3.7	3.5	3.0	3.0	5.1	5.5	2.1	2.4	3.1	7.8	9.6	2.8	3.7	0.3	2.7	1.9	2.6	4.5	3.4	4.6	2.9	2.5	2.3	6.8	4.3	4.5	0.7	2.7	6.9	4.3	2.3	1.4	9.6	17.5	21.3	28.5	10.8	12.4	9.1	16.7	13.6	5.0	3.0	3.5	0.9	1.7	0.0	11.3	0.0	2.5	0.0	0.0	17.4	2.0	5.6	1.7	1.9	7.0	0.0	0.0	23.3	1.2	2.7	1.0	3.8	0.0	2.0	3.1	3.2	11.7	4.9	1.3	2.7	5.2	0.5	0.0	2.8	0.1	3.8	1.2	0.0	4.9	1.0	2.9	0.0	0.0	8.8	10.9	0.0	3.0	0.0	0.0	1.1
FAU	"asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30"	ENSG00000149806	"FAU, ubiquitin like and ribosomal protein S30 fusion"	"P35544, P62861"	11	65120628-65122473	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059015	Supported		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA059015: AB_2683881"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-2)"	79.7	95.0	90.6	84.9	76.2	186.7	95.4	50.9	80.9	103.6	134.8	77.6	63.4	77.8	84.0	80.5	115.2	100.0	87.2	133.9	70.0	58.9	88.0	162.9	77.5	182.6	78.9	40.8	176.0	202.8	27.5	56.1	73.2	46.6	123.5	53.0	67.8	97.3	76.7	190.8	86.8	93.8	97.5	72.4	130.9	79.2	53.6	53.2	126.8	121.5	83.6	149.5	122.0	136.6	291.3	169.7	90.9	119.0	116.3	253.8	346.5	78.9	52.0	46.0	72.8	45.0	67.3	63.0	45.1	43.9	63.2	40.1	58.8	79.3	94.1	122.5	38.7	42.6	69.8	42.6	60.1	26.3	69.0	65.3	75.8	54.7	80.7	82.8	89.8	83.6	82.9	100.1	54.3	73.9	60.2	48.7	91.0	70.7	111.5	33.4	98.7	103.8	181.4	126.5	59.2	86.7	101.0	36.8	184.5	58.2	44.7	64.0	64.3	35.0	101.3	140.8	28.6	90.5	124.6	46.0	57.2	66.0	88.2	72.0	121.3	115.2	160.1	69.3	70.0	64.7	90.9	119.0	70.6	128.9	107.0	176.1	291.3	212.1	165.5	132.1	281.7	253.8	198.1	78.9	116.3	92.8	169.7	153.8	346.5	90.6	76.2	50.9	80.9	70.0	58.9	78.9	40.8	46.6	53.2	595.5	951.7	2941.4	2547.1	3351.7	327.7	460.8	1579.6	745.5	1039.6	909.0	184.6	1889.5	1737.5	1225.7	710.1	1573.3	1664.2	1027.9	2337.8	2188.3	1714.1	2189.0	1307.1	1658.9	1928.3	179.6	1179.1	1412.4	2371.4	1489.6	2116.5	2866.9	2014.3	2418.4	1788.3	428.5	1806.3	2457.4	1155.5	1844.9	362.4	1099.5	2206.1	745.0	649.0	3667.7	2335.8	2033.7	2040.2	2956.6
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 287.9;vagina: 228.2"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 571.3;Extravillous trophoblasts: 448.0;Fibroblasts: 795.3;Syncytiotrophoblasts: 1016.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 29.1"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 157.8;ASC TERT1: 70.0;BJ: 84.6;BJ hTERT+: 134.5;HSkMC: 115.4;RT4: 121.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		34000000000	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	42.3	14.9	2.6	16.9	3.7	0.0	101.2	2.9	6.0	141.6	20.5	11.6	30.3	8.6	62.4	69.7	48.3	47.1	123.7	86.4	6.6	1.3	8.1	2.9	42.5	9.2	3.8	4.2	46.6	12.3	30.0	10.0	287.9	29.1	99.0	10.0	35.3	12.8	21.8	11.5	33.1	16.9	136.1	6.1	2.7	30.3	20.7	2.8	1.1	21.6	18.9	5.3	67.1	228.2	0.4	2.9	0.9	5.7	0.1	0.3	0.2	1.4	3.4	10.2	21.4	157.8	70.0	46.9	84.6	134.5	7.5	2.8	14.5	0.4	0.0	3.6	3.1	0.2	7.4	6.4	0.2	0.9	0.0	1.7	0.0	18.4	9.7	20.9	0.0	0.0	115.4	1.3	7.5	2.7	0.1	0.0	0.1	0.0	0.1	5.2	0.2	0.0	0.2	14.4	0.3	1.2	0.1	0.0	0.1	3.4	121.1	0.7	13.6	10.4	49.3	0.0	30.3	0.3	0.4	0.6	1.4	9.4	38.9	0.0	0.1	0.0	0.1	0.1	0.0	3.6	0.9	0.1	0.0	0.2	0.7	0.2	0.1	0.2	0.1	1.2	0.4	0.3	0.2	0.6	0.1	5.7	2.9	0.2	0.2	2.6	3.7	2.9	6.0	6.6	1.3	3.8	4.2	29.1	2.8	6.0	2.2	0.0	92.6	151.8	0.0	8.6	12.7	1.4	13.6	1.8	0.0	571.3	0.0	0.5	8.4	22.5	0.0	0.0	0.2	448.0	795.3	17.7	1.1	0.4	73.2	0.0	0.0	36.2	0.0	18.3	85.4	3.3	161.9	0.0	0.0	0.0	0.7	0.0	28.7	0.3	0.5	116.4	93.7	18.7	76.7	113.9	1016.7	0.0	0.2	69.1
FDFT1		ENSG00000079459	"Farnesyl-diphosphate farnesyltransferase 1"	P37268	8	11795573-11839309	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008874	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA008874: AB_1078844"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.92e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.57e-1)"	"prognostic favorable (6.59e-9)"	"unprognostic (2.28e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.06e-1)"	20.8	44.3	26.3	22.7	27.7	30.6	57.5	19.5	43.6	27.6	41.7	45.9	20.0	44.6	26.9	29.1	59.4	27.5	19.9	27.1	29.8	32.1	24.9	45.9	30.7	23.4	36.2	34.4	22.9	18.0	17.1	18.2	22.1	47.4	38.8	32.9	32.4	46.5	20.6	71.2	38.4	30.2	18.0	56.5	18.4	35.4	41.3	40.5	25.9	24.7	32.2	25.4	25.8	34.2	44.0	30.5	42.2	19.6	22.6	31.0	29.0	21.6	10.5	47.1	18.8	10.2	17.5	14.3	8.5	14.5	9.0	18.7	14.7	26.8	30.1	4.2	8.5	52.3	18.0	23.3	71.0	7.3	5.0	24.9	14.1	8.0	35.0	21.7	7.3	9.9	15.7	18.0	20.1	10.0	6.9	11.3	35.0	20.3	39.7	8.8	14.1	25.7	17.4	41.2	18.0	6.2	15.8	10.9	61.8	41.8	78.8	15.1	9.4	7.4	12.6	21.3	18.7	20.7	21.3	14.1	4.2	10.5	1.9	5.3	8.2	20.7	32.8	7.4	24.8	12.4	42.2	19.6	22.6	21.6	17.2	20.8	44.0	22.7	21.2	30.5	35.3	21.5	20.3	18.6	22.6	11.7	22.7	31.0	29.0	26.3	27.7	19.5	43.6	29.8	32.1	36.2	34.4	47.4	40.5	50.6	130.3	65.1	88.1	46.6	14.4	61.6	107.0	89.7	86.4	75.0	13.7	242.8	74.6	133.2	225.3	35.0	92.9	46.7	248.7	118.9	42.5	90.7	54.4	67.1	77.6	11.1	75.9	16.5	49.7	171.1	71.4	48.9	96.2	125.4	83.9	56.6	133.6	63.2	50.2	63.4	19.7	51.8	62.1	181.7	75.9	77.7	146.3	48.4	83.2	141.3
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583126-154590766	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	740	"liver: 2009.3"	"Cell type enriched"	"Detected in many"	40	"Hepatocytes: 16694.6"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 96.9"	"Not detected"	"Not detected"							"CAB016776, HPA051370, HPA064755"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	170000000000	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.7	2009.3	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	96.9	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.4	83.9	0.0	0.0	0.0	0.4	420.4	17.4	5.7	0.0	0.0	0.0	1.7	5.5	23.9	0.0	0.0	256.9	1.5	0.0	0.0	0.0	0.0	16694.6	0.1	0.0	0.0	255.3	257.1	29.3	0.6	0.0	0.0	0.0	0.0	0.0	31.5	0.0	1.1	1.0	0.0	0.0	0.0	14.4	0.6	0.0	0.1	4.3	0.0	0.0
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154562956-154571086	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"liver: 1908.6"	"Cell type enriched"	"Detected in some"	33	"Hepatocytes: 15347.2"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 77.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		120000000000	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	1908.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	77.7	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	153.8	0.0	0.0	0.0	0.4	257.4	0.0	0.0	3.5	0.0	0.0	1.7	3.0	0.4	0.0	0.0	467.2	3.2	0.1	0.0	0.0	0.0	15347.2	0.3	0.0	1.7	349.9	342.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 131.7"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 92.2;Cholangiocytes: 94.3;Suprabasal keratinocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.3;HaCaT: 15.1;Hep G2: 32.5;NTERA-2: 15.8;RT4: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		670000	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.5	1.5	24.7	1.7	30.3	1.6	4.2	10.2	22.0	4.1	4.9	15.8	3.4	9.9	1.8	2.7	26.9	2.0	5.0	2.0	21.6	11.7	9.6	7.4	4.5	1.3	17.6	21.5	1.1	23.0	1.2	3.0	5.6	15.1	3.7	3.8	1.7	3.8	9.0	1.7	131.7	7.4	1.3	9.0	2.1	4.9	8.1	10.6	0.1	1.3	8.5	7.3	8.5	10.1	0.1	0.6	0.1	0.1	0.2	0.3	0.0	0.0	1.5	9.2	2.6	0.0	0.1	9.4	1.1	0.1	0.4	0.2	19.3	0.4	0.0	7.7	0.3	0.4	15.1	2.6	0.1	0.1	0.1	9.7	6.0	1.5	32.5	0.0	0.0	0.2	0.0	5.1	0.1	0.0	0.0	0.0	0.9	6.5	0.0	0.0	9.6	0.4	0.2	15.8	8.8	0.0	0.5	0.5	0.1	1.3	19.3	2.7	0.7	0.8	1.6	0.0	11.1	9.0	1.1	0.4	0.0	0.9	0.2	0.6	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.6	0.1	0.0	24.7	30.3	10.2	22.0	21.6	11.7	17.6	21.5	15.1	10.6	0.0	23.8	2.4	3.6	92.2	0.0	2.0	94.3	0.0	21.6	14.0	0.0	0.4	0.0	4.8	5.4	0.9	20.6	0.0	0.6	9.2	7.0	3.3	0.0	27.0	0.5	0.0	4.1	14.7	1.2	0.4	0.6	1.2	11.8	1.0	20.7	0.2	0.4	17.3	0.4	7.5	0.6	0.0	2.8	0.4	17.9	77.5	0.7	0.0	13.0	11.8
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	495	"liver: 2225.7"	"Cell type enriched"	"Detected in many"	15	"Hepatocytes: 7797.1"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	55	"Hep G2: 128.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	68000000000	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	2.7	2225.7	4.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	128.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	17.9	218.6	146.9	0.0	0.0	0.0	0.2	507.0	2.7	4.5	0.0	0.0	0.0	0.0	3.8	2.8	0.0	0.0	327.1	40.0	0.1	0.0	0.0	10.5	7797.1	0.2	0.0	0.0	232.7	240.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	266.1	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.0	0.3	20.1	0.0	0.0
FKBP7	FKBP23	ENSG00000079150	"FK506 binding protein 7"	Q9Y680	2	178463664-178478600	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 116.0;Fibroblasts: 67.2;Leydig cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 52.8;ASC TERT1: 32.8;HSkMC: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008707	Approved	Supported	Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA008707: AB_1848624"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (4.61e-6)"	"unprognostic (3.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.10e-1)"	9.6	4.6	1.5	4.3	4.1	0.7	11.1	3.5	2.3	20.5	6.9	1.0	10.0	1.8	21.4	21.9	8.4	12.4	12.8	12.1	1.5	1.5	5.5	7.4	6.8	5.2	4.0	1.8	34.6	4.3	1.5	11.1	8.2	2.9	19.5	4.2	7.1	4.9	9.7	4.4	4.0	3.9	19.9	3.9	3.0	5.3	8.3	2.2	2.2	8.7	8.0	2.3	15.5	9.9	2.8	5.8	0.2	1.6	1.2	2.8	0.8	0.0	0.6	6.1	9.0	52.8	32.8	0.5	10.9	18.1	2.0	6.4	0.1	0.6	1.7	2.4	19.9	1.8	0.1	2.3	0.9	3.5	1.4	1.3	1.7	2.5	1.7	8.1	1.1	1.3	22.0	0.5	8.0	1.1	14.7	6.5	2.1	0.8	1.1	8.4	0.1	1.9	1.9	1.2	1.1	0.9	2.5	10.7	2.3	2.7	0.2	3.2	10.6	2.3	0.0	1.8	4.5	0.1	2.1	6.0	3.7	2.3	4.3	1.0	2.1	2.2	0.8	6.8	2.7	8.0	0.0	1.1	0.1	2.3	1.6	2.8	2.8	2.0	1.6	5.8	1.7	2.2	2.4	0.2	1.2	0.0	4.5	2.2	0.8	1.5	4.1	3.5	2.3	1.5	1.5	4.0	1.8	2.9	2.2	6.0	2.6	2.2	6.7	6.3	4.6	12.6	2.5	2.7	3.4	7.0	0.0	6.2	1.7	9.1	116.0	18.6	0.1	0.0	7.4	18.5	67.2	3.6	13.9	9.8	5.3	4.8	1.2	13.5	4.3	22.0	59.2	4.8	16.9	1.8	4.8	3.7	4.0	0.0	45.6	3.5	3.3	6.5	39.2	3.7	5.5	5.1	4.2	5.0	2.6	3.4
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FK506 binding protein 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 972.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 32.5;neutrophil: 31.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 32.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"		NA	NA			Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: AB_2679244"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	44.3	38.1	75.9	27.5	82.1	82.5	26.5	43.4	113.7	35.2	31.9	41.2	34.6	31.1	31.4	27.2	48.7	39.3	34.5	43.4	69.6	62.1	28.9	42.7	34.3	31.1	55.3	54.3	56.1	60.4	28.8	42.2	36.6	51.2	36.5	12.9	31.9	73.1	46.1	56.7	35.1	31.6	34.6	46.3	36.7	31.9	49.5	26.9	32.1	38.8	24.2	30.7	36.3	45.8	4.3	4.3	32.5	6.9	3.1	6.6	9.1	36.9	26.5	20.8	39.5	21.5	33.8	52.2	29.9	31.9	22.9	31.8	25.1	50.5	21.2	48.7	36.7	15.4	20.1	12.8	41.7	6.5	25.8	60.9	19.8	34.6	30.2	37.0	19.6	43.6	44.1	40.2	20.6	13.1	44.1	23.5	41.3	41.4	50.5	19.9	61.6	35.6	58.7	42.5	33.2	38.5	37.4	17.3	72.4	30.8	24.2	23.1	42.1	21.0	17.3	37.3	16.5	20.4	57.2	27.4	28.7	26.2	55.9	22.7	38.6	22.2	24.6	64.8	31.5	25.4	6.3	5.6	32.5	6.0	5.8	5.5	4.1	6.1	6.6	4.3	4.3	4.7	5.3	31.0	3.1	6.9	4.3	6.0	9.1	75.9	82.1	43.4	113.7	69.6	62.1	55.3	54.3	51.2	26.9	8.9	1.4	107.1	128.1	84.6	57.2	2.0	71.4	2.7	5.7	96.0	13.7	219.4	210.5	151.9	314.6	76.6	289.8	233.6	111.8	173.9	174.8	132.3	54.0	55.9	208.7	93.8	197.7	79.8	159.9	972.7	188.7	127.3	192.3	254.3	108.6	104.6	130.6	224.5	155.6	222.1	41.3	97.0	149.9	203.6	97.7	103.1	261.7	163.0	127.0	126.6
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.9;brain: 19.3;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"	25	"Kupffer cells: 29.6;Macrophages: 12.4;monocytes: 55.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8"	"Region enhanced"	"Detected in many"		"cerebellum: 19.3"	"Group enriched"	"Detected in some"	11	"myeloid DC: 29.9;plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 29.9"	"Group enriched"	"Detected in some"	11	"REH: 28.5;THP-1: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"		NA	NA		180000	"Endoplasmic reticulum"		"HPA047539: AB_2680080"	"unprognostic (2.19e-3)"	"unprognostic (3.16e-3)"	"unprognostic (6.54e-3)"	"unprognostic (9.96e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.96e-7)"	"unprognostic (7.99e-3)"	"unprognostic (1.65e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	0.9	0.6	0.6	7.2	1.1	7.5	2.6	19.3	3.5	0.9	1.2	0.1	0.1	0.4	0.8	0.8	1.0	1.2	4.6	0.5	0.9	1.7	2.8	0.7	2.7	15.0	1.8	1.1	0.5	5.7	0.0	0.4	0.0	7.4	0.6	1.4	0.1	2.3	0.6	0.4	1.2	3.0	1.3	4.4	8.8	0.9	1.2	0.0	8.2	0.6	0.0	5.8	2.4	0.7	0.1	29.9	1.4	1.8	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.5	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	1.4	0.0	0.3	0.0	0.1	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.8	0.0	12.1	0.0	1.2	0.6	1.1	19.3	3.5	0.9	1.7	1.8	1.1	7.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	29.6	1.6	0.0	12.4	1.7	55.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0
FMO5		ENSG00000131781	"Flavin containing monooxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 61.1;liver: 119.4;stomach 1: 38.6"	"Cell type enhanced"	"Detected in many"	17	"Cholangiocytes: 117.2;Hepatocytes: 260.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Hep G2: 29.0;HMC-1: 6.6;THP-1: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	1.1	2.4	1.1	1.9	5.5	0.2	8.6	0.6	4.5	1.3	61.1	1.5	0.8	12.5	1.0	1.3	0.7	1.1	8.5	1.0	1.3	0.5	9.0	119.4	17.0	0.8	17.1	0.5	1.0	11.9	8.8	4.9	0.6	5.2	1.9	8.2	0.5	9.7	0.6	0.4	4.2	53.6	0.9	7.1	1.2	38.6	1.2	6.0	0.2	1.1	1.5	0.5	1.9	0.8	9.2	4.9	6.2	12.1	1.0	2.0	3.6	0.1	0.7	0.5	0.1	1.9	0.5	0.7	0.4	0.4	0.2	0.6	0.4	1.5	0.3	0.5	0.4	0.1	0.3	0.0	0.0	0.0	1.0	0.1	1.2	0.0	29.0	0.6	1.0	6.6	0.9	0.1	0.3	0.0	0.3	0.4	0.2	0.1	0.1	1.1	1.0	0.2	0.5	2.1	3.6	0.5	0.3	0.3	0.2	2.4	0.4	0.4	0.2	0.6	2.0	0.9	1.0	1.4	7.4	0.7	0.0	0.2	0.6	0.0	0.2	0.0	0.2	0.7	0.3	0.2	6.2	12.1	3.5	2.0	5.6	0.3	3.6	0.5	0.6	4.9	9.2	0.3	1.3	1.2	1.0	1.6	2.4	1.4	3.6	1.1	5.5	0.6	4.5	1.3	0.5	17.1	0.5	5.2	6.0	8.9	48.6	8.5	3.5	1.4	2.0	1.4	117.2	21.4	13.6	14.0	0.0	1.2	6.6	4.3	5.9	2.7	52.0	0.0	5.1	0.9	1.3	4.1	5.7	260.8	3.2	3.2	6.4	3.1	10.1	4.1	2.6	2.6	27.0	0.0	25.3	0.3	5.7	28.1	1.4	41.5	1.3	0.0	0.8	1.8	0.7	1.4	1.1	4.3	16.4	6.2
FNDC3B	"DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421"	ENSG00000075420	"Fibronectin type III domain containing 3B"	Q53EP0	3	172039628-172401665	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 22.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007859	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007859: AB_1078900"	"unprognostic (7.18e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (2.17e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (5.65e-7)"	"unprognostic (4.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-2)"	39.6	22.1	4.0	16.5	5.7	18.2	27.3	2.9	5.1	20.8	18.4	4.2	20.9	7.5	28.9	21.7	13.2	12.3	18.3	18.9	4.9	4.2	17.6	35.6	23.1	10.9	6.7	2.3	26.4	30.7	12.3	21.4	64.1	5.9	15.1	11.5	13.4	27.7	19.8	22.0	8.1	13.1	17.8	6.6	17.5	15.0	10.5	5.0	4.8	21.2	10.5	12.8	25.4	25.8	0.6	2.7	22.7	5.0	2.4	2.6	1.8	12.2	14.2	9.9	12.0	31.0	21.4	24.0	17.6	19.9	11.9	16.3	7.8	27.1	1.2	47.2	26.5	23.7	7.3	3.4	14.3	21.0	7.0	2.5	1.7	9.1	21.4	31.2	15.7	27.6	21.6	7.3	22.2	21.2	28.6	31.7	2.2	2.8	8.9	12.5	3.8	0.6	6.9	5.7	4.7	5.8	1.4	10.2	5.9	13.1	10.9	0.6	3.0	16.8	8.7	14.6	14.3	8.2	8.1	45.8	16.8	7.8	21.2	13.8	18.7	20.7	2.4	17.7	9.1	16.5	7.8	5.0	11.4	2.6	3.0	1.1	0.6	0.8	1.4	2.7	0.0	0.9	1.6	22.7	2.4	1.5	0.4	0.7	1.8	4.0	5.7	2.9	5.1	4.9	4.2	6.7	2.3	5.9	5.0	80.4	43.5	12.0	47.6	56.7	7.5	43.1	50.9	13.4	35.2	43.6	11.8	35.6	13.3	62.0	7.7	56.2	22.4	0.0	39.5	90.0	84.5	54.9	15.0	60.6	44.9	0.0	16.1	62.0	65.2	5.3	53.2	61.1	65.8	50.5	28.4	16.6	73.1	40.8	51.2	30.5	12.2	51.8	50.5	2.4	2.7	29.4	29.1	19.2	20.0	74.5
FUT10		ENSG00000172728	"Fucosyltransferase 10"	Q6P4F1	8	33370824-33473422	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 187.5;Late spermatids: 217.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053970, HPA058655"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Endoplasmic reticulum, Golgi apparatus"		"HPA053970: AB_2682327, HPA058655: AB_2683789"	"unprognostic (6.02e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.07e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.76e-4)"	"unprognostic (3.06e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.01e-3)"	5.6	7.2	7.9	3.9	10.9	2.0	8.9	18.8	8.6	10.9	6.3	6.9	5.0	6.4	10.5	5.3	5.8	8.4	4.8	5.4	7.4	4.5	8.3	5.2	6.0	4.1	5.8	7.2	13.6	10.9	14.5	11.7	8.2	6.8	6.0	6.9	12.4	6.7	5.9	2.4	9.7	6.1	7.3	5.1	3.8	5.7	4.1	4.6	5.8	6.9	2.2	6.0	6.6	7.2	2.4	3.5	1.9	1.5	3.8	4.1	2.1	2.2	4.4	7.1	8.4	11.1	11.3	3.7	4.5	7.3	4.4	5.9	6.7	3.9	2.5	5.5	5.6	3.7	6.1	10.2	4.1	4.4	5.7	3.9	8.4	3.7	7.3	5.1	1.8	3.0	7.9	7.4	1.1	5.4	9.4	8.7	4.6	7.6	3.4	4.1	1.3	6.5	2.8	10.0	6.3	2.9	4.9	5.5	1.4	6.2	5.5	2.4	2.3	2.5	3.8	4.9	7.8	3.8	1.9	7.1	3.3	1.5	8.5	3.5	1.4	2.2	1.7	2.0	5.4	3.4	1.1	1.5	1.9	3.7	0.7	4.0	2.4	2.2	3.5	3.5	1.0	2.5	2.4	1.1	3.8	0.5	2.0	4.1	2.1	7.9	10.9	18.8	8.6	7.4	4.5	5.8	7.2	6.8	4.6	3.0	1.3	0.0	2.6	2.4	3.1	2.2	5.1	1.4	3.4	3.5	9.8	9.6	1.7	4.1	187.5	3.0	2.6	0.0	3.5	5.8	4.1	1.1	5.7	3.9	3.0	3.2	3.5	4.3	1.8	217.3	6.4	1.9	1.7	2.8	2.9	31.7	3.1	0.0	4.6	2.8	10.8	0.0	2.8	1.6	2.4	1.5	5.0	0.5	2.9	1.3
FXYD5	OIT2	ENSG00000089327	"FXYD domain containing ion transport regulator 5"	Q96DB9	19	35154730-35169883	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 407.2;Kupffer cells: 403.3;Macrophages: 433.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA010817	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010817: AB_1849214"	"unprognostic (3.97e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.66e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.71e-9)"	"unprognostic (6.07e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"	58.8	10.6	6.0	47.4	9.0	72.4	66.9	2.7	7.1	44.3	15.6	14.4	10.4	8.8	33.6	25.9	31.3	26.0	28.6	29.1	7.0	7.9	13.7	13.2	39.5	110.7	12.0	7.6	18.9	8.0	3.4	11.7	56.9	11.8	27.3	14.0	19.8	19.7	16.7	17.0	22.7	27.0	18.7	18.2	80.3	20.8	10.8	9.3	33.9	16.0	26.9	97.4	36.6	59.8	73.3	91.4	66.5	76.9	99.6	109.0	94.6	98.9	23.7	0.0	0.1	35.4	44.9	23.8	56.9	75.9	40.7	30.4	6.7	29.1	22.8	15.6	68.7	14.6	23.3	14.6	35.1	26.3	28.1	9.6	42.6	13.1	0.0	27.9	24.2	42.5	26.6	15.7	29.5	51.1	24.0	38.3	6.3	39.9	110.3	25.3	0.1	2.8	10.1	7.3	92.0	13.8	13.6	5.0	28.8	14.9	0.5	4.3	0.0	31.4	16.5	33.2	13.5	8.6	19.5	54.0	50.3	19.1	54.5	4.3	0.1	1.6	5.8	76.6	56.4	76.7	66.5	73.5	13.4	60.3	76.9	56.8	73.3	102.5	62.8	91.4	66.7	68.0	55.0	18.1	99.6	74.5	41.9	109.0	94.6	6.0	9.0	2.7	7.1	7.0	7.9	12.0	7.6	11.8	9.3	3.0	14.9	263.7	53.6	95.1	0.3	2.4	22.9	1.4	7.9	94.2	0.0	9.5	0.0	153.7	1.1	336.6	0.8	0.0	176.3	377.4	156.4	26.1	356.4	4.3	407.2	0.0	10.3	249.2	403.3	2.7	6.1	433.0	199.1	27.9	5.1	0.0	365.9	7.0	0.7	2.5	0.2	64.7	75.9	1.1	7.0	60.5	42.6	318.2	5.2	88.0
FZD8		ENSG00000177283	"Frizzled class receptor 8"	Q9H461	10	35638249-35642278	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 17.9;Muller glia cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.8;PC-3: 27.5;U-138 MG: 10.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045025, HPA071142"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045025: AB_10795888, HPA071142: AB_2686349"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.21e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.19e-1)"	8.9	2.6	7.4	2.7	5.1	0.7	4.9	0.5	8.5	5.2	10.4	4.9	0.6	1.8	3.4	2.2	2.1	7.9	3.9	12.5	12.0	1.7	13.1	5.0	9.5	4.3	2.7	3.8	4.9	9.5	6.0	4.0	1.8	7.1	3.4	4.6	14.2	4.5	3.5	5.8	4.6	2.6	3.6	1.4	21.3	10.4	4.1	5.5	3.3	14.7	2.4	3.0	2.8	5.4	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	2.9	0.5	0.0	1.2	0.0	1.8	3.2	0.1	0.1	0.1	0.3	0.5	0.0	0.5	1.4	3.3	1.0	0.3	1.0	0.0	0.0	8.4	0.0	0.3	0.1	0.6	0.0	0.2	1.0	4.1	6.7	2.6	10.8	2.3	0.0	0.1	0.0	0.9	1.2	0.0	0.0	2.7	0.2	27.5	2.7	1.7	0.0	5.2	0.2	8.3	0.2	0.6	0.2	0.0	4.0	0.0	0.4	5.5	10.3	1.6	5.0	8.8	0.0	0.0	0.0	5.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.4	5.1	0.5	8.5	12.0	1.7	2.7	3.8	7.1	5.5	17.9	3.5	0.0	0.6	0.2	0.2	8.9	2.5	1.4	0.0	0.0	2.0	0.1	0.0	2.2	0.0	4.4	5.3	0.0	2.7	0.1	1.1	0.8	0.0	3.4	0.5	0.0	1.2	9.2	0.6	0.0	1.1	0.8	0.0	0.0	2.9	31.4	2.6	0.0	2.1	3.1	1.0	6.5	2.3	0.1	1.1	1.0	0.1	0.0	3.5	0.1
G6PC3	UGRP	ENSG00000141349	"Glucose-6-phosphatase catalytic subunit 3"	Q9BUM1	17	44070735-44076344	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067052			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA067052: AB_2685771"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.88e-3)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.87e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.49e-2)"	25.4	38.1	25.8	15.6	25.4	11.1	23.4	12.9	35.3	25.3	17.8	37.8	28.3	21.1	22.0	50.9	14.4	27.7	20.5	22.2	25.4	37.8	42.8	15.3	18.7	29.8	32.9	21.3	28.1	29.1	38.4	37.7	22.2	34.0	26.1	15.2	37.4	27.7	33.8	22.9	9.9	17.7	17.8	33.1	19.7	18.2	20.7	16.0	18.5	35.1	11.4	14.8	21.4	14.0	5.9	33.4	3.1	19.0	7.2	6.1	6.5	10.2	61.3	21.4	34.5	22.8	17.0	15.1	11.7	24.2	27.6	18.5	25.3	16.6	23.6	17.0	26.2	19.0	17.7	16.3	25.1	13.2	12.1	25.2	13.0	41.5	46.1	23.7	11.6	16.4	22.3	12.1	26.1	18.4	16.8	22.8	10.1	13.3	30.1	20.6	28.6	5.7	18.0	26.8	13.4	39.9	11.9	13.4	54.7	37.4	24.1	25.8	22.8	13.0	15.6	15.0	25.3	43.0	11.8	22.8	27.3	14.5	7.3	16.3	20.1	14.3	6.7	30.4	10.2	34.7	1.2	15.2	3.1	4.6	19.0	5.6	5.5	3.6	4.4	24.6	5.9	4.6	6.1	0.5	7.2	11.1	33.4	3.5	6.5	25.8	25.4	12.9	35.3	25.4	37.8	32.9	21.3	34.0	16.0	3.0	11.7	11.1	13.2	2.3	9.0	5.9	15.3	16.0	13.6	38.4	11.8	55.8	11.6	46.4	3.3	15.6	15.1	0.0	43.1	32.6	15.4	16.0	17.4	5.0	51.3	4.8	22.1	18.4	20.6	4.0	18.7	18.3	13.5	22.6	12.2	34.1	31.2	14.0	21.5	29.3	7.9	12.9	8.6	27.2	28.1	2.3	35.6	8.2	16.9	12.9
GANAB	"G2AN, GIIA, GluII, KIAA0088"	ENSG00000089597	"Glucosidase II alpha subunit"	Q14697	11	62624826-62646726	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026874, HPA061426"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		37000000	"Endoplasmic reticulum"		"HPA026874: AB_1849745, HPA061426: AB_2684516"	"unprognostic (2.12e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (5.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.54e-4)"	33.6	34.6	16.2	23.3	20.7	17.9	30.1	19.9	31.0	38.9	31.5	29.8	43.4	26.0	44.0	38.6	29.2	34.2	33.8	32.6	17.2	16.5	35.9	91.5	31.4	30.2	21.7	19.5	49.0	51.4	56.6	27.3	61.1	20.0	29.4	32.6	33.7	43.5	40.7	28.2	24.5	39.8	37.4	19.5	37.4	31.2	27.7	20.2	41.8	45.6	25.2	34.0	36.0	29.4	14.6	17.5	16.5	18.8	22.5	20.0	17.6	42.5	37.3	46.7	84.6	72.1	63.1	50.6	48.0	72.1	66.5	57.5	31.1	79.2	29.2	97.1	84.8	52.9	58.2	56.3	53.9	68.9	23.5	24.3	28.8	51.2	12.9	53.3	44.6	36.3	61.2	35.0	66.1	69.4	84.2	61.6	30.0	40.8	52.7	59.7	37.4	23.2	14.5	39.5	35.0	30.3	31.0	56.0	73.3	32.6	34.8	24.7	33.5	68.6	44.5	51.1	52.5	58.3	38.1	46.3	66.6	42.6	52.2	44.6	52.9	61.2	22.3	73.1	24.0	64.7	16.5	15.0	14.4	20.0	18.8	20.0	14.6	13.8	15.9	17.5	13.1	17.9	16.3	7.0	22.5	16.4	11.6	13.0	17.6	16.2	20.7	19.9	31.0	17.2	16.5	21.7	19.5	20.0	20.2	11.9	26.8	19.7	22.3	25.1	29.5	6.5	61.1	10.7	7.9	64.6	56.9	71.8	5.0	43.0	15.3	31.5	35.1	0.0	36.9	114.6	43.7	31.3	10.5	80.2	51.7	33.4	30.6	51.5	41.2	11.0	54.1	24.9	33.7	36.9	50.5	40.2	38.3	25.9	64.0	24.2	33.9	32.3	26.7	18.4	48.6	27.4	67.1	24.2	55.2	26.0
GCG	"GLP-1, GLP1, GLP2, GRPP"	ENSG00000115263	Glucagon	P01275	2	162142873-162152404	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"pancreas: 202.8"	"Cell type enriched"	"Detected in some"	14	"Intestinal endocrine cells: 5260.0"	"Cancer enriched"	"Detected in some"	209	"pancreatic cancer: 428.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 38.0;U-2 OS: 54.1"	"Region enriched"	"Detected in single"	10	"pons and medulla: 3.7"	"Region enhanced"	"Detected in single"		"midbrain: 2.0"	"CAB000040, HPA036760, HPA036761"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	127000		"Endoplasmic reticulum"	Vesicles	"CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297"			"unprognostic (3.13e-3)"								"unprognostic (9.99e-2)"	"unprognostic (1.16e-2)"		"unprognostic (1.26e-2)"				1.0	0.1	0.2	0.6	0.2	1.1	0.2	0.2	1.8	0.2	6.6	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	3.4	0.2	0.2	0.2	0.2	0.2	0.2	202.8	0.0	0.2	0.2	0.5	0.2	12.6	0.2	0.2	0.2	0.2	2.5	11.0	0.2	0.2	0.2	2.4	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	2.9	0.0	1.4	9.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5260.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	8.5	0.0	378.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0
GDAP1L1		ENSG00000124194	"Ganglioside induced differentiation associated protein 1 like 1"	Q96MZ0	20	44247099-44280917	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.4"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 8.8;Early spermatids: 7.1;Horizontal cells: 14.3;Late spermatids: 21.0"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 9.8;SCLC-21H: 24.2;SH-SY5Y: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054182, HPA063265"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA054182: , HPA063265: AB_2684972"	"unprognostic (6.58e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-4)"	"unprognostic (3.69e-1)"	"unprognostic (5.15e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.07e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.81e-5)"	"unprognostic (8.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.13e-1)"	1.1	3.9	18.9	1.3	14.9	1.2	1.1	17.8	47.4	1.2	1.2	1.4	0.0	1.0	1.5	1.1	1.1	1.2	1.1	1.3	13.1	14.3	1.1	1.0	1.0	1.0	9.1	12.2	3.0	1.8	2.4	7.1	1.0	10.6	1.1	1.1	0.9	1.0	1.1	1.1	1.5	1.3	1.2	2.6	1.0	1.9	2.8	1.6	0.0	1.1	0.0	1.0	1.1	0.0	0.1	0.0	0.7	0.1	0.5	0.8	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.6	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	11.8	0.0	0.1	1.0	0.2	0.0	3.1	0.1	0.9	0.5	0.2	0.0	0.0	0.1	0.6	0.8	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.7	0.5	0.1	0.0	0.0	0.0	18.9	14.9	17.8	25.7	13.1	14.3	9.1	12.2	10.6	1.6	0.0	0.0	0.0	0.0	0.0	8.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.0	0.0	0.0	21.0	0.6	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.4	0.0	4.1	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0
GDAP2	"dJ776P7.1, FLJ20142, MACROD3"	ENSG00000196505	"Ganglioside induced differentiation associated protein 2"	Q9NXN4	1	117863485-117929630	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046185	Approved		Approved	"Endoplasmic reticulum"		Yes	No			"Endoplasmic reticulum"		"HPA046185: AB_10960897"	"unprognostic (4.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.28e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.68e-1)"	12.1	9.7	9.3	10.2	10.8	18.9	11.3	12.9	12.7	10.7	10.5	10.7	13.1	11.1	10.4	12.9	12.7	7.6	9.2	9.5	8.6	7.3	13.5	14.5	15.3	13.9	11.7	8.8	10.6	15.2	17.1	12.3	11.8	11.5	10.3	12.6	9.7	12.8	10.5	7.8	11.0	13.3	12.0	8.8	12.7	11.8	12.6	10.7	13.0	13.1	6.2	11.9	12.3	12.9	2.7	7.0	13.1	7.8	4.2	4.4	3.3	8.6	4.9	6.0	5.0	6.5	3.1	8.9	5.1	6.6	10.2	9.9	5.2	6.0	3.4	6.2	6.8	7.8	5.2	7.9	6.6	12.6	6.8	4.6	5.1	6.8	5.6	7.9	6.3	6.6	2.5	8.4	12.8	9.9	4.6	6.7	7.8	5.3	7.5	8.4	9.0	5.6	5.2	10.4	6.6	8.6	3.0	16.5	5.0	5.8	8.8	4.5	5.0	6.1	10.5	8.0	19.0	3.6	6.5	4.1	7.3	8.6	8.4	6.8	7.8	5.6	4.8	9.4	4.6	8.9	9.6	7.4	13.1	2.8	7.8	4.4	2.7	3.1	3.3	7.0	2.7	2.9	2.8	7.1	4.2	7.6	1.6	4.0	3.3	9.3	10.8	12.9	12.7	8.6	7.3	11.7	8.8	11.5	10.7	8.9	7.5	8.2	5.5	11.9	13.4	6.3	5.1	6.7	9.1	3.5	17.7	10.7	6.6	9.4	13.4	7.3	13.1	0.0	5.5	9.5	6.2	9.8	0.0	7.8	11.8	14.3	4.1	6.2	16.1	2.2	5.5	13.5	10.1	5.4	9.9	9.7	9.0	7.2	6.7	8.8	13.2	0.0	8.3	30.5	10.4	12.0	17.6	6.9	7.0	8.2
GGNBP2	"DIF-3, DIF3, FLJ21230, FLJ22561, LZK1, ZFP403, ZNF403"	ENSG00000278311	"Gametogenetin binding protein 2"	Q9H3C7	17	36544888-36589848	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018914, HPA073392"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA018914: AB_2294667, HPA073392: AB_2686599"	"unprognostic (2.68e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	9.6	7.3	8.7	13.4	10.0	24.7	8.3	11.3	10.7	8.5	11.0	5.7	9.2	9.5	7.4	7.9	8.2	6.3	7.0	7.6	8.3		8.8	10.2	7.6	12.8	7.5	9.9	9.6	8.5	10.8	9.6	8.9	12.4	8.8	9.1	5.6	8.2	10.2	14.0	8.7	12.8	9.5	8.0	11.1	7.3	15.9	8.6	11.7	8.3	7.2	12.6	12.1	12.3	20.6	33.3	24.4	14.1	12.9	26.1	8.4	15.0	17.1	15.2	12.8	17.8	21.2	12.4	20.2	15.1	15.0	14.5	16.2	11.1	20.9	13.6	15.5	15.3	16.8	12.1	18.1	19.6	13.0	14.3	14.1	19.6	14.2	19.1	20.5	16.7	20.8	22.5	15.0	20.5	18.6	12.3	15.8	17.3	21.0	20.1	9.3	20.8	16.5	4.9	9.7	8.7	14.7	20.6	13.8	19.0	31.2	13.1	11.6	20.5	10.9	30.0	16.6	20.8	20.4	14.4	21.4	15.4	14.7	20.1	15.1	17.5	16.6	13.5	11.6	12.7	14.7	12.9	24.4	15.1	13.7	17.7	20.6	18.7	16.0	16.3	19.8	26.1	24.5	17.0	12.9	14.1	33.3	17.3	8.4											62.5	73.4	96.8	86.9	85.3	64.7	70.3	63.7	83.0	92.1	29.6	35.3	68.3	44.7	65.2	295.0	68.7	91.1	46.7	59.8	64.7	78.6	71.7	93.7	58.0	65.0	54.0	55.0	51.0	64.6	83.5	73.6	82.5	55.6	75.7	64.7	66.9	62.7	67.1	67.8	56.8	68.4	58.2	83.9	159.7	97.9	84.3	80.0	101.5	82.1	88.7
GIMAP1	"HIMAP1, IAN2, IMAP1, IMAP38"	ENSG00000213203	"GTPase, IMAP family member 1"	Q8WWP7	7	150716557-150724284	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 75.5;Hofbauer cells: 34.2;Ito cells: 91.4;Kupffer cells: 83.8;T-cells: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 16.9;MOLT-4: 9.7;TIME: 4.3"	"Low region specificity"	"Detected in all"							"HPA044887, HPA053441"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044887: AB_10960351, HPA053441: AB_2682152"	"unprognostic (1.60e-2)"	"unprognostic (6.58e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-1)"	18.9	3.6	3.5	11.5	4.9	1.3	10.3	1.2	4.1	8.5	4.1	2.8	3.6	4.2	12.4	5.5	6.2	5.5	5.9	7.4	3.8	2.9	5.3	4.6	11.2	23.8	4.1	2.1	2.6	3.7	1.8	2.2	8.3	4.4	6.3	3.0	5.2	3.6	2.8	6.4	3.6	8.2	4.9	4.6	28.9	3.8	2.9	3.8	6.7	7.9	5.4	12.0	4.9	11.5	0.2	5.1	1.0	11.5	14.6	27.4	11.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	16.9	2.2	0.0	0.0	0.0	0.0	9.7	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.9	11.5	0.0	17.2	10.4	20.3	0.1	18.8	21.4	5.1	0.2	27.4	22.2	1.0	14.6	10.4	0.3	11.8	11.4	3.5	4.9	1.2	4.1	3.8	2.9	4.1	2.1	4.4	3.8	3.0	1.0	6.5	0.5	4.8	0.2	4.8	2.5	0.0	1.2	0.0	0.0	0.3	0.0	0.1	0.1	75.5	0.0	0.0	0.3	0.2	1.8	0.5	8.1	1.6	34.2	0.0	0.0	91.4	83.8	0.8	1.4	15.8	8.5	2.8	0.0	0.2	0.1	0.0	0.0	0.5	0.9	0.0	3.8	0.2	0.2	2.8	0.3	81.2	0.0	0.5
GIMAP1-GIMAP5		ENSG00000281887	"GIMAP1-GIMAP5 readthrough"		7	150716668-150743646	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 37.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"monocytes: 15.5;NK-cells: 21.5;T-cells: 37.5"	"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 8.4;JURKAT: 5.0;MOLT-4: 13.1;THP-1: 3.2;TIME: 6.2"									HPA053441			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053441: AB_2682152"																		12.2	2.1	1.8	12.9	2.7	1.0	6.4	0.0	2.2	5.2	2.2	1.3	1.8	7.0	7.8	3.1	3.6	2.1	3.3	3.8	1.9		3.0	2.5	6.2	15.5	2.0	0.8	1.6	1.9	0.7	0.0	4.6	2.3	3.6	0.5	2.9	2.2	0.9	4.4	0.2	3.1	2.7	2.5	16.4	3.0	1.3	2.0	3.9	4.7	3.0	7.6	2.5	7.2	0.2	4.8	1.5	15.5	21.5	37.5	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	5.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	15.5	0.0	23.3	13.5	27.9	0.2	26.4	34.0	4.8	0.2	37.5	30.2	1.5	21.5	9.8	0.3	16.4	20.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GNPTG	"C16orf27, c316G12.3, CAB56184, GNPTAG"	ENSG00000090581	"N-acetylglucosamine-1-phosphate transferase gamma subunit"	Q9UJJ9	16	1351923-1364113	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004055	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		420000000	"Endoplasmic reticulum"	Cytosol	"HPA004055: AB_1079006"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.07e-2)"	23.1	67.3	38.0	16.9	35.7	19.9	20.2	22.0	38.8	19.6	23.5	41.7	22.2	16.5	18.9	28.4	17.3	19.1	22.2	17.8	38.5	31.7	29.9	41.1	21.7	22.6	39.3	28.6	22.3	34.6	33.7	25.1	27.2	28.9	21.1	15.6	20.5	37.8	22.2	28.1	33.4	19.5	15.1	43.3	26.3	21.2	18.0	31.0	11.1	24.0	13.2	13.2	20.0	17.8	15.5	29.3	25.8	37.1	14.6	21.7	20.9	4.7	7.8	5.7	10.0	52.5	19.6	7.3	14.1	18.5	5.6	10.8	6.9	13.6	3.0	16.3	19.0	8.5	8.8	3.4	8.2	2.9	9.7	7.6	4.0	24.1	11.8	22.3	6.5	16.3	26.0	14.4	5.4	7.7	15.8	10.3	5.6	4.8	18.2	9.2	11.0	3.0	6.6	5.3	12.3	4.4	11.0	4.8	13.9	14.0	6.3	4.4	5.9	14.2	14.7	10.1	3.3	13.6	9.9	10.0	11.3	9.7	9.2	6.8	19.2	13.9	6.3	9.3	5.6	7.4	25.8	37.1	22.2	21.7	34.0	19.9	15.5	18.7	20.5	29.3	14.6	17.3	15.8	15.0	14.6	31.9	24.7	21.3	20.9	38.0	35.7	22.0	38.8	38.5	31.7	39.3	28.6	28.9	31.0	38.7	42.0	23.2	23.3	18.5	13.9	7.7	40.8	38.8	58.0	19.2	23.6	22.0	8.3	22.9	2.3	20.2	23.2	0.0	12.6	16.8	30.5	22.2	23.2	26.0	44.9	7.9	8.7	36.2	34.5	2.7	27.9	37.0	32.1	18.0	18.4	24.7	14.7	28.8	16.6	37.7	23.3	19.4	18.4	24.7	27.2	17.8	26.0	20.3	20.0	22.0
GPAA1	"GAA1, hGAA1"	ENSG00000197858	"Glycosylphosphatidylinositol anchor attachment 1"	O43292	8	144082590-144086216	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077224	Approved		Approved	"Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Centrosome, Mitochondria"	"HPA077224: "	"unprognostic (2.53e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	25.2	35.3	23.0	15.9	25.5	32.1	20.0	19.9	43.7	23.6	24.4	27.1	32.3	28.2	26.3	38.3	23.2	24.0	31.1	35.0	20.3	17.4	29.3	47.2	24.9	31.4	19.9	19.0	23.8	46.6	36.4	17.1	32.9	25.1	23.1	10.7	27.4	46.0	35.4	28.5	23.3	31.0	16.3	22.3	21.9	23.0	24.6	16.1	24.0	29.0	22.2	18.6	19.3	18.6	17.2	41.0	21.7	33.3	24.7	34.5	26.1	16.4	29.1	6.8	21.3	15.8	13.5	23.7	16.9	16.8	14.2	14.8	12.0	27.3	9.0	24.7	18.3	6.7	20.5	4.5	16.8	2.1	15.1	15.3	14.1	13.6	8.8	15.3	6.9	21.3	14.8	15.7	14.5	10.1	11.5	11.7	15.3	10.2	31.9	13.6	57.9	13.3	6.4	6.8	19.4	70.8	9.3	8.6	42.8	12.3	11.6	11.8	16.2	22.1	28.5	12.4	3.9	18.3	19.5	7.7	13.2	23.0	7.5	18.9	17.8	13.7	5.9	23.4	8.5	17.9	11.8	24.8	21.7	34.5	29.9	23.7	15.5	17.4	27.1	23.1	17.2	17.3	24.1	5.8	24.7	33.3	41.0	15.0	26.1	23.0	25.5	19.9	43.7	20.3	17.4	19.9	19.0	25.1	16.1	35.7	40.2	43.2	39.6	25.5	57.0	39.1	40.8	26.8	11.4	41.8	60.9	106.7	21.6	110.5	4.7	29.4	99.5	0.0	78.8	116.9	52.6	52.7	65.6	67.2	78.9	52.4	54.6	43.0	45.7	6.6	37.4	40.2	69.2	59.5	47.2	94.2	69.6	80.7	35.3	71.5	53.5	58.2	37.1	132.9	51.7	19.4	91.4	48.0	73.6	37.1
GPANK1	"ANKRD59, BAT4, D6S54E, G5, GPATCH10"	ENSG00000204438	"G-patch domain and ankyrin repeats 1"	O95872	6	31661229-31666283	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 161.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006301	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA006301: AB_1078267"	"unprognostic (2.03e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.81e-2)"	"prognostic favorable (5.89e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	8.6	8.0	8.4	9.8	9.0	8.1	11.3	9.8	11.9	8.8	17.5	12.3	4.3	5.6	10.8	10.8	9.3	14.4	8.8	14.6	7.7	6.9	11.7	10.4	11.1	12.1	9.0	6.8	20.8	10.6	1.1	11.5	13.8	9.0	10.8	9.4	11.6	13.7	8.4	16.9	12.2	11.6	7.2	8.8	12.0	9.8	26.7	10.2	40.3	13.8	9.3	10.1	10.7	10.0	3.9	4.8	11.4	3.7	4.7	5.4	2.8	3.2	3.3	1.7	5.0	8.5	6.5	4.7	3.1	4.9	3.8	4.5	0.4	5.0	10.6	5.4	3.3	3.7	4.8	0.0	8.3	2.2	5.9	5.1	11.2	0.0	3.3	5.6	3.2	3.9	2.9	3.8	10.3	7.3	6.3	3.7	10.3	2.6	9.3	3.9	2.5	10.7	3.7	0.0	4.8	1.1	3.9	6.8	6.5	5.1	2.5	13.3	7.9	4.1	1.8	4.5	5.0	4.8	8.0	3.9	6.5	6.9	0.0	0.0	5.9	8.4	3.3	7.4	7.3	4.1	10.9	3.7	11.4	5.4	3.0	5.1	2.4	4.1	3.2	3.8	3.9	5.2	4.3	10.6	4.7	3.1	4.8	5.2	2.8	8.4	9.0	9.8	11.9	7.7	6.9	9.0	6.8	9.0	10.2	35.7	20.0	26.8	20.9	22.1	26.8	33.6	25.5	16.0	18.2	17.4	33.4	24.3	38.1	26.7	27.1	28.6	27.3	0.0	20.7	31.7	23.0	23.7	33.6	28.2	24.1	11.1	26.0	22.1	26.4	38.0	31.9	22.9	18.6	47.7	22.5	36.1	20.0	26.2	23.3	53.2	41.2	19.4	35.7	161.5	75.2	29.9	39.4	34.1	25.0	17.4
GPR89A	UNQ192	ENSG00000117262	"G protein-coupled receptor 89A"	B7ZAQ6	1	145607990-145670648	"Predicted membrane proteins"	"Ion transport, Protein transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 40.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA076096			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA076096: AB_2686777"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.14e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.02e-5)"	"unprognostic (1.42e-1)"	"unprognostic (3.70e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.21e-1)"	4.0	9.3	4.3	3.8	5.4	2.2	9.2	4.6	6.9	6.2	4.7	7.0	7.5	5.4	9.0	4.5	4.1	4.7	5.9	5.9	5.2	5.1	17.5	15.3	4.8	9.6	4.9	4.0	4.2	13.6	5.9	4.2	3.5	3.9	5.5	7.5	4.9	9.0	9.9	7.6	3.3	7.0	6.1	4.7	2.9	8.7	6.7	4.0	3.3	6.6	6.5	7.0	5.2	8.8	6.2	5.5	6.3	5.1	7.6	8.3	2.8	10.4	6.9	8.4	3.7	19.6	17.7	8.2	9.8	10.8	13.9	17.7	14.5	9.0	3.1	5.4	13.4	5.7	9.1	9.0	9.9	12.8	7.6	6.2	3.9	7.8	7.9	11.1	12.1	3.1	18.7	13.8	11.7	13.1	7.0	8.5	7.4	11.2	14.9	22.2	13.4	5.0	6.3	11.0	12.4	11.1	5.5	10.0	18.4	9.4	6.0	2.6	7.8	9.1	20.6	7.4	13.7	15.4	9.4	5.0	13.2	3.4	7.9	10.5	6.0	12.8	8.7	9.5	7.5	9.9	6.3	4.2	4.0	7.1	4.7	8.3	6.2	5.2	7.2	5.5	3.0	5.2	6.1	0.3	7.6	5.1	5.4	6.1	2.8	4.3	5.4	4.6	6.9	5.2	5.1	4.9	4.0	3.9	4.0	20.8	5.1	11.8	7.8	6.8	6.5	11.1	12.7	5.3	6.8	14.0	11.8	17.5	0.0	12.8	5.5	4.7	9.2	0.0	17.6	17.8	8.8	7.2	5.7	9.0	8.2	3.2	13.1	7.4	4.0	6.8	8.9	4.5	10.1	8.2	9.4	6.9	13.3	6.6	6.7	10.2	6.2	12.9	7.6	40.7	17.9	7.4	13.5	14.1	8.9	4.7
GPR89B	"GPR89, GPR89C, SH120"	ENSG00000188092	"G protein-coupled receptor 89B"	P0CG08	1	147928393-147993521	"Predicted membrane proteins"	"Ion transport, Protein transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA076096			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA076096: AB_2686777"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.15e-4)"	4.0	5.1	4.0	4.0	4.0	2.0	5.4	5.1	5.4	6.0	4.1	4.0	4.0	6.0	4.9	4.0	4.0	3.6	4.0	4.0	4.0	4.8	20.3	9.4	4.0	4.0	4.0	4.0	4.7	5.1	4.4	4.0	4.0	4.0	4.8	3.9	4.0	4.7	4.3	5.2	5.4	7.9	4.0	5.3	4.0	4.8	7.6	4.0	4.0	4.0	4.0	4.0	4.0	4.0	8.2	9.5	9.3	8.1	10.8	12.6	7.1	7.1	1.0	7.1	7.4	8.3	9.0	10.7	8.8	7.9	10.5	11.2	10.2	11.2	13.8	8.4	7.3	8.2	10.2	10.2	7.2	8.5	12.7	11.0	8.4	7.4	4.6	14.6	10.0	5.4	8.5	10.4	6.7	13.9	3.4	9.5	9.8	6.6	11.8	6.6	16.3	11.5	5.9	13.6	17.8	10.8	10.6	11.8	21.1	13.7	6.8	4.7	5.8	19.2	6.1	8.7	13.3	11.8	10.8	3.0	7.6	3.5	11.5	10.7	19.2	16.0	8.5	9.8	7.6	5.4	6.7	7.7	9.3	11.3	6.1	12.6	7.6	12.4	12.0	9.5	8.2	11.3	10.7	4.3	10.8	8.1	7.9	9.7	7.1	4.0	4.0	5.1	4.1	4.0	4.8	4.0	4.0	4.0	4.0	6.0	4.0	6.9	5.2	0.1	3.2	5.7	0.0	6.7	6.8	5.2	2.0	12.1	0.0	6.1	3.4	3.8	7.7	0.0	6.2	11.1	5.1	3.6	6.9	6.6	3.7	0.0	4.6	3.1	1.0	3.6	5.2	2.9	0.0	3.6	6.8	2.9	5.5	7.8	3.2	20.0	3.6	0.0	5.1	23.7	9.1	0.0	13.2	11.8	5.1	3.1
GRAMD1B	"KIAA1201, LINC01059"	ENSG00000023171	"GRAM domain containing 1B"	Q3KR37	11	123358428-123627774	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 67.7;brain: 55.2;intestine: 21.7"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 41.9;Cone photoreceptor cells: 108.0;Horizontal cells: 42.9;Rod photoreceptor cells: 85.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 11.5"	"Group enriched"	"Detected in many"	4	"A549: 22.2;HDLM-2: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008557, HPA075204"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"		NA	NA			"Endoplasmic reticulum, Plasma membrane"	Vesicles	"HPA008557: AB_1079197, HPA075204: "	"unprognostic (1.86e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (4.30e-7)"	"unprognostic (1.39e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	1.4	67.7	15.5	3.1	16.0	11.8	1.1	55.2	25.0	1.2	3.1	5.1	5.9	21.7	1.2	6.6	0.9	2.9	8.1	4.3	13.6	7.5	10.4	1.3	1.9	3.6	6.8	15.1	7.6	2.0	0.6	6.7	5.0	14.4	1.1	1.2	11.9	1.3	2.5	1.8	0.8	15.6	1.3	4.1	2.7	7.8	10.6	5.1	3.4	3.7	0.0	2.7	1.5	0.8	0.1	11.5	0.6	2.0	2.6	2.7	0.7	0.0	22.2	1.2	0.0	0.1	0.2	3.6	7.4	5.3	1.6	0.6	0.9	0.1	1.3	3.9	3.7	2.5	0.0	2.3	0.0	1.7	58.9	2.0	0.0	10.0	0.2	0.0	7.6	0.0	0.4	0.0	2.8	0.0	1.9	0.7	0.6	0.0	0.0	1.4	0.1	1.3	2.6	2.8	9.9	8.4	4.0	3.6	2.4	0.1	0.0	7.4	6.0	1.7	0.1	0.0	3.4	0.2	4.3	4.4	8.9	1.4	1.5	0.3	0.0	0.0	0.0	1.8	8.0	0.4	0.0	2.0	0.6	0.7	1.0	0.4	0.0	2.7	2.1	3.0	0.1	0.3	0.3	0.2	2.6	1.0	11.5	1.1	0.7	15.5	16.0	55.2	25.0	13.6	7.5	6.8	15.1	14.4	5.1	0.0	0.3	0.0	0.0	0.0	41.9	5.5	25.5	0.0	0.0	5.2	108.0	4.5	3.3	0.5	5.2	0.7	0.3	0.0	0.4	3.0	1.1	0.1	0.0	0.0	2.3	42.9	0.0	0.6	3.5	2.3	0.6	2.8	0.0	1.0	0.8	21.5	2.3	0.2	0.7	5.5	85.7	0.0	0.8	1.0	1.5	0.4	2.1	1.0	0.4	0.0
GVQW3		ENSG00000179240	"GVQW motif containing 3"	Q3ZCU0	11	76381313-76414619	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"		"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 3.8;Ciliated cells: 4.0;Club cells: 4.5;Distal tubular cells: 8.3;granulocytes: 3.5;Proximal tubular cells: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA057405	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Centrosome"		NA	NA			"Nucleoplasm, Centrosome"	"Endoplasmic reticulum"	"HPA057405: AB_2683429"	"unprognostic (8.90e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.56e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.05e-4)"	"unprognostic (7.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.28e-2)"	"unprognostic (2.13e-1)"	3.3	5.8	7.0	4.7	11.8	3.5	5.8	13.9	14.3	5.0	3.2	5.0	2.2	4.5	6.7	4.0	1.8	7.1	2.5	3.2	6.2	5.2	5.1	2.5	2.9	6.0	4.0	7.2	8.4	16.0	3.2	15.9	3.0	8.7	3.5	4.9	7.6	9.1	3.3	2.9	4.5	3.6	3.5	4.2	5.0	4.2	9.6	4.6	5.5	5.5	0.4	5.7	2.8	4.0	3.1	1.7	5.1	1.2	3.8	4.1	1.2	1.7	2.2	9.4	5.0	2.3	4.7	2.5	1.2	1.0	2.2	2.1	6.5	3.9	7.4	3.3	1.2	3.6	5.3	5.1	1.3	3.0	5.1	3.0	3.8	8.4	2.1	1.2	3.4	2.0	1.1	1.5	3.4	1.3	2.1	1.4	9.6	2.4	4.4	0.7	2.1	4.7	5.6	1.5	2.3	3.3	6.9	5.5	4.6	0.7	1.8	12.2	4.3	2.9	1.3	0.8	3.7	3.8	1.0	0.8	3.9	3.8	6.1	1.4	4.8	2.3	6.8	1.2	3.0	2.2	3.5	1.2	1.2	3.7	0.7	2.5	3.1	3.8	1.7	1.7	3.1	4.1	4.1	5.1	3.8	0.8	1.2	3.3	1.2	7.0	11.8	13.9	14.3	6.2	5.2	4.0	7.2	8.7	4.6	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.5	1.8	0.0	0.9	8.3	1.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	3.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
HACD3	"B-ind1, HSPC121, PTPLAD1"	ENSG00000074696	"3-hydroxyacyl-CoA dehydratase 3"	Q9P035	15	65530418-65578352	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014837, HPA060347"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		27000	"Endoplasmic reticulum"		"HPA014837: AB_1855914, HPA060347: AB_2684260"	"unprognostic (1.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.57e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (3.44e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.04e-2)"	9.6	37.4	31.0	7.4	36.0	6.2	33.3	28.6	37.6	18.5	12.5	24.2	10.1	12.2	13.1	19.4	8.4	14.3	14.7	5.9	29.2	44.8	35.0	50.0	12.7	7.2	36.5	26.0	21.7	12.6	22.5	33.9	15.9	45.9	18.5	15.1	17.9	11.6	15.8	3.3	11.7	12.0	12.2	41.5	8.5	29.0	13.9	19.7	8.9	30.7	5.6	8.3	18.8	10.4	13.0	9.0	2.7	6.1	11.7	19.9	11.2	19.4	43.6	48.5	24.2	30.6	18.5	23.0	21.6	18.7	24.6	27.8	33.4	29.2	24.5	18.9	23.4	30.7	53.9	78.2	18.0	22.1	13.6	43.6	19.5	21.9	36.4	15.5	24.1	15.0	18.9	13.5	16.8	12.2	23.8	23.9	14.7	25.5	9.3	39.6	23.2	17.8	18.8	41.3	52.2	14.8	20.2	41.1	27.6	35.1	33.9	29.3	25.9	23.3	26.3	24.4	47.7	26.7	12.8	18.9	31.3	27.6	15.3	29.9	18.2	54.0	34.6	20.9	23.6	18.7	2.7	3.9	1.2	17.6	5.8	19.9	13.0	16.1	16.6	6.8	13.0	18.9	18.5	0.4	11.7	6.1	9.0	12.4	11.2	31.0	36.0	28.6	34.1	29.2	44.8	36.5	26.0	45.9	19.7	59.6	49.7	22.9	50.2	0.0	116.3	6.4	61.1	66.9	51.2	167.5	94.2	155.3	21.6	61.1	83.6	35.9	7.7	46.7	39.9	101.8	47.3	63.7	15.1	153.2	44.7	131.9	42.1	42.4	18.0	21.8	80.8	16.2	0.0	3.6	25.8	78.8	35.8	14.0	83.1	44.0	65.7	77.6	27.2	123.2	116.2	0.0	94.6	13.1	52.6	77.6
HACE1	KIAA1320	ENSG00000085382	"HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1"	Q8IYU2	6	104728093-104859919	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 41.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046071			Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nuclear bodies"	"HPA046071: AB_2679524"	"unprognostic (6.32e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.75e-1)"	6.4	5.4	12.7	3.7	16.1	4.3	6.1	15.5	13.1	6.6	4.8	6.8	2.5	3.6	8.5	2.9	8.1	5.4	5.0	5.2	7.5	8.6	9.4	2.9	5.7	3.5	8.8	9.6	6.4	3.8	12.0	7.4	41.9	10.2	6.1	3.3	7.7	6.2	6.9	4.4	4.8	3.6	6.5	9.5	4.1	3.9	14.1	8.9	5.4	7.1	2.7	3.9	6.4	5.8	2.9	2.4	2.2	2.9	2.2	3.9	1.6	3.6	2.5	10.9	13.6	6.5	8.7	12.9	7.3	11.3	4.6	7.0	2.3	2.1	2.1	3.3	5.5	7.9	2.5	2.7	5.0	9.8	8.4	6.9	7.2	2.3	3.1	6.5	6.2	2.4	5.8	4.6	6.0	5.1	6.1	7.6	8.7	6.9	2.3	9.1	2.6	4.6	3.7	4.7	2.7	2.5	7.3	12.4	0.8	3.7	6.2	5.8	8.8	3.9	4.1	2.1	7.3	2.6	8.5	8.0	3.7	3.1	10.0	6.9	3.3	3.7	7.0	3.9	5.9	6.8	0.0	1.9	2.2	3.7	2.9	3.9	2.9	3.7	3.6	1.9	2.7	3.9	3.0	0.4	2.2	1.5	2.4	1.2	1.6	12.7	16.1	15.5	13.1	7.5	8.6	8.8	9.6	10.2	8.9	3.0	0.6	0.0	1.6	4.1	11.4	6.3	2.5	0.0	4.5	5.2	43.2	7.5	1.7	1.7	3.1	6.7	1.3	0.0	1.3	4.6	4.8	2.2	1.1	2.5	4.6	15.9	1.7	4.3	2.2	3.3	5.8	2.4	1.7	4.6	1.4	5.8	1.1	2.9	3.5	4.1	30.6	6.5	6.6	12.5	2.7	4.1	5.3	2.2	2.1	1.8
HM13	"dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1"	ENSG00000101294	"Histocompatibility minor 13"	Q8TCT9	20	31514428-31577923	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 292.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045089, HPA056062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045089: AB_10962054, HPA056062: AB_2683022"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.87e-3)"	"prognostic unfavorable (1.95e-5)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-2)"	"prognostic unfavorable (4.64e-12)"	"unprognostic (3.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.17e-2)"	25.2	34.3	9.2	20.1	11.1	19.8	36.4	10.2	17.5	37.9	17.0	13.2	64.7	18.1	23.3	40.7	39.2	21.4	24.1	17.9	9.3	13.0	30.2	121.3	25.5	38.7	10.8	9.8	20.8	132.3	24.4	28.6	45.9	14.5	22.4	16.3	15.4	149.6	84.3	13.1	15.0	17.8	17.9	11.0	22.0	25.3	11.7	9.0	15.5	33.5	21.5	30.5	18.1	21.4	16.7	48.2	50.1	65.3	19.4	29.8	52.6	24.8	26.3	10.6	15.6	48.3	31.1	36.5	42.6	39.9	29.1	30.0	52.1	29.9	16.1	57.4	46.4	38.5	45.5	14.9	28.6	19.1	8.1	20.1	35.5	19.1	31.2	53.8	20.2	14.3	28.4	18.7	24.6	33.7	29.4	22.5	10.6	15.6	63.9	27.0	29.4	17.3	14.6	12.2	40.8	45.0	11.0	49.9	74.9	28.1	13.3	13.9	16.9	43.5	42.0	34.4	11.0	32.6	19.3	27.3	44.3	23.6	44.6	23.9	41.3	24.5	12.7	60.4	72.9	39.1	18.4	65.3	31.8	21.7	64.0	29.8	16.7	20.5	20.9	46.0	12.6	13.8	16.2	50.1	19.4	58.6	48.2	18.1	52.6	9.2	11.1	10.2	17.5	9.3	13.0	10.8	9.8	14.5	9.0	47.6	55.6	31.3	46.0	29.8	39.1	11.5	58.6	38.8	43.3	50.6	115.8	131.4	11.6	140.0	12.3	43.8	63.3	23.3	146.7	111.1	86.5	75.1	40.5	74.0	292.9	41.3	59.0	58.3	73.4	10.6	56.1	83.9	62.4	38.7	63.2	49.7	138.8	42.7	41.1	44.1	38.7	32.3	39.1	21.7	29.0	30.9	178.6	56.7	51.9	55.3
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.1;liver: 52.9;placenta: 110.8"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 137.6;Enterocytes: 250.1;Hepatocytes: 98.5;Paneth cells: 199.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.4;Hep G2: 17.8;hTERT-HME1: 10.7;OE19: 32.8;RT4: 36.8;TIME: 20.6"	"Group enriched"	"Detected in some"	5	"midbrain: 2.6;pons and medulla: 3.5"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.83e-4)"	0.7	0.1	0.2	4.1	0.2	0.0	3.9	0.2	0.3	0.7	41.3	0.3	0.2	71.3	0.6	0.2	1.7	0.2	13.3	0.2	0.2	0.2	2.8	52.9	1.0	0.2	0.2	0.2	0.2	16.0	0.0	0.6	110.8	0.4	3.1	9.4	21.3	9.4	0.2	0.3	1.8	83.1	1.5	0.2	0.2	3.2	0.2	0.2	0.2	0.2	1.1	1.3	21.4	6.6	1.3	1.4	3.6	1.1	1.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	22.4	0.0	0.0	4.1	0.6	0.0	4.5	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.1	17.8	0.1	0.1	0.1	0.0	1.2	0.0	10.7	0.2	0.3	0.0	0.0	0.1	3.3	0.0	0.0	0.3	0.1	32.8	8.1	0.0	0.0	0.4	0.4	36.8	0.2	0.6	0.0	1.0	0.1	0.0	0.0	0.0	20.6	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	1.6	1.1	0.6	0.7	0.5	0.4	0.6	0.4	0.4	0.3	1.3	0.4	0.6	3.6	1.0	0.6	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	3.0	3.8	0.0	2.7	0.3	0.1	0.4	137.6	6.7	2.3	0.0	0.0	2.1	0.0	47.5	0.1	0.2	250.1	0.0	5.5	1.5	3.1	1.8	0.0	98.5	3.0	0.0	2.9	3.1	2.4	0.8	0.0	0.0	1.7	0.0	19.3	42.0	13.6	199.9	0.0	1.0	0.6	0.0	0.3	0.0	0.0	1.0	5.4	0.0	33.8	10.0
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"placenta: 231.4"	"Group enriched"	"Detected in some"	23	"Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 36.4;SuSa: 16.3"									"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favorable (4.59e-5)"	0.1	0.6	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	231.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	11.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	4.0	0.4	0.5	16.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	115.9	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.8	0.0	0.0	0.0
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 223.2"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Region enriched"	"Detected in single"	198	"basal ganglia: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2"									"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.0	223.2	0.0	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.5	43.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.4	0.0	0.0	5.1	1.9	0.0	0.0	1.2	0.2	0.1	0.1	0.7	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0
HSP90B1	"GP96, GRP94, TRA1"	ENSG00000166598	"Heat shock protein 90 beta family member 1"	P14625	12	103930107-103953645	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 325.1;thyroid gland: 338.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003901, CAB005224, HPA008424, CAB078151"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		410000000	"Endoplasmic reticulum"		"CAB005224: AB_2119181, CAB078151: AB_2665765, HPA003901: AB_1851181, HPA008424: AB_1851184"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.03e-10)"	"unprognostic (2.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-2)"	49.0	57.1	26.9	50.0	32.0	45.9	60.3	16.5	25.5	45.7	43.4	17.5	108.5	32.1	42.2	127.2	34.3	42.0	32.4	67.0	27.1	32.0	74.0	325.1	46.6	49.2	31.5	26.0	53.9	95.5	47.1	50.0	123.6	29.4	46.9	46.9	15.8	43.8	136.8	25.4	19.2	54.4	45.0	37.8	89.3	37.0	25.7	27.9	44.5	338.5	24.0	36.9	66.1	106.1	25.6	81.0	22.2	23.8	40.2	53.3	33.9	72.0	39.1	78.9	81.0	80.8	76.3	107.1	121.5	91.9	64.7	86.4	69.7	67.6	21.1	96.6	127.5	83.5	50.4	77.7	130.5	87.4	49.8	29.6	56.7	44.1	71.9	124.7	57.1	44.4	44.7	58.2	79.7	114.4	219.3	124.5	25.7	45.3	80.2	85.5	25.9	34.3	63.9	64.9	73.3	47.1	31.3	50.9	88.1	86.6	45.5	23.4	56.2	75.8	78.5	76.6	126.8	63.8	84.9	71.6	49.0	42.0	39.8	50.6	82.1	76.8	39.0	97.7	42.3	75.8	22.2	21.2	6.9	45.6	23.8	53.3	25.6	26.7	39.3	28.0	15.9	18.0	31.3	4.9	40.2	19.3	81.0	16.4	33.9	26.9	32.0	16.5	25.5	27.1	32.0	31.5	26.0	29.4	27.9	220.3	319.5	129.9	714.2	274.9	44.0	581.2	221.7	394.9	445.9	244.3	147.3	520.4	48.0	366.6	40.3	299.0	344.0	186.9	218.9	824.3	597.0	564.5	392.9	721.4	494.0	73.1	389.8	556.8	268.7	19.1	521.5	350.1	399.9	234.4	276.1	146.4	329.7	262.6	317.5	229.3	75.2	213.4	401.9	313.5	187.6	227.8	770.3	202.8	314.4	519.2
IER3IP1		ENSG00000134049	"Immediate early response 3 interacting protein 1"	Q9Y5U9	18	47152834-47176374	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Diabetes mellitus, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 322.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA010027	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010027: AB_1079098"	"unprognostic (6.13e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (6.47e-6)"	"unprognostic (9.86e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.53e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.27e-3)"	16.9	21.7	13.1	13.7	12.9	15.0	33.1	22.4	21.4	15.7	17.7	7.3	18.4	20.3	15.6	19.6	19.2	12.8	17.9	40.2	12.3	15.3	38.1	45.7	28.3	25.7	12.5	9.1	15.7	30.6	16.3	30.5	29.7	13.9	17.7	16.4	13.3	29.8	17.9	33.8	16.7	27.7	17.7	11.3	22.7	19.0	17.0	7.6	16.4	19.7	24.8	17.6	17.9	15.9	14.2	24.5	10.7	12.4	11.5	18.6	11.8	12.8	7.4	11.3	10.0	15.4	17.3	7.9	30.5	14.9	15.2	16.1	6.0	11.0	12.6	9.6	13.5	12.4	15.7	10.6	10.7	16.7	20.6	9.5	11.0	11.6	18.1	16.5	33.1	16.5	13.6	13.7	13.7	10.3	14.4	13.0	11.5	9.0	19.5	16.1	7.1	11.7	15.9	5.7	5.5	9.0	11.7	17.8	17.9	15.3	12.5	13.1	14.6	10.4	8.9	17.9	8.5	8.8	19.1	18.7	22.7	11.6	10.9	16.6	28.4	30.9	13.4	17.6	21.2	18.1	8.3	12.4	10.7	18.6	11.2	16.6	13.2	16.0	16.0	11.7	14.2	15.3	15.9	1.3	11.5	11.6	24.5	15.8	11.8	13.1	12.9	22.4	21.4	12.3	15.3	12.5	9.1	13.9	7.6	80.4	47.5	40.4	52.1	0.0	44.4	56.7	71.4	48.2	35.2	48.8	7.9	93.8	119.3	98.9	15.0	64.4	58.4	46.7	121.4	103.0	48.3	96.8	12.8	120.7	96.4	38.1	36.3	71.2	54.7	10.5	78.6	44.2	0.0	84.8	96.6	50.4	129.9	66.6	45.6	322.7	34.3	51.8	36.5	70.2	134.6	0.0	148.2	59.8	85.7	73.1
IGFBP2	IBP2	ENSG00000115457	"Insulin like growth factor binding protein 2"	P18065	2	216632828-216664436	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 165.3;pancreas: 228.7"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 536.0;Collecting duct cells: 251.2;Hepatocytes: 556.2;Intestinal endocrine cells: 307.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 141.7;HMC-1: 330.5;NB-4: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077723			Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	303000000	1000000000	"Endoplasmic reticulum"		"HPA077723: AB_2686853"	"unprognostic (2.58e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (5.04e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.22e-1)"	21.7	6.4	0.9	13.7	2.8	2.6	17.5	1.0	10.4	11.9	12.6	4.5	20.6	11.4	28.7	37.7	26.4	19.4	11.8	29.6	1.5	0.9	21.3	165.3	8.7	3.8	1.4	3.4	35.7	228.7	0.8	8.2	32.0	7.6	25.7	5.2	8.0	9.1	32.6	5.3	3.1	7.8	7.5	1.8	46.7	50.2	13.7	1.0	12.1	8.4	29.3	12.9	23.4	11.4	0.0	0.3	0.0	0.4	2.0	0.8	1.3	0.0	3.2	25.9	25.2	141.7	43.3	0.5	7.8	3.9	0.3	0.0	0.0	0.0	0.0	11.1	0.0	0.9	0.7	9.3	9.9	0.0	0.0	5.3	5.6	0.0	1.6	3.5	2.3	330.5	14.4	1.0	0.1	0.4	0.8	0.0	11.7	0.2	0.7	0.1	6.3	9.8	68.2	27.9	6.1	0.3	8.5	0.5	0.1	0.1	7.3	5.4	28.6	0.0	0.2	0.1	24.6	21.2	4.1	0.0	0.1	0.1	0.1	0.3	0.4	0.0	0.5	0.3	10.8	30.2	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	1.3	0.9	2.8	1.0	10.4	1.5	0.9	1.4	3.4	7.6	1.0	3.0	1.1	8.3	536.0	12.2	0.0	11.2	10.2	13.4	3.4	251.2	2.0	1.6	24.9	2.4	0.6	38.2	7.3	0.0	111.9	2.0	21.3	92.5	4.6	556.2	4.8	0.0	307.8	26.4	24.0	2.6	5.2	2.5	3.3	1.8	53.3	3.8	95.4	31.9	74.6	1.0	1.6	103.5	14.6	2.8	44.3	4.8	1.8	13.8	47.1	201.7
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580308	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"blood: 11.6;bone marrow: 37.7;lymphoid tissue: 29.4;testis: 20.8"	"Group enriched"	"Detected in some"	10	"Early spermatids: 60.5;Late spermatids: 104.2;Melanocytes: 113.1"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 11.6;naive B-cell: 9.8"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.6"	"Cell line enriched"	"Detected in some"	34	"REH: 129.9"									"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		100000000000	"Endoplasmic reticulum"		"HPA051134: AB_2681356, HPA071406: AB_2686393"	"unprognostic (6.21e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.91e-6)"		"unprognostic (1.08e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.1	0.1	0.2	37.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.8	0.0	29.4	0.0	0.0	1.1	0.0	0.0	11.6	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.0	129.9	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	60.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	104.2	1.1	0.0	113.1	0.0	0.0	0.0	0.0	0.0	0.4	4.4	0.0	0.0	0.0	9.7	0.5	0.3	0.0	0.0	0.0	0.1
IKBIP	"FLJ31051, IKIP"	ENSG00000166130	"IKBKB interacting protein"	Q70UQ0	12	98613405-98645113	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 19.8"	"Cell line enhanced"	"Detected in all"		"BJ: 53.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038677, HPA038678, HPA061541"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038677: AB_2676146, HPA038678: AB_10672723, HPA061541: AB_2684555"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (6.28e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.60e-9)"	"unprognostic (7.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.16e-2)"	21.0	8.9	3.7	12.2	4.6	3.6	13.6	1.1	4.0	17.0	12.3	1.7	6.0	3.3	9.5	10.2	8.5	7.3	11.0	23.6	4.0	3.7	17.0	25.3	16.1	14.0	4.2	1.7	12.8	5.8	4.1	12.6	22.1	6.3	12.2	6.1	3.6	7.6	6.7	10.0	3.2	6.2	13.3	5.2	30.6	5.3	5.8	3.8	15.2	19.8	6.2	7.8	15.1	26.2	3.3	3.7	19.8	4.3	3.7	2.4	1.1	3.2	10.1	11.6	7.2	27.9	29.5	10.1	53.6	32.9	14.2	18.1	2.2	3.2	10.8	9.2	32.9	9.9	7.0	4.5	20.5	24.1	3.2	6.9	4.1	6.5	15.2	10.7	7.6	8.2	22.1	4.4	16.3	14.7	26.0	19.9	2.0	6.2	4.3	34.9	3.0	3.4	17.6	4.4	2.6	8.8	3.0	16.7	5.4	23.4	3.7	1.7	5.6	15.3	1.1	8.5	20.3	3.3	9.5	18.6	30.3	10.8	13.3	13.7	4.6	4.9	8.1	9.0	7.0	21.8	6.0	4.3	12.6	2.1	3.3	2.4	3.3	1.3	2.1	3.7	2.2	1.4	1.5	19.8	3.7	3.7	2.6	1.6	1.1	3.7	4.6	1.1	4.0	4.0	3.7	4.2	1.7	6.3	3.8	11.9	17.8	22.0	12.9	6.8	3.2	2.6	0.0	5.3	21.6	3.5	3.9	28.7	10.0	9.6	1.6	38.4	1.1	0.0	5.0	49.4	34.3	6.4	19.7	8.9	40.4	3.2	0.0	32.5	25.0	2.5	28.4	36.1	13.5	21.6	3.8	2.3	5.8	2.9	15.9	8.5	2.5	38.8	19.1	30.8	14.0	6.4	8.5	20.8	1.7	4.6
IL18BP	IL18BPa	ENSG00000137496	"Interleukin 18 binding protein"	O95998	11	71998541-72005715	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.3;lymphoid tissue: 71.5"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 11.8;Hofbauer cells: 10.7;Macrophages: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB025980, HPA041061"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	3070000	14000000	"Endoplasmic reticulum"		"CAB025980: , HPA041061: AB_2677280"	"unprognostic (2.66e-3)"	"unprognostic (2.04e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.58e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.93e-2)"	23.7	10.6	6.5	19.7	7.7	6.0	7.2	6.2	5.7	6.3	6.7	6.7	1.0	7.1	6.1	4.1	4.1	5.8	7.2	4.7	3.8	4.1	37.0	54.3	20.8	20.2	7.0	1.9	10.1	4.9	2.8	6.4	28.4	9.0	8.9	9.8	5.3	6.4	4.0	6.2	5.1	9.2	11.4	6.1	71.5	6.1	3.0	6.3	6.1	17.3	3.6	15.6	8.6	6.2	13.6	22.3	22.2	30.5	1.9	23.4	13.9	2.0	2.7	6.2	3.6	1.3	1.9	7.0	3.4	2.0	3.3	4.5	13.2	2.6	1.2	2.7	1.7	3.8	5.1	3.7	2.8	2.6	3.0	4.4	5.2	7.0	3.7	1.4	3.0	12.6	2.9	3.2	3.0	1.6	4.5	6.4	8.1	8.9	2.3	1.8	3.4	3.8	6.5	4.5	2.4	2.5	5.8	6.4	2.1	2.2	5.5	3.3	6.4	3.8	4.3	5.0	6.6	4.3	2.8	13.8	5.4	4.2	6.2	2.1	3.7	2.2	2.5	2.3	11.0	2.6	2.3	8.5	22.2	23.4	30.5	10.5	13.6	12.4	13.8	15.5	7.0	10.4	15.0	3.6	1.9	23.7	22.3	6.1	13.9	6.5	7.7	6.2	5.7	3.8	4.1	7.0	1.9	9.0	6.3	6.0	3.5	5.7	0.4	1.8	3.1	0.8	0.0	2.7	1.2	0.0	9.8	0.7	0.0	1.9	0.0	7.9	0.7	0.0	11.8	0.9	2.3	0.9	7.0	0.5	10.7	3.2	0.0	8.0	7.2	0.0	0.9	11.1	0.0	0.0	0.7	1.6	7.3	0.0	0.7	0.7	3.0	0.0	1.2	0.5	0.4	1.8	0.7	3.2	0.6	0.1
INF2	"C14orf151, C14orf173, MGC13251"	ENSG00000203485	"Inverted formin, FH2 and WH2 domain containing"	Q27J81	14	104689606-104722535	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 200.6"					HPA000724	Approved		Approved	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		15000000	"Endoplasmic reticulum"	"Nuclear bodies"	"HPA000724: AB_1078325"	"unprognostic (1.42e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (1.13e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (7.24e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.70e-2)"	34.7	13.1	14.4	17.8	49.9	12.7	20.2	4.4	37.9	13.3	27.0	70.2	6.1	43.1	12.8	6.3	12.5	9.3	26.5	14.1	19.7	12.6	17.9	21.3	22.2	15.0	66.2	22.5	7.7	14.8	4.1	4.7	28.0	28.5	13.2	13.2	18.8	15.4	16.3	10.0	23.9	36.5	10.7	36.8	24.4	48.2	18.1	54.6	3.2	11.7	9.8	9.1	16.8	15.5	3.1	11.0	2.3	3.3	2.0	5.3	4.8	17.5	35.8	3.2	7.9	6.6	8.5	47.3	19.3	10.1	10.7	8.0	13.1	39.4	2.5	21.5	13.7	9.0	26.7	4.0	18.9	4.1	7.4	9.7	9.1	24.7	12.9	13.8	2.8	8.8	8.0	10.7	10.1	7.0	10.2	12.6	4.8	4.3	8.9	10.0	39.6	3.4	7.1	8.0	20.5	38.3	14.9	10.7	6.9	13.4	23.9	9.1	4.3	15.7	29.8	10.1	7.0	10.2	6.5	22.3	13.4	9.4	25.8	10.8	3.1	1.4	1.3	23.1	7.9	14.5	1.3	3.3	0.2	1.6	1.1	0.8	3.1	5.3	1.1	4.1	3.1	4.4	2.9	2.3	2.0	0.7	11.0	5.3	4.8	14.4	49.9	4.4	37.9	19.7	12.6	66.2	22.5	28.5	54.6	59.6	14.9	14.7	12.9	20.1	0.2	10.6	40.8	1.4	10.3	3.5	0.0	47.0	5.0	20.7	0.9	24.8	131.6	0.0	21.8	69.2	16.9	24.0	14.9	24.2	28.8	0.0	16.7	24.5	19.1	0.9	5.2	16.4	8.5	19.0	64.2	52.5	41.8	50.4	4.2	6.4	1.8	32.3	28.1	0.9	3.8	16.4	26.4	5.7	33.0	24.4
ISOC1	CGI-111	ENSG00000066583	"Isochorismatase domain containing 1"	Q96CN7	5	129094751-129114028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070307			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA		1500000	"Endoplasmic reticulum, Vesicles"		"HPA070307: AB_2686249"	"unprognostic (1.67e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.42e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.18e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.32e-2)"	10.5	13.1	9.2	8.9	9.7	4.1	20.7	2.2	8.4	26.3	14.6	7.5	2.1	12.8	44.3	9.0	17.1	13.6	6.4	48.6	7.3	14.2	13.7	40.3	7.1	10.3	11.3	9.5	14.7	22.0	6.8	18.0	7.5	11.2	9.2	9.1	5.4	19.0	3.8	6.6	11.4	19.6	27.1	11.5	5.8	7.9	5.5	9.2	10.4	9.3	11.2	10.2	8.2	10.9	23.2	15.6	24.2	12.8	26.9	32.8	22.0	8.7	6.9	7.2	11.0	11.9	6.3	31.8	3.8	3.3	4.3	7.7	24.2	12.4	6.3	9.5	2.2	13.3	4.8	15.2	11.4	8.1	34.2	17.3	12.4	7.0	17.7	8.4	4.9	4.5	4.1	3.4	6.8	5.9	3.1	10.3	10.0	13.4	10.9	3.8	35.0	9.1	8.0	11.1	8.4	18.9	13.2	21.0	6.1	10.8	17.9	12.2	52.3	10.9	13.9	6.8	6.9	11.5	4.1	4.3	4.9	9.4	3.9	12.2	9.1	7.1	10.4	5.5	15.5	5.5	24.2	12.8	18.1	28.5	12.2	31.9	23.2	26.8	30.0	15.6	21.1	23.7	27.9	15.9	26.9	11.5	14.2	32.8	22.0	9.2	9.7	2.2	8.4	7.3	14.2	11.3	9.5	11.2	9.2	11.9	15.0	21.0	35.7	117.1	7.6	53.2	28.1	6.7	12.5	19.2	9.8	68.2	106.1	19.6	1.0	9.7	23.6	0.0	24.6	63.8	32.8	34.2	18.4	71.8	21.7	0.0	30.5	4.3	6.5	2.1	12.7	11.0	27.0	26.2	25.2	50.0	17.1	28.1	18.0	69.2	6.4	0.0	17.6	5.7	29.3	73.5	42.6	21.4	33.2	32.4
ITFG2	"FGGAP1, MDS028"	ENSG00000111203	"Integrin alpha FG-GAP repeat containing 2"	Q969R8	12	2812622-2859791	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038664, HPA038665"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytokinetic bridge"		Yes	No			"Nucleoplasm, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA038664: AB_10672722, HPA038665: AB_2676138"	"unprognostic (5.70e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.24e-1)"	"unprognostic (5.89e-1)"	"unprognostic (4.35e-2)"	"unprognostic (7.43e-2)"	12.2	16.1	11.1	15.4	14.0	12.0	14.3	17.8	17.2	16.2	13.2	23.2	21.3	11.8	19.6	16.6	13.2	17.2	14.7	12.0	8.7	9.8	15.0	11.4	14.4	14.0	13.3	9.9	29.0	28.4	22.7	23.0	13.8	13.3	13.8	14.7	22.1	23.0	19.5	7.8	10.9	13.9	13.5	10.6	20.3	14.8	10.6	15.2	25.4	26.2	9.3	23.0	14.4	15.3	17.7	12.9	5.4	21.2	13.8	14.4	10.0	4.8	7.1	8.3	6.6	7.2	8.3	7.7	10.8	6.1	13.1	9.7	15.3	12.0	11.1	3.0	10.1	6.6	6.2	12.7	10.7	9.8	9.8	7.6	15.7	8.1	6.1	13.3	14.2	8.5	11.1	12.8	11.9	18.4	10.8	8.9	10.7	8.4	12.1	7.4	14.6	20.5	8.3	16.9	11.0	5.5	10.4	9.2	6.4	7.8	8.2	4.0	12.7	13.4	11.8	4.8	11.7	7.3	6.6	9.1	8.7	5.4	8.3	20.6	1.6	0.9	16.9	5.7	8.3	8.6	2.8	10.9	5.4	13.7	14.3	12.8	17.7	10.5	13.4	12.9	17.1	14.4	13.5	1.3	13.8	21.2	9.8	8.5	10.0	11.1	14.0	17.8	17.2	8.7	9.8	13.3	9.9	13.3	15.2	11.9	19.9	25.1	8.5	3.0	34.9	15.1	15.3	9.4	13.6	12.2	60.9	23.3	10.0	7.9	42.6	6.0	13.5	0.0	6.3	8.5	9.4	7.3	5.8	10.2	11.3	30.2	9.1	13.5	7.2	9.0	15.5	9.8	1.7	9.0	12.6	14.7	6.1	16.1	12.4	4.4	52.4	6.5	8.4	12.6	17.9	3.4	14.5	25.9	16.4	4.6
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32900319-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Ductal cells: 1163.1;Pancreatic endocrine cells: 917.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"		NA	NA		540000000	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (3.07e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	95.2	30.6	13.7	32.1	19.7	9.7	107.7	6.5	14.8	55.1	61.3	17.0	80.2	20.2	84.2	56.2	59.9	45.0	49.8	68.7	15.0	14.4	47.3	85.8	55.4	34.5	23.0	11.1	47.4	37.4	17.6	35.2	83.3	19.5	53.1	32.2	18.6	30.3	76.2	58.0	19.5	42.3	109.3	30.1	59.8	45.4	26.9	18.8	12.7	36.8	27.6	19.4	92.7	47.4	31.3	9.1	4.3	27.1	21.9	68.4	26.2	45.6	67.0	36.2	40.1	87.3	75.2	31.6	153.5	89.0	73.1	66.9	15.0	106.9	12.3	27.8	128.7	48.0	31.9	10.9	87.3	81.6	12.1	8.8	14.8	31.9	17.5	61.5	3.3	14.7	76.2	47.8	76.9	31.3	196.1	89.8	6.1	10.2	5.4	120.5	7.5	5.7	3.3	8.0	13.9	34.0	3.7	26.8	2.2	104.2	13.2	8.6	21.4	47.8	8.1	34.4	61.5	10.9	11.9	100.4	94.2	54.7	66.9	51.1	5.0	1.1	6.9	69.4	14.1	36.9	1.6	9.8	4.3	25.5	17.8	6.0	31.3	54.6	37.5	9.1	8.6	7.1	19.1	2.3	21.9	27.1	3.7	68.4	26.2	13.7	19.7	6.5	14.8	15.0	14.4	23.0	11.1	19.5	18.8	318.6	128.6	76.4	295.7	485.6	32.6	175.3	242.0	164.6	252.5	214.6	29.5	156.7	11.6	1163.1	4.3	314.7	83.6	70.0	355.7	460.3	265.1	177.2	86.6	221.3	161.3	36.5	185.6	387.9	152.7	9.7	235.6	174.3	325.6	83.0	81.4	76.8	917.0	113.2	565.7	64.3	45.2	627.3	497.4	10.0	63.7	149.1	183.8	106.6	98.8	257.2
ITPR2	"CFAP48, IP3R2"	ENSG00000123104	"Inositol 1,4,5-trisphosphate receptor type 2"	Q14571	12	26336515-26833198	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059144, HPA062260"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA059144: AB_2683925, HPA062260: AB_2684728"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.76e-1)"	8.8	20.6	12.8	14.5	13.8	6.1	18.5	9.3	15.0	7.9	9.9	7.8	3.7	6.0	7.2	7.8	12.0	7.3	8.0	7.1	14.2	6.0	14.4	47.1	6.5	8.1	12.8	4.6	8.0	9.2	17.4	9.9	11.9	13.0	6.6	7.8	4.8	17.6	3.8	4.7	13.3	8.9	5.4	20.3	12.5	5.9	3.4	15.3	35.3	5.3	6.6	10.7	5.5	8.1	4.3	9.0	17.3	5.2	3.6	3.1	0.7	2.7	1.2	1.6	2.6	5.0	5.1	1.8	2.5	3.5	1.8	1.9	0.1	1.4	9.4	1.6	3.4	1.9	3.0	8.7	5.3	2.4	2.2	2.9	7.5	2.5	15.1	4.6	6.7	3.4	4.8	0.7	3.7	7.0	3.5	16.6	3.7	3.3	3.0	2.2	2.3	4.7	9.0	7.2	2.4	0.9	1.5	3.9	5.9	4.1	4.3	0.5	2.6	11.4	2.1	6.3	7.0	4.3	3.3	36.3	3.6	1.4	3.4	3.2	2.8	2.1	17.6	3.3	3.1	2.3	17.3	5.2	7.1	2.4	2.2	2.0	4.2	2.1	1.9	1.0	4.3	2.5	2.2	13.5	3.6	3.0	9.0	3.1	0.7	12.8	13.8	9.3	15.0	14.2	6.0	12.8	4.6	13.0	15.3	44.7	38.7	25.7	17.2	18.5	3.1	19.1	35.7	8.1	13.6	22.7	137.4	16.2	6.6	19.4	2.6	26.3	10.3	23.3	20.5	7.7	11.6	22.1	43.8	96.9	31.6	0.0	75.3	16.5	35.2	4.7	16.7	48.3	32.1	6.4	36.5	12.6	14.9	35.3	16.6	14.6	67.9	0.0	11.7	2.8	4.9	23.3	23.3	16.0	8.4	14.6
JSRP1	"FLJ32416, JP-45"	ENSG00000167476	"Junctional sarcoplasmic reticulum protein 1"	Q96MG2	19	2252252-2269759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"skeletal muscle: 92.0;tongue: 33.9"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 13.1;Late spermatids: 14.7;Melanocytes: 43.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	6	"B-cells: 4.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 35.8;RPMI-8226: 22.4;U-266/70: 97.8;U-266/84: 11.7"	"Group enriched"	"Detected in many"	6	"amygdala: 8.6;basal ganglia: 11.5;cerebral cortex: 10.1;hippocampal formation: 4.9"					HPA044741	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044741: AB_10794295"	"unprognostic (9.41e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.64e-5)"	"unprognostic (3.63e-1)"	"unprognostic (4.43e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.71e-1)"	1.1	0.1	0.0	0.9	0.1	0.2	0.1	0.0	0.1	0.4	3.0	0.0	0.0	0.9	0.1	4.5	1.7	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.2	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	2.7	0.0	92.0	0.0	0.6	0.0	0.0	1.4	0.6	0.3	0.0	0.0	1.8	33.9	5.0	0.6	0.1	4.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	22.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.8	11.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.5	0.3	0.8	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	0.5	0.7	0.4	0.0	2.7	0.0	0.0	2.0	0.2	0.0	1.3	13.1	0.3	0.7	0.0	0.9	0.6	0.5	0.2	5.8	0.5	0.4	0.0	5.2	1.3	1.5	14.7	0.6	1.0	43.9	0.0	1.6	0.3	0.6	0.0	0.0	0.1	0.5	0.0	0.4	4.7	2.1	0.9	0.2	3.8	0.6	0.1
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400210-63472677	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 10.8;Horizontal cells: 12.7;Late spermatids: 5.7;Spermatocytes: 6.6;Spermatogonia: 17.0"	"Cancer enriched"	"Detected in some"	9	"glioma: 8.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.2;T-reg: 1.5"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"AF22: 8.5;AN3-CA: 14.0;NTERA-2: 7.8;SCLC-21H: 27.5;SH-SY5Y: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: AB_2683339"	"unprognostic (2.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-4)"	"unprognostic (8.21e-6)"	"unprognostic (6.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.96e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.43e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	1.2	10.0	18.7	1.3	21.4	1.2	1.2	24.1	50.8	1.2	1.3	2.4	0.0	1.3	1.2	1.3	1.2	1.7	1.7	1.2	15.4	10.0	1.2	1.2	1.2	1.2	8.4	14.1	1.2	1.9	1.2	9.2	1.2	8.9	2.8	1.2	0.0	1.2	1.2	1.2	1.2	1.3	1.2	2.6	1.2	1.3	6.9	4.2	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	8.5	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	27.5	48.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	1.5	0.0	18.7	21.4	24.1	31.2	15.4	10.0	8.4	14.1	8.9	4.2	0.0	0.0	0.0	0.0	0.1	1.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	12.7	0.0	0.0	0.0	5.7	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	2.1	0.0	0.0	6.6	17.0	0.0	0.0	0.0	0.0	0.0
KCTD20	"C6orf69, dJ108K11.3, MGC14254"	ENSG00000112078	"Potassium channel tetramerization domain containing 20"	Q7Z5Y7	6	36442767-36491143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030092	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nuclear speckles"	"HPA030092: AB_10601437"	"unprognostic (2.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.94e-2)"	34.3	23.1	18.4	22.8	17.6	20.1	39.0	15.7	21.4	22.2	20.7	18.7	22.4	12.0	25.5	23.1	24.6	22.0	25.1	21.0	16.3	17.1	16.2	29.7	20.5	26.2	18.0	14.4	25.6	12.7	15.7	16.1	21.7	16.5	17.5	16.0	17.9	16.2	19.2	20.4	24.6	17.6	30.8	17.3	24.2	16.6	10.2	13.3	31.6	13.6	18.1	24.9	21.5	18.3	6.2	14.0	19.4	14.4	6.4	8.5	10.9	11.0	5.0	14.7	28.1	20.2	13.0	7.1	13.5	18.7	14.7	16.5	13.0	6.3	37.4	12.2	21.9	8.4	10.3	19.2	9.8	24.5	26.6	10.6	21.3	8.0	13.7	9.4	20.6	14.8	13.1	10.1	11.2	7.2	9.8	15.0	19.9	32.8	21.4	13.8	9.7	23.3	7.8	5.4	8.8	4.6	23.2	16.7	21.0	8.0	12.5	3.5	20.8	11.8	12.0	35.9	15.2	16.5	20.5	17.1	40.0	13.7	11.8	16.7	16.9	39.3	27.1	6.9	28.4	40.7	19.4	14.4	9.2	7.5	13.1	8.5	6.2	5.9	6.2	14.0	5.1	6.2	6.1	10.6	6.4	7.2	7.6	6.9	10.9	18.4	17.6	15.7	21.4	16.3	17.1	18.0	14.4	16.5	13.3	35.7	21.3	25.3	14.7	44.5	17.2	13.2	33.1	21.4	23.9	15.7	9.8	22.6	1.7	14.7	0.4	31.4	13.2	70.0	12.3	15.4	34.9	16.2	52.0	41.2	23.8	14.3	14.6	49.1	52.1	1.5	29.4	33.6	32.1	32.5	15.2	17.9	16.3	14.0	50.2	16.1	9.5	19.4	53.6	5.2	26.0	55.5	19.2	29.9	15.1	27.3
KDELR3		ENSG00000100196	"KDEL endoplasmic reticulum protein retention receptor 3"	O43731	22	38468062-38483447	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 48.5;salivary gland: 57.2"	"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 62.1;Fibroblasts: 54.4;Mucus-secreting cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.3;BJ: 36.7;BJ hTERT+: 37.8;fHDF/TERT166: 59.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043477, HPA076405"	Uncertain		Supported	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA043477: AB_10962952, HPA076405: AB_2686797"	"unprognostic (1.76e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.05e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.07e-2)"	10.5	4.0	1.3	3.4	1.4	0.2	11.6	0.9	1.3	15.7	7.7	1.8	5.3	6.6	6.2	14.8	5.5	5.7	20.9	14.2	1.5	1.1	10.9	44.5	8.6	5.8	1.0	1.2	7.2	48.5	9.3	12.4	11.6	1.8	9.2	10.3	5.5	57.2	7.1	2.1	3.6	15.1	6.6	2.2	3.0	15.5	4.1	0.9	1.1	6.7	6.5	16.9	6.8	6.5	1.2	4.3	0.9	0.1	0.3	2.4	0.3	7.0	2.2	1.8	7.8	30.9	58.3	1.3	36.7	37.8	9.0	22.5	4.0	9.3	0.0	7.8	59.5	3.2	1.0	1.8	2.2	10.9	0.0	4.1	0.5	1.9	11.1	13.6	0.0	4.9	21.4	1.7	11.3	1.2	12.8	10.8	0.0	1.7	0.0	14.8	11.5	0.0	0.2	0.4	30.6	6.4	0.0	0.5	2.3	10.9	0.9	0.1	0.9	9.4	0.5	4.6	0.8	2.7	0.4	8.2	9.7	6.1	33.3	3.6	0.3	0.1	0.0	15.6	0.0	13.4	0.0	0.1	0.0	0.8	0.1	2.4	1.2	0.8	0.2	0.2	0.4	0.8	0.8	0.9	0.3	0.1	4.3	0.7	0.3	1.3	1.4	0.9	1.3	1.5	1.1	1.0	1.2	1.8	0.9	0.0	3.7	1.5	4.6	6.8	1.0	2.4	7.6	8.1	7.9	14.0	2.0	4.0	6.6	16.9	0.1	8.7	9.7	0.0	28.0	62.1	54.4	28.3	1.1	5.0	4.1	0.0	4.7	22.1	1.9	0.2	30.2	1.7	15.1	1.8	58.9	5.7	29.2	3.5	15.2	0.5	1.0	0.0	7.6	0.2	1.9	6.1	6.9	0.0	9.9	4.8
KIAA1324L	"EIG121L, FLJ31340"	ENSG00000164659	"KIAA1324 like"	A8MWY0	7	86876906-87059699	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.9"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 73.9;Early spermatids: 53.7;Horizontal cells: 31.8;Late spermatids: 70.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.8"	"Group enriched"	"Detected in many"	5	"B-cells: 2.7;NK-cells: 4.8;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;hTERT-HME1: 17.9;HUVEC TERT2: 15.0;K-562: 23.0;SCLC-21H: 19.1;SuSa: 17.5;TIME: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044527, HPA076093"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044527: AB_10963793, HPA076093: AB_2686776"	"unprognostic (2.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.37e-1)"	11.1	4.5	7.7	2.3	17.3	1.0	6.5	15.6	15.8	4.0	5.0	28.9	1.2	1.8	4.3	1.0	4.5	3.9	5.0	5.5	10.8	8.7	2.9	1.5	24.4	3.8	22.4	10.4	2.7	5.5	11.7	13.5	9.0	22.7	7.6	6.5	2.4	3.6	6.3	3.5	3.4	2.7	6.4	23.5	6.4	4.1	3.6	21.7	0.0	6.1	1.0	4.0	5.9	2.8	2.7	0.9	0.4	0.0	4.8	5.8	0.7	0.9	0.0	15.4	0.0	0.2	0.0	4.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	3.8	0.3	0.1	0.0	1.6	0.0	0.0	3.7	0.3	11.8	4.1	1.3	0.1	0.1	1.5	1.2	0.0	0.0	17.9	0.1	15.0	5.8	23.0	0.4	1.7	4.7	0.3	0.0	8.4	0.0	3.8	0.0	1.0	2.4	1.6	6.8	19.1	14.3	4.1	5.4	1.7	17.5	1.6	0.3	17.6	0.2	6.0	0.1	0.0	8.5	5.0	0.1	4.5	0.0	0.2	0.0	0.0	0.4	0.7	0.0	5.8	0.9	2.1	1.3	0.4	2.7	2.2	1.2	0.0	4.8	0.0	0.9	0.7	0.7	7.7	17.3	15.6	15.8	10.8	8.7	22.4	10.4	22.7	21.7	11.9	73.9	0.0	1.4	1.0	11.6	2.0	0.0	6.7	3.4	3.5	9.8	0.4	3.3	1.3	53.7	10.0	1.7	0.0	1.0	0.4	3.1	3.6	2.3	0.0	0.3	31.8	8.1	0.6	0.8	70.4	2.3	1.6	0.0	0.0	2.7	1.1	1.0	1.9	2.1	0.7	3.2	6.5	6.2	0.7	2.1	1.4	0.1	0.7	2.6	1.4
KTN1	"CG1, KIAA0004, KNT"	ENSG00000126777	"Kinectin 1"	Q86UP2	14	55559072-55701526	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003178, CAB015331, HPA017876"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652"	"unprognostic (7.00e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.83e-5)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.72e-2)"	"prognostic favorable (1.01e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	26.5	27.5	30.8	18.9	37.3	9.5	44.2	30.8	35.2	22.7	28.8	15.8	23.4	13.0	18.8	30.8	26.1	16.8	18.1	36.1	32.2	25.3	33.1	31.8	21.2	16.9	39.3	24.5	23.1	22.8	48.3	54.7	21.3	49.5	26.9	28.7	13.1	21.4	24.0	101.9	41.4	20.1	40.5	51.9	22.1	18.9	40.9	42.0	14.5	33.3	37.9	17.9	32.7	39.7	35.6	58.3	27.0	15.5	19.6	24.0	4.8	40.7	28.2	21.1	23.0	29.2	28.0	30.6	33.3	26.8	20.9	18.6	18.8	50.7	31.4	47.7	34.2	22.3	76.3	25.8	29.0	35.4	52.8	14.1	22.2	46.7	35.6	27.6	32.5	18.0	26.0	26.6	25.8	44.8	45.0	34.3	25.1	21.6	18.4	40.1	31.8	27.9	19.3	16.2	18.9	42.1	22.3	55.5	14.9	52.5	64.1	26.0	21.7	52.7	24.2	29.2	45.0	25.1	20.9	48.3	42.8	54.8	21.9	31.2	8.3	11.2	23.4	50.1	19.1	23.7	27.0	14.8	14.6	19.6	13.1	18.7	28.3	23.2	22.1	14.2	35.6	24.0	20.6	9.4	19.6	15.5	58.3	14.8	4.8	30.8	37.3	30.8	35.2	32.2	25.3	39.3	24.5	49.5	42.0	285.9	218.9	134.1	191.3	581.3	188.0	751.3	254.8	254.3	215.0	406.5	339.7	116.7	26.6	214.2	480.1	300.8	208.9	46.7	262.9	169.7	168.2	247.6	130.6	360.3	102.3	308.3	215.0	264.6	155.1	281.2	230.1	161.1	163.6	161.5	208.3	454.2	307.7	252.8	415.1	100.9	370.8	329.8	235.9	615.9	350.9	632.0	137.8	123.1	224.4	298.6
LAMA3	"BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa"	ENSG00000053747	"Laminin subunit alpha 3"	Q16787	18	23689443-23955066	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 70.8"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 107.2;Pancreatic endocrine cells: 340.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"HBEC3-KT: 154.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009309, CAB010757"	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		810000	"Endoplasmic reticulum"		"CAB010757: AB_477162, HPA009309: AB_1079224"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (3.58e-6)"	"unprognostic (1.98e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.91e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.13e-1)"	8.2	0.9	2.9	8.2	1.9	0.0	16.7	0.6	2.3	18.2	13.3	2.4	5.4	11.2	19.1	9.5	12.4	7.8	8.1	2.7	1.8	1.5	3.1	1.3	26.2	7.0	2.4	0.9	5.8	3.1	10.3	2.3	70.8	1.6	8.7	5.2	5.7	14.9	9.1	2.2	20.7	27.8	10.2	1.3	0.8	19.7	3.8	0.5	3.3	1.8	9.7	8.0	11.5	15.2	0.0	0.0	0.8	0.0	0.0	1.3	0.2	17.3	2.2	0.0	0.0	0.9	0.2	0.0	0.3	0.2	0.1	0.2	0.7	20.1	0.0	2.3	0.2	0.0	31.7	0.0	154.2	0.1	0.0	1.2	0.0	0.6	0.3	0.1	0.0	0.0	0.2	17.3	0.1	18.3	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	5.4	2.0	0.3	0.0	0.0	6.8	2.0	0.0	0.3	0.7	0.3	0.0	0.0	0.6	0.2	1.6	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	2.9	1.9	0.6	2.3	1.8	1.5	2.4	0.9	1.6	0.5	107.2	23.7	0.5	53.6	27.8	3.8	2.0	5.1	13.4	23.9	1.8	0.0	0.1	0.0	30.0	3.7	2.8	50.4	0.0	30.6	0.2	2.0	16.7	5.7	0.8	0.2	0.0	7.9	1.8	0.0	2.8	5.5	1.1	1.7	1.0	11.0	0.0	340.7	31.6	3.2	0.0	1.9	6.5	19.6	3.1	1.9	8.7	0.1	0.7	6.6	15.4
LAMC1	LAMB2	ENSG00000135862	"Laminin subunit gamma 1"	P11047	1	183023460-183145592	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Leydig cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 1.1;naive B-cell: 3.2;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	15	"B-cells: 3.2;dendritic cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 170.5;ASC TERT1: 93.8;HSkMC: 105.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001908, HPA001909, CAB004486, CAB078163"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		90000000	"Endoplasmic reticulum, Plasma membrane"		"CAB004486: AB_627870, CAB078163: AB_2665817, HPA001908: AB_1079229, HPA001909: AB_1079230"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.30e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.85e-5)"	49.0	6.8	2.9	11.3	4.0	0.2	51.5	5.9	3.4	30.4	27.7	2.8	12.8	4.9	30.5	28.7	31.5	21.5	25.9	39.5	3.4	2.0	10.0	6.8	22.5	10.6	3.9	2.7	22.7	9.8	7.4	4.1	73.1	3.5	23.9	11.4	11.7	11.6	17.3	32.2	15.6	17.6	41.3	3.0	4.7	22.3	16.1	2.7	3.5	21.7	16.4	7.3	40.2	37.6	3.2	1.3	0.0	0.1	0.0	0.0	0.2	5.2	8.5	28.2	8.0	170.5	93.8	42.7	38.6	38.8	15.6	9.2	25.3	6.0	1.9	17.8	18.5	9.2	13.1	5.3	10.2	11.9	0.0	5.4	0.0	7.7	9.2	26.8	1.6	0.9	105.6	5.5	18.6	14.7	27.9	27.1	0.0	0.0	5.7	18.9	2.3	0.0	1.7	11.4	9.7	1.6	1.3	23.8	0.9	25.2	14.0	1.8	5.3	10.1	0.0	9.9	50.7	2.2	4.4	50.0	19.1	7.5	17.6	9.6	2.2	0.0	1.2	15.8	1.2	18.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	2.9	4.0	5.9	3.4	3.4	2.0	3.9	2.7	3.5	2.7	32.8	16.3	4.5	38.6	27.8	1.9	48.8	25.5	10.7	17.0	34.9	3.9	80.1	1.7	50.0	5.4	59.4	0.7	0.0	19.8	53.9	99.3	48.3	2.3	17.8	16.1	1.6	1.2	26.4	10.8	3.8	111.9	5.3	32.1	10.0	1.7	2.0	39.3	3.5	58.7	10.2	0.6	71.1	83.0	7.0	39.9	14.8	60.3	0.5	2.6	21.6
LARP1	"KIAA0731, LARP, MGC19556"	ENSG00000155506	"La ribonucleoprotein domain family member 1"	Q6PKG0	5	154712902-154817607	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015222, HPA051397, HPA054819"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoplasm, Endoplasmic reticulum, Cytosol"		"CAB015222: , HPA051397: AB_2681467, HPA054819: AB_2682612"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	24.9	30.1	30.5	21.9	31.9	18.9	20.3	25.7	46.5	21.3	20.4	27.3	23.2	21.0	26.5	23.0	29.2	25.4	18.5	28.5	27.8	29.1	25.6	22.6	19.9	23.1	26.8	29.7	28.4	81.2	55.9	23.6	25.1	29.2	18.2	21.3	18.9	38.8	21.4	41.7	24.7	22.3	23.8	22.2	21.5	24.4	27.8	27.4	26.1	33.5	16.4	25.8	22.1	28.7	5.2	6.4	2.8	7.9	10.1	5.8	2.5	26.2	36.7	28.7	32.9	25.0	20.3	31.8	26.7	27.3	31.3	30.6	57.7	31.6	69.3	37.9	33.3	45.8	26.4	52.3	49.1	36.2	22.9	29.5	50.1	38.2	26.6	31.8	67.0	23.3	25.1	28.5	38.9	49.7	17.8	27.5	31.3	41.1	48.1	29.0	25.9	39.6	26.2	30.5	22.8	18.5	44.4	27.3	33.0	19.2	32.7	52.1	28.0	36.2	58.2	32.1	30.8	34.6	31.7	36.4	39.4	24.7	29.7	47.8	43.0	30.9	59.1	26.1	37.1	27.5	2.8	4.0	1.1	4.5	4.9	5.8	4.3	5.4	5.3	4.0	5.2	4.3	4.7	2.4	10.1	7.9	6.4	3.4	2.5	30.5	31.9	25.7	46.5	27.8	29.1	26.8	29.7	29.2	27.4	41.7	26.0	38.9	30.3	69.5	60.5	94.4	40.8	37.5	26.1	38.4	35.3	37.5	24.9	38.5	9.8	50.1	45.7	23.3	70.6	28.5	46.8	41.1	17.3	58.2	49.0	82.6	42.2	50.3	51.5	7.7	64.5	38.5	35.4	31.5	52.6	32.3	54.8	28.1	75.3	40.9	38.4	12.9	41.1	37.6	41.4	73.9	20.0	24.9	61.7	53.6
LCLAT1	"AGPAT8, ALCAT1, FLJ37965, LYCAT"	ENSG00000172954	"Lysocardiolipin acyltransferase 1"	Q6UWP7	2	30447226-30644225	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031880, HPA049217"	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum"	Cytosol	"HPA031880: AB_10610002, HPA049217: AB_2680678"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.52e-3)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (9.67e-4)"	"prognostic unfavorable (8.72e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.85e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.10e-1)"	7.7	9.7	7.0	13.7	8.7	12.3	7.1	10.2	10.1	11.6	10.7	5.2	12.6	15.7	18.7	15.0	13.0	9.9	12.6	21.7	7.5	9.2	15.2	13.8	10.0	12.5	6.1	6.0	15.4	16.7	10.8	21.8	5.7	7.0	10.7	10.6	9.7	9.5	16.3	10.9	9.4	25.0	11.3	5.5	8.0	8.4	12.1	4.2	20.7	17.9	11.9	11.7	9.1	10.4	9.6	2.8	10.5	3.9	4.1	12.6	2.8	11.0	14.6	7.9	13.3	1.8	4.2	11.3	8.0	8.0	8.5	7.2	14.7	13.0	7.1	7.4	12.4	10.6	12.5	26.1	10.8	8.5	9.0	8.9	13.1	9.2	14.1	8.4	18.5	10.0	3.2	8.5	9.0	12.6	5.6	5.9	4.1	12.0	6.8	6.5	8.6	10.5	10.9	8.6	9.0	8.4	10.3	15.8	14.5	6.8	16.2	9.2	14.2	17.9	11.9	10.3	5.7	8.6	6.4	6.7	15.5	12.9	8.3	12.5	4.9	10.3	16.0	15.8	13.6	11.8	10.5	2.5	4.8	5.6	3.9	6.6	7.5	8.7	7.1	2.8	9.6	12.6	12.1	7.4	4.1	3.5	2.2	4.0	2.8	7.0	8.7	10.2	10.1	7.5	9.2	6.1	6.0	7.0	4.2	8.9	5.8	4.5	4.6	6.4	12.5	15.1	22.9	13.4	7.9	14.0	25.5	4.3	0.0	7.2	3.1	6.7	11.5	0.0	14.3	4.3	5.5	7.7	3.5	19.0	4.9	14.3	12.6	11.1	5.4	1.2	5.2	2.7	5.0	0.0	15.3	7.3	10.3	7.0	8.5	12.2	16.7	6.5	16.2	8.9	20.5	5.8	1.6	8.7	14.3	4.4
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 199.7;gallbladder: 173.3;lymphoid tissue: 178.1;salivary gland: 168.7"	"Cell type enhanced"	"Detected in many"	16	"Ductal cells: 4866.3;Exocrine glandular cells: 1633.7;Pancreatic endocrine cells: 4295.8;Urothelial cells: 1384.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"basophil: 5.4;neutrophil: 11.4;non-classical monocyte: 4.5"	"Group enriched"	"Detected in many"	72	"granulocytes: 11.4;monocytes: 4.5"	"Group enriched"	"Detected in some"	11	"CAPAN-2: 277.6;EFO-21: 113.7"									"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA	297000000	870000000	"Endoplasmic reticulum"		"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favorable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	0.3	0.5	0.2	24.6	0.3	199.7	2.7	0.2	0.5	78.7	19.4	1.0	0.5	2.4	7.9	9.1	77.0	4.0	173.3	20.4	0.2	0.2	12.7	12.8	32.6	0.2	0.2	0.1	6.7	17.4	0.0	5.4	7.1	0.8	17.0	10.5	1.0	168.7	0.9	1.0	3.1	17.0	0.7	0.2	8.1	35.1	5.8	0.1	5.0	3.8	142.0	178.1	68.9	48.5	0.0	0.0	11.4	4.5	0.0	0.1	9.6	8.7	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	277.6	0.0	113.7	0.0	0.2	18.1	0.0	0.5	0.0	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	5.1	0.0	0.0	0.6	0.1	0.0	0.2	1.2	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	4.5	0.0	0.0	9.6	0.2	0.3	0.2	0.5	0.2	0.2	0.2	0.1	0.8	0.1	0.0	17.3	2.4	352.2	0.2	0.0	0.2	932.5	180.7	184.2	130.9	0.0	0.3	0.0	4866.3	1.9	0.1	78.8	23.3	1633.7	0.3	0.2	349.2	13.8	18.3	0.5	0.0	55.6	2.5	0.6	10.5	3.1	0.6	0.0	103.6	135.4	0.0	4295.8	131.2	0.0	0.7	0.0	0.0	3.1	0.0	0.2	0.0	0.2	0.7	262.6	1384.7
LCTL	"FLJ33279, KLG, KLPH"	ENSG00000188501	"Lactase like"	Q6UWM7	15	66547179-66565979	"Cancer-related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 10.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 5.0;Late spermatids: 7.5;Spermatogonia: 2.7"	"Group enriched"	"Detected in some"	5	"glioma: 1.5;melanoma: 0.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;hTERT-RPE1: 7.5;NTERA-2: 5.8;SuSa: 7.0;U-2 OS: 16.2;U-251 MG: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071640			Approved	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Plasma membrane"	"Endoplasmic reticulum"	"HPA071640: AB_2686428"	"unprognostic (4.60e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.51e-3)"	"unprognostic (4.44e-16)"	"unprognostic (6.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	0.4	0.7	6.0	0.9	4.3	3.1	0.4	0.7	3.1	0.4	0.5	3.1	0.0	1.4	0.8	0.9	0.7	0.3	1.0	0.4	3.3	1.2	0.4	0.4	0.4	1.0	5.3	3.1	0.6	0.7	0.2	0.4	0.3	4.9	0.4	0.3	1.1	0.6	0.3	3.0	2.6	0.7	0.4	10.4	0.8	0.7	1.5	2.3	0.0	0.5	0.0	0.2	0.3	0.3	0.9	0.6	3.9	0.7	1.0	0.5	0.2	0.3	0.3	3.2	0.3	0.1	0.1	0.8	0.8	0.0	0.0	0.3	0.4	0.4	0.4	6.3	0.2	0.6	0.6	0.0	0.0	0.2	0.2	0.2	0.7	1.0	1.5	0.0	0.2	0.4	0.4	0.0	0.3	0.0	7.5	0.0	0.2	0.4	0.4	0.2	0.1	0.2	0.4	5.8	0.4	0.1	0.2	3.4	0.3	0.0	0.4	0.4	0.3	0.1	0.3	1.8	7.0	0.4	0.5	0.4	1.6	16.2	0.6	6.9	0.2	0.2	0.2	2.1	0.7	2.9	1.6	0.7	0.5	0.5	0.4	0.3	0.4	0.5	0.3	0.2	0.9	0.5	0.4	3.9	1.0	0.4	0.6	0.5	0.2	6.0	4.3	0.7	2.7	3.3	1.2	5.3	3.1	4.9	2.3	0.0	0.0	0.0	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.0	0.1	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	7.5	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	1.1	0.0	0.4	1.2	2.7	0.3	0.2	0.0	0.0	0.3
LNPK	"KIAA1715, LNP, LNP1, Ul"	ENSG00000144320	"Lunapark, ER junction formation factor"	Q9C0E8	2	175923892-176002839	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9;Ciliated cells: 16.0;Collecting duct cells: 15.7;Extravillous trophoblasts: 15.2;Hofbauer cells: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 60.1"	"Low region specificity"	"Detected in all"							HPA014205	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA014205: AB_2234186"	"unprognostic (4.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.43e-2)"	14.2	10.8	13.4	8.4	16.0	29.4	11.3	12.9	26.5	15.0	13.3	13.4	7.1	8.6	11.9	7.7	15.1	8.2	9.1	13.6	13.8	16.1	9.8	16.3	8.1	7.6	19.9	14.2	12.8	6.4	16.8	22.8	9.4	21.1	12.0	11.9	10.1	8.6	10.1	33.5	13.5	8.4	11.3	26.2	6.6	8.9	25.4	14.6	16.4	10.3	14.8	8.7	12.2	15.1	7.1	6.7	11.6	7.3	9.7	11.6	5.2	8.7	4.4	10.6	14.9	22.3	13.9	5.3	25.9	12.5	12.1	17.1	6.1	10.4	8.8	14.8	11.4	15.9	9.7	9.9	6.9	16.9	13.3	10.1	9.9	5.7	5.4	5.3	16.7	12.3	11.4	6.6	11.7	5.8	9.9	2.2	7.0	10.1	11.7	16.5	5.7	11.0	6.7	3.4	9.0	8.6	11.2	10.7	6.4	5.1	8.0	12.2	12.4	11.4	6.5	8.6	10.4	9.7	5.5	3.3	60.1	8.9	20.0	12.1	6.9	12.6	7.3	18.6	5.5	11.2	5.7	6.6	11.6	8.1	7.3	9.5	7.1	7.2	8.9	6.0	5.0	7.2	11.2	5.6	9.7	6.7	6.7	11.6	5.2	13.4	16.0	12.9	23.3	13.8	16.1	19.9	14.2	21.1	14.6	17.9	9.9	0.0	0.0	0.0	0.0	0.0	0.0	16.0	11.4	15.7	0.0	4.3	5.0	14.3	0.0	0.0	0.0	0.0	8.3	15.2	0.0	0.0	10.5	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	3.6	0.0	0.0	11.1	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 34.9;Fibroblasts: 69.8;Peritubular cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 105.1;fHDF/TERT166: 160.3;HSkMC: 39.1;hTERT-RPE1: 42.3;U-138 MG: 53.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043930			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		290000	"Endoplasmic reticulum"		"HPA043930: AB_2678736"	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (3.32e-4)"	33.8	1.8	1.0	7.2	1.2	0.0	37.4	0.9	0.9	16.1	11.7	0.1	4.1	3.8	6.3	20.1	11.1	7.6	12.8	21.4	1.2	1.3	6.5	2.4	20.6	4.3	0.9	1.1	15.7	6.0	0.8	1.5	14.8	1.6	11.2	3.0	3.2	3.4	3.5	12.7	11.3	4.5	9.5	1.5	7.7	4.0	10.6	0.1	0.7	10.8	4.2	2.7	36.9	10.4	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.1	0.0	0.3	0.1	18.3	21.6	0.0	105.1	22.1	8.1	28.7	0.1	0.0	0.0	2.5	160.3	0.4	0.0	0.4	0.2	17.4	0.0	0.3	0.0	2.1	0.8	23.1	0.0	0.0	39.1	0.4	13.5	0.6	42.3	10.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.5	7.4	0.0	0.7	3.4	0.0	0.0	0.8	53.3	3.6	31.5	1.4	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.0	1.2	0.9	0.9	1.2	1.3	0.9	1.1	1.6	0.1	8.9	0.6	0.0	1.6	6.9	0.6	1.2	0.0	4.0	1.2	0.0	0.0	0.7	0.0	7.1	34.9	3.3	0.0	0.0	0.5	17.3	69.8	1.8	0.0	0.4	1.9	1.6	0.0	14.1	1.5	2.4	13.0	0.3	5.0	1.0	0.0	0.0	1.4	0.0	36.7	0.0	1.1	19.4	8.2	0.5	0.0	9.4	4.0	0.0	0.0	0.7
LOXL1	"LOL, LOXL"	ENSG00000129038	"Lysyl oxidase like 1"	Q08397	15	73925989-73952137	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Oxidoreductase	Glaucoma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 84.0;Extravillous trophoblasts: 135.9;Fibroblasts: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.5"	"Lineage enriched"	"Detected in single"	45	"T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"BJ: 23.4;BJ hTERT+: 26.8;hTERT-RPE1: 26.7;U-87 MG: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA042111, HPA063583"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		120000	"Endoplasmic reticulum"		"HPA042111: AB_10794412, HPA063583: AB_2685050"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (7.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.76e-2)"	9.4	2.5	2.4	6.7	1.2	0.9	5.0	0.4	1.8	19.3	7.0	1.6	7.0	2.3	12.3	8.4	9.9	6.9	12.4	19.1	2.4	1.6	7.9	1.3	7.0	13.6	1.3	1.6	9.6	3.0	3.8	7.4	16.1	4.4	14.8	1.7	26.7	5.7	15.5	4.2	4.7	5.3	26.6	2.1	2.8	6.5	3.7	1.3	1.2	3.9	10.5	10.4	16.9	11.7	0.1	0.0	0.0	0.0	0.0	6.5	0.6	1.1	0.0	0.3	0.0	16.7	20.3	0.7	23.4	26.8	9.9	17.6	0.4	0.6	0.0	4.3	17.2	2.5	6.9	0.1	0.0	2.4	0.0	1.5	0.0	0.7	0.1	2.3	0.0	0.0	16.5	0.0	7.4	0.0	26.7	0.3	0.4	0.0	0.1	11.8	0.8	0.1	0.4	2.2	1.5	16.0	0.0	13.8	0.2	0.9	4.1	1.9	0.0	0.7	0.1	0.0	2.4	0.1	0.0	1.7	19.5	17.3	15.3	8.9	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.1	2.9	1.5	0.0	0.1	0.7	0.8	0.0	0.0	0.0	0.0	6.5	0.6	2.4	1.2	0.4	1.8	2.4	1.6	1.3	1.6	4.4	1.3	0.0	1.1	0.0	5.2	5.3	0.4	84.0	0.0	0.0	0.0	8.7	0.0	1.8	3.3	2.5	1.2	2.9	0.0	0.0	1.2	135.9	59.0	2.9	1.1	0.0	5.6	0.0	3.4	19.0	0.0	1.0	9.2	0.0	10.1	0.0	0.1	5.2	8.2	0.0	19.8	1.4	0.2	0.0	20.5	2.6	1.9	3.0	4.2	0.0	0.9	3.1
LPCAT1	"AGPAT10, AGPAT9, AYTL2, FLJ12443"	ENSG00000153395	"Lysophosphatidylcholine acyltransferase 1"	Q8NF37	5	1456480-1523977	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 35.6"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 286.5;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.9;EFO-21: 33.5;PC-3: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012501, HPA022268"	Enhanced		Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA012501: AB_1845224, HPA022268: AB_1845225"	"unprognostic (5.33e-3)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.88e-8)"	"unprognostic (5.90e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (4.90e-5)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.60e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.03e-1)"	9.8	5.6	5.2	9.0	5.7	5.1	7.4	9.2	9.5	5.4	7.5	2.9	4.5	3.9	7.0	3.2	3.2	5.9	5.8	4.3	5.3	5.2	4.9	3.1	35.6	8.5	3.2	3.7	5.0	5.4	3.1	5.6	10.0	4.6	5.2	2.3	13.6	4.5	4.4	3.5	3.2	5.9	5.5	3.3	28.8	9.4	3.0	2.9	5.8	4.7	1.4	8.1	6.6	10.6	0.9	0.7	2.4	1.7	1.7	3.6	0.6	2.0	3.0	0.5	3.3	0.3	0.5	34.9	7.8	0.4	0.4	0.3	1.1	0.9	6.8	33.5	0.2	1.4	5.8	0.6	0.2	0.2	16.5	14.2	1.6	4.9	2.0	0.6	1.7	4.6	0.6	0.1	0.3	0.1	0.5	0.4	2.3	3.7	1.3	0.0	4.3	6.4	2.6	12.3	0.1	23.3	12.3	0.6	4.9	1.4	2.8	4.4	4.3	6.2	5.7	1.8	0.3	2.6	2.7	3.9	0.6	7.7	2.3	2.8	4.4	4.2	1.6	1.4	2.8	2.1	0.0	0.6	0.8	3.6	1.7	3.6	0.9	0.8	1.8	0.7	0.7	0.1	1.0	2.4	1.7	1.2	0.2	0.8	0.6	5.2	5.7	9.2	8.0	5.3	5.2	3.2	3.7	4.6	2.9	80.4	286.5	25.1	1.9	5.6	52.2	3.2	7.6	5.3	21.6	14.0	137.4	5.1	0.0	16.9	1.5	10.3	2.6	0.0	11.7	67.8	9.3	5.6	8.1	4.0	21.8	22.3	14.3	18.4	26.3	1.5	10.0	16.2	6.8	10.8	9.0	28.2	22.2	0.0	14.5	4.4	124.0	0.0	12.3	1.7	9.8	3.4	26.5	26.7	2.5	1.6
LPCAT2	"AGPAT11, AYTL1, FLJ20481, LysoPAFAT"	ENSG00000087253	"Lysophosphatidylcholine acyltransferase 2"	Q7L5N7	16	55508998-55586670	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 64.6;granulocytes: 165.5;Kupffer cells: 68.0;Macrophages: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 28.8;eosinophil: 49.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 49.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 32.0;HaCaT: 24.5;HL-60: 27.3;HMC-1: 45.6;hTERT-RPE1: 45.8;WM-115: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007891, HPA008433"	Enhanced	Supported	Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA007891: AB_1845223, HPA008433: "	"unprognostic (1.43e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.18e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	10.5	7.5	10.5	8.0	16.2	43.5	9.9	1.7	7.5	11.0	5.2	18.2	36.5	4.3	17.0	21.5	7.2	8.5	6.2	5.7	9.6	6.3	6.7	2.4	7.4	10.3	18.6	3.1	11.0	3.8	12.7	1.9	9.0	16.1	8.2	5.5	5.1	7.7	33.2	3.0	10.2	5.4	8.9	30.7	8.9	5.3	4.6	14.9	0.9	49.0	5.2	2.6	8.5	8.5	0.0	5.4	49.4	9.3	0.0	0.0	1.4	8.9	1.1	0.9	0.0	3.1	1.2	1.6	3.8	3.7	1.9	1.9	2.0	32.0	0.0	13.2	5.4	1.5	24.5	0.6	5.3	3.1	2.4	2.6	9.2	2.9	4.6	1.1	27.3	45.6	0.6	5.3	2.1	1.7	45.8	14.7	0.5	0.4	0.1	3.2	0.5	0.0	11.0	1.4	2.5	0.1	2.8	1.0	1.3	1.8	3.5	0.6	7.1	7.4	3.0	5.3	4.6	1.3	6.9	16.5	0.3	0.0	1.9	2.6	0.1	0.0	0.0	0.7	13.3	32.5	28.8	4.5	49.4	0.0	6.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	12.1	0.0	9.3	0.1	0.0	1.4	10.5	16.2	1.7	7.5	9.6	6.3	18.6	3.1	16.1	14.9	6.0	31.3	1.7	29.9	13.7	1.6	1.6	5.1	2.7	23.9	64.6	9.8	0.7	1.7	7.2	1.3	22.7	4.1	0.0	8.5	6.9	13.8	6.0	165.5	1.7	33.6	0.0	1.2	4.3	68.0	1.7	15.3	64.1	16.9	7.2	11.9	26.1	20.5	31.6	12.0	4.4	5.2	0.0	2.4	11.6	3.8	13.4	1.6	1.3	9.8	15.9
LRAT	LCA14	ENSG00000121207	"Lecithin retinol acyltransferase"	O95237	4	154626945-154753118	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"Acyltransferase, Transferase"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 82.4"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 7.6;Early spermatids: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"NTERA-2: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA070726			Uncertain	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA070726: "	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-4)"	"unprognostic (4.49e-6)"	"unprognostic (6.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-1)"	0.9	0.8	2.2	0.8	3.2	1.8	1.4	0.7	1.1	0.9	4.2	3.0	0.8	3.7	0.5	1.2	0.5	0.9	2.3	0.6	3.1	4.2	0.6	3.3	1.0	0.5	2.9	2.4	1.0	2.9	0.3	1.0	0.3	8.9	1.6	0.4	82.4	0.5	1.6	2.3	1.4	11.1	0.3	7.0	0.7	0.9	2.9	3.1	0.0	4.9	0.2	0.6	0.5	0.7	0.9	3.7	2.0	4.5	0.6	0.3	3.9	0.7	0.5	0.4	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.2	0.0	0.0	0.1	0.8	0.6	0.1	0.1	0.2	0.5	0.4	0.3	0.1	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.3	16.5	0.0	0.0	0.1	0.0	0.1	2.0	0.5	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.0	0.4	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.2	0.5	1.0	4.5	0.4	0.3	1.6	0.3	0.5	0.3	0.3	3.7	0.9	0.3	0.3	2.0	0.6	0.5	0.5	0.2	3.9	2.2	3.2	0.7	1.1	3.1	4.2	2.9	2.4	8.9	3.1	0.0	4.1	0.0	4.2	1.0	0.8	0.2	7.6	0.0	1.2	0.0	0.0	0.1	3.3	0.8	7.2	0.2	2.0	0.0	0.7	0.1	0.3	2.4	0.0	2.0	0.1	0.0	0.0	1.8	0.0	1.6	0.0	0.0	5.0	0.0	0.7	3.7	1.4	0.0	0.0	0.3	0.9	0.0	0.1	4.8	4.5	1.0	0.2	0.7	0.3	0.6
LRPAP1	"A2MRAP, HBP44, RAP"	ENSG00000163956	"LDL receptor related protein associated protein 1"	P30533	4	3506376-3532559	"Disease related genes, Predicted intracellular proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 500.6;Syncytiotrophoblasts: 580.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008001, CAB025518"	Enhanced	Supported	Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB025518: , HPA008001: AB_1853292"	"unprognostic (3.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.89e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (4.67e-11)"	"unprognostic (6.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.61e-2)"	9.4	11.3	13.7	8.7	34.4	17.4	8.5	11.4	22.1	10.1	9.3	9.1	15.5	10.6	11.1	16.7	7.2	10.5	11.2	28.1	11.6	13.1	17.7	16.5	10.8	9.9	10.6	14.5	13.2	28.8	20.0	18.1	35.2	9.9	11.2	7.6	11.5	23.0	18.9	12.5	10.9	10.3	8.4	7.2	10.9	10.7	10.9	12.0	4.8	11.6	6.9	6.5	8.6	8.0	6.2	8.8	37.7	15.9	7.3	7.1	15.1	4.3	9.1	6.6	9.6	9.3	4.9	14.2	7.1	8.1	6.4	5.2	17.9	8.7	2.3	7.5	6.8	8.8	7.0	4.2	7.6	3.8	1.8	9.9	3.2	9.1	11.8	5.8	5.3	15.3	6.2	5.9	5.1	2.8	6.1	7.9	4.5	5.8	8.9	5.6	7.0	3.4	20.3	5.5	6.5	9.5	4.6	5.1	8.5	7.0	9.9	6.0	5.3	8.7	3.6	9.2	4.4	7.8	9.8	6.4	6.2	5.8	4.8	9.2	5.0	3.3	3.2	7.4	15.7	8.4	11.2	15.9	37.7	6.5	12.5	5.6	6.2	6.0	6.1	8.8	5.9	6.7	6.1	13.3	7.3	11.4	6.6	7.1	15.1	13.7	34.4	11.4	22.1	11.6	13.1	10.6	14.5	9.9	12.0	101.3	71.8	70.1	148.3	60.2	64.5	138.2	94.3	111.1	83.0	184.9	43.2	500.6	43.1	137.9	29.8	84.7	141.2	0.0	93.8	144.8	164.2	115.9	79.6	88.4	225.9	36.5	79.3	47.9	91.5	43.0	116.8	129.5	140.0	128.0	72.2	127.1	91.5	101.7	142.5	235.8	70.5	77.6	128.1	198.2	166.9	53.6	580.0	69.2	81.2	127.8
LRRC59	"FLJ21675, PRO1855"	ENSG00000108829	"Leucine rich repeat containing 59"	Q96AG4	17	50375059-50397553	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030827, HPA030829"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		5400000	"Endoplasmic reticulum"		"HPA030827: AB_10602704, HPA030829: AB_10670045"	"unprognostic (4.73e-2)"	"unprognostic (2.15e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (5.63e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (1.00e-5)"	"prognostic unfavorable (3.12e-6)"	"unprognostic (1.88e-3)"	"unprognostic (9.95e-2)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (2.77e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (1.90e-5)"	20.7	40.5	10.6	21.8	14.5	28.4	16.3	11.5	21.6	28.2	30.0	11.4	28.8	19.6	17.2	24.9	23.5	15.8	22.8	17.4	10.2	8.8	22.1	74.7	23.0	15.9	12.7	11.5	15.8	87.9	15.4	11.6	35.3	10.8	17.7	31.5	10.0	48.6	26.2	16.0	11.2	27.3	22.0	8.9	19.0	30.7	18.2	10.4	18.0	22.8	22.4	20.8	13.7	17.0	8.6	14.9	14.4	19.6	5.9	9.1	9.0	62.1	47.4	13.6	20.5	23.2	27.4	24.5	51.0	28.5	47.8	42.3	108.3	18.0	27.2	35.0	58.0	29.4	22.7	33.9	43.5	57.1	14.4	49.4	47.6	26.9	57.9	48.7	46.7	22.6	24.1	35.4	51.1	59.6	13.9	35.2	15.8	44.0	25.9	31.3	42.3	32.9	22.2	15.4	58.8	69.5	28.2	43.9	52.0	26.0	31.7	33.5	27.8	17.6	19.8	25.9	21.2	33.4	25.4	37.5	55.5	23.0	51.1	66.3	39.0	31.9	35.2	37.6	31.8	34.8	14.4	15.7	13.4	7.4	19.6	9.1	8.6	7.5	8.9	14.9	6.4	5.0	6.3	8.0	5.9	18.6	12.1	7.5	9.0	10.6	14.5	11.5	21.6	10.2	8.8	12.7	11.5	10.8	10.4	20.8	21.3	38.0	75.9	123.9	20.8	4.0	38.2	14.7	35.2	19.2	2.0	78.1	24.9	166.2	37.0	22.6	79.6	23.3	164.5	210.3	84.3	117.1	30.0	58.2	94.9	20.6	36.8	25.8	26.9	12.2	32.8	46.2	62.4	46.9	93.0	24.6	158.0	71.6	27.3	38.3	11.1	12.9	67.0	41.7	28.5	115.9	197.4	27.7	82.6	133.9
LRRN2	"FIGLER7, GAC1, LRANK1, LRRN5"	ENSG00000170382	"Leucine rich repeat neuronal 2"	O75325	1	204617170-204685733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 49.3"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 7.1;NTERA-2: 14.3;RPMI-8226: 22.2;SuSa: 8.2;T-47d: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029124	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029124: AB_10601545"	"unprognostic (2.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-3)"	4.9	6.6	11.8	3.7	16.5	2.4	3.3	9.7	20.3	1.9	7.9	5.3	1.0	1.9	3.9	0.8	2.4	10.2	6.1	6.0	11.7	12.8	7.3	0.7	2.5	2.9	6.3	13.8	3.3	1.4	19.1	9.7	1.3	8.1	1.6	7.5	12.2	2.8	3.7	2.2	0.7	3.3	9.9	3.1	6.3	1.4	3.8	6.1	3.2	2.8	0.0	1.3	2.1	1.5	0.4	0.1	1.7	0.3	0.7	0.8	0.2	0.0	3.3	2.7	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	7.1	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	1.1	0.0	14.3	0.0	0.1	0.2	0.0	22.2	0.0	0.1	1.9	0.3	4.4	0.1	0.0	8.2	7.9	0.0	0.0	0.0	3.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.2	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.1	0.2	0.7	0.7	0.0	0.1	0.8	0.2	11.8	16.5	9.7	15.7	11.7	12.8	6.3	13.8	8.1	6.1	0.0	0.0	0.0	0.5	0.3	4.6	1.0	0.0	0.0	0.0	1.8	2.0	0.1	0.0	2.7	0.0	0.7	1.7	0.0	0.8	0.1	1.1	0.3	0.0	0.0	5.3	49.3	10.9	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.9	3.3	0.3	0.0	2.7	0.9	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.7	0.3
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 31.3"	"Cell type enriched"	"Detected in many"	6	"granulocytes: 332.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 8.5;eosinophil: 31.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 31.3"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	9.0	6.7	3.5	2.8	3.5	8.6	4.6	1.7	5.0	6.9	5.0	9.4	5.4	3.6	8.7	10.4	4.2	13.0	15.7	11.3	3.9	3.1	6.2	2.3	28.3	8.0	6.8	4.2	5.8	2.4	2.0	3.2	2.9	4.3	5.6	1.9	3.3	7.4	11.6	2.7	3.5	5.7	4.5	6.3	6.7	5.0	3.3	3.9	0.8	5.3	5.6	3.2	3.6	3.9	0.1	4.5	31.3	0.3	2.2	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	5.3	0.0	0.2	0.2	0.3	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	8.5	0.2	31.3	0.5	0.3	1.7	0.1	1.2	0.8	4.5	0.1	0.2	0.5	0.1	2.2	0.0	0.2	0.1	0.3	3.5	3.5	1.7	5.0	3.9	3.1	6.8	4.2	4.3	3.9	0.0	5.6	2.2	7.5	8.9	0.2	0.0	12.7	4.0	3.4	14.0	0.0	6.9	1.7	4.1	0.3	11.3	0.4	0.0	2.1	1.5	4.7	3.1	332.3	0.8	33.8	0.0	2.9	53.4	8.9	0.0	15.3	23.5	1.7	1.0	1.6	0.0	2.1	0.0	44.6	40.2	0.3	0.0	0.9	0.0	0.7	6.0	2.5	5.0	2.6	5.0
LYPD3	C4.4A	ENSG00000124466	"LY6/PLAUR domain containing 3"	O95274	19	43460787-43465660	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 110.5;lymphoid tissue: 75.2;skin 1: 86.4;tongue: 70.6"	"Cell type enhanced"	"Detected in many"	25	"Basal keratinocytes: 448.4;Suprabasal keratinocytes: 2015.9;Syncytiotrophoblasts: 598.6;Urothelial cells: 616.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 235.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.5;granulocytes: 3.0;T-cells: 7.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.8;HaCaT: 30.1;MCF7: 33.6;RT4: 32.3;SK-BR-3: 48.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041529, HPA041797, HPA077859"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA		9700000	"Endoplasmic reticulum, Vesicles"		"HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: "	"unprognostic (1.07e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-3)"	0.3	0.4	0.3	0.4	0.3	0.8	5.8	0.3	0.3	28.0	0.3	0.3	0.3	0.0	2.1	0.7	110.5	0.5	0.3	0.3	0.3	0.0	0.4	0.3	0.3	0.3	0.3	0.3	0.8	0.3	0.0	0.3	7.4	0.3	1.4	0.0	0.5	21.7	0.3	0.6	86.4	0.4	0.8	0.3	0.3	0.1	0.3	0.3	1.9	0.3	70.6	75.2	4.1	48.3	0.2	3.5	3.0	0.4	0.1	7.9	1.9	11.2	0.1	0.0	0.2	0.1	0.0	4.7	0.4	1.2	0.4	0.5	0.1	12.8	0.0	0.5	0.3	1.7	30.1	0.0	1.3	0.2	0.0	0.1	0.2	1.5	0.2	0.1	0.0	0.2	0.5	11.4	0.0	0.1	0.5	0.0	0.9	0.0	0.0	0.0	33.6	0.2	0.0	0.0	7.2	2.5	0.1	0.0	0.0	0.3	32.3	0.0	0.1	0.1	48.4	0.5	1.5	5.3	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	1.6	0.2	4.2	1.6	3.5	0.0	7.9	6.7	3.0	0.1	0.0	0.4	1.2	1.9	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.6	0.5	55.8	448.4	0.6	0.5	5.1	0.0	1.2	14.0	0.0	74.6	1.7	1.6	0.0	2.2	0.3	0.0	0.2	59.2	26.8	34.6	5.7	0.0	12.7	3.2	0.0	0.0	0.0	0.0	0.6	2.7	140.0	1.0	1.0	3.2	2.8	0.0	0.4	0.6	0.2	0.0	18.6	0.0	0.9	2015.9	598.6	2.5	0.7	616.2
MANF	"ARMET, ARP"	ENSG00000145050	"Mesencephalic astrocyte derived neurotrophic factor"		3	51385047-51389397	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 383.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011175	Approved		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA			"Endoplasmic reticulum"		"HPA011175: AB_1845039"	"unprognostic (2.90e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (9.58e-6)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.10e-2)"	13.2	14.6	11.6	18.9	16.8	8.3	19.8	6.7	12.4	20.7	16.1	5.2	47.4	11.6	15.1	52.8	19.9	14.0	16.1	23.4	9.7	9.8	22.2	65.6	16.9	15.9	12.9	5.7	11.5	64.2	6.5	23.4	23.3	20.9	16.1	16.8	5.1	64.7	37.9	7.8	13.1	11.9	14.3	8.8	21.7	16.4	14.3	12.5	12.7	64.4	20.7	21.4	14.0	37.2	5.4	32.7	19.2	4.8	7.4	11.2	4.9	18.5	9.3	24.9	30.7	17.2	22.4	26.6	29.9	24.7	30.5	29.3	14.4	43.5	40.7	25.0	18.5	70.4	11.1	30.9	30.8	29.8	18.7	15.6	32.7	14.0	33.1	56.3	15.6	21.0	9.6	26.0	31.6	42.5	29.4	39.3	16.9	7.0	44.6	28.2	11.3	25.9	31.2	21.6	44.2	40.4	11.2	16.0	41.8	25.6	12.4	9.4	30.4	25.1	15.1	18.1	28.6	12.1	21.0	18.4	17.3	17.0	21.0	32.8	36.2	14.7	26.3	30.3	31.2	33.5	19.2	4.8	2.7	8.9	3.8	11.2	5.4	6.5	8.5	4.7	3.5	4.9	5.1	2.4	7.4	2.4	32.7	3.9	4.9	11.6	16.8	6.7	12.4	9.7	9.8	12.9	5.7	20.9	12.5	29.8	19.2	79.0	180.0	144.9	12.1	43.7	68.8	24.1	18.2	52.4	5.9	166.0	36.5	141.5	75.3	67.4	57.1	0.0	109.7	259.3	107.8	169.1	63.3	130.9	163.5	11.1	111.7	81.0	38.0	80.4	55.5	75.0	172.1	98.2	64.3	32.2	172.7	66.6	48.4	54.7	15.7	64.7	82.0	145.8	74.5	140.4	383.9	60.7	57.1	181.4
MARCH2	"HSPC240, MARCH-II, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.48e-4)"	"prognostic favorable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	37.7	12.4	30.7	13.5	28.3	17.5	23.9	8.6	39.1	9.8	29.8	20.7	9.7	11.2	12.5	39.0	19.3	10.0	11.4	38.9	23.5	21.9	11.0	17.9	18.2	15.0	30.8	19.8	8.2	10.0	10.5	11.3	13.9	20.2	16.0	10.3	12.7	13.4	21.8	46.9	12.7	11.7	28.5	27.8	18.9	13.3	8.6	13.3	8.4	21.3	14.1	10.0	20.4	9.7	3.6	26.5	20.4	14.6	3.7	7.3	10.1	5.6	7.2	3.2	15.1	19.9	6.5	5.5	6.1	7.5	4.9	5.1	3.5	2.6	2.2	18.0	13.1	6.5	4.0	4.2	8.6	3.8	11.1	9.9	17.0	3.3	7.8	10.8	2.5	25.7	7.8	9.9	4.7	4.2	7.1	19.2	9.0	2.4	12.5	3.8	10.7	3.4	8.1	6.8	6.8	17.4	5.4	1.0	5.6	11.3	6.7	1.6	9.1	0.4	6.6	11.5	11.6	5.0	5.4	19.3	6.9	4.2	22.8	5.1	11.2	13.3	2.5	11.2	5.1	5.2	20.4	10.0	15.4	5.7	14.6	5.9	3.6	5.9	4.6	6.7	3.5	4.0	5.4	12.5	3.7	12.8	26.5	7.3	10.1	30.7	28.3	8.6	39.1	23.5	21.9	30.8	19.8	20.2	13.3	3.0	10.9	4.5	0.0	6.6	10.7	38.1	7.6	2.7	3.4	19.2	2.0	6.6	33.2	0.0	8.1	27.0	13.6	23.3	0.0	9.3	10.5	0.0	12.7	24.6	57.4	22.3	11.6	47.9	48.6	36.4	8.6	19.4	23.6	0.0	5.5	17.5	0.0	7.4	11.0	43.4	7.7	12.9	20.6	5.4	8.5	11.3	4.8	18.1	4.6	0.0
MARCH6	"MARCH-VI, RNF176, TEB4"	ENSG00000145495	"Membrane associated ring-CH-type finger 6"	O60337	5	10353703-10440388	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040841, HPA063246"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA040841: AB_2677162, HPA063246: AB_2684970"	"unprognostic (3.31e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.50e-3)"	22.5	25.6	28.6	21.2	25.5	57.0	62.4	42.0	53.8	21.4	23.0	24.0	18.3	28.6	24.7	24.2	22.8	25.1	22.0	35.5	27.6	23.7	31.9	28.9	35.0	33.2	29.8	39.1	34.0	41.5	56.0	27.4	20.3	33.4	21.4	18.4	20.3	28.0	23.4	49.8	23.9	32.1	27.4	38.6	31.2	26.0	25.6	26.9	18.0	26.8	17.1	20.3	24.6	36.4	13.4	7.3	15.6	12.1	9.9	15.7	9.4	12.6	19.0	31.9	24.7	18.3	14.7	26.1	20.1	18.7	17.3	22.2	18.1	33.9	13.3	30.6	18.7	24.0	17.6	16.9	13.0	23.5	28.2	15.4	17.3	63.2	12.3	12.9	20.5	19.5	17.1	14.4	17.3	19.0	17.9	16.0	14.4	20.7	30.1	15.7	14.4	11.1	15.9	11.6	10.2	13.4	17.3	13.3	19.2	13.5	24.6	13.7	19.9	37.3	20.4	13.1	15.4	17.0	11.1	15.4	21.0	20.5	10.3	14.9	21.1	30.3	19.0	15.5	14.3	14.9	15.6	8.5	13.6	13.5	9.6	15.4	13.4	13.4	13.4	7.3	11.5	15.7	14.6	13.7	9.9	12.1	5.6	11.7	9.4	28.6	25.5	42.0	53.8	27.6	23.7	29.8	39.1	33.4	26.9	50.6	44.3	66.5	0.0	124.9	104.6	89.0	53.5	62.9	56.9	68.0	62.8	47.1	18.3	0.0	9.4	58.6	66.9	93.5	0.0	24.4	54.5	0.0	48.5	71.6	32.5	128.7	95.5	58.9	54.8	10.0	64.5	39.1	89.4	0.0	73.5	52.7	0.0	56.1	72.2	52.5	79.3	77.6	80.4	84.4	67.3	119.4	68.0	58.0	58.3	0.0
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857362-113863471	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 652.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 10.1;neutrophil: 15.0"	"Group enriched"	"Detected in many"	10	"B-cells: 3.9;granulocytes: 15.0;monocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"AF22: 74.7;TIME: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		17000000	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133"	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	13.0	5.0	11.2	17.0	12.9	26.9	16.0	18.5	43.3	12.1	23.2	17.9	0.9	11.6	9.7	4.0	17.0	8.4	10.9	9.7	10.5		5.3	8.7	12.9	13.3	8.8	15.9	12.6	11.2	1.2	6.5	39.5	13.8	14.1	21.6	11.4	8.2	5.6	5.0	9.5	12.9	9.1	42.3	20.9	18.8	5.2	8.5	30.0	4.9	7.9	13.6	23.5	7.8	3.9	0.9	15.0	10.1	0.0	0.0	0.4	6.8	4.0	74.7	4.0	25.3	16.5	0.4	22.2	31.2	15.7	26.2	7.2	9.8	0.0	4.7	40.9	12.4	21.3	12.3	6.4	20.5	0.0	7.3	0.0	4.3	9.4	16.9	1.8	0.1	17.0	12.7	15.1	14.4	43.1	44.2	0.0	0.8	19.7	22.2	0.0	0.2	0.0	9.6	7.7	5.3	0.0	7.5	0.7	4.9	13.2	10.4	30.3	14.2	7.2	15.2	18.4	0.3	2.0	58.7	14.6	0.1	23.9	37.8	53.3	3.8	2.0	11.2	9.9	27.9	0.0	3.4	0.0	0.0	10.1	0.0	3.9	0.0	0.0	0.9	1.6	0.0	0.0	15.0	0.0	5.5	0.0	0.0	0.4											8.9	19.9	84.3	477.4	447.8	131.4	10.5	56.0	99.0	62.6	36.6	27.5	5.0	31.5	120.8	46.4	214.9	254.5	0.0	195.2	5.5	224.2	281.9	2.3	4.3	324.8	79.4	322.8	234.5	223.1	24.8	111.7	249.4	259.8	652.8	331.8	330.7	220.9	241.8	62.9	3.4	33.7	38.8	128.7	20.0	15.6	558.1	24.6	7.5	259.9	481.3
MATN3	"EDM5, HOA"	ENSG00000132031	"Matrilin 3"	O15232	2	19992111-20012694	"Disease related genes, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 19.5;placenta: 16.6"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 35.7;Sertoli cells: 25.8;Smooth muscle cells: 11.4"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 13.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"Hep G2: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051250			Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Endoplasmic reticulum, Golgi apparatus"		"HPA051250: AB_2681406"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.51e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.15e-2)"	2.4	1.3	6.6	1.0	5.1	0.3	3.4	1.8	7.9	4.1	1.0	2.4	2.6	0.9	2.7	1.8	1.4	2.6	3.4	0.9	6.2	4.9	4.1	0.4	19.5	0.7	8.6	3.7	1.1	1.3	0.4	0.3	16.6	7.4	2.7	1.0	1.9	0.8	7.2	0.5	0.9	0.8	2.8	7.9	0.7	2.8	1.6	6.0	0.0	1.7	0.0	0.7	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	1.9	6.5	0.0	1.9	4.1	0.4	0.8	0.4	2.6	3.4	1.8	1.1	0.0	0.3	0.6	2.5	0.4	0.1	5.0	3.8	0.0	0.1	0.0	0.4	56.1	0.4	0.0	0.0	8.8	0.3	2.9	0.7	1.8	3.5	0.0	0.0	0.0	5.5	0.9	0.0	0.0	2.0	0.0	0.9	0.0	0.0	0.0	7.9	1.7	0.0	0.8	4.2	0.7	2.4	11.6	7.7	0.0	1.9	3.9	4.8	0.1	0.4	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	5.1	1.8	7.9	6.2	4.9	8.6	3.7	7.4	6.0	35.7	2.1	0.0	0.3	0.2	0.0	0.2	0.0	2.7	2.3	1.8	0.0	0.0	0.0	0.2	0.4	1.4	0.0	0.0	0.2	1.6	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.3	0.0	0.0	0.0	0.7	0.0	4.2	0.3	0.0	25.8	11.4	0.0	1.5	0.1	0.1	0.0	0.0	0.1
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898479-112029561	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Ito cells: 36.8;Kupffer cells: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 10.3;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in single"	48	"monocytes: 10.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;Hep G2: 22.1;HUVEC TERT2: 22.0;RT4: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		NA	NA		29000000	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: AB_2686759"	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	55.1	13.1	12.5	17.8	1.9	31.8	6.2	13.8	10.8	13.8	6.8	27.7	11.5	11.3	25.4	8.4	12.8	11.7	7.1	16.5	6.3	14.2	18.9	12.7	30.3	8.1	10.1	12.9	9.0	23.9	14.3	18.4	18.6	14.1	7.9	20.4	6.8	24.9	6.4	6.4	12.8	13.6	12.2	38.4	12.3	17.3	9.8	1.7	9.9	2.0	8.4	14.1	26.6	0.0	0.2	0.1	10.3	0.0	0.0	0.3	0.5	0.9	4.4	10.0	0.2	0.1	7.1	0.0	0.1	0.5	1.0	21.3	1.3	0.1	4.7	0.0	4.6	0.1	5.8	0.0	0.8	0.8	3.1	3.8	0.0	22.1	0.1	0.1	0.9	0.2	0.0	5.1	0.3	2.3	22.0	0.8	1.2	2.0	1.7	1.0	0.0	5.0	2.7	0.6	3.4	1.4	1.2	1.7	11.2	13.1	0.1	4.2	0.1	0.3	1.7	1.6	0.0	0.2	3.3	0.6	2.0	0.0	0.0	1.7	2.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	6.4	0.1	0.0	0.3	13.1	17.8	6.2	13.8	16.5	6.3	8.1	10.1	18.6	9.8	3.0	20.1	0.8	2.9	1.4	0.6	2.1	5.1	1.4	11.4	0.0	2.0	2.6	1.7	0.8	1.6	7.1	1.6	0.0	0.8	1.0	4.1	2.0	0.0	8.9	23.6	0.0	0.0	36.8	92.6	1.5	4.6	11.0	0.0	0.0	2.3	8.6	1.7	1.9	6.3	1.9	9.2	6.5	11.3	0.5	1.5	1.1	15.8	0.8	1.8	1.4
MESD	"BOCA, KIAA0081, MESDC2"	ENSG00000117899	"Mesoderm development LRP chaperone"	Q14696	15	80946289-80989878	"Predicted intracellular proteins"	"Wnt signaling pathway"	Chaperone	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 294.4;Extravillous trophoblasts: 237.4;monocytes: 150.5;Syncytiotrophoblasts: 364.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039414, HPA041721"	Approved		Supported	"Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		690000	"Endoplasmic reticulum"	"Nuclear bodies, Cytosol"	"HPA039414: AB_10674981, HPA041721: AB_2756310"	"unprognostic (9.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.02e-2)"	"prognostic favorable (2.31e-4)"	"unprognostic (4.93e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.09e-3)"	"unprognostic (4.04e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.88e-1)"	15.5	19.5	15.5	19.7	17.6	5.7	23.5	15.6	14.4	21.1	15.8	15.3	31.3	14.0	14.5	48.3	17.1	14.3	16.2	15.5	14.0	17.6	16.4	28.2	17.6	23.8	20.9	13.4	22.2	34.7	12.8	23.4	32.1	17.0	20.8	16.4	15.0	20.4	37.6	14.2	12.3	13.7	13.9	22.4	16.2	16.5	13.6	17.8	13.0	37.1	12.7	14.3	13.7	17.1	19.0	25.6	17.7	15.0	24.7	25.1	16.0	12.3	18.7	16.7	10.7	28.3	16.1	25.9	18.9	22.6	20.7	25.3	16.7	34.7	10.4	21.9	15.2	22.0	20.8	25.8	19.4	19.7	22.9	16.5	13.1	16.2	28.4	21.7	15.5	14.5	16.7	22.5	17.4	20.8	17.4	19.6	12.8	15.7	26.7	17.5	15.5	9.5	13.0	20.1	18.3	7.7	14.7	10.3	27.7	17.1	17.0	14.5	8.5	20.7	14.1	30.9	31.7	16.3	12.4	15.2	20.0	19.0	10.7	24.2	16.9	21.5	14.3	18.8	27.8	20.8	17.7	15.0	10.3	21.6	13.8	25.1	19.0	22.8	21.1	15.3	18.1	21.5	21.6	4.5	24.7	11.6	25.6	22.8	16.0	15.5	17.6	15.6	14.4	14.0	17.6	20.9	13.4	17.0	17.8	74.5	55.2	0.0	0.0	0.0	0.0	0.0	0.0	78.9	51.2	55.8	0.0	294.4	11.6	87.8	0.0	0.0	0.0	0.0	97.3	237.4	0.0	0.0	33.7	0.0	108.4	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	150.5	0.0	0.0	77.9	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	364.7	0.0	0.0	0.0
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387240	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 593.8;Peritubular cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 2.3;intermediate monocyte: 4.0;non-classical monocyte: 4.2"	"Group enriched"	"Detected in many"	15	"granulocytes: 2.3;monocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 60.2;ASC TERT1: 91.9;fHDF/TERT166: 41.1;HHSteC: 42.1;HSkMC: 63.7;MOLT-4: 52.6;SH-SY5Y: 52.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		140000000	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	41.5	10.0	1.3	37.3	4.1	0.0	34.9	1.3	3.7	62.5	44.8	5.1	18.1	12.1	64.3	58.7	64.2	32.2	150.2	46.9	1.8	1.3	15.9	12.0	106.1	10.7	2.4	5.8	57.6	8.5	0.0	15.8	43.3	6.8	102.4	17.2	102.5	16.3	16.6	18.7	25.9	43.8	88.9	3.2	7.6	31.4	26.2	1.3	8.4	20.3	55.3	39.0	79.2	73.7	0.0	0.2	2.3	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	60.2	91.9	0.1	6.5	23.5	0.6	0.4	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	42.1	2.0	0.0	63.7	0.0	0.3	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	52.6	4.8	1.0	0.0	0.0	3.7	3.7	0.0	0.0	0.0	5.3	52.5	0.0	0.0	0.0	0.3	0.0	11.8	0.0	7.6	0.5	0.3	0.0	0.0	0.0	0.0	7.3	2.2	0.0	0.0	0.3	2.3	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.3	4.1	1.3	3.7	1.8	1.3	2.4	5.8	6.8	1.3	3.0	15.5	0.0	0.5	42.2	0.7	9.5	0.0	5.3	5.7	1.8	0.0	5.9	0.0	0.0	0.3	4.4	0.0	0.0	0.0	3.1	593.8	1.2	1.1	0.0	8.2	0.0	0.0	19.0	0.0	2.0	72.5	2.4	64.1	0.0	0.0	71.0	0.1	0.0	225.6	0.0	2.9	19.4	95.8	0.2	0.5	35.9	16.2	0.0	0.0	0.4
MGRN1	"KIAA0544, RNF156"	ENSG00000102858	"Mahogunin ring finger 1"	O60291	16	4616493-4690974	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 16.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 16.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007653, HPA008033"	Approved		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA007653: AB_1846304, HPA008033: "	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.04e-2)"	18.7	23.1	22.9	24.0	24.3	29.7	19.9	43.1	37.6	16.3	16.6	28.7	16.8	28.9	23.7	13.8	14.7	20.9	20.2	20.7	24.3	18.6	15.9	30.4	21.6	22.2	27.9	21.5	21.3	34.9	19.7	21.5	18.8	18.6	19.0	11.6	20.7	23.8	22.9	29.9	13.5	28.6	20.0	17.2	26.2	25.2	11.5	24.5	12.9	19.7	10.4	11.0	18.7	14.2	1.7	4.1	16.6	3.9	1.4	3.3	2.9	5.3	25.4	13.2	13.4	7.9	7.7	17.9	11.4	8.1	9.6	8.2	16.7	12.8	15.7	14.8	13.8	7.2	8.5	10.4	9.4	2.9	21.8	11.6	8.6	17.7	23.0	14.5	12.4	21.4	14.3	6.1	13.4	5.7	6.9	9.2	10.4	12.5	11.5	6.6	23.3	12.9	16.6	19.4	7.5	11.1	23.7	6.9	21.1	8.5	15.6	21.1	17.5	19.0	20.5	11.4	6.6	12.4	12.3	16.2	18.0	10.0	50.5	9.8	18.3	14.2	10.6	7.6	12.5	12.9	4.5	3.5	3.4	2.7	3.9	2.5	1.4	1.5	2.3	2.3	1.7	3.3	2.0	16.6	1.4	2.4	4.1	1.7	2.9	22.9	24.3	43.1	37.6	24.3	18.6	27.9	21.5	18.6	24.5	23.8	30.6	16.0	25.4	8.1	26.6	8.9	20.4	5.3	6.8	17.4	41.2	19.1	5.0	16.7	16.3	14.6	24.5	0.0	19.7	14.0	16.1	20.3	13.9	27.7	25.8	23.8	35.5	14.1	21.9	20.6	24.7	20.4	20.3	31.5	18.9	21.5	25.2	18.6	23.3	11.0	28.4	0.0	13.7	9.6	11.8	14.3	28.6	21.3	18.7	22.0
MGST1	"GST12, MGST-I"	ENSG00000008394	"Microsomal glutathione S-transferase 1"	P10620	12	16347142-16609259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 382.8"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 3471.1;Proximal tubular cells: 978.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 46.1;myeloid DC: 34.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 34.1;monocytes: 46.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 342.0;ASC TERT1: 132.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044840	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			Mitochondria	"Endoplasmic reticulum"	"HPA044840: AB_10965550"	"unprognostic (4.57e-2)"	"unprognostic (4.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.92e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (9.90e-2)"	"unprognostic (4.61e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (4.19e-1)"	127.9	106.0	18.5	10.8	32.6	9.5	116.8	10.3	14.0	9.3	39.7	9.6	2.6	17.0	4.1	6.4	19.5	6.9	26.6	12.1	19.6	13.9	56.9	382.8	42.0	2.7	18.9	8.9	3.1	12.4	0.8	5.3	8.7	18.4	23.5	28.3	3.0	14.7	8.2	8.9	7.0	15.5	11.5	20.1	0.9	10.3	6.8	12.0	0.0	69.9	13.9	3.6	32.6	37.2	0.2	34.1	2.7	46.1	0.0	0.2	13.0	0.0	30.6	7.3	8.5	342.0	132.0	0.0	25.1	25.7	13.7	21.3	11.6	51.3	0.0	3.0	32.1	43.1	0.1	19.0	40.2	12.4	0.0	2.5	10.4	17.0	40.7	79.9	20.2	0.0	85.6	44.8	41.8	44.1	34.0	24.0	0.0	7.3	0.0	29.4	6.2	0.0	8.1	60.9	0.0	24.3	0.0	4.3	13.8	30.8	60.5	1.3	1.1	39.2	25.2	1.0	41.3	27.1	11.4	15.1	14.1	1.9	27.7	32.3	0.0	0.0	0.0	46.4	32.3	0.4	2.7	46.1	0.4	0.0	7.0	0.1	0.2	0.0	0.0	34.1	0.0	0.0	0.0	1.5	0.0	1.5	9.6	0.2	13.0	18.5	32.6	10.3	14.0	19.6	13.9	18.9	8.9	18.4	12.0	247.1	493.0	46.4	120.5	22.8	0.0	5.3	738.8	293.1	502.7	68.0	0.0	2.3	154.2	22.7	20.8	14.2	262.1	46.7	371.4	189.8	162.1	379.2	32.4	3471.1	168.6	0.0	43.8	78.5	223.7	10.9	30.8	51.0	37.1	187.6	224.9	0.0	374.3	135.3	106.4	978.0	1.0	0.0	12.2	0.5	2.2	15.4	6.6	37.4	362.2	564.6
MMP19	"MMP18, RASI-1"	ENSG00000123342	"Matrix metallopeptidase 19"	Q99542	12	55835433-55842966	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Angiogenesis, Collagen degradation, Differentiation"	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.7"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 42.0;Hofbauer cells: 31.2;Kupffer cells: 30.5;Macrophages: 48.2;monocytes: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"classical monocyte: 3.2;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.0;monocytes: 3.2"	"Cell line enriched"	"Detected in many"	6	"BEWO: 57.2"	"Region enriched"	"Detected in single"	6	"olfactory region: 8.8"	"Low region specificity"	"Detected in all"			HPA070804			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		800000	"Endoplasmic reticulum, Vesicles"		"HPA070804: AB_2686315"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.77e-3)"	"unprognostic (2.01e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (8.56e-9)"	"unprognostic (5.06e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.73e-2)"	"unprognostic (4.00e-2)"	60.7	1.9	0.2	10.9	0.7	0.0	9.9	0.2	0.5	7.6	3.9	0.4	1.4	0.8	12.7	6.0	3.6	11.8	30.3	4.7	0.6	0.1	4.1	3.0	14.0	15.5	0.5	0.2	7.4	8.1	0.0	0.5	24.5	1.0	2.9	2.8	3.1	2.0	3.5	2.1	2.7	4.1	7.7	0.8	27.4	5.0	2.9	0.2	2.7	3.3	1.8	7.1	5.9	3.5	0.0	1.0	0.1	3.2	0.0	0.0	0.6	0.8	0.0	0.0	0.0	6.3	8.1	57.2	6.0	7.1	2.5	2.9	0.3	0.2	0.0	0.0	8.4	0.1	0.0	0.0	1.8	3.4	0.3	0.0	0.0	0.0	0.1	5.2	0.0	0.2	8.4	0.2	1.5	1.6	3.0	0.4	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	1.1	2.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	9.7	1.5	3.3	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.7	0.2	0.5	0.6	0.1	0.5	0.2	1.0	0.2	0.0	5.8	0.9	0.2	6.4	0.5	0.6	5.1	2.7	5.7	0.0	3.9	14.4	0.0	0.3	0.4	2.1	0.0	0.0	0.4	42.0	24.0	0.4	2.3	0.5	31.2	0.0	0.0	4.9	30.5	0.4	5.5	48.2	11.8	38.7	0.0	0.3	0.1	0.0	4.9	0.0	1.7	0.0	9.6	0.0	0.2	3.8	15.7	0.0	0.0	0.1
MMRN1	"ECM, EMILIN4, GPIa*, MMRN"	ENSG00000138722	"Multimerin 1"	Q13201	4	89879532-89954629	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endothelial cells: 46.9;Ito cells: 114.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"NK-cell: 9.3;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.4;NK-cells: 9.3"	"Cell line enriched"	"Detected in some"	13	"HUVEC TERT2: 168.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035769	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		300000000	"Endoplasmic reticulum"		"HPA035769: AB_10696511"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.23e-2)"	13.9	1.9	1.4	5.3	1.4	0.5	14.8	0.7	1.3	22.8	14.9	0.1	9.0	2.6	9.2	12.2	17.4	18.1	11.5	4.9	1.6	1.3	3.3	9.5	22.4	30.7	2.6	0.0	10.2	2.2	0.1	1.3	38.1	2.7	10.0	8.1	3.7	3.3	2.4	6.8	6.5	10.1	14.2	3.4	1.6	5.3	16.7	2.1	2.3	43.1	7.0	3.7	19.6	30.4	0.8	3.4	0.1	0.0	9.3	0.3	1.7	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.3	0.0	0.1	9.3	0.0	3.4	0.3	1.7	1.4	1.4	0.7	1.3	1.6	1.3	2.6	0.0	2.7	2.1	0.0	11.8	6.1	0.1	3.8	0.0	2.0	0.0	2.7	1.2	0.0	0.0	0.0	1.7	0.0	11.8	46.9	0.0	0.0	0.0	0.0	1.5	0.1	2.3	0.8	0.4	0.0	0.0	114.2	6.3	3.2	0.3	2.5	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	1.4	1.7	0.0	4.0	0.0	0.0	0.0	0.1
MOGS	"CWH41, DER7, GCS1"	ENSG00000115275	"Mannosyl-oligosaccharide glucosidase"	Q13724	2	74461057-74465410	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Late spermatids: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011322, HPA011969"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		88000000	"Endoplasmic reticulum"		"HPA011322: AB_2668483, HPA011969: AB_1849579"	"unprognostic (5.66e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.34e-6)"	"unprognostic (1.48e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.36e-1)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	15.8	12.8	8.7	15.2	10.6	8.5	13.1	11.3	12.1	13.9	19.4	10.8	24.9	36.5	14.2	15.8	15.5	13.4	16.4	11.2	7.7	6.1	14.8	40.5	17.2	15.6	9.2	7.9	14.2	30.6	20.4	15.7	35.8	8.3	15.9	11.2	11.7	24.5	25.3	14.1	17.4	35.8	9.8	7.1	22.4	22.3	11.9	8.1	17.6	18.9	11.4	19.5	14.1	12.9	3.9	3.4	2.3	4.4	12.7	5.1	2.5	22.2	19.8	13.1	12.6	27.1	19.2	40.3	18.2	26.5	27.7	26.7	36.2	23.8	24.1	16.3	18.4	20.8	22.4	19.8	20.6	17.2	20.8	19.2	11.3	12.8	27.7	22.4	26.4	22.7	11.2	33.0	19.6	19.2	30.9	31.0	14.3	19.6	23.4	12.2	27.7	14.3	20.3	17.3	28.2	11.0	16.4	29.3	31.2	15.1	13.8	10.8	14.2	8.7	36.3	23.7	13.0	17.5	14.2	22.1	12.8	22.3	18.5	24.1	36.2	14.9	10.7	20.1	21.6	17.3	2.3	4.0	1.1	5.0	2.5	5.1	2.5	4.2	4.5	3.4	3.9	3.7	2.4	0.7	12.7	4.4	3.2	3.8	2.5	8.7	10.6	11.3	12.1	7.7	6.1	9.2	7.9	8.3	8.1	6.0	15.7	9.0	17.4	14.1	14.2	5.8	15.3	9.4	12.5	22.7	17.7	32.9	5.0	19.7	52.1	10.9	21.0	23.3	22.8	34.8	8.7	19.5	4.6	22.1	17.5	6.4	13.4	17.8	7.9	186.6	14.1	16.0	10.1	27.1	24.4	8.3	19.0	20.3	6.7	8.4	12.7	12.9	7.6	8.6	3.2	15.2	43.5	14.0	17.9	17.3
MOK	"RAGE, RAGE1, STK30"	ENSG00000080823	"MOK protein kinase"	Q9UQ07	14	102224500-102305200	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 45.0"	"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 214.2;Cone photoreceptor cells: 174.7;Early spermatids: 171.0;Rod photoreceptor cells: 441.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 28.6;hTEC/SVTERT24-B: 72.8;NB-4: 90.6;U-138 MG: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA027292			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA027292: AB_10600989"	"unprognostic (8.16e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.49e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.48e-1)"	5.9	6.8	12.9	2.7	17.3	3.7	7.8	9.7	15.9	7.6	3.6	8.7	6.2	4.7	7.6	10.2	3.9	26.4	6.4	8.3	13.5	10.2	7.7	3.6	6.1	2.5	6.0	13.7	12.4	8.6	9.4	22.1	3.6	16.6	5.1	3.0	15.2	6.1	5.4	1.9	8.6	4.1	5.9	6.2	3.8	11.7	45.0	6.2	0.4	11.7	2.3	2.2	6.2	3.9	0.7	3.9	0.9	1.1	10.6	2.4	1.3	3.4	3.0	0.4	1.7	0.7	2.5	0.7	7.0	2.0	10.1	12.2	0.2	8.4	2.6	0.5	1.3	2.2	0.7	0.6	3.6	28.6	2.9	2.6	0.6	0.4	2.3	3.1	0.3	3.4	2.1	0.9	72.8	6.7	7.9	0.3	0.5	0.6	0.1	6.6	2.3	0.2	90.6	0.1	1.5	7.4	0.4	0.2	0.0	4.1	0.1	1.1	0.7	1.2	0.4	19.6	0.1	2.1	0.2	0.2	38.5	1.9	1.4	2.2	0.2	0.4	0.2	7.7	0.2	17.4	0.0	1.1	0.0	0.7	0.7	1.2	0.0	0.5	1.9	3.9	0.7	1.1	2.4	0.9	10.6	0.1	0.0	0.0	1.3	12.9	17.3	9.7	15.9	13.5	10.2	6.0	13.7	16.6	6.2	17.9	17.4	0.5	6.5	9.5	36.2	12.2	10.2	214.2	43.3	12.2	174.7	1.0	5.0	7.0	171.0	6.7	3.8	0.0	14.2	2.1	7.6	3.6	3.5	1.7	2.0	15.9	4.6	7.4	1.8	130.3	28.1	4.2	75.9	0.0	2.0	58.0	5.6	0.0	15.2	8.1	441.5	25.8	12.1	81.9	27.2	5.1	1.0	6.7	3.8	3.0
MOSPD2	MGC26706	ENSG00000130150	"Motile sperm domain containing 2"	Q8NHP6	X	14873441-14922327	"Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 30.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 30.2;monocytes: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003334	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003334: AB_2146004"	"unprognostic (2.74e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (1.51e-1)"	"unprognostic (7.24e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.96e-2)"	11.2	7.1	11.9	10.4	20.8	12.4	8.5	8.0	18.0	11.3	6.2	24.6	8.5	7.4	9.1	9.9	11.9	6.5	10.9	5.9	16.7	11.1	8.6	8.3	12.2	11.1	33.0	13.8	10.4	7.8	6.6	11.5	14.1	33.9	7.1	8.1	4.9	18.5	6.4	3.7	21.4	7.3	8.0	40.4	12.0	7.3	5.6	27.0	7.8	13.1	6.2	9.2	7.8	10.6	2.3	2.7	30.2	8.4	4.3	2.3	2.7	5.5	7.4	5.6	3.0	18.9	11.9	6.0	12.6	11.9	9.0	10.9	3.7	6.8	7.0	3.5	21.1	14.3	8.9	6.9	5.3	12.0	5.3	6.3	2.4	7.1	3.4	11.7	4.6	7.0	10.8	7.6	8.0	10.8	9.0	8.0	7.7	3.2	10.1	8.6	2.4	4.6	3.8	3.8	4.9	6.7	4.4	7.4	5.9	7.4	3.7	1.8	4.2	9.7	4.5	20.5	22.7	3.9	6.8	8.0	8.6	3.6	29.0	4.9	6.0	5.6	4.7	11.2	3.8	11.7	7.8	8.3	3.9	2.0	7.9	2.1	1.2	1.8	1.2	2.7	2.3	2.0	2.3	30.2	4.3	8.4	1.1	1.9	2.7	11.9	20.8	8.0	18.0	16.7	11.1	33.0	13.8	33.9	27.0	20.8	15.6	11.3	5.6	7.6	6.2	5.7	5.1	17.4	13.6	21.0	5.9	8.8	8.3	5.5	4.4	12.3	5.9	0.0	5.4	7.5	12.6	7.4	7.0	6.8	19.6	6.4	12.1	22.1	28.4	12.1	9.8	26.2	10.1	23.4	7.7	6.8	5.9	5.8	14.2	9.1	4.3	12.9	7.4	3.4	8.3	11.2	19.7	6.9	5.9	5.8
MPDU1	"CDGIf, Lec35, PQLC5, SL15"	ENSG00000129255	"Mannose-P-dolichol utilization defect 1"	O75352	17	7583529-7592789	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Transport		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014845	Uncertain		Supported	"Endoplasmic reticulum,Mitochondria"		NA	NA			"Endoplasmic reticulum"	Mitochondria	"HPA014845: AB_1854072"	"unprognostic (1.96e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.93e-1)"	15.4	24.6	12.6	10.3	16.5	16.6	16.7	9.1	26.2	16.0	27.3	22.8	4.6	18.5	8.2	15.3	20.5	14.2	16.4	9.1	11.6	10.3	36.0	80.1	15.4	12.3	12.9	8.4	10.8	24.3	21.0	9.3	27.4	15.7	15.1	30.0	17.3	17.2	9.6	11.0	14.7	39.0	11.8	13.3	23.8	20.3	9.1	10.9	17.6	21.4	12.5	17.5	15.5	11.3	7.5	19.7	5.5	26.8	6.4	10.0	8.7	12.5	26.3	19.2	12.6	24.3	22.4	11.6	20.8	30.6	39.5	29.0	13.7	21.2	7.5	15.1	36.0	17.0	24.4	29.1	35.7	33.7	15.6	26.6	13.6	17.4	23.4	30.4	11.3	21.2	22.8	29.5	36.8	21.8	18.3	29.8	21.0	22.2	9.7	42.7	18.0	7.4	7.0	20.7	29.3	12.5	17.2	14.8	12.7	39.6	12.3	12.1	22.0	27.1	18.9	7.2	17.9	22.1	9.2	20.0	16.3	8.4	9.5	25.9	4.9	9.0	6.2	23.3	14.7	23.2	5.5	16.2	4.8	6.7	26.8	5.5	7.5	6.5	9.0	19.7	7.5	6.7	7.6	2.6	6.4	24.2	18.5	10.0	8.7	12.6	16.5	9.1	26.2	11.6	10.3	12.9	8.4	15.7	10.9	8.9	26.0	42.4	30.9	9.5	15.5	4.3	40.8	17.4	12.5	22.7	11.8	99.2	29.9	56.7	2.3	16.3	81.1	0.0	66.5	77.5	25.4	35.1	13.9	42.4	70.3	15.9	35.7	27.0	31.6	3.6	15.8	35.1	23.6	39.7	56.4	28.4	60.1	66.6	6.0	39.4	20.1	25.8	11.3	19.7	30.4	11.0	131.8	21.8	53.6	36.1
MPIG6B	"C6orf25, G6b, G6b-B, NG31"	ENSG00000204420	"Megakaryocyte and platelet inhibitory receptor G6b"	O95866	6	31718594-31726714	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.2"	"Cell type enriched"	"Detected in single"	30	"granulocytes: 9.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NK-cell: 3.0;plasmacytoid DC: 1.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.8;NK-cells: 3.0"	"Cell line enriched"	"Detected in single"	17	"HEL: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054404, HPA073017"			Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		7400000	"Golgi apparatus"	"Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol"	"HPA054404: , HPA073017: AB_2686566"	"unprognostic (1.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.71e-2)"	0.8	0.2	0.0	1.2	0.5	5.3	0.7	0.1	0.4	1.0	0.9	0.0	0.0	0.9	1.0	0.8	2.0	0.7	1.5	7.4	0.2	0.0	0.4	0.5	7.6	2.8	1.0	0.0	2.7	0.2	0.2	0.2	1.4	0.7	0.9	0.2	1.1	1.8	0.3	1.2	10.5	0.8	1.9	0.6	33.2	0.4	2.7	0.1	1.2	1.0	1.4	0.8	1.6	1.6	0.2	1.8	0.5	0.1	3.0	0.1	5.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.5	3.0	0.1	1.8	0.0	5.7	0.0	0.5	0.1	0.4	0.2	0.0	1.0	0.0	0.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MRAP	"B27, C21orf61, FALP"	ENSG00000170262	"Melanocortin 2 receptor accessory protein"	Q8TCY5	21	32291813-32314784	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"adipose tissue: 28.3;adrenal gland: 52.7;breast: 68.6"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 41.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"basal ganglia: 2.6"	"Cell type enhanced"	"Detected in many"		"NK-cell: 5.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Hep G2: 4.7;HSkMC: 5.4"									"HPA011024, HPA011093"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"HPA011024: AB_10599292, HPA011093: AB_10600889"	"unprognostic (1.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-1)"		"unprognostic (1.11e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.30e-6)"	"unprognostic (3.32e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.76e-2)"	28.3	52.7	0.0	1.6	2.6	0.0	68.6	0.3	0.1	0.0	3.0	0.7	0.0	0.1	0.1	0.2	0.0	0.0	0.4	1.6	0.0	0.0	0.1	0.6	0.2	1.8	0.2	0.1	0.8	0.1	0.0	0.0	1.1	0.3	0.1	0.1	0.2	1.7	0.0	0.9	0.2	1.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.1	0.6	4.3	1.8	1.5	0.0	0.5	5.5	1.8	0.1	0.0	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.9	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.9	0.5	0.7	1.8	0.7	1.2	0.5	1.4	0.8	1.6	0.0	5.5	0.3	1.5	1.8	0.1	0.0	2.6	0.3	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.3	0.1	41.3	0.0	0.0	0.0	4.6	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"intestine: 64.7;lymphoid tissue: 28.6"	"Group enriched"	"Detected in some"	6	"Enterocytes: 108.9;Paneth cells: 59.6"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;LHCN-M2: 2.2;NTERA-2: 3.1;RH-30: 4.3;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoli, Endoplasmic reticulum, Golgi apparatus"	"HPA048616: , HPA057657: AB_2683491"			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.1	0.0	0.1	28.6	0.1	0.0	0.1	0.1	0.1	0.1	57.7	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	64.7	0.1	0.1	0.1	0.1	0.0	0.2	1.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.1	0.0	0.0	0.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	1.8	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	108.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	59.6	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	13.2	0.0
MSH5	G7	ENSG00000204410	"MutS homolog 5"	O43196	6	31739948-31762834	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Meiosis"	DNA-binding	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	15	"Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 6.9;Spermatogonia: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"basophil: 9.3"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 9.3"	"Low cell line specificity"	"Detected in many"											HPA062688			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA062688: AB_2684835"	"unprognostic (3.21e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.51e-1)"	"unprognostic (9.20e-4)"	"unprognostic (7.67e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.59e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.19e-5)"	"unprognostic (3.75e-2)"	"unprognostic (8.83e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.34e-4)"	3.6	2.7	3.2	8.0	4.4	6.8	4.1	1.6	4.4	3.9	5.8	6.9	9.3	3.0	9.8	8.5	4.7	5.8	15.2	2.0	3.2	2.1	10.5	4.7	4.3	5.7	4.0	3.6	6.9	4.0	1.6	6.5	3.0	4.1	7.9	5.3	12.4	4.7	9.2	2.3	12.3	5.2	6.0	5.7	7.6	6.8	15.9	3.8	12.0	4.3	2.7	10.6	3.6	4.0	1.0	0.5	9.3	0.9	0.1	0.8	0.0	2.0	2.0	2.3	4.7	0.8	0.8	0.7	0.6	0.2	0.8	0.3	1.2	2.6	2.5	0.7	0.6	0.7	2.9	0.0	1.2	0.3	0.4	1.1	2.4	0.6	1.4	0.3	1.9	2.0	0.8	0.5	1.9	2.4	1.0	0.9	3.7	4.9	6.1	0.7	2.6	3.6	4.2	0.9	0.4	0.4	1.3	1.0	3.9	1.4	0.4	0.6	2.5	0.8	0.0	0.0	1.7	1.3	2.8	0.7	1.7	3.5	0.0	1.6	2.7	1.0	2.9	0.8	4.0	3.6	9.3	0.4	0.0	0.7	0.3	0.2	1.0	0.4	0.2	0.2	0.5	0.1	0.0	0.0	0.1	0.9	0.5	0.8	0.0	3.2	4.4	1.6	4.4	3.2	2.1	4.0	3.6	4.1	3.8	0.0	2.9	0.0	0.5	0.5	0.7	0.3	0.0	1.4	1.2	3.5	17.7	0.6	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.2	0.4	0.5	3.5	0.0	0.4	0.0	1.2	0.6	0.3	0.0	1.1	1.0	0.0	0.0	1.1	0.4	0.3	0.0	0.7	0.6	6.9	0.0	0.5	2.6	5.1	0.4	0.5	0.0	1.7	0.3
MTDH	"3D3, AEG-1, LYRIC"	ENSG00000147649	Metadherin	Q86UE4	8	97644179-97728770	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010932, HPA015104, CAB068204, CAB068205"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB068204: AB_2665655, CAB068205: AB_2665654, HPA010932: AB_1079422, HPA015104: AB_1854173"	"unprognostic (1.01e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.84e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	26.5	28.5	17.2	28.3	21.9	44.5	29.0	21.8	20.2	27.5	24.9	20.7	24.7	23.2	31.6	28.6	27.6	23.6	23.5	23.6	18.7	16.6	24.3	97.8	21.9	31.4	26.5	19.6	26.7	22.7	27.1	18.0	13.4	23.0	24.0	22.8	16.4	22.3	21.2	49.8	19.5	32.7	29.5	34.6	35.8	21.8	19.0	24.8	40.0	30.5	22.7	27.5	27.5	35.7	26.2	42.4	17.4	26.6	19.2	20.9	10.1	38.8	20.2	13.2	18.1	22.0	23.3	6.5	35.0	29.8	22.4	17.4	11.9	29.1	36.0	39.5	34.3	24.8	25.9	32.0	24.3	31.4	38.3	16.8	66.1	21.9	14.1	26.7	34.6	30.8	17.8	24.5	27.1	61.8	21.2	25.7	26.6	43.1	64.0	23.7	16.1	58.3	9.6	8.1	34.0	24.6	38.2	15.7	52.3	14.6	22.4	20.0	15.0	24.8	21.9	27.4	13.3	33.4	22.2	26.7	31.8	11.4	29.2	25.8	35.7	38.9	36.5	29.2	40.7	27.7	17.4	26.6	13.4	14.2	17.8	20.1	26.2	20.4	20.9	32.6	18.6	20.8	18.4	3.8	19.2	19.5	42.4	11.7	10.1	17.2	21.9	21.8	20.2	18.7	16.6	26.5	19.6	23.0	24.8	119.1	103.5	196.6	171.8	232.4	0.0	87.6	201.2	52.2	100.1	134.3	0.0	9.1	21.6	197.1	211.2	149.0	122.0	46.7	201.2	89.0	152.1	236.8	136.0	389.3	243.9	0.0	116.8	148.0	225.6	132.2	180.9	250.7	175.5	149.7	148.0	0.0	214.1	126.3	203.3	76.1	0.0	219.9	203.9	116.5	108.0	275.1	11.4	146.0	177.0	291.2
MXRA7	"FLJ46603, PS1TP1, TMAP1"	ENSG00000182534	"Matrix remodeling associated 7"	P84157	17	76672551-76711016	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 140.1;Muller glia cells: 291.2;Peritubular cells: 134.7;Rod photoreceptor cells: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 93.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044819, HPA075316"	Uncertain		Enhanced	"Endoplasmic reticulum"	"Secreted - unknown location"	NA	NA			"Endoplasmic reticulum"		"HPA044819: AB_10964134, HPA075316: "	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.67e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.80e-5)"	28.4	46.7	14.7	18.2	43.2	1.8	32.4	15.6	30.5	31.0	44.0	14.6	16.9	6.6	44.5	40.4	33.2	28.0	28.1	93.3	15.1	13.1	14.1	5.1	24.7	13.3	16.2	16.3	36.1	16.4	40.1	7.8	21.1	20.6	32.8	14.5	41.9	15.0	61.7	13.9	10.8	13.3	59.9	15.8	31.4	21.9	20.7	10.0	6.4	51.0	9.3	6.6	44.7	31.4	2.9	3.6	1.9	3.9	7.8	7.0	4.0	2.5	7.6	11.4	21.5	60.5	55.4	5.7	36.1	29.3	26.4	25.8	10.2	0.4	0.0	16.4	49.9	27.6	10.3	12.7	20.0	43.2	0.1	12.6	6.5	5.7	16.9	37.0	3.0	0.8	34.4	23.9	30.6	25.2	59.4	38.8	1.6	4.6	0.1	60.8	0.7	0.3	2.1	3.6	4.0	21.6	5.7	44.9	2.1	21.2	0.6	4.0	29.1	10.7	0.1	20.6	34.0	7.1	3.9	47.5	59.7	12.7	24.3	37.9	3.4	0.6	0.1	93.7	1.3	8.6	1.5	3.9	0.8	6.3	1.2	4.8	2.9	3.5	7.0	3.1	0.7	2.3	4.9	1.9	7.8	0.4	3.6	0.8	4.0	14.7	43.2	15.6	30.5	15.1	13.1	16.2	16.3	20.6	10.0	14.9	10.5	2.9	23.3	9.2	140.1	103.5	2.5	9.4	11.4	29.6	90.3	1.0	1.7	20.9	3.3	36.2	0.9	0.0	3.6	4.2	41.8	16.2	2.3	3.2	2.8	104.9	6.4	54.0	5.6	6.6	93.7	2.2	13.5	1.8	5.6	291.2	7.9	0.0	134.7	5.8	125.1	12.9	36.0	1.2	12.1	7.8	0.7	9.6	1.2	18.1
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 176.1"	"Cell type enhanced"	"Detected in single"	29	"Hofbauer cells: 1.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.3;RH-30: 13.5;RPMI-8226: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA059704: AB_2684108, HPA059890: AB_2684153"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	1.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	176.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.1	18.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.8	0.0	0.0	0.5	0.1	0.0	0.4	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	1.7	1.0	0.7	0.2	5.3	0.1	0.8	0.7	0.4	0.7	0.0	0.4	0.8	13.5	10.9	0.1	0.1	0.7	0.6	3.4	0.1	0.0	0.1	0.1	0.1	2.7	0.3	1.0	0.6	3.0	0.1	1.0	0.2	0.2	3.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0
NAT8	"ATase2, GLA, Hcml1, TSC501"	ENSG00000144035	"N-acetyltransferase 8 (putative)"	Q9UHE5	2	73640832-73642393	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 140.4"	"Cell type enriched"	"Detected in some"	12	"Proximal tubular cells: 1951.9"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 242.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 16.9"					"Low region specificity"	"Detected in all"			"HPA067855, HPA074519"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA067855: AB_2732774, HPA074519: AB_2686699"	"unprognostic (4.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.36e-5)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	140.4	15.8	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	1.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	16.9	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	159.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	0.0	22.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1951.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NCEH1	"AADACL1, KIAA1363, NCEH"	ENSG00000144959	"Neutral cholesterol ester hydrolase 1"	Q6PIU2	3	172630249-172711218	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 30.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 15.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 70.8;LHCN-M2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026888, HPA043873"	Enhanced		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA026888: AB_10601557, HPA043873: "	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.88e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (5.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.28e-1)"	17.0	14.8	6.5	7.1	23.8	6.0	5.1	14.3	30.1	4.1	9.8	2.3	1.4	3.5	3.9	2.9	4.4	3.5	6.0	14.6	13.2	9.6	18.8	4.2	17.0	11.2	6.6	11.4	2.5	4.0	6.3	4.2	5.7	17.7	6.0	10.7	4.3	8.2	4.2	6.6	2.7	4.1	2.9	5.0	9.1	10.9	2.0	4.0	1.9	3.9	3.1	9.3	5.1	3.4	3.0	10.6	4.8	15.1	2.8	2.3	4.8	23.3	13.6	0.4	0.7	0.8	0.9	1.9	17.6	11.7	11.7	6.8	3.4	70.8	1.9	26.5	10.6	11.2	4.7	0.5	8.6	27.2	6.5	1.1	1.3	2.2	2.6	1.0	3.5	4.9	0.4	0.8	8.0	12.0	11.0	7.8	1.0	0.3	1.7	33.1	1.9	0.5	1.2	0.6	6.6	11.2	0.5	1.3	2.4	20.9	3.1	0.4	0.2	10.6	11.2	2.3	0.8	3.8	1.6	21.1	18.0	2.7	8.4	31.8	2.0	3.8	1.6	13.4	3.4	13.6	4.8	15.1	0.5	2.3	9.6	1.5	3.0	1.5	1.6	10.6	1.9	1.5	1.8	0.5	2.8	6.2	0.6	1.3	4.8	6.5	23.8	14.3	30.1	13.2	9.6	6.6	11.4	17.7	4.0	44.7	19.9	6.4	16.9	6.1	12.9	27.7	25.5	30.8	28.4	15.7	21.6	6.2	3.3	54.9	4.5	8.7	13.1	46.7	26.6	3.8	6.1	23.2	4.7	1.6	48.4	4.8	7.5	5.5	34.7	2.6	0.9	14.5	5.0	1.8	9.7	4.9	50.0	10.5	2.5	25.4	19.2	6.5	5.8	0.0	0.9	3.0	8.8	3.8	6.0	22.8
NCR1	"CD335, LY94, NK-p46, NKP46"	ENSG00000189430	"Natural cytotoxicity triggering receptor 1"	O76036	19	54906150-54916140	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 5.5;lymphoid tissue: 13.9"	"Cell type enriched"	"Detected in some"	9	"T-cells: 10.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049311			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049311: AB_2680707"	"unprognostic (3.92e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.87e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.32e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.05e-3)"	1.4	0.2	0.1	3.7	0.4	2.1	0.3	0.1	0.3	0.3	2.1	0.0	0.5	0.1	1.2	1.3	0.3	0.2	2.1	1.9	0.2	0.2	0.3	2.5	5.5	3.8	0.2	0.0	0.2	0.1	0.1	0.2	0.4	0.0	0.6	0.2	1.0	0.4	0.1	0.3	0.5	3.4	1.2	0.2	13.9	0.3	0.4	0.0	2.0	0.3	0.1	2.6	0.7	0.3	0.2	0.2	1.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.2	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.1
NECAP2	FLJ10420	ENSG00000157191	"NECAP endocytosis associated 2"	Q9NVZ3	1	16440672-16460078	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cone photoreceptor cells: 296.5;monocytes: 288.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028077	Approved		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA028077: AB_10601273"	"unprognostic (6.92e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.38e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.58e-2)"	23.6	22.0	13.6	25.0	15.0	12.6	19.4	10.2	13.8	15.9	18.6	19.8	12.6	11.9	18.2	15.9	24.1	17.6	18.6	12.5	12.6	11.0	19.3	23.6	26.5	39.4	17.5	12.2	28.0	19.5	12.0	12.4	37.8	14.4	16.9	15.6	15.6	21.1	11.7	9.8	25.7	19.2	15.5	18.1	48.1	15.1	27.4	14.5	43.3	20.8	15.9	36.1	22.1	17.5	25.7	27.5	24.8	57.1	26.7	47.9	54.4	16.7	9.3	9.7	11.4	19.8	21.5	5.7	19.3	26.4	25.0	22.0	10.0	28.3	15.1	23.2	35.1	11.4	11.2	13.6	19.0	20.7	31.4	14.0	14.8	11.1	13.6	25.8	18.4	13.8	23.9	19.8	17.5	14.4	21.3	40.7	17.2	20.5	49.7	21.7	11.0	17.1	19.4	8.6	12.7	13.3	19.3	8.9	24.1	24.6	9.6	6.1	15.9	14.8	8.8	19.0	15.2	10.0	20.4	47.6	16.2	8.8	18.6	12.9	23.6	22.9	14.8	13.7	26.7	15.6	17.3	40.2	24.8	23.8	53.7	23.3	25.7	40.9	28.1	27.5	23.2	42.2	26.7	15.5	26.7	57.1	16.4	47.9	54.4	13.6	15.0	10.2	13.8	12.6	11.0	17.5	12.2	14.4	14.5	20.8	30.2	42.2	31.9	46.4	24.0	6.5	17.8	24.1	14.8	19.2	296.5	43.0	19.9	64.1	42.7	55.5	29.6	23.3	47.5	51.8	39.4	35.2	26.6	11.0	106.9	14.3	18.0	94.5	78.3	29.5	27.6	75.8	23.6	288.6	28.3	23.1	86.4	42.1	31.8	18.6	50.9	38.8	26.5	25.6	26.1	48.9	41.3	67.3	20.6	51.6
NINJ2		ENSG00000171840	"Ninjurin 2"	Q9NZG7	12	564296-663779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.7;brain: 43.6"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 32.8;Hofbauer cells: 25.9;Kupffer cells: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 41.4;MOLT-4: 70.0;THP-1: 14.8;U-698: 13.3"	"Low region specificity"	"Detected in many"							"HPA058980, HPA067226"			Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Centriolar satellite, Cytosol"	"HPA058980: AB_2683869, HPA067226: "	"unprognostic (1.16e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.60e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.23e-1)"	11.8	1.4	9.8	9.2	14.1	27.8	9.2	2.4	18.5	7.3	5.0	43.6	1.6	4.6	2.9	3.3	8.4	3.8	4.7	7.9	16.4	8.7	1.4	13.8	31.3	10.8	21.8	10.2	0.8	1.8	0.9	1.1	3.9	17.2	2.7	4.5	2.9	4.5	2.8	20.1	6.7	3.9	4.8	26.4	8.8	3.6	3.9	21.1	3.6	2.6	2.2	9.2	9.0	3.9	5.6	14.9	34.2	17.7	5.7	44.7	9.1	0.4	0.1	0.0	0.4	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.8	3.2	0.0	0.1	1.6	0.4	0.0	0.0	0.0	0.0	2.3	0.0	41.4	9.9	0.5	0.0	1.1	1.7	0.6	0.0	0.0	0.0	0.0	0.8	0.8	2.4	7.1	0.0	0.0	70.0	2.2	0.7	0.0	0.0	1.8	0.0	0.2	0.7	0.0	0.0	0.0	7.8	0.0	0.0	0.1	0.0	14.8	0.2	0.0	0.4	2.7	0.0	0.0	1.1	13.3	0.1	7.7	0.0	2.0	17.7	14.1	10.5	13.7	3.1	5.6	11.8	11.1	14.9	4.5	2.6	5.5	34.2	5.7	11.2	7.8	44.7	9.1	9.8	14.1	2.4	18.5	16.4	8.7	21.8	10.2	17.2	21.1	20.8	32.8	6.5	0.2	5.0	0.0	1.2	0.0	6.7	14.8	0.0	0.0	2.3	1.7	0.0	2.1	5.4	1.6	0.0	0.0	3.2	5.6	0.2	2.3	10.6	25.9	0.0	4.1	5.5	33.3	1.9	7.5	17.3	6.8	6.4	3.2	0.3	0.5	3.5	3.9	0.0	0.0	0.0	1.0	3.2	2.5	4.8	0.7	14.4	3.3	0.0
NKIRAS1	"kappaB-Ras1, KBRAS1"	ENSG00000197885	"NFKB inhibitor interacting Ras like 1"	Q9NYS0	3	23891660-23946591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 60.9;Rod photoreceptor cells: 54.6;Spermatocytes: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077387	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA077387: "	"unprognostic (1.36e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (1.08e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.30e-2)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.69e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.37e-2)"	"prognostic favorable (7.71e-13)"	"unprognostic (1.98e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.63e-3)"	8.1	12.2	20.2	4.2	20.8	2.3	8.1	21.8	30.3	8.7	5.8	7.4	6.3	3.3	7.8	8.5	7.6	7.2	5.7	13.3	18.3	25.0	14.2	21.6	5.7	4.0	18.1	15.5	10.8	5.1	19.2	16.2	5.7	23.7	8.8	3.9	8.5	5.9	12.3	24.0	4.4	3.5	8.0	11.2	5.3	4.4	18.4	8.2	0.5	9.0	2.5	4.0	7.1	9.2	8.8	5.1	9.4	5.3	4.0	10.7	4.7	6.5	5.5	6.0	6.1	16.6	8.1	5.2	15.6	9.5	11.3	9.7	5.6	1.9	3.4	6.8	8.8	6.8	3.2	10.0	6.8	10.2	12.6	6.9	1.9	5.4	5.4	8.5	3.4	1.8	6.3	9.7	13.9	7.1	11.7	3.2	3.3	3.2	12.9	12.5	3.4	2.3	3.0	7.5	4.1	7.3	3.5	8.7	3.3	8.4	2.8	2.2	10.8	4.8	7.8	10.8	6.6	5.6	4.9	5.9	5.5	6.0	13.6	12.6	28.6	28.0	2.2	7.1	5.1	4.9	9.4	5.3	6.8	9.5	3.8	10.6	6.5	6.9	9.1	5.1	8.8	10.7	8.9	2.7	4.0	4.1	3.6	5.2	4.7	20.2	20.8	21.8	30.3	18.3	25.0	18.1	15.5	23.7	8.2	6.0	8.0	2.2	9.5	10.0	31.6	17.4	0.0	16.0	10.3	5.2	60.9	10.1	13.3	6.4	10.5	5.8	3.6	0.0	4.0	8.6	9.7	6.7	6.9	13.9	6.4	12.7	1.2	6.7	3.1	4.5	6.9	8.8	10.1	6.4	2.0	42.9	4.5	3.1	8.5	19.1	54.6	12.9	12.3	67.0	40.9	8.7	8.7	5.0	2.2	6.7
NOMO1	PM5	ENSG00000103512	"NODAL modulator 1"	Q15155	16	14833681-14896160	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 40.0"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.0;Hep G2: 37.3;RPMI-8226: 23.8;SiHa: 43.2"									"CAB025192, HPA046697, HPA061174"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB025192: , HPA046697: AB_2679758, HPA061174: AB_2684444"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (3.15e-4)"	4.2	3.3	4.4	10.1	11.1	0.8	4.6	7.9	10.2	2.4	3.7	5.4	1.5	1.4	6.1	3.6	3.4	8.3	2.8	12.9	5.2	6.4	11.3	8.9	4.1	3.4	4.6	10.6	11.7	40.0	1.2	3.3	9.1	6.6	5.9	10.3	2.7	4.1	5.9	12.2	6.9	7.0	9.0	3.5	1.8	5.9	15.0	2.8	1.5	9.9	1.5	2.4	2.6	1.9	1.2	3.8	5.2	4.0	1.4	1.0	1.0	0.3	12.7	16.0	21.0	0.0	1.5	10.4	1.3	3.2	3.9	4.0	0.2	0.9	1.3	1.0	2.9	0.3	0.2	2.9	0.1	4.0	1.9	0.0	1.2	17.0	37.3	13.9	1.8	1.0	0.2	0.2	2.0	2.2	0.4	2.9	0.0	7.2	0.8	18.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	1.5	23.8	0.0	0.7	0.3	11.8	43.2	0.0	0.2	0.8	17.6	0.1	0.4	0.5	0.0	1.8	14.8	0.0	0.6	1.5	0.9	0.7	0.5	5.2	0.6	0.6	0.3	1.2	0.7	0.2	0.3	0.9	0.5	1.2	0.5	0.8	1.6	1.4	4.0	3.8	1.0	1.0	4.4	11.1	7.9	10.2	5.2	6.4	4.6	10.6	6.6	2.8	3.0	8.0	5.2	1.2	5.7	8.3	40.4	2.5	4.0	5.7	10.4	5.9	5.1	0.0	13.8	22.9	7.4	13.6	0.0	25.8	11.0	5.7	1.6	24.1	6.8	5.7	33.4	7.5	8.6	10.4	6.4	2.6	2.6	5.0	6.4	10.8	5.1	26.8	8.6	6.0	8.2	7.1	6.5	7.2	9.8	13.8	5.1	8.0	4.4	11.1	1.3
NOTUM		ENSG00000185269	"Notum, palmitoleoyl-protein carboxylesterase"	Q6P988	17	81952507-81961840	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"placenta: 127.4"	"Cell type enriched"	"Detected in some"	47	"Extravillous trophoblasts: 865.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 96.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022851			Approved	"Endoplasmic reticulum"	"Secreted in female reproductive system"	NA	NA		59000	"Endoplasmic reticulum"		"HPA022851: "	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.02e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.48e-6)"	"unprognostic (1.76e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.00e-1)"	0.2	0.1	1.1	0.2	1.2	0.1	0.2	0.3	1.0	0.2	0.2	0.2	0.5	0.6	1.0	1.3	0.3	0.2	0.3	0.3	0.5	0.9	0.8	10.4	1.8	0.2	0.7	0.4	0.2	0.2	0.0	0.2	127.4	0.6	0.4	0.0	0.2	0.3	0.2	4.9	2.4	0.2	0.2	0.3	0.3	0.9	3.0	0.5	0.2	0.2	0.3	0.2	1.3	1.3	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.5	0.6	96.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	15.6	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.9	0.4	1.4	0.5	0.0	1.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	1.2	0.3	1.0	0.5	0.9	0.7	0.4	0.6	0.5	0.0	3.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	865.2	2.3	0.0	0.0	0.9	17.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.8	0.0	18.4	0.0	0.0	0.0
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"	17.4	24.8	11.0	7.7	10.5	6.0	20.4	7.7	15.0	13.4	23.4	13.9	20.5	13.3	10.4	35.7	36.2	11.9	7.4	16.7	14.3	11.4	11.6	38.1	9.9	8.7	9.7	10.4	9.8	7.9	9.8	6.9	7.9	18.9	12.0	10.7	7.9	12.2	17.7	6.9	14.5	24.0	9.9	14.2	7.3	9.6	8.6	9.3	6.0	11.0	22.2	17.0	7.5	16.1	16.2	17.5	16.4	17.7	17.0	17.3	13.0	40.6	14.9	20.4	10.6	17.6	13.4	11.5	8.1	10.9	14.8	18.8	20.6	22.2	20.1	27.3	11.0	55.0	20.9	26.5	37.5	13.1	6.7	15.2	8.2	14.6	20.9	12.8	8.2	6.7	16.4	14.5	28.9	7.3	6.4	13.7	8.9	13.6	9.1	11.2	18.0	8.0	10.7	8.1	20.4	18.0	6.0	14.8	16.5	30.7	16.8	7.4	8.4	7.2	10.9	8.5	14.8	7.2	10.5	11.6	6.9	11.4	16.6	15.6	12.9	8.6	34.6	12.8	12.9	6.5	16.4	17.7	15.8	15.6	16.2	15.7	16.2	15.6	13.5	17.5	12.9	11.4	12.6	1.9	17.0	12.1	15.6	17.3	13.0	11.0	10.5	7.7	15.0	14.3	11.4	9.7	10.4	18.9	9.3	11.9	14.7	9.7	9.8	9.6	3.8	21.0	15.3	18.7	10.3	12.2	0.0	18.3	8.3	16.9	8.7	7.4	12.0	0.0	17.6	18.3	9.8	7.8	8.1	26.3	16.1	1.6	5.8	8.0	8.3	5.9	7.8	9.3	5.0	15.4	8.7	10.3	16.2	7.8	8.5	11.5	5.4	0.0	8.2	3.7	8.2	10.7	15.6	5.7	9.4	15.3
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383967-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 68.7"	"Group enriched"	"Detected in many"	5	"Fibroblasts: 137.8;Leydig cells: 153.9;Peritubular cells: 199.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"T-reg: 5.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 18.1;HSkMC: 8.1;JURKAT: 11.6;MOLT-4: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		190000000	"Endoplasmic reticulum"		"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (2.03e-4)"	35.6	3.9	0.7	7.1	1.3	0.0	14.7	2.0	2.2	47.8	15.2	0.7	11.7	1.5	25.2	19.8	11.7	12.9	47.5	27.6	0.9	0.7	1.9	1.0	7.8	1.3	2.8	1.6	26.1	1.9	68.7	7.1	9.7	2.9	27.7	5.7	10.7	2.9	4.9	2.4	1.6	5.9	31.1	6.0	0.8	9.4	10.7	0.8	1.3	5.9	7.0	1.5	32.0	10.0	0.6	0.3	0.0	0.0	0.4	5.1	0.2	0.0	0.0	0.0	0.0	3.9	18.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	23.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.5	0.3	0.6	0.1	0.1	0.0	0.4	0.0	0.1	5.1	0.2	0.7	1.3	2.0	2.2	0.9	0.7	2.8	1.6	2.9	0.8	6.0	1.0	0.0	0.0	3.8	0.6	2.4	0.0	5.3	13.6	3.5	0.0	1.6	0.0	0.0	1.2	3.5	0.0	0.0	0.0	1.5	137.8	0.2	1.1	0.0	4.2	0.0	0.0	30.7	0.3	1.3	153.9	1.2	1.7	0.0	0.0	0.0	0.0	0.0	199.4	0.0	0.2	6.5	11.8	0.6	0.3	4.0	4.8	0.0	0.0	0.1
OMD	"osteoadherin, SLRR2C"	ENSG00000127083	Osteomodulin	Q99983	9	92414245-92424461	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Fibroblasts: 27.7;Leydig cells: 90.6;Peritubular cells: 103.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"ASC diff: 12.6;ASC TERT1: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069948			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		14000000	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA069948: AB_2732144"	"unprognostic (1.18e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.31e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-3)"	"unprognostic (5.81e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.08e-3)"	14.0	7.9	2.2	1.2	4.3	0.0	14.6	3.7	3.4	20.3	8.3	1.0	8.0	0.8	8.2	19.3	14.0	8.7	8.9	20.2	2.8	1.7	2.9	0.8	12.2	0.8	7.0	5.4	15.3	1.8	1.5	4.2	11.5	6.0	13.6	2.2	14.2	2.3	4.2	2.8	3.5	3.7	13.9	19.3	0.7	5.0	12.8	1.3	0.2	9.2	14.5	3.2	22.1	7.6	0.3	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	12.6	11.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	2.2	4.3	3.7	3.4	2.8	1.7	7.0	5.4	6.0	1.3	0.0	0.0	0.0	0.2	2.4	0.6	1.1	0.0	0.0	1.2	1.8	0.0	0.1	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.1	27.7	0.1	0.0	0.0	0.3	0.0	0.0	16.5	0.3	1.3	90.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	103.6	0.0	1.3	0.0	3.4	0.2	0.1	2.4	0.0	0.0	0.0	0.1
ORMDL1		ENSG00000128699	"ORMDL sphingolipid biosynthesis regulator 1"	Q9P0S3	2	189770323-189784371	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA065643			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA065643: AB_2685525"	"unprognostic (1.45e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.70e-3)"	"prognostic favorable (3.04e-5)"	"unprognostic (5.90e-3)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.84e-9)"	"unprognostic (2.62e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.49e-5)"	24.9	31.1	23.1	27.3	29.6	28.5	36.8	29.4	30.8	24.7	23.1	24.1	56.0	24.2	28.9	63.8	21.8	25.7	28.5	17.9	22.6	25.1	26.5	30.3	31.5	40.4	30.6	24.1	25.7	39.9	25.1	50.6	37.5	29.9	29.7	30.5	30.4	55.2	41.2	18.3	47.0	38.1	25.6	25.1	63.1	28.1	37.3	24.7	26.3	31.1	21.7	40.3	24.6	23.9	28.7	36.8	29.0	35.2	21.0	37.7	26.2	13.2	10.4	27.6	21.4	37.6	42.7	30.4	25.8	28.1	33.7	33.7	20.4	21.8	22.8	19.5	20.8	18.8	20.7	19.2	17.2	36.6	26.1	24.1	32.4	36.6	25.5	47.8	28.0	27.1	47.7	21.6	28.2	32.3	39.3	24.1	26.3	21.7	35.4	32.6	13.8	26.1	52.4	29.8	15.7	47.5	17.7	23.7	32.4	39.0	20.4	18.1	20.8	14.4	13.8	34.7	32.7	15.7	31.0	22.1	29.8	22.3	21.5	28.5	32.4	26.9	23.9	32.4	30.5	16.3	25.7	25.0	29.0	28.7	30.5	28.6	28.7	33.3	31.1	20.5	24.5	37.7	34.6	10.0	21.0	35.2	36.8	33.8	26.2	23.1	29.6	29.4	30.8	22.6	25.1	30.6	24.1	29.9	24.7	74.5	42.8	77.9	46.4	50.0	133.7	29.1	35.7	62.9	48.9	34.9	164.9	178.2	28.2	47.2	32.5	57.1	35.5	46.7	58.9	59.1	53.0	65.1	43.9	30.6	77.0	62.0	40.7	40.5	102.6	15.7	68.7	72.5	37.1	81.2	33.3	99.7	53.1	47.6	45.6	41.1	186.8	51.8	49.5	126.1	133.3	53.1	182.4	89.2	41.3	44.2
ORMDL2	"adoplin-2, HSPC160, MST095, MSTP095"	ENSG00000123353	"ORMDL sphingolipid biosynthesis regulator 2"	Q53FV1	12	55817919-55821879	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065643			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA065643: AB_2685525"	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.68e-2)"	19.5	20.3	6.7	14.1	8.5	9.5	26.9	6.5	10.0	14.6	23.9	11.7	25.7	14.6	15.4	29.9	37.6	13.7	23.3	17.2	7.3	8.2	32.0	44.4	20.1	22.5	10.1	7.7	18.6	34.7	15.9	15.6	31.9	11.4	15.8	27.8	9.1	24.0	20.9	14.5	16.9	24.8	14.5	13.0	24.0	16.2	31.9	8.7	28.4	22.2	23.0	22.0	14.6	17.5	38.8	53.3	45.2	44.6	29.8	45.8	29.0	15.4	29.5	12.5	6.4	24.1	12.1	13.9	19.0	18.9	16.6	14.7	32.9	38.3	9.6	20.3	22.8	17.1	28.7	9.9	39.5	16.6	10.0	14.8	13.0	28.5	18.3	25.6	15.6	13.8	15.1	36.4	29.1	30.4	21.5	23.2	10.9	6.8	26.3	21.1	24.8	9.5	7.0	6.0	24.6	23.5	6.3	10.0	24.7	43.1	45.1	10.9	6.9	24.2	28.9	10.5	19.8	34.6	11.3	16.8	9.0	12.6	10.5	12.0	12.7	10.4	7.9	14.3	6.3	12.4	21.1	32.8	45.2	40.5	39.9	36.2	38.8	39.3	42.9	32.6	34.2	32.9	39.2	41.1	29.8	44.6	53.3	45.8	29.0	6.7	8.5	6.5	10.0	7.3	8.2	10.1	7.7	11.4	8.7	68.5	31.8	52.9	52.0	20.7	9.4	3.4	58.6	69.6	43.3	50.6	11.8	65.8	24.9	118.7	136.0	35.0	96.4	0.0	146.5	97.7	20.3	85.8	49.8	82.3	112.2	7.9	44.3	33.2	42.9	45.2	23.6	61.7	54.0	155.1	48.2	22.3	157.8	91.2	21.9	66.7	14.0	19.4	14.1	69.9	49.6	29.2	126.8	41.5	43.3	74.9
ORMDL3		ENSG00000172057	"ORMDL sphingolipid biosynthesis regulator 3"	Q8N138	17	39921041-39927601	"Disease related genes, Predicted membrane proteins"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 239.1;Late spermatids: 240.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 92.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065643			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA065643: AB_2685525"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.09e-3)"	"prognostic favorable (5.18e-4)"	48.9	12.4	16.1	19.9	20.6	11.7	36.1	14.9	18.2	14.9	17.4	12.6	29.9	17.2	15.3	23.8	10.9	10.4	17.3	21.6	16.1	12.5	14.1	83.0	16.9	17.3	14.6	16.3	15.7	68.4	14.9	21.0	28.6	12.6	17.0	13.7	14.4	24.4	24.1	13.5	15.4	16.2	14.1	13.5	15.5	16.9	18.1	16.1	29.7	20.9	11.0	24.9	17.8	10.4	11.9	8.8	24.9	4.3	7.4	24.8	15.9	7.2	8.9	9.4	7.8	24.6	9.4	8.6	10.6	12.4	11.4	11.1	10.1	8.1	5.4	10.2	13.1	7.8	12.4	6.6	8.5	10.7	92.6	11.9	5.2	5.0	24.4	9.6	6.1	9.2	10.2	9.0	7.9	4.5	13.0	5.1	15.3	6.6	43.9	6.2	6.5	18.2	6.9	5.3	9.6	4.5	15.4	8.5	16.9	6.3	17.7	8.3	8.4	7.0	44.4	7.0	11.0	15.9	6.7	4.1	6.2	7.8	5.3	8.0	23.7	20.0	7.5	6.4	6.0	4.6	3.5	2.0	24.9	17.5	3.1	12.5	11.9	17.8	19.3	1.7	10.8	20.9	24.8	3.3	7.4	4.3	8.8	11.3	15.9	16.1	20.6	14.9	18.2	16.1	12.5	14.6	16.3	12.6	16.1	47.6	27.5	22.9	12.1	14.5	16.0	23.6	17.8	2.7	15.9	40.1	0.0	21.4	3.3	16.6	239.1	10.5	23.4	70.0	25.7	14.9	13.9	17.1	18.4	78.8	7.0	12.7	24.9	3.7	5.7	240.9	17.3	5.8	15.1	32.5	22.8	38.4	28.9	17.5	26.9	10.2	9.8	25.8	13.7	6.4	5.7	12.5	7.8	34.8	16.6	11.3
OS9	"ERLEC2, OS-9"	ENSG00000135506	"OS9, endoplasmic reticulum lectin"	Q13438	12	57693955-57721557	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 291.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011518, HPA013694"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB011518: AB_776918, HPA013694: AB_1854812"	"unprognostic (1.67e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.21e-2)"	39.3	32.9	24.4	28.1	27.6	32.2	38.0	27.0	34.9	37.4	39.1	27.6	34.5	37.2	36.2	37.7	35.2	32.0	33.0	39.2	23.2	23.1	42.9	94.4	40.2	34.2	27.7	22.0	44.2	110.7	49.5	29.2	47.0	28.2	34.7	34.1	42.0	53.2	28.5	19.0	36.9	47.4	28.1	18.6	37.5	35.7	21.4	24.0	23.8	47.6	23.2	34.4	33.3	35.1	11.5	35.8	54.1	48.7	11.4	16.1	36.7	6.7	13.8	7.0	17.4	36.7	24.9	15.6	17.0	21.7	12.6	12.8	14.3	22.1	8.7	28.4	20.3	9.7	12.3	6.5	11.0	10.0	11.1	7.9	9.8	9.8	12.9	24.0	15.3	25.2	22.8	17.7	12.3	12.6	43.4	20.9	5.8	7.4	34.7	13.1	11.7	4.1	18.6	7.9	13.5	9.8	5.4	291.6	21.8	9.6	16.8	7.2	9.6	24.2	16.7	13.7	13.4	19.9	30.2	19.1	17.0	10.2	11.5	10.7	20.7	17.8	9.0	14.4	11.2	23.4	30.6	48.7	54.1	16.1	44.4	15.2	10.9	13.7	14.2	35.8	11.5	10.7	12.3	52.0	11.4	35.0	31.1	15.0	36.7	24.4	27.6	27.0	34.9	23.2	23.1	27.7	22.0	28.2	24.0	80.4	110.4	55.1	75.1	51.3	42.6	12.6	91.7	93.7	103.5	69.8	72.6	122.4	8.3	114.5	4.8	76.5	142.5	46.7	96.4	106.6	99.6	64.6	86.8	139.4	128.9	47.7	99.5	76.7	105.2	9.1	105.0	115.3	113.1	158.7	107.2	85.8	84.7	129.8	74.3	44.0	34.1	90.5	57.7	33.4	54.8	45.0	165.3	69.2	78.8	57.0
P3H4	"LEPREL4, NO55, SC65"	ENSG00000141696	"Prolyl 3-hydroxylase family member 4 (non-enzymatic)"	Q92791	17	41801947-41812604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 4.4;MAIT T-cell: 5.9;memory CD4 T-cell: 2.9;memory CD8 T-cell: 2.8;naive CD4 T-cell: 3.5;naive CD8 T-cell: 4.2;NK-cell: 9.5"	"Group enriched"	"Detected in many"	9	"NK-cells: 9.5;T-cells: 5.9"	"Cell line enriched"	"Detected in many"	12	"OE19: 144.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA022520			Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA022520: "	"unprognostic (9.11e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (8.69e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (4.48e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.96e-3)"	5.0	13.6	5.4	6.0	5.0	0.5	12.7	7.8	6.2	11.5	8.9	2.9	17.9	8.6	11.9	10.4	5.3	8.3	11.2	9.7	4.3	5.0	7.9	2.7	6.4	6.7	5.5	6.0	12.2	34.5	11.5	11.8	12.8	4.4	10.0	4.3	7.3	10.9	9.5	3.9	7.7	7.6	10.5	3.7	4.4	5.4	3.5	5.9	0.9	20.9	4.5	4.4	7.6	7.1	0.8	0.3	0.0	0.2	9.5	5.9	1.5	1.2	6.6	4.0	10.4	4.3	4.2	3.9	9.7	4.9	3.8	5.2	3.2	1.8	0.2	4.1	8.4	2.9	2.2	3.4	4.7	1.3	2.6	5.4	1.6	6.4	4.3	5.3	0.3	0.5	4.4	1.3	3.3	2.9	8.9	4.7	0.4	0.2	1.6	2.3	4.4	0.0	0.8	2.5	144.7	3.6	3.3	4.4	4.3	2.3	0.3	2.0	4.1	1.8	11.8	4.0	2.6	6.8	1.1	4.9	3.7	5.4	6.7	4.8	1.5	0.3	0.0	5.6	1.5	5.6	0.0	0.2	0.0	4.4	0.0	5.9	0.6	2.9	2.8	0.3	0.8	3.5	4.2	0.0	9.5	0.0	0.0	0.7	1.5	5.4	5.0	7.8	6.2	4.3	5.0	5.5	6.0	4.4	5.9	0.0	8.5	0.0	4.7	0.0	3.4	8.3	7.6	1.4	3.4	5.2	7.9	8.8	6.6	19.2	0.4	6.0	9.1	23.3	5.8	23.2	10.0	7.7	1.1	2.4	2.5	25.4	2.4	12.3	0.6	0.4	19.5	1.0	0.0	1.0	13.6	11.6	8.0	10.5	19.4	4.8	2.5	19.4	3.4	2.5	8.3	0.0	4.5	2.9	11.8	1.8
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 105.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 94.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"	Yes	No			"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavorable (9.01e-4)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	16.8	14.4	16.5	10.4	20.2	7.0	47.6	9.9	18.2	18.5	10.9	11.3	7.4	5.6	14.8	12.2	11.6	22.4	14.1	23.9	17.0	10.9	19.0	39.9	18.1	7.5	33.5	4.9	22.3	13.1	11.1	8.6	33.5	25.4	17.9	9.4	8.6	8.5	10.4	63.5	10.3	7.8	15.1	45.8	9.7	11.1	9.7	30.9	4.1	19.4	7.5	7.3	34.4	105.7	6.9	14.8	10.2	17.3	3.4	7.3	6.1	15.2	3.9	11.4	22.1	35.2	27.1	9.5	44.7	40.5	17.3	41.6	6.5	11.9	5.2	17.1	44.2	10.5	17.3	7.1	16.3	37.9	6.6	2.7	4.4	3.7	7.7	14.7	8.1	3.1	16.4	9.5	14.7	19.5	94.8	8.1	4.4	6.8	2.7	14.9	4.0	3.2	7.8	4.1	7.1	17.3	2.9	7.6	9.3	9.7	6.6	1.0	6.4	9.1	27.0	10.6	26.9	4.1	7.6	7.7	21.2	8.7	5.9	10.4	15.6	5.6	2.5	38.0	11.8	10.3	0.8	13.5	10.2	5.2	16.4	6.7	6.0	6.2	6.0	14.8	6.9	4.6	4.7	7.4	3.4	17.3	11.8	7.3	6.1	16.5	20.2	9.9	18.2	17.0	10.9	33.5	4.9	25.4	30.9	6.0	27.9	18.6	25.1	32.3	12.9	37.9	2.5	56.2	31.8	22.7	25.5	25.0	0.0	26.6	10.0	23.3	10.7	0.0	17.0	76.6	76.1	22.0	39.3	25.1	39.6	11.1	9.9	19.0	44.8	4.7	48.1	41.1	42.2	36.1	7.6	33.4	37.2	18.2	44.2	22.8	17.6	38.8	31.1	35.7	35.8	20.8	27.8	13.8	6.5	17.3
P4HA2	C-P4Halpha(II)	ENSG00000072682	"Prolyl 4-hydroxylase subunit alpha 2"	O15460	5	132191838-132295315	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 62.2;U-87 MG: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA016997, HPA027824, CAB062557"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No			"Endoplasmic reticulum, Vesicles"		"CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402"	"unprognostic (1.30e-3)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.56e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (2.77e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.12e-4)"	10.2	5.6	7.1	6.5	5.4	0.8	12.2	9.5	7.8	14.4	12.5	4.6	6.1	9.8	20.0	35.3	11.6	13.7	9.7	26.1	6.6	7.0	34.4	6.3	16.0	4.3	6.3	4.2	6.7	42.5	6.7	15.8	15.1	9.5	9.3	14.6	15.1	21.1	8.4	7.1	9.3	17.1	23.3	5.1	6.3	12.6	5.1	4.4	4.1	12.2	10.8	5.4	11.3	34.5	0.2	1.0	3.1	1.3	2.6	2.6	0.7	10.3	6.3	2.0	10.1	28.3	33.8	11.5	48.2	41.2	20.5	50.8	14.2	9.1	0.2	14.2	51.6	22.9	13.0	6.3	25.2	32.5	7.6	2.1	0.0	9.3	8.6	62.2	0.0	6.2	20.4	37.3	24.3	22.4	30.7	10.8	0.0	3.7	0.6	25.0	4.1	0.0	0.0	0.5	9.5	5.2	0.1	0.6	1.6	5.7	2.0	1.0	2.8	12.3	4.1	8.2	16.5	5.1	0.7	16.5	31.2	12.2	9.4	10.4	4.4	4.7	2.0	60.1	0.0	8.7	0.0	1.3	0.0	2.6	1.1	2.4	0.0	1.4	0.4	0.6	0.2	0.0	0.4	3.1	2.6	0.2	1.0	0.0	0.7	7.1	5.4	9.5	7.8	6.6	7.0	6.3	4.2	9.5	4.4	32.8	10.1	1.4	26.7	14.9	7.9	11.8	12.7	60.2	14.8	10.4	21.6	2.4	5.0	58.5	1.0	9.8	35.4	0.0	62.7	51.9	40.5	21.4	5.7	5.9	7.2	0.0	14.5	15.4	1.8	1.6	7.5	4.7	28.7	3.6	12.9	7.5	69.0	34.5	4.9	34.1	5.5	25.8	27.8	18.2	29.4	8.5	6.3	2.5	10.8	16.5
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860694	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 383.4;pancreas: 677.5"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 1160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	No	No		140000000	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	18.0	34.7	6.3	15.4	8.4	35.0	16.1	6.1	6.5	22.1	40.5	9.0	45.0	42.6	14.7	29.1	40.3	12.8	42.3	20.7	6.3	5.9	27.2	383.4	20.9	29.1	7.9	4.5	14.3	677.5	6.4	23.4	58.5	7.2	22.5	8.5	12.3	251.9	42.5	31.0	24.3	112.8	11.0	5.2	36.7	31.6	9.1	7.2	10.5	29.7	50.7	46.4	16.5	20.5	21.6	71.3	45.8	60.8	38.8	55.9	70.8	58.4	50.9	18.9	60.8	51.0	60.1	44.7	114.3	73.7	49.8	67.5	37.4	51.3	23.6	50.3	73.4	30.1	41.5	20.7	44.7	28.9	15.2	35.1	35.3	53.6	152.0	67.1	111.5	58.5	45.3	30.4	39.9	42.3	64.5	82.1	16.9	25.0	102.0	35.5	53.4	31.9	88.6	14.8	62.0	46.4	26.1	33.8	46.8	38.7	70.7	22.7	25.1	57.0	164.5	59.3	32.6	74.4	131.4	63.7	93.6	46.9	53.1	55.7	73.4	53.1	22.3	123.0	43.0	71.3	45.8	60.8	38.3	53.5	38.7	55.9	21.6	36.4	42.8	43.4	18.7	21.2	31.5	20.0	38.8	27.6	71.3	25.7	70.8	6.3	8.4	6.1	6.5	6.3	5.9	7.9	4.5	7.2	7.2	95.3	135.6	82.0	139.4	106.7	53.8	19.6	234.4	58.9	83.0	106.4	31.4	682.3	34.9	562.2	31.8	104.1	635.2	0.0	930.3	1160.9	218.5	265.2	99.1	768.8	403.4	58.8	191.7	211.1	166.1	51.9	130.9	120.0	129.9	349.9	361.7	113.5	636.3	443.3	105.4	92.7	40.7	155.2	103.8	85.8	107.3	126.5	837.3	139.5	385.8	170.2
PAH	PH	ENSG00000171759	"Phenylalanine hydroxylase"	P00439	12	102836885-102958410	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism"	"Allosteric enzyme, Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 65.1;liver: 220.0"	"Group enriched"	"Detected in some"	8	"Cholangiocytes: 226.7;Hepatocytes: 723.9;Proximal tubular cells: 215.9"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 94.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"Hep G2: 72.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA028407, HPA031642"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		No	NA			"Endoplasmic reticulum, Vesicles"		"HPA028407: AB_10601241, HPA031642: AB_2673974"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.13e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.99e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.68e-2)"	0.1	1.3	0.5	0.0	0.5	0.0	0.1	0.2	1.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	20.3	0.1	0.8	0.3	65.1	220.0	0.0	0.0	0.3	0.7	0.1	1.7	0.0	1.6	0.0	0.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	2.8	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	1.0	0.8	0.3	0.3	0.7	0.8	0.4	0.0	0.0	16.2	0.0	0.0	0.0	0.4	226.7	0.0	0.0	5.2	0.0	0.0	18.3	2.0	50.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	723.9	0.0	3.2	1.7	14.1	22.2	13.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	215.9	0.1	0.0	0.0	0.7	0.4	0.0	0.0	5.0	0.0	0.0
PAPPA2	"PAPP-A2, PAPPE, PLAC3"	ENSG00000116183	"Pappalysin 2"	Q9BXP8	1	176463171-176845605	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 406.4"	"Group enriched"	"Detected in many"	7	"Intestinal endocrine cells: 135.4;Muller glia cells: 47.6;Syncytiotrophoblasts: 61.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 21.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018412, HPA018430"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted in female reproductive system"	NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA018412: AB_1854962, HPA018430: AB_1854961"	"unprognostic (2.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.52e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.18e-4)"	"unprognostic (4.35e-2)"	0.6	0.0	0.6	0.2	0.2	0.0	3.0	0.8	0.3	5.0	0.6	0.2	0.2	0.0	0.3	0.2	0.2	0.2	1.1	0.2	0.2	0.1	11.6	0.7	0.2	0.2	0.2	0.2	0.2	1.5	0.0	1.2	406.4	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.3	0.5	0.2	1.0	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.3	4.6	2.2	3.8	0.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.8	0.5	0.5	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.3	1.7	1.4	0.1	0.6	0.3	0.4	0.0	21.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.8	0.3	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	5.2	0.0	0.8	10.0	0.0	1.9	0.0	0.0	0.0	0.2	11.6	0.6	0.0	0.0	0.2	1.2	0.0	135.4	0.0	0.0	1.3	10.6	0.0	0.0	0.0	0.2	47.6	1.2	0.0	10.3	0.3	1.1	6.5	0.5	1.2	1.9	0.0	61.9	0.0	0.0	0.0
PCNX2	"FLJ11383, KIAA0435, PCNXL2"	ENSG00000135749	"Pecanex homolog 2"	A6NKB5	1	232983435-233295713	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 29.6"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 8.9;Ciliated cells: 8.1;Club cells: 12.5;Collecting duct cells: 12.2;Distal tubular cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013815, HPA014427"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013815: AB_2236561, HPA014427: AB_1855081"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.27e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	4.7	4.7	11.4	7.5	16.8	4.2	7.7	29.6	23.1	4.9	3.9	6.3	4.2	3.4	6.6	14.0	5.2	9.0	8.1	2.3	11.9	8.2	5.4	1.2	4.7	9.4	8.0	13.1	11.4	5.2	8.6	18.6	2.4	14.3	6.2	4.8	6.0	6.0	8.1	5.6	6.3	5.6	5.2	5.8	5.3	5.8	5.5	5.5	4.0	7.9	3.4	8.8	6.0	5.7	1.5	1.8	0.9	0.9	0.8	3.1	1.1	3.8	9.4	5.1	0.1	8.4	9.2	1.5	2.3	6.8	2.4	4.3	3.0	4.7	8.1	5.5	6.3	9.0	6.4	2.3	6.7	5.7	6.8	6.9	0.1	4.8	0.0	3.8	2.6	1.6	7.0	5.9	4.8	19.1	8.3	4.5	6.1	0.0	4.3	2.4	2.3	7.4	0.2	16.5	3.3	5.7	0.1	1.4	1.1	4.4	6.0	8.8	7.3	3.4	1.5	1.4	3.0	3.4	0.7	1.7	6.8	4.4	7.7	7.6	5.2	5.4	0.1	6.2	3.0	7.8	0.9	0.9	0.4	3.1	0.5	2.4	1.5	2.5	2.9	1.8	1.3	1.1	2.1	0.7	0.8	0.7	0.6	2.7	1.1	11.4	16.8	29.6	23.1	11.9	8.2	8.0	13.1	14.3	5.5	8.9	5.1	0.0	0.0	0.0	0.0	0.0	0.0	8.1	12.5	12.2	0.0	0.3	6.6	5.1	0.0	0.0	0.0	0.0	2.9	1.1	0.0	0.0	1.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.8	0.0	0.0	4.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PDE3B	HcGIP1	ENSG00000152270	"Phosphodiesterase 3B"	Q13370	11	14643723-14872044	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	Angiogenesis	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 42.6"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 34.7;Hepatocytes: 50.5;Spermatocytes: 45.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.2"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 5.0;T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"HL-60: 13.6;Karpas-707: 15.7;THP-1: 16.7;U-266/70: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056111			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA056111: AB_2683041"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.03e-3)"	42.6	1.0	2.3	12.6	2.2	6.7	17.0	19.2	3.0	2.9	21.8	0.9	0.8	2.2	0.9	1.4	2.6	1.0	6.9	4.7	2.2	2.1	2.4	18.2	10.2	14.1	1.6	1.6	0.9	7.3	0.3	5.1	5.5	1.5	10.7	8.1	1.9	16.5	1.3	0.8	0.9	6.3	9.7	2.1	8.7	3.0	12.5	0.8	7.8	1.2	2.3	7.1	10.5	4.5	0.3	0.4	5.0	1.2	0.1	8.7	1.8	0.0	1.5	3.4	5.5	6.8	0.0	1.3	0.4	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	1.6	0.0	5.1	0.0	0.0	0.1	11.3	0.1	8.3	10.2	2.4	13.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	4.0	11.9	15.7	0.0	0.1	2.7	6.6	4.6	1.8	2.5	6.5	1.5	10.3	0.0	1.1	5.2	9.7	1.3	8.8	3.0	1.6	0.0	16.7	0.0	0.0	0.8	0.0	0.0	17.7	5.4	0.4	0.1	2.3	1.0	0.0	0.7	2.9	1.4	0.7	2.9	0.3	4.2	3.2	0.4	0.2	8.7	7.5	5.0	0.1	1.2	0.1	4.2	1.8	2.3	2.2	19.2	3.0	2.2	2.1	1.6	1.6	1.5	0.8	14.9	9.9	1.9	0.8	0.2	0.4	8.2	0.0	6.7	11.4	1.8	0.0	1.0	1.7	0.0	12.4	2.2	2.6	23.3	4.3	1.9	8.5	3.4	34.7	50.5	6.3	0.0	1.2	7.4	14.0	10.1	1.4	12.3	0.0	1.0	13.1	4.5	2.9	17.5	8.5	1.9	0.3	0.0	0.1	45.1	11.1	0.1	2.1	11.7	9.7	0.9
PDIA3	"ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC"	ENSG00000167004	"Protein disulfide isomerase family A member 3"	P30101	15	43746392-43773279	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 877.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002645, HPA003230, CAB011199, CAB015181, CAB075744"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		390000000	"Endoplasmic reticulum"		"CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030"	"unprognostic (9.20e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.63e-2)"	16.9	21.2	10.0	20.5	13.5	20.8	31.1	12.7	9.2	24.7	19.4	12.3	33.9	22.2	19.7	42.4	21.7	18.4	25.1	20.6	10.2	12.7	27.3	112.5	20.0	34.6	12.4	10.3	22.4	46.8	21.1	21.7	44.0	13.3	24.6	21.2	13.7	43.4	36.9	8.7	17.9	28.8	15.8	11.4	25.2	20.5	17.1	14.3	15.6	74.0	16.4	19.8	14.7	28.3	7.7	18.3	13.5	10.8	11.7	14.1	14.5	12.3	4.6	9.8	21.9	19.9	21.4	30.1	24.7	24.5	18.4	22.9	12.9	12.7	14.1	16.1	28.2	12.3	19.7	12.4	24.0	16.1	10.2	18.4	19.1	7.4	11.9	32.8	10.7	13.9	13.7	19.9	13.9	23.5	21.7	32.0	4.5	11.0	6.9	17.9	4.2	3.6	12.2	9.9	19.0	18.7	7.1	15.4	10.6	15.7	10.1	9.9	11.0	20.6	19.8	7.8	10.4	13.8	11.0	21.6	15.3	8.1	12.3	12.0	3.2	3.6	14.8	19.6	17.0	11.5	10.0	10.3	13.5	13.4	10.5	14.1	6.5	8.5	10.8	9.6	7.7	7.2	8.4	2.9	11.7	10.8	18.3	6.7	14.5	10.0	13.5	12.7	9.2	10.2	12.7	12.4	10.3	13.3	14.3	178.6	134.5	154.1	249.6	170.7	50.3	49.5	142.7	231.6	287.8	158.7	39.3	559.5	59.7	337.0	18.9	151.7	227.1	23.3	345.2	636.6	296.9	292.3	254.2	280.2	396.2	66.7	178.5	269.5	152.1	20.5	234.7	267.6	231.2	285.9	259.4	139.7	260.6	167.0	260.3	106.7	46.2	122.9	160.2	185.1	135.1	129.7	877.1	174.3	233.4	256.5
PDIA4	"ERP70, ERP72"	ENSG00000155660	"Protein disulfide isomerase family A member 4"	P13667	7	149003062-149028641	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 164.3"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 542.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006139, HPA006140, CAB017368"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		12000000	"Endoplasmic reticulum"		"CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257"	"unprognostic (1.98e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-3)"	"unprognostic (6.08e-3)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (5.20e-9)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	17.6	13.0	7.7	25.6	11.9	7.4	27.4	5.1	7.9	25.5	20.9	12.1	28.8	18.2	19.4	46.3	15.2	20.8	28.1	16.9	7.3	8.0	27.7	164.3	19.1	29.1	11.6	6.2	19.4	76.3	7.0	19.1	24.7	12.0	18.0	21.9	7.8	36.4	26.5	5.8	10.1	21.3	17.8	13.9	27.9	23.7	11.5	11.3	19.2	89.8	11.9	24.3	17.4	22.6	26.6	63.3	16.2	21.2	21.5	35.9	34.5	32.4	30.9	33.6	93.9	30.7	21.9	48.7	45.7	30.6	26.2	42.8	25.6	87.8	23.4	102.6	37.5	72.2	21.3	22.6	43.3	23.1	16.6	13.3	11.2	8.9	56.1	41.2	25.5	31.7	21.5	19.4	28.7	23.1	34.2	53.2	12.0	18.3	63.8	23.0	35.5	24.3	29.1	50.1	66.4	18.0	16.0	26.1	56.6	30.6	25.5	10.7	28.2	41.5	29.9	15.9	41.9	17.0	19.7	29.0	20.7	11.7	50.1	32.1	48.6	21.8	16.4	48.3	30.2	70.3	16.2	20.1	12.1	34.3	21.2	35.9	26.6	22.6	26.7	19.4	15.1	21.5	22.7	2.7	21.5	21.0	63.3	16.6	34.5	7.7	11.9	5.1	7.9	7.3	8.0	11.6	6.2	12.0	11.3	26.8	33.4	29.0	71.4	30.8	3.3	20.4	96.8	65.6	44.3	40.1	3.9	152.3	13.3	102.2	2.7	35.1	89.5	46.7	79.9	277.0	90.5	103.6	57.6	542.5	131.4	0.0	59.1	95.8	80.7	3.2	54.7	53.4	82.7	48.7	104.5	19.3	96.2	87.1	40.3	54.4	6.1	32.3	34.2	53.4	71.9	25.0	192.7	54.6	97.0	59.2
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Extravillous trophoblasts: 955.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		53000000	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.20e-4)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	26.9	32.7	16.7	25.0	29.9	19.9	28.7	11.3	16.8	33.4	26.1	13.9	53.7	20.4	30.4	76.1	27.1	25.5	22.4	32.7	14.2	13.9	42.1	118.4	30.4	36.3	17.8	12.7	26.5	141.6	24.9	23.3	39.5	19.0	22.6	30.1	14.6	53.4	45.0	15.7	16.1	28.4	26.5	14.3	35.1	30.9	12.4	19.5	18.1	97.9	20.1	29.7	21.9	30.6	45.2	61.0	52.0	46.2	51.5	52.2	59.7	33.2	36.1	51.7	81.1	66.6	57.6	92.0	80.9	75.1	42.5	57.3	51.2	65.7	54.0	57.0	79.1	82.6	27.3	38.8	67.7	45.7	42.3	30.6	43.8	28.3	83.1	72.1	44.8	32.9	41.5	52.1	41.1	74.2	78.8	95.7	20.5	37.6	116.5	41.9	39.4	17.2	46.5	43.2	108.3	28.6	41.4	52.7	97.8	60.5	40.2	33.2	66.5	31.9	46.8	45.4	70.0	16.5	76.1	47.0	39.9	51.0	35.9	46.7	110.0	67.8	35.0	53.9	56.4	55.8	52.0	44.4	20.5	47.5	46.2	52.2	45.2	37.7	44.7	48.6	33.1	18.4	31.0	8.1	51.5	33.9	61.0	37.7	59.7	16.7	29.9	11.3	16.8	14.2	13.9	17.8	12.7	19.0	19.5	53.6	94.6	111.7	205.7	91.5	66.3	27.4	152.8	108.4	161.5	186.7	27.5	420.2	36.5	263.9	6.1	114.4	100.2	23.3	210.7	955.4	173.7	256.1	129.2	285.4	369.6	39.7	151.3	244.9	137.9	12.1	112.2	137.1	189.0	126.2	149.4	95.2	191.3	100.8	126.9	98.3	45.7	84.1	115.4	95.8	139.7	89.6	463.4	112.4	196.3	240.5
PEMT	"PEMPT, PEMT2"	ENSG00000133027	"Phosphatidylethanolamine N-methyltransferase"	Q9UBM1	17	17505563-17591708	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 95.7;liver: 103.5"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 168.4;Peritubular cells: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042375, HPA073930"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol"		NA	NA			"Endoplasmic reticulum, Mitochondria"	"Vesicles, Cytosol"	"HPA042375: AB_10796905, HPA073930: "	"unprognostic (1.39e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.77e-6)"	"unprognostic (2.85e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.63e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.60e-2)"	21.8	7.5	5.6	2.8	6.2	4.2	26.5	2.9	8.1	16.1	6.1	6.4	13.2	7.4	8.7	95.7	5.6	10.5	4.7	5.3	5.3	6.1	8.5	103.5	5.5	6.7	6.3	4.8	7.7	11.4	4.4	5.7	7.1	6.2	7.3	2.2	7.3	12.7	12.9	7.4	7.3	5.8	4.0	6.4	2.8	4.6	19.1	3.2	3.8	9.9	6.3	5.4	3.9	5.2	12.8	17.0	1.6	23.4	15.1	14.4	11.6	14.2	27.3	7.2	18.8	15.4	10.8	10.8	9.1	8.2	12.5	9.9	15.9	9.7	12.5	16.6	9.3	9.4	17.0	10.6	5.5	3.2	9.2	37.0	6.2	14.9	22.8	17.0	5.5	9.3	11.0	11.5	8.3	12.7	4.2	6.7	17.6	5.9	5.3	5.5	27.2	9.8	9.9	10.1	27.3	22.4	9.2	11.6	11.4	10.3	5.3	7.2	17.2	6.5	4.4	16.3	14.5	6.7	2.1	5.8	12.3	12.4	20.5	7.9	7.3	4.9	2.2	11.4	7.7	10.1	1.0	23.4	1.1	10.1	20.8	14.4	12.6	13.2	12.7	17.0	12.8	10.6	11.9	1.6	15.1	14.2	15.5	12.0	11.6	5.6	6.2	2.9	8.1	5.3	6.1	6.3	4.8	6.2	3.2	14.9	13.7	17.0	16.7	16.3	4.4	12.5	12.7	16.0	26.1	26.2	0.0	16.2	14.9	26.3	2.2	18.3	14.6	0.0	33.6	18.8	27.5	23.7	12.7	168.4	21.4	4.8	66.0	9.2	11.1	6.8	87.8	10.8	20.3	1.0	24.8	26.7	26.0	10.5	326.0	21.4	4.8	6.5	30.9	11.1	18.5	15.8	12.2	7.0	22.8	16.6
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 284.3"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 326.0;Horizontal cells: 114.4;Muller glia cells: 114.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		NA	NA		1100000	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	4.4	11.6	10.0	3.0	16.2	2.3	3.9	13.0	23.6	5.8	5.3	6.1	5.4	3.0	6.4	5.8	9.1	5.4	4.8	55.5	8.2	10.1	10.9	2.7	3.6	2.4	9.4	10.8	10.8	3.0	14.2	11.4	3.3	17.9	7.1	4.2	10.8	5.2	9.4	284.3	2.6	2.8	8.3	4.6	2.7	4.1	10.3	3.8	0.0	5.5	54.9	4.6	5.3	3.7	10.7	6.7	8.7	3.2	2.2	5.4	3.5	8.7	8.5	27.0	24.5	27.5	20.0	5.5	23.7	21.8	20.5	14.5	21.0	11.0	52.1	19.6	11.4	12.0	9.7	23.3	23.9	19.3	1.2	12.2	14.8	19.3	0.6	14.7	0.7	8.6	28.3	14.1	18.0	29.7	34.3	23.2	0.8	17.8	26.3	18.8	6.6	18.3	1.2	19.2	9.6	26.5	30.8	15.7	40.0	14.0	9.7	31.9	23.5	14.0	22.2	23.7	22.4	22.5	3.2	20.9	9.5	13.1	13.9	19.7	14.4	38.3	28.5	18.4	1.5	7.9	0.4	3.2	8.7	2.5	2.8	1.0	10.7	4.3	2.4	6.7	7.0	5.4	3.0	0.8	2.2	2.3	1.0	3.8	3.5	10.0	16.2	13.0	23.6	8.2	10.1	9.4	10.8	17.9	3.8	14.9	5.9	6.8	17.7	6.5	38.0	326.0	17.8	9.4	7.9	21.0	41.2	2.2	56.3	9.4	29.7	15.8	2.2	0.0	2.2	3.5	16.7	6.1	1.1	2.5	3.5	114.4	8.7	9.8	2.7	19.6	28.4	3.2	52.3	18.0	6.2	114.5	3.3	0.0	44.9	25.8	41.0	25.8	26.2	46.8	11.5	4.5	2.1	4.4	12.1	7.6
PGGT1B	"BGGI, GGTI"	ENSG00000164219	"Protein geranylgeranyltransferase type I subunit beta"	P53609	5	115204012-115262872	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030646	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"	Cytosol	"HPA030646: AB_10602019"	"unprognostic (2.73e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (7.34e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.15e-2)"	10.5	12.4	7.3	13.3	10.1	10.9	13.9	8.8	22.1	10.8	13.8	7.7	7.9	12.3	9.2	4.6	14.9	7.3	7.0	13.5	9.5	5.9	8.2	13.7	22.2	22.2	10.2	10.0	9.6	10.1	12.0	13.4	7.8	8.2	8.4	15.1	5.7	10.6	8.4	10.2	9.9	10.4	9.5	6.9	10.4	11.0	5.1	10.5	10.2	8.8	9.9	10.1	9.6	10.5	8.0	11.5	21.8	16.7	6.7	6.3	6.4	10.2	11.2	12.8	16.5	7.5	6.3	6.3	12.7	7.5	10.6	11.0	12.2	11.0	20.9	17.3	8.8	11.0	8.0	16.8	16.7	15.9	23.0	9.3	12.0	14.6	9.7	10.0	16.5	17.8	9.4	10.3	10.4	10.9	6.8	10.6	12.4	9.7	8.9	12.1	16.0	14.4	5.5	9.5	11.6	8.7	15.8	17.1	21.2	11.1	19.4	12.5	9.5	15.1	11.5	12.1	8.0	15.4	12.4	12.1	10.9	10.3	7.5	14.8	15.0	16.7	11.0	7.9	17.2	15.1	8.3	12.8	21.8	5.0	16.6	5.6	6.8	5.7	6.3	11.5	8.0	5.4	5.0	13.1	6.7	16.7	10.3	4.9	6.4	7.3	10.1	8.8	22.1	9.5	5.9	10.2	10.0	8.2	10.5	11.9	14.4	20.7	10.2	8.9	22.7	15.7	5.1	25.4	18.2	15.7	45.2	12.3	23.2	17.0	28.4	16.1	17.8	0.0	18.9	11.6	11.7	13.7	23.1	24.5	19.5	22.3	28.9	20.3	18.3	8.1	12.4	23.0	10.1	12.6	23.0	25.4	17.9	21.0	14.5	18.3	111.9	12.9	14.1	11.4	15.6	10.8	11.3	19.1	23.3	17.8
PGRMC1	HPR6.6	ENSG00000101856	"Progesterone receptor membrane component 1"	O00264	X	119236245-119244466	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 163.9"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 412.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002877, HPA064724"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		6000000	"Endoplasmic reticulum"	Nucleoli	"HPA002877: AB_1079602, HPA064724: "	"unprognostic (6.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (1.58e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	25.0	46.0	37.7	11.9	36.9	5.6	60.2	21.8	37.8	36.2	30.5	30.9	42.9	27.0	39.9	71.4	15.0	38.9	20.1	10.0	38.6	50.4	58.7	163.9	15.6	8.8	38.1	29.6	24.7	10.9	23.8	15.5	12.3	35.3	33.5	22.5	22.1	17.5	53.7	5.7	12.5	42.9	22.0	46.9	10.0	18.9	14.2	27.1	6.9	24.7	12.2	7.7	21.3	17.3	3.6	9.9	11.4	11.8	4.8	8.0	28.7	27.3	17.3	34.0	39.1	73.6	35.3	22.1	41.3	48.2	22.0	27.4	20.9	33.6	7.9	45.3	42.8	25.7	21.9	37.1	17.3	29.7	8.4	42.6	8.9	16.6	23.4	12.3	14.5	4.8	36.3	9.8	26.7	13.9	16.3	14.1	9.5	9.3	4.9	25.7	29.2	10.9	10.7	89.1	30.0	29.2	13.0	21.3	11.4	29.0	20.9	31.8	14.2	30.2	50.3	16.2	34.3	11.6	9.3	10.9	15.3	22.6	54.1	38.9	5.2	9.5	8.5	41.9	23.2	29.2	9.2	11.8	11.4	5.5	11.3	7.3	3.6	7.5	8.0	9.9	3.1	7.7	6.3	5.7	4.8	10.0	7.1	7.6	28.7	37.7	36.9	21.8	37.2	38.6	50.4	38.1	29.6	35.3	27.1	116.1	75.0	12.3	114.6	83.6	185.1	15.3	109.5	124.5	78.5	69.8	64.8	71.9	58.0	77.8	2.7	78.8	222.6	23.3	64.6	112.3	104.2	108.1	39.3	412.3	46.0	62.0	55.4	54.6	35.5	4.9	159.3	45.1	97.8	14.4	77.2	101.7	56.7	112.1	170.8	277.5	72.5	103.5	130.8	27.1	70.9	76.7	51.9	21.5	125.9	110.4
PID1	"FLJ20701, NYGGF4"	ENSG00000153823	"Phosphotyrosine interaction domain containing 1"	Q7Z2X4	2	228850526-229271285	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 116.5;Leydig cells: 81.4;Peritubular cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 23.5;intermediate monocyte: 26.5;myeloid DC: 28.1"	"Group enriched"	"Detected in many"	58	"dendritic cells: 28.1;monocytes: 26.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.4;hTEC/SVTERT24-B: 32.9;LHCN-M2: 21.8;REH: 22.9;RH-30: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036103	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA036103: AB_10602144"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.91e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-6)"	18.9	24.8	21.4	11.3	12.7	2.5	29.6	2.7	34.4	17.8	19.4	3.9	12.1	4.9	13.8	16.0	11.6	15.5	14.1	11.5	13.6	11.7	5.3	52.4	22.8	18.8	15.7	16.7	27.1	11.4	1.8	5.3	20.9	11.9	16.6	18.2	17.9	5.8	13.1	14.6	11.4	13.8	27.8	6.2	15.6	15.6	6.2	6.2	0.1	9.8	8.9	3.4	16.8	50.6	0.0	28.1	0.4	26.5	0.0	0.1	8.1	0.0	0.7	0.0	0.0	21.4	4.1	0.0	3.4	13.1	2.2	2.8	0.2	0.0	0.0	0.1	4.8	6.9	0.6	0.0	0.6	3.0	0.0	0.0	0.0	1.6	0.0	8.8	0.0	0.0	7.7	5.9	32.9	5.4	6.2	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.3	2.8	2.0	22.9	35.0	0.0	0.4	0.0	0.7	0.9	7.3	0.7	0.0	0.3	0.0	0.0	0.0	8.7	3.2	8.1	3.2	0.0	0.0	0.0	11.4	0.0	1.4	0.0	23.5	0.0	0.0	26.5	0.1	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.4	0.0	5.1	0.1	0.1	8.1	21.4	12.7	2.7	15.1	13.6	11.7	15.7	16.7	11.9	6.2	6.0	52.7	1.4	5.0	13.9	3.7	1.9	10.2	4.0	14.8	0.0	0.0	1.3	0.0	2.3	0.1	2.2	40.7	0.0	3.5	27.3	55.1	10.1	5.8	116.5	3.1	0.0	4.7	6.7	36.8	1.1	81.4	58.0	20.3	0.0	13.0	11.8	1.9	20.1	70.7	0.0	1.3	0.0	9.2	0.2	0.5	12.7	4.0	2.2	26.1	1.0
PIGV	FLJ20477	ENSG00000060642	"Phosphatidylinositol glycan anchor biosynthesis class V"	Q9NUD9	1	26787472-26798398	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 65.1;Spermatocytes: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054181			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA054181: "	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (7.60e-7)"	"unprognostic (1.71e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (5.96e-3)"	6.2	14.6	8.1	5.3	8.9	4.6	9.2	6.1	10.3	10.5	7.5	9.9	9.3	7.3	8.3	14.7	8.7	10.6	8.9	4.4	7.2	6.6	10.6	24.6	6.8	5.1	11.6	6.8	9.0	13.5	15.8	13.5	9.3	9.7	11.5	8.4	6.6	9.9	10.6	5.0	10.1	10.7	7.1	7.5	7.2	7.7	31.3	10.0	7.2	20.0	8.2	7.8	9.3	7.6	8.3	9.7	23.5	12.9	18.0	19.1	9.2	9.4	5.7	4.6	4.0	8.9	11.0	3.9	6.5	15.4	6.2	7.6	3.1	19.6	5.6	5.9	8.1	6.9	16.9	2.4	7.6	7.7	9.5	4.0	4.9	7.6	7.8	10.0	8.9	12.1	11.4	31.6	8.5	10.4	13.2	4.7	9.1	8.9	9.0	11.1	5.3	4.4	5.0	6.9	13.9	4.6	3.2	5.3	10.6	9.8	2.4	6.6	3.5	6.4	3.2	6.3	8.3	11.0	4.4	7.8	11.2	4.8	5.4	2.2	3.2	2.1	3.0	9.2	9.5	6.6	23.5	10.3	7.7	13.3	10.1	19.1	7.4	9.0	13.0	9.7	8.3	9.1	11.1	12.5	18.0	12.9	3.8	7.7	9.2	8.1	8.9	6.1	10.3	7.2	6.6	11.6	6.8	9.7	10.0	3.0	5.9	6.7	10.3	3.8	2.9	1.8	2.5	8.1	1.2	7.0	7.9	22.6	6.6	6.3	40.4	5.0	6.1	23.3	4.0	12.3	8.7	6.7	0.0	14.1	8.1	7.9	3.4	7.4	4.7	65.1	6.6	4.0	6.8	10.0	6.5	10.3	4.6	2.9	9.2	7.9	2.7	0.0	5.1	82.9	13.9	3.6	11.8	6.1	9.8	5.8
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007668-88077777	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 66.3;Peritubular cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 36.9;BJ hTERT+: 56.1;fHDF/TERT166: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB004544: AB_672377, HPA015794: AB_1855437"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	18.4	13.6	8.2	7.7	10.9	5.0	15.1	15.1	10.7	31.4	19.4	15.5	18.5	5.6	42.7	9.8	13.9	25.7	15.3	12.8	9.0	5.2	27.5	7.9	13.4	5.5	12.6	6.4	27.0	9.8	21.9	8.1	12.8	9.2	15.6	7.3	14.1	7.4	22.3	5.4	6.2	9.6	29.3	7.2	5.4	14.8	9.9	12.0	5.5	10.2	3.3	4.9	13.9	21.4	0.5	1.3	4.8	0.8	1.0	1.4	0.4	1.9	10.9	12.3	6.3	28.6	19.1	3.6	36.9	56.1	17.3	17.3	0.5	3.4	1.0	8.1	44.4	6.6	2.4	2.2	5.5	15.2	5.5	1.9	1.7	5.6	1.1	15.9	4.2	3.5	15.8	2.5	13.5	7.3	23.7	7.8	2.0	0.2	2.9	15.0	3.7	2.9	2.0	6.4	1.4	1.8	5.6	7.3	1.5	15.4	4.6	2.5	5.5	6.8	0.3	8.7	13.0	2.6	3.2	12.0	16.4	3.6	4.6	4.9	2.4	0.7	1.2	9.7	0.6	15.0	4.8	0.5	0.9	0.8	0.8	1.4	0.5	0.8	0.6	0.3	0.5	0.9	0.6	0.9	1.0	0.3	1.3	0.4	0.4	8.2	10.9	15.1	10.7	9.0	5.2	12.6	6.4	9.2	12.0	3.0	4.6	1.4	4.2	6.5	14.6	6.3	20.4	16.0	10.3	66.3	9.8	8.7	0.0	10.3	0.3	11.2	0.7	0.0	3.3	3.5	23.9	4.3	1.1	6.8	10.3	25.4	6.4	20.9	4.9	0.7	21.3	8.3	21.9	9.0	2.7	20.1	3.0	5.7	47.7	14.7	1.5	25.8	20.6	0.7	0.9	5.8	2.3	0.7	2.6	2.5
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607765-218637184	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 81.4;Cone photoreceptor cells: 231.7;Rod photoreceptor cells: 181.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009914, HPA038139, HPA038140"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.1	2.5	1.5	1.0	1.6	0.5	1.0	0.9	2.4	0.6	6.4	0.3	3.8	0.9	0.8	1.1	3.7	0.6	0.9	0.9	1.0	1.5	3.9	0.5	0.7	0.7	1.6	1.0	0.7	0.4	1.4	4.7	0.6	2.6	6.4	1.5	23.0	1.4	0.6	62.5	0.8	1.4	33.1	1.1	0.5	3.5	3.9	0.5	0.0	1.4	6.8	0.5	9.6	5.3	0.9	1.2	0.3	0.4	0.9	0.9	1.0	0.6	1.6	2.2	0.4	0.2	1.4	1.2	1.2	2.6	0.4	1.4	2.4	0.3	1.4	1.8	0.4	1.0	1.0	0.0	1.5	0.3	0.5	1.8	1.2	3.6	1.9	0.2	1.2	0.6	3.0	0.1	2.0	0.5	4.8	2.8	0.8	1.0	1.1	2.3	1.8	0.4	1.2	0.7	0.2	3.4	0.9	0.8	0.5	4.4	3.0	2.3	21.5	1.0	0.8	0.3	1.3	2.6	0.5	6.1	1.6	1.2	0.7	0.7	0.5	0.8	0.9	4.7	0.3	1.6	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.3	0.9	0.3	0.9	0.7	0.8	0.3	0.9	0.0	1.2	0.7	1.0	1.5	1.6	0.9	2.4	1.0	1.5	1.6	1.0	2.6	0.5	0.0	1.4	0.0	0.2	0.5	81.4	0.8	0.0	0.0	0.0	0.0	231.7	0.1	0.0	0.2	14.2	1.1	0.0	0.0	0.0	12.6	0.6	0.0	0.0	0.0	0.5	7.9	0.0	0.0	0.0	22.0	0.3	0.0	0.0	0.0	0.0	8.8	0.4	0.0	0.0	1.4	181.4	0.0	1.4	2.2	0.8	0.1	0.7	0.0	0.0	0.1
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 638.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 149.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 149.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		490000	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	45.7	57.5	44.6	23.1	79.0	12.8	21.9	35.5	126.1	31.2	23.5	25.4	17.1	22.6	26.3	35.0	18.3	30.0	30.8	33.0	46.4	73.4	22.1	25.6	49.7	25.2	44.7	53.9	44.8	42.5	32.9	122.1	38.9	62.2	29.6	16.1	31.6	35.3	37.2	27.4	24.2	23.5	25.6	28.6	48.9	23.0	17.0	19.3	11.9	20.6	11.2	12.9	27.3	20.7	3.6	23.0	149.2	24.6	9.7	7.8	16.8	14.1	43.7	28.3	44.5	78.9	37.6	21.6	35.1	35.8	25.5	29.2	8.3	16.0	6.1	36.9	30.5	8.3	6.6	6.8	13.8	11.2	22.9	24.9	6.6	15.0	10.4	53.9	2.7	75.9	71.5	28.9	19.4	13.4	42.8	21.4	10.1	23.3	24.9	18.3	18.5	4.8	13.1	18.5	23.2	9.0	6.1	21.6	25.2	13.1	10.6	20.3	33.8	16.8	10.4	18.8	30.9	14.3	47.6	37.6	21.5	10.3	18.2	7.8	26.0	27.7	6.3	34.6	11.0	13.3	149.2	24.6	35.3	7.8	12.8	6.4	3.6	6.2	6.9	23.0	3.1	6.5	6.5	2.5	9.7	5.7	3.3	6.1	16.8	44.6	79.0	35.5	126.1	46.4	73.4	44.7	53.9	62.2	19.3	29.8	62.9	34.4	70.6	31.5	98.5	18.5	25.5	12.0	28.4	54.1	31.4	137.8	18.3	50.7	5.8	46.8	52.7	0.0	51.3	94.8	142.4	49.1	59.9	35.8	638.2	114.4	69.9	90.9	219.8	8.6	140.4	84.2	87.7	44.1	36.8	99.5	49.7	41.2	135.1	30.0	39.3	19.4	53.1	13.9	57.5	29.2	163.8	35.4	34.5	52.0
PLSCR2		ENSG00000163746	"Phospholipid scramblase 2"	Q9NRY7	3	146391421-146495991	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 8.1;testis: 16.8"	"Group enriched"	"Detected in some"	25	"Early spermatids: 161.5;Late spermatids: 194.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.9;EFO-21: 2.3;GAMG: 3.7;Karpas-707: 2.5;U-266/70: 2.1"									HPA051352			Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA051352: "	"unprognostic (1.11e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.94e-3)"	"unprognostic (7.53e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.88e-4)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.23e-2)"	0.3	0.3	0.3	1.7	0.3	1.3	0.4	1.0	0.4	0.4	1.5	0.0	1.3	0.2	0.3	8.1	0.6	0.9	1.4	0.3	1.1	0.3	1.4	0.3	1.0	1.8	0.3	0.4	1.0	1.2	0.3	3.2	0.5	1.6	0.4	0.5	0.6	1.4	3.0	0.3	0.3	0.4	0.2	0.8	0.3	0.5	16.8	0.0	0.1	2.5	0.7	0.1	0.3	2.2	0.6	0.5	1.7	1.1	1.3	1.6	0.6	0.0	0.3	0.0	0.0	0.0	1.4	0.2	0.0	0.4	0.6	0.8	0.2	1.9	0.0	2.3	0.0	3.7	0.2	0.3	0.0	0.4	0.1	0.4	0.6	0.8	0.2	0.8	0.0	0.7	0.5	0.5	0.2	0.9	0.6	0.0	0.2	0.3	2.5	0.1	0.0	0.0	0.0	0.5	0.0	1.5	0.2	0.0	0.0	1.5	0.0	0.6	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.6	0.6	1.3	0.6	0.9	1.4	0.5	0.3	1.4	1.6	1.7	1.3	0.0	0.4	0.0	0.6	0.3	0.3	1.0	0.4	1.1	0.3	0.3	0.4	1.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.5	1.4	0.0	7.0	0.0	0.1	1.7	0.8	161.5	0.0	0.0	0.0	0.5	0.1	0.3	0.3	0.0	0.0	0.1	0.0	1.7	0.6	0.0	194.1	1.7	0.3	0.0	0.0	0.0	1.0	0.7	0.0	1.4	1.1	0.3	0.0	0.1	4.8	2.3	0.1	0.0	0.0	0.6	0.1
PMEL	"D12S53E, gp100, Pmel17, SI, SIL, SILV"	ENSG00000185664	"Premelanosome protein"	P40967	12	55954105-55973317	"Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 230.1"	"Cell type enriched"	"Detected in many"	34	"Melanocytes: 1396.9"	"Cancer enriched"	"Detected in many"	500	"melanoma: 2481.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	66	"SK-MEL-30: 442.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031649	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA		14000000	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA031649: AB_2673976"	"unprognostic (4.63e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.98e-1)"	"prognostic favorable (3.70e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.04e-1)"	0.9	0.1	0.4	0.4	0.5	0.4	3.4	0.4	0.5	38.2	1.0	0.4	0.5	0.4	11.8	0.4	0.4	0.2	0.6	0.5	0.4	0.0	0.6	1.8	0.7	1.9	0.4	0.4	1.6	0.6	0.9	0.4	0.9	0.4	0.5	0.2	230.1	1.1	0.4	0.6	46.8	0.6	1.3	0.8	0.4	0.2	1.5	0.4	0.4	0.4	0.6	0.6	0.5	0.8	1.3	2.3	2.1	1.4	0.2	1.9	0.6	0.7	0.0	0.2	0.0	4.5	0.0	6.6	0.0	0.0	0.1	0.1	0.6	0.3	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	442.3	0.2	0.2	0.4	0.0	0.0	0.3	0.0	0.4	0.1	0.5	0.1	0.0	0.1	0.0	0.0	1.4	0.7	0.3	0.0	1.9	1.3	0.5	0.4	0.0	0.9	1.1	0.1	2.1	0.2	0.4	2.3	0.4	0.6	0.4	0.5	0.4	0.5	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.3	0.0	0.6	40.8	0.0	0.2	2.5	0.0	2.3	0.0	0.0	8.0	0.0	1.3	6.7	0.6	1.3	0.0	2.0	12.0	2.4	0.7	0.0	2.4	1.5	0.0	0.0	0.0	0.3	4.1	11.2	0.3	1396.9	1.0	1.5	0.3	0.9	0.0	0.7	2.1	0.0	0.0	0.5	3.0	2.7	8.9	20.8	0.0	1.5	0.3
PMFBP1		ENSG00000118557	"Polyamine modulated factor 1 binding protein 1"	Q8TBY8	16	72112157-72176878	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.6;testis: 30.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 98.0;Late spermatids: 189.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 21.0;SH-SY5Y: 10.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA056716, HPA075825"	Approved		Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA056716: AB_2683215, HPA075825: "	"unprognostic (1.46e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.68e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.67e-2)"	1.1	0.9	1.1	1.1	1.1	3.9	1.1	2.1	1.1	1.1	2.1	1.1	1.1	2.6	1.1	13.6	1.6	0.9	1.1	1.1	1.1	0.7	1.3	1.6	1.1	1.5	1.1	1.1	1.5	4.2	2.9	1.5	1.1	1.1	2.1	3.3	1.1	1.1	1.1	1.1	4.1	2.9	1.1	1.1	2.9	1.1	30.8	1.1	1.1	1.1	1.1	1.1	1.1	1.1	0.5	1.9	0.9	2.0	0.0	0.3	0.2	0.2	0.4	2.8	2.5	0.0	0.6	1.8	0.5	0.2	0.5	2.1	1.0	2.6	1.8	0.4	0.1	0.1	1.8	1.0	0.1	1.3	0.2	4.2	1.8	3.0	2.9	0.0	4.1	3.2	0.0	0.8	0.1	2.1	0.6	0.8	2.1	0.3	1.6	0.1	2.3	1.0	6.0	0.8	0.1	1.2	2.7	0.2	1.4	0.3	0.7	21.0	10.5	0.0	0.0	0.2	2.0	0.5	2.6	1.7	1.3	2.1	0.6	1.3	3.9	1.4	1.2	0.6	2.7	0.7	0.0	1.6	0.9	0.1	0.5	0.0	0.0	0.1	0.2	1.6	0.5	0.1	0.1	0.2	0.0	2.0	1.9	0.3	0.2	1.1	1.1	2.1	1.1	1.1	0.7	1.1	1.1	1.1	1.1	0.0	1.1	0.0	0.1	0.3	0.0	0.7	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	98.0	0.2	0.0	0.0	0.2	0.1	0.2	0.1	3.5	0.0	4.6	28.6	5.2	0.0	1.0	189.3	1.1	2.8	0.0	0.0	0.3	1.3	0.1	0.0	1.4	0.3	0.1	0.0	0.1	1.6	0.8	0.0	0.1	0.0	0.5	0.0
PNPLA6	"iPLA2delta, NTE, SPG39, sws"	ENSG00000032444	"Patatin like phospholipase domain containing 6"	Q8IY17	19	7534004-7561764	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007522, HPA064773"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA007522: AB_1079649, HPA064773: "	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (3.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (7.53e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	12.9	19.7	25.9	25.0	29.3	22.3	17.8	22.1	35.8	10.2	15.9	26.1	10.0	26.3	13.7	6.3	16.4	12.6	14.0	12.0	22.6	19.1	17.1	13.7	30.4	17.6	36.3	19.2	12.5	14.2	15.6	21.6	13.9	29.2	13.4	8.9	15.8	13.7	14.3	27.0	15.3	28.7	14.5	23.5	28.3	12.2	31.3	33.0	7.1	14.7	6.1	8.8	15.9	14.7	3.8	7.3	21.8	19.0	5.0	3.9	4.1	13.2	31.9	6.3	15.2	11.0	16.0	14.5	17.2	17.7	13.4	12.4	7.4	18.3	10.9	29.3	22.2	8.3	17.0	5.3	16.2	6.9	26.6	12.3	7.2	17.0	5.6	12.7	8.0	22.5	13.8	9.4	17.2	10.0	21.3	26.4	13.0	5.9	15.1	11.9	6.2	8.8	10.5	6.9	6.2	29.3	7.1	3.8	12.8	11.9	12.6	8.0	13.9	14.6	6.6	18.7	8.9	5.9	11.5	27.9	16.3	9.6	22.3	18.0	17.9	11.5	4.8	27.4	9.5	15.2	7.9	6.1	21.8	3.5	12.1	3.5	3.8	2.5	3.8	7.3	2.8	2.2	2.9	1.9	5.0	19.0	2.4	3.9	4.1	25.9	29.3	22.1	35.8	22.6	19.1	36.3	19.2	29.2	33.0	6.0	11.8	6.5	2.7	4.2	10.9	8.6	17.8	8.1	6.8	31.4	25.5	14.9	1.7	13.7	60.0	10.8	52.1	0.0	6.1	12.2	4.1	4.5	11.5	19.2	24.9	20.6	16.7	10.4	55.8	82.5	8.9	23.8	8.5	10.0	13.4	10.6	8.4	12.9	7.1	17.0	16.2	0.0	6.2	58.2	10.0	4.8	10.4	10.0	14.0	3.1
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468938-119494708	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	13	"monocytes: 247.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (2.23e-4)"	11.9	12.1	7.6	10.7	12.0	3.9	10.9	13.9	10.6	10.1	9.5	9.8	27.4	5.9	13.7	11.7	9.3	10.1	6.9	8.3	7.3	8.9	8.3	10.3	9.1	14.3	15.0	5.6	10.5	29.2	12.1	14.5	11.5	10.9	9.4	10.9	8.7	7.8	25.7	5.1	14.0	12.1	15.2	14.0	14.9	8.2	4.7	8.9	11.7	8.6	4.1	15.6	10.6	10.2	9.9	14.3	9.4	11.5	19.8	16.0	10.3	7.5	5.1	8.8	9.8	22.3	12.8	6.3	12.1	12.4	9.9	13.5	8.3	4.9	11.7	16.4	15.2	7.9	9.0	11.8	12.0	15.7	10.1	7.7	13.7	8.0	8.9	14.6	15.0	16.2	13.2	7.9	9.7	13.7	11.5	11.2	7.9	7.5	14.3	10.0	7.6	8.6	14.6	9.1	13.3	9.3	8.5	9.0	17.2	8.6	9.8	9.7	14.8	5.8	3.6	9.4	9.0	9.7	12.6	14.1	9.7	6.0	2.8	6.2	19.7	17.1	15.9	8.4	15.3	13.6	1.9	11.5	9.4	12.0	10.8	13.8	9.9	13.6	12.5	14.3	7.0	16.0	15.2	0.9	19.8	7.0	8.0	14.7	10.3	7.6	12.0	13.9	10.6	7.3	8.9	15.0	5.6	10.9	8.9	0.0	3.8	8.8	5.8	14.9	14.7	3.4	15.3	6.7	7.9	19.2	5.9	9.2	0.0	6.3	0.5	13.9	6.5	0.0	4.5	12.3	10.1	5.0	17.3	9.8	7.5	4.8	9.1	11.1	13.0	0.0	8.1	16.5	11.8	247.1	11.4	12.1	5.1	7.0	15.9	5.5	12.5	12.9	9.9	1.4	0.9	13.0	5.5	14.6	12.1	5.8
POU2F1	"OCT1, OTF1"	ENSG00000143190	"POU class 2 homeobox 1"	P14859	1	167220829-167427345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002608, HPA058559, HPA064323"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		No	No			"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB002608: , HPA058559: AB_2683756, HPA064323: AB_2685245"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-3)"	"unprognostic (4.26e-2)"	"unprognostic (5.67e-6)"	"unprognostic (4.47e-2)"	"unprognostic (5.14e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.17e-2)"	6.9	5.7	15.5	7.3	11.9	12.6	7.2	36.4	13.8	7.7	6.6	9.5	5.2	4.1	7.5	8.4	5.3	6.5	4.3	5.1	14.5	6.7	7.0	5.8	6.6	8.2	7.7	10.8	8.1	6.1	15.5	8.3	9.6	7.1	6.7	6.8	12.0	5.5	6.5	10.5	8.8	6.6	5.5	6.3	9.3	6.1	10.1	10.9	7.4	6.9	4.9	9.7	7.6	6.2	7.5	5.9	8.6	5.9	1.4	4.4	2.2	6.4	5.2	13.5	4.1	1.6	1.6	5.5	0.8	1.4	1.6	1.6	7.5	3.7	7.3	3.5	1.3	1.5	5.0	8.2	2.5	2.4	2.9	3.1	5.1	3.6	6.1	1.0	5.6	3.4	1.1	1.4	1.8	3.3	2.0	2.1	5.1	5.4	4.2	2.1	3.4	5.1	3.6	15.7	3.5	2.1	7.5	4.9	3.2	2.8	3.6	8.2	6.2	5.0	3.7	3.3	7.1	4.1	6.9	3.4	3.1	4.9	1.9	3.1	4.0	1.8	16.9	1.4	3.4	3.9	8.6	2.3	2.8	4.4	2.7	3.3	7.5	2.3	2.0	2.5	6.8	3.2	2.4	3.3	1.4	5.9	5.9	2.1	2.2	15.5	11.9	36.4	13.8	14.5	6.7	7.7	10.8	7.1	10.9	11.9	12.1	21.9	10.4	11.8	54.9	13.2	12.7	6.7	10.3	19.2	96.2	15.4	5.0	8.8	23.3	16.6	8.5	0.0	10.1	15.3	13.4	14.9	19.6	11.6	11.2	44.5	23.2	11.1	35.6	28.6	23.9	14.6	6.8	23.4	14.3	47.2	12.6	7.0	19.4	6.9	106.3	25.8	11.9	18.5	40.0	9.7	43.3	13.8	13.0	9.7
PPIB	"CYPB, OI9"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155812-64163205	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	No	No		120000000	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	56.9	64.3	23.9	49.3	26.9	54.9	48.1	15.1	32.1	75.3	44.1	35.4	102.8	42.0	64.2	106.9	48.0	54.8	58.1	44.5	23.8	27.3	89.5	285.9	57.2	63.8	29.7	19.6	67.5	193.7	26.7	71.8	120.2	27.5	51.0	47.7	36.2	123.3	95.4	19.5	33.1	57.5	54.3	30.7	78.0	47.7	27.2	29.5	53.7	154.3	45.7	69.1	49.2	51.7	63.5	191.6	41.0	51.1	44.9	71.6	87.1	39.7	50.0	45.2	102.6	158.3	91.9	39.8	94.9	124.7	75.2	89.4	71.9	73.8	38.0	77.2	147.0	76.4	64.9	82.5	63.8	38.8	24.1	31.1	53.6	55.2	94.1	166.0	53.4	48.5	84.6	68.8	43.8	106.9	93.2	90.8	18.2	37.3	132.4	56.9	63.5	16.3	82.0	39.4	110.7	32.2	31.2	48.0	193.7	78.0	62.0	25.6	40.3	43.5	74.8	69.1	69.6	44.7	163.5	55.8	75.2	62.3	42.0	64.0	71.9	69.6	39.9	70.2	86.1	75.0	41.0	51.1	33.9	71.6	39.2	71.5	63.5	50.5	58.1	67.4	38.0	33.0	44.2	25.5	44.9	25.2	191.6	40.1	87.1	23.9	26.9	15.1	32.1	23.8	27.3	29.7	19.6	27.5	29.5	116.1	168.3	153.4	361.8	142.3	26.7	0.7	280.2	128.5	194.5	258.2	29.5	546.5	76.3	534.3	16.2	209.5	301.3	70.0	495.6	1107.3	581.4	486.2	176.7	431.7	566.9	42.9	284.9	371.4	213.7	20.8	422.5	284.2	266.6	285.9	313.7	126.6	471.5	326.7	369.5	231.9	33.9	226.4	234.9	37.1	72.8	126.6	935.7	261.7	353.5	357.9
PRAF2	"JM4, Yip6a"	ENSG00000243279	"PRA1 domain family member 2"	O60831	X	49071156-49074071	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 125.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA002859, HPA005504, CAB011655"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"CAB011655: , HPA002859: AB_1079672, HPA005504: AB_2667340"	"unprognostic (1.50e-1)"	"prognostic favorable (7.42e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.67e-1)"	"prognostic unfavorable (1.66e-6)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"prognostic favorable (4.88e-6)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (5.83e-6)"	"unprognostic (4.96e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	13.5	17.5	25.0	12.3	26.9	6.7	9.0	18.0	39.7	28.1	11.8	26.3	12.6	6.0	22.1	125.1	7.3	15.6	12.3	12.9	25.3	29.9	12.4	6.9	11.5	11.3	26.1	18.9	20.1	6.2	19.7	31.0	9.8	25.5	12.2	10.0	13.0	7.5	29.4	6.8	7.6	6.6	33.2	23.1	10.9	9.2	17.7	17.0	14.4	13.3	3.8	11.9	12.6	10.7	14.6	6.7	16.4	6.4	16.8	29.4	11.1	4.5	9.6	11.3	14.4	40.6	24.7	1.5	16.4	17.1	11.1	12.3	0.5	1.5	0.4	3.9	35.4	9.2	4.3	0.4	8.9	12.4	8.4	12.8	3.6	12.5	0.4	41.6	2.3	7.1	31.3	7.6	21.1	15.4	23.0	17.0	11.5	0.5	1.3	19.4	8.4	15.1	2.9	6.3	2.2	0.6	8.3	6.2	1.0	16.5	1.3	7.5	18.8	13.7	7.1	9.3	10.3	6.9	1.6	10.3	8.6	11.4	18.4	4.7	20.4	5.1	3.7	20.7	4.2	13.3	16.4	5.9	7.9	18.3	6.4	20.7	14.6	20.1	16.1	6.7	13.6	18.1	19.4	15.4	16.8	4.8	2.6	29.4	11.1	25.0	26.9	18.0	39.7	25.3	29.9	26.1	18.9	25.5	17.0	11.9	7.7	10.0	12.1	6.8	21.7	5.1	12.7	10.7	9.1	10.4	11.8	2.9	10.0	14.9	2.9	30.3	1.3	0.0	5.0	10.4	36.2	8.7	16.1	2.5	5.8	15.9	9.8	23.9	4.6	3.5	35.4	7.7	13.5	3.6	3.4	26.4	4.6	0.0	38.9	15.8	6.7	19.4	40.1	10.7	3.9	6.5	8.1	25.3	1.3	8.1
PRDX4	AOE37-2	ENSG00000123131	"Peroxiredoxin 4"	Q13162	X	23664262-23686399	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 127.6;pancreas: 320.8"	"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 604.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008659, CAB027389, CAB047362, HPA067039"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		11000000	"Endoplasmic reticulum, Cytosol"		"CAB008659: AB_1620984, CAB027389: , CAB047362: , HPA067039: "	"unprognostic (3.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (7.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.10e-2)"	11.6	14.8	3.8	7.0	6.4	3.9	11.2	3.3	5.4	13.2	10.7	6.5	17.4	8.9	11.5	10.5	13.1	9.6	12.9	17.6	3.8	4.0	11.8	127.6	8.9	16.9	7.2	4.0	14.6	320.8	6.1	15.8	21.9	7.4	9.3	11.4	8.0	25.4	14.1	7.8	7.2	10.6	8.8	8.1	12.6	12.8	25.2	6.1	4.7	12.0	10.0	15.0	10.8	8.7	27.9	31.4	2.0	39.3	24.1	22.7	21.3	23.9	33.1	14.0	27.1	76.5	39.1	19.7	32.3	35.2	29.4	42.8	34.6	30.2	20.6	15.2	41.8	34.1	29.1	40.3	20.0	28.1	12.6	77.5	14.6	29.2	43.8	31.9	18.8	13.9	41.4	26.0	28.5	28.7	32.0	36.7	6.9	28.2	76.2	27.1	35.7	9.6	29.5	48.4	47.1	48.6	13.3	35.1	116.3	26.2	8.4	20.6	17.5	29.8	35.3	23.8	80.2	37.3	24.0	24.2	21.0	13.8	54.0	24.2	25.0	30.2	22.1	37.5	24.4	29.8	1.7	20.6	2.0	17.8	32.2	21.8	27.9	22.7	18.6	31.4	16.2	16.4	16.7	1.5	24.1	39.3	22.0	22.1	21.3	3.8	6.4	3.3	5.4	3.8	4.0	7.2	4.0	7.4	6.1	53.6	69.3	34.3	72.4	53.0	14.1	33.1	117.2	62.9	56.9	47.1	7.9	283.9	8.3	219.7	305.3	87.4	33.6	23.3	310.3	449.8	156.0	130.0	41.6	497.8	155.7	11.1	56.3	100.1	55.2	604.6	233.8	49.6	189.0	103.6	79.9	51.0	268.1	31.6	135.4	36.5	17.9	142.3	69.0	183.9	270.0	45.7	216.3	25.4	110.8	64.0
PREB	SEC12	ENSG00000138073	"Prolactin regulatory element binding"	Q9HCU5	2	27130756-27134675	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 89.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013582, HPA014133"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013582: AB_1855694, HPA014133: AB_1855695"	"unprognostic (2.32e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.28e-2)"	18.7	17.1	11.4	14.4	12.3	7.9	15.7	13.8	16.9	18.5	15.5	14.9	29.1	13.4	23.6	51.1	15.1	17.6	14.2	19.5	13.8	12.5	21.2	70.1	12.9	15.3	13.0	11.8	27.3	31.5	13.8	17.0	21.5	12.9	16.2	13.2	14.8	42.3	22.4	46.3	11.0	17.3	19.4	11.6	19.8	14.9	15.6	10.1	17.6	19.6	16.3	19.5	15.1	14.2	22.1	35.1	45.8	28.3	28.9	27.0	27.2	15.4	15.5	9.0	14.3	19.6	7.6	16.8	11.2	11.2	16.3	11.5	14.5	9.7	19.2	11.9	11.0	17.6	8.9	17.6	14.0	8.9	14.4	16.1	15.7	7.8	31.3	29.1	17.9	14.9	7.5	17.0	15.3	17.6	8.0	10.5	15.4	11.5	17.3	13.9	17.9	16.6	13.9	9.4	20.0	16.5	15.7	18.1	89.8	10.8	8.2	20.4	11.0	10.8	22.3	16.0	8.4	10.0	30.9	6.2	8.7	12.7	7.5	12.5	38.6	16.1	23.2	14.6	20.5	16.5	28.2	28.3	45.8	24.7	23.4	27.0	22.1	21.1	25.0	29.5	20.1	20.5	21.1	12.0	28.9	24.3	35.1	22.8	27.2	11.4	12.3	13.8	16.9	13.8	12.5	13.0	11.8	12.9	10.1	14.9	10.1	22.3	8.5	16.0	12.0	14.1	20.4	1.4	3.4	19.2	11.8	39.5	29.9	25.3	2.8	9.0	22.4	0.0	31.0	52.2	16.7	13.3	24.1	28.8	33.7	6.4	8.1	13.5	17.2	6.0	21.9	12.8	18.6	16.2	13.2	20.3	27.2	17.5	42.1	21.4	9.6	32.3	19.8	29.8	46.7	15.2	64.8	24.9	17.0	11.2
PREX2	"DEP.2, DEPDC2, FLJ12987, P-REX2, PPP1R129"	ENSG00000046889	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2"	Q70Z35	8	67952118-68237030	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 31.5;Endothelial cells: 35.0;Ito cells: 52.8;Muller glia cells: 74.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 12.8;HUVEC TERT2: 17.4;JURKAT: 7.5;NTERA-2: 11.1;RH-30: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015234, HPA075956"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA015234: AB_1847604, HPA075956: AB_2686769"	"unprognostic (2.25e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (6.64e-2)"	18.8	3.0	14.1	3.3	17.9	1.0	8.5	11.4	16.4	10.8	4.4	13.1	3.0	4.3	6.2	4.5	4.4	12.4	7.6	7.6	15.5	8.1	4.1	3.2	9.1	2.4	12.4	10.0	5.2	3.1	3.7	4.4	17.5	17.2	6.3	4.4	2.6	3.0	5.7	4.9	4.4	4.0	6.1	12.7	3.5	4.1	2.7	16.2	0.0	12.1	3.9	2.9	5.9	15.8	1.1	0.3	0.8	0.1	0.2	0.4	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	7.5	0.0	0.0	0.0	0.0	2.6	0.0	11.1	0.0	0.0	0.0	5.0	0.0	0.6	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.1	0.1	0.4	0.1	0.2	0.5	0.2	0.2	0.0	1.1	0.2	0.3	0.5	0.2	0.1	0.3	0.0	0.0	14.1	17.9	11.4	13.6	15.5	8.1	12.4	10.0	17.2	16.2	3.0	5.3	0.0	3.2	3.5	24.6	4.4	0.0	1.4	5.7	1.8	2.0	0.0	0.0	0.0	31.5	35.0	0.0	0.0	0.0	0.0	5.5	0.5	1.1	0.4	0.1	4.8	0.0	52.8	3.1	4.9	10.3	0.2	8.5	0.0	0.0	74.9	0.0	0.0	9.9	0.0	3.0	25.8	3.4	0.7	0.7	2.3	0.0	0.0	0.0	1.4
PRKCD		ENSG00000163932	"Protein kinase C delta"	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 17.7;classical monocyte: 22.9;eosinophil: 17.0;intermediate monocyte: 22.2;myeloid DC: 17.6;neutrophil: 20.7;non-classical monocyte: 15.3;plasmacytoid DC: 8.5"	"Group enriched"	"Detected in all"	7	"dendritic cells: 17.6;granulocytes: 20.7;monocytes: 22.9"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 64.7;THP-1: 46.1"	"Group enriched"	"Detected in many"	5	"basal ganglia: 124.2;thalamus: 366.1"	"Low region specificity"	"Detected in all"			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		300000	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	"unprognostic (3.59e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.24e-4)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.95e-3)"	27.8	33.4	9.4	29.7	11.5	30.3	17.6	5.7	10.7	10.3	27.8	10.1	43.7	21.4	5.5	21.3	18.3	16.1	33.7	11.9	8.3	3.7	16.5	4.5	29.2	24.5	10.2	5.6	8.1	13.4	6.1	5.1	7.5	7.1	17.9	16.1	10.3	14.1	40.7	3.9	17.1	42.9	17.4	10.2	32.1	24.8	9.6	8.0	10.5	26.9	13.4	26.3	22.9	12.7	3.1	17.6	20.7	22.9	2.4	1.5	6.4	7.9	3.0	1.2	2.1	9.2	5.3	11.4	4.8	6.1	5.9	5.8	7.4	7.8	20.4	2.1	10.4	10.3	3.6	8.1	11.8	4.9	17.8	6.1	11.3	4.2	7.9	5.9	14.9	25.7	4.1	8.6	6.1	5.6	5.3	5.1	2.2	2.2	2.9	8.5	19.5	1.6	25.5	3.2	11.9	5.6	1.7	3.1	4.9	6.4	17.0	2.0	1.4	3.6	64.7	9.9	6.3	5.4	46.1	7.4	2.9	3.6	3.8	4.5	4.5	6.9	10.5	6.8	25.8	5.5	17.7	22.9	17.0	1.5	22.2	1.0	3.1	1.1	1.2	17.6	2.9	0.8	0.7	20.7	2.4	15.3	8.5	1.1	6.4	9.4	11.5	5.7	10.7	8.3	3.7	10.2	5.6	7.1	8.0	3.0	19.7	17.6	21.2	26.0	0.0	4.5	12.7	16.0	17.0	14.0	0.0	2.5	3.3	7.6	26.7	1.8	56.8	0.0	9.6	13.5	8.7	14.8	5.7	1.7	38.4	1.6	25.5	3.7	43.0	59.4	8.3	35.2	10.1	21.6	29.0	1.8	10.3	49.1	6.3	10.9	0.0	6.5	9.4	5.2	1.9	24.3	7.3	7.5	20.6	28.8
PRKCSH	"G19P1, GIIB, PCLD, PLD1, VASAP-60"	ENSG00000130175	"Protein kinase C substrate 80K-H"	P14314	19	11435288-11450968	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004465, HPA041940, HPA043560"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		62000000	"Endoplasmic reticulum"		"CAB004465: AB_626622, HPA041940: AB_2677758, HPA043560: AB_2678553"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.18e-1)"	46.9	37.4	26.9	32.5	28.5	50.9	45.0	37.8	39.4	46.8	42.6	36.3	50.1	43.6	50.1	48.4	41.2	50.2	50.2	31.5	27.7	27.3	41.2	85.6	39.9	53.2	29.6	32.1	72.6	77.7	52.9	40.3	72.7	27.0	48.8	38.4	43.9	58.8	53.1	31.3	43.8	41.8	40.1	38.6	42.5	37.9	42.8	29.8	51.6	60.1	32.7	41.9	44.6	44.9	26.2	44.1	32.8	29.8	19.5	28.5	19.4	48.4	34.0	37.8	63.3	64.8	84.0	39.3	52.2	71.3	61.2	57.8	49.6	54.6	31.2	84.6	71.8	30.6	48.2	38.9	56.8	49.6	33.4	25.0	27.1	42.7	43.0	48.5	42.2	39.8	76.7	42.5	57.5	45.4	75.7	41.9	35.1	31.3	70.7	52.9	71.5	32.9	48.8	79.5	23.1	44.0	35.2	34.5	79.3	42.6	42.5	24.0	47.3	45.6	47.5	42.7	36.1	48.8	46.8	42.2	74.4	35.1	70.5	61.1	87.0	103.5	21.7	56.9	44.4	50.7	15.9	29.8	23.8	24.9	22.2	28.5	23.9	21.0	23.8	22.6	26.2	20.3	21.3	32.8	19.5	24.4	44.1	22.0	19.4	26.9	28.5	37.8	39.4	27.7	27.3	29.6	32.1	27.0	29.8	11.9	16.3	75.4	50.7	37.2	17.1	7.8	66.2	16.0	11.4	61.1	31.4	147.4	28.2	75.5	15.3	39.1	147.7	0.0	111.1	158.0	54.4	53.8	41.5	78.4	82.6	9.5	56.6	52.2	73.7	39.6	72.8	59.1	50.6	87.4	103.8	61.8	88.9	99.5	68.2	54.0	21.2	38.8	46.2	36.5	51.7	33.1	120.0	55.4	107.3	50.1
PRR11	FLJ11029	ENSG00000068489	"Proline rich 11"	Q96HE9	17	59155499-59204705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.8"	"Cell type enhanced"	"Detected in many"	14	"Erythroid cells: 46.7;Extravillous trophoblasts: 19.2;Kupffer cells: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 10.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023923, HPA052376"	Uncertain		Approved	"Endoplasmic reticulum"		Yes	Yes			"Endoplasmic reticulum"		"HPA023923: AB_1855783, HPA052376: AB_2681803"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.55e-3)"	3.2	1.4	2.8	13.8	4.2	14.9	2.0	0.9	2.8	3.1	4.2	2.2	0.7	6.9	2.0	2.1	10.3	1.7	2.1	1.4	3.1	2.3	1.7	1.1	3.4	9.6	3.2	1.6	1.7	1.0	0.2	0.6	4.8	2.0	1.2	5.5	1.2	2.2	0.5	1.3	2.9	4.8	3.2	5.1	7.3	2.5	2.5	2.1	40.8	1.3	7.7	11.7	2.8	3.2	1.4	3.0	2.5	10.6	0.7	2.0	0.8	27.6	13.3	21.0	6.1	0.6	4.9	8.6	17.2	10.8	17.9	14.3	16.4	18.7	17.9	17.6	12.6	14.6	10.2	16.1	17.7	39.3	24.8	10.3	19.7	14.7	11.0	0.2	20.8	8.3	1.1	1.3	19.7	26.2	4.4	20.2	15.0	10.7	19.5	19.1	21.5	20.4	3.7	8.7	13.0	22.5	16.4	31.5	11.5	4.8	7.5	9.1	12.6	14.2	5.2	7.5	10.6	14.0	8.0	13.7	36.8	43.0	18.5	30.6	12.6	24.2	18.0	8.2	11.6	35.9	1.0	2.3	2.5	0.8	5.1	0.3	1.4	0.6	1.0	3.0	0.9	0.6	0.8	2.3	0.7	10.6	1.6	2.0	0.8	2.8	4.2	0.9	2.8	3.1	2.3	3.2	1.6	2.0	2.1	0.0	1.7	7.0	1.9	1.6	2.0	0.8	0.0	0.0	2.3	0.0	0.0	1.8	0.0	0.3	0.5	1.1	0.4	46.7	0.4	19.2	1.6	1.0	2.3	0.0	6.5	1.6	4.7	3.7	13.3	0.2	0.9	5.1	1.7	6.4	2.2	0.8	0.6	0.0	2.1	0.3	2.8	0.0	2.1	3.0	5.1	1.1	1.7	2.5	4.3	1.4
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1708	"pancreas: 3057.4"	"Cell type enriched"	"Detected in some"	17	"Exocrine glandular cells: 49265.4"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.7;OE19: 10.1;RPMI-8226: 5.4;U-2 OS: 3.2;U-266/84: 1.9"									"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		26000000000	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favorable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.12e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3057.4	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	1.7	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.1	0.0	1.9	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	49265.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	208.2	0.0	0.5	2827.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1
PRSS2	TRY2	ENSG00000275896	"Serine protease 2"	P07478	7	142760398-142774564	"Enzymes, Plasma proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	708	"pancreas: 6267.9"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 92348.3"	"Cancer enriched"	"Detected in many"	72	"pancreatic cancer: 3463.4"					"Group enriched"	"Detected in some"	6	"basophil: 5.6;T-reg: 5.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.6;T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"OE19: 11.6;RPMI-8226: 37.4;U-2 OS: 8.1"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		27000000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"prognostic favorable (2.32e-4)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-3)"		"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.36e-1)"		"unprognostic (4.62e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.6	6267.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.6	0.0	0.7	5.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	2.4	0.2	0.0	0.0	0.0	1.1	0.0	11.6	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.5	2.1	0.0	1.6	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.1	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	307.0	0.0	0.0	0.0	0.0	92348.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	608.7	0.0	0.0	14696.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS3	"PRSS4, TRY3, TRY4"	ENSG00000010438	"Serine protease 3"	P35030	9	33750466-33799231	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"pancreas: 984.9"	"Cell type enhanced"	"Detected in many"	19	"Enterocytes: 998.3;Exocrine glandular cells: 1691.4;Pancreatic endocrine cells: 545.2;Paneth cells: 388.3"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	82	"basophil: 39.0"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 39.0"	"Group enriched"	"Detected in some"	5	"OE19: 46.2;PC-3: 121.2"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		490000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.94e-2)"	"unprognostic (7.75e-4)"	"unprognostic (5.46e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-1)"	0.3	0.3	1.6	1.7	1.5	0.2	0.2	2.8	4.2	0.9	8.2	0.0	0.0	2.8	0.2	0.2	2.9	0.2	4.8	0.4	1.2	0.7	0.3	0.4	0.2	0.2	0.3	1.6	0.7	984.9	0.2	0.1	0.2	2.3	0.2	2.3	0.0	0.6	0.2	0.2	2.0	23.9	0.3	0.2	0.2	0.8	0.3	0.0	0.0	0.2	6.6	3.5	0.2	1.3	0.0	0.1	39.0	0.4	0.1	0.3	0.1	1.7	1.9	0.1	0.0	0.0	0.9	0.0	4.8	1.1	0.5	0.2	4.7	0.4	0.0	0.0	2.1	0.0	2.1	0.0	4.4	1.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.5	15.8	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	46.2	121.2	0.0	0.0	0.0	0.0	0.2	0.0	12.2	0.0	0.0	0.0	0.1	0.0	0.0	10.7	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	39.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	1.6	1.5	2.8	4.2	1.2	0.7	0.3	1.6	2.3	0.0	0.0	0.0	2.2	0.2	50.7	0.2	0.9	48.4	0.0	0.0	1.8	0.0	0.0	3.3	13.8	29.4	1.1	998.3	0.0	1691.4	0.0	0.4	7.0	9.2	1.0	0.0	0.0	184.8	1.3	0.3	56.5	1.4	1.2	6.8	10.0	156.0	0.0	545.2	388.3	0.7	6.7	0.0	0.0	3.1	0.5	0.4	117.2	0.1	0.0	282.9	19.5
PTDSS1	"KIAA0024, PSS1, PSSA"	ENSG00000156471	"Phosphatidylserine synthase 1"	P48651	8	96261715-96336995	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016852	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA016852: AB_1855878"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (1.08e-5)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.55e-2)"	8.2	7.9	8.0	8.1	14.7	10.2	10.4	10.2	15.0	9.7	8.3	5.1	22.5	10.6	8.4	7.8	9.6	7.0	7.9	20.1	8.6	9.9	9.5	12.8	7.8	21.8	7.1	8.0	9.6	12.1	23.2	4.9	10.8	9.6	5.7	7.4	5.2	8.8	29.8	10.1	10.4	8.3	9.0	6.0	11.8	8.1	5.1	3.6	20.7	11.0	7.7	11.8	9.3	6.8	3.6	6.1	9.4	3.7	5.0	4.6	7.8	10.4	8.1	1.4	3.9	2.9	6.1	2.4	7.6	10.5	7.3	5.1	3.0	3.0	17.2	7.0	7.1	1.5	4.3	9.9	7.6	11.4	8.8	7.1	16.9	15.7	1.6	3.0	12.4	5.9	5.1	7.3	10.2	7.2	1.8	4.7	5.3	8.4	8.9	6.6	3.0	9.6	1.9	2.2	3.4	7.6	7.7	7.3	13.0	4.1	8.9	6.1	2.5	2.8	2.5	1.1	1.7	5.9	4.2	8.3	6.6	4.1	4.6	8.7	1.8	9.3	8.4	4.1	13.1	5.4	9.4	3.7	2.1	2.8	2.5	4.0	2.6	4.6	3.4	6.1	3.6	4.0	2.9	1.3	5.0	2.4	1.8	2.6	7.8	8.0	14.7	10.2	15.0	8.6	9.9	7.1	8.0	9.6	3.6	17.9	10.8	40.8	14.5	28.0	8.9	88.9	22.9	2.7	14.8	10.4	9.8	67.1	1.7	16.6	53.9	21.0	13.3	23.3	38.8	47.5	19.7	14.5	32.3	28.4	42.1	4.8	5.2	19.0	42.5	34.9	21.6	30.4	18.6	17.2	15.0	4.8	21.4	5.8	24.4	15.9	4.3	0.0	17.6	10.3	16.6	29.4	67.6	35.2	29.4	13.6
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753047	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 118.4;Extravillous trophoblasts: 226.1;Fibroblasts: 92.9;Syncytiotrophoblasts: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 16.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.0;BEWO: 31.9;GAMG: 57.8;HaCaT: 41.7;SK-BR-3: 30.6;U-2197: 79.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	17.0	0.6	1.1	6.2	1.7	3.0	16.7	1.1	1.8	11.9	4.2	0.8	59.8	1.2	2.0	9.1	8.7	2.7	4.1	4.2	2.1	3.5	3.9	0.4	3.5	3.1	1.3	0.7	2.7	0.6	6.3	0.7	51.7	2.1	11.2	2.0	2.9	16.3	182.9	2.5	19.8	3.7	4.8	1.4	1.3	3.4	9.9	0.6	2.3	1.7	6.6	14.1	14.5	15.0	0.0	0.1	16.8	3.2	0.0	0.0	0.1	0.2	18.7	0.0	8.9	30.0	10.4	31.9	1.4	12.3	0.2	0.3	0.9	13.7	0.0	0.5	3.4	57.8	41.7	0.1	1.4	0.1	0.0	0.1	0.0	13.3	0.0	0.7	0.0	0.0	6.1	9.7	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	8.9	1.6	0.0	0.0	0.0	1.0	19.9	0.1	0.7	16.7	30.6	0.1	1.3	16.0	0.0	0.0	0.0	0.0	79.1	0.0	0.0	0.0	0.0	15.7	0.0	0.1	16.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.1	1.1	1.7	1.1	1.8	2.1	3.5	1.3	0.7	2.1	0.6	0.0	0.0	0.0	8.2	15.9	0.0	0.0	0.0	0.0	4.5	3.5	0.0	118.4	1.7	10.6	0.4	0.3	0.0	0.0	1.0	226.1	92.9	6.9	1.1	0.0	15.4	0.0	7.0	0.0	0.0	0.0	0.3	3.8	13.5	12.6	6.4	0.0	5.7	0.0	0.0	0.5	0.0	0.0	11.2	0.3	0.0	37.6	231.0	0.0	0.3	38.2
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568146	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 88.2"	"Group enriched"	"Detected in many"	8	"Ito cells: 78.5;Leydig cells: 24.7;Peritubular cells: 98.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"ASC diff: 17.8;ASC TERT1: 17.9;U-2197: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavorable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (9.99e-5)"	18.2	2.5	0.6	8.0	1.3	0.1	28.3	0.2	1.6	23.3	14.6	0.5	6.5	1.7	36.5	21.7	13.2	32.0	36.3	23.8	0.3	0.5	3.0	3.8	7.5	1.6	0.5	0.9	51.2	1.3	0.2	0.5	1.0	1.0	27.2	3.7	3.2	3.7	4.6	7.0	3.2	4.4	88.2	1.4	0.3	8.7	16.2	0.3	0.0	6.7	5.6	1.7	64.2	36.1	1.0	0.8	2.7	0.6	0.8	0.5	0.1	0.0	0.0	0.7	0.0	17.8	17.9	0.2	0.3	2.1	0.0	0.0	0.0	0.0	0.0	7.1	5.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.3	0.0	0.2	0.0	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.3	0.9	55.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.1	1.0	0.4	0.5	2.7	0.8	0.3	0.8	0.2	0.1	0.6	1.3	0.2	1.6	0.3	0.5	0.5	0.9	1.0	0.3	3.0	2.4	0.0	0.6	3.3	0.8	3.4	0.0	4.0	3.4	3.5	0.0	0.3	0.0	0.4	1.7	3.8	0.0	0.0	0.0	0.1	8.3	0.3	0.0	0.6	0.3	0.0	0.0	78.5	1.5	2.2	24.7	0.7	1.7	0.0	0.0	0.3	0.7	0.0	98.6	0.0	4.6	0.0	2.5	0.7	1.1	4.3	0.2	0.5	0.0	0.6
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680427	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"ductus deferens: 324.6;seminal vesicle: 377.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 318.6;Glandular cells: 122.9;granulocytes: 329.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"neutrophil: 12.8"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 12.8"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 95.4"	"Region enhanced"	"Detected in many"		"hippocampal formation: 16.5"	"Low region specificity"	"Detected in all"			"CAB000113, HPA001335"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	5.7	2.1	1.2	3.7	1.1	32.6	1.5	0.8	1.9	21.1	11.4	1.1	324.6	0.4	2.3	1.8	1.7	4.0	9.5	9.1	1.1	1.0	3.3	2.7	22.1	2.3	1.3	0.8	1.6	0.4	3.1	2.2	2.5	1.9	9.2	2.7	3.9	0.9	377.9	1.0	1.1	2.4	7.7	4.7	0.9	11.4	1.0	0.9	0.6	1.5	3.4	1.3	17.3	1.9	0.0	0.5	12.8	0.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.6	0.5	0.0	21.8	95.4	0.1	0.8	3.4	4.0	0.0	0.0	0.1	0.6	2.9	0.0	1.7	0.3	0.0	0.0	0.2	0.5	0.0	3.2	0.0	0.1	0.2	0.6	2.7	6.9	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.3	4.6	0.1	3.2	0.1	0.0	0.0	0.0	6.7	0.1	0.5	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.8	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.8	1.9	1.1	1.0	1.3	0.8	1.9	0.9	318.6	102.3	0.5	47.5	105.6	0.0	1.9	0.0	8.1	53.4	0.0	0.0	0.1	0.0	0.8	0.2	14.3	0.0	0.0	0.2	0.2	36.1	122.9	329.1	0.0	11.5	0.0	1.2	6.7	16.5	0.0	0.0	112.3	33.7	0.0	0.5	0.0	3.2	0.0	0.0	0.0	0.2	0.0	21.7	0.1	0.4	24.8	0.5	0.0	1.3	107.5
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343865	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 160.7"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 182.0;Extravillous trophoblasts: 368.5;Fibroblasts: 184.0;Horizontal cells: 497.4;Leydig cells: 159.9;Muller glia cells: 523.9;Peritubular cells: 174.3;Syncytiotrophoblasts: 161.7"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"AF22: 190.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	167000	1800000	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	7.8	6.6	55.5	2.0	43.3	0.9	27.7	38.6	58.5	30.7	7.2	26.9	9.9	2.5	25.2	18.7	25.0	7.2	18.2	29.4	42.3	29.7	12.7	3.4	6.5	2.6	31.6	27.0	7.2	3.4	160.7	52.5	11.8	31.4	38.5	7.7	19.0	12.0	18.1	1.5	3.6	4.0	17.7	23.4	12.4	5.4	16.8	23.3	1.3	5.1	8.7	5.3	7.7	18.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	190.8	2.3	0.0	0.1	15.6	4.9	14.6	2.7	3.8	0.0	0.0	0.0	0.0	6.4	1.7	0.1	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	1.8	0.0	2.7	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	14.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.9	13.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	4.2	3.7	0.2	10.6	0.0	0.0	0.0	13.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	43.3	38.6	42.0	42.3	29.7	31.6	27.0	31.4	23.3	0.0	0.0	0.0	1.3	20.6	19.5	14.2	0.0	2.7	4.5	1.8	5.9	182.0	8.3	1.2	11.9	8.4	0.0	0.0	0.0	368.5	184.0	17.1	0.0	0.0	18.1	497.4	0.0	8.6	0.3	8.3	159.9	1.4	42.2	0.0	0.0	523.9	0.2	0.0	174.3	5.1	27.0	58.2	33.4	1.8	1.5	12.2	161.7	0.0	0.0	2.0
PTPN1	PTP1B	ENSG00000196396	"Protein tyrosine phosphatase, non-receptor type 1"	P18031	20	50510321-50585241	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 211.4;monocytes: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009329, HPA012542, CAB015217"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		11000	"Endoplasmic reticulum"		"CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915"	"unprognostic (1.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.47e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.58e-2)"	22.1	22.2	12.1	31.9	16.0	35.3	17.9	12.9	16.6	18.2	17.8	18.8	14.2	10.5	20.0	16.6	23.2	17.1	18.0	20.5	15.8	9.0	43.8	16.7	42.7	36.1	14.1	14.1	21.8	12.2	31.2	18.8	28.3	18.7	20.0	14.8	21.0	16.3	15.0	41.0	18.6	21.9	16.9	15.8	45.3	17.5	23.5	13.3	26.9	15.7	13.9	42.8	20.0	18.4	15.9	9.4	18.8	16.4	3.9	10.7	6.4	21.1	10.7	12.9	8.9	8.5	11.7	18.4	14.2	13.6	41.9	15.3	31.3	44.6	10.5	25.3	13.1	16.5	18.8	10.2	40.9	26.7	15.5	9.1	14.8	10.4	16.5	16.9	15.4	20.4	13.6	28.7	18.9	23.3	18.4	24.0	12.8	25.8	9.7	22.7	11.8	16.5	12.2	6.8	11.7	14.7	14.7	15.0	10.0	24.1	15.9	10.4	11.9	20.4	26.0	23.0	11.3	16.8	16.5	35.6	36.6	14.7	16.4	17.6	10.6	8.5	12.8	22.9	10.5	13.5	12.0	5.6	18.8	10.7	9.5	7.9	15.9	9.0	8.2	5.5	13.7	7.7	8.3	12.2	3.9	16.4	9.4	7.1	6.4	12.1	16.0	12.9	16.6	15.8	9.0	14.1	14.1	18.7	13.3	211.4	72.3	67.9	44.4	76.4	23.0	27.2	10.2	32.1	47.8	34.9	45.2	41.8	19.9	20.5	47.2	26.1	20.4	0.0	16.9	17.3	21.4	26.7	67.2	18.6	32.9	41.3	17.9	37.4	28.2	22.4	13.0	52.2	35.4	327.4	13.7	13.8	28.9	11.5	11.3	59.6	25.9	19.4	34.0	20.7	24.3	41.3	45.4	43.7	15.5	55.1
PTPN5	"PTPSTEP, STEP, STEP61"	ENSG00000110786	"Protein tyrosine phosphatase, non-receptor type 5"	P54829	11	18727928-18792721	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 70.0"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 2.4;Distal tubular cells: 1.7;Endothelial cells: 2.4"	"Group enriched"	"Detected in some"	6	"glioma: 1.6;testis cancer: 2.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 70.0"	"Cell type enriched"	"Detected in single"	9	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HMC-1: 3.7;NTERA-2: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031014, HPA072091"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031014: AB_10669550, HPA072091: AB_2686487"	"unprognostic (1.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.83e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.44e-4)"	"unprognostic (4.21e-3)"	"unprognostic (3.90e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.49e-2)"	2.5	1.6	16.3	1.1	70.0	1.1	1.2	0.9	47.5	1.5	1.1	0.4	0.0	1.1	1.2	1.0	1.3	1.7	1.4	4.3	9.1	8.6	1.1	0.9	2.7	1.1	3.5	16.0	2.5	1.2	1.5	0.5	0.9	6.1	1.6	1.4	0.0	1.3	1.7	1.8	1.0	1.4	1.4	2.1	1.3	1.3	3.4	9.3	0.0	1.2	0.0	1.0	1.5	0.3	0.1	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	3.7	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	5.8	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.4	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	70.0	0.9	25.1	9.1	8.6	3.5	16.0	6.1	9.3	0.0	0.0	0.0	0.0	0.1	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase, receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Receptor	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.6;pancreas: 28.9;pituitary gland: 43.4"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 48.9;Cone photoreceptor cells: 56.9;Horizontal cells: 92.2;Intestinal endocrine cells: 45.2;Rod photoreceptor cells: 31.1"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-2 OS: 20.3;U-87 MG: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007152: AB_2667759, HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"	1.7	22.3	19.3	4.7	35.7	1.7	1.3	17.3	89.6	1.2	2.4	2.5	0.0	2.5	1.5	1.2	1.5	1.3	1.5	1.4	21.6	40.1	1.5	1.2	1.4	1.3	14.4	19.8	1.3	28.9	1.2	43.4	1.4	22.0	1.4	1.9	3.1	1.2	1.3	1.2	2.0	2.5	2.4	3.5	1.3	6.0	1.4	2.1	0.0	1.5	0.0	1.2	2.7	0.0	0.1	0.3	0.2	0.0	0.0	0.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.3	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.1	2.5	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	3.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.2	75.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	3.7	19.3	35.7	17.3	54.0	21.6	40.1	14.4	19.8	22.0	2.1	0.0	0.0	0.0	0.1	0.1	48.9	1.7	0.0	0.0	0.0	0.0	56.9	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	92.2	45.2	0.0	0.0	0.2	0.3	0.0	1.7	0.0	0.0	4.1	4.3	0.0	0.0	0.0	31.1	0.0	0.3	2.2	2.3	0.1	0.0	0.0	0.0	0.0
PVRIG	"C7orf15, CD112R, MGC2463"	ENSG00000213413	"PVR related immunoglobulin domain containing"	Q6DKI7	7	100218241-100221490	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 51.7;lymphoid tissue: 21.0"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 1.1;granulocytes: 2.3;Horizontal cells: 3.2;T-cells: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	32	"gdT-cell: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8"	"Group enriched"	"Detected in many"	37	"B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7"	"Group enriched"	"Detected in some"	26	"Daudi: 36.9;JURKAT: 21.8;MOLT-4: 40.2;U-698: 11.9"					"Low region specificity"	"Detected in all"			HPA047497	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Nucleoli, Endoplasmic reticulum"		"HPA047497: AB_2680069"	"unprognostic (1.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.13e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.71e-3)"	0.5	0.1	0.4	5.6	0.7	1.2	0.4	0.4	1.1	0.4	0.5	0.7	0.4	0.5	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.0	0.5	0.9	0.9	15.9	0.4	0.4	0.6	0.5	0.0	0.4	0.4	0.8	0.4	0.0	0.4	0.7	0.4	2.0	0.0	8.9	0.4	0.4	21.0	1.4	0.6	0.4	18.0	0.5	0.4	4.2	1.0	0.4	24.8	0.2	1.0	0.1	42.9	51.7	17.5	0.1	0.8	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	21.8	0.0	0.1	0.0	0.1	40.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.1	0.1	0.0	43.5	0.1	51.7	24.8	28.9	42.9	0.1	19.3	32.6	32.2	1.0	42.9	0.1	0.2	22.8	17.5	0.4	0.7	0.4	0.4	0.4	0.0	0.4	0.4	0.8	0.4	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0
RAB1A	"RAB1, YPT1"	ENSG00000138069	"RAB1A, member RAS oncogene family"	P62820	2	65070701-65130106	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 746.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005331, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		19000000	"Endoplasmic reticulum, Cytosol"		"CAB005331: AB_632290, HPA056141: AB_2683051"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (1.55e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.63e-2)"	53.0	57.6	54.6	34.8	58.4	80.8	54.0	47.7	63.2	49.2	50.3	24.8	53.8	52.7	46.7	75.8	58.8	40.7	40.9	49.9	48.1	52.8	77.8	75.4	48.2	40.7	44.0	55.3	37.1	53.5	38.5	59.7	108.6	47.3	40.5	52.2	34.0	68.7	57.1	43.8	35.5	51.6	47.6	49.6	34.5	53.2	30.9	42.4	21.5	56.9	53.1	34.9	52.2	45.1	19.1	33.2	45.0	37.1	24.4	25.1	22.2	39.2	29.1	35.8	20.8	86.7	51.1	56.5	58.4	39.8	25.9	27.5	50.2	26.0	15.9	33.7	57.6	43.7	25.3	32.5	52.0	41.0	19.6	19.5	20.1	23.2	73.7	55.0	20.8	18.3	45.1	53.1	34.0	30.4	41.1	50.9	12.9	28.6	18.5	50.9	35.2	12.2	25.1	28.3	61.0	26.3	12.6	34.0	25.4	50.1	44.1	25.9	23.1	26.8	44.0	49.2	44.0	27.3	19.6	48.8	33.5	42.7	35.3	32.6	29.0	17.8	38.3	44.5	32.3	32.3	35.3	37.1	32.2	19.5	36.8	21.5	19.1	21.1	21.0	33.2	13.9	20.5	20.4	45.0	24.4	31.6	27.6	25.1	22.2	54.6	58.4	47.7	63.2	48.1	52.8	44.0	55.3	47.3	42.4	77.4	77.9	67.8	291.2	264.0	45.0	107.0	101.9	97.7	81.9	118.7	5.9	278.0	278.5	190.5	294.3	131.9	149.5	23.3	192.4	316.0	221.3	287.0	49.7	169.6	323.3	55.6	128.1	101.9	104.9	746.6	134.9	144.4	187.3	121.8	119.0	115.2	187.9	110.1	200.1	344.5	38.6	71.1	188.1	130.7	123.3	256.8	588.6	66.1	113.3	383.2
RAB1B		ENSG00000174903	"RAB1B, member RAS oncogene family"	Q9H0U4	11	66268533-66277492	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010225, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		26000000	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB010225: AB_2284660, HPA056141: AB_2683051"	"unprognostic (6.07e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (2.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.85e-2)"	47.5	47.7	36.2	32.5	42.4	33.1	47.8	35.6	60.6	42.0	45.6	38.0	35.7	46.5	42.0	37.2	61.2	45.8	48.4	50.2	34.5	31.5	47.3	67.8	43.0	51.8	34.8	38.6	44.4	52.9	55.0	42.5	63.6	34.6	49.5	38.4	45.3	62.2	48.6	82.8	50.6	58.0	49.2	38.7	47.3	45.6	36.5	30.9	49.2	54.7	50.4	55.9	40.1	41.2	26.3	36.4	84.7	44.2	36.3	47.3	59.7	39.7	46.2	23.2	31.6	39.9	29.9	21.6	33.0	40.6	45.0	31.8	26.3	42.3	16.6	43.7	48.6	31.0	38.5	26.5	47.4	24.7	33.1	23.9	26.4	29.9	22.7	26.7	22.4	48.6	31.2	41.0	37.9	19.7	30.2	42.3	26.2	27.1	30.3	42.7	80.1	38.8	36.1	24.6	35.0	43.8	24.0	19.2	43.4	45.1	37.6	23.3	25.7	24.8	60.9	24.1	17.7	92.8	25.9	42.6	43.0	29.1	50.6	29.3	16.6	13.1	21.7	48.8	19.1	39.2	27.2	38.8	61.2	47.3	40.8	35.7	22.7	28.5	38.4	31.6	26.3	25.0	29.7	84.7	36.3	44.2	36.4	30.7	59.7	36.2	42.4	35.6	60.6	34.5	31.5	34.8	38.6	34.6	30.9	35.7	58.9	22.3	27.5	29.9	20.8	0.9	43.3	36.1	46.6	34.9	27.5	49.4	43.1	41.9	8.3	40.7	98.6	0.0	62.1	70.2	32.9	38.2	52.0	42.7	47.6	15.9	51.9	47.9	52.6	21.9	33.1	34.2	23.6	45.1	70.8	37.2	53.6	55.4	39.6	40.3	15.8	38.8	31.6	26.7	12.8	36.8	67.1	48.1	48.9	33.5
RAB42	MGC45806	ENSG00000188060	"RAB42, member RAS oncogene family"	Q8N4Z0	1	28592200-28595443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.3"	"Cell type enriched"	"Detected in some"	7	"Hofbauer cells: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.6;Hep G2: 15.5;HSkMC: 11.0;REH: 8.5"									HPA050290			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA050290: AB_2681075"	"unprognostic (1.10e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.00e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.07e-3)"	4.3	1.2	0.8	1.8	1.6	0.4	3.2	0.8	1.6	3.7	2.3	0.8	0.8	1.8	3.1	4.1	1.5	1.4	2.4	1.3	1.6	0.5	1.5	3.2	3.4	14.3	1.2	0.8	1.4	0.8	5.0	0.8	6.2	1.2	3.3	2.5	1.7	4.2	0.8	1.5	0.9	2.3	1.8	5.5	5.9	1.6	3.0	0.8	3.4	1.0	0.8	4.4	4.1	1.8	0.7	0.7	1.2	0.9	2.4	0.5	0.1	0.1	1.2	1.0	0.0	4.6	10.6	0.0	0.7	4.4	4.6	6.1	2.2	1.5	0.2	2.9	5.0	0.4	0.1	4.5	0.0	3.0	0.1	0.1	0.4	7.1	15.5	1.8	1.2	0.0	11.0	0.2	2.8	0.0	0.4	1.4	0.1	0.2	0.1	0.9	0.0	0.2	2.4	5.4	0.1	0.0	8.5	0.0	1.8	1.8	0.0	0.3	2.1	4.2	0.1	0.0	0.7	0.1	2.0	0.7	0.0	1.4	4.6	0.1	0.4	2.8	0.2	0.2	4.5	0.1	1.2	0.9	0.2	0.3	0.4	0.3	0.6	0.2	0.2	0.7	0.7	0.5	0.4	0.9	2.4	0.8	0.4	0.1	0.1	0.8	1.6	0.8	1.6	1.6	0.5	1.2	0.8	1.2	0.8	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	1.2	0.0	0.0	0.5	0.0	6.9	4.0	0.1	0.0	0.0	0.0	0.6	2.3	0.2	0.0	0.0	74.2	0.0	0.0	2.5	2.9	10.0	1.4	4.4	0.0	1.8	0.0	0.9	1.9	0.3	0.0	0.3	0.9	0.0	0.9	1.5	1.9	0.4	0.3	0.0	0.0	0.1
RARRES1	"LXNL, TIG1"	ENSG00000118849	"Retinoic acid receptor responder 1"	P49788	3	158696892-158732696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 105.0;vagina: 111.3"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 153.1;Glandular cells: 151.9;Paneth cells: 100.4;Urothelial cells: 237.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"CAPAN-2: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003892	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA003892: AB_1856079"	"unprognostic (5.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.09e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.88e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	49.4	6.1	0.4	26.5	0.5	0.0	54.5	0.3	0.4	18.5	29.9	0.6	10.0	2.1	6.8	24.2	11.5	40.6	8.3	105.0	0.6	0.3	26.8	2.7	13.4	13.3	0.5	0.5	75.5	3.9	0.0	19.7	1.6	2.0	46.2	15.7	19.4	49.0	17.9	10.5	3.3	9.3	20.7	2.4	3.2	6.6	19.0	0.2	1.0	31.5	1.7	5.9	39.6	111.3	1.0	1.2	0.0	0.9	0.2	0.7	0.1	2.5	0.8	0.0	0.1	0.5	1.6	0.0	0.2	0.7	0.1	0.2	0.1	162.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	17.8	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.2	2.2	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.4	0.0	0.4	1.0	0.7	0.3	0.0	0.2	0.9	1.2	0.3	0.1	0.4	0.5	0.3	0.4	0.6	0.3	0.5	0.5	2.0	0.2	0.0	1.1	0.0	153.1	0.5	0.4	0.8	7.6	28.1	30.7	14.0	0.0	2.4	0.0	8.0	19.5	1.6	68.0	0.0	4.2	0.6	13.4	151.9	29.9	3.8	10.7	0.0	35.9	16.5	1.5	25.5	10.0	2.9	5.0	0.0	75.6	3.4	1.6	100.4	1.1	18.7	0.4	0.0	1.0	2.3	0.5	0.4	9.5	0.0	69.1	237.5
RASGRF2	"GRF2, Ras-GRF2"	ENSG00000113319	"Ras protein specific guanine nucleotide releasing factor 2"	O14827	5	80960672-81230156	"Predicted intracellular proteins, RAS pathway related proteins"		"Calmodulin-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 23.8;ovary: 24.6"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 55.0;Extravillous trophoblasts: 22.2;Rod photoreceptor cells: 37.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.8;MAIT T-cell: 7.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 2.2;naive CD4 T-cell: 6.4;naive CD8 T-cell: 4.3"	"Lineage enriched"	"Detected in single"	78	"T-cells: 7.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 23.7;CACO-2: 14.3;EFO-21: 7.5;Hep G2: 19.0;HHSteC: 13.2;hTERT-RPE1: 9.6;SuSa: 10.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 41.1;cerebral cortex: 118.3;hippocampal formation: 72.9;olfactory region: 58.3"	HPA018679	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA018679: AB_1856089"	"unprognostic (1.32e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-1)"	13.3	1.6	11.6	4.3	14.0	1.5	5.4	1.5	23.8	3.8	2.7	18.7	1.5	2.7	3.9	1.6	2.1	2.6	7.1	4.3	11.1	6.6	6.6	1.0	3.8	4.5	8.5	5.5	24.6	1.4	6.8	3.4	13.2	8.9	5.3	2.3	17.1	1.9	2.4	3.1	1.5	2.9	3.8	15.2	3.0	2.3	2.9	5.6	0.0	4.3	1.1	3.9	4.1	2.4	0.0	0.0	0.0	0.0	0.0	7.7	1.5	0.0	1.3	0.3	0.1	0.0	0.0	23.7	0.4	5.7	0.2	0.3	14.3	0.0	0.2	7.5	0.0	0.1	0.4	0.0	0.0	0.7	0.3	2.4	0.1	0.1	19.0	13.2	0.0	0.0	0.6	0.0	5.5	0.0	9.6	0.1	0.3	0.0	0.1	0.0	0.2	0.1	0.1	2.8	0.0	0.0	0.1	2.8	0.0	0.9	0.0	0.2	0.3	0.1	0.0	0.2	10.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	2.8	0.0	7.7	0.0	3.8	2.2	0.0	0.0	6.4	4.3	0.0	0.0	0.0	0.0	0.8	1.5	11.6	14.0	1.5	23.8	11.1	6.6	8.5	5.5	8.9	5.6	0.0	1.4	0.0	0.2	1.4	11.6	3.2	0.0	0.0	1.2	8.7	55.0	0.2	0.0	0.2	9.9	14.6	0.0	0.0	0.0	22.2	0.8	0.2	0.0	0.0	1.0	1.6	0.0	4.9	0.8	2.1	0.9	0.0	1.7	0.0	0.0	2.0	0.4	0.2	8.5	2.1	37.2	0.0	1.0	7.2	1.4	0.5	0.7	4.4	0.8	0.4
RCN1	"FLJ37041, PIG20, Rcal, RCN"	ENSG00000049449	"Reticulocalbin 1"	Q15293	11	32090904-32105755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 123.1"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 242.1;Muller glia cells: 309.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038474, HPA062104"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		2300000	"Endoplasmic reticulum"		"HPA038474: AB_10672595, HPA062104: AB_2684683"	"unprognostic (1.65e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (7.13e-6)"	"unprognostic (8.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (2.70e-13)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.93e-3)"	25.0	19.8	9.6	14.3	38.8	1.6	38.2	7.6	11.4	22.3	13.6	5.8	17.0	10.8	23.3	123.1	12.2	18.2	15.3	19.4	9.2	9.8	12.4	33.7	17.9	20.2	7.0	5.9	35.2	16.4	17.9	34.9	32.6	9.7	22.6	12.6	11.4	37.0	24.2	12.8	9.1	10.5	19.2	10.9	11.5	11.8	11.4	6.9	5.4	16.8	10.0	6.9	25.3	32.3	4.3	11.0	0.5	11.8	7.5	12.4	6.5	13.4	14.5	33.6	22.4	82.6	63.0	38.7	46.2	56.4	32.6	58.9	12.7	17.2	0.0	32.0	75.3	40.8	16.6	12.1	13.7	49.1	6.5	26.4	2.9	10.5	4.6	61.1	2.1	4.4	87.7	17.1	20.6	23.3	36.9	71.4	6.2	1.7	2.4	37.3	11.1	6.1	4.1	14.4	0.1	16.4	4.7	42.1	3.9	27.8	31.3	9.0	4.7	12.3	2.9	35.4	24.6	17.7	8.5	37.2	42.3	24.1	36.6	39.1	0.1	0.1	0.1	58.7	2.7	23.9	0.2	10.0	0.3	12.4	11.8	9.7	4.3	5.7	9.9	11.0	3.5	4.2	8.0	0.5	7.5	7.2	6.4	2.0	6.5	9.6	38.8	7.6	11.4	9.2	9.8	7.0	5.9	9.7	6.9	50.6	33.3	14.5	59.0	37.0	39.4	8.5	35.7	38.8	54.6	45.4	11.8	140.9	6.6	116.4	132.8	75.8	7.0	0.0	39.7	242.1	157.4	112.2	12.7	53.4	41.2	14.3	51.0	85.3	14.3	130.4	74.5	21.1	30.4	70.3	54.8	309.5	40.2	24.6	68.6	12.6	14.1	25.8	71.0	10.7	6.4	24.7	181.5	9.2	62.9	78.0
RCN2	"E6BP, ERC-55, ERC55, TCBP49"	ENSG00000117906	"Reticulocalbin 2"	Q14257	15	76931619-76954392	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 147.5"	"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 314.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030694, HPA030695"	Enhanced	Supported	Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		41000	"Endoplasmic reticulum"		"HPA030694: AB_2673573, HPA030695: AB_2673574"	"unprognostic (1.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (7.36e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.67e-2)"	13.8	14.7	29.9	12.1	32.6	9.9	16.8	25.1	37.5	16.8	15.0	17.3	28.1	10.4	20.6	147.5	14.9	25.0	15.3	17.3	29.5	41.5	22.6	9.3	13.5	12.5	27.2	29.5	18.8	11.0	28.4	17.8	27.7	24.6	19.6	17.2	15.5	12.0	21.9	22.7	10.6	11.0	18.2	18.5	12.4	13.8	48.2	14.8	14.8	22.1	17.0	14.3	17.8	13.3	15.9	12.0	9.8	7.2	14.1	19.0	11.5	20.2	14.4	64.4	30.3	27.9	31.8	40.3	24.2	33.1	31.6	26.5	17.8	17.5	12.7	35.2	26.3	34.1	31.2	48.6	20.9	40.5	9.7	38.0	6.3	21.1	29.4	33.3	22.6	9.7	28.7	28.9	15.5	20.0	33.5	33.3	21.9	15.8	12.7	32.9	13.0	22.4	15.6	49.0	21.4	16.1	23.7	42.4	8.1	20.8	27.4	36.8	36.8	39.6	22.2	46.1	59.9	21.6	25.2	17.8	37.4	30.2	23.7	49.7	18.3	56.3	15.1	21.3	19.1	33.8	4.5	4.8	9.8	14.8	4.4	17.2	14.8	15.7	19.0	10.2	15.9	17.8	17.2	2.6	14.1	7.2	12.0	10.9	11.5	29.9	32.6	25.1	37.5	29.5	41.5	27.2	29.5	24.6	14.8	23.8	40.4	56.2	99.4	72.9	83.3	92.8	50.9	25.4	19.4	94.2	35.3	163.6	41.4	99.8	42.5	52.4	14.8	23.3	39.4	255.8	92.7	76.9	28.8	26.7	49.5	120.8	70.6	55.9	24.2	59.2	57.2	29.6	87.7	34.3	51.1	85.4	53.2	35.1	88.1	44.0	51.5	58.2	72.1	314.9	144.1	61.9	136.8	66.0	76.6	95.7
RCN3	RLP49	ENSG00000142552	"Reticulocalbin 3"	Q96D15	19	49527618-49546962	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Fibroblasts: 101.3;Ito cells: 43.6;Leydig cells: 35.4;Peritubular cells: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 9.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 30.9;ASC diff: 53.2;ASC TERT1: 36.8;BJ: 58.2;BJ hTERT+ SV40 Large T+ RasG12V: 33.6;fHDF/TERT166: 50.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA043134, HPA050402"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No			"Endoplasmic reticulum"	Vesicles	"HPA043134: AB_2678332, HPA050402: AB_2681114"	"unprognostic (7.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.87e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.47e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (5.80e-12)"	"unprognostic (5.26e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.20e-3)"	19.6	10.9	3.7	18.2	5.3	3.2	15.6	7.2	6.6	36.3	10.7	2.0	9.6	22.2	28.2	33.9	11.4	10.7	26.2	18.2	3.4	3.5	12.6	18.6	12.6	4.4	3.3	2.8	29.5	5.1	2.1	9.0	18.0	6.0	19.4	7.0	10.7	6.2	8.2	10.6	8.2	23.7	16.8	2.9	21.3	7.8	17.3	4.2	1.8	9.9	9.8	7.9	21.5	21.6	0.6	0.5	3.9	0.4	2.3	9.7	1.6	0.5	0.9	0.5	30.9	53.2	36.8	0.3	58.2	15.1	21.9	33.6	0.7	0.2	0.2	3.5	50.8	0.2	0.0	1.4	0.1	10.5	0.0	0.4	3.2	0.2	1.7	18.7	0.0	7.6	20.7	0.0	15.3	0.0	0.6	8.4	0.4	1.4	0.1	17.8	0.6	0.0	0.3	0.2	1.8	4.0	0.1	0.7	0.9	0.2	0.0	0.3	1.9	0.0	0.2	0.0	0.6	0.2	2.1	19.5	0.3	9.8	25.4	0.0	2.8	8.5	0.5	1.4	1.8	2.4	0.0	0.3	2.2	0.9	0.0	1.0	0.6	2.5	0.9	0.5	0.4	9.7	3.2	3.9	2.3	0.4	0.4	1.9	1.6	3.7	5.3	7.2	6.6	3.4	3.5	3.3	2.8	6.0	4.2	0.0	9.6	2.2	0.5	16.6	0.6	1.4	2.5	1.4	0.0	1.8	0.0	2.4	1.7	1.6	1.9	9.0	7.4	0.0	0.4	4.3	101.3	0.6	1.1	2.6	18.2	1.6	1.2	43.6	11.4	2.2	35.4	6.9	10.1	1.0	6.1	0.6	2.4	5.8	42.1	0.3	0.8	12.9	11.3	6.0	6.8	12.2	5.1	0.5	5.5	0.4
REEP5	"C5orf18, D5S346, DP1, TB2, Yip2e"	ENSG00000129625	"Receptor accessory protein 5"	Q00765	5	112876379-112922539	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003895, HPA069960"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		13000	"Endoplasmic reticulum"		"HPA003895: AB_1845723, HPA069960: AB_2686221"	"unprognostic (3.26e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (5.23e-6)"	"unprognostic (8.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.05e-5)"	"unprognostic (2.88e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.24e-2)"	22.7	35.7	39.7	14.2	47.9	7.3	46.2	33.9	65.2	32.3	21.6	23.1	33.2	17.1	19.7	45.7	16.7	22.1	20.6	42.3	37.9	45.8	50.9	50.6	26.6	13.9	37.8	37.2	25.0	56.7	45.5	21.8	41.3	72.7	34.8	20.7	20.7	49.0	32.4	31.9	20.8	18.9	18.5	33.1	19.0	22.0	10.0	21.7	6.3	84.6	20.1	18.1	22.0	19.9	38.8	42.8	55.3	63.4	23.4	39.1	44.7	19.5	17.0	6.4	13.8	30.6	27.0	21.5	18.1	17.8	19.6	20.0	14.4	26.7	7.6	35.9	22.3	19.9	19.3	14.5	28.7	20.7	37.2	19.1	8.1	13.6	11.4	28.4	6.6	14.1	17.7	28.8	15.9	15.9	21.1	24.4	6.5	4.7	17.5	26.2	18.5	3.0	11.8	8.9	12.7	12.3	4.1	18.0	22.2	51.7	21.5	11.4	8.7	24.5	49.2	17.8	18.2	56.6	12.0	25.6	17.6	6.6	24.1	24.7	18.6	22.7	6.5	30.6	12.2	9.0	34.7	50.7	49.3	33.6	54.7	35.3	38.8	27.2	31.9	42.8	32.4	12.6	23.3	55.3	23.4	63.4	31.2	39.1	44.7	39.7	47.9	33.9	65.2	37.9	45.8	37.8	37.2	72.7	21.7	154.9	81.7	96.8	143.7	82.7	81.7	184.9	124.9	96.4	99.0	184.9	84.4	245.6	69.6	243.7	114.2	118.6	82.0	0.0	360.9	269.2	175.7	189.5	105.2	181.1	246.4	82.6	113.3	107.4	124.9	21.8	107.6	190.0	195.7	116.4	93.7	87.2	282.5	138.2	125.9	116.5	66.5	109.9	132.3	117.2	39.2	88.8	409.6	104.6	92.3	181.0
REEP6	"C19orf32, DP1L1, FLJ25383, Yip2f"	ENSG00000115255	"Receptor accessory protein 6"	Q96HR9	19	1490747-1497927	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 90.8;liver: 119.0;testis: 71.2"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 2546.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 114.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.1;Hep G2: 15.4;K-562: 42.7;T-47d: 35.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA003895, HPA048015"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		26000	"Endoplasmic reticulum"		"HPA003895: AB_1845723, HPA048015: AB_2680233"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.38e-2)"	2.4	20.1	4.1	0.7	5.9	0.6	3.9	3.1	6.0	1.4	41.7	2.8	4.4	60.2	1.0	5.7	2.7	1.4	7.6	0.9	4.5	1.9	6.1	119.0	0.6	0.7	2.6	2.1	1.7	10.1	0.5	2.2	0.7	2.1	4.9	0.7	27.4	5.6	11.8	0.7	1.7	90.8	1.1	1.6	0.6	1.3	71.2	1.1	0.3	1.6	1.1	2.1	3.2	1.2	1.0	4.2	0.1	4.8	5.8	7.1	2.3	2.0	2.5	0.8	10.5	1.6	0.5	11.7	0.5	0.1	0.5	0.5	16.1	6.6	1.1	3.7	0.3	0.7	2.1	2.7	0.1	0.2	0.5	1.1	6.1	0.3	15.4	1.2	0.4	2.0	1.3	1.1	0.0	0.3	0.9	0.3	1.4	42.7	1.5	0.1	8.1	0.5	1.3	3.9	5.9	5.7	1.6	0.3	2.7	3.0	0.9	0.2	5.8	2.8	4.1	1.7	0.4	35.7	1.6	0.9	0.8	1.7	2.5	0.4	5.1	1.4	0.1	3.6	2.6	2.3	0.0	1.5	0.0	7.1	1.7	3.8	0.1	2.1	1.5	2.5	1.0	2.8	3.2	0.1	5.8	4.8	4.2	2.0	2.3	4.1	5.9	3.1	6.0	4.5	1.9	2.6	2.1	2.1	1.1	3.0	2.7	3.4	6.8	6.1	23.2	1.6	86.6	5.3	6.8	5.2	31.4	55.0	6.6	28.9	512.6	2.8	17.0	0.0	61.1	7.5	2.5	15.7	10.3	229.1	8.2	22.3	5.8	4.3	5.7	2546.7	31.7	4.3	28.7	1.8	10.4	27.6	24.6	6.0	15.6	36.0	217.9	19.4	2.6	24.2	30.4	5.8	30.1	5.1	11.0	11.2
RETREG1	"FAM134B, FLJ20152, JK1"	ENSG00000154153	"Reticulophagy regulator 1"	Q9H6L5	5	16473038-16617058	"Disease related genes, Predicted membrane proteins"	Autophagy		"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 45.0;skeletal muscle: 78.5"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 68.5;Exocrine glandular cells: 51.0;Pancreatic endocrine cells: 69.1;Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.0;T-cells: 4.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.3;GAMG: 12.6;HSkMC: 18.1;RPTEC TERT1: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012077			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA012077: AB_2668621"	"unprognostic (1.63e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (5.25e-10)"	"unprognostic (3.75e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.58e-1)"	9.8	2.0	8.5	3.7	11.2	1.1	8.7	9.6	19.6	7.4	12.4	14.9	0.3	6.5	2.3	5.4	2.0	4.1	7.1	45.0	11.2	9.4	30.3	21.8	4.9	3.1	13.2	11.4	1.7	19.0	17.7	8.0	6.7	18.5	5.9	16.9	1.5	3.9	3.0	78.5	5.6	12.8	1.5	16.8	1.6	6.1	5.7	15.4	14.1	3.6	12.5	2.3	2.0	4.4	0.9	0.1	4.0	0.4	0.1	4.4	0.6	0.8	0.3	0.1	2.1	16.3	2.0	9.5	0.1	2.1	1.9	2.6	1.4	0.1	0.2	1.5	0.0	12.6	2.4	4.8	0.5	0.6	2.4	2.1	0.0	7.2	0.0	0.1	3.1	0.0	18.1	7.4	0.3	2.0	4.7	0.0	9.3	0.0	0.1	0.7	0.6	11.9	0.0	0.5	2.1	0.3	1.9	0.0	0.7	16.6	0.5	10.8	1.2	0.6	0.7	7.8	1.2	3.6	1.4	0.0	1.5	0.2	4.0	1.8	0.4	0.0	0.0	9.3	10.7	3.9	4.0	0.4	0.1	0.6	0.0	1.6	0.0	1.5	0.8	0.1	0.9	4.4	2.7	2.3	0.1	0.1	0.0	1.9	0.6	8.5	11.2	9.6	14.4	11.2	9.4	13.2	11.4	18.5	15.4	68.5	7.5	0.0	0.0	0.0	0.0	0.0	0.0	34.8	18.2	41.8	0.0	39.1	14.9	25.9	0.0	0.0	0.0	0.0	51.0	2.5	0.0	0.0	1.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	0.0	69.1	0.0	0.0	147.8	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0
REXO5	NEF-sp	ENSG00000005189	"RNA exonuclease 5"	Q96IC2	16	20806429-20849668	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"blood: 33.9;testis: 119.4"	"Cell type enhanced"	"Detected in some"	7	"Ciliated cells: 2.7;Club cells: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 2.0;Hofbauer cells: 1.9;monocytes: 2.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	15	"basophil: 33.9"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 33.9"	"Cell line enhanced"	"Detected in many"		"K-562: 24.4;U-266/70: 25.2"					"Low region specificity"	"Detected in all"			"HPA040755, HPA040868, HPA066145"	Approved		Approved	"Nuclear membrane,Nucleoli,Endoplasmic reticulum"		NA	NA			"Nuclear membrane"	"Nucleoli, Endoplasmic reticulum"	"HPA040755: AB_10965790, HPA040868: AB_10963549, HPA066145: "	"unprognostic (2.39e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.42e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.93e-2)"	0.8	0.7	0.7	1.4	1.9	2.6	1.0	1.0	1.0	0.4	0.6	0.6	0.2	0.7	0.9	0.8	0.6	1.1	0.7	1.1	0.6	0.5	0.5	0.5	0.6	0.7	0.4	1.2	0.8	0.6	3.3	0.4	0.4	0.6	1.4	0.8	0.7	0.8	0.7	0.4	0.6	0.6	0.7	0.3	0.3	1.6	119.4	0.4	4.1	0.3	0.5	0.9	0.8	0.6	0.0	0.3	33.9	0.2	0.8	0.7	0.1	6.4	3.6	5.7	2.5	2.3	4.8	1.9	4.3	4.8	4.8	5.3	2.7	5.6	3.9	6.9	3.6	3.3	3.2	4.3	1.9	5.0	4.1	3.1	6.5	5.4	3.7	0.5	9.6	9.5	2.2	0.8	5.6	7.3	2.1	1.6	0.0	24.4	17.5	11.7	8.3	1.5	7.2	3.1	2.5	3.7	7.8	10.8	7.0	1.4	2.2	5.1	5.7	4.0	5.5	1.4	1.7	9.3	8.2	0.8	3.5	3.2	4.7	5.1	25.2	17.0	1.5	7.4	12.4	3.4	33.9	0.2	2.2	0.1	0.0	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.7	0.1	0.7	1.9	1.0	1.0	0.6	0.5	0.4	1.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.0	1.3	2.0	0.0	0.0	1.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605158-49636884	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 54.1"	"Cell type enriched"	"Detected in some"	50	"Erythroid cells: 116.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	190	"HEL: 87.8;K-562: 86.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA046051: , HPA055331: AB_2682785"					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				1.2	0.2	0.0	1.1	0.5	54.1	3.2	0.0	0.1	2.3	1.0	0.5	1.7	0.2	0.4	0.1	2.6	0.5	0.8	5.3	0.0	0.0	0.1	0.7	3.3	0.1	0.0	0.0	0.1	0.2	0.1	0.1	5.8	0.1	1.3	0.2	0.0	0.2	0.5	0.4	0.1	0.9	0.1	0.0	4.5	0.6	0.2	0.0	1.7	1.8	0.0	0.1	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	116.8	0.2	0.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	1.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
RHBDD1	DKFZp547E052	ENSG00000144468	"Rhomboid domain containing 1"	Q8TEB9	2	226835581-226999215	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013972, HPA057125"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013972: AB_2178629, HPA057125: AB_2683343"	"unprognostic (1.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.04e-2)"	12.7	14.8	10.8	16.7	16.0	11.0	13.6	8.3	13.0	13.8	14.3	21.2	9.4	11.0	20.6	16.3	13.6	15.4	12.4	14.5	11.4	9.0	13.6	16.9	12.6	17.7	17.6	11.0	18.8	20.4	18.6	17.1	10.5	13.0	15.7	12.4	13.1	14.3	15.5	13.9	13.0	17.5	15.6	16.5	17.3	13.2	25.6	14.7	56.6	17.3	8.8	18.9	18.7	15.4	19.9	16.6	9.8	15.5	8.8	12.5	8.5	5.2	4.5	4.8	7.4	14.6	14.6	0.0	12.5	10.0	6.2	7.1	3.9	9.1	4.9	10.4	12.6	9.0	6.1	0.0	13.0	11.8	12.5	5.0	7.2	2.9	3.4	15.7	7.6	4.2	13.6	19.0	11.8	25.7	7.2	4.7	13.0	19.3	12.9	6.4	10.0	12.9	3.9	0.0	6.1	4.8	5.6	0.0	7.1	5.0	6.3	4.7	3.6	6.8	2.4	9.2	9.5	6.9	8.8	6.2	2.8	6.3	10.7	3.5	14.4	6.7	35.4	9.1	9.3	8.2	8.1	11.1	9.8	6.1	15.5	9.7	17.3	9.6	7.5	13.7	19.9	10.8	8.9	2.5	8.8	10.3	16.6	12.5	8.5	10.8	16.0	8.3	13.0	11.4	9.0	17.6	11.0	13.0	14.7	11.9	5.4	22.9	7.2	4.6	6.3	14.0	2.5	4.0	7.9	10.4	15.7	6.0	3.3	6.1	12.7	5.8	5.0	0.0	8.0	3.3	5.2	9.4	8.1	11.3	4.6	11.1	1.7	3.1	9.2	13.7	5.2	5.0	11.8	1.8	7.1	9.3	7.2	0.0	6.3	2.9	5.9	0.0	7.2	12.9	7.1	4.8	4.7	6.5	3.7	7.7
RNF5	"G16, NG2, RING5, RMA1"	ENSG00000204308	"Ring finger protein 5"	Q99942	6	32178354-32180793	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 293.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034107, HPA065032"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB034107: AB_2238618, HPA065032: AB_2685408"	"unprognostic (1.94e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (2.44e-4)"	"unprognostic (1.95e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.91e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	9.8	20.6	19.3	9.0	20.6	10.3	14.0	13.6	16.8	11.3	25.7	17.4	14.7	18.1	12.3	14.6	15.9	16.9	13.9	19.2	16.9	12.0	32.7	38.1	14.7	11.6	16.3	14.2	19.0	19.3	7.2	5.8	23.4	12.3	13.1	19.1	12.2	25.3	15.3	24.5	13.4	36.7	13.7	19.7	10.2	14.2	9.6	9.6	10.8	18.0	14.2	12.5	13.2	9.9	6.7	26.9	7.2	6.4	7.5	7.0	6.5	5.3	6.9	4.7	18.1	5.2	3.6	3.7	2.1	2.7	4.7	5.4	9.2	4.5	6.9	7.8	5.2	6.7	4.4	8.8	4.9	5.0	4.3	11.9	5.5	7.8	19.0	6.1	0.0	11.3	3.5	6.6	7.9	6.0	8.6	9.5	12.4	14.1	7.5	6.8	7.5	6.7	15.9	0.0	7.5	2.9	4.6	5.3	9.7	13.3	3.4	4.9	10.2	4.2	4.5	4.7	4.4	9.4	19.4	4.2	5.2	5.1	0.0	8.2	4.1	6.2	8.2	3.6	12.3	3.0	5.1	4.6	7.2	7.0	6.4	6.1	6.7	5.7	6.2	6.6	6.0	6.4	6.3	2.4	7.5	4.5	26.9	5.7	6.5	19.3	20.6	13.6	16.8	16.9	12.0	16.3	14.2	12.3	9.6	17.9	31.3	63.3	54.1	85.1	21.8	54.9	81.5	48.2	43.3	87.2	0.0	66.6	240.4	91.9	15.7	46.6	171.7	70.0	79.3	85.9	60.9	53.6	54.4	112.5	61.3	31.8	70.3	41.7	42.8	15.3	55.0	53.8	81.0	88.4	77.1	59.7	70.4	152.6	68.2	293.3	20.3	64.7	69.2	57.6	36.2	73.8	70.4	52.4	93.3	42.3
RPL10	"DXS648, DXS648E, FLJ23544, L10, NOV, QM"	ENSG00000147403	"Ribosomal protein L10"	P27635	X	154389955-154409168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010339, HPA011311"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		130000	"Endoplasmic reticulum, Cytosol"		"CAB010339: AB_2181277, HPA011311: AB_1856431"	"unprognostic (2.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (6.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.68e-2)"	103.6	65.3	41.4	108.0	48.5	103.7	152.6	82.4	70.7	118.2	80.6	44.6	107.8	51.3	100.4	75.5	105.2	122.3	52.6	82.5	38.2	31.9	112.1	155.0	97.6	190.2	48.2	37.4	223.5	242.3	35.0	51.9	87.4	53.1	83.6	77.1	66.7	109.9	101.5	125.9	121.8	108.9	78.7	51.4	93.9	90.5	33.9	47.2	158.9	198.9	137.9	134.4	86.9	119.3	252.9	168.6	64.4	124.1	149.1	304.9	445.3	190.6	88.4	88.6	67.9	201.2	381.1	78.4	73.4	170.1	141.3	179.7	78.4	85.8	378.1	177.6	122.3	139.8	74.1	173.4	175.7	121.4	83.0	137.5	51.0	63.4	85.9	236.7	109.5	75.5	287.6	278.2	84.9	265.3	244.2	221.6	161.8	71.8	120.9	137.9	95.7	119.3	106.6	69.8	188.1	152.9	143.1	84.0	210.1	154.1	68.1	71.1	118.8	17.7	156.2	216.7	89.4	56.8	153.2	106.6	49.4	94.0	111.2	162.3	287.9	207.9	376.0	75.1	158.2	61.7	64.4	124.1	18.1	149.9	107.7	256.2	252.9	251.6	186.2	151.2	243.2	304.9	231.1	13.0	149.1	94.9	168.6	178.0	445.3	41.4	48.5	82.4	70.7	38.2	31.9	48.2	37.4	53.1	47.2	1664.5	2043.1	10322.4	11239.3	10721.6	451.7	309.0	3949.0	1271.5	2545.5	1934.9	233.7	5960.7	5721.4	3854.4	49.9	6113.6	2058.8	1915.6	11641.3	8484.3	6948.0	9869.1	2815.7	3204.1	6194.0	254.3	2785.1	5085.5	7653.2	131.8	7835.9	9465.3	7747.1	9437.5	6244.9	793.3	8332.0	5018.5	3353.3	5769.1	609.3	2942.7	9122.3	99.1	315.1	12724.6	6324.6	8194.7	7230.3	10693.0
RPL10A	"Csa-19, L10A, NEDD6"	ENSG00000198755	"Ribosomal protein L10a"	P62906	6	35468408-35470785	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053803	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		360000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA053803: AB_2682268"	"unprognostic (5.47e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.72e-2)"	55.0	41.7	35.5	80.8	28.0	79.0	96.9	25.3	37.6	71.5	76.4	22.8	62.3	35.0	91.2	62.5	88.7	91.0	72.6	45.2	28.1	23.1	45.4	71.1	44.8	94.0	28.5	38.0	155.3	141.2	18.6	35.6	56.6	25.6	86.5	55.2	34.7	104.5	66.1	98.5	92.9	47.2	56.8	27.3	51.4	55.5	33.2	20.1	70.6	62.0	121.6	76.5	77.4	86.4	165.3	104.4	8.5	62.8	101.1	186.5	235.1	66.6	68.9	78.3	73.6	117.4	214.2	88.8	69.1	142.3	97.5	77.8	99.6	64.6	200.2	63.8	93.6	47.9	59.2	105.5	157.7	81.0	69.4	92.9	76.8	63.8	139.1	174.0	112.0	64.1	249.0	185.0	71.4	239.9	158.1	142.7	100.7	90.5	99.0	110.5	117.8	118.1	136.2	82.2	105.4	60.8	93.6	75.5	154.9	123.2	110.4	55.3	81.0	42.5	97.8	195.2	66.0	105.8	204.3	82.3	31.9	57.7	42.3	86.9	62.6	101.9	132.2	40.0	130.7	57.0	8.5	62.8	5.9	82.7	61.2	146.9	165.3	137.8	106.1	104.4	146.8	186.5	145.8	6.1	101.1	52.4	98.5	104.4	235.1	35.5	28.0	25.3	37.6	28.1	23.1	28.5	38.0	25.6	20.1	497.3	826.2	3505.8	4941.4	4796.5	207.9	239.4	1668.8	799.0	1510.5	567.0	68.7	3327.1	2528.3	1289.0	177.8	1494.7	980.5	513.9	2845.5	4591.2	2345.1	3300.9	883.5	1243.6	1940.9	103.3	1454.5	1261.4	1687.0	354.9	2330.6	2284.0	2282.6	2326.4	2431.8	212.5	2052.4	1855.2	1390.9	2230.9	177.0	756.7	2794.2	210.8	382.0	5789.4	3433.4	2382.6	3597.4	4457.4
RPL10L		ENSG00000165496	"Ribosomal protein L10 like"	Q96L21	14	46651010-46651821	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"testis: 45.5"	"Cell type enhanced"	"Detected in many"	29	"Early spermatids: 439.0;Late spermatids: 154.0;Spermatocytes: 85.2"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 6.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	45	"U-2 OS: 30.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011311	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA011311: AB_1856431"	"unprognostic (7.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.70e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.44e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.3	0.6	0.4	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.4	0.3	0.5	1.0	0.6	0.8	0.2	0.7	0.9	0.9	0.0	0.4	0.2	0.4	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	8.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	439.0	0.6	0.2	0.0	0.0	0.2	1.7	5.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	154.0	5.8	2.0	10.1	0.0	1.8	0.0	0.0	0.0	2.1	0.0	0.0	6.5	4.7	85.2	11.5	16.4	0.2	0.0	2.3	2.6
RPL13	"BBC1, D16S444E, L13"	ENSG00000167526	"Ribosomal protein L13"	P26373	16	89560657-89566828	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051702	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		53000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA051702: AB_2681579"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	82.5	56.0	46.7	105.0	38.4	112.7	150.9	37.7	44.0	114.5	114.9	31.3	76.9	65.5	118.4	85.4	144.0	98.4	101.6	85.2	38.6	32.1	60.8	118.3	90.4	385.1	38.8	37.4	231.3	255.8	36.5	57.5	66.0	27.0	136.2	44.4	43.0	267.3	87.6	197.4	137.7	66.7	90.2	44.8	104.7	71.1	106.5	24.6	135.0	102.4	129.6	98.6	109.3	156.8	277.8	163.1	26.9	96.9	120.7	299.0	355.4	67.5	75.1	53.4	86.5	96.1	160.2	111.9	42.7	92.6	89.3	36.3	113.4	104.8	95.0	88.2	72.4	35.5	94.0	63.4	112.3	44.6	26.6	176.0	32.3	41.9	150.3	205.8	39.2	39.5	194.0	239.4	57.2	144.3	145.7	93.0	120.4	98.7	54.2	68.5	211.6	107.4	308.2	109.2	133.6	79.9	160.2	56.6	133.5	108.4	56.8	75.3	110.2	59.1	77.3	128.1	35.2	152.0	233.4	54.2	57.7	62.3	50.8	58.5	82.2	77.2	96.9	75.3	138.7	60.5	26.9	96.9	15.3	129.1	74.9	239.2	252.5	234.3	176.5	116.8	277.8	299.0	230.2	10.7	120.7	56.7	163.1	163.7	355.4	46.7	38.4	37.7	44.0	38.6	32.1	38.8	37.4	27.0	24.6	1676.5	3076.1	8572.3	13242.6	11129.2	658.9	392.1	3263.7	1810.8	3433.9	1533.6	178.7	5497.3	3942.5	3304.0	3376.6	4985.3	2353.5	1588.5	9512.5	8594.0	5542.1	9230.0	2503.8	3991.9	4585.6	235.2	2827.6	3949.3	6200.5	9204.7	7634.3	6835.9	5176.0	5670.1	5289.2	713.9	6690.8	4380.2	3433.2	5399.2	577.3	2050.2	5882.2	1406.9	1082.9	14135.8	5156.1	7058.2	8155.8	12161.4
RPL14	"CTG-B33, hRL14, L14, RL14"	ENSG00000188846	"Ribosomal protein L14"	P50914	3	40457292-40468587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 95.3"	"Low region specificity"	"Detected in all"							HPA004136	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		210000	"Endoplasmic reticulum, Cytosol"		"HPA004136: AB_1079839"	"unprognostic (1.36e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.15e-1)"	49.9	33.5	28.3	57.4	43.8	47.2	134.4	28.7	57.6	85.4	68.2	21.4	48.0	29.8	87.0	30.9	66.0	61.0	56.7	46.7	40.8	22.8	42.5	69.8	44.6	61.7	24.7	22.2	151.9	117.3	48.4	34.4	60.8	40.6	81.8	42.0	36.2	162.9	73.6	72.3	66.7	39.0	59.1	24.7	69.6	52.4	23.8	11.7	42.9	63.3	100.2	58.5	48.7	77.0	26.6	16.0	4.6	11.6	14.3	38.3	47.9	9.4	5.2	32.0	11.4	25.9	91.2	18.6	14.5	48.6	54.7	41.5	11.0	3.7	41.3	12.3	14.3	20.9	2.9	16.2	25.4	32.3	14.0	17.9	19.8	9.1	10.5	39.7	28.1	10.7	44.1	95.3	15.5	33.0	66.1	50.1	49.6	23.2	5.8	37.8	9.1	9.2	25.6	9.1	46.3	17.1	4.3	12.1	20.0	40.5	7.0	10.0	16.0	7.6	7.4	22.0	38.0	11.5	15.5	16.6	11.1	8.1	14.0	18.3	18.1	21.7	22.5	5.0	21.2	10.2	3.7	11.6	4.6	21.1	11.6	35.5	26.6	31.7	27.7	16.0	24.1	38.3	34.9	1.8	14.3	9.9	14.6	24.9	47.9	28.3	43.8	28.7	57.6	40.8	22.8	24.7	22.2	40.6	11.7	771.2	883.3	2536.9	4403.4	2765.6	207.8	306.9	1449.7	777.6	1508.2	642.0	96.2	2943.8	2143.7	1521.6	222.8	1840.1	1118.8	887.7	3599.1	4111.4	1918.7	2744.5	1484.2	1016.8	1943.1	95.3	1181.4	1316.6	1781.7	387.3	2000.3	2174.5	1690.4	2539.2	2184.9	232.3	2849.1	1855.2	1019.7	2575.0	247.3	950.7	1701.5	263.4	350.5	2988.0	2771.9	1999.5	2848.8	3958.2
RPL17	"L17, rpL23"	ENSG00000265681	"Ribosomal protein L17"	P18621	18	49488453-49492523	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043724, HPA046385"	Supported		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		28000	"Endoplasmic reticulum, Cytosol"		"HPA043724: AB_2678637, HPA046385: AB_2679646"	"unprognostic (1.11e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-3)"	59.6	60.0	40.5	57.8	58.1	101.1	127.2	41.7	42.9	66.7	64.4	26.3	67.8	40.9	64.1	65.5	84.9	76.7	79.7	49.5	32.2	31.1	99.4	184.2	48.0	106.0	42.9	32.3	177.4	203.2	21.7	72.5	77.1	43.6	60.7	53.1	39.8	83.3	83.8	67.6	76.3	69.7	43.7	38.1	78.5	66.8	92.7	32.9	66.6	81.7	146.2	75.2	58.2	70.4	140.6	102.8	22.2	59.2	95.1	158.9	142.2	98.1	62.5	91.1	107.5	150.7	308.0	86.8	110.5	128.7	104.8	79.5	84.0	47.9	170.4	76.3	109.2	58.8	117.9	123.5	198.2	112.3	70.6	127.7	89.9	74.3	114.4	131.4	291.6	72.3	293.3	224.7	109.1	258.9	244.5	143.1	116.7	87.9	125.1	130.0	79.8	105.2	187.3	92.7	60.2	51.4	104.6	118.7	219.3	141.9	117.7	69.8	84.2	40.8	85.1	170.8	116.8	80.5	191.1	113.6	77.8	66.2	38.1	115.9	112.9	105.2	157.8	74.4	177.7	74.0	22.2	59.2	15.2	82.8	53.2	158.9	140.6	134.5	109.0	93.7	117.9	150.4	127.9	12.7	95.1	43.8	102.8	104.8	142.2	40.5	58.1	41.7	42.9	32.2	31.1	42.9	32.3	43.6	32.9	616.4	735.4	700.8	208.7	623.3	13.1	0.4	244.5	961.0	1629.9	97.7	9.8	382.5	421.1	712.5	158.5	310.1	430.2	93.5	1412.1	483.3	308.4	144.8	940.4	188.7	239.1	9.5	788.1	335.1	623.8	325.1	488.1	506.6	276.7	1072.2	977.1	22.1	1309.5	501.5	256.0	473.5	23.7	245.8	414.1	85.4	63.9	806.4	346.9	622.0	1301.1	184.7
RPL17-C18orf32		ENSG00000215472	"RPL17-C18orf32 readthrough"		18	49481681-49492479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	48	"Alveolar cells type 1: 142.9;Alveolar cells type 2: 140.3;Ciliated cells: 215.5;Club cells: 177.5;granulocytes: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA043724, HPA046385"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA043724: AB_2678637, HPA046385: AB_2679646"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-2)"			"unprognostic (1.70e-3)"	"unprognostic (3.83e-4)"		"unprognostic (1.95e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"		"unprognostic (2.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"		"unprognostic (5.42e-2)"		7.8	34.4	16.3	17.1	12.5	7.2	8.5	23.6	28.6	9.7	10.7	3.5	11.5	22.8	10.4	9.9	14.8	5.9	13.8	13.7	11.8	14.8	17.6	34.0	8.9	18.9	14.8	4.6	10.5	37.7	3.4	13.7	13.3	6.8	9.6	5.3	6.1	12.6	14.6	11.4	5.6	15.2	5.8	14.1	13.5	10.4	16.3	4.7	11.2	14.2	26.7	12.9	9.1	7.0	6.7	10.6	9.7	9.3	5.8	9.7	10.2	6.6	3.2	13.3	15.7	15.2	9.7	0.3	6.8	5.7	2.6	7.8	2.1	13.7	3.9	3.6	7.2	9.9	7.6	10.5	2.2	9.3	8.3	3.5	7.3	2.1	2.8	3.4	7.4	17.2	16.1	5.7	4.1	9.4	19.8	3.6	13.7	1.4	17.6	15.8	3.2	11.2	5.7	5.9	2.3	0.3	6.2	6.1	12.1	22.6	0.7	12.7	23.9	3.1	11.7	15.9	5.3	14.8	17.1	1.5	7.6	3.5	8.0	3.8	6.7	8.7	6.5	11.1	4.7	9.7	3.5	9.3	4.9	7.1	6.4	9.2	6.7	9.2	9.4	10.6	6.2	6.3	9.7	9.7	5.8	6.1	7.1	8.4	10.2	16.3	12.5	23.6	11.7	11.8	14.8	14.8	4.6	6.8	4.7	142.9	140.3	0.0	0.5	0.2	0.1	0.0	0.0	215.5	177.5	0.0	0.0	0.1	0.0	0.2	2.2	0.0	0.0	0.0	0.2	0.1	0.4	0.2	60.5	0.2	0.2	0.0	0.0	0.6	0.3	3.1	0.0	0.3	0.0	1.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.7	0.6	0.1	0.2	0.0	0.0	0.1
RPL18	L18	ENSG00000063177	"Ribosomal protein L18"	Q07020	19	48615328-48619536	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"NB-4: 559.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046572	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		100000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA046572: AB_2679705"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.27e-2)"	56.2	57.3	50.3	79.1	40.8	122.4	84.9	35.2	51.1	89.8	76.6	44.8	60.8	66.1	100.6	56.1	129.6	78.2	99.2	43.4	38.3	33.1	56.4	101.9	62.1	194.1	40.3	27.0	206.5	260.5	19.8	57.1	74.8	26.8	100.5	39.6	54.6	136.7	62.3	78.8	108.6	60.5	69.1	39.7	88.7	64.0	45.8	28.6	114.9	115.8	116.5	122.2	91.2	90.5	137.1	84.5	19.0	57.5	71.1	144.1	148.6	58.3	91.0	33.5	58.2	34.2	67.5	49.0	26.8	44.7	55.7	46.9	82.1	54.3	85.4	28.2	25.6	21.1	48.4	30.4	61.0	21.2	36.4	105.9	30.9	42.6	78.4	69.2	43.0	48.3	79.5	89.5	29.8	40.2	40.8	54.7	62.6	43.6	75.3	34.9	74.1	67.6	559.5	53.4	76.1	45.4	70.8	27.0	77.4	45.0	72.2	47.7	62.1	24.2	85.4	81.0	16.2	48.0	83.8	31.2	41.3	45.9	25.6	61.5	62.6	72.9	50.9	26.0	66.4	48.6	19.0	57.5	12.2	65.7	47.6	115.3	130.3	116.4	88.1	79.2	137.1	144.1	113.9	8.6	71.1	37.3	84.5	89.6	148.6	50.3	40.8	35.2	51.1	38.3	33.1	40.3	27.0	26.8	28.6	550.9	838.5	3591.6	3815.8	3969.4	373.7	225.2	1370.7	546.0	953.2	671.7	135.5	3294.6	1175.5	1414.5	62.6	1818.4	1578.0	724.2	3930.9	4507.0	2016.4	3365.3	983.1	1161.9	1943.0	127.1	1609.4	1403.2	2086.4	135.2	3008.2	2285.6	2161.1	2417.6	2644.1	668.4	2833.8	2163.8	1372.2	1352.6	310.0	1015.4	2447.3	225.6	356.8	4859.7	3460.6	2407.5	3173.8	4275.2
RPL21	"DKFZp686C06101, FLJ27458, L21, MGC104274, MGC104275, MGC71252"	ENSG00000122026	"Ribosomal protein L21"	P46778	13	27251309-27256691	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047252	Approved		Supported	"Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		22000	"Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol"		"HPA047252: AB_2680000"	"unprognostic (4.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.55e-2)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.44e-1)"	54.7	44.0	57.3	52.2	68.7	133.6	105.9	39.8	50.7	63.7	61.7	46.3	32.7	42.7	57.8	53.0	59.3	57.7	55.0	63.9	48.0	36.8	64.3	148.7	44.8	100.9	53.6	44.4	142.9	109.8	19.0	48.2	57.8	61.2	52.5	57.2	36.5	85.7	47.2	68.0	72.2	66.3	64.4	48.7	72.8	58.0	46.4	50.0	60.5	58.3	87.6	92.6	59.1	64.9	178.1	103.2	34.8	57.9	95.6	224.2	258.9	56.6	47.6	84.4	68.1	87.9	167.5	71.4	103.1	94.5	80.9	52.5	114.8	105.8	217.6	39.8	81.8	36.3	76.0	96.6	104.9	95.7	68.7	88.0	170.1	48.5	88.7	83.2	232.1	67.6	148.7	172.1	52.9	134.8	111.6	90.6	96.9	70.2	54.2	91.7	81.0	117.0	144.3	110.1	169.9	80.1	87.4	162.0	91.3	75.5	68.3	73.1	68.1	47.9	96.3	83.5	74.3	64.8	207.7	100.1	35.9	46.9	56.4	84.0	36.7	51.5	162.2	46.1	148.4	61.0	34.8	55.8	22.1	101.6	56.9	162.9	178.1	153.1	125.7	75.9	164.1	224.2	177.8	11.9	95.6	57.9	103.2	104.1	258.9	57.3	68.7	39.8	50.7	48.0	36.8	53.6	44.4	61.2	50.0	1566.3	2465.6	8666.4	5097.3	6791.1	357.6	159.0	3671.3	1711.8	3044.9	1484.8	135.5	4221.2	4483.0	2755.0	52.8	3084.7	1963.1	4088.2	6776.1	5196.5	3900.6	3121.1	2648.9	4092.7	3478.3	151.0	2295.8	3659.0	6728.2	139.6	3664.1	5222.3	4960.0	8005.6	4231.5	566.0	5014.1	3464.9	2259.0	4273.9	452.0	1869.1	3093.6	744.9	864.3	7190.7	4605.9	4837.7	5859.2	3904.4
RPL23A	L23A	ENSG00000198242	"Ribosomal protein L23a"	P62750	17	28719393-28724359	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 261.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA051754, HPA077474"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		15000	"Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol"		"HPA051754: AB_2681593, HPA077474: AB_2686841"	"unprognostic (1.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (3.91e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.68e-1)"	49.1	38.5	48.6	43.3	62.1	67.9	87.0	40.6	75.5	63.8	47.0	27.3	48.5	34.8	53.2	44.0	56.5	64.1	35.1	48.8	56.6	28.7	39.5	93.2	62.3	108.0	42.6	39.6	142.1	63.3	21.4	45.3	51.0	40.5	44.9	48.8	27.6	61.3	41.7	64.9	70.5	44.6	39.8	63.4	59.1	47.8	108.1	35.7	56.1	44.4	78.8	84.9	51.1	61.0	261.4	139.2	30.6	75.3	142.1	254.7	206.1	59.4	121.4	73.5	91.1	97.3	156.9	71.6	55.8	98.0	94.6	80.0	123.5	57.7	134.5	52.6	77.5	49.4	81.4	96.7	124.6	98.1	71.1	267.4	64.2	119.3	131.4	88.7	133.4	67.3	152.5	160.5	75.3	119.1	137.4	102.4	62.4	83.4	91.3	94.6	98.2	148.9	176.0	69.9	152.8	74.0	88.2	132.7	158.9	102.5	121.5	75.9	88.6	39.6	288.0	125.0	107.5	143.2	156.7	60.7	52.1	74.2	60.6	98.7	113.9	105.2	78.5	82.6	73.8	57.4	30.6	66.3	19.4	156.5	75.3	232.3	261.4	227.4	203.4	108.7	227.4	254.7	229.5	9.4	142.1	59.6	139.2	154.0	206.1	48.6	62.1	40.6	75.5	56.6	28.7	42.6	39.6	40.5	35.7	801.0	1123.4	5775.1	4513.0	4612.6	216.8	263.3	2257.3	837.9	1637.9	820.0	66.8	3852.2	2612.9	1885.1	774.8	2545.4	1436.7	1541.8	4018.0	5653.9	2983.4	3636.7	1439.5	1994.3	2312.0	154.1	1776.5	2366.9	2960.5	235.1	4219.8	3481.8	2908.6	3701.6	2998.1	414.4	2891.2	3114.2	2224.7	2308.4	257.2	1681.6	3269.7	698.0	548.5	5416.5	4120.8	3800.4	4030.5	4740.6
RPL24	L24	ENSG00000114391	"Ribosomal protein L24"	P83731	3	101681091-101686782	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA051653	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		19000	"Endoplasmic reticulum, Cytosol"		"HPA051653: AB_2681564"	"unprognostic (7.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.08e-1)"	"prognostic favorable (8.25e-4)"	"unprognostic (5.37e-2)"	61.3	58.9	60.6	99.3	68.8	87.9	135.5	73.0	90.1	94.7	64.0	15.8	84.3	49.6	74.2	98.0	75.5	65.4	82.9	110.0	45.6	43.8	58.3	70.3	122.0	256.0	50.7	46.3	174.7	211.4	25.9	65.5	68.2	53.4	69.0	54.7	30.4	133.9	109.9	175.9	66.2	46.2	98.7	80.7	51.4	60.5	30.2	44.1	61.3	84.7	134.3	71.7	105.1	175.4	128.2	107.7	29.6	65.6	85.5	173.8	214.1	165.3	55.0	84.4	93.1	92.6	165.8	127.7	95.3	106.6	129.0	94.5	109.4	73.3	182.5	118.4	72.9	51.6	88.1	97.7	118.2	129.2	97.8	98.0	108.2	47.8	81.8	91.0	121.6	57.3	160.9	151.6	81.1	145.0	127.7	109.1	88.3	99.0	91.1	118.6	110.6	129.7	186.4	151.8	150.8	119.5	114.4	83.3	174.3	131.6	73.9	180.7	84.0	49.7	89.3	211.5	75.5	109.1	223.9	79.7	56.3	104.4	30.7	115.9	80.1	102.2	319.2	75.4	128.8	94.2	29.6	65.6	16.3	86.1	57.1	125.2	128.2	136.4	104.2	90.5	127.0	173.8	132.3	10.9	85.5	56.9	107.7	121.1	214.1	60.6	68.8	73.0	90.1	45.6	43.8	50.7	46.3	53.4	44.1	881.4	1070.5	2163.1	2834.4	2028.6	247.2	305.0	1187.2	758.8	1325.1	579.3	80.5	1779.8	1921.5	1279.6	726.1	1676.7	912.8	607.3	2525.7	2622.3	1595.4	2203.5	1283.3	1194.7	1386.3	111.2	1311.9	1225.8	1564.2	477.7	2781.1	1768.0	1307.5	1765.6	1777.1	437.9	2399.6	1553.6	1411.5	2120.0	319.1	860.2	1451.3	472.4	280.9	2033.8	1958.3	1532.8	2167.1	2738.5
RPL26	L26	ENSG00000161970	"Ribosomal protein L26"	P61254	17	8377516-8383250	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 586.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030449, CAB037301"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"CAB037301: AB_796168, HPA030449: AB_10602125"	"unprognostic (2.02e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.38e-1)"	122.5	64.5	70.2	102.5	49.8	132.2	170.4	44.4	52.4	127.6	131.6	34.8	68.1	53.1	76.4	97.0	161.2	87.6	98.6	68.1	54.8	42.5	100.6	138.3	97.5	117.5	61.6	32.6	183.0	586.0	32.2	41.1	82.2	47.7	129.0	84.0	41.5	95.3	87.4	170.8	106.3	98.6	103.6	62.9	129.0	75.9	53.0	45.1	104.9	131.6	145.8	107.9	154.7	127.6	154.9	120.8	25.1	92.1	93.0	158.2	165.0	103.5	95.3	93.8	111.0	177.2	291.8	91.7	90.0	133.9	122.3	92.4	100.7	53.4	181.0	103.5	106.6	50.0	115.1	119.2	184.4	144.0	67.6	214.8	70.6	105.2	116.1	207.2	104.9	91.7	248.7	369.2	101.2	304.3	172.0	150.5	104.1	79.9	54.6	128.4	71.3	115.6	143.5	88.1	108.9	63.3	115.5	95.3	112.6	164.3	77.9	39.0	83.3	48.5	90.6	208.1	86.7	92.7	140.5	94.3	49.5	61.8	68.2	157.5	43.9	51.2	79.1	81.0	149.3	73.3	25.1	92.1	18.2	89.9	78.3	130.5	154.9	134.3	116.8	120.8	140.1	158.2	136.0	10.9	93.0	69.5	104.5	111.3	165.0	70.2	49.8	44.4	52.4	54.8	42.5	61.6	32.6	47.7	45.1	833.7	960.0	5357.4	2721.4	4954.5	234.8	252.2	2797.5	959.6	1909.7	952.6	125.7	3974.4	3344.0	2212.2	695.5	2535.1	1389.0	1425.0	4263.0	6092.8	2980.6	2437.9	1777.7	2307.8	2989.4	128.7	2198.5	2802.7	4762.9	1400.7	4423.2	3635.2	3033.3	3719.6	3654.9	300.8	3633.9	3236.9	2028.4	4497.4	340.9	1487.5	2382.4	569.4	578.1	6200.9	3820.5	3284.3	5356.2	2887.4
RPL26L1	RPL26P1	ENSG00000037241	"Ribosomal protein L26 like 1"	Q9UNX3	5	172958729-172969771	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.6"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 286.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030449	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA030449: AB_10602125"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.86e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-3)"	11.2	23.0	17.9	14.7	17.9	18.0	15.2	10.5	21.1	13.1	12.8	8.2	14.4	13.5	14.5	21.6	18.1	14.7	11.9	19.5	20.7	16.8	20.0	25.9	10.5	16.7	16.2	18.0	14.1	25.5	9.1	15.4	14.2	16.3	12.1	14.6	11.5	18.4	16.7	19.0	9.7	10.8	14.0	12.8	13.3	12.2	73.6	11.8	20.0	16.2	18.2	14.9	13.1	11.9	19.7	40.0	17.5	36.2	14.6	21.7	20.9	29.6	26.9	24.4	33.5	16.9	17.9	31.6	28.4	16.7	41.1	36.7	32.8	32.0	22.3	73.0	38.9	43.8	19.3	40.2	56.3	38.0	28.5	52.3	16.5	31.5	40.1	33.2	24.0	14.7	22.3	23.8	42.3	29.7	16.7	23.5	22.0	22.6	18.8	29.2	65.8	29.3	38.0	15.5	13.8	42.8	21.4	37.8	29.6	23.9	18.7	24.6	15.1	26.0	23.9	37.7	16.3	29.3	25.9	24.7	47.0	26.1	27.4	21.2	16.9	26.3	41.8	37.0	30.2	27.8	7.8	36.2	15.5	14.3	31.4	18.3	19.7	17.4	19.6	40.0	15.1	14.5	18.4	17.5	14.6	26.8	27.5	21.7	20.9	17.9	17.9	10.5	21.1	20.7	16.8	16.2	18.0	16.3	11.8	38.7	26.2	23.1	45.5	43.4	14.3	38.4	50.9	62.9	35.2	55.8	17.7	94.5	154.2	102.8	286.5	45.0	32.9	93.5	97.7	103.7	39.0	47.6	25.5	104.6	100.3	14.3	38.7	41.7	51.6	40.1	35.1	50.7	49.0	97.4	42.9	42.9	113.2	38.6	38.5	146.6	13.9	19.4	39.1	214.9	161.4	46.2	66.0	27.7	55.4	43.0
RPL27A	L27A	ENSG00000166441	"Ribosomal protein L27a"	P46776	11	8682411-8714759	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 555.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA060776, HPA063379"	Supported		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA060776: AB_2684359, HPA063379: AB_2684997"	"prognostic favorable (7.84e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (2.83e-10)"	"unprognostic (2.28e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-2)"	65.9	58.8	49.6	116.1	81.5	146.4	149.4	47.8	80.5	69.7	69.9	25.1	64.2	60.1	73.2	74.9	98.4	76.4	88.5	103.5	59.9	33.9	57.0	71.3	111.1	316.9	44.5	49.3	132.2	278.5	10.4	54.6	64.8	64.0	70.1	75.7	42.1	115.8	70.1	124.6	97.9	69.2	109.2	47.1	92.0	72.4	56.8	28.5	74.6	89.3	127.5	120.5	71.0	128.7	341.9	188.5	71.3	122.3	161.9	351.8	555.6	169.7	118.2	75.5	90.6	104.1	199.1	114.2	110.4	139.5	126.6	97.4	149.4	158.7	240.8	87.3	96.5	54.0	124.3	99.6	154.0	95.5	87.9	214.1	106.0	115.4	184.3	172.7	192.0	124.8	217.5	275.3	19.9	211.4	174.9	125.4	144.2	109.1	76.0	106.9	127.9	143.0	289.5	122.7	126.4	123.8	125.3	79.3	146.3	118.9	170.2	86.5	155.5	40.9	157.2	171.4	83.3	69.5	220.1	113.9	41.3	111.3	106.0	139.4	86.6	189.8	197.0	94.8	131.6	74.8	71.3	122.3	37.8	208.1	119.1	266.8	341.9	295.7	244.4	188.5	301.2	351.8	290.3	29.7	161.9	108.1	180.0	198.2	555.6	49.6	81.5	47.8	80.5	59.9	33.9	44.5	49.3	64.0	28.5	1042.2	1639.1	5447.5	5197.7	4315.3	211.8	780.0	2010.1	1169.7	2127.0	936.9	108.0	4955.4	2420.5	2120.6	640.6	2975.9	1990.9	1378.3	4688.2	6270.1	2784.5	3963.3	2012.4	2288.9	3821.7	76.3	2038.1	2441.8	3815.0	1497.4	3355.1	4578.8	2687.5	3973.9	4593.3	390.8	4009.3	4780.0	1839.6	2272.7	251.4	1532.8	3189.9	395.7	439.9	5297.8	5030.9	4388.7	5800.0	5583.1
RPL28	"FLJ43307, L28"	ENSG00000108107	"Ribosomal protein L28"	P46779	19	55385345-55403250	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA050459	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA050459: AB_2681135"	"unprognostic (4.70e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.86e-3)"	"unprognostic (6.53e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.61e-5)"	"unprognostic (4.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.93e-3)"	91.7	86.3	81.9	112.8	68.3	166.7	88.9	32.8	84.1	117.1	107.7	86.7	71.1	89.9	144.6	81.3	224.2	105.0	118.0	72.9	66.2	54.4	87.1	228.8	133.0	398.1	70.4	50.7	200.5	198.5	25.5	73.7	88.7	53.2	122.7	61.2	88.0	143.3	77.9	102.1	136.4	108.1	76.8	70.7	205.5	85.8	75.9	27.4	375.5	144.6	108.5	269.6	131.8	121.7	139.5	93.6	27.8	77.2	66.7	146.6	190.9	119.8	139.6	48.6	96.6	86.9	140.0	82.1	81.4	78.0	71.3	66.2	136.0	64.1	180.3	58.6	73.8	30.4	75.5	55.2	104.7	31.7	69.7	313.8	111.2	88.3	165.4	144.5	129.2	98.0	196.3	150.5	53.0	107.3	94.2	76.5	87.2	85.9	148.5	63.4	138.7	144.5	120.2	116.4	102.7	152.8	146.7	70.1	137.2	90.3	240.3	61.9	102.4	51.8	170.9	122.7	28.2	71.0	138.7	92.7	63.8	71.9	51.0	129.1	122.4	176.4	112.5	81.5	158.3	53.7	27.8	77.2	21.9	77.0	67.8	119.7	137.8	129.9	101.2	93.6	139.5	146.6	130.8	24.4	66.7	56.3	88.3	117.7	190.9	81.9	68.3	32.8	84.1	66.2	54.4	70.4	50.7	53.2	27.4	291.8	450.6	5533.4	3559.5	3364.2	265.4	142.6	1745.2	448.3	752.9	1106.2	153.2	2957.6	2161.9	2047.1	1154.7	2503.9	2388.1	1308.2	3801.8	5038.4	2290.4	3623.5	840.2	2219.1	3594.0	170.0	2198.1	2534.5	5084.5	2612.5	3193.3	4690.0	2006.0	3396.8	4331.0	518.7	4110.9	3699.9	1545.1	2484.8	343.9	957.2	2029.1	824.7	973.3	4286.9	2830.6	4025.5	5879.2	5548.6
RPL29	"HIP, HUMRPL29, L29, RPL29P10"	ENSG00000162244	"Ribosomal protein L29"	P47914	3	51993600-51995942	"Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 434.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA069064	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA069064: AB_2686077"	"unprognostic (3.77e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	91.6	61.7	42.5	64.6	33.0	110.2	111.0	30.1	39.7	102.4	98.1	30.3	57.1	53.6	59.6	72.8	124.7	76.0	68.7	72.1	33.8	26.0	55.7	122.9	64.8	219.4	36.0	26.0	150.1	434.1	16.3	34.3	50.7	26.3	91.1	41.2	38.9	103.7	54.8	160.8	102.5	73.8	80.2	38.1	83.9	59.7	58.7	25.2	85.9	83.3	123.3	92.4	88.5	87.1	137.9	98.1	32.8	80.0	74.8	132.2	202.9	69.9	91.0	70.2	107.0	125.2	196.8	99.0	78.3	96.8	107.6	89.5	108.3	107.5	195.7	34.1	79.5	65.9	63.7	101.2	166.6	51.5	79.6	137.7	101.3	117.7	180.6	148.5	146.9	97.8	240.5	236.9	79.3	141.3	123.3	120.4	87.9	79.0	150.3	79.2	159.8	127.5	191.1	116.5	106.6	154.5	59.3	77.3	189.8	137.5	146.3	56.8	110.8	58.5	135.2	133.7	46.8	101.2	251.4	104.3	60.4	81.1	93.1	116.7	98.1	139.0	139.2	79.9	176.2	79.8	32.8	80.0	22.6	68.8	61.7	115.0	137.9	112.2	87.6	98.1	128.2	132.2	109.9	10.8	74.8	48.4	82.8	100.8	202.9	42.5	33.0	30.1	39.7	33.8	26.0	36.0	26.0	26.3	25.2	175.7	330.0	3392.7	4367.8	3531.6	218.0	72.2	1398.7	310.5	437.9	675.2	96.2	2332.5	1848.6	1477.5	867.6	2040.8	1839.8	957.8	3975.0	4390.8	2112.5	3132.4	683.0	1270.4	2074.0	101.7	1376.0	1509.4	2270.2	3389.8	3344.0	2646.2	2103.8	1980.2	2585.2	359.2	2990.7	2489.9	1488.6	2639.2	288.1	1125.4	2454.4	526.4	450.8	4436.8	2053.3	2519.7	3632.3	5133.1
RPL30	L30	ENSG00000156482	"Ribosomal protein L30"	P62888	8	98024851-98046469	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002651	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		52000	"Endoplasmic reticulum, Cytosol"		"HPA002651: AB_1079842"	"unprognostic (3.28e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (1.41e-9)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.97e-3)"	146.2	68.8	77.6	75.4	56.2	153.1	195.1	54.3	62.0	158.8	123.2	64.1	96.3	57.5	146.1	120.3	164.9	126.6	113.5	147.3	64.5	53.1	75.7	140.6	121.2	383.2	78.6	46.4	284.8	344.3	44.6	62.1	97.5	49.3	154.7	96.3	66.2	172.7	131.4	191.2	144.8	90.1	164.3	85.2	146.6	96.3	79.5	58.7	168.1	170.4	102.5	176.5	153.6	197.4	180.4	94.5	42.1	70.0	94.2	238.2	179.6	140.6	96.6	104.1	99.8	150.1	278.4	100.3	83.1	145.4	140.3	123.3	106.6	133.1	184.2	217.7	118.6	61.8	92.4	129.6	154.4	146.2	72.6	108.3	160.4	96.7	139.7	221.0	85.4	80.2	236.1	245.3	103.9	298.2	166.0	144.0	163.1	114.4	122.2	119.0	187.2	199.2	160.3	93.1	345.6	140.4	107.9	79.3	169.4	114.4	130.8	150.5	128.9	48.1	120.3	189.7	109.9	158.4	203.3	80.0	55.0	59.1	81.9	99.4	129.0	104.4	150.8	77.2	174.8	80.2	42.1	70.0	31.6	104.4	63.1	154.1	180.4	181.2	138.9	94.5	171.7	238.2	186.0	26.3	94.2	55.6	94.0	117.8	179.6	77.6	56.2	54.3	62.0	64.5	53.1	78.6	46.4	49.3	58.7	792.1	1260.6	3527.5	3700.2	3367.9	233.0	62.5	1253.5	748.2	1387.6	526.9	131.6	2248.9	1518.6	1338.6	1083.1	1770.9	1274.6	771.0	3239.9	3233.6	1966.2	2865.1	1485.8	1753.3	1997.4	136.7	1584.7	1633.3	2339.1	2033.5	4049.5	3046.8	1886.1	2374.3	2539.3	588.0	2447.0	2198.9	2259.0	2091.2	300.7	1384.1	2144.4	839.5	561.5	3649.2	2426.7	3150.2	3341.5	3592.2
RPL32	L32	ENSG00000144713	"Ribosomal protein L32"	P62910	3	12834485-12841588	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 406.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047501, HPA051994"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		140000	"Endoplasmic reticulum, Cytosol"		"HPA047501: AB_2680070, HPA051994: AB_2681686"	"unprognostic (6.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.44e-2)"	80.5	42.2	62.9	55.4	44.5	106.7	109.0	33.2	50.8	101.5	58.9	34.9	38.3	37.3	63.1	91.5	94.8	82.3	49.5	53.5	46.5	36.5	68.4	132.9	63.7	117.4	50.1	41.1	167.0	406.2	20.4	38.6	48.6	32.8	62.6	68.4	41.8	67.9	43.3	121.4	90.5	48.6	78.0	48.4	77.7	52.0	55.9	30.7	103.9	66.9	87.7	121.5	91.2	68.9	230.3	119.2	38.8	86.1	104.4	281.7	293.2	74.3	89.4	78.1	99.5	122.9	220.1	258.1	61.4	114.5	129.9	89.1	118.1	76.3	129.7	56.2	88.2	42.7	46.7	88.5	127.7	106.9	59.8	148.2	75.4	113.4	127.6	183.7	121.4	76.5	197.5	278.9	99.1	191.7	128.7	113.3	95.8	92.5	120.7	106.1	224.3	136.5	209.9	131.5	107.3	169.8	109.0	70.2	168.9	131.2	123.8	49.6	99.3	41.4	111.2	132.1	73.0	162.7	234.2	65.3	56.4	72.1	74.0	112.7	81.6	128.1	226.8	71.8	174.4	83.9	38.8	86.1	22.9	99.1	66.7	178.3	230.3	197.2	143.1	119.2	214.7	281.7	213.1	12.7	104.4	53.6	118.2	147.0	293.2	62.9	44.5	33.2	50.8	46.5	36.5	50.1	41.1	32.8	30.7	994.6	1705.3	6619.8	6646.5	8194.1	323.1	436.2	2817.8	1037.3	2033.7	1385.3	157.1	4359.8	3864.6	2400.6	1607.7	4582.5	1755.3	1822.2	5640.8	6521.8	3945.6	4507.1	2255.6	2952.6	3734.4	170.0	2220.9	3848.6	5359.1	5126.5	6169.0	6114.9	4595.6	3626.7	4532.6	595.4	4264.1	3517.5	2818.3	4510.9	491.8	1933.8	4140.6	977.2	891.7	9583.4	4079.8	4680.5	6188.5	6735.9
RPL34	L34	ENSG00000109475	"Ribosomal protein L34"	P49207	4	108620566-108630412	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 400.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035139	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA035139: AB_10602925"	"unprognostic (1.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (2.76e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.72e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.96e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.19e-2)"	68.5	52.6	65.9	77.6	63.7	118.0	165.2	43.7	52.9	82.0	70.1	25.5	57.5	47.3	106.0	111.1	76.4	75.2	61.9	59.2	53.7	41.4	60.2	98.4	56.1	110.1	54.6	49.7	157.4	305.1	17.8	68.3	63.8	59.0	74.3	61.0	35.2	129.9	60.2	87.1	77.6	57.6	87.5	57.5	70.8	60.3	43.2	32.2	63.3	82.2	109.5	95.4	67.6	102.3	300.5	153.8	56.2	116.4	134.2	331.0	400.6	59.2	43.3	78.7	111.9	170.9	270.5	77.5	91.6	116.4	75.6	63.3	109.7	105.5	180.4	55.2	89.0	37.8	42.3	84.6	142.9	99.3	66.5	135.5	75.3	91.0	167.9	143.9	188.8	84.4	240.5	204.2	61.7	140.4	146.0	135.9	100.8	131.9	103.6	124.5	115.1	115.6	230.6	90.3	132.9	87.7	106.2	84.6	109.2	157.8	100.0	84.5	108.2	37.4	218.5	128.3	65.5	72.6	172.7	100.3	51.9	70.4	54.2	80.9	77.4	100.9	145.4	70.7	118.0	63.4	56.2	116.4	35.6	122.0	86.8	207.8	300.5	247.8	165.5	121.2	257.1	331.0	244.9	24.9	134.2	74.9	153.8	176.2	400.6	65.9	63.7	43.7	52.9	53.7	41.4	54.6	49.7	59.0	32.2	1313.2	2435.5	8127.2	9688.6	11162.7	321.1	1043.1	4914.6	1694.4	3137.0	2053.6	70.7	5336.7	5859.0	3087.8	1166.8	4211.1	1851.3	2850.1	7573.3	5633.2	3960.7	4740.0	3107.4	4896.8	3604.2	146.2	2618.2	5127.8	6804.9	1575.7	6923.4	6371.5	5538.7	4548.4	5463.9	625.8	5524.0	4699.4	3790.7	6994.4	382.0	1882.0	3701.7	706.0	481.2	13381.8	5336.0	5116.7	7038.7	7765.2
RPL35	L35	ENSG00000136942	"Ribosomal protein L35"	P42766	9	124857880-124861981	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA006047	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA006047: AB_1856443"	"unprognostic (1.16e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.58e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	91.6	70.1	81.9	116.6	59.2	178.1	156.1	49.2	55.6	109.3	118.5	45.8	86.8	63.0	95.1	98.9	158.5	98.4	89.9	97.0	60.2	55.0	77.5	140.3	89.1	228.4	65.9	48.1	189.1	492.3	25.7	67.0	71.8	45.8	118.3	56.6	63.9	150.9	98.5	247.1	142.7	75.6	131.5	60.8	113.4	78.2	60.5	46.0	113.3	128.4	154.6	130.1	125.5	176.4	201.4	172.2	31.1	82.2	105.1	165.8	281.7	92.1	144.0	81.7	112.1	89.4	189.6	112.2	72.8	117.7	151.9	103.7	237.6	91.4	138.3	75.8	81.0	90.8	178.8	94.8	159.3	55.8	84.6	164.0	55.9	195.6	153.5	159.7	124.3	74.8	174.5	249.4	89.8	159.9	83.9	111.5	132.0	119.8	175.6	113.8	299.6	146.3	285.2	153.2	277.3	177.6	125.0	126.1	307.8	130.3	109.5	110.7	89.9	66.1	156.8	147.5	42.4	159.3	205.3	57.1	67.8	71.7	117.5	147.7	99.1	230.7	206.2	95.2	131.0	113.8	28.5	82.2	31.1	116.6	72.1	155.1	201.4	156.5	133.8	121.0	189.4	165.8	143.9	10.8	105.1	58.8	172.2	122.6	281.7	81.9	59.2	49.2	55.6	60.2	55.0	65.9	48.1	45.8	46.0	592.6	1127.4	4054.2	3642.8	4892.3	209.9	654.8	1602.5	592.9	1178.4	1076.5	80.5	2511.2	2289.6	1953.2	1188.8	2070.4	1494.7	1448.3	5315.3	3981.0	2376.0	2324.3	1249.1	2646.1	2485.0	103.3	1248.3	1951.4	2954.3	3494.2	2571.6	3157.2	2675.7	2877.4	2738.3	357.7	3375.0	1946.4	1208.2	2550.5	284.6	976.6	2381.7	761.7	853.4	6349.1	2061.3	2553.9	3546.1	3372.3
RPL36	"DKFZp566B023, L36"	ENSG00000130255	"Ribosomal protein L36"	Q9Y3U8	19	5674947-5691876	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047153	Supported		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA047153: AB_2679958"	"unprognostic (2.81e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	52.2	101.2	56.3	80.9	43.1	120.2	88.4	40.8	71.1	59.7	63.4	21.2	58.0	60.4	72.2	64.9	79.6	63.2	66.2	69.6	39.7	33.9	48.4	59.7	58.6	201.6	38.7	52.9	225.0	196.1	12.9	48.0	38.6	34.9	65.0	36.7	29.4	129.4	70.4	78.7	101.9	61.4	60.8	39.5	75.3	64.7	53.8	32.3	39.9	40.9	106.1	55.5	48.4	103.1	163.2	79.0	29.1	57.6	68.6	180.7	220.0	101.3	50.9	35.7	88.2	42.7	82.5	52.8	55.9	36.5	56.9	47.0	94.3	51.7	69.2	135.4	26.3	26.9	71.5	32.0	66.4	17.3	52.3	225.5	43.5	52.2	77.6	94.6	93.8	61.2	70.2	109.4	35.2	74.1	57.0	48.0	89.6	55.7	225.4	33.1	108.2	116.3	130.1	119.9	60.9	173.0	72.3	41.9	187.7	54.9	67.9	63.5	85.2	32.9	94.5	156.1	17.8	72.9	161.5	51.3	37.6	50.4	54.9	121.9	111.3	101.0	108.4	71.4	150.5	52.3	29.1	57.6	21.4	77.3	48.3	125.2	161.4	157.2	113.1	79.0	163.2	180.7	146.6	8.0	68.6	40.4	74.6	120.6	220.0	56.3	43.1	40.8	71.1	39.7	33.9	38.7	52.9	34.9	32.3	539.0	792.8	4383.3	2587.1	5914.7	210.4	280.4	1931.2	633.0	1136.3	1175.9	76.6	2530.1	2224.9	2450.7	422.3	2391.0	1994.6	934.5	7046.1	4296.7	2490.5	2459.5	1236.6	2515.3	2437.5	92.2	1971.2	2721.6	3281.5	1128.6	3011.7	2570.0	2884.9	4260.7	4637.6	399.1	5342.0	3492.9	1450.3	2290.2	228.2	911.9	2225.2	393.6	813.8	8042.2	2327.4	2040.6	4783.5	2658.3
RPL36A	"L36A, RPL44"	ENSG00000241343	"Ribosomal protein L36a"	P83881	X	101390824-101396154	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Undifferentiated cells: 3155.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA063979, HPA077586"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA063979: AB_2685164, HPA077586: AB_2686846"	"unprognostic (3.38e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (8.81e-11)"	"unprognostic (1.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	62.9	40.7	50.7	81.5	53.8	139.8	136.1	27.7	46.8	65.3	71.0	25.1	53.4	45.6	67.5	71.4	77.1	59.0	60.6	54.9	43.1	31.1	47.3	60.1	43.4	190.1	42.1	50.6	165.3	171.4	15.0	35.1	44.7	41.8	55.9	68.3	26.1	158.1	71.5	125.7	96.5	54.1	65.5	44.6	67.9	54.6	26.3	32.6	60.8	69.3	118.6	104.0	71.9	74.0	162.9	113.2	13.7	74.2	86.7	175.5	199.2	121.6	65.9	101.2	49.8	124.8	224.0	64.8	93.8	102.9	123.1	188.1	78.0	62.6	235.8	93.9	77.8	75.9	82.2	151.3	131.4	128.3	83.0	166.0	109.0	116.2	71.9	179.5	198.3	105.1	212.5	248.1	99.7	184.9	165.2	113.8	103.1	131.7	126.8	99.1	175.3	91.8	236.6	134.6	252.8	134.0	86.2	221.6	184.8	112.5	50.8	68.0	135.7	87.6	98.4	167.8	84.2	47.5	224.4	105.0	36.6	89.6	101.0	95.0	108.0	154.1	186.4	45.0	295.6	39.0	12.5	74.2	13.7	86.6	73.6	140.3	162.9	162.3	120.6	111.4	134.0	175.5	156.7	7.2	86.7	70.4	113.2	84.9	199.2	50.7	53.8	27.7	46.8	43.1	31.1	42.1	50.6	41.8	32.6	408.0	871.7	1431.2	350.0	815.0	25.3	12.6	713.4	501.9	1443.4	165.7	13.7	675.4	368.1	934.6	6.2	708.2	731.9	397.1	2614.9	904.3	568.3	225.8	1204.1	656.9	533.8	14.3	1058.9	1162.0	2037.4	20.4	977.8	917.6	497.7	1450.9	2170.9	77.3	2295.7	1329.1	393.5	579.9	33.5	232.8	598.3	23.3	110.3	980.8	628.4	1100.0	3155.0	282.8
RPL36A-HNRNPH2		ENSG00000257529	"RPL36A-HNRNPH2 readthrough"		X	101391011-101412297	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 2: 29.9;Ciliated cells: 33.5;Club cells: 53.4;granulocytes: 25.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 14.8"									HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: AB_2686846"	"unprognostic (3.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"		"unprognostic (4.65e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.04e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-1)"	6.7	6.0	3.7	8.5	5.0	7.2	6.1	15.3	5.2	5.9	9.9	1.4	4.9	1.5	6.7	7.2	6.9	4.5	5.8	5.1	3.7	5.4	4.3	5.8	4.5	22.1	4.6	4.6	12.7	19.7	1.5	3.6	4.2	3.5	5.2	4.5	1.5	18.1	7.2	14.0	5.3	4.4	6.4	5.0	6.5	4.3	2.5	2.3	5.9	6.9	13.1	6.2	7.3	7.5	16.2	19.8	13.6	16.1	10.6	14.3	22.4	3.7	0.0	5.1	1.0	2.3	5.2	1.7	14.8	0.7	3.0	2.2	0.0	2.2	3.5	4.6	2.1	0.2	0.4	4.4	0.6	1.0	4.4	1.7	4.1	2.7	1.3	4.0	3.6	1.7	5.6	2.8	1.6	1.1	3.8	1.8	2.2	1.4	4.3	4.0	0.6	5.7	2.3	0.4	1.9	2.0	7.2	5.3	2.8	1.3	0.6	3.2	4.6	1.8	1.6	1.8	1.3	1.8	2.0	2.1	0.5	2.8	2.5	2.6	3.7	6.4	1.2	1.4	3.5	3.1	7.5	14.9	13.6	13.1	16.1	11.5	16.2	12.3	12.4	19.8	15.4	14.3	13.6	4.7	10.6	9.9	10.7	9.0	22.4	3.7	5.0	15.3	5.2	3.7	5.4	4.6	4.6	3.5	2.3	11.9	29.9	0.0	0.0	0.0	0.0	0.0	0.0	33.5	53.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RPL36AL	RPL36A	ENSG00000165502	"Ribosomal protein L36a like"	Q969Q0	14	49618519-49620685	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	Yes			"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: AB_2686846"	"unprognostic (1.55e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.00e-1)"	60.3	55.8	45.9	46.5	40.9	68.2	66.5	35.9	37.7	69.3	74.3	29.2	56.6	52.1	54.9	102.1	61.8	45.9	31.5	48.2	38.0	34.4	69.9	139.2	54.8	63.6	45.3	34.1	105.3	131.9	35.7	62.0	56.9	40.3	62.9	50.5	30.8	85.2	68.6	82.4	40.8	99.8	71.1	48.0	78.8	61.8	36.7	41.8	65.4	72.5	67.6	71.0	87.6	63.9	105.8	112.7	119.5	66.7	84.5	132.0	139.8	73.4	55.4	40.1	23.2	57.7	79.8	23.5	60.7	67.1	56.9	64.5	57.6	50.9	96.9	57.9	50.2	40.1	53.0	34.0	51.8	66.6	33.2	39.2	60.7	58.5	74.3	73.1	96.9	52.2	81.6	79.4	43.5	58.8	67.6	72.0	43.8	38.5	86.3	43.7	94.8	57.0	87.0	22.5	52.9	57.0	36.1	63.1	51.9	86.3	111.8	35.1	21.7	53.4	42.4	60.8	39.8	91.8	53.9	55.4	35.7	56.8	46.4	46.7	52.6	53.7	97.8	25.8	43.9	33.9	119.5	66.7	99.6	98.6	63.2	132.0	105.8	129.3	123.0	68.7	79.9	120.7	112.6	74.0	84.5	55.9	112.7	118.2	139.8	45.9	40.9	35.9	37.7	38.0	34.4	45.3	34.1	40.3	41.8	285.9	358.6	508.2	1190.5	840.1	106.5	561.0	550.3	325.2	378.7	296.6	23.6	568.2	843.9	636.4	440.5	541.3	862.9	397.1	1188.0	608.8	559.0	968.4	688.3	743.7	689.7	76.3	351.4	449.9	649.0	160.8	672.0	707.1	799.7	1234.5	570.5	159.8	1112.3	813.6	502.0	790.1	95.2	478.6	799.2	285.3	135.9	733.7	431.8	698.8	483.1	1226.2
RPL37A	L37A	ENSG00000197756	"Ribosomal protein L37a"	P61513	2	216498189-216579180	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065327	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA065327: AB_2685469"	"unprognostic (9.94e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.84e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.49e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.67e-1)"	115.0	109.4	130.0	114.9	104.2	153.1	252.9	78.4	82.8	134.5	129.9	66.0	80.5	79.8	188.5	123.9	154.9	131.5	90.7	154.0	91.2	81.7	81.0	116.7	100.7	283.5	108.6	91.0	281.8	423.2	47.3	84.3	74.1	89.0	134.7	115.2	77.9	265.7	107.8	307.2	159.0	76.6	171.8	98.6	97.6	99.0	130.3	60.1	117.2	123.7	186.1	154.7	137.2	195.1	215.6	197.7	39.6	103.3	119.1	222.5	229.2	81.9	70.2	152.5	102.6	159.6	281.3	113.4	111.8	150.3	114.2	97.7	177.9	80.1	90.7	157.1	137.3	122.8	86.3	144.1	164.9	118.2	103.1	152.7	148.1	127.2	251.1	273.3	162.6	93.3	304.6	347.5	98.7	279.0	313.3	157.3	180.8	115.3	133.2	147.6	165.4	154.1	334.9	176.5	183.8	80.3	112.0	114.6	110.4	159.0	144.6	99.1	111.5	41.3	129.4	254.7	226.8	81.9	281.6	105.4	82.7	90.3	80.9	122.2	141.7	199.6	173.0	92.2	114.0	83.5	39.6	103.3	24.2	122.9	77.1	168.0	215.2	190.4	151.9	143.0	215.6	222.5	198.2	13.5	119.1	63.9	197.7	136.5	229.2	130.0	104.2	78.4	82.8	91.2	81.7	108.6	91.0	89.0	60.1	1113.6	1605.4	4470.7	2849.7	4385.4	480.1	1288.8	2771.9	1195.1	2353.3	1200.4	174.7	2558.5	2674.2	2235.0	3158.6	2255.3	1994.6	1401.6	7324.8	4423.3	2457.1	2614.9	2050.5	4095.4	2673.7	189.1	2525.5	3209.1	4083.5	6452.6	5314.9	2718.4	2706.1	2655.6	4289.5	857.5	5221.5	4229.5	2791.1	2456.8	499.9	1972.6	2514.2	2077.9	1466.6	6429.9	2683.3	2745.2	5422.7	2918.7
RPL38	L38	ENSG00000172809	"Ribosomal protein L38"	P63173	17	74203582-74210655	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052543	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA052543: AB_2681864"	"unprognostic (1.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.71e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.17e-8)"	"unprognostic (1.89e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-2)"	105.7	85.6	114.6	92.9	94.2	140.7	148.5	58.8	142.3	91.1	107.6	42.6	88.1	74.9	88.2	104.6	89.3	88.2	86.2	152.3	87.3	69.2	67.5	83.5	132.5	313.8	111.4	104.1	258.2	305.8	26.7	59.9	62.8	95.4	73.0	79.4	41.2	118.9	101.8	283.6	108.0	73.8	150.8	162.9	108.0	77.7	99.6	108.3	77.1	67.7	143.5	133.2	92.9	195.6	174.9	141.2	54.0	106.3	80.4	217.6	213.6	95.8	95.3	91.9	93.7	125.9	149.2	91.0	104.5	67.5	95.7	67.1	106.9	73.7	169.8	73.3	89.3	88.8	86.8	109.5	135.6	75.1	47.3	175.7	97.1	80.9	137.9	147.1	181.1	86.7	286.5	190.8	89.7	146.4	129.2	139.8	137.6	119.0	94.7	79.8	101.0	175.3	219.0	107.4	216.2	144.4	127.0	194.9	150.7	113.3	75.3	83.4	155.5	43.6	182.7	225.9	119.9	139.1	188.6	91.3	80.1	130.5	73.6	136.3	128.8	198.4	175.1	65.6	120.1	76.0	54.0	106.3	37.3	112.2	84.4	132.9	174.9	190.5	140.5	115.2	174.7	217.6	185.8	34.0	80.4	74.5	141.2	117.4	213.6	114.6	94.2	58.8	142.3	87.3	69.2	111.4	104.1	95.4	108.3	419.9	815.0	2505.1	1061.7	2071.2	181.9	640.3	1464.9	655.8	904.3	582.7	68.7	1161.4	1221.8	1260.5	1133.6	1076.0	1322.1	1027.9	2476.7	1954.3	1215.5	1111.3	1165.0	1997.2	1559.4	82.6	1413.5	1769.7	2441.1	2536.5	2793.1	1753.9	1150.6	2001.8	2524.9	303.2	2314.6	1848.1	1418.9	1584.9	191.2	944.3	1350.6	946.2	865.8	2351.9	1212.7	1556.7	2721.5	1107.0
RPL4	L4	ENSG00000174444	"Ribosomal protein L4"	P36578	15	66498015-66524532	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034600	Uncertain		Supported	"Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol"		Yes	No		830000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nuclear bodies"	"HPA034600: AB_10601483"	"unprognostic (1.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.27e-1)"	63.6	33.4	37.0	59.0	40.4	70.6	88.2	34.5	42.2	73.6	60.5	33.5	42.3	18.8	67.3	49.8	81.3	65.7	39.4	38.8	31.7	26.4	53.2	84.5	46.1	103.9	35.1	26.3	139.1	159.9	33.1	42.0	52.0	34.1	67.6	50.9	35.9	66.2	51.0	87.2	77.1	36.4	67.3	47.9	60.3	46.3	42.8	20.0	81.3	66.1	91.7	102.8	74.2	55.9	72.5	58.7	5.9	40.9	45.0	97.0	135.7	45.1	91.1	38.6	64.9	173.7	316.0	68.1	55.1	113.9	85.4	66.3	100.7	79.3	178.9	62.9	131.3	40.4	82.2	275.6	213.2	94.6	49.4	165.2	109.6	81.7	83.7	244.9	114.8	54.9	310.0	278.0	92.8	371.0	105.2	136.6	84.9	100.3	70.4	127.7	74.5	76.4	51.1	84.4	100.9	65.3	85.8	88.0	173.6	117.4	89.7	68.6	71.7	34.0	96.8	136.2	84.5	71.5	166.0	80.0	44.7	67.5	41.5	87.6	69.2	107.3	119.6	55.0	154.6	50.2	3.5	40.9	5.9	38.2	36.2	71.1	72.5	74.6	53.7	58.7	60.5	97.0	75.7	2.7	45.0	33.5	37.4	57.0	135.7	37.0	40.4	34.5	42.2	31.7	26.4	35.1	26.3	34.1	20.0	419.9	882.0	1803.2	2287.0	2152.7	118.6	357.6	588.5	738.8	1063.5	324.5	76.6	1844.2	1399.3	929.4	510.9	791.2	291.1	327.1	1855.6	3103.9	1180.5	1227.4	901.9	616.8	1082.4	38.1	731.3	578.2	1045.6	1022.7	1235.2	1320.8	1032.5	1779.1	995.5	130.7	1271.8	480.5	936.2	1212.4	111.6	452.7	1291.3	308.9	412.0	2258.1	2005.7	1400.6	1218.5	2270.0
RPL41	L41	ENSG00000229117	"Ribosomal protein L41"	P62945	12	56116586-56117943	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053169	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053169: AB_2682067"	"unprognostic (7.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	98.5	110.3	143.6	75.9	178.6	148.9	195.6	79.5	215.4	106.8	115.5	35.9	97.1	80.0	92.1	140.7	139.3	117.6	74.2	113.4	104.3	59.9	95.5	109.2	84.1	125.0	91.5	167.3	235.3	238.3	38.1	116.4	78.5	108.2	110.5	115.8	46.3	129.7	105.6	182.5	161.0	92.4	84.6	103.4	112.0	115.2	60.6	80.2	73.6	103.5	133.3	157.2	93.8	118.0	381.7	228.0	112.6	145.3	178.3	351.7	503.4	195.8	249.4	227.8	156.2	248.7	389.2	147.1	178.6	233.8	228.4	184.8	242.0	233.6	371.8	232.6	226.3	72.1	162.8	282.7	287.5	197.4	151.4	278.0	162.6	192.5	245.6	281.3	291.1	141.5	431.9	390.3	207.2	454.5	440.6	263.8	202.3	160.4	356.3	221.5	358.7	264.3	434.8	272.8	250.7	237.1	198.1	216.4	297.2	291.9	280.2	136.2	236.4	167.3	252.7	351.4	162.6	301.6	354.1	165.0	98.5	181.5	122.5	177.4	163.2	283.8	300.4	152.5	236.1	104.3	112.6	145.3	79.4	203.4	128.5	283.3	381.7	331.0	262.1	187.5	334.4	351.7	298.2	59.8	178.3	119.0	228.0	245.5	503.4	143.6	178.6	79.5	215.4	104.3	59.9	91.5	167.3	108.2	80.2	2307.7	3920.9	13212.4	3047.7	18335.7	450.9	526.2	6402.5	3590.9	5100.2	3745.9	206.2	4772.7	8743.8	5307.6	676.1	3878.6	5142.7	2966.8	15534.3	7330.7	6049.5	3737.7	3330.2	8563.3	5181.1	201.8	4950.1	5347.0	8241.5	1910.5	6240.5	5956.9	10547.6	11845.2	12005.5	1116.6	10850.6	10920.7	2745.1	7365.3	553.9	2108.4	5517.6	464.9	549.6	22578.4	5011.8	5870.7	14997.3	3615.1
RPL5	"L5, PPP1R135"	ENSG00000122406	"Ribosomal protein L5"	P46777	1	92831983-92841924	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Cancer-related genes, Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043717, HPA054444"	Approved		Supported	"Nucleoli,Nucleoli rim,Endoplasmic reticulum,Cytosol"		NA	NA		130000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nucleoli rim"	"HPA043717: AB_10964719, HPA054444: AB_2732584"	"unprognostic (5.81e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (2.26e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-1)"	119.4	80.3	50.0	70.0	50.1	113.8	140.5	46.9	46.8	158.6	111.4	45.0	75.1	61.7	135.2	114.6	159.4	100.5	73.1	73.0	43.5	43.1	99.7	114.9	89.9	148.2	54.5	36.2	296.8	306.5	40.8	90.3	90.2	44.3	175.4	78.8	64.3	121.5	73.2	109.1	97.8	95.3	153.4	61.9	130.1	90.0	68.8	45.7	156.6	210.0	97.7	118.9	191.2	146.6	104.5	85.2	12.8	45.9	72.4	143.0	142.1	118.8	51.1	91.0	76.7	118.4	239.2	146.0	71.1	95.2	88.5	63.5	135.2	52.0	224.2	114.2	79.8	84.0	76.0	104.3	133.2	113.2	71.0	142.8	116.3	85.0	124.4	142.0	178.1	49.1	195.6	210.2	78.6	173.1	160.6	122.3	118.5	144.0	118.2	101.4	67.4	141.8	201.9	140.6	90.4	96.5	130.3	176.3	144.8	107.4	99.0	77.6	92.9	46.3	129.2	206.7	78.2	71.2	245.0	74.2	44.7	81.8	84.6	128.1	73.2	69.5	151.7	30.3	153.6	30.3	12.8	45.9	7.2	60.9	44.8	122.1	104.5	111.5	91.6	85.2	88.4	143.0	123.9	4.4	72.4	38.3	71.1	83.2	142.1	50.0	50.1	46.9	46.8	43.5	43.1	54.5	36.2	44.3	45.7	607.4	848.7	2690.4	3540.6	2525.4	316.8	352.2	1200.0	674.6	1189.7	390.8	84.4	2237.8	1689.4	1278.7	1159.8	1643.6	564.1	537.3	2338.5	3530.6	1572.9	2535.7	1002.7	856.3	1297.7	138.2	1189.1	1198.2	1468.3	888.7	2620.2	1565.9	1334.5	1646.5	1585.6	343.0	1936.2	1164.3	2027.0	1766.3	226.7	1034.8	1885.9	531.9	457.4	2528.9	2185.2	1965.9	2487.8	3230.9
RPL7	"humL7-1, L7"	ENSG00000147604	"Ribosomal protein L7"	P18124	8	73290267-73295789	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 536.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 638.4"									HPA058373	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		170000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA058373: AB_2683694"	"unprognostic (3.75e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.31e-1)"	54.7	36.5	54.6	37.9	49.3	67.6	86.9	55.9	54.1	57.5	46.2	36.4	41.0	33.6	54.9	50.6	59.5	50.6	26.5	36.7	32.1	22.0	46.4	67.6	40.3	53.3	55.9	20.5	125.8	87.5	22.9	67.7	33.4	55.0	43.6	44.9	44.1	51.8	36.6	61.9	72.7	37.0	49.5	46.9	46.5	51.2	135.1	54.9	33.7	42.6	69.0	66.6	50.8	58.5	338.1	231.5	66.1	171.7	205.0	464.0	536.3	99.7	72.5	78.0	93.8	159.2	204.1	76.7	109.7	88.2	75.0	59.2	87.2	104.6	296.9	89.8	88.4	51.2	95.8	102.9	140.1	117.1	79.8	85.4	162.5	94.9	89.7	95.7	114.5	83.4	191.0	165.6	69.4	217.2	138.4	121.5	100.9	144.9	112.7	106.4	84.7	181.7	175.2	90.9	182.4	78.0	122.9	89.3	115.7	116.9	100.1	108.0	78.7	51.5	638.4	153.6	67.0	161.3	150.6	114.0	57.7	88.3	73.3	101.3	65.2	92.3	191.6	60.3	142.3	94.7	66.1	171.7	41.1	179.1	138.9	322.3	338.1	314.4	232.5	231.5	282.6	464.0	327.0	22.3	205.0	118.6	192.4	237.0	536.3	54.6	49.3	55.9	54.1	32.1	22.0	55.9	20.5	55.0	54.9	759.3	1377.6	4083.1	8227.6	7155.0	251.0	580.3	2023.0	1007.8	1723.2	1244.0	117.8	3979.6	4725.1	2246.6	1393.0	2953.4	897.4	1004.5	4388.5	6073.2	3431.1	4195.6	1418.7	1830.9	2853.5	89.0	1556.2	2090.7	3232.1	609.0	3931.9	3610.7	3514.2	2982.9	2652.3	679.5	3206.0	2051.6	2172.0	4500.4	280.8	1435.8	4545.3	828.4	372.8	8292.9	4080.0	3000.7	4416.0	6170.5
RPL8	L8	ENSG00000161016	"Ribosomal protein L8"	P62917	8	144789765-144792587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 323.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045095, HPA050165"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		240000000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA045095: AB_2679213, HPA050165: AB_2681038"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.13e-2)"	65.9	45.5	32.1	53.7	34.7	120.1	115.2	31.0	61.9	63.9	78.4	26.4	51.1	95.2	106.4	57.1	76.0	51.2	68.9	78.7	27.2	23.6	48.2	62.6	54.5	169.4	29.0	28.8	125.7	349.6	11.8	45.2	38.4	28.8	61.3	15.7	45.6	174.7	57.3	202.1	89.0	82.8	84.9	29.2	79.7	96.4	48.9	17.0	61.2	73.2	103.2	72.8	64.7	100.0	174.8	117.5	31.1	82.7	77.9	136.8	251.3	120.9	142.8	10.2	44.4	11.5	26.1	98.2	87.7	16.5	26.9	19.1	124.7	65.5	162.8	126.9	10.3	8.9	73.3	13.4	30.5	4.9	70.7	162.5	96.5	110.0	87.9	28.7	63.2	52.7	28.1	34.8	12.1	20.7	12.7	19.7	35.6	130.0	37.8	11.4	323.4	90.3	85.7	95.4	33.2	162.0	88.5	59.1	153.0	14.3	91.8	62.5	104.4	84.2	45.9	120.4	4.3	106.3	61.3	78.7	35.7	135.8	74.4	105.3	69.1	58.9	140.8	71.0	105.2	48.8	24.1	80.3	31.1	70.5	82.7	117.9	166.8	119.3	86.9	117.5	174.8	136.8	105.0	9.8	77.9	78.5	64.5	113.8	251.3	32.1	34.7	31.0	61.9	27.2	23.6	29.0	28.8	28.8	17.0	792.1	1172.5	3639.8	5704.0	5720.2	400.0	926.5	1594.9	667.9	1239.8	975.3	253.3	3837.7	3756.8	1939.3	708.6	1998.1	1895.6	1261.4	5072.3	5914.7	2684.9	4292.9	1005.1	1181.4	2697.5	157.3	1633.5	1478.1	2282.6	2004.1	2891.5	2666.3	3338.7	2696.1	3081.8	500.6	3359.4	2949.4	1346.4	3180.5	483.0	1060.7	3222.8	573.1	569.6	7189.2	3651.1	2078.6	4568.6	6042.4
RPL9	L9	ENSG00000163682	"Ribosomal protein L9"	P32969	4	39452521-39458949	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003372	Approved	Approved	Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		24000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA003372: AB_1079843"	"unprognostic (1.08e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.06e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.58e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-2)"	52.6	35.2	42.2	73.9	44.4	179.1	202.3	35.7	51.6	63.0	59.8	34.5	42.2	69.8	50.4	226.8	49.9	48.1	69.7	58.2	42.3	27.6	47.4	73.2	35.8	48.7	34.7	51.7	158.5	126.2	37.4	44.7	38.7	42.5	47.8	59.1	31.7	93.7	71.4	66.3	62.9	38.8	49.5	34.0	45.2	46.5	56.9	25.9	36.0	63.2	70.1	59.0	46.0	56.6	118.3	72.5	26.2	41.4	63.0	145.0	148.9	3.2	2.8	122.9	2.8	6.6	9.0	4.8	57.9	87.4	72.3	54.8	8.1	65.7	143.5	6.6	58.2	57.3	65.4	5.5	6.3	79.1	52.3	115.6	4.5	24.2	7.8	8.6	9.3	38.0	11.9	181.8	4.4	83.1	107.6	5.5	5.8	109.7	67.0	5.0	4.3	77.9	9.9	109.8	79.6	3.9	71.9	123.2	4.9	89.9	3.8	4.6	49.0	2.0	47.5	7.4	118.9	104.9	6.8	4.1	3.1	4.6	84.1	8.0	103.0	144.6	124.7	83.4	87.3	3.3	26.2	41.4	12.3	52.1	40.1	101.2	118.3	102.2	71.4	57.2	103.8	145.0	111.7	6.9	63.0	31.2	72.5	77.0	148.9	42.2	44.4	35.7	51.6	42.3	27.6	34.7	51.7	42.5	25.9	616.4	695.5	3946.9	4635.1	3670.9	362.7	367.2	1765.6	426.9	687.0	673.4	151.2	2652.9	2316.1	1697.3	1288.9	2348.7	1394.0	817.7	3813.6	4743.2	2040.6	3407.8	885.2	1749.4	2435.4	187.5	1780.1	1927.4	2668.8	1161.7	4462.6	2606.9	1756.2	2952.2	2900.0	510.1	3233.5	2563.6	2250.5	2828.8	405.3	1487.5	2143.4	695.4	462.3	4086.9	2843.5	2427.5	4009.2	4396.5
RPLP0	"L10E, LP0, P0, PRLP0, RPP0"	ENSG00000089157	"Ribosomal protein lateral stalk subunit P0"	P05388	12	120196686-120201235	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 408.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003512, HPA073501"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA003512: AB_1079844, HPA073501: "	"unprognostic (2.39e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (7.66e-12)"	"unprognostic (2.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.47e-1)"	67.3	59.5	20.6	76.6	31.6	100.5	119.8	26.8	26.0	58.4	76.8	22.0	61.8	50.5	95.9	66.0	128.3	74.8	88.6	49.8	28.9	16.2	47.1	121.7	55.4	59.7	21.9	26.6	117.5	408.6	13.5	36.6	70.1	41.5	72.4	60.8	32.8	138.5	54.6	101.0	113.9	57.3	63.8	23.4	60.0	69.0	73.0	18.7	89.6	90.8	162.5	82.8	64.2	116.6	135.9	143.3	10.7	63.4	82.7	172.4	193.3	125.7	108.9	92.6	158.4	189.2	311.6	132.1	96.9	168.3	151.7	98.8	120.4	77.5	275.6	97.9	169.5	37.7	100.0	163.9	201.2	96.1	106.4	124.9	131.5	72.3	102.8	204.1	176.6	99.5	280.8	344.6	106.2	315.7	258.9	179.1	158.6	161.0	79.9	144.1	136.1	177.8	119.5	176.4	128.2	145.8	129.7	130.3	215.9	151.7	145.2	98.8	120.4	69.8	104.6	190.4	114.2	186.7	213.6	120.3	71.5	109.2	90.6	120.1	180.7	190.1	137.5	128.5	127.1	60.2	10.7	63.4	5.3	71.5	58.3	172.4	135.9	131.9	97.1	137.0	123.2	131.4	104.4	5.0	82.7	35.1	143.3	83.4	193.3	20.6	31.6	26.8	26.0	28.9	16.2	21.9	26.6	41.5	18.7	544.9	1103.9	2148.7	3806.4	3443.2	197.9	209.4	1085.3	926.2	1446.8	533.9	145.3	3866.1	1598.2	1545.3	333.2	1285.7	1169.7	864.3	4155.9	5327.9	1860.1	2549.8	765.8	1006.6	1782.0	89.0	1170.4	829.9	1076.1	733.9	1611.7	1293.2	1612.9	1872.0	2272.8	178.1	2945.4	1050.9	747.5	1579.0	330.6	413.9	1621.9	303.3	717.8	4153.8	3690.5	1762.1	3426.9	4264.4
RPLP1	LP1	ENSG00000137818	"Ribosomal protein lateral stalk subunit P1"	P05386	15	69452784-69456194	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 1030.2"	"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 24827.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003368			Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		1000000	"Endoplasmic reticulum, Cytosol"		"HPA003368: AB_1079845"	"unprognostic (5.04e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (2.30e-9)"	"unprognostic (7.75e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.83e-2)"	59.6	57.2	47.5	76.8	42.9	171.7	451.2	68.8	103.3	70.1	79.0	20.8	57.9	87.5	73.5	76.3	100.7	65.7	80.6	341.6	35.5	29.7	55.8	69.9	290.9	1030.2	42.4	33.3	134.3	209.0	8.6	36.0	52.3	45.6	71.0	33.3	61.3	102.8	60.7	262.9	155.2	74.3	128.2	38.8	77.4	77.1	45.7	32.7	73.0	50.8	146.9	71.8	72.3	95.5	329.0	226.3	79.6	176.1	169.8	267.2	368.8	83.9	85.9	38.5	88.8	55.3	66.7	82.8	73.9	43.9	41.4	33.1	87.1	85.6	117.5	110.5	38.8	38.0	114.9	59.3	58.1	9.1	117.8	181.4	99.0	98.7	85.0	96.8	87.5	90.4	83.8	101.9	30.1	56.5	67.8	49.8	104.3	93.0	100.2	29.2	78.6	95.5	258.3	144.0	52.7	82.8	98.0	125.9	171.9	39.8	90.9	61.8	120.3	74.2	91.8	301.5	36.5	75.8	201.8	87.5	60.0	134.3	71.6	120.0	205.5	327.6	99.6	71.8	223.7	49.5	79.6	176.1	60.4	119.5	124.7	220.2	329.0	247.2	162.7	215.0	278.5	267.2	223.0	26.2	169.8	70.2	226.3	202.7	368.8	47.5	42.9	68.8	103.3	35.5	29.7	42.4	33.3	45.6	32.7	1756.9	3079.2	10545.4	15462.2	21484.5	610.5	1535.2	3648.4	2472.0	4955.7	2149.5	329.9	7737.4	4357.0	4586.1	334.7	5371.3	2418.0	3387.3	6194.3	10107.4	5970.9	9644.5	2461.9	5669.3	7196.3	352.8	2817.1	4601.8	7392.9	1146.7	7821.5	8502.7	8585.5	10174.3	7223.7	1445.4	6675.7	4201.4	4449.0	6344.8	808.4	2490.0	6776.3	667.6	1530.1	24827.4	7946.7	8933.3	9955.9	14669.5
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619970-128681075	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		8200000	"Endoplasmic reticulum"	Cytosol	"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	52.3	37.5	22.2	26.6	23.8	24.4	48.2	20.9	31.4	45.8	40.8	31.9	58.8	28.5	38.3	110.2	32.2	38.3	38.8	47.1	23.0	28.0	55.4	174.0	47.4	50.6	26.4	18.3	37.8	62.9	43.5	36.9	58.3	24.3	31.4	41.1	28.6	54.1	55.5	34.4	24.0	37.0	33.5	31.8	48.0	33.7	26.9	23.3	34.3	69.1	27.3	36.5	32.7	39.7	26.7	53.1	64.4	43.5	23.4	45.1	53.3	60.5	33.0	27.6	50.7	74.7	50.1	62.5	52.2	68.7	69.4	80.9	68.4	57.1	37.9	49.3	75.3	64.7	61.0	44.5	46.5	68.0	27.2	28.6	66.8	24.6	56.2	82.4	54.2	35.2	41.5	54.4	45.6	67.5	46.5	54.2	28.7	27.5	50.9	45.5	55.4	30.0	59.6	35.0	81.1	30.3	32.9	37.1	91.2	48.1	36.4	42.5	24.5	42.9	44.5	52.8	36.9	47.6	56.1	35.2	35.9	28.1	52.5	38.7	54.9	43.2	40.5	58.9	40.4	51.8	38.8	43.5	35.7	37.3	40.0	45.1	26.7	30.7	33.8	43.5	18.3	19.1	29.2	64.4	23.4	40.2	53.1	30.5	53.3	22.2	23.8	20.9	31.4	23.0	28.0	26.4	18.3	24.3	23.3	56.6	71.5	37.3	71.3	44.0	11.5	35.3	61.1	66.9	47.8	106.4	7.9	108.3	13.3	99.9	13.7	58.2	107.9	46.7	81.2	161.1	79.3	88.0	42.7	155.3	122.7	19.1	41.6	107.4	134.1	20.7	87.2	73.4	55.6	36.9	102.4	27.5	98.9	83.4	60.5	80.2	11.7	45.3	39.6	49.9	59.8	46.7	131.0	50.0	106.2	66.4
RPN2	"RIBIIR, RPN-II, RPNII, SWP1"	ENSG00000118705	"Ribophorin II"	P04844	20	37178410-37241623	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 520.7;Syncytiotrophoblasts: 519.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008297, CAB019277, HPA025922"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		2800000	"Endoplasmic reticulum"		"CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458"	"unprognostic (9.59e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.44e-10)"	"unprognostic (2.83e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.44e-4)"	29.2	47.6	16.6	24.2	19.6	30.1	34.8	13.2	21.4	34.3	30.5	23.3	52.6	24.0	38.3	70.3	35.1	29.5	34.8	36.3	14.2	14.1	52.9	105.7	38.7	53.0	19.1	14.7	33.3	72.2	38.2	28.7	110.3	19.8	33.3	34.7	43.1	64.6	49.1	32.9	26.0	43.2	30.2	15.6	47.5	35.7	43.5	14.5	27.9	56.8	26.4	42.3	27.8	27.7	48.1	96.3	55.8	70.1	60.8	72.3	92.9	36.7	33.2	34.8	46.3	48.4	36.3	69.1	48.7	57.9	62.4	53.1	105.4	64.5	28.8	59.6	62.7	58.2	53.6	36.0	57.9	56.9	13.4	22.3	32.9	38.8	70.2	46.8	51.9	55.2	34.2	57.9	49.5	51.5	59.7	59.8	27.0	50.4	93.9	43.7	33.2	29.8	53.0	28.1	93.3	47.2	27.2	64.6	94.4	42.8	35.0	28.8	30.8	59.0	142.5	56.6	42.6	70.4	87.3	38.6	70.9	43.2	36.9	42.2	56.5	67.4	30.3	69.5	35.2	57.2	55.8	70.1	45.1	62.8	66.6	72.3	48.1	59.2	62.8	78.7	37.4	53.8	55.5	13.0	60.8	53.7	96.3	52.9	92.9	16.6	19.6	13.2	21.4	14.2	14.1	19.1	14.7	19.8	14.5	110.2	155.8	75.4	110.3	55.0	62.6	70.6	129.9	77.6	87.6	76.8	43.2	403.6	19.9	222.8	23.6	87.5	73.5	93.5	212.6	520.7	89.4	118.5	102.7	173.2	208.9	60.4	60.5	106.8	138.1	22.0	97.2	119.0	86.0	115.4	110.0	140.5	151.9	100.8	104.3	52.6	62.7	84.1	70.1	327.7	305.6	50.6	519.4	74.0	130.8	106.2
RPS11	S11	ENSG00000142534	"Ribosomal protein S11"	P62280	19	49496365-49499689	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049719	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA049719: AB_2680860"	"unprognostic (1.49e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (5.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.71e-3)"	103.0	76.8	80.6	187.8	68.7	161.8	165.7	50.4	75.3	138.6	134.1	43.2	105.8	67.0	149.4	132.4	142.8	132.3	133.0	135.9	63.2	53.5	84.3	105.7	101.9	354.2	71.5	64.2	242.4	490.0	41.7	89.7	72.2	63.4	116.6	103.4	72.7	193.2	104.0	223.4	140.8	88.1	198.4	69.9	132.6	96.3	67.2	48.3	137.3	119.0	190.7	169.5	145.6	230.6	232.4	173.3	45.1	96.7	91.3	161.6	231.8	109.9	171.4	130.3	201.2	188.4	285.3	87.3	93.6	185.0	133.4	127.9	118.7	91.9	269.9	58.4	127.4	58.2	74.2	153.6	185.5	131.5	115.1	266.6	163.2	112.8	170.5	176.0	288.2	121.3	283.0	302.6	89.1	229.4	226.9	192.4	166.1	161.1	143.9	143.9	122.9	134.5	217.1	120.3	276.2	176.8	129.7	165.0	143.5	191.4	259.9	139.2	185.8	63.7	214.8	139.2	132.5	69.8	299.8	110.2	106.0	95.2	51.4	123.1	144.1	219.0	191.9	44.1	198.6	90.3	45.1	96.7	29.9	95.6	82.8	127.6	232.4	137.5	110.9	144.1	221.1	161.6	135.7	25.9	91.3	70.6	173.3	109.8	231.8	80.6	68.7	50.4	75.3	63.2	53.5	71.5	64.2	63.4	48.3	777.2	1364.0	2990.9	2041.9	2385.3	290.8	613.7	1123.6	1019.8	1465.0	450.1	135.5	1657.4	1031.2	1067.3	717.3	1435.9	1074.1	934.5	2445.2	2866.6	1515.8	1592.1	1273.2	1366.5	1658.3	89.0	1443.9	1317.9	2294.0	1350.9	2974.6	2278.1	1459.3	1700.6	2280.4	469.1	1978.0	1439.5	1446.5	1386.6	340.6	860.2	1282.2	599.4	586.0	2983.4	1970.5	1736.0	2339.2	2255.1
RPS13	S13	ENSG00000110700	"Ribosomal protein S13"	P62277	11	17074389-17077787	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005985	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA		56000	"Endoplasmic reticulum"		"HPA005985: AB_10960703"	"unprognostic (7.74e-3)"	"unprognostic (2.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	119.9	51.1	49.0	80.4	40.3	120.2	120.6	36.0	38.8	129.2	91.3	49.0	52.0	54.5	74.1	70.7	143.1	74.2	83.1	70.5	43.4	38.8	84.9	133.7	97.3	151.2	55.4	26.2	190.8	234.2	29.2	47.8	98.5	34.9	117.2	66.3	57.4	101.7	67.9	203.5	102.6	91.0	90.2	60.3	115.0	75.8	82.1	39.3	146.2	118.0	132.0	127.4	135.4	87.4	166.8	139.3	20.7	103.6	72.0	204.5	216.1	108.5	77.6	77.5	65.0	133.0	202.2	87.1	75.9	93.9	106.5	86.5	121.3	134.6	158.9	53.6	81.1	72.2	79.9	107.0	115.4	106.3	68.4	230.5	71.2	81.1	126.0	161.1	146.3	74.7	156.5	186.8	45.7	181.3	125.0	122.6	103.4	102.3	89.2	101.5	100.2	115.8	193.0	90.8	138.3	153.0	111.2	111.4	98.6	102.1	118.0	64.0	110.7	37.0	140.7	170.4	78.4	63.3	218.2	82.4	51.4	89.8	119.6	94.8	64.7	131.9	123.3	59.7	117.7	68.2	20.7	103.6	15.3	64.2	77.2	126.1	166.8	135.3	93.8	132.8	152.0	204.5	151.5	10.6	72.0	60.9	139.3	94.0	216.1	49.0	40.3	36.0	38.8	43.4	38.8	55.4	26.2	34.9	39.3	860.5	1324.4	3859.3	3661.0	4056.8	255.9	720.6	1864.9	1102.8	1633.3	631.6	98.2	3330.4	2470.2	1793.4	1053.3	2297.1	956.0	817.7	3950.3	4558.3	2409.4	2957.7	1429.6	1826.7	2531.3	85.8	1317.4	1933.5	3782.3	1414.9	3288.7	3755.9	2068.4	3014.5	2386.6	599.7	2990.2	2142.8	1668.1	2743.0	320.5	860.2	2530.8	433.3	316.8	4762.2	3753.8	2537.2	3057.2	3744.2
RPS14	"EMTB, S14"	ENSG00000164587	"Ribosomal protein S14"	P62263	5	150442635-150449756	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 708.0;pancreas: 483.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018504	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		540000	"Endoplasmic reticulum, Cytosol"		"HPA018504: AB_1856463"	"unprognostic (5.70e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.17e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (1.47e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.14e-2)"	60.9	43.2	50.1	64.3	39.1	92.8	111.6	22.6	37.2	85.1	70.3	28.0	50.6	33.6	59.6	86.4	79.4	91.7	57.2	59.2	35.7	30.3	53.6	74.7	57.0	96.6	39.8	32.5	115.1	483.0	17.4	38.9	62.0	35.3	69.7	61.5	41.1	61.8	50.8	93.4	95.0	60.6	67.0	37.0	68.4	58.3	48.5	33.8	84.5	93.9	71.2	83.6	87.1	65.2	360.5	205.3	51.0	166.0	157.4	465.9	708.0	89.3	163.8	85.3	173.6	130.6	245.7	140.0	68.6	115.1	112.0	102.2	223.2	115.2	202.7	101.1	129.6	97.8	71.6	127.5	305.2	76.2	94.0	154.0	73.7	152.0	167.5	185.8	210.2	76.3	186.5	119.5	114.1	269.2	114.3	155.6	135.1	97.1	80.3	141.7	241.1	90.7	177.3	87.8	132.7	139.2	89.1	98.2	217.1	146.5	164.3	94.0	107.1	49.8	249.0	197.0	72.6	109.7	230.7	96.4	60.6	50.9	51.2	92.3	108.9	153.2	133.2	75.6	206.1	39.9	51.0	166.0	36.7	186.2	114.2	261.9	360.5	313.3	226.8	181.1	299.4	465.9	319.4	25.7	157.4	97.0	205.3	196.8	708.0	50.1	39.1	22.6	37.2	35.7	30.3	39.8	32.5	35.3	33.8	1241.7	2223.5	5848.4	7839.1	10367.0	470.3	1738.9	3103.1	1474.9	2518.3	1402.8	174.7	6156.5	3836.4	2863.1	930.3	4248.1	1996.7	1495.1	7588.8	7324.6	4606.0	5276.5	2165.3	3416.6	4101.9	192.3	2300.5	3299.3	4925.3	1358.8	4034.1	6269.0	6141.0	5451.9	4847.3	751.5	5031.6	4334.6	2100.9	3824.8	499.4	1578.1	4450.7	718.4	798.9	13425.3	5960.1	3922.9	6829.3	8560.7
RPS15	"MGC111130, RIG, S15"	ENSG00000115268	"Ribosomal protein S15"	P62841	19	1438358-1440494	"Cancer-related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA054510, HPA057793"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		170000	"Endoplasmic reticulum, Cytosol"		"HPA054510: AB_2682510, HPA057793: AB_2683528"	"unprognostic (4.47e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.08e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.33e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.44e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-2)"	61.7	61.2	63.0	67.5	51.4	123.6	74.2	46.0	87.5	56.2	66.4	46.1	41.2	69.0	73.6	52.3	80.9	61.2	73.7	72.1	50.4	40.5	64.8	103.7	43.0	95.3	52.1	52.6	144.8	136.0	21.6	59.3	60.9	45.2	66.9	37.1	61.2	123.7	53.2	154.9	102.4	67.6	51.8	51.0	76.2	63.5	60.8	24.9	70.7	74.2	127.6	82.9	47.6	70.9	237.3	149.5	48.6	106.7	103.8	218.1	269.2	103.9	111.1	48.8	66.4	45.8	66.8	84.2	54.5	43.5	65.4	51.2	178.1	36.8	129.0	49.0	35.0	23.1	66.3	47.6	67.5	25.7	107.3	248.7	42.2	101.7	168.2	48.5	107.3	80.6	82.0	81.6	44.2	43.4	63.5	57.5	118.1	85.6	185.9	40.8	182.9	88.7	144.3	110.5	83.3	142.8	92.4	58.3	168.5	59.4	114.5	78.7	93.4	46.0	79.3	156.2	27.1	60.6	144.8	58.0	55.4	63.4	110.4	120.2	161.5	159.8	125.4	55.0	98.1	63.3	48.6	106.7	44.5	116.2	89.5	160.8	237.3	179.3	146.1	149.5	222.5	218.1	177.4	21.6	103.8	68.2	124.2	162.9	269.2	63.0	51.4	46.0	87.5	50.4	40.5	52.1	52.6	45.2	24.9	845.7	1291.0	5528.5	5609.3	8137.2	413.6	279.6	2101.9	934.2	1767.5	1455.1	164.9	3608.1	3294.2	1842.6	725.7	3005.1	2262.4	2453.0	4593.9	5682.0	3308.9	4379.3	1687.8	2548.8	3281.3	144.6	1742.9	2587.2	4363.2	2200.3	3679.4	4495.5	4398.2	3907.2	3542.4	728.2	3370.7	3075.6	1974.7	3966.5	432.6	1319.4	2967.7	790.1	989.9	11039.2	3219.2	4153.4	4441.6	5090.7
RPS16	S16	ENSG00000105193	"Ribosomal protein S16"	P62249	19	39433207-39435948	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA064222	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		No	No		36000	"Endoplasmic reticulum, Cytosol"		"HPA064222: AB_2685218"	"unprognostic (4.63e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.89e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.28e-2)"	"unprognostic (5.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.62e-2)"	89.8	60.8	49.0	123.2	46.1	127.3	126.9	39.8	46.8	124.8	120.7	48.6	80.0	67.2	97.9	80.8	150.1	108.1	105.9	118.7	41.7	35.7	81.5	147.6	103.7	243.2	49.2	29.9	248.1	457.6	19.9	48.8	97.0	35.5	129.5	52.8	73.8	130.5	87.6	205.5	113.4	110.9	126.3	52.2	136.7	92.1	57.4	37.7	153.9	125.1	183.6	151.0	143.8	159.8	153.7	106.4	17.6	71.8	71.7	179.1	225.5	138.9	297.8	80.0	90.7	120.5	148.7	74.3	64.1	75.0	83.8	77.2	189.4	77.2	117.8	83.2	79.9	31.8	46.4	93.6	155.9	53.0	137.6	221.5	93.0	101.4	195.7	123.1	135.7	63.1	173.4	243.1	73.8	117.9	114.0	107.3	152.3	118.7	133.3	87.3	214.7	185.4	136.9	98.8	176.8	109.0	124.3	82.7	142.4	91.9	156.9	81.5	117.2	48.1	216.7	164.7	56.2	62.1	263.7	64.5	69.9	91.6	74.0	139.4	185.8	192.2	149.3	72.3	129.9	67.4	17.6	71.8	11.0	84.5	57.9	120.9	153.7	140.8	105.6	91.9	143.2	179.1	143.0	13.2	71.7	48.2	106.4	94.7	225.5	49.0	46.1	39.8	46.8	41.7	35.7	49.2	29.9	35.5	37.7	1051.1	1483.9	3949.0	3037.8	3456.7	300.0	882.4	2025.5	1279.5	2023.5	772.9	182.6	3919.4	1871.8	1658.2	460.7	2103.8	1281.1	1471.8	3703.3	5212.0	2075.3	2629.1	1071.8	2095.9	2461.9	108.1	1421.1	1433.3	2612.0	1078.8	3908.0	3281.4	1931.7	3389.6	2360.5	436.5	2661.2	1690.0	1746.6	2505.6	404.4	1261.2	2305.1	506.0	777.6	3962.5	3964.9	2423.2	3346.2	3508.5
RPS17	"MGC72007, RPS17L, RPS17L1, RPS17L2, S17"	ENSG00000182774	"Ribosomal protein S17"	P08708	15	82536750-82540564	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 149.0"					"Low region specificity"	"Detected in all"			HPA055060	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		39000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA055060: AB_2682686"	"unprognostic (3.37e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.83e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.31e-1)"	40.1	37.3	23.9	41.5	28.0	78.5	93.7	20.5	39.7	41.3	35.4	18.0	32.7	12.0	34.4	69.6	58.2	48.5	36.3	36.2	24.9	16.0	33.0	56.8	30.4	75.5	22.2	22.4	100.0	160.7	8.0	28.1	28.7	29.1	32.2	54.1	21.2	64.2	38.1	47.5	60.8	33.0	54.2	26.6	40.9	38.1	29.3	19.2	36.1	38.5	85.2	82.2	34.1	55.8	42.1	34.6	12.5	19.7	26.5	48.5	63.4	10.4	75.5	24.4	15.8	41.3	57.4	18.9	5.7	10.6	18.1	16.6	107.6	34.5	14.9	10.7	23.1	32.1	33.1	58.8	58.3	32.6	9.1	149.0	2.6	78.0	72.2	56.4	13.2	14.4	73.9	107.7	22.3	76.5	48.5	38.3	39.2	10.2	39.9	27.8	84.1	16.9	46.6	36.7	67.8	60.3	11.4	6.2	26.8	53.9	95.3	17.8	11.5	2.3	32.0	31.5	42.3	38.9	40.7	9.9	28.2	20.6	17.4	12.6	12.0	18.6	13.0	23.1	34.1	15.4	12.5	19.7	4.5	16.6	17.2	43.6	39.9	41.3	26.8	27.2	42.1	48.5	42.4	2.5	26.5	14.8	34.6	23.7	63.4	23.9	28.0	20.5	39.7	24.9	16.0	22.2	22.4	29.1	19.2	756.3	1289.8	2965.8	4861.9	38.4	77.5	373.2	1826.7	922.1	1902.9	167.5	47.1	3046.0	462.6	1389.5	55.8	1090.9	569.4	1962.4	2604.1	5603.8	1698.1	3804.0	863.8	2556.7	2408.0	39.7	929.1	1950.1	2775.5	119.3	4074.2	1038.9	28.7	2043.3	2571.6	141.3	2469.3	1560.6	1761.1	737.0	85.0	1164.2	222.0	396.6	646.1	55.8	2855.8	2041.0	4254.9	4758.2
RPS2	"LLREP3, S2"	ENSG00000140988	"Ribosomal protein S2"	P15880	16	1962052-1964860	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 284.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA055133	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		140000	"Endoplasmic reticulum, Cytosol"		"HPA055133: AB_2682708"	"unprognostic (2.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (7.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (3.04e-7)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.47e-1)"	46.1	41.0	28.0	101.8	40.4	97.6	65.9	34.7	30.7	48.2	47.0	22.2	28.8	39.9	45.7	27.1	100.7	61.7	55.7	38.2	19.5	16.0	34.2	107.4	71.1	104.2	36.6	18.6	112.6	284.3	9.6	32.2	45.4	30.1	43.6	32.5	18.3	53.6	28.9	67.3	78.3	47.5	25.8	22.4	131.9	47.8	18.9	28.1	115.2	50.3	114.5	78.3	51.6	77.6	137.5	69.0	18.2	44.9	53.6	125.4	54.7	82.1	119.4	69.2	222.4	100.5	248.0	122.5	56.4	135.8	148.3	105.4	212.5	57.6	157.7	90.4	97.6	49.6	103.4	99.8	189.4	55.8	99.4	197.5	53.2	133.2	190.4	245.5	124.7	87.7	331.0	271.7	123.9	206.3	151.2	143.8	142.6	108.6	89.6	102.3	381.5	156.5	218.6	219.8	106.7	107.9	191.9	112.1	188.6	135.4	78.3	124.1	112.7	55.3	173.7	133.8	63.0	117.1	219.0	65.6	80.0	105.5	19.2	118.1	34.9	57.3	200.7	43.1	108.1	100.4	4.9	37.6	18.2	50.7	44.9	84.6	137.5	99.9	78.4	68.7	117.9	125.4	93.8	7.6	53.6	36.0	69.0	68.1	54.7	28.0	40.4	34.7	30.7	19.5	16.0	36.6	18.6	30.1	28.1	482.4	958.5	7786.3	8744.5	10604.5	334.0	200.5	2094.2	638.4	1375.2	863.7	176.7	7309.9	2722.3	3301.1	203.5	3456.8	1531.9	1775.4	9857.9	13493.6	4843.2	5941.0	994.5	1678.5	5355.9	262.2	2031.1	2492.1	3769.8	337.5	3898.8	5677.6	4852.0	6570.0	4025.4	405.5	5646.9	1494.2	1481.1	1482.6	356.9	1235.3	5926.4	173.6	2431.8	13172.5	6844.1	5004.5	6746.1	10161.2
RPS20	S20	ENSG00000008988	"Ribosomal protein S20"	P60866	8	56067295-56074581	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003570	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		100000	"Endoplasmic reticulum, Cytosol"		"HPA003570: AB_1856466"	"unprognostic (2.57e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.78e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (3.64e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.33e-3)"	"unprognostic (2.19e-2)"	164.6	74.7	74.1	177.3	61.8	191.2	193.8	30.4	57.8	148.1	118.9	49.5	104.1	58.3	100.6	108.4	161.3	91.2	108.3	140.0	57.3	47.0	88.0	136.5	124.0	280.9	67.7	41.8	267.4	218.0	28.5	69.2	77.9	48.1	136.7	60.5	70.2	165.9	104.1	161.5	132.2	86.1	152.5	75.9	157.1	98.5	79.6	47.5	168.0	141.7	143.6	140.8	179.7	157.7	214.3	142.6	64.0	77.1	78.0	248.9	267.6	143.4	128.7	126.9	123.3	182.2	210.6	107.7	96.7	143.7	115.1	105.8	133.3	139.4	211.8	119.7	101.8	80.8	90.7	79.1	152.6	97.4	91.6	109.9	175.6	118.5	166.2	175.1	97.9	115.6	205.7	159.8	75.2	217.6	188.6	139.3	163.1	140.3	126.9	113.3	177.1	267.8	196.1	170.2	197.1	55.5	147.2	46.8	109.4	138.2	155.9	42.5	132.0	41.7	113.6	189.1	109.2	164.9	203.7	91.1	87.0	149.6	114.6	152.7	138.4	119.1	154.6	132.0	171.8	77.4	64.0	77.1	31.3	101.6	64.5	144.7	214.3	189.1	135.6	100.5	180.9	248.9	181.3	14.6	78.0	59.0	142.6	125.7	267.6	74.1	61.8	30.4	57.8	57.3	47.0	67.7	41.8	48.1	47.5	1170.3	1705.4	3250.1	3140.9	3331.0	118.5	883.4	1505.7	1205.9	1967.7	657.8	106.0	2526.9	1865.2	1585.6	1562.5	1721.8	878.7	887.7	3526.4	3548.9	1962.4	2542.1	1581.7	1854.2	2209.3	52.4	1161.6	1947.6	2779.3	1231.8	4163.7	2722.3	1849.0	3059.6	1734.1	312.3	3157.9	1195.9	1870.7	2420.8	238.0	1377.6	1760.0	1442.2	1214.3	3430.4	2525.1	2932.0	2190.1	3494.3
RPS21	S21	ENSG00000171858	"Ribosomal protein S21"	P63220	20	62387116-62388520	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003371	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA003371: AB_1079846"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (6.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.60e-1)"	69.0	66.0	93.6	140.3	61.5	191.6	177.7	59.2	89.7	93.5	105.1	24.3	84.0	72.0	121.5	85.7	99.6	93.3	97.8	66.0	65.6	47.3	62.9	86.1	66.4	199.9	74.0	86.6	189.4	321.2	12.8	49.2	53.0	52.7	76.3	61.9	33.1	164.2	97.3	172.3	129.6	71.5	120.0	51.1	94.9	73.3	92.9	60.0	92.9	86.3	175.2	90.8	84.4	229.7	170.4	122.5	18.1	59.8	71.0	175.9	158.2	100.3	104.9	53.5	101.2	59.7	105.9	70.7	64.9	52.0	162.9	62.1	349.8	134.6	123.3	134.4	50.0	57.8	141.0	59.3	180.7	56.2	30.6	154.2	203.1	150.4	265.9	121.8	156.1	91.6	117.8	253.0	61.6	112.2	65.5	75.5	138.1	103.7	102.8	55.7	152.7	175.2	222.3	81.9	177.5	321.0	119.0	136.0	186.4	76.4	113.6	98.6	97.7	66.7	299.0	135.7	34.9	127.1	205.0	79.3	96.4	127.4	81.5	126.9	164.5	186.8	134.2	115.2	95.3	51.0	18.1	59.8	13.9	85.7	50.5	122.2	170.4	146.0	112.6	87.6	170.0	175.9	152.7	9.4	71.0	40.0	122.5	92.7	158.2	93.6	61.5	59.2	89.7	65.6	47.3	74.0	86.6	52.7	60.0	544.9	871.0	2744.2	1386.7	2358.7	131.9	315.5	1105.7	568.8	1113.5	464.1	210.1	1422.8	586.9	1199.5	94.5	989.5	1167.3	1261.4	3073.7	1728.6	985.1	983.6	913.6	1456.6	1120.9	141.4	1166.7	1306.8	1870.6	83.0	1440.9	1380.7	924.5	1612.3	2330.7	235.6	2068.5	1690.4	754.2	950.5	251.0	549.7	1020.7	274.4	908.8	2741.5	1370.2	1658.2	3629.5	1316.9
RPS23	S23	ENSG00000186468	"Ribosomal protein S23"	P62266	5	82273358-82278577	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054853	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		130000	"Endoplasmic reticulum, Cytosol"		"HPA054853: AB_2682625"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (6.61e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (3.87e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-1)"	114.6	62.1	72.6	129.7	54.8	139.2	191.8	45.1	53.7	141.2	118.9	46.5	83.5	62.2	131.8	94.1	145.2	118.3	114.4	79.4	61.4	52.9	92.8	134.8	90.1	200.7	74.4	34.7	269.5	211.6	41.6	65.6	94.6	51.9	134.3	89.8	52.9	126.7	84.7	205.4	134.3	97.0	129.6	77.7	150.1	83.8	61.4	51.5	194.5	141.5	171.9	173.8	160.7	165.8	140.7	110.8	11.1	56.6	63.8	136.1	158.2	92.5	36.5	105.3	80.7	177.2	239.7	107.3	89.0	134.9	134.6	134.0	51.2	63.3	218.4	62.4	115.1	83.5	47.7	157.3	255.9	139.9	79.2	88.8	89.3	54.1	49.7	234.1	128.9	64.9	230.0	304.6	102.7	269.9	202.2	173.4	139.1	92.8	68.8	116.2	60.2	142.0	130.9	67.3	49.6	85.1	95.2	150.8	196.3	130.7	39.2	67.7	88.5	45.8	79.8	180.2	109.7	60.6	200.0	123.0	19.2	74.8	46.7	139.7	99.0	144.6	153.5	45.4	167.0	42.1	11.1	56.6	8.7	60.1	52.4	92.2	140.7	103.0	81.1	97.6	130.8	136.1	112.3	6.0	63.8	43.3	110.8	73.4	158.2	72.6	54.8	45.1	53.7	61.4	52.9	74.4	34.7	51.9	51.5	988.6	1141.9	5759.9	4914.2	5245.2	367.5	259.5	2438.2	829.8	1736.9	1080.0	163.0	4238.7	3231.3	2015.9	794.6	3082.6	1557.8	1238.1	4142.3	6097.5	3274.2	3882.5	1615.9	2361.6	3614.8	220.9	1831.3	2502.0	3505.0	1289.5	5717.9	4715.7	2717.9	3404.0	3317.6	563.2	3460.3	2745.9	2903.9	4001.7	470.7	1675.1	2898.4	786.8	872.2	6212.4	4350.9	3718.5	5163.2	5114.9
RPS24	S24	ENSG00000138326	"Ribosomal protein S24"	P62847	10	78033732-78056813	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003364, HPA073508"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		70000	"Endoplasmic reticulum, Cytosol"		"HPA003364: AB_1079847, HPA073508: "	"prognostic favorable (1.50e-4)"	"unprognostic (1.58e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.10e-10)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.22e-2)"	171.6	122.0	127.7	80.8	79.0	186.2	231.3	56.2	68.4	242.4	201.1	37.9	112.4	86.2	159.2	148.8	277.8	125.1	128.5	123.9	90.4	83.8	134.4	176.6	147.0	263.8	100.6	70.2	369.4	279.3	49.1	86.1	139.3	64.6	251.6	130.0	49.8	176.0	139.5	320.4	192.3	148.9	182.4	111.7	175.8	85.3	87.9	79.5	197.1	221.4	130.0	123.5	271.7	237.7	171.5	180.5	49.6	123.2	156.4	187.3	213.6	111.1	43.4	109.4	170.7	135.6	239.4	98.6	119.5	164.6	126.3	111.1	62.5	78.5	231.0	65.7	103.3	43.9	86.6	126.0	154.0	115.9	76.9	142.8	94.1	28.9	59.5	153.8	224.8	53.6	226.9	230.8	89.3	324.4	254.4	149.9	99.2	127.6	46.3	136.1	45.3	119.9	370.7	76.7	199.9	406.5	81.5	130.9	111.0	161.2	52.2	55.3	108.3	60.1	202.3	147.6	119.9	114.0	249.9	127.0	38.3	91.3	51.9	158.0	60.9	123.1	178.1	47.3	313.4	31.3	49.6	123.2	46.5	102.4	118.3	167.4	171.5	140.6	129.8	180.5	145.4	187.3	168.2	16.9	156.4	91.0	155.4	112.3	213.6	127.7	79.0	56.2	68.4	90.4	83.8	100.6	70.2	64.6	79.5	690.8	1269.5	3209.8	4202.0	3647.0	323.7	537.2	1994.9	927.5	1705.0	760.7	102.1	2994.5	2778.6	1946.3	1157.3	2319.7	1458.1	1097.9	3916.2	5172.5	2049.1	2966.1	1188.1	1848.0	2894.9	143.0	2011.7	1935.4	4187.3	3507.5	5250.7	4018.5	1926.6	2732.2	3111.1	529.6	2893.5	2823.1	2432.9	2781.3	330.7	1248.2	2260.6	575.1	551.3	4012.4	2962.0	2362.2	4939.3	4132.1
RPS25	S25	ENSG00000118181	"Ribosomal protein S25"	P62851	11	119015712-119018691	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031801, HPA078683"	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		54000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA031801: AB_10610419, HPA078683: "	"unprognostic (1.60e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.75e-3)"	"prognostic unfavorable (3.00e-7)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.20e-1)"	72.3	68.1	54.9	99.5	60.7	117.7	140.7	38.1	62.2	84.9	69.4	26.8	87.7	53.5	79.6	93.4	92.9	68.0	78.6	87.3	44.4	41.7	58.6	76.5	88.4	256.5	57.1	48.1	190.0	274.5	34.3	67.5	52.5	54.3	77.1	52.2	41.6	113.5	131.7	173.6	82.0	57.7	125.4	68.3	80.7	68.3	35.3	47.3	78.5	83.9	128.8	86.4	112.2	110.6	136.6	83.3	30.0	43.2	64.7	166.9	150.1	39.1	22.5	48.5	48.5	65.3	101.1	39.8	53.0	47.7	31.3	27.3	59.5	68.7	99.1	92.7	36.9	37.1	54.4	42.9	57.0	35.7	48.7	46.8	141.1	19.9	49.9	50.7	100.2	44.1	91.0	101.7	29.9	74.7	98.9	56.9	80.2	73.3	59.8	43.5	80.7	78.3	137.7	50.0	99.7	54.5	68.7	50.9	107.6	57.8	34.5	35.6	67.8	28.2	87.8	54.8	57.4	70.6	109.3	54.0	30.7	35.7	31.1	50.8	50.7	41.3	81.9	21.3	99.7	36.2	30.0	43.2	27.1	75.8	42.5	120.7	136.6	133.4	102.4	69.1	112.6	166.9	128.2	11.7	64.7	37.2	83.3	88.7	150.1	54.9	60.7	38.1	62.2	44.4	41.7	57.1	48.1	54.3	47.3	753.4	1471.8	4134.9	3644.0	3526.8	272.7	156.5	1931.2	1062.7	1885.9	884.5	108.0	3031.7	2773.7	1545.4	1495.6	2111.7	1048.3	1191.4	2746.5	3534.5	2149.5	2685.4	1909.4	2155.6	2228.4	127.1	1279.9	2210.4	2932.5	2021.0	3541.3	3243.7	2073.4	4078.5	2284.3	466.6	2362.4	1995.5	1610.5	3361.8	311.5	1312.9	2458.2	606.9	848.3	4074.2	3057.4	2507.2	2899.2	3437.7
RPS26	S26	ENSG00000197728	"Ribosomal protein S26"	P62854	12	56041351-56044676	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043961, HPA055803"	Uncertain		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043961: AB_10963579, HPA055803: AB_2682927"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.74e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.99e-2)"	36.5	66.6	33.3	29.0	48.8	39.2	49.7	23.8	73.7	44.5	45.6	34.9	20.5	20.0	35.9	50.4	49.9	43.5	28.4	39.8	25.8	24.8	61.8	154.3	29.5	56.0	31.4	26.2	75.8	80.4	25.6	29.7	28.7	45.1	35.4	49.1	28.5	38.0	41.1	62.2	50.9	57.5	36.9	30.0	51.6	40.3	47.0	32.5	47.3	58.4	60.0	78.4	46.7	41.2	93.0	69.8	29.8	42.8	63.6	107.4	108.8	53.4	65.8	75.0	27.8	103.9	154.2	75.2	54.5	81.0	90.9	53.2	101.0	24.2	119.3	34.5	57.5	30.0	25.2	84.2	46.9	62.3	47.2	135.1	63.0	43.9	60.2	96.0	40.9	34.6	93.3	150.3	47.9	54.6	35.9	69.0	85.6	42.9	39.8	73.5	82.9	30.6	74.3	73.6	65.4	149.1	41.7	22.5	73.4	75.9	54.2	28.2	48.8	21.3	47.2	30.9	23.3	41.7	45.8	22.3	22.6	46.3	28.8	43.7	34.3	65.6	64.4	25.1	81.7	28.9	29.8	41.4	27.1	74.6	42.8	83.8	93.0	97.8	81.8	55.3	79.8	107.4	99.3	17.0	63.6	38.2	69.8	101.7	108.8	33.3	48.8	23.8	73.7	25.8	24.8	31.4	26.2	45.1	32.5	208.4	201.5	1424.8	560.8	1563.9	119.2	23.8	1184.7	333.3	536.9	408.2	58.9	1212.8	824.0	801.2	63.2	800.7	1808.5	1004.5	2275.1	2554.3	1158.0	914.2	500.2	1753.2	1234.1	71.5	826.4	935.4	838.0	37.7	273.5	701.1	1386.7	874.7	1010.7	278.9	1348.0	1392.2	208.2	969.4	134.7	304.0	900.2	204.7	313.7	1585.9	1428.5	824.9	1127.8	1109.2
RPS27	"MPS-1, MPS1, S27"	ENSG00000177954	"Ribosomal protein S27"	P42677	1	153990755-153992155	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 778.4;lymphoid tissue: 769.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066851			Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: AB_2685737"	"prognostic favorable (9.69e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.05e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.86e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.81e-2)"	120.7	72.5	74.9	188.7	118.6	186.7	268.2	51.3	91.4	172.5	114.2	35.9	136.4	58.1	169.0	135.6	107.5	129.0	144.1	176.5	59.6	50.1	98.6	102.5	167.8	769.0	92.1	76.0	317.8	227.2	44.6	91.5	67.5	71.2	117.6	113.6	63.5	248.2	116.1	243.8	160.1	115.9	254.3	65.6	159.3	111.5	119.0	81.9	118.2	113.0	224.0	270.9	162.9	286.0	720.2	296.5	132.9	139.9	324.1	750.5	778.4	103.7	121.7	160.9	87.6	378.8	373.5	99.8	125.8	301.7	169.5	153.2	243.8	114.7	236.3	105.7	181.5	56.5	104.6	141.7	208.3	143.3	114.7	182.7	93.1	161.4	158.1	251.1	206.9	122.8	362.6	409.8	134.8	248.4	252.8	138.9	197.5	113.6	128.5	160.9	260.8	222.5	131.0	194.8	347.8	177.5	142.6	117.8	183.8	156.6	210.3	85.5	190.7	72.1	254.0	218.7	229.1	141.6	415.8	82.0	58.6	97.1	93.4	125.7	258.2	263.2	286.4	101.7	116.2	80.3	132.9	139.9	68.1	393.0	138.9	473.7	720.2	594.4	502.0	179.5	637.3	750.5	579.6	32.4	324.1	127.0	296.5	397.8	778.4	74.9	118.6	51.3	91.4	59.6	50.1	92.1	76.0	71.2	81.9	2045.7	3610.2	12664.6	4456.3	11098.6	390.9	812.1	5699.4	2137.4	3923.0	2044.8	182.6	5213.2	3755.2	3414.7	2254.7	2990.8	2165.3	4461.9	9085.2	5382.4	5444.6	3827.3	4020.8	6408.4	3759.0	181.1	2910.0	5208.2	8634.5	6446.8	6571.4	6944.5	5609.6	8769.4	6097.0	734.9	5926.8	6112.7	3330.7	4371.1	465.9	2690.5	3231.1	1566.2	1451.5	12519.6	5337.4	8309.1	7958.0	4025.9
RPS27A	"S27A, Uba80, UBCEP80"	ENSG00000143947	"Ribosomal protein S27a"	P62979	2	55231903-55235853	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033319, HPA041344, HPA049132, HPA054087"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"CAB033319: AB_793618, HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373"	"unprognostic (7.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (1.09e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.60e-1)"	54.1	45.0	46.8	66.0	85.5	111.5	120.1	33.3	77.9	74.5	60.0	21.4	43.0	37.3	66.0	57.8	68.3	61.4	51.2	47.1	57.0	32.7	71.1	172.7	43.9	84.3	42.4	68.3	167.1	88.9	20.7	53.7	57.1	52.1	57.7	52.5	25.3	70.5	46.9	101.9	69.1	52.5	46.3	40.4	77.1	58.9	48.6	36.4	62.8	64.0	144.0	82.1	52.1	71.1	194.8	130.9	42.2	62.9	122.8	253.3	267.6	106.0	61.7	67.7	112.4	94.5	180.5	129.4	83.7	96.3	91.9	58.2	115.1	120.4	148.5	141.5	79.8	54.7	100.8	97.7	114.4	107.5	125.9	113.1	136.8	66.4	153.9	137.5	204.0	93.8	162.3	227.7	61.6	168.3	153.5	124.6	92.0	122.0	136.4	105.0	83.0	119.2	245.7	162.6	130.4	79.0	113.8	172.4	175.6	103.9	101.6	89.5	71.0	57.4	250.0	186.5	110.1	111.1	174.3	118.6	84.3	128.3	75.2	141.6	122.8	85.1	96.5	120.6	173.6	83.9	42.2	62.9	24.1	129.3	59.1	183.5	194.8	197.3	154.8	91.1	179.3	253.3	206.8	14.4	122.8	52.5	130.9	120.7	267.6	46.8	85.5	33.3	77.9	57.0	32.7	42.4	68.3	52.1	36.4	1182.1	2168.7	6366.0	7790.9	7391.5	428.3	362.3	2830.5	1535.1	2713.9	1326.0	202.2	4414.5	3436.8	2947.8	844.4	3491.0	1693.7	1752.0	6390.1	5764.5	3524.5	5396.1	2833.4	2701.0	3058.4	206.6	1979.6	3107.2	4338.7	1140.7	4705.1	4812.5	3451.8	4888.3	3292.1	886.8	4792.0	3026.5	2708.4	4047.2	553.4	1616.9	4201.8	922.6	805.1	7807.0	4507.9	4717.9	5337.4	6552.6
RPS27L		ENSG00000185088	"Ribosomal protein S27 like"	Q71UM5	15	63125872-63158021	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Proximal tubular cells: 1955.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066851			Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: AB_2685737"	"unprognostic (4.62e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (9.08e-6)"	"unprognostic (1.75e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.10e-3)"	46.8	64.2	21.3	19.8	29.7	18.2	53.6	16.3	23.4	29.4	58.5	15.5	30.4	46.0	30.2	49.3	40.4	27.0	38.3	47.1	22.8	22.2	61.0	75.2	31.7	23.4	32.6	19.2	26.5	65.9	19.2	38.8	35.6	43.9	56.2	55.3	18.3	99.8	46.0	47.1	18.1	80.4	54.8	39.9	28.2	41.9	15.7	27.3	19.4	53.9	25.7	19.8	55.0	36.3	34.5	30.9	51.5	47.6	27.2	75.4	38.3	16.5	46.4	42.1	11.3	61.6	73.0	42.2	52.4	37.4	11.5	28.2	8.5	23.1	15.6	18.8	50.1	20.6	6.4	14.2	25.8	19.5	11.5	19.2	12.8	39.2	60.7	70.9	10.2	35.7	57.1	34.7	26.1	19.8	87.6	65.3	9.8	11.8	15.7	96.0	23.0	13.1	15.9	12.4	21.2	13.6	10.2	20.2	17.6	32.4	33.6	6.1	9.3	19.0	8.0	37.1	88.4	17.8	23.7	69.0	61.2	57.6	13.2	23.2	17.7	15.0	13.8	64.9	28.2	55.1	51.5	34.3	40.0	27.5	35.9	33.9	34.5	41.6	32.0	30.9	26.9	32.9	33.1	11.4	27.2	47.6	30.8	75.4	38.3	21.3	29.7	16.3	23.4	22.8	22.2	32.6	19.2	43.9	27.3	89.3	200.0	257.3	226.5	226.9	32.3	318.9	598.7	234.2	153.6	389.0	45.2	244.0	766.0	754.9	35.9	230.2	819.3	233.6	678.9	1142.2	251.0	333.1	292.5	900.4	483.1	12.7	274.1	300.8	377.4	21.8	291.4	318.2	442.1	1587.0	624.8	110.3	1030.5	691.6	279.7	1955.0	68.4	258.7	357.4	142.8	82.2	216.4	196.7	234.3	638.5	176.3
RPS29	S29	ENSG00000213741	"Ribosomal protein S29"	P62273	14	49570984-49599164	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 526.9;pancreas: 892.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA004107	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA004107: AB_1079848"	"prognostic favorable (2.66e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.48e-3)"	"unprognostic (7.71e-2)"	59.9	53.6	54.5	108.8	58.9	140.0	155.5	34.4	88.2	68.6	89.6	17.9	67.6	71.4	54.9	67.9	75.3	56.1	63.5	108.2	43.1	33.8	54.5	75.3	74.3	232.1	64.3	56.2	128.3	892.4	8.5	41.6	44.5	53.1	50.6	58.9	29.2	86.0	67.9	177.4	102.6	70.9	76.3	74.6	98.1	63.3	94.0	60.6	53.2	45.6	136.9	101.6	47.1	83.8	303.1	164.3	62.9	102.0	123.1	363.7	526.9	145.4	96.5	101.0	90.4	116.2	198.2	133.8	99.9	85.3	91.3	74.9	97.4	135.0	132.8	114.5	83.9	45.1	127.6	116.0	142.1	101.6	86.6	209.6	104.0	87.5	169.4	142.4	265.3	90.5	204.9	232.7	59.9	175.0	161.0	129.9	232.4	115.9	174.6	88.3	193.6	181.0	165.4	123.2	244.9	272.8	152.2	125.9	152.0	110.0	130.4	76.6	88.3	70.9	131.2	231.4	102.1	171.0	232.2	119.8	70.0	187.8	64.9	88.2	201.8	223.9	179.8	49.3	109.6	67.3	62.9	102.0	46.1	175.8	81.1	219.7	303.1	322.1	227.3	122.6	281.3	363.7	295.6	24.4	123.1	73.4	164.3	181.8	526.9	54.5	58.9	34.4	88.2	43.1	33.8	64.3	56.2	53.1	60.6	1051.1	2086.9	7098.8	857.1	3036.7	210.9	491.6	2858.6	1213.9	2286.2	1018.9	121.7	2892.9	2054.1	2102.7	1067.1	1733.4	2036.9	2266.0	6120.8	4195.6	1983.5	887.8	2827.7	5978.4	2666.5	101.7	2573.6	3469.9	4942.1	2443.6	3469.6	4021.8	1899.7	4276.1	6903.3	431.8	4513.7	4892.2	1520.7	2216.4	241.3	1073.6	1689.2	1106.2	954.6	4278.5	3071.9	5097.1	8179.1	1080.6
RPS3	"FLJ26283, FLJ27450, MGC87870, S3"	ENSG00000149273	"Ribosomal protein S3"	P23396	11	75399486-75422280	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063339	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		430000	"Endoplasmic reticulum, Cytosol"		"HPA063339: AB_2684990"	"unprognostic (3.62e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-1)"	72.2	52.7	36.6	108.4	41.2	122.2	136.6	32.1	33.8	105.1	102.0	32.5	65.2	65.8	102.4	84.7	136.5	92.2	107.7	58.5	29.7	26.5	52.9	78.1	71.0	218.6	47.6	30.6	224.7	288.7	13.8	51.3	75.9	35.0	105.7	65.7	47.6	151.0	61.8	86.9	117.6	78.0	110.6	42.1	121.4	75.4	54.1	36.5	126.5	119.4	134.7	130.1	110.3	118.9	104.5	69.7	22.6	44.5	64.6	144.2	213.9	84.0	52.1	74.1	81.7	93.8	167.4	95.9	80.6	103.9	107.1	69.8	150.4	100.7	294.1	98.8	72.4	59.0	121.9	95.7	150.0	98.7	77.8	74.8	120.4	52.0	66.4	140.0	194.4	79.0	196.4	205.0	73.1	203.4	126.2	140.4	131.7	120.0	83.7	96.1	92.3	116.6	93.5	93.1	295.8	61.9	110.8	260.2	214.2	105.1	70.4	63.9	90.6	59.4	141.4	82.0	75.2	144.2	149.0	112.4	51.8	86.3	70.5	72.8	76.9	94.8	325.8	31.1	109.1	52.3	22.6	44.5	14.7	94.2	31.6	129.1	104.5	123.0	99.4	69.7	95.6	144.2	111.8	11.2	64.6	30.1	60.8	78.2	213.9	36.6	41.2	32.1	33.8	29.7	26.5	47.6	30.6	35.0	36.5	866.5	1237.3	4967.7	6162.8	5594.2	395.4	375.5	1814.0	683.9	1733.4	689.2	125.7	5421.9	1850.2	2098.6	348.9	3202.9	1729.9	1308.2	4686.8	7893.8	2767.0	3521.3	1562.3	1179.0	3205.3	125.5	1988.8	2139.1	2727.1	762.5	3476.8	3124.5	2689.2	3452.7	3995.8	368.1	3769.5	2872.2	1695.0	1677.7	343.0	1099.5	3088.9	437.8	578.7	6855.6	4907.0	4548.4	5852.6	6063.3
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099573-151104652	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 440.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No		63000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	71.7	46.9	48.4	69.2	47.7	124.7	160.3	40.4	43.5	114.1	98.4	30.4	61.9	45.0	75.3	84.4	142.8	73.3	53.9	51.1	36.8	33.3	72.8	94.2	79.4	102.5	42.6	43.5	179.5	143.8	18.1	49.3	70.5	38.0	113.3	62.4	39.0	113.8	48.5	116.8	97.1	73.5	62.0	43.1	94.2	64.2	61.9	30.7	120.4	126.8	111.6	90.6	111.4	86.3	211.6	187.7	44.3	92.8	142.9	282.7	440.7	80.5	59.3	113.1	111.1	145.6	285.0	115.5	85.9	132.7	121.8	75.4	114.6	117.8	365.6	43.0	93.6	43.0	53.5	114.6	143.5	115.8	80.5	110.9	78.9	73.3	132.3	168.6	187.3	81.9	211.3	296.1	74.9	199.3	172.0	144.4	137.0	126.9	191.5	144.6	120.4	202.3	222.6	106.1	129.0	45.9	148.2	110.4	122.3	141.0	97.9	108.8	107.7	38.6	141.4	189.2	83.4	94.6	227.8	87.6	59.6	78.9	65.7	94.5	148.9	239.5	223.9	76.5	136.8	70.6	44.3	92.8	27.2	120.6	74.5	203.9	211.6	203.1	157.9	156.5	185.7	282.7	226.9	15.1	142.9	62.1	187.7	145.5	440.7	48.4	47.7	40.4	43.5	36.8	33.3	42.6	43.5	38.0	30.7	902.2	1351.4	4981.2	6887.5	5470.3	389.5	334.4	1689.1	1088.1	1918.8	783.4	113.9	3954.4	3630.9	1946.8	1331.3	2405.0	1231.3	1425.0	3246.4	6519.9	2822.1	4092.8	1400.9	1318.9	2985.4	154.1	2072.9	2006.5	3842.5	3230.8	4100.5	4536.3	3092.4	3236.3	3439.0	634.6	3016.2	2304.0	2436.9	3691.6	432.9	1739.7	3595.7	655.4	688.2	5905.5	3840.1	4239.4	5672.4	6561.2
RPS5	S5	ENSG00000083845	"Ribosomal protein S5"	P46782	19	58386400-58394806	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 503.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055878, HPA061979"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		860000	"Endoplasmic reticulum, Cytosol"		"HPA055878: AB_2682954, HPA061979: AB_2684650"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-1)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (2.79e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.01e-1)"	93.2	62.4	40.6	71.7	36.4	118.0	111.7	28.4	34.9	105.3	100.7	34.6	69.1	51.1	108.4	66.2	159.0	103.7	81.4	50.9	33.3	28.9	63.1	160.1	79.1	162.1	37.8	30.9	199.2	376.8	19.4	45.0	72.5	31.9	112.3	50.9	45.5	145.6	54.9	162.7	122.7	63.3	81.1	39.0	103.1	66.0	66.8	34.0	136.8	134.5	144.1	129.6	104.5	131.0	150.0	86.6	16.9	44.9	64.8	138.0	156.5	76.4	112.5	43.0	68.3	83.7	108.5	67.2	42.8	71.2	52.7	33.6	83.7	56.5	159.0	53.9	60.6	51.5	49.9	68.2	105.3	21.9	43.1	503.9	62.9	62.6	105.7	103.9	105.4	53.7	137.6	175.3	54.7	125.0	58.7	68.7	73.9	79.9	85.1	56.2	62.1	101.9	72.5	71.3	121.1	151.9	99.0	61.6	139.4	58.2	96.7	64.5	80.5	30.0	86.1	87.8	26.4	49.6	128.2	43.2	79.7	58.5	31.8	93.1	114.5	194.0	117.2	49.8	79.0	43.7	16.9	44.9	8.6	54.2	41.1	99.7	150.0	94.6	70.4	82.9	141.7	138.0	106.0	6.5	64.8	30.1	86.6	74.7	156.5	40.6	36.4	28.4	34.9	33.3	28.9	37.8	30.9	31.9	34.0	631.3	923.7	3948.5	4136.7	5255.7	230.2	214.1	1398.7	744.2	1369.4	499.0	115.8	2770.1	1545.2	1264.7	385.1	1386.8	1114.0	957.8	3964.4	3619.5	2102.1	2995.6	962.6	1143.3	1752.2	154.1	1188.7	1112.8	1555.1	982.1	2000.1	1866.3	2306.2	1598.8	2098.1	277.7	2061.4	1315.1	888.5	1782.0	311.8	685.6	2561.6	411.2	549.1	6343.4	2655.0	2337.7	2937.0	3861.2
RPS6	S6	ENSG00000137154	"Ribosomal protein S6"	P62753	9	19375715-19380254	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 584.2"	"Low region specificity"	"Detected in all"							"CAB004027, HPA031153"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		100000	"Endoplasmic reticulum, Cytosol"		"CAB004027: AB_2238583, HPA031153: AB_10602245"	"unprognostic (3.95e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.34e-2)"	"prognostic favorable (4.12e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.06e-3)"	90.0	65.3	64.1	110.2	70.2	166.3	152.8	37.0	50.4	125.4	149.9	38.8	57.4	73.0	91.6	97.7	166.8	87.7	81.5	70.0	51.5	44.4	88.5	91.3	104.0	243.5	66.0	36.2	206.6	441.2	26.1	64.0	67.9	64.7	152.5	83.9	53.3	109.1	72.1	129.5	139.9	96.3	157.8	84.5	137.8	87.5	67.2	53.2	127.9	147.0	119.7	125.8	207.4	143.4	237.2	135.7	30.1	75.5	129.7	274.9	399.9	108.2	71.2	72.4	84.8	122.8	189.6	87.0	73.2	95.6	88.0	73.7	59.2	50.2	249.0	72.5	69.9	31.2	53.3	81.1	112.7	95.7	129.7	77.6	164.1	92.2	107.3	150.0	86.9	82.0	157.2	206.1	58.6	172.9	126.7	105.8	112.5	68.9	101.6	94.9	65.2	184.0	584.2	135.8	86.0	48.5	144.1	73.3	118.4	121.8	93.2	72.4	97.4	27.7	118.0	151.3	60.7	76.8	317.7	77.5	50.7	54.3	52.4	114.4	48.1	93.1	169.0	34.3	130.7	29.6	30.1	75.5	23.3	111.6	67.1	193.2	237.2	205.0	150.5	135.7	196.8	274.9	215.8	12.8	129.7	60.6	126.1	152.7	399.9	64.1	70.2	37.0	50.4	51.5	44.4	66.0	36.2	64.7	53.2	1536.5	2830.0	6502.2	11967.4	8648.0	283.0	709.9	2662.4	2307.4	4835.2	1210.9	119.8	4727.3	4907.4	2480.2	2006.9	4335.8	1389.0	2149.2	5906.0	7578.1	3573.8	7361.0	3033.7	1998.6	3545.0	71.5	1975.3	3407.3	3797.3	4913.1	4288.0	4784.3	4367.8	4093.0	4198.5	516.9	4659.6	3594.7	2278.1	5890.0	305.7	1461.7	5142.7	1143.2	654.9	10561.7	4523.6	5315.7	7244.9	10415.6
RPS7	S7	ENSG00000171863	"Ribosomal protein S7"	P62081	2	3575205-3580919	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056586	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	Yes		1000000	"Endoplasmic reticulum, Cytosol"		"HPA056586: AB_2683179"	"unprognostic (3.28e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (6.41e-2)"	"unprognostic (6.02e-3)"	"unprognostic (7.08e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (1.34e-8)"	"unprognostic (3.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	54.0	42.1	41.7	57.4	47.8	91.9	112.1	35.1	52.6	57.9	54.4	22.5	35.3	38.3	49.4	70.5	75.2	60.6	80.9	42.7	35.6	28.9	88.1	184.7	40.5	73.8	35.4	49.9	128.7	94.3	19.0	42.3	56.0	46.5	49.6	61.0	27.5	61.1	46.8	96.7	74.9	53.8	46.2	35.2	74.2	55.7	120.7	30.3	59.0	49.0	129.1	89.6	54.8	62.3	124.7	91.6	22.4	53.7	83.8	117.9	145.9	62.6	61.4	94.7	101.7	94.2	206.7	155.5	76.2	133.1	126.8	74.0	106.1	99.2	209.9	127.4	88.0	88.2	69.2	107.0	123.7	112.2	65.7	144.3	76.6	45.1	152.7	227.3	132.6	79.8	173.5	186.7	78.6	171.0	137.4	148.1	194.4	118.2	106.7	128.2	84.5	146.9	296.0	139.7	189.1	95.4	117.4	96.6	186.7	143.2	77.2	108.0	162.4	40.3	155.3	231.8	83.4	85.4	192.4	69.1	76.4	50.2	52.5	122.0	119.8	218.3	205.7	80.3	159.9	85.0	22.4	53.7	19.9	74.4	47.3	109.5	124.7	107.1	94.6	91.6	107.1	117.9	103.2	11.4	83.8	44.3	87.8	90.6	145.9	41.7	47.8	35.1	52.6	35.6	28.9	35.4	49.9	46.5	30.3	461.6	611.6	3582.6	3530.2	3485.1	365.6	144.4	1480.3	812.4	1235.2	614.1	306.3	3079.2	2208.3	1634.1	1148.8	1674.5	681.7	724.2	2971.3	4852.3	1818.6	2622.1	1119.4	1214.5	2053.4	133.5	1202.6	1662.2	2169.7	372.0	2710.8	2469.9	1898.0	2610.5	1831.6	516.1	2628.7	1420.3	1643.8	3007.3	556.0	1429.3	2159.8	1061.8	775.2	4415.0	3108.3	2545.2	2502.1	3299.7
RPS8	S8	ENSG00000142937	"Ribosomal protein S8"	P62241	1	44775251-44778779	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029266			Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		52000	"Endoplasmic reticulum, Cytosol"		"HPA029266: AB_10601611"	"unprognostic (9.70e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.02e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (9.05e-9)"	"unprognostic (1.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.57e-2)"	55.7	60.7	44.8	44.4	46.3	100.1	82.0	50.1	65.5	69.6	47.8	33.8	37.0	40.7	61.9	48.4	78.0	66.7	43.9	36.8	34.6	23.7	41.6	74.1	36.5	77.7	34.8	34.6	195.0	98.3	13.1	37.2	45.4	36.8	53.5	42.5	32.3	61.0	72.7	53.7	91.2	45.6	39.4	35.6	57.0	47.4	71.9	29.0	64.8	40.9	97.3	72.0	52.7	71.2	146.1	98.0	15.3	50.2	61.2	128.4	168.5	102.3	51.3	82.4	108.5	143.3	225.6	134.8	75.3	119.5	106.5	85.7	87.9	112.1	194.1	83.1	91.2	68.6	70.3	105.6	131.1	78.8	70.2	184.5	72.3	73.0	116.8	203.7	143.7	71.0	179.4	217.6	70.9	190.6	153.6	127.2	117.8	107.4	136.5	99.0	81.0	157.9	153.8	180.0	86.4	88.8	127.3	100.9	216.6	119.5	88.1	88.2	101.8	40.7	228.4	298.5	83.3	79.8	289.3	86.7	53.0	92.9	81.2	127.8	107.8	105.6	146.7	64.8	172.7	63.4	10.3	50.2	15.3	55.1	49.1	94.1	146.1	101.4	76.7	79.2	124.5	128.4	106.7	5.0	61.2	38.1	98.0	84.2	168.5	44.8	46.3	50.1	65.5	34.6	23.7	34.8	34.6	36.8	29.0	1316.1	1723.1	6218.3	8263.7	7023.7	212.5	618.5	2667.5	1619.4	2842.4	1036.4	86.4	4856.6	3516.4	2080.0	402.3	3276.6	1407.7	2826.7	5263.3	6516.1	3553.3	5089.6	1744.1	1895.9	3113.3	57.2	2060.2	2974.6	3941.2	529.4	5688.8	4066.1	2795.5	3230.1	3644.2	416.1	4072.9	3794.5	2586.4	2671.8	154.0	1481.1	4301.1	393.8	413.6	9798.1	4485.5	3459.3	5777.2	7011.6
RRBP1	"ES/130, hES"	ENSG00000125844	"Ribosome binding protein 1"	Q9P2E9	20	17613678-17682295	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 136.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.8;plasmacytoid DC: 23.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009026, HPA011924"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		44000	"Endoplasmic reticulum"		"HPA009026: AB_1079852, HPA011924: AB_1856476"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.46e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.38e-4)"	19.9	18.3	6.7	16.1	11.2	5.9	13.8	4.9	7.4	22.1	23.6	17.8	49.5	18.5	16.3	24.4	17.1	12.3	37.3	15.8	7.8	6.3	27.1	88.9	20.5	10.6	13.0	5.6	23.4	136.1	24.7	18.4	51.4	10.4	19.4	16.7	14.8	84.2	56.0	7.7	11.0	32.2	13.0	13.3	20.4	30.0	12.1	12.2	5.0	32.8	11.6	19.2	18.7	18.9	0.9	23.5	18.8	4.7	5.7	2.5	1.5	30.4	21.7	6.5	14.6	30.1	32.7	34.4	47.8	40.2	20.2	27.5	48.3	28.8	11.8	16.1	45.1	20.9	30.7	7.0	38.8	16.6	5.4	5.4	13.6	6.3	49.8	43.3	5.0	17.2	43.1	11.7	32.7	19.4	30.0	19.9	4.2	5.6	11.5	30.3	13.8	1.9	11.5	7.6	67.9	21.0	3.5	17.3	40.5	17.1	10.4	3.3	2.5	27.2	64.6	19.6	14.5	11.3	7.7	35.7	43.3	16.1	22.4	15.7	21.1	16.0	3.9	16.4	5.4	22.0	5.4	4.7	18.8	2.5	2.9	1.7	0.5	0.8	1.4	2.4	0.9	0.8	0.9	4.2	5.7	4.0	23.5	0.7	1.5	6.7	11.2	4.9	7.4	7.8	6.3	13.0	5.6	10.4	12.2	89.3	202.0	34.3	70.6	52.5	17.0	30.9	147.7	131.2	145.6	90.7	29.5	233.8	38.1	171.5	35.2	132.5	313.0	0.0	359.4	194.5	183.3	135.6	113.5	227.0	102.0	23.8	93.1	135.1	51.8	28.3	117.6	73.6	67.4	86.6	259.3	193.4	291.3	208.5	78.1	62.7	35.4	32.3	138.2	74.8	93.6	48.8	445.7	36.3	168.2	180.5
RSAD2	"cig5, vig1, viperin"	ENSG00000134321	"Radical S-adenosyl methionine domain containing 2"	Q8WXG1	2	6865806-6898239	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"		Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 31.8"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 32.8;Ciliated cells: 17.4;granulocytes: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 24.3"	"Group enriched"	"Detected in some"	5	"BJ hTERT+ SV40 Large T+: 31.1;BJ hTERT+ SV40 Large T+ RasG12V: 48.0;HMC-1: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA041160, HPA049409"	Approved		Supported	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA041160: AB_10795489, HPA049409: AB_2680751"	"unprognostic (8.91e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (3.27e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-3)"	"unprognostic (9.47e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.79e-1)"	31.8	3.1	4.8	10.1	8.7	12.5	4.1	1.1	7.8	7.2	5.6	4.7	2.1	3.4	4.8	7.8	2.9	5.5	6.2	5.3	5.3	5.8	6.1	3.6	15.3	7.7	4.8	5.6	3.5	2.1	1.2	6.2	10.1	12.5	3.7	3.1	7.5	20.2	2.5	5.5	1.0	4.9	5.2	6.1	10.8	7.2	2.3	2.0	11.5	10.2	3.5	2.8	4.0	2.0	0.4	2.7	24.3	5.1	1.6	3.2	2.2	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.5	31.1	48.0	0.0	1.0	0.5	0.0	0.0	5.3	0.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	22.4	0.0	0.0	2.1	0.0	0.0	0.0	1.3	0.5	0.4	0.0	0.0	2.8	0.6	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.5	0.1	14.6	3.6	24.3	1.8	5.1	2.2	0.2	1.9	1.7	2.7	0.4	3.2	2.4	14.4	1.6	4.5	0.2	0.9	2.2	4.8	8.7	1.1	7.8	5.3	5.8	4.8	5.6	12.5	2.0	32.8	4.6	0.0	2.8	0.5	0.2	2.5	5.1	17.4	3.4	0.0	2.0	0.6	0.0	3.3	0.9	9.1	2.5	0.0	5.3	0.7	1.5	3.3	23.1	0.4	7.8	0.0	8.6	11.1	2.4	0.4	1.4	7.4	0.0	2.8	1.6	6.2	5.4	0.3	2.1	0.0	0.6	0.0	3.1	0.2	0.4	0.3	2.4	2.2	0.4	6.3
RTBDN	FLJ36353	ENSG00000132026	Retbindin	Q9BSG5	19	12825478-12835428	"Predicted membrane proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 17.3;pituitary gland: 25.8;retina: 57.0"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 289.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7;neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.2;SH-SY5Y: 5.4;U-266/84: 21.1;U-87 MG: 4.8"					"Not detected"	"Not detected"			HPA052511			Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Endoplasmic reticulum"		"HPA052511: AB_2797243"	"unprognostic (4.55e-4)"	"unprognostic (3.94e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.66e-9)"	"unprognostic (3.55e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.24e-2)"	0.3	6.9	10.2	0.5	3.4	0.9	0.3	2.7	17.3	0.2	0.9	0.4	0.0	1.0	0.3	1.5	0.3	0.3	0.4	0.3	7.3	5.1	0.2	0.4	0.5	0.4	2.8	2.8	0.3	2.5	0.2	25.8	0.3	4.0	0.4	0.9	57.0	0.3	0.3	0.3	0.5	1.0	0.6	1.0	0.4	2.5	3.5	0.0	7.0	0.4	0.0	0.4	0.3	0.0	0.3	0.2	1.8	0.2	0.4	0.2	0.0	0.9	0.1	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.1	0.9	0.9	0.0	0.6	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.4	0.9	0.0	0.1	2.4	0.0	0.0	0.4	0.2	0.0	0.0	0.1	1.2	2.7	0.0	0.1	0.0	0.0	0.9	0.7	1.1	0.7	0.1	1.0	0.0	0.0	8.2	5.4	0.1	0.1	0.4	0.4	2.7	0.7	0.0	0.8	1.0	0.7	0.1	1.2	21.1	4.0	4.8	0.0	0.0	1.7	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	1.8	0.4	0.2	0.2	0.1	0.0	10.2	3.4	2.7	8.6	7.3	5.1	2.8	2.8	4.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	1.4	0.0	0.0	0.0	0.0	329.9	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	45.9	0.1	0.0	0.0	0.0	289.4	0.0	0.0	11.5	5.1	0.0	0.0	0.0	0.0	0.0
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870966	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 144.6"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 227.2"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9"	"Group enriched"	"Detected in many"	15	"dendritic cells: 7.9;monocytes: 4.6"	"Group enriched"	"Detected in some"	4	"HEL: 23.2;SCLC-21H: 28.7;SH-SY5Y: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		140000	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874"	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	6.3	8.3	27.4	6.1	46.3	1.6	3.0	98.5	144.6	2.6	2.9	11.0	0.0	2.7	2.1	1.6	2.3	8.6	4.4	1.9	32.3	50.7	2.3	1.9	4.8	2.7	21.3	45.9	1.7	3.6	19.2	10.3	2.7	35.1	5.0	3.0	1.2	2.3	2.6	1.6	2.3	3.4	2.7	12.1	10.6	3.6	2.6	10.5	0.0	2.7	0.0	2.3	2.5	0.9	0.0	7.9	0.4	4.6	0.0	0.0	1.0	0.0	0.0	0.3	0.4	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.8	23.2	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	28.7	46.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.1	0.0	2.1	0.0	0.0	0.0	7.7	1.6	0.2	0.0	4.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	1.0	27.4	46.3	98.5	94.7	32.3	50.7	21.3	45.9	35.1	10.5	0.0	0.6	0.0	0.4	4.2	26.8	0.8	2.5	1.4	1.2	0.0	23.6	0.8	0.0	0.0	13.2	0.5	0.2	0.0	0.0	0.7	2.1	6.2	0.0	0.4	15.8	227.2	51.9	0.0	15.9	14.4	2.6	24.4	10.1	1.8	0.0	13.1	2.2	0.0	1.1	0.3	29.4	0.0	2.1	2.1	2.5	5.6	2.1	0.0	0.2	0.3
RTN3	"ASYIP, HAP, NSPL2, NSPLII, RTN3-A1"	ENSG00000133318	"Reticulon 3"	O95197	11	63681446-63759891	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 122.2;brain: 149.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 122.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 122.2;monocytes: 42.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015649, HPA015650"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		620000	"Endoplasmic reticulum"		"HPA015649: AB_1856498, HPA015650: AB_1856499"	"unprognostic (8.11e-3)"	"unprognostic (8.51e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (5.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-2)"	43.6	19.6	72.2	11.9	71.6	22.3	21.5	55.9	149.6	21.7	20.0	50.2	9.3	12.3	14.8	19.7	12.4	21.0	13.1	12.8	78.3	72.9	22.0	19.9	17.7	7.3	72.6	53.5	11.9	20.7	36.4	14.0	14.1	109.9	12.9	18.8	12.7	30.4	18.9	10.8	22.6	14.6	18.6	66.0	9.2	12.8	10.3	39.2	6.8	40.9	5.1	10.7	13.1	8.9	3.3	14.7	122.2	42.2	4.6	7.4	28.1	31.4	23.3	28.1	26.7	52.0	37.0	11.2	28.6	30.5	25.3	27.2	20.2	69.8	37.2	49.0	42.8	24.4	32.4	40.1	14.1	33.5	29.9	21.4	47.6	34.1	14.1	43.3	42.3	38.4	24.3	41.9	30.8	34.4	42.5	34.2	32.8	26.9	60.5	22.2	25.8	22.4	47.1	32.7	25.7	26.4	29.8	19.6	68.6	49.9	17.8	59.5	34.6	46.4	51.2	53.4	21.0	56.4	34.9	31.8	15.1	20.5	52.5	21.9	38.5	33.2	29.8	58.2	35.3	15.9	40.1	42.2	52.8	4.9	21.1	5.3	3.3	5.0	4.9	14.7	2.3	3.7	4.0	122.2	4.6	25.1	8.8	7.4	28.1	72.2	71.6	55.9	118.2	78.3	72.9	72.6	53.5	109.9	39.2	125.0	58.7	40.2	86.8	128.3	148.4	30.7	73.9	174.0	93.3	232.1	66.8	60.7	24.9	121.1	28.8	64.2	94.1	46.7	101.6	81.1	86.1	70.4	76.1	65.2	130.9	77.9	95.7	66.3	177.0	55.9	73.4	125.9	108.0	117.2	63.4	133.1	92.8	64.7	84.5	45.4	75.4	77.6	79.5	130.3	150.5	127.8	72.3	60.9	84.0	86.5
RTN4	"ASY, KIAA0886, NOGO, NSP-CL"	ENSG00000115310	"Reticulon 4"	Q9NQC3	2	54972187-55112621	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Muller glia cells: 3179.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 159.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005388, HPA023977"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		13000000	"Endoplasmic reticulum"		"CAB005388: AB_2285559, HPA023977: AB_2671391"	"unprognostic (1.31e-2)"	"unprognostic (1.71e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (5.79e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.91e-2)"	103.7	60.5	75.1	27.9	85.0	19.3	63.6	66.6	105.5	24.8	35.4	52.9	17.5	45.0	29.3	36.0	43.0	26.3	38.5	30.8	71.9	69.7	86.5	103.5	36.2	19.6	84.9	75.8	27.4	23.7	59.9	16.1	33.8	99.0	45.2	35.7	24.7	23.6	38.1	171.1	48.1	55.2	47.4	92.6	20.1	23.5	14.6	62.7	14.7	25.9	47.2	16.5	48.1	35.4	2.8	6.1	33.3	7.7	16.8	15.8	4.4	33.0	24.0	23.5	6.1	80.1	75.2	13.2	110.1	93.6	34.1	31.9	19.7	31.5	7.2	58.6	74.6	57.1	30.1	15.4	44.3	52.1	20.4	11.8	9.9	14.8	31.1	159.5	17.8	5.1	56.3	42.4	46.6	90.9	68.9	63.9	18.3	20.2	16.7	147.0	9.6	21.7	18.2	21.1	7.2	21.5	9.7	31.0	14.9	79.1	39.9	15.5	18.3	25.2	14.8	30.8	42.1	12.6	13.7	90.6	66.7	28.3	26.2	62.9	10.2	8.2	4.6	67.9	20.7	53.6	33.3	4.3	10.9	4.3	4.9	3.5	2.8	6.9	3.8	4.0	1.6	11.7	4.8	7.0	16.8	7.7	6.1	15.8	4.4	75.1	85.0	66.6	105.5	71.9	69.7	84.9	75.8	99.0	62.7	163.8	161.9	100.2	1062.9	943.4	647.1	108.1	226.7	159.3	127.4	642.0	357.4	421.2	247.1	487.4	360.7	341.8	464.3	70.0	283.5	513.5	379.7	775.3	148.7	573.6	570.9	402.0	213.0	178.0	338.1	193.3	155.1	405.6	323.9	461.7	231.2	3179.0	405.8	189.0	212.5	568.0	465.4	213.4	311.0	240.3	85.0	925.9	302.8	121.8	187.3	1082.8
SAMD8	"FLJ25082, SMSr"	ENSG00000156671	"Sterile alpha motif domain containing 8"	Q96LT4	10	75099586-75182123	"Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 18.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044402			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044402: "	"unprognostic (4.32e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.87e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-1)"	"unprognostic (3.12e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.26e-3)"	17.6	14.6	18.8	9.3	18.9	20.7	11.9	12.4	34.8	15.6	7.9	20.1	10.2	8.2	15.0	10.1	17.9	9.4	12.5	14.3	18.6	15.9	10.1	10.1	10.7	8.7	22.7	13.8	18.7	7.6	13.0	17.1	14.8	17.4	11.5	7.0	10.9	8.9	11.5	28.3	7.6	9.3	13.7	37.8	10.0	7.7	19.9	15.5	5.5	10.7	7.3	8.6	10.9	18.1	5.7	3.6	18.3	5.9	3.8	3.3	1.5	5.5	5.3	8.1	6.5	17.9	16.6	10.3	10.1	19.3	6.7	9.1	7.9	7.9	4.5	6.7	9.4	7.1	10.1	4.6	6.9	12.0	5.0	6.7	1.8	5.4	5.3	9.9	2.0	4.6	15.9	7.0	12.4	18.0	15.4	9.2	5.1	3.8	7.8	12.8	4.3	3.3	2.5	3.5	3.8	20.9	3.0	7.5	1.6	6.4	4.8	1.2	5.8	9.2	11.0	8.9	9.3	4.6	1.9	15.8	6.6	12.4	8.0	6.6	5.5	4.2	4.3	10.3	4.4	4.2	2.4	3.7	2.2	2.9	4.5	1.9	4.8	3.1	3.3	3.2	5.7	2.7	3.1	18.3	3.8	5.9	3.6	2.8	1.5	18.8	18.9	12.4	21.3	18.6	15.9	22.7	13.8	17.4	15.5	8.9	12.2	13.7	23.3	37.5	19.1	22.6	10.2	25.4	17.0	14.0	13.7	9.1	0.0	9.7	29.4	21.3	9.6	0.0	9.0	9.6	22.6	18.9	12.7	11.6	11.8	17.5	22.4	23.9	16.2	9.0	23.3	27.6	11.8	27.1	3.3	21.8	13.2	8.6	23.7	6.2	31.9	32.3	24.7	47.0	23.4	37.5	56.9	20.1	4.1	32.5
SAR1A	"SAR1, Sara, SARA1"	ENSG00000079332	"Secretion associated Ras related GTPase 1A"	Q9NR31	10	70147289-70170523	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, CAB022545, HPA048368"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		10000000	"Endoplasmic reticulum"		"CAB022545: , HPA006923: AB_1856577, HPA048368: AB_2680373"	"unprognostic (3.77e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.13e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (7.00e-5)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.13e-2)"	52.7	40.0	26.7	24.5	31.9	91.1	37.8	27.8	35.7	32.6	26.9	28.6	38.3	17.3	35.7	34.6	30.8	28.2	30.4	34.6	25.6	27.0	31.7	48.8	38.2	27.0	26.6	27.8	36.5	29.8	30.0	37.0	51.6	30.3	28.5	25.3	29.5	39.6	40.5	35.9	27.5	25.1	36.0	28.3	31.8	28.6	18.4	23.5	24.9	34.8	28.9	25.5	36.4	28.8	18.7	22.9	27.7	30.4	40.2	40.1	32.6	21.9	14.6	20.9	36.1	71.7	43.5	15.4	35.0	43.8	33.5	40.4	42.9	19.7	19.7	17.4	42.6	13.0	24.0	27.0	20.1	33.0	25.5	12.8	14.5	17.2	20.9	33.0	22.5	14.9	44.8	19.7	21.3	37.3	34.1	17.6	15.1	19.0	26.9	30.7	14.9	18.9	18.7	17.8	14.0	41.2	18.5	23.3	11.4	25.0	16.9	11.8	20.1	26.4	37.4	18.7	19.9	17.8	15.4	24.4	17.2	24.1	23.9	23.9	17.8	30.8	27.3	23.0	30.1	13.1	25.4	24.7	27.7	36.3	30.4	40.1	18.7	29.3	36.1	22.9	15.0	29.0	38.1	27.4	40.2	26.6	17.8	20.0	32.6	26.7	31.9	27.8	35.7	25.6	27.0	26.6	27.8	30.3	23.5	119.1	113.7	49.2	120.4	209.4	35.6	67.5	58.6	41.5	64.8	47.1	31.4	109.9	46.4	67.1	2.5	99.1	49.2	0.0	67.5	161.5	172.2	111.8	51.9	103.0	90.8	25.4	41.0	67.5	47.8	4.0	50.6	90.6	108.0	65.9	46.7	57.3	62.0	52.1	55.2	76.7	31.0	77.6	129.6	54.3	49.0	217.4	199.8	94.9	47.8	134.4
SAR1B	SARA2	ENSG00000152700	"Secretion associated Ras related GTPase 1B"	Q9Y6B6	5	134601144-134649271	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 296.4;Hepatocytes: 238.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, HPA048368"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA006923: AB_1856577, HPA048368: AB_2680373"	"unprognostic (6.14e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.32e-2)"	"prognostic favorable (7.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (5.92e-2)"	"prognostic favorable (6.59e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.87e-2)"	15.0	24.4	14.4	9.2	16.4	9.0	15.0	11.2	17.4	11.7	20.9	23.2	20.5	26.7	8.2	15.8	19.0	7.7	11.6	17.9	15.1	12.7	23.2	78.8	9.6	9.4	26.7	12.1	9.7	17.5	27.9	27.3	11.6	19.7	16.0	15.3	10.9	19.1	16.8	68.6	8.5	45.1	10.8	26.5	11.4	16.6	23.9	20.1	8.6	13.8	30.2	12.9	12.2	10.4	22.0	28.9	23.9	33.2	14.5	33.4	29.3	17.0	14.9	11.1	25.5	35.3	17.2	15.1	28.8	24.8	26.0	40.1	25.2	24.3	9.4	24.5	29.5	36.2	15.9	19.2	27.9	33.8	21.8	11.2	9.9	25.5	24.0	29.0	8.4	13.8	19.2	17.9	30.2	25.8	13.2	19.5	12.6	13.0	22.0	26.5	25.3	11.2	12.9	3.7	21.0	10.5	9.9	19.3	20.7	18.9	28.7	11.3	5.2	20.3	11.1	20.8	15.4	22.7	10.6	15.6	22.7	13.7	20.5	21.5	27.9	61.2	17.1	17.5	16.6	24.8	9.8	32.0	23.9	20.5	31.1	25.1	22.0	23.7	23.6	28.9	13.3	21.1	20.7	11.7	14.5	33.2	19.7	33.4	29.3	14.4	16.4	11.2	17.4	15.1	12.7	26.7	12.1	19.7	20.1	29.8	28.8	28.3	36.3	33.4	28.9	69.9	63.7	46.8	36.4	54.1	39.3	30.5	48.0	41.7	296.4	30.0	96.1	0.0	72.9	33.5	40.9	74.8	25.5	238.0	47.2	31.8	26.6	38.6	54.8	51.0	33.9	46.0	60.8	30.7	50.3	41.1	59.5	28.8	42.1	102.9	37.4	19.4	43.4	103.0	38.3	44.7	96.3	37.4	42.9	76.5
SARAF	"MGC8721, TMEM66"	ENSG00000133872	"Store-operated calcium entry associated regulatory factor"	Q96BY9	8	30063012-30083208	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040400			Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA		17000	"Endoplasmic reticulum"	"Rods & Rings"	"HPA040400: AB_2676962"	"unprognostic (1.11e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.38e-3)"	"unprognostic (7.86e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.03e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-1)"	30.7	80.7	58.1	37.3	69.0	57.8	62.1	45.8	89.0	40.9	32.8	35.8	49.3	26.9	35.0	65.9	20.2	42.9	39.5	34.3	57.5	80.9	38.7	67.0	39.1	77.7	59.1	49.8	60.6	67.8	44.6	48.9	61.6	53.4	45.6	28.1	26.1	69.4	45.5	29.7	18.4	30.7	30.4	62.4	36.4	38.7	21.3	35.4	50.3	50.0	16.0	36.0	35.4	37.3	36.9	30.2	96.2	36.9	29.0	99.7	91.0	21.6	15.4	19.6	13.0	33.6	23.4	14.9	26.8	38.5	23.3	30.2	8.3	24.3	14.7	39.4	29.1	22.5	19.2	19.7	22.2	19.2	7.8	14.3	20.1	11.0	10.7	33.8	6.4	24.0	36.5	41.8	26.2	21.6	37.6	32.4	28.0	23.5	31.4	17.6	8.2	23.5	10.6	17.4	39.9	16.7	19.0	13.0	20.2	32.4	8.8	8.5	30.2	23.4	23.3	30.0	16.0	20.1	13.5	23.0	15.6	44.8	7.1	8.8	22.2	20.2	13.3	38.7	17.5	25.3	96.2	30.1	50.8	41.3	28.9	45.2	27.0	59.4	47.5	30.2	36.9	99.7	67.4	58.4	29.0	36.9	25.1	53.5	91.0	58.1	69.0	45.8	89.0	57.5	80.9	59.1	49.8	53.4	35.4	157.8	151.5	175.3	315.5	0.0	275.4	116.6	183.4	389.5	151.2	200.7	115.8	212.5	107.8	306.4	503.5	140.5	151.8	23.3	314.8	218.5	186.1	398.0	205.8	225.0	268.6	131.9	111.2	216.7	320.6	650.1	202.5	236.8	0.0	172.3	165.1	296.0	289.2	188.4	276.5	210.5	171.0	174.6	120.5	100.9	125.1	0.0	231.6	276.7	147.8	245.7
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292453-121308694	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 143.5"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 117.3;Ito cells: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: AB_2685648, HPA070248: AB_2686240"	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	10.9	15.3	16.9	5.5	18.4	2.7	23.3	10.4	26.9	9.4	9.4	17.8	24.5	17.4	6.8	30.1	19.5	7.2	7.4	9.4	18.7	19.6	19.7	143.5	10.1	5.5	20.8	17.8	7.8	8.9	17.5	14.7	6.3	40.8	40.3	8.6	8.2	9.5	24.0	3.9	7.7	13.4	7.6	43.4	4.1	8.8	9.7	16.0	3.7	10.4	8.2	8.1	14.0	14.6	6.0	9.8	7.5	6.3	6.8	10.0	3.8	6.8	3.4	51.8	11.0	20.1	17.5	7.3	7.7	14.5	5.2	9.2	21.6	25.5	6.5	24.4	8.4	41.5	25.7	16.1	19.5	5.1	3.2	22.0	9.6	22.6	17.2	16.4	6.0	3.3	14.3	16.0	16.4	16.9	4.4	7.8	6.4	6.2	9.4	24.0	7.1	2.4	7.9	16.1	19.8	11.0	3.4	13.0	5.5	36.5	30.8	13.7	7.7	17.7	4.0	10.1	36.2	16.2	10.4	14.9	5.0	8.1	8.8	3.6	1.8	2.9	8.7	1.9	13.4	8.6	7.5	4.8	1.2	5.0	6.3	8.5	6.0	6.8	6.0	8.5	6.0	10.0	9.5	0.4	6.8	4.5	9.8	6.9	3.8	16.9	18.4	10.4	26.9	18.7	19.6	20.8	17.8	40.8	16.0	17.9	26.4	26.2	53.7	8.7	21.9	17.8	15.3	14.7	18.2	19.2	29.5	13.8	5.0	17.3	2.2	8.4	23.5	0.0	25.4	14.2	17.3	59.7	17.3	117.3	17.9	22.3	13.8	163.9	25.6	1.0	17.8	15.1	18.6	22.6	12.7	40.5	14.5	11.4	15.9	14.6	29.6	12.9	16.7	6.0	13.0	13.6	15.6	21.7	11.9	45.5
SCARA3	"APC7, CSR, CSR1, MSLR1, MSRL1"	ENSG00000168077	"Scavenger receptor class A member 3"	Q6AZY7	8	27633868-27676776	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 52.2"	"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 62.8;Cytotrophoblasts: 37.1;Muller glia cells: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 50.6;HeLa: 55.7;HUVEC TERT2: 38.6;U-2 OS: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029861, HPA047386"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029861: AB_2673225, HPA047386: AB_2680024"	"unprognostic (2.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.31e-3)"	"unprognostic (6.03e-3)"	7.5	4.6	16.4	9.0	27.3	0.4	10.6	10.3	26.8	19.9	11.2	7.7	14.2	3.4	33.8	9.4	14.5	52.2	18.4	4.8	16.2	13.0	3.8	2.7	7.8	7.4	16.4	10.3	13.1	2.8	2.2	3.6	11.8	21.2	12.4	5.4	8.6	13.7	42.6	1.1	6.0	5.1	40.5	21.8	2.0	5.9	3.9	12.1	3.2	19.2	4.7	13.2	11.3	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	16.5	2.6	0.0	13.8	50.6	11.5	6.6	10.4	7.2	5.4	6.1	4.3	0.0	15.6	13.3	5.8	12.4	0.0	12.2	3.4	0.0	1.4	4.8	55.7	0.2	1.4	0.0	0.0	21.2	0.7	11.1	0.6	9.6	38.6	1.2	0.0	0.0	4.0	3.0	0.0	0.0	3.5	0.0	6.3	0.0	0.0	0.0	2.2	7.3	0.0	1.7	1.5	8.7	0.0	1.3	8.6	0.1	13.7	5.9	35.7	21.9	3.5	0.0	0.0	0.0	10.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	27.3	10.3	22.5	16.2	13.0	16.4	10.3	21.2	12.1	0.0	0.3	0.0	13.3	3.2	0.4	2.0	7.6	4.0	7.9	62.8	0.0	37.1	0.0	0.2	2.4	3.3	0.0	0.0	0.7	14.6	12.8	2.8	0.0	0.2	4.0	0.0	0.0	12.3	0.3	1.1	14.7	0.8	16.9	1.0	0.0	54.2	1.6	0.0	6.0	0.0	1.1	6.5	13.7	0.2	1.0	3.3	6.9	0.0	0.0	8.6
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347124-100364834	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 300.1;Hepatocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 204.0;CAPAN-2: 141.3"					"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"		No	Yes			"Endoplasmic reticulum"		"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (7.79e-5)"	245.0	21.3	59.8	11.4	32.7	5.5	94.0	12.7	83.9	5.3	10.8	63.6	0.1	21.4	3.7	7.0	13.4	1.7	18.3	109.2	61.5	43.4	5.0	130.8	32.2	23.1	65.1	23.6	12.7	6.1	7.7	1.5	5.3	34.5	24.4	10.1	4.5	24.9	3.7	2.4	3.4	6.1	4.6	130.0	4.2	5.9	12.2	35.4	1.4	2.0	6.9	5.4	3.7	5.0	2.0	5.3	0.2	3.3	2.9	5.1	2.1	31.0	28.6	61.1	41.9	204.0	117.7	12.5	3.3	73.7	8.0	42.8	24.6	141.3	13.1	2.6	7.8	36.6	55.6	33.6	119.4	7.0	4.4	13.9	7.3	18.2	49.2	39.4	10.2	8.0	64.0	36.2	31.1	54.8	21.6	15.2	29.1	20.4	40.1	3.2	48.6	11.6	12.2	21.2	9.1	8.2	5.4	22.6	41.1	34.9	34.9	3.8	14.7	6.6	31.2	64.1	18.5	35.0	22.0	6.0	0.8	9.5	0.7	6.8	11.2	6.0	20.2	14.6	32.0	5.1	0.0	1.5	0.0	3.0	3.3	5.1	1.3	1.2	1.6	5.3	2.0	1.0	2.9	0.2	2.9	0.0	3.0	0.0	2.1	59.8	32.7	12.7	27.9	61.5	43.4	65.1	23.6	34.5	35.4	50.6	300.1	34.7	3.9	3.3	4.0	2.9	35.7	9.4	23.9	0.0	5.9	2.0	0.0	12.5	52.9	9.3	13.7	0.0	59.1	53.1	9.3	26.0	5.8	153.5	29.3	25.4	24.8	41.7	97.6	68.6	3.4	8.2	55.6	17.2	15.7	11.8	21.6	2.9	1.4	3.8	4.7	0.0	4.4	0.9	1.1	1.9	14.5	5.2	16.8	3.5
SEC16A	"KIAA0310, p250, Sec16L"	ENSG00000148396	"SEC16 homolog A, endoplasmic reticulum export factor"	O15027	9	136440096-136483759	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005684	Supported		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA005684: AB_1079189"	"unprognostic (1.24e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.41e-1)"	9.7	11.2	13.4	10.6	16.4	21.5	10.1	36.8	21.0	11.4	9.4	9.2	10.7	10.0	11.7	8.9	10.9	10.4	9.0	8.7	13.3	5.4	10.0	23.8	11.6	10.5	12.3	11.5	10.7	20.2	11.9	26.3	7.6	13.2	13.2	7.2	10.4	16.3	9.7	14.3	13.4	11.3	7.3	6.7	13.4	19.1	46.7	12.9	19.6	15.8	5.7	8.1	10.0	8.4	5.9	6.1	4.7	7.2	3.3	7.1	4.5	10.7	24.0	12.1	19.9	12.9	13.3	14.3	13.4	11.7	10.0	7.7	17.2	9.2	10.8	9.5	16.2	12.3	29.8	13.4	19.2	5.5	22.8	8.7	11.0	22.3	13.7	12.5	18.7	19.6	14.3	13.9	13.9	16.4	8.1	13.6	14.5	13.7	15.0	10.5	46.6	12.5	10.1	10.6	32.4	17.0	18.0	15.0	18.3	10.2	14.5	17.1	11.4	17.3	26.3	8.2	6.1	26.9	14.7	19.5	16.2	12.2	13.0	10.3	7.2	10.9	14.0	12.6	8.5	16.1	3.9	5.9	2.8	6.3	7.1	6.5	5.9	6.4	7.1	3.6	3.8	4.2	6.7	4.7	3.3	7.2	6.1	4.5	4.5	13.4	16.4	36.8	21.0	13.3	5.4	12.3	11.5	13.2	12.9	23.8	39.0	11.5	13.2	22.0	19.1	10.8	12.7	28.1	20.5	12.2	23.6	6.9	6.6	12.7	3.8	15.2	20.6	0.0	14.2	9.5	15.3	23.5	23.1	50.5	14.4	31.8	39.1	18.4	21.3	3.6	12.0	16.3	13.5	12.6	57.7	12.5	18.6	8.6	15.6	8.6	16.0	12.9	12.7	23.8	12.8	23.5	12.6	13.8	17.8	20.7
SEC16B	"LZTR2, PGPR-p117, RGPR, Sec16S"	ENSG00000120341	"SEC16 homolog B, endoplasmic reticulum export factor"	Q96JE7	1	177923956-177984303	"Predicted intracellular proteins"	"ER-Golgi transport, Peroxisome biogenesis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 43.4;liver: 47.4"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 57.2;Late spermatids: 36.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.5;CAPAN-2: 9.0;EFO-21: 6.9;HDLM-2: 6.9;Karpas-707: 6.1;RPMI-8226: 7.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054292, HPA072913"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Actin filaments"		NA	NA			"Endoplasmic reticulum, Plasma membrane"	"Actin filaments"	"HPA054292: AB_2682439, HPA072913: AB_2732213"	"unprognostic (2.31e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.34e-4)"	"unprognostic (6.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-1)"	1.4	1.8	1.1	3.2	0.9	0.0	1.5	0.9	2.3	1.7	19.6	0.9	0.9	14.3	1.3	0.9	0.9	1.6	2.5	2.2	0.9	0.4	2.5	47.4	0.9	0.9	0.9	0.9	1.8	4.8	0.1	1.4	0.9	1.0	0.9	1.6	0.9	1.4	0.9	3.9	0.9	43.4	0.9	0.9	2.7	4.0	0.9	0.9	0.9	1.4	0.9	1.0	0.9	1.0	0.0	0.7	0.0	0.7	0.0	0.0	0.2	2.3	1.9	0.1	1.9	2.5	8.5	0.1	1.9	0.6	0.1	0.9	1.3	9.0	0.8	6.9	1.5	0.1	0.0	0.5	0.2	0.1	6.9	0.1	0.0	0.0	4.2	0.2	0.1	0.0	5.0	0.6	0.3	0.1	0.2	2.7	0.0	0.0	6.1	4.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	7.8	0.1	0.2	0.8	1.6	0.1	0.2	1.0	0.0	0.1	1.6	0.9	1.3	0.2	0.8	0.0	2.0	0.8	0.1	3.4	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.1	0.9	0.9	2.3	0.9	0.4	0.9	0.9	1.0	0.9	0.0	1.3	0.5	0.2	0.2	1.0	0.4	10.2	2.7	2.3	1.8	2.0	0.3	0.0	0.4	9.0	1.4	1.0	0.0	1.0	0.0	0.8	0.1	1.1	57.2	0.6	11.1	3.5	4.3	2.7	36.6	2.3	0.6	1.7	0.0	4.4	0.8	1.2	3.7	1.1	1.7	4.3	0.0	1.4	0.3	0.9	0.9	0.0	0.0	4.3	0.1
SEC61A1		ENSG00000058262	"Sec61 translocon alpha 1 subunit"	P61619	3	128051641-128071683	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 178.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022076			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB022076: "	"unprognostic (1.84e-1)"	"unprognostic (8.00e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (2.84e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.84e-9)"	"unprognostic (2.73e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.51e-2)"	28.6	38.2	15.2	23.2	16.2	18.5	38.4	12.8	16.2	45.0	24.2	15.9	77.9	22.1	32.6	52.8	31.1	28.3	34.4	27.6	14.3	13.5	37.6	132.2	33.2	44.9	17.4	10.3	28.5	178.4	31.5	36.5	51.6	15.2	26.2	26.0	19.0	87.1	81.7	22.7	22.7	32.5	31.3	15.4	28.8	33.8	21.2	15.4	22.9	35.5	28.8	36.6	24.2	26.4	13.8	35.6	40.0	25.1	18.7	39.3	29.0	40.1	21.1	21.2	37.7	60.3	52.1	39.1	64.8	75.2	56.5	61.0	40.0	29.3	26.8	39.1	83.6	42.3	35.7	33.2	45.8	54.8	24.2	18.2	30.5	23.6	42.1	88.9	38.7	34.8	57.1	55.4	53.2	68.8	42.8	49.6	18.7	20.0	65.7	65.5	36.6	19.9	12.8	28.6	35.6	29.6	21.0	19.0	52.5	29.4	35.2	24.2	23.7	32.0	30.5	40.8	25.6	28.4	33.1	48.7	44.6	25.3	51.7	30.2	60.1	28.6	38.6	72.9	25.2	57.5	40.0	25.1	19.1	28.3	23.0	39.3	13.8	20.5	24.8	24.7	8.5	13.0	15.0	6.6	18.7	22.4	35.6	13.1	29.0	15.2	16.2	12.8	16.2	14.3	13.5	17.4	10.3	15.2	15.4	29.8	34.5	23.1	22.5	32.7	16.8	12.9	35.7	10.7	20.5	47.1	33.4	56.4	3.3	77.1	35.8	35.6	73.5	23.3	133.3	103.4	63.4	59.6	25.4	101.3	67.9	25.4	70.7	53.4	26.8	17.6	38.0	27.4	32.1	25.2	85.2	24.5	95.2	53.4	41.1	22.6	14.1	32.3	34.0	9.3	15.8	25.7	107.0	25.4	63.1	30.3
SEC61B		ENSG00000106803	"Sec61 translocon beta subunit"	P60468	9	99222064-99230615	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"monocytes: 2395.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049407	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049407: AB_2680750"	"unprognostic (1.11e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.96e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.75e-1)"	26.2	39.8	20.3	27.1	20.7	41.1	37.2	12.6	20.2	36.5	26.2	15.8	47.9	28.5	32.1	52.7	29.3	26.8	26.4	19.8	19.3	17.7	42.0	153.0	31.9	49.3	19.9	14.8	31.6	175.5	13.6	38.5	36.3	17.7	28.9	19.8	21.3	116.6	50.8	16.9	20.5	31.2	21.0	20.1	41.4	29.7	19.9	16.8	43.8	49.3	29.2	35.9	24.5	24.0	36.9	173.3	71.5	48.5	31.0	52.5	47.1	37.7	37.1	42.9	42.5	42.5	54.5	51.9	56.4	59.3	53.5	46.7	53.0	29.9	51.9	43.2	51.5	58.1	46.8	30.0	45.0	25.8	54.6	41.8	27.1	36.1	74.8	92.7	46.5	34.9	48.6	69.6	42.0	37.6	47.7	65.1	42.6	42.4	101.6	50.3	69.6	42.2	68.1	34.3	90.6	87.3	41.0	36.5	66.9	57.8	27.3	44.7	31.7	31.6	73.6	72.2	35.4	28.5	64.4	45.5	38.3	45.7	63.9	46.8	54.8	36.8	33.2	63.9	30.1	25.2	71.5	48.5	44.5	39.1	38.4	52.5	36.9	43.3	39.3	49.4	25.0	27.5	30.1	40.6	31.0	33.2	173.3	38.3	47.1	20.3	20.7	12.6	20.2	19.3	17.7	19.9	14.8	17.7	16.8	95.3	187.1	256.1	245.3	351.6	50.7	48.6	280.2	210.1	184.2	190.1	29.5	281.8	537.2	460.0	124.8	278.2	231.9	23.3	685.9	442.0	377.2	528.8	210.1	851.3	458.0	50.9	289.9	218.5	275.4	31.8	303.8	326.5	470.7	2395.0	308.0	128.3	615.7	260.3	286.0	654.7	66.5	135.8	230.8	200.9	174.6	387.6	463.2	262.1	249.2	374.6
SEC62	"Dtrp1, HTP1, TLOC1"	ENSG00000008952	"SEC62 homolog, preprotein translocation factor"	Q99442	3	169966635-169998373	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014059, HPA061450"	Approved		Approved	"Endoplasmic reticulum,Intermediate filaments"		NA	NA			"Endoplasmic reticulum"	"Intermediate filaments"	"HPA014059: AB_1858029, HPA061450: AB_2684524"	"unprognostic (8.15e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.13e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-1)"	33.2	30.8	43.1	18.8	46.0	27.3	22.5	30.3	51.7	28.7	26.6	19.7	33.1	19.6	26.1	47.7	25.5	18.7	20.2	21.0	41.7	40.7	41.7	65.7	25.7	19.5	53.2	25.9	31.9	39.5	37.3	34.7	37.8	53.9	34.0	19.9	10.5	39.7	30.8	22.1	11.2	24.4	32.5	55.1	35.3	30.1	16.3	40.2	17.6	42.3	12.2	21.8	43.7	28.3	38.5	14.9	25.0	15.5	12.7	23.6	11.0	34.3	24.2	19.1	16.8	57.2	30.3	12.0	44.1	32.5	20.6	21.5	25.8	36.3	38.7	49.3	31.5	34.4	32.9	23.4	21.3	32.4	30.2	22.7	26.8	15.1	25.9	41.6	27.1	17.6	30.2	20.5	22.6	22.1	28.3	20.3	12.0	16.4	37.5	24.4	28.7	14.2	14.4	19.5	27.6	15.9	19.1	27.6	52.1	29.5	22.1	19.6	18.5	36.1	39.7	30.1	19.2	59.4	25.0	27.0	29.3	13.3	24.4	35.5	43.5	32.6	60.5	30.7	21.2	27.3	6.4	14.1	25.0	19.4	15.5	22.2	33.2	18.4	19.4	13.0	38.5	23.6	20.9	22.2	12.7	11.6	14.9	16.0	11.0	43.1	46.0	30.3	51.7	41.7	40.7	53.2	25.9	53.9	40.2	220.3	262.7	342.9	200.0	226.0	367.3	496.5	300.7	294.5	280.9	645.6	261.1	203.3	165.8	224.9	14.0	313.8	139.0	771.0	299.5	183.3	350.0	241.8	280.2	977.5	192.3	427.5	250.7	386.1	211.1	22.8	518.6	248.1	264.9	296.6	208.7	387.4	260.2	190.0	409.4	320.7	346.7	291.1	249.2	173.4	114.7	150.7	363.1	201.5	162.6	151.0
SEC63	"DNAJC23, ERdj2, PRO2507, SEC63L"	ENSG00000025796	"SEC63 homolog, protein translocation regulator"	Q9UGP8	6	107867756-107958189	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053295, HPA060535"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053295: AB_2682105, HPA060535: AB_2684312"	"prognostic unfavorable (3.32e-4)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.51e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (6.16e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.41e-2)"	19.9	26.0	22.2	14.4	20.0	20.2	17.4	17.3	19.2	22.8	17.6	13.9	21.9	11.5	22.4	21.5	16.3	18.6	15.4	19.5	18.4	14.5	14.2	35.2	17.6	10.6	19.2	17.9	30.5	45.8	24.9	32.3	27.9	16.8	20.0	13.3	14.0	46.6	27.2	15.3	14.6	12.6	20.2	20.0	13.7	18.5	21.6	21.5	16.7	36.2	9.3	11.7	24.2	21.4	6.1	9.6	6.3	12.0	9.2	11.1	4.9	11.3	6.9	19.2	23.8	20.1	23.8	17.3	24.3	26.9	11.6	16.6	12.4	14.2	21.2	20.8	21.8	14.4	16.7	13.3	15.6	17.9	25.4	14.7	22.9	11.0	12.7	31.4	26.1	13.6	18.6	25.9	18.6	41.2	21.1	16.2	13.0	19.1	34.3	23.8	9.0	8.1	11.8	15.1	12.1	7.5	26.0	22.7	17.3	14.1	15.1	16.9	19.2	13.4	20.3	24.3	13.7	14.4	38.7	17.4	17.6	10.9	17.5	18.8	13.1	9.6	21.2	19.4	22.9	20.0	6.3	7.3	6.3	7.0	6.3	11.1	6.1	5.9	5.7	7.4	6.1	6.6	5.1	2.5	9.2	12.0	9.6	3.1	4.9	22.2	20.0	17.3	19.2	18.4	14.5	19.2	17.9	16.8	21.5	110.2	115.9	47.7	57.1	75.6	58.2	69.4	73.9	135.1	136.5	50.6	37.3	67.2	10.0	69.3	20.3	58.5	30.2	0.0	109.1	79.1	85.4	76.0	66.0	118.1	56.0	44.5	51.5	63.3	51.7	13.6	98.4	64.0	75.9	27.1	61.3	52.4	75.9	58.8	111.7	36.6	44.0	45.3	91.8	139.3	53.4	69.9	76.1	46.5	54.2	62.9
SELENOS	"AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP"	ENSG00000131871	"Selenoprotein S"	Q9BQE4	15	101270817-101277500	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 173.0;Exocrine glandular cells: 166.1;Extravillous trophoblasts: 174.9;Pancreatic endocrine cells: 185.9;Syncytiotrophoblasts: 254.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"plasmacytoid DC: 96.1"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 96.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 81.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010025	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010025: AB_1079900"	"unprognostic (1.90e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.74e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (5.19e-4)"	"unprognostic (2.42e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.66e-2)"	25.1	34.7	16.3	19.6	17.1	18.0	38.3	11.4	15.6	22.8	33.7	20.7	51.6	33.2	21.6	33.7	24.8	20.5	21.9	35.0	15.6	14.6	30.9	58.2	27.0	24.5	24.6	13.4	19.3	80.9	14.6	27.5	38.2	21.2	23.5	37.8	16.5	58.0	42.1	28.3	20.6	41.5	21.8	26.8	27.5	26.8	44.4	18.7	9.7	34.0	22.5	26.4	21.0	30.9	10.0	96.1	17.5	14.8	14.3	17.2	9.6	9.4	15.1	13.6	12.0	29.8	21.2	11.3	28.9	22.2	20.2	20.4	17.9	23.0	7.2	10.8	25.6	34.0	27.0	14.7	13.0	13.2	13.0	19.6	12.1	13.5	18.5	47.3	9.1	14.1	18.4	37.3	13.5	40.2	15.9	15.0	9.6	12.1	81.9	21.6	15.2	6.6	14.2	10.3	36.4	9.8	8.5	11.1	15.7	20.3	22.7	7.6	19.3	20.1	19.0	40.2	18.7	14.2	20.7	15.9	19.1	12.5	25.6	21.9	59.5	49.7	10.4	20.8	10.9	22.9	17.5	10.8	12.3	16.0	12.9	15.4	10.0	12.4	17.2	9.3	7.0	9.4	14.0	3.7	14.3	14.8	96.1	10.9	9.6	16.3	17.1	11.4	15.6	15.6	14.6	24.6	13.4	21.2	18.7	110.2	99.5	0.0	0.0	0.0	0.0	0.0	0.0	104.4	118.3	146.5	0.0	113.3	26.6	173.0	0.0	0.0	0.0	0.0	166.1	174.9	0.0	0.0	27.9	0.0	109.2	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	160.5	0.0	0.0	185.9	0.0	0.0	69.8	0.0	0.0	0.0	0.0	0.0	0.0	254.0	0.0	0.0	0.0
SERP1	"FLJ43424, RAMP4"	ENSG00000120742	"Stress associated endoplasmic reticulum protein 1"	Q9Y6X1	3	150541994-150603228	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 122.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038970	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038970: AB_2676296"	"unprognostic (8.81e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.78e-1)"	24.5	34.2	23.1	22.4	22.6	25.4	38.0	12.5	18.4	38.6	26.7	15.6	59.9	21.4	20.2	56.7	29.6	28.1	25.1	15.1	17.4	16.5	27.7	93.6	38.1	47.8	17.5	15.6	31.5	137.6	21.1	33.0	33.2	14.7	32.9	23.8	15.6	103.1	58.9	9.7	18.1	33.5	15.6	18.9	42.9	38.4	17.8	16.0	38.4	51.3	17.3	33.6	31.2	29.8	49.6	67.9	76.4	89.1	36.8	68.2	90.5	33.1	7.1	10.9	8.2	16.0	18.8	25.0	23.7	15.3	13.0	15.3	18.5	14.6	26.8	45.8	17.1	10.8	16.2	17.6	12.2	17.3	16.5	15.2	28.4	6.2	18.7	31.3	25.6	19.1	11.2	22.0	7.5	37.7	14.2	15.1	18.3	13.8	37.9	11.0	14.3	21.6	22.3	20.4	21.0	18.5	28.2	8.3	83.3	15.7	10.7	18.8	16.0	9.1	20.1	35.9	13.7	17.7	25.1	14.6	6.2	11.4	13.3	18.2	122.2	34.9	36.0	11.3	25.2	5.7	62.2	88.3	76.4	52.9	81.8	68.2	49.6	56.9	53.3	67.5	47.9	56.7	52.1	64.4	36.8	89.1	67.9	54.3	90.5	23.1	22.6	12.5	18.4	17.4	16.5	17.5	15.6	14.7	16.0	62.5	139.6	390.1	556.3	477.8	73.3	37.8	160.5	156.6	144.5	164.0	55.0	242.2	310.0	207.9	287.5	159.5	300.1	0.0	263.4	394.7	208.5	631.9	219.9	431.3	345.7	39.7	243.7	217.3	540.1	505.4	203.4	389.3	330.7	232.6	361.6	114.7	332.1	414.1	178.9	241.5	64.5	109.9	173.1	132.7	83.4	518.0	790.1	279.9	304.6	899.5
SERP2	"bA269C23.1, C13orf21"	ENSG00000151778	"Stress associated endoplasmic reticulum protein family member 2"	Q8N6R1	13	44373665-44397714	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 40.7"	"Group enriched"	"Detected in many"	13	"Early spermatids: 499.5;Late spermatids: 180.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 5.9;SH-SY5Y: 8.3;U-2197: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038970	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038970: AB_2676296"	"unprognostic (6.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (1.48e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	1.7	3.2	30.0	2.0	34.1	0.8	4.0	14.3	40.7	2.7	2.3	3.9	1.3	4.2	4.8	12.4	1.7	3.0	1.8	14.6	24.8	20.9	2.6	1.8	2.0	2.3	19.0	15.6	5.9	2.8	1.9	2.4	1.2	10.1	4.1	2.1	2.0	2.0	5.8	1.4	1.4	3.2	3.4	10.4	1.1	2.4	15.3	6.4	1.2	2.1	0.4	2.1	1.4	1.0	0.0	0.0	6.0	0.0	1.3	0.3	0.2	0.0	0.0	3.4	0.0	0.5	2.9	0.0	0.6	1.0	3.7	2.5	0.0	0.0	0.0	2.9	2.7	0.0	0.1	0.0	0.0	3.6	0.0	0.1	0.6	0.0	0.2	3.2	0.1	0.0	0.4	0.0	2.6	0.0	0.7	0.5	0.0	0.0	0.0	5.9	0.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.9	8.3	0.0	0.4	0.0	0.8	0.0	0.0	0.7	0.0	0.2	7.6	0.0	0.0	0.2	0.0	1.7	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.2	30.0	34.1	14.3	37.2	24.8	20.9	19.0	15.6	10.1	6.4	0.0	1.0	0.0	3.9	1.5	18.6	13.2	7.6	0.0	1.2	8.7	13.7	2.4	14.9	9.3	499.5	2.7	2.9	0.0	11.6	2.3	6.0	5.6	18.4	5.6	0.2	14.3	13.8	2.5	0.0	180.5	12.0	0.6	11.8	1.0	1.9	14.7	4.4	1.7	18.0	5.8	15.3	25.8	5.6	7.9	11.3	0.9	1.7	5.0	2.5	1.4
SERPINB7	MEGSIN	ENSG00000166396	"Serpin family B member 7"	O75635	18	63752935-63805376	"Disease related genes, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 16.7;skin 1: 54.6;tongue: 22.6"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 70.6;Ductal cells: 49.1;Extravillous trophoblasts: 68.8;Pancreatic endocrine cells: 169.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 46.7;fHDF/TERT166: 32.9;HaCaT: 80.4;HBEC3-KT: 25.6;HBF TERT88: 44.7;hTERT-HME1: 26.0;U-138 MG: 44.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024200	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			"Endoplasmic reticulum"	Mitochondria	"HPA024200: AB_1856730"	"unprognostic (8.66e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.55e-2)"	"unprognostic (4.03e-4)"	"unprognostic (9.11e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-3)"	0.2	0.0	0.1	0.1	0.1	0.0	6.6	0.1	0.1	2.0	0.2	0.0	0.0	0.0	0.5	0.0	2.6	0.1	1.3	0.1	0.1	0.1	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	54.6	0.1	0.0	0.1	0.0	0.3	0.3	0.0	6.7	0.1	22.6	16.7	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.7	0.0	46.7	9.4	7.1	5.3	0.0	0.2	0.0	0.0	32.9	12.4	80.4	0.0	25.6	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.6	1.1	26.0	0.3	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	44.0	1.6	0.9	4.4	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	70.6	0.0	0.0	0.0	1.4	1.2	0.0	0.0	1.2	0.0	49.1	0.0	0.0	0.0	0.0	7.8	68.8	1.1	2.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.3	2.8	0.0	0.0	169.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	19.2	5.1	0.0	0.0	2.5
SERPINH1	"CBP1, CBP2, colligen, HSP47, SERPINH2"	ENSG00000149257	"Serpin family H member 1"	P50454	11	75562056-75572783	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 165.4"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 237.4;Extravillous trophoblasts: 249.1;Fibroblasts: 319.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 118.7;HHSteC: 105.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004441, HPA029198"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		730000	"Endoplasmic reticulum"		"CAB004441: AB_627757, HPA029198: AB_10601712"	"unprognostic (3.80e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (5.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.35e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.22e-15)"	"unprognostic (2.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	38.2	20.1	10.5	29.3	10.9	1.0	54.1	5.7	8.4	39.4	16.9	6.0	10.3	6.4	32.7	16.8	17.8	23.6	21.4	29.6	11.8	7.0	18.5	11.5	35.7	13.5	17.1	2.7	48.3	13.9	5.9	11.0	69.9	23.2	26.2	11.0	13.8	7.7	16.7	9.5	12.3	9.4	57.8	12.9	14.3	14.2	12.5	13.0	7.4	36.1	8.7	8.2	38.7	165.4	1.3	5.5	5.0	1.6	7.1	7.4	2.4	5.4	18.5	34.8	71.6	54.0	49.8	15.9	50.8	34.6	38.3	48.9	98.2	28.8	0.0	46.2	118.7	0.3	33.0	23.8	15.8	18.6	2.2	4.5	3.9	18.3	19.7	105.3	0.1	0.7	59.3	16.3	36.6	12.3	47.8	52.3	2.0	8.4	1.7	17.9	43.1	0.1	7.0	30.9	20.6	4.9	2.7	19.2	4.5	9.3	10.5	0.8	11.5	31.8	5.9	9.6	56.6	14.2	6.8	27.5	39.6	33.0	26.9	12.3	2.3	2.2	0.5	17.1	0.0	53.0	5.0	1.6	0.1	7.4	1.5	6.7	1.2	5.1	5.3	5.5	1.3	5.7	4.6	0.3	7.1	0.2	4.7	4.2	2.4	10.5	10.9	5.7	8.4	11.8	7.0	17.1	2.7	23.2	13.0	35.7	30.1	6.4	237.4	72.7	2.9	29.5	5.1	9.4	18.2	24.4	55.0	184.7	0.0	59.0	1.8	84.9	20.7	0.0	10.4	249.1	319.9	138.1	9.2	8.6	78.7	6.4	58.5	154.1	6.7	2.7	152.1	16.7	42.2	15.4	21.1	19.3	26.7	20.3	113.5	24.1	1.0	90.5	199.9	9.9	10.2	38.9	138.7	12.1	24.3	59.6
SGPL1	SPL	ENSG00000166224	"Sphingosine-1-phosphate lyase 1"	O95470	10	70815961-70881173	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021125, HPA023086"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA021125: AB_1856803, HPA023086: AB_1856804"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.68e-3)"	9.6	11.2	12.0	20.2	11.4	4.9	24.4	10.8	10.6	16.2	17.1	16.0	21.9	13.3	15.5	16.8	26.7	13.5	13.4	8.3	11.3	9.8	18.2	27.1	10.4	20.1	11.9	9.5	10.0	34.6	15.4	10.2	11.3	10.4	16.1	15.6	7.6	15.0	19.5	7.6	28.6	32.5	12.1	15.7	22.9	10.3	15.3	11.0	14.7	17.6	12.8	18.0	21.4	26.8	5.6	9.7	8.9	24.8	10.9	11.5	6.6	10.7	14.4	13.9	15.9	3.8	5.0	9.2	6.3	6.8	6.9	9.0	15.6	23.9	9.7	7.5	6.4	6.7	18.2	11.9	12.8	9.9	15.5	6.4	1.0	7.3	18.6	14.5	4.2	8.8	9.4	21.7	9.3	24.5	14.7	4.3	9.2	2.8	8.5	9.8	11.9	5.1	2.8	6.3	14.3	8.0	6.6	10.6	3.6	11.1	45.7	9.5	11.6	12.7	19.5	11.6	11.4	10.1	3.0	8.3	6.3	16.5	4.8	12.1	3.5	4.8	4.5	6.2	7.8	4.4	0.6	11.5	7.9	11.5	20.3	10.4	4.7	7.5	9.4	9.7	5.6	5.7	9.0	8.9	10.9	24.8	5.4	6.8	6.6	12.0	11.4	10.8	10.4	11.3	9.8	11.9	9.5	10.4	11.0	14.9	5.4	9.9	14.9	10.9	6.5	5.6	30.6	14.7	14.8	43.6	19.6	6.6	3.3	32.5	2.3	6.4	38.8	0.0	33.2	10.9	12.4	23.9	14.9	39.5	25.3	14.3	24.1	6.2	30.2	4.5	10.6	15.9	6.8	16.2	20.8	9.3	41.0	17.3	19.1	11.5	8.2	6.5	11.4	19.9	31.5	19.8	5.3	11.4	16.2	20.4
SLC16A14	"FLJ30794, MCT14"	ENSG00000163053	"Solute carrier family 16 member 14"	Q7RTX9	2	230034974-230068999	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 4.5;Suprabasal keratinocytes: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"eosinophil: 12.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 12.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 16.7;Karpas-707: 11.5;REH: 14.3;RPMI-8226: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040518	Uncertain		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA040518: AB_10794877"	"unprognostic (2.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	5.4	5.2	7.0	2.2	11.1	6.6	4.0	14.4	16.2	6.5	4.6	3.2	1.1	1.3	4.9	3.2	5.3	4.1	3.6	3.0	6.9	8.2	1.7	2.5	2.5	1.6	6.2	8.2	10.2	1.1	12.4	1.9	1.6	6.7	5.9	5.0	12.0	20.5	4.7	1.3	13.4	1.6	4.9	4.4	10.1	1.8	2.0	1.3	1.1	2.0	3.4	3.3	3.8	4.8	0.4	0.5	12.0	0.0	0.1	0.4	0.1	2.1	1.3	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.4	3.7	1.1	0.1	0.0	6.3	0.1	2.5	0.0	0.2	16.7	0.0	0.4	2.9	0.0	0.0	3.1	0.1	3.4	0.0	11.5	0.2	0.0	1.6	2.1	0.8	0.2	2.0	14.3	0.0	12.9	4.4	1.9	4.8	1.5	3.5	0.0	0.1	0.0	5.7	1.5	0.0	0.0	0.9	2.4	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.0	0.4	0.0	0.3	0.4	0.2	0.0	0.5	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	7.0	11.1	14.4	16.2	6.9	8.2	6.2	8.2	6.7	1.3	0.0	0.0	0.0	0.6	2.3	2.9	3.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	4.5	0.0	0.0	0.5	0.0	0.8	0.8	0.0	1.0	0.1	3.2	3.5	3.1	0.3	0.0	1.1	0.0	1.7	0.0	0.0	1.8	0.7	0.0	2.8	0.5	1.1	0.0	1.0	0.2	0.2	4.1	0.2	0.0	1.6	0.2
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.6;HaCaT: 12.5;MCF7: 18.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"		Yes	No			"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: AB_2685857"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	20.7	3.7	4.9	6.4	4.3	3.7	15.0	7.5	6.6	11.1	11.6	3.6	7.9	3.5	10.1	39.1	9.4	9.5	9.2	7.0	3.5	2.4	12.2	19.5	21.1	7.0	3.5	4.7	13.6	5.7	4.5	6.7	9.7	3.3	11.6	6.1	4.6	7.7	9.7	3.6	11.0	6.8	10.5	1.8	6.9	14.4	15.4	3.4	3.5	8.6	10.3	5.5	9.7	9.4	0.6	5.9	13.7	8.7	2.2	2.2	2.5	4.0	0.2	1.7	0.8	35.6	6.9	3.1	1.5	3.0	0.6	0.8	2.3	1.8	0.5	4.2	1.7	0.3	12.5	1.7	1.4	0.4	0.3	2.3	0.8	2.2	1.0	4.3	1.4	2.9	4.6	4.7	0.2	0.9	0.6	4.8	0.2	0.4	0.7	0.2	18.8	0.1	4.1	4.1	8.6	1.9	7.1	0.3	0.4	1.0	0.5	3.5	3.9	0.8	8.3	1.5	2.4	2.2	4.1	1.1	0.8	1.7	4.4	0.0	1.3	1.2	0.1	2.0	4.8	0.6	7.2	8.7	13.7	2.1	7.3	1.5	0.5	1.0	2.2	5.9	0.6	0.5	1.1	1.7	2.2	7.2	1.0	0.3	2.5	4.9	4.3	7.5	6.6	3.5	2.4	3.5	4.7	3.3	3.4	17.9	43.8	4.5	9.1	10.4	0.8	2.5	38.2	0.0	7.9	3.5	0.0	24.4	0.0	3.1	0.4	20.2	2.5	0.0	6.4	10.1	17.3	4.2	25.3	25.9	29.3	1.6	4.1	131.3	31.9	2.4	17.5	32.9	21.9	45.1	16.0	1.5	3.7	33.6	13.4	3.4	1.0	6.5	12.8	1.1	3.4	6.8	7.3	15.9	9.1	2.6
SLC35B1	UGTREL1	ENSG00000121073	"Solute carrier family 35 member B1"	P78383	17	49700943-49709014	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048655, HPA057418"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"HPA048655: AB_2680481, HPA057418: AB_2683432"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.36e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.17e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (5.69e-7)"	"unprognostic (6.28e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-2)"	8.5	8.3	8.4	7.4	11.8	8.0	10.7	8.2	14.0	9.3	13.0	9.3	9.2	13.7	7.6	26.5	9.4	9.9	7.3	15.8	8.6	9.2	16.0	46.7	10.1	16.0	9.8	7.9	7.5	22.3	13.5	13.2	12.4	9.9	7.4	13.1	8.4	22.4	12.7	33.7	9.2	27.3	8.0	8.1	10.2	9.3	9.1	7.1	6.5	19.7	13.8	10.8	9.9	6.7	6.6	25.0	8.1	15.1	7.0	9.5	7.9	13.6	22.9	17.2	27.0	15.8	9.9	19.5	14.5	23.6	30.9	24.8	47.3	16.0	9.5	34.0	20.1	18.6	10.2	27.1	17.3	33.9	11.6	19.8	12.0	15.1	27.7	27.6	22.5	11.4	10.1	19.0	22.2	27.8	7.9	19.0	15.6	11.7	27.4	21.2	27.8	16.5	14.6	7.6	25.6	25.9	11.1	18.6	25.7	15.1	14.5	14.9	19.1	8.5	6.8	9.9	19.3	21.8	15.4	8.1	23.6	10.5	25.2	19.0	14.5	23.8	14.2	15.4	17.1	20.6	8.1	15.1	5.0	9.5	13.5	6.9	6.6	6.5	8.9	16.7	3.6	6.6	6.0	6.7	7.0	9.1	25.0	7.4	7.9	8.4	11.8	8.2	14.0	8.6	9.2	9.8	7.9	9.9	7.1	14.9	27.2	30.7	36.3	19.8	25.8	35.5	20.4	30.8	31.8	26.2	33.4	49.1	29.9	55.6	40.4	35.0	41.9	0.0	89.2	91.8	36.1	53.6	41.5	49.5	66.9	20.6	48.6	22.7	21.3	11.3	27.9	37.0	35.4	45.9	30.5	41.4	64.2	27.5	19.4	37.9	30.4	12.9	15.3	44.2	33.8	22.0	67.3	35.2	36.0	37.4
SLC39A14	"KIAA0062, NET34, ZIP14"	ENSG00000104635	"Solute carrier family 39 member 14"	Q15043	8	22367249-22434129	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport, Zinc transport"		"Disease mutation, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 135.5;pancreas: 77.2"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 491.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 66.5"	"Low region specificity"	"Detected in all"							"HPA016508, HPA056732"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA		950000	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"		"HPA016508: AB_1857148, HPA056732: "	"unprognostic (1.67e-1)"	"unprognostic (6.67e-3)"	"prognostic favorable (5.00e-5)"	"unprognostic (9.83e-3)"	"unprognostic (9.21e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.79e-7)"	"unprognostic (4.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.11e-3)"	15.0	16.1	2.6	7.7	5.4	0.1	45.5	2.4	6.1	3.6	13.7	1.9	2.8	31.6	6.7	2.8	3.9	5.6	9.8	41.1	2.8	2.4	10.4	135.5	4.8	5.3	3.7	1.9	10.6	77.2	3.0	6.4	4.0	9.2	5.1	11.4	4.1	20.2	4.4	46.1	4.4	18.2	14.1	4.7	2.3	16.2	5.9	2.8	0.7	25.1	2.1	1.4	11.3	19.0	5.0	1.8	2.5	0.5	2.9	8.7	3.9	10.4	13.9	3.9	7.8	14.0	11.8	8.5	15.0	66.5	23.5	37.1	46.2	9.9	10.4	8.5	17.6	61.2	11.5	19.2	18.7	38.8	10.8	11.0	8.3	11.1	46.5	33.3	5.7	9.1	12.5	15.3	41.6	29.1	11.9	10.4	7.5	7.2	10.7	11.9	4.8	8.6	3.6	23.7	16.6	10.7	12.3	7.3	22.2	8.6	4.5	6.6	10.3	15.3	6.6	31.0	8.7	5.2	8.3	5.7	29.2	14.9	18.4	15.4	6.2	5.6	13.6	41.3	7.6	17.0	0.0	0.5	2.5	8.3	0.1	8.7	5.0	4.8	6.3	1.8	2.6	5.7	7.6	0.2	2.9	0.1	0.8	3.8	3.9	2.6	5.4	2.4	6.1	2.8	2.4	3.7	1.9	9.2	2.8	3.0	4.8	3.7	8.8	29.7	7.1	50.1	50.9	0.0	3.4	7.0	2.0	0.2	1.7	48.7	0.4	31.6	63.6	0.0	63.9	2.1	30.9	17.2	0.0	491.4	1.5	46.1	32.0	31.9	15.9	1.8	22.2	1.6	42.2	4.6	51.4	4.6	55.6	28.8	39.3	21.4	7.4	0.0	46.7	0.0	2.4	18.3	0.5	4.9	33.7	9.8
SLC39A7	"D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7"	ENSG00000112473	"Solute carrier family 39 member 7"	Q92504	6	33200445-33204439	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053999	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053999: AB_2682338"	"unprognostic (3.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (4.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	14.7	25.1	9.0	12.1	9.5	6.1	15.8	11.9	11.9	24.7	19.8	12.2	43.3	17.3	20.1	24.6	14.4	13.6	25.6	20.7	8.7	8.9	24.6	55.1	20.2	11.6	12.6	9.6	14.4	49.2	37.1	24.2	43.8	18.8	22.8	22.9	16.8	48.0	41.7	10.4	11.3	18.8	20.1	10.6	15.2	21.1	9.5	10.7	9.9	28.2	14.4	17.0	16.6	13.9	2.6	3.4	6.2	2.8	4.2	5.1	2.1	8.5	9.9	15.2	14.1	22.9	15.7	13.3	22.9	30.1	17.8	21.0	16.2	8.3	6.4	11.2	25.5	13.8	9.7	11.5	13.5	15.9	8.1	10.2	10.9	11.6	20.8	16.6	10.8	13.2	14.8	11.4	15.7	17.0	17.6	14.2	6.8	11.9	10.5	12.2	9.7	5.9	6.3	6.5	12.5	9.1	6.4	8.9	10.6	11.9	10.7	9.9	8.0	9.3	22.0	12.5	9.6	21.3	10.1	14.0	16.4	10.0	12.2	15.2	16.5	14.5	5.7	9.9	10.3	18.1	6.2	2.4	2.3	5.1	2.8	4.8	1.8	3.2	3.9	2.3	2.6	2.9	3.3	2.4	4.2	1.6	3.4	3.0	2.1	9.0	9.5	11.9	11.9	8.7	8.9	12.6	9.6	18.8	10.7	23.8	33.3	14.5	25.7	32.1	27.2	29.7	28.1	22.7	33.0	24.4	27.5	88.4	5.0	60.8	0.6	33.7	62.8	23.3	75.1	113.6	62.0	56.4	19.7	31.1	38.7	11.1	24.3	29.4	17.0	1.9	42.6	23.9	38.8	27.9	109.3	41.2	56.0	56.2	40.3	20.1	22.2	19.4	33.9	7.9	10.6	35.8	141.1	27.4	54.4	33.5
SLC39A9	FLJ11274	ENSG00000029364	"Solute carrier family 39 member 9"	Q9NUM3	14	69398015-69462388	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007921, HPA075390"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007921: AB_1080007, HPA075390: AB_2686748"	"unprognostic (2.37e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	15.8	22.2	19.5	11.3	19.2	8.8	24.8	15.0	26.3	19.5	25.5	22.4	20.6	20.8	19.1	25.6	22.3	16.5	16.7	14.5	18.9	19.1	31.2	52.9	15.7	13.0	17.8	13.7	16.3	28.0	24.5	24.6	29.7	17.1	19.4	22.7	17.0	65.2	24.2	7.7	16.7	27.8	16.3	19.3	16.3	19.8	17.4	14.1	18.3	22.4	13.7	19.2	14.5	14.6	9.9	17.2	12.5	14.8	9.2	12.5	9.2	29.4	23.2	14.9	15.0	25.6	19.9	13.4	18.1	21.0	15.5	17.9	17.4	27.9	24.0	13.2	20.9	7.9	24.3	16.2	17.0	19.6	16.2	8.7	15.2	13.2	13.2	19.2	11.2	21.6	16.0	27.2	14.2	21.4	16.6	16.2	20.4	11.6	24.0	18.0	16.4	16.7	12.1	11.9	24.7	16.5	16.9	21.0	15.6	20.9	32.2	15.3	25.1	17.5	30.6	10.5	12.0	43.0	18.3	17.2	28.4	20.3	11.8	12.3	26.4	14.7	18.5	26.8	12.8	23.1	11.9	14.8	12.5	11.7	14.1	12.5	9.9	10.2	11.5	17.2	7.7	10.3	11.2	12.0	9.2	13.0	8.3	7.4	9.2	19.5	19.2	15.0	26.3	18.9	19.1	17.8	13.7	17.1	14.1	17.9	13.0	13.7	6.6	10.8	7.2	7.0	20.4	12.0	10.3	15.7	5.9	12.4	5.0	12.6	13.3	14.6	36.8	0.0	21.6	13.5	14.1	18.8	11.5	62.5	14.0	9.5	28.3	23.4	21.5	15.1	12.0	9.3	6.8	10.0	31.8	10.4	22.1	20.1	12.0	14.6	11.0	6.5	12.9	11.8	6.4	10.9	14.9	8.2	22.3	12.4
SLMAP	"KIAA1601, SLAP"	ENSG00000163681	"Sarcolemma associated protein"	Q14BN4	3	57755450-57929168	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 133.6;urinary bladder: 114.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 272.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002357, HPA002358"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		12000	"Endoplasmic reticulum"		"HPA002357: AB_1080023, HPA002358: AB_1080021"	"unprognostic (3.70e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.82e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.58e-6)"	"unprognostic (8.18e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.08e-2)"	10.6	10.7	7.0	22.4	11.1	7.4	12.0	10.2	7.2	26.5	50.3	5.8	24.7	9.8	43.0	19.5	44.0	21.3	15.0	58.2	6.5	5.6	8.0	7.8	8.0	7.2	6.9	6.0	21.4	5.8	16.0	8.0	7.7	6.8	47.8	12.2	8.7	8.6	37.7	26.1	9.4	23.3	133.6	6.0	7.2	27.2	14.9	6.8	11.2	11.1	12.1	6.3	114.2	26.4	5.9	5.1	15.8	5.5	7.1	5.9	4.5	22.1	12.5	10.7	15.4	16.1	16.2	14.6	20.5	21.2	14.4	13.9	30.0	33.0	14.9	9.8	16.3	25.8	12.2	19.1	27.3	18.9	16.4	10.9	25.8	17.7	23.5	15.7	25.5	14.4	11.7	21.9	17.7	33.0	18.6	16.4	15.1	21.0	13.5	14.7	7.2	17.4	13.1	16.1	16.1	24.3	7.2	11.7	14.8	29.4	24.2	6.1	7.2	26.7	20.3	12.6	14.7	11.0	16.2	19.4	15.9	12.7	20.1	26.5	15.7	26.7	20.3	14.3	22.3	14.9	7.5	5.5	15.8	5.9	3.6	4.9	5.9	4.6	5.0	5.1	4.5	5.4	5.5	13.4	7.1	3.6	2.9	5.1	4.5	7.0	11.1	10.2	7.2	6.5	5.6	6.9	6.0	6.8	6.8	35.7	34.1	6.2	37.6	81.7	24.0	272.3	33.1	29.4	29.6	31.4	47.1	15.6	16.6	39.8	28.6	23.2	38.0	0.0	29.8	10.7	23.5	70.4	3.5	20.3	13.9	30.2	13.8	16.0	19.4	17.7	30.2	18.8	27.0	11.8	24.3	98.5	46.3	29.2	67.5	24.5	32.2	51.8	116.9	81.2	26.8	64.1	13.6	23.0	23.4	106.8
SMPD3	NSMASE2	ENSG00000103056	"Sphingomyelin phosphodiesterase 3"	Q9NY59	16	68358325-68448688	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Lipid metabolism, Sphingolipid metabolism"	"Developmental protein, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;intestine: 46.4;lymphoid tissue: 73.0"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 284.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"plasmacytoid DC: 44.5"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 44.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.6;MOLT-4: 13.6;RPMI-8226: 11.3;SCLC-21H: 13.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 103.1"	"Low region specificity"	"Detected in all"			"CAB033885, HPA065535, HPA069383"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB033885: AB_1126788, HPA065535: , HPA069383: "	"unprognostic (1.21e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (5.61e-3)"	"prognostic favorable (3.86e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.85e-4)"	"unprognostic (7.87e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-3)"	3.5	2.3	6.0	3.1	18.3	1.8	1.6	9.4	15.4	1.0	9.6	2.5	0.0	46.4	1.7	0.7	1.8	2.7	17.2	1.2	8.7	3.6	0.9	3.8	2.1	3.5	2.5	5.0	2.7	1.9	0.7	10.7	0.8	3.9	2.2	5.8	4.3	2.2	0.9	1.8	8.1	42.7	1.2	1.4	3.0	18.6	4.2	4.4	73.0	1.3	1.3	4.3	1.6	1.2	0.6	44.5	6.1	0.0	0.0	0.7	0.3	0.3	0.7	0.3	0.1	0.0	0.0	5.3	0.4	0.0	0.4	0.1	2.9	0.9	0.4	0.5	0.2	0.2	1.1	0.0	0.0	0.1	0.3	0.7	0.1	2.1	0.3	0.0	0.0	9.6	0.0	0.0	0.0	0.2	0.5	0.0	0.9	0.8	0.3	0.3	0.2	13.6	2.6	0.6	4.6	0.1	0.6	0.2	11.3	0.0	0.1	13.1	2.6	0.4	1.5	0.6	0.3	1.0	0.9	0.0	0.4	0.8	1.4	0.1	2.2	1.1	0.2	0.2	0.9	0.2	1.0	0.0	6.1	0.7	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	44.5	0.5	0.3	6.0	18.3	9.4	15.4	8.7	3.6	2.5	5.0	3.9	4.4	3.0	0.6	0.0	1.4	0.1	39.5	2.5	5.1	16.0	1.2	0.0	0.0	0.0	0.0	0.9	6.0	0.0	51.1	0.0	0.8	0.2	0.3	3.7	0.0	5.0	0.2	284.4	24.8	0.0	0.6	13.0	14.1	0.0	0.0	0.0	25.6	0.8	1.2	43.0	43.2	0.0	3.3	0.0	0.0	5.4	0.3	0.9	0.0	5.0	18.7	4.7
SOAT1	"ACAT, SOAT, STAT"	ENSG00000057252	"Sterol O-acyltransferase 1"	P35610	1	179293714-179358680	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 87.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009533, HPA047171"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB009533: AB_633499, HPA047171: AB_2679967"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (7.81e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.45e-3)"	"unprognostic (7.02e-3)"	"unprognostic (4.67e-3)"	"unprognostic (9.64e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.82e-1)"	23.9	87.4	4.1	8.3	5.7	7.0	9.6	2.9	4.0	6.8	7.2	5.6	7.8	5.5	8.2	6.0	3.4	8.3	9.8	5.7	5.5	4.1	12.1	8.8	18.6	13.0	6.2	2.3	10.8	15.5	8.1	14.6	11.6	4.9	13.1	6.9	9.6	51.1	8.9	4.1	5.8	7.0	7.5	10.5	13.6	8.1	6.8	4.9	4.0	6.2	2.9	7.2	9.4	8.7	6.6	24.3	19.8	26.8	18.5	16.0	14.8	20.4	9.6	7.9	11.7	30.9	16.9	42.5	9.9	17.5	22.0	25.7	9.8	23.4	11.6	15.7	18.0	26.8	7.5	25.1	5.9	23.8	13.2	5.2	5.4	8.1	10.2	12.7	9.2	2.1	13.3	3.8	25.7	22.1	9.3	9.4	14.3	11.6	6.0	34.2	4.3	9.8	3.0	3.8	3.3	3.2	12.2	10.3	6.8	19.4	12.8	2.4	6.2	15.3	6.5	5.7	9.8	6.8	6.3	8.9	26.2	12.6	28.6	21.8	8.5	31.0	9.9	10.4	5.0	48.5	19.6	26.8	0.7	14.0	17.0	13.5	6.6	13.1	13.1	24.3	5.5	12.7	12.6	19.8	18.5	11.1	4.4	16.0	14.8	4.1	5.7	2.9	4.0	5.5	4.1	6.2	2.3	4.9	4.9	20.8	33.1	10.4	8.5	8.9	7.2	5.6	22.9	48.2	14.8	19.2	13.7	14.8	1.7	33.4	19.5	13.0	7.9	0.0	21.9	46.9	18.6	33.8	13.9	21.9	69.5	6.4	57.5	21.5	66.9	10.8	30.2	63.1	21.9	44.1	27.7	6.8	20.1	10.5	24.4	12.8	13.0	25.8	13.0	5.6	8.2	4.5	7.3	27.9	16.8	6.5
SOCS2	"CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2"	ENSG00000120833	"Suppressor of cytokine signaling 2"	O14508	12	93569814-93583487	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 123.3;monocytes: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 45.5"	"Lineage enhanced"	"Detected in many"		"granulocytes: 45.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 39.4;K-562: 31.9;REH: 75.7;THP-1: 32.6"	"Low region specificity"	"Detected in all"							CAB010356	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB010356: AB_2239660"	"unprognostic (4.16e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	"prognostic favorable (1.09e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.35e-3)"	"prognostic favorable (8.17e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.09e-2)"	25.2	14.3	2.6	5.1	4.1	3.6	39.6	2.3	4.3	37.9	14.2	2.4	23.1	4.3	38.8	21.4	7.7	15.0	15.5	12.4	4.9	3.1	14.6	28.2	22.7	12.3	3.3	1.4	14.1	7.1	18.7	26.7	21.9	11.0	33.5	6.9	7.0	4.9	32.5	12.0	3.7	10.7	36.9	3.3	4.3	12.3	10.3	2.9	12.7	12.7	7.1	4.3	15.6	21.3	0.8	0.6	45.5	0.1	8.2	11.5	5.1	0.8	1.0	4.0	3.5	2.3	4.1	4.5	4.9	17.9	3.5	1.6	39.4	1.8	0.2	0.1	4.5	1.0	9.1	20.7	1.4	4.1	15.8	0.5	3.2	0.1	0.5	3.3	1.0	6.8	6.7	1.2	4.1	5.5	0.3	0.5	2.0	31.9	0.6	0.5	0.4	0.2	1.4	11.2	0.7	1.6	75.7	0.0	0.8	1.0	1.6	6.8	8.1	1.6	2.7	12.6	4.0	0.0	32.6	0.5	10.6	0.2	0.0	2.7	0.4	0.2	0.2	0.2	2.4	6.7	45.5	0.0	2.2	8.4	0.1	11.5	0.1	10.5	7.7	0.0	0.8	10.7	6.3	0.3	8.2	0.1	0.6	6.0	5.1	2.6	4.1	2.3	4.3	4.9	3.1	3.3	1.4	11.0	2.9	8.9	64.9	0.0	42.5	16.0	3.8	4.4	0.0	4.0	31.8	21.0	3.9	28.9	53.0	10.2	7.0	46.6	15.5	0.0	32.8	4.5	32.4	113.6	23.1	9.7	11.0	65.2	7.9	123.3	11.9	14.7	84.8	9.2	16.9	188.4	14.6	1.3	9.3	17.5	95.1	17.2	0.7	77.6	40.1	2.6	7.9	9.3	29.3	13.8	15.6	25.7
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	16.4	17.7	13.3	11.4	17.1	9.9	16.8	19.9	17.6	20.3	17.2	20.9	18.1	14.0	17.3	15.1	30.5	19.2	15.5	11.4	13.9	15.3	19.0	13.5	14.8	10.6	18.0	12.2	35.3	15.8	23.6	23.1	28.3	20.5	14.5	18.8	12.0	18.5	13.3	9.4	20.1	17.8	15.1	20.8	10.7	16.0	19.8	14.1	9.7	26.2	16.0	16.5	17.4	20.9	9.3	21.0	21.1	22.1	10.2	15.2	16.0	18.4	16.8	11.6	9.7	28.4	22.2	20.1	19.4	24.9	16.8	18.3	10.5	38.7	10.2	12.4	24.6	20.4	48.5	12.5	16.5	19.6	11.8	7.3	9.4	9.5	10.2	21.4	15.5	12.7	19.9	20.0	17.4	18.9	16.0	15.3	11.0	21.9	12.7	19.1	19.9	9.7	3.8	15.6	20.9	12.2	10.8	14.1	7.8	16.7	11.3	9.4	8.8	26.2	20.1	11.8	14.5	10.3	9.2	19.4	16.4	12.7	18.8	13.5	9.2	12.6	5.7	19.6	7.7	19.6	14.6	22.1	11.9	11.5	21.6	11.0	8.9	11.6	11.6	21.0	9.3	14.2	10.7	21.1	10.2	19.2	10.8	15.2	16.0	13.3	17.1	19.9	17.6	13.9	15.3	18.0	12.2	20.5	14.1	35.7	41.3	10.3	9.6	9.4	8.1	3.7	2.5	40.2	35.2	34.9	13.7	10.9	8.3	46.0	76.8	8.7	7.7	0.0	49.5	11.1	12.2	7.8	23.2	4.4	9.7	6.4	2.4	6.7	6.5	22.6	5.8	22.2	11.8	28.9	6.2	11.3	47.8	4.0	5.6	22.6	7.9	12.9	10.3	33.1	25.8	8.0	18.2	11.4	6.0	13.2
SREBF2	"bHLHd2, SREBP2"	ENSG00000198911	"Sterol regulatory element binding transcription factor 2"	Q12772	22	41833079-41907308	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031962, HPA031963"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"HPA031962: AB_10601266, HPA031963: AB_2674090"	"unprognostic (6.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.41e-3)"	"unprognostic (9.08e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.85e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.93e-3)"	13.9	45.2	42.9	19.6	41.7	18.2	16.3	51.9	66.5	16.5	27.7	32.7	22.3	26.1	19.4	41.5	42.4	18.9	28.7	33.9	37.3	33.6	18.9	20.4	27.9	21.1	21.7	38.4	22.7	29.7	34.2	17.4	15.8	34.2	22.8	20.9	25.4	29.0	20.0	17.2	32.9	22.3	19.8	24.7	16.0	30.2	13.5	21.0	15.6	14.3	20.5	26.1	17.1	19.0	9.6	8.4	2.0	5.5	1.8	6.4	4.9	18.4	13.2	35.2	32.7	20.7	27.7	19.7	6.2	20.8	7.3	15.1	15.5	24.5	33.0	8.8	15.1	27.1	31.8	20.1	41.0	5.2	9.2	21.9	16.5	23.3	15.4	34.6	24.0	11.2	25.9	23.3	19.2	24.1	16.9	14.4	18.7	16.9	39.9	7.7	23.5	17.4	18.2	22.3	23.1	10.2	20.2	20.1	52.9	30.5	19.5	14.3	10.7	14.2	26.2	26.3	21.5	16.4	42.9	15.3	9.9	18.6	4.6	7.3	29.2	14.8	26.3	9.7	18.3	15.1	0.0	5.5	2.0	6.4	4.9	4.4	9.6	3.5	4.6	6.6	7.3	3.2	3.6	1.0	1.8	4.0	8.4	2.1	4.9	42.9	41.7	51.9	66.5	37.3	33.6	21.7	38.4	34.2	21.0	41.7	33.4	16.0	10.9	14.4	35.6	26.3	38.2	21.4	18.2	55.8	9.8	22.2	3.3	17.6	15.3	9.8	40.6	0.0	37.7	17.9	14.6	18.9	12.7	20.4	12.4	54.0	47.2	6.7	13.8	5.3	29.1	8.0	6.8	21.6	38.3	18.8	30.8	24.6	25.8	4.5	16.2	19.4	18.4	7.7	15.8	24.6	30.6	13.1	31.8	20.2
SSR1	TRAPA	ENSG00000124783	"Signal sequence receptor subunit 1"	P43307	6	7268306-7347446	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011276, HPA017062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA011276: AB_1857503, HPA017062: AB_1857505"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.79e-6)"	"unprognostic (3.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.19e-2)"	37.8	38.5	22.5	35.8	25.7	37.3	29.9	30.8	24.1	41.6	26.9	28.6	35.7	27.4	33.2	34.2	38.7	25.7	27.7	27.8	21.6	29.8	41.4	99.0	30.0	41.7	25.1	18.8	36.5	53.6	21.7	40.3	37.1	24.7	26.0	33.3	25.9	55.8	39.9	24.2	21.8	31.5	32.6	31.4	40.1	28.2	18.6	24.6	32.0	36.8	28.2	34.6	34.3	26.0	22.8	60.3	33.8	50.3	24.9	33.9	54.1	20.0	20.5	15.9	29.3	43.2	30.8	24.8	46.4	38.3	31.7	38.3	27.9	16.7	27.1	82.1	47.3	29.2	18.1	19.0	26.5	43.9	28.3	16.1	28.9	24.1	58.0	44.9	53.2	32.8	27.2	29.2	36.3	74.8	24.5	34.8	13.6	32.3	32.7	34.8	24.1	14.5	14.0	13.4	22.7	23.3	19.8	20.0	101.4	27.7	28.7	21.5	10.0	28.2	15.6	43.1	50.1	25.3	23.6	30.8	34.2	26.1	26.4	39.6	33.8	50.1	21.9	16.6	30.1	62.4	33.8	50.3	33.2	26.9	36.8	33.9	22.8	30.1	30.1	60.3	17.7	28.8	28.8	28.4	24.9	31.1	42.0	31.8	54.1	22.5	25.7	30.8	24.1	21.6	29.8	25.1	18.8	24.7	24.6	26.8	37.9	78.9	52.1	69.0	70.6	38.3	91.7	32.1	53.4	123.9	94.2	69.1	13.3	83.2	10.0	65.3	48.5	23.3	89.4	184.0	80.1	92.1	46.2	127.8	119.1	66.7	59.8	77.3	135.2	9.6	72.8	143.0	89.4	55.1	89.0	65.4	68.5	31.6	68.6	56.7	95.4	25.8	62.9	44.0	54.3	65.9	101.8	73.0	76.6	57.0
SSR4	TRAPD	ENSG00000180879	"Signal sequence receptor subunit 4"	P51571	X	153793516-153798505	"Disease related genes, Plasma proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 699.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045209	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		600000	"Endoplasmic reticulum"		"HPA045209: AB_10961407"	"unprognostic (3.56e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	"prognostic favorable (1.76e-4)"	"unprognostic (8.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.04e-3)"	"unprognostic (5.74e-3)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (5.51e-6)"	"unprognostic (8.18e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.33e-2)"	17.4	30.0	13.2	29.5	22.6	37.5	46.0	12.2	20.6	30.4	31.7	9.0	152.0	30.7	19.1	81.4	21.4	18.3	30.2	40.7	23.0	17.7	21.8	48.0	42.1	136.9	14.5	11.6	18.4	699.0	7.2	67.7	30.3	26.0	24.0	24.0	11.7	83.7	192.6	12.1	16.9	24.1	19.5	26.3	37.9	43.6	19.6	8.2	15.3	22.6	21.0	29.4	27.7	20.0	67.1	171.0	50.7	58.6	62.0	78.7	108.1	34.3	44.2	15.0	84.3	81.0	43.1	31.4	29.4	43.6	30.6	41.8	54.9	30.5	49.0	77.9	44.5	27.6	34.1	26.1	27.3	11.2	19.9	22.4	13.8	41.5	43.1	70.1	37.9	36.8	53.7	38.0	26.3	35.9	27.0	32.8	24.5	15.1	104.1	23.7	61.5	21.5	56.5	9.1	93.4	72.1	24.3	19.5	90.7	38.6	41.0	29.3	24.2	17.5	30.2	31.8	17.1	19.5	81.8	27.2	18.0	20.0	34.7	38.1	154.6	75.5	57.4	38.3	64.8	30.1	50.7	58.6	26.1	63.6	44.4	78.7	67.1	65.5	62.9	58.5	56.6	57.0	58.4	9.3	62.0	35.5	171.0	47.9	108.1	13.2	22.6	12.2	20.6	23.0	17.7	14.5	11.6	26.0	8.2	154.9	288.1	268.7	274.5	228.5	46.7	258.0	412.7	216.8	227.5	301.8	53.0	273.1	142.6	480.5	402.2	256.1	483.1	163.5	550.9	548.3	330.2	594.2	342.0	631.0	408.8	33.4	718.3	247.4	326.6	1155.6	311.8	347.4	1354.7	339.0	538.4	117.5	526.9	501.2	232.3	335.7	57.8	116.4	210.1	119.2	239.9	281.7	472.2	373.9	490.6	402.8
ST8SIA6	SIAT8F	ENSG00000148488	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6"	P61647	10	17318383-17454330	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.5"	"Group enriched"	"Detected in some"	7	"Endothelial cells: 8.7;granulocytes: 10.3;Ito cells: 15.4;Melanocytes: 8.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 108.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011635, HPA072708"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA011635: AB_2194921, HPA072708: "	"unprognostic (4.86e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-3)"	1.8	0.9	3.1	1.0	5.0	4.0	14.4	2.5	3.4	1.1	1.7	3.3	0.4	1.0	1.6	10.4	2.4	1.3	1.9	9.1	3.7	4.4	2.5	2.4	17.5	0.8	8.8	1.7	1.1	0.5	0.3	1.3	3.5	5.5	4.3	1.8	13.7	1.9	0.6	2.0	2.8	1.3	1.3	4.3	1.5	1.0	1.2	2.5	0.0	1.8	0.5	2.0	1.1	3.9	0.9	0.7	3.8	1.4	2.1	5.6	0.9	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	13.3	0.0	0.1	0.0	0.0	108.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.1	0.9	1.3	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.4	1.3	2.5	0.4	0.5	0.3	1.2	1.4	0.7	0.9	1.0	1.7	2.9	2.1	0.7	0.6	5.6	0.9	3.1	5.0	2.5	3.4	3.7	4.4	8.8	1.7	5.5	2.5	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.7	0.0	0.0	0.0	0.0	0.2	1.6	10.3	0.0	0.1	0.0	0.0	15.4	0.8	0.4	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.0	0.0	0.0
STARD3	"es64, MLN64"	ENSG00000131748	"StAR related lipid transfer domain containing 3"	Q14849	17	39637065-39663484	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"SK-BR-3: 89.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017021, HPA024307, HPA073948"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB017021: , HPA024307: , HPA073948: "	"unprognostic (1.11e-1)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.92e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.25e-3)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.51e-3)"	"unprognostic (3.00e-2)"	22.2	34.8	23.3	27.5	28.0	33.5	22.8	27.7	30.1	17.1	23.7	38.1	21.7	26.6	20.6	20.7	22.4	25.6	27.7	17.8	21.0	16.8	18.2	24.0	27.0	31.5	28.5	25.7	21.5	32.7	21.9	23.7	26.9	25.7	19.0	9.7	17.9	21.4	26.7	20.8	24.5	34.2	15.8	27.8	32.3	25.3	26.7	26.1	33.0	21.1	15.1	24.8	28.8	18.7	15.3	23.2	35.3	21.2	21.4	25.3	17.4	7.9	12.6	5.7	10.1	6.9	8.4	8.5	6.5	8.5	8.5	7.8	7.4	13.1	7.1	14.2	5.9	10.5	15.2	3.4	7.7	1.9	9.6	12.9	4.8	5.5	8.6	9.7	9.7	10.8	9.1	6.3	9.6	4.6	6.5	8.2	9.9	11.1	9.2	7.8	7.0	9.1	9.2	6.3	5.4	6.9	7.2	9.8	10.5	5.8	9.0	7.2	7.7	4.9	89.9	16.1	4.0	10.6	11.6	7.7	12.0	8.3	13.1	12.2	8.8	10.8	5.7	10.7	10.5	12.3	12.5	21.2	29.3	25.3	19.6	18.5	11.9	18.3	19.0	23.2	15.3	18.4	16.9	35.3	21.4	15.6	10.8	20.4	17.4	23.3	28.0	27.7	30.1	21.0	16.8	28.5	25.7	25.7	26.1	3.0	9.8	21.7	11.2	14.7	13.5	3.0	20.4	5.3	3.4	10.4	35.3	24.1	8.3	20.7	2.3	23.3	21.4	0.0	30.9	31.1	16.0	17.5	18.5	10.6	45.2	17.5	26.4	42.4	36.6	4.1	15.8	20.8	5.0	17.2	11.7	17.0	30.5	15.8	12.4	8.7	13.2	12.9	9.5	8.4	13.9	14.8	33.4	34.8	12.4	16.9
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306026-76311599	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 12.0;Ductal cells: 5.3;Enterocytes: 4.9;Exocrine glandular cells: 3.5;Pancreatic endocrine cells: 3.5;Paneth cells: 3.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.0;Karpas-707: 31.5;U-266/70: 20.4"	"Low region specificity"	"Detected in many"							"HPA011952, HPA012849"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	16.1	1.2	0.1	0.7	0.0	1.9	3.7	0.0	0.5	1.2	2.7			1.2	2.3	0.0	1.6	1.2	1.0	7.1	0.0	0.5	0.7	14.3	2.6	0.0	0.3		1.3	1.9	0.4	0.2	1.2		2.1	1.6		1.2	1.1	34.5	0.0	3.9	2.4	0.6	0.0	2.3	0.5			0.1		0.0	3.4	1.4	0.2	3.2	5.9	3.6	3.7	3.6	1.4	3.8	1.8	0.2	2.4	5.3	1.4	3.3	4.2	2.5	1.6	1.9	1.8	4.5	0.0	3.4	2.7	3.7	2.4	0.7	0.9	0.6	15.0	1.0	0.2	2.3	2.2	0.7	2.1	2.8	0.8	2.7	1.3	0.7	4.1	0.0	0.0	0.1	31.5	2.8	2.5	0.2	1.8	0.4	2.7	2.0	0.0	0.9	2.6	0.9	1.9	0.8	4.4	3.3	4.2	0.0	0.4	1.1	0.7	0.7	3.2	2.0	7.5	2.3	20.4	3.7	0.0	4.4	1.4	1.0	0.3	3.6	5.9	2.7	3.3	1.7	0.2	3.6	3.4	3.2	0.0	0.6	1.1	0.7	3.7	1.6	0.2	0.6	1.4											0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	4.9	0.0	3.5	1.1	0.3	0.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	0.0	3.5	3.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	1.5	0.6
STC2	STC-2	ENSG00000113739	"Stanniocalcin 2"	O76061	5	173314713-173329503	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 68.5;pancreas: 51.8"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 33.9;Ductal cells: 28.6;Extravillous trophoblasts: 43.0;Leydig cells: 21.3"	"Cancer enriched"	"Detected in all"	6	"breast cancer: 91.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 115.7;T-47d: 109.8;U-138 MG: 45.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA045372	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		15000000	"Endoplasmic reticulum"		"HPA045372: AB_10961040"	"prognostic favorable (7.40e-5)"	"unprognostic (2.40e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-3)"	"prognostic unfavorable (1.76e-6)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (5.28e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.17e-8)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (8.56e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.93e-3)"	3.6	0.7	0.3	1.4	0.8	0.2	68.5	0.4	2.4	6.5	2.4	0.1	1.4	0.5	1.6	2.4	3.1	1.3	5.8	17.4	0.9	0.4	1.7	0.6	17.3	0.7	2.4	0.0	2.0	51.8	1.5	1.2	12.1	2.8	3.0	0.6	0.1	0.6	5.7	10.8	7.4	1.7	8.8	7.1	14.8	2.2	0.8	1.0	0.0	4.5	0.7	0.4	9.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	1.8	0.3	1.5	5.6	2.4	15.4	26.4	26.3	6.7	13.0	8.4	4.3	0.0	4.0	15.6	34.7	2.4	3.9	8.2	11.8	0.0	2.2	0.0	2.8	5.6	35.2	1.8	0.5	5.1	13.2	15.6	1.1	31.3	1.8	5.5	0.2	0.0	115.7	4.7	0.0	0.0	0.9	2.5	8.9	0.0	3.9	3.0	0.0	0.4	4.2	1.1	1.1	0.1	4.6	1.2	109.8	1.8	16.8	45.4	0.1	26.4	5.5	5.1	2.7	1.2	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.4	2.4	0.9	0.4	2.4	0.0	2.8	1.0	0.0	0.0	0.0	0.2	4.4	10.0	12.1	0.0	0.0	0.0	0.0	0.0	33.9	0.0	28.6	0.5	10.5	0.0	0.0	11.2	43.0	20.0	0.3	0.0	0.0	4.5	0.0	6.9	3.1	0.0	1.1	21.3	0.2	10.1	0.0	0.0	1.1	12.1	0.0	0.4	4.1	2.2	0.0	2.7	0.9	1.0	5.5	18.3	0.0	0.0	0.0
STIM1	"D11S4896E, GOK"	ENSG00000167323	"Stromal interaction molecule 1"	Q13586	11	3854527-4093210	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA011088, HPA012123, CAB037128, CAB037288"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		4900000	"Endoplasmic reticulum"		"CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882"	"unprognostic (2.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	20.8	9.9	15.5	28.9	19.9	23.1	53.1	14.1	16.8	20.5	21.2	8.5	16.5	9.2	20.6	20.3	35.1	19.8	35.6	14.3	10.3	10.5	13.2	29.0	21.6	34.0	7.7	10.3	21.7	21.2	27.7	9.4	18.1	9.0	18.2	13.7	23.5	46.9	17.0	49.4	22.1	16.0	22.5	8.7	23.2	15.6	20.1	6.0	39.7	34.2	26.6	23.4	19.5	21.7	11.1	8.5	17.1	20.6	17.6	18.2	13.3	14.9	19.4	6.1	10.6	29.0	25.2	8.4	13.5	13.7	9.6	11.9	8.7	5.0	15.9	14.0	18.6	20.1	27.4	7.7	7.9	8.0	13.0	11.6	25.6	7.4	13.1	23.6	20.6	14.9	28.6	19.7	14.0	34.4	13.1	12.5	21.7	15.5	30.3	9.9	3.4	19.4	7.5	2.4	8.3	6.9	4.9	8.7	14.9	15.2	8.8	1.2	5.6	19.2	12.3	7.2	10.3	4.6	11.7	12.8	17.7	5.9	17.2	9.2	32.8	24.7	8.1	14.7	8.7	10.1	12.4	9.5	17.1	17.3	13.0	13.9	7.3	12.6	18.2	8.5	11.1	14.3	12.8	15.2	17.6	20.6	7.5	12.8	13.3	15.5	19.9	14.1	16.7	10.3	10.5	7.7	10.3	9.0	6.0	14.9	8.0	10.3	6.0	14.5	4.9	3.9	12.7	9.4	5.7	5.2	13.7	20.7	1.7	12.2	3.6	14.7	8.6	0.0	12.5	11.0	12.4	10.5	28.9	28.0	13.7	15.9	8.7	20.3	19.4	4.9	25.3	12.4	16.9	5.4	12.9	16.9	10.2	3.5	10.6	3.5	3.6	25.8	18.1	20.9	8.1	19.4	14.5	22.0	7.5	10.3
STMN2	"SCG10, SCGN10"	ENSG00000104435	"Stathmin 2"	Q93045	8	79610814-79666175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 153.3"	"Cell type enhanced"	"Detected in some"	26	"Horizontal cells: 139.8;Intestinal endocrine cells: 23.8;Rod photoreceptor cells: 40.3"	"Group enriched"	"Detected in many"	5	"glioma: 26.1;pancreatic cancer: 10.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 5.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.6"	"Cell line enriched"	"Detected in some"	9	"SH-SY5Y: 123.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026922			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA026922: AB_1857605"	"unprognostic (4.41e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.20e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-13)"	"unprognostic (1.14e-1)"	"unprognostic (3.86e-1)"	"unprognostic (5.77e-3)"	"unprognostic (9.59e-2)"	1.7	35.4	35.2	5.6	35.0	1.4	2.5	99.8	153.3	5.3	10.7	4.2	0.0	7.7	1.9	1.3	1.8	1.4	3.0	1.3	40.3	71.9	1.4	1.8	1.5	1.6	44.7	60.4	1.4	3.2	1.4	1.5	1.4	102.4	2.5	14.2	2.6	1.7	2.1	1.3	6.4	9.8	4.3	19.0	3.1	2.4	2.2	6.6	0.0	1.3	0.0	1.9	1.5	0.9	0.0	5.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	123.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	5.6	0.0	0.0	35.2	35.0	99.8	68.3	40.3	71.9	44.7	60.4	102.4	6.6	0.0	0.0	0.0	0.0	0.9	18.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.8	139.8	23.8	0.0	0.0	8.1	0.3	0.0	1.7	0.0	0.0	17.0	1.1	0.0	0.0	0.0	40.3	0.0	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3B, catalytic subunit of the oligosaccharyltransferase complex"	Q8TCJ2	3	31532638-31637622	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		9300	"Endoplasmic reticulum"		"HPA036448: AB_2675129, HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	23.0	30.3	16.0	27.5	16.7	21.7	27.4	15.4	19.4	28.4	25.0	16.9	37.0	18.6	28.4	37.9	28.8	22.4	29.0	27.5	15.1	15.6	28.2	64.1	30.1	36.9	16.5	15.5	62.3	39.4	36.2	20.3	85.9	16.5	26.3	25.1	22.3	25.2	26.3	31.2	19.2	29.2	23.2	19.7	29.4	22.9	36.7	13.6	60.2	44.3	23.4	30.3	27.5	27.7	3.6	7.7	8.4	5.3	8.4	8.5	3.0	16.6	28.0	25.8	27.0	32.5	32.8	56.4	31.3	27.5	23.4	27.2	25.5	36.2	29.0	15.4	28.3	19.3	14.1	23.8	27.1	30.8	81.6	15.7	24.8	28.5	27.1	25.1	53.5	29.7	25.1	29.1	33.3	42.2	36.2	23.6	37.2	13.3	46.5	31.8	9.4	52.3	33.1	20.8	27.9	15.8	54.7	14.0	42.0	27.2	24.1	11.0	13.4	31.0	46.1	18.1	23.0	20.7	28.6	45.9	31.7	20.3	31.3	27.5	29.3	35.1	24.3	28.7	36.8	26.0	2.3	4.6	8.4	4.7	5.3	7.5	3.4	8.5	6.5	4.0	3.6	8.2	6.5	1.7	8.4	3.7	7.7	4.1	3.0	16.0	16.7	15.4	19.4	15.1	15.6	16.5	15.5	16.5	13.6	80.4	51.9	42.7	51.5	60.6	48.3	64.1	56.0	40.2	88.7	41.8	64.8	58.7	11.6	32.8	125.1	35.0	40.6	0.0	38.9	84.1	47.2	61.2	31.1	58.2	50.2	42.9	43.4	38.6	46.8	186.1	33.6	58.1	49.0	9.0	50.8	36.3	38.5	49.1	30.8	26.4	33.6	25.8	38.9	61.2	52.7	54.1	79.8	62.1	51.2	55.9
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134533	"Enzymes, Predicted membrane proteins"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	13.8	20.8	11.0	33.0	15.3	13.8	14.9	13.3	19.3	15.1	14.2	21.0	20.2	13.2	16.0	21.1	14.4	16.1	15.3	12.9	11.3	10.0	16.4	78.0	14.2	28.9	18.2	8.7	17.1	68.1	24.4	21.0	20.9	14.4	15.0	15.4	13.3	48.9	22.6	16.7	14.4	19.6	13.6	12.8	27.1	18.3	14.4	14.9	10.3	23.5	8.0	42.2	13.3	12.6	17.5	13.0	11.6	5.4	2.2	5.5	3.8	8.6	11.1	6.7	9.0	17.1	9.8	6.7	9.0	9.3	11.5	8.2	6.0	15.2	49.0	12.3	11.5	15.2	13.5	7.3	9.1	9.5	7.6	5.5	7.7	12.9	13.4	20.8	11.5	14.0	12.4	16.5	10.1	23.0	10.3	7.4	5.2	9.6	25.1	6.7	12.9	5.0	8.3	7.2	9.1	7.7	8.5	5.7	19.7	7.2	8.6	4.4	9.0	8.3	20.7	14.5	6.2	15.4	7.6	7.1	8.0	5.3	14.3	6.0	50.2	34.7	56.6	10.8	5.9	8.9	11.6	5.4	9.3	5.5	3.3	5.0	15.4	3.9	5.1	3.1	17.5	2.9	3.0	5.2	2.2	3.2	13.0	3.6	3.8	11.0	15.3	13.3	19.3	11.3	10.0	18.2	8.7	14.4	14.9	14.9	21.3	22.2	6.0	15.7	10.2	3.4	33.1	9.4	20.5	10.4	31.4	11.5	1.7	10.5	4.3	8.3	15.8	23.3	16.3	12.6	12.1	13.4	1.1	60.4	13.6	12.7	8.1	14.1	14.8	3.5	19.0	11.6	11.8	6.4	25.0	10.8	17.1	12.4	12.4	7.2	17.1	12.9	7.5	21.0	10.9	14.1	35.8	10.2	14.5	11.6
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853978	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.3"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 144.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite"		NA	NA		110000	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: AB_2686513"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	10.7	7.9	3.8	20.4	5.2	6.1	8.7	3.1	4.9	6.5	12.6	4.5	1.9	9.1	8.2	3.9	10.5	6.4	9.6	6.5	3.5	3.3	6.5	6.4	17.6	26.9	6.4	3.6	5.0	4.4	3.0	3.6	8.7	6.0	9.0	5.4	6.6	9.4	4.4	7.5	15.3	19.5	5.7	5.2	24.2	12.6	5.8	4.9	20.8	13.1	8.9	20.3	6.6	7.6	22.7	8.8	45.3	10.9	14.4	25.3	21.0	2.8	1.8	0.0	1.7	0.9	1.2	16.8	1.5	3.4	7.0	9.5	0.1	3.0	6.0	4.0	1.1	6.5	5.5	1.2	2.5	0.4	10.2	1.6	6.7	1.4	2.3	4.4	0.0	2.4	1.3	2.1	1.9	1.2	0.0	1.7	2.2	0.4	5.7	0.8	1.7	1.1	13.3	0.0	0.6	2.0	5.9	1.2	4.0	9.0	0.5	0.0	0.3	1.6	4.3	5.8	0.3	3.9	12.0	0.9	2.6	1.0	6.4	0.0	7.6	10.6	1.7	1.7	4.0	1.8	27.7	10.6	44.2	15.5	10.9	16.3	22.7	17.5	16.4	8.8	20.9	25.3	19.4	45.3	14.4	10.5	7.2	21.7	21.0	3.8	5.2	3.1	4.9	3.5	3.3	6.4	3.6	6.0	4.9	23.8	29.5	66.8	38.2	66.3	4.1	5.3	35.7	8.1	17.0	5.2	0.0	3.2	5.0	68.6	0.4	41.7	52.4	0.0	65.7	73.1	29.1	47.1	26.5	9.7	45.6	14.3	16.1	26.4	22.4	0.0	12.0	40.0	21.9	144.3	54.7	32.1	71.9	35.1	9.9	5.0	3.0	6.5	44.0	0.9	0.7	66.9	4.0	91.4	30.7	39.7
TAP2	"ABCB3, D6S217E, PSF2, RING11"	ENSG00000204267	"Transporter 2, ATP binding cassette subfamily B member"	Q03519	6	32821833-32838780	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"monocytes: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.6;U-251 MG: 28.3"									HPA001312	Approved		Supported	"Nuclear speckles,Endoplasmic reticulum"		NA	NA		14000	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA001312: AB_1080206"	"unprognostic (2.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (5.22e-8)"	"unprognostic (5.32e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.71e-2)"	12.8	8.4	6.5	22.5	6.9	14.7	9.5	6.3	7.3	8.8	15.0	7.6	3.3	15.3	9.6	5.9	17.4	7.9	11.5	7.7	5.2	6.0	10.8	19.0	18.0	14.0	7.1	6.3	9.7	6.1	2.6	5.8	5.7	7.9	8.2	11.9	7.9	12.1	5.2	5.8	9.6	28.0	7.0	6.1	24.9	7.7	3.3	6.9	25.9	14.7	7.1	20.1	23.6	10.7	0.9	2.8	4.9	5.4	2.9	4.1	1.9	7.9	0.0	0.0	2.3	2.2	3.1	0.0	0.5	1.6	6.2	8.5	2.1	16.3	15.5	3.1	4.0	11.2	8.3	7.1	28.6	2.5	10.5	0.9	1.8	6.1	0.7	1.0	0.0	12.3	0.3	0.4	8.4	13.1	0.0	4.0	0.0	8.6	5.2	0.0	0.6	2.0	1.0	0.3	0.6	4.0	8.4	0.0	5.9	5.2	0.1	0.1	0.0	7.7	16.4	1.6	0.3	0.8	0.0	2.3	8.8	2.0	2.3	28.3	8.1	13.4	14.5	8.1	10.9	1.6	1.7	2.0	1.8	4.1	5.4	2.0	0.9	1.2	2.7	2.0	0.6	1.0	0.6	4.9	2.9	4.1	2.8	1.9	1.9	6.5	6.9	6.3	7.3	5.2	6.0	7.1	6.3	7.9	6.9	0.0	6.9	28.3	12.0	0.0	4.5	2.4	2.5	2.7	6.8	14.0	2.0	1.2	1.7	33.7	0.0	28.7	19.3	0.0	28.6	35.6	4.1	11.3	4.7	5.8	22.4	17.5	3.5	16.0	12.3	0.0	5.2	14.5	0.0	92.8	18.4	18.9	27.4	13.9	5.6	4.7	4.8	0.0	7.5	0.4	1.2	0.0	1.4	24.5	10.3	14.8
TCL1A	TCL1	ENSG00000100721	"T cell leukemia/lymphoma 1A"	P56279	14	95709967-95714196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"blood: 179.4;lymphoid tissue: 63.7"	"Group enriched"	"Detected in some"	5	"B-cells: 166.3;Spermatogonia: 48.5"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 64.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	381	"memory B-cell: 45.6;naive B-cell: 179.4;plasmacytoid DC: 79.8"	"Group enriched"	"Detected in many"	487	"B-cells: 179.4;dendritic cells: 79.8"	"Group enriched"	"Detected in some"	157	"Daudi: 71.1;REH: 92.4;U-698: 94.4"					"Not detected"	"Not detected"			"CAB004045, HPA016604"	Enhanced		Enhanced	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB004045: AB_2179419, HPA016604: AB_1857859"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-4)"	"unprognostic (2.61e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.75e-4)"	"unprognostic (7.70e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.55e-1)"	0.4	0.2	0.2	53.4	0.2	4.8	0.3	0.2	0.2	0.2	0.9	0.0	0.2	0.0	0.3	0.0	0.8	0.3	0.6	0.3	0.2	0.2	1.1	0.4	3.2	63.7	0.2	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.4	0.2	0.1	2.9	0.0	0.2	0.2	10.4	0.1	0.2	33.5	0.5	5.3	0.0	4.7	0.8	1.2	53.6	3.6	0.3	179.4	79.8	0.2	0.1	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.5	94.4	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	45.6	0.0	0.0	0.1	179.4	0.1	0.0	0.2	0.0	0.1	79.8	0.0	6.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	2.2	166.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	20.6	48.5	0.0	0.0	0.0	0.0	0.0
TECR	"GPSN2, MRT14, SC2, TER"	ENSG00000099797	"Trans-2,3-enoyl-CoA reductase"	Q9NZ01	19	14517085-14565980	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 750.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029780, HPA056488"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029780: AB_10603348, HPA056488: AB_2683149"	"unprognostic (9.73e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.60e-4)"	32.8	43.2	45.0	15.0	43.7	23.0	26.2	51.7	70.8	34.9	26.1	64.5	40.1	37.8	16.5	38.2	89.6	32.4	19.0	22.3	42.9	38.3	29.0	45.9	20.7	17.8	45.6	34.7	25.0	37.0	95.0	20.9	68.5	50.4	23.9	21.7	34.5	69.8	42.0	121.4	89.5	34.8	13.8	53.3	20.0	24.5	59.6	40.2	29.8	33.5	40.7	49.5	18.3	43.8	21.7	30.2	10.7	22.8	34.3	60.6	32.7	36.5	27.3	26.1	29.4	38.1	17.4	27.6	10.7	30.3	34.5	42.9	36.3	42.3	19.6	22.5	22.4	26.7	57.1	27.5	43.5	13.9	32.2	23.6	33.4	40.9	39.9	23.0	23.6	25.5	25.8	34.8	30.3	16.6	17.2	16.2	29.3	21.4	67.8	17.6	46.0	27.8	41.2	27.3	94.0	29.6	25.9	17.0	87.0	46.8	19.7	32.6	20.0	17.9	48.2	22.9	13.6	25.9	46.9	9.4	27.7	11.9	24.0	36.0	20.8	19.9	20.3	28.4	35.6	27.6	9.2	16.0	10.7	32.0	22.8	34.7	21.7	42.0	36.6	27.3	21.0	49.2	38.8	7.2	34.3	17.1	30.2	60.6	32.7	45.0	43.7	51.7	70.8	42.9	38.3	45.6	34.7	50.4	40.2	68.5	70.5	64.7	187.4	150.7	86.7	43.3	104.4	85.6	61.4	157.1	115.8	406.1	48.0	132.1	327.6	56.2	226.7	46.7	199.9	418.2	76.1	121.3	34.7	135.7	163.0	106.5	96.0	70.6	99.0	750.0	67.3	92.0	155.3	61.3	121.5	562.9	101.5	115.2	56.6	150.3	157.6	64.7	100.0	163.9	115.2	209.5	406.6	101.5	176.8	172.7
TLR6	CD286	ENSG00000174130	"Toll like receptor 6"	Q9Y2C9	4	38823715-38856817	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.2;brain: 16.0;lymphoid tissue: 16.2"	"Cell type enhanced"	"Detected in some"	12	"B-cells: 5.0;Hofbauer cells: 5.9;Kupffer cells: 11.8;Macrophages: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 14.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 12.5;GAMG: 12.9;RPMI-8226: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062733			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA062733: AB_2684853"	"unprognostic (9.82e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.62e-7)"	"unprognostic (4.89e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.12e-2)"	2.9	2.7	6.1	10.7	7.9	6.4	2.1	2.0	3.9	1.8	1.6	2.6	0.2	1.7	1.4	2.0	1.8	1.9	3.9	1.5	4.5	1.7	1.7	2.1	5.0	11.2	10.6	1.9	1.6	1.2	0.7	1.9	2.8	7.2	1.6	2.4	0.9	4.3	0.5	0.9	1.7	7.8	2.1	16.0	16.2	2.1	0.8	6.8	1.8	1.5	1.1	14.8	5.8	1.9	1.8	1.8	14.2	2.6	0.3	0.4	0.6	1.4	5.7	0.2	0.1	0.3	6.7	0.0	1.6	6.9	0.7	2.3	0.0	12.5	6.9	2.7	0.3	12.9	0.6	0.1	1.2	1.1	0.0	0.5	3.2	6.9	0.2	0.4	3.5	5.2	2.8	1.3	2.8	1.5	0.2	1.4	1.1	3.5	2.2	3.1	0.0	0.0	6.1	0.2	0.0	0.9	3.4	3.1	9.8	0.4	0.1	0.0	0.1	0.2	0.0	0.9	0.3	0.3	1.8	1.9	2.2	7.5	0.9	2.4	0.1	0.0	5.8	5.1	4.1	1.6	0.0	2.6	0.7	0.2	2.4	0.0	1.8	0.1	0.1	1.8	1.2	0.3	0.2	14.2	0.3	1.2	1.3	0.4	0.6	6.1	7.9	2.0	3.9	4.5	1.7	10.6	1.9	7.2	6.8	0.0	0.0	5.0	1.1	0.6	0.7	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.8	0.8	2.3	0.0	5.9	0.0	0.0	0.6	11.8	0.0	0.6	9.5	0.0	1.8	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.4	0.2	0.0	0.6	0.2	0.0	0.0	0.9
TM7SF2	"ANG1, DHCR14A, NET47"	ENSG00000149809	"Transmembrane 7 superfamily member 2"	O76062	11	65111845-65116384	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.1"	"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 176.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 22.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 22.1;RPTEC TERT1: 25.4;T-47d: 49.4"					"Low region specificity"	"Detected in all"			"HPA030691, HPA072704"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"HPA030691: AB_10602480, HPA072704: AB_2686551"	"unprognostic (1.62e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.06e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.49e-8)"	"unprognostic (8.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.44e-2)"	27.7	78.1	6.9	2.2	12.5	2.0	10.0	5.6	21.7	4.7	3.1	22.4	5.1	4.8	1.5	11.0	11.5	6.4	8.5	28.2	7.4	6.6	8.3	38.6	5.1	1.7	10.3	9.6	13.5	22.6	11.8	6.2	2.2	13.2	19.8	2.3	5.4	28.5	3.3	3.3	17.9	2.8	1.3	7.3	1.9	8.8	5.3	8.8	1.9	7.4	13.6	10.4	2.6	6.1	7.4	22.6	1.8	1.0	7.3	7.6	3.0	2.6	3.6	8.5	12.2	3.4	0.2	5.4	0.6	1.3	1.0	1.1	8.8	12.4	5.4	9.6	0.4	0.3	4.3	3.7	6.0	0.7	5.2	1.9	3.3	1.0	17.7	6.9	1.3	3.7	1.5	1.8	4.9	0.6	4.0	0.9	10.3	1.9	4.2	0.3	22.1	2.3	5.8	4.6	5.6	4.1	7.2	0.4	12.7	25.4	3.9	9.6	10.8	0.4	9.3	2.1	5.6	49.4	3.6	0.6	0.1	1.3	1.2	0.8	9.6	6.0	3.1	0.8	2.1	0.3	0.5	1.0	1.8	5.5	0.8	4.3	7.1	3.5	4.5	0.9	7.4	7.6	5.5	0.7	7.3	0.5	22.6	3.1	3.0	6.9	12.5	5.6	21.7	7.4	6.6	10.3	9.6	13.2	8.8	8.9	36.6	11.1	5.3	1.6	15.6	89.9	50.9	6.7	5.7	41.8	9.8	64.7	14.9	20.7	26.9	4.5	21.7	0.0	24.2	1.7	3.3	37.3	6.9	79.7	12.7	23.8	57.1	4.3	6.3	49.4	9.2	3.5	11.8	13.6	16.5	176.3	28.8	11.5	2.1	62.4	21.2	12.9	2.3	10.9	9.4	6.0	68.7	8.5	12.4	8.4
TMCC3	KIAA1145	ENSG00000057704	"Transmembrane and coiled-coil domain family 3"	Q9ULS5	12	94567124-94650562	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 44.2;Urothelial cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 19.2;neutrophil: 30.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 30.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 18.2;Karpas-707: 24.6;U-266/84: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014272	Approved		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"HPA014272: AB_1858059"	"unprognostic (1.03e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.11e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	10.6	4.0	10.2	7.7	20.9	8.1	9.9	2.7	9.9	11.0	19.7	32.6	6.8	13.1	6.9	3.0	6.1	5.5	4.7	4.4	14.7	10.8	7.4	3.5	5.9	3.9	25.8	7.4	5.2	2.8	5.0	4.7	15.7	17.8	7.7	15.0	7.3	5.8	5.1	20.2	7.0	23.0	7.2	25.5	11.6	6.4	2.2	20.4	0.1	12.0	3.3	5.3	7.2	5.9	2.5	1.1	30.0	3.0	1.3	1.5	1.1	4.4	0.2	1.1	0.0	0.4	1.6	8.0	0.0	0.0	0.3	1.1	0.0	1.0	0.1	0.0	0.0	4.0	11.0	6.2	7.5	1.5	2.0	1.5	2.9	0.5	0.0	0.3	0.0	6.0	1.0	1.0	4.2	6.0	6.7	18.2	0.0	0.1	24.6	0.6	0.2	0.0	0.2	0.5	1.5	3.8	0.0	0.3	2.9	1.2	9.4	0.1	0.5	0.1	4.7	0.2	5.4	0.0	0.2	11.0	0.0	0.1	0.0	1.9	11.5	16.4	0.1	2.3	0.9	1.0	6.5	1.8	19.2	1.5	2.6	0.1	2.5	0.6	0.8	1.0	1.4	0.0	1.0	30.0	1.3	3.0	1.1	0.0	1.1	10.2	20.9	2.7	9.9	14.7	10.8	25.8	7.4	17.8	20.4	0.0	2.4	6.0	26.2	18.3	1.7	1.7	5.1	0.0	0.0	7.0	0.0	12.5	0.0	1.4	4.6	12.1	44.2	0.0	3.4	2.7	3.4	12.5	0.0	0.5	3.5	0.0	11.5	21.5	13.7	4.7	1.7	11.0	3.3	22.6	11.3	0.0	7.7	18.7	1.1	8.4	0.2	6.5	3.1	0.0	1.1	14.2	5.9	4.9	5.5	78.1
TMCO1	"HP10122, TMCC4"	ENSG00000143183	"Transmembrane and coiled-coil domains 1"	Q9UM00	1	165724293-165827755	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, Glaucoma, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054768, HPA078775"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA054768: AB_2682597, HPA078775: "	"unprognostic (1.22e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (5.17e-7)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (5.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.80e-2)"	28.8	48.5	28.1	18.7	29.8	17.2	34.1	21.5	28.7	30.2	47.4	26.9	37.6	43.0	28.4	43.3	34.3	24.9	30.6	25.9	23.8	26.8	62.6	89.8	24.9	23.6	27.2	21.0	30.6	37.3	32.6	50.1	47.0	31.1	30.7	48.8	29.9	43.5	38.5	20.2	20.9	70.9	23.7	31.4	29.4	29.9	34.4	22.4	36.3	53.7	24.1	31.1	29.4	25.2	46.0	76.6	52.5	57.6	45.1	61.7	78.0	28.0	31.7	24.3	14.6	44.8	21.2	23.7	48.2	34.2	28.4	29.6	45.2	42.5	17.9	50.1	34.9	12.5	40.0	31.5	25.3	31.0	45.4	29.2	22.6	36.9	27.9	36.2	38.4	29.8	28.9	29.5	33.0	26.6	26.2	20.6	22.1	58.6	35.1	39.8	21.7	30.4	29.2	31.0	92.2	36.0	22.4	27.2	45.2	34.4	37.0	25.0	43.8	36.9	39.3	29.3	37.4	51.5	48.9	22.6	26.2	21.8	22.9	44.6	67.2	90.9	63.0	21.0	25.1	34.7	52.5	55.6	51.2	53.0	50.8	55.6	46.0	56.5	56.5	41.8	39.8	46.0	53.2	43.1	45.1	57.6	76.6	61.7	78.0	28.1	29.8	21.5	28.7	23.8	26.8	27.2	21.0	31.1	22.4	89.3	64.3	79.5	78.2	75.3	77.8	52.9	242.0	129.8	92.1	202.4	64.8	116.6	36.5	176.6	62.6	87.0	250.8	46.7	166.4	124.7	115.1	88.8	73.0	298.8	125.0	71.5	85.0	87.8	100.9	101.4	114.5	87.4	94.5	55.9	105.0	214.5	177.4	168.4	121.6	108.8	60.1	122.9	83.4	191.2	73.2	81.2	93.1	105.4	127.3	85.0
TMCO4	DKFZp686C23231	ENSG00000162542	"Transmembrane and coiled-coil domains 4"	Q5TGY1	1	19682213-19799945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA014601, HPA014620"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA014601: AB_2204302, HPA014620: AB_2669051"	"unprognostic (3.31e-3)"	"unprognostic (8.94e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (6.99e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (9.21e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-2)"	"prognostic favorable (4.12e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.81e-2)"	"prognostic favorable (3.64e-4)"	10.6	8.8	2.4	9.0	3.3	2.5	11.3	0.9	2.3	9.1	6.1	2.8	15.2	11.8	16.9	15.1	8.0	7.3	7.4	4.9	1.6	1.3	9.5	7.9	5.2	12.6	2.6	1.2	8.6	15.3	17.3	10.5	7.3	3.3	12.1	3.9	8.8	25.8	19.0	2.0	5.2	6.4	11.2	2.0	9.1	8.7	3.3	2.4	3.5	10.8	7.6	9.5	11.6	10.0	7.2	9.3	2.7	8.1	4.6	6.7	4.4	5.8	3.6	0.0	0.2	5.0	3.6	4.1	4.4	13.4	8.6	4.8	2.9	27.5	10.2	6.5	12.5	3.8	4.5	1.1	4.4	1.7	8.6	1.1	3.9	4.3	1.4	4.1	0.0	5.4	3.7	4.9	2.9	1.6	3.1	4.1	0.2	0.7	6.9	3.7	4.9	0.0	2.2	0.4	7.8	5.1	1.9	11.5	6.2	7.4	4.6	0.0	0.5	5.8	8.0	9.1	0.6	7.0	6.6	2.5	6.7	3.1	4.6	3.0	0.8	0.3	2.9	7.6	8.8	4.1	0.1	4.8	2.7	6.3	8.1	6.2	5.6	6.7	6.6	9.3	7.2	5.2	4.3	0.3	4.6	4.9	0.2	4.9	4.4	2.4	3.3	0.9	2.3	1.6	1.3	2.6	1.2	3.3	2.4	11.9	8.3	8.2	10.2	2.5	0.1	5.6	2.5	24.1	7.9	10.4	0.0	8.0	8.3	9.0	0.3	4.3	6.7	0.0	14.6	16.0	4.5	12.2	3.5	4.4	8.2	0.0	5.8	5.5	6.3	0.0	5.8	5.7	10.1	12.6	10.8	2.8	10.4	5.8	5.3	6.0	0.6	0.0	7.5	0.2	2.0	2.3	6.1	8.2	12.1	6.5
TMEM14A	"C6orf73, PTD011"	ENSG00000096092	"Transmembrane protein 14A"	Q9Y6G1	6	52671109-52686588	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072536	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"		"HPA072536: AB_2686531"	"unprognostic (6.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.56e-3)"	"unprognostic (8.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.64e-1)"	8.7	24.4	26.7	6.2	32.0	4.3	12.9	25.7	40.0	13.9	12.5	13.5	5.8	18.9	14.3	19.3	18.0	16.3	12.6	8.1	25.5	40.7	25.8	52.7	9.0	8.8	28.3	22.6	21.0	23.8	9.2	12.9	7.9	31.7	19.0	13.3	25.7	9.6	11.7	2.0	6.8	17.4	13.4	29.1	6.5	20.3	8.4	10.7	5.8	14.6	11.1	11.6	14.1	11.6	22.3	14.3	6.4	0.2	4.0	25.7	11.9	67.3	10.2	7.6	21.5	20.8	16.1	6.4	13.6	18.7	12.6	19.6	15.6	17.5	8.3	15.2	17.1	26.6	25.8	16.8	22.8	21.3	33.3	13.8	12.2	16.7	25.5	6.8	6.2	15.3	14.4	16.1	13.8	3.1	16.7	17.0	10.6	2.5	23.7	14.9	13.7	12.1	7.1	4.5	44.7	17.9	9.6	10.8	6.5	24.4	13.0	39.6	19.2	15.2	12.2	25.4	9.9	18.8	12.0	12.5	17.5	23.6	6.8	21.9	11.4	9.6	12.5	24.6	3.9	13.9	6.4	0.2	6.4	16.4	0.0	10.6	22.3	21.2	17.2	7.8	13.2	16.4	17.5	0.9	4.0	0.0	14.3	25.7	11.9	26.7	32.0	25.7	40.0	25.5	40.7	28.3	22.6	31.7	10.7	23.8	14.5	18.0	51.6	42.9	20.8	12.5	50.9	61.6	33.0	48.8	7.9	51.8	54.7	95.2	1.1	42.1	22.0	0.0	122.4	120.9	88.8	80.6	25.3	119.7	38.4	4.8	32.1	33.7	7.3	2.0	40.3	16.9	84.4	6.4	47.0	24.6	77.7	28.8	47.0	136.7	10.1	6.5	75.2	4.4	24.5	33.4	12.9	22.7	47.2	49.8
TMEM18	"DKFZp434C1714, lncND"	ENSG00000151353	"Transmembrane protein 18"	Q96B42	2	667335-677439	"Predicted membrane proteins, Transporters"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040233	Approved		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			Mitochondria	"Endoplasmic reticulum"	"HPA040233: AB_10794737"	"unprognostic (9.01e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.98e-3)"	"unprognostic (8.08e-2)"	18.9	22.1	13.7	11.3	14.4	12.9	23.4	10.0	18.7	17.6	17.4	16.0	12.0	13.9	19.3	19.5	16.1	15.6	18.1	12.3	13.4	14.5	17.3	18.1	12.2	12.5	14.8	15.6	43.7	31.7	13.2	13.5	19.6	12.3	19.2	9.5	18.3	19.5	16.5	28.3	14.2	15.5	18.4	21.9	12.5	13.4	19.1	11.4	23.9	23.1	19.7	13.8	15.0	14.1	17.3	19.7	5.8	14.4	16.2	14.8	11.2	9.8	9.4	11.6	13.1	12.9	19.8	12.3	13.6	10.8	12.2	11.6	1.8	16.1	14.0	25.6	16.7	6.3	14.0	4.7	15.7	10.1	21.8	11.3	8.2	5.6	20.2	16.6	8.2	7.4	14.1	16.0	20.7	14.1	10.5	3.7	23.8	8.3	8.7	16.3	33.2	19.1	19.8	8.5	8.6	13.9	11.1	6.2	10.6	11.2	10.7	9.6	15.6	7.9	14.6	14.7	5.3	9.8	15.3	11.6	11.2	15.3	7.4	20.5	11.6	19.0	12.1	13.7	9.1	7.8	3.7	14.4	5.8	11.3	13.8	11.8	17.3	12.5	9.2	14.9	13.6	14.8	13.9	1.2	16.2	14.1	19.7	14.4	11.2	13.7	14.4	10.0	18.7	13.4	14.5	14.8	15.6	12.3	11.4	20.8	26.2	26.8	25.3	31.9	18.7	21.3	28.1	34.8	27.3	26.2	7.9	62.0	26.6	32.1	11.2	32.9	25.7	46.7	39.9	50.7	45.7	34.7	28.9	31.8	43.3	19.1	19.0	31.9	30.8	9.1	58.7	29.1	38.8	26.2	36.8	41.0	36.0	43.2	48.1	36.3	27.2	19.4	40.1	80.7	64.7	37.8	67.9	17.3	41.4	31.5
TMEM185A	"CXorf13, FAM11A, FRAXF"	ENSG00000269556	"Transmembrane protein 185A"	Q8NFB2	X	149596556-149631912	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048295, HPA071744"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA048295: AB_2680345, HPA071744: AB_2686441"	"unprognostic (9.76e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"	4.3	5.0	6.8	4.8	6.2	1.7	4.1	7.2	8.2	5.1	3.8	3.1	7.3	2.3	6.2	7.4	5.8	5.8	5.3	12.0	4.4		4.4	3.1	3.4	3.3	3.0	3.3	13.8	5.4	7.3	4.8	10.8	6.0	5.5	3.5	6.3	4.8	7.2	4.5	6.2	3.3	6.6	3.7	7.8	2.7	12.3	4.0	3.8	3.8	4.5	4.3	4.6	5.8	5.3	7.7	12.2	5.0	13.5	10.4	6.3	11.1	11.3	13.1	7.7	17.8	12.1	5.2	11.0	13.5	11.2	16.9	6.9	19.3	13.7	24.7	12.2	15.0	14.2	15.1	10.4	12.2	8.8	11.3	7.9	13.2	7.4	12.9	11.5	8.1	11.5	17.7	11.5	7.2	13.0	9.6	10.4	3.3	8.9	8.0	18.3	7.9	7.9	9.8	5.7	12.7	7.8	19.9	7.8	12.9	14.7	4.5	6.5	8.4	14.5	14.4	12.5	7.7	6.6	11.5	8.5	7.8	15.6	13.5	8.4	7.4	20.1	15.1	13.5	11.7	2.2	5.0	12.2	10.1	3.0	9.0	5.3	7.3	10.4	7.7	5.0	10.3	9.2	7.1	13.5	2.5	5.7	9.0	6.3											6.0	1.6	3.9	10.3	9.8	13.3	9.3	2.5	9.4	2.3	14.0	5.9	23.0	3.3	4.1	0.2	10.2	5.5	0.0	8.1	9.7	19.0	9.2	5.7	6.6	9.5	17.5	12.6	23.4	12.5	1.9	21.0	6.9	13.5	19.0	6.9	12.9	8.9	8.7	22.3	4.8	8.1	45.3	14.0	6.9	15.8	17.6	14.4	8.6	5.0	14.1
TMEM185B	"FAM11B, FLJ20979"	ENSG00000226479	"Transmembrane protein 185B"	Q9H7F4	2	120221278-120223408	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048295, HPA071744"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA048295: AB_2680345, HPA071744: AB_2686441"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.44e-4)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (5.71e-7)"	"unprognostic (3.09e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	16.9	14.2	10.4	12.7	14.2	14.4	15.7	8.3	15.2	14.4	12.7	24.7	9.9	9.8	17.7	10.6	16.3	17.1	12.4	18.3	13.2	9.7	12.3	19.1	14.5	18.4	15.3	9.2	14.6	20.2	46.3	12.2	13.8	13.1	16.1	10.4	15.1	16.2	12.6	16.5	11.9	12.6	16.8	14.5	12.6	13.4	19.4	13.4	16.3	19.1	15.5	13.2	15.9	12.9	1.4	2.6	5.8	3.4	4.6	2.4	0.6	24.7	10.4	7.1	11.5	12.3	17.3	18.4	17.9	17.1	17.5	15.4	31.3	24.4	0.0	17.7	15.6	17.8	16.0	7.2	15.0	19.7	10.7	14.2	11.0	7.2	7.1	17.6	0.0	19.8	14.7	18.5	18.7	22.8	11.7	12.3	10.4	12.7	12.8	15.2	17.0	9.4	11.0	10.7	10.0	22.1	7.4	0.0	8.2	13.9	16.7	10.8	9.0	16.2	19.8	14.5	9.0	11.4	12.4	14.7	7.8	21.2	13.9	6.7	8.9	11.0	10.2	9.3	10.9	18.2	0.0	1.9	2.3	1.6	3.4	1.9	0.8	2.0	1.0	2.6	1.4	1.6	2.4	5.8	4.6	2.2	0.8	1.9	0.6	10.4	14.2	8.3	15.2	13.2	9.7	15.3	9.2	13.1	13.4	14.9	1.6	6.4	26.6	7.4	2.1	7.9	5.1	6.7	2.3	7.0	5.9	9.2	1.7	14.8	8.4	7.7	4.9	0.0	10.8	25.8	8.4	11.0	6.9	3.4	13.2	1.6	1.2	5.5	5.1	5.1	4.4	5.6	6.8	5.4	3.7	8.8	9.8	3.5	2.1	3.3	3.6	0.0	8.0	17.3	11.5	3.9	12.1	5.1	4.7	15.8
TMEM189	Kua	ENSG00000240849	"Transmembrane protein 189"	A5PLL7	20	50118254-50153734	"Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 139.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059549	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA059549: AB_2684059"	"unprognostic (3.11e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (5.79e-11)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.42e-2)"	15.1	13.9	12.0	11.0	23.8	7.7	13.6	7.9	18.1	13.0	14.5	33.7	20.5	13.2	16.3	17.3	27.0	10.0	12.3	15.5	15.0	10.7	9.1	21.0	14.3	8.3	33.1	9.0	6.5	8.9	19.8	6.5	26.1	20.7	13.3	11.5	7.9	14.6	22.0	17.1	24.3	13.2	32.2	32.1	10.4	14.5	11.3	24.9	10.0	8.5	11.7	14.8	16.0	15.4	2.0	6.2	6.3	13.9	4.1	5.8	3.9	8.6	8.0	9.6	7.5	14.6	11.0	16.0	6.1	5.8	12.9	7.3	21.6	13.9	3.2	9.9	5.8	18.5	24.2	4.8	12.4	4.7	1.7	3.6	4.1	11.6	18.4	8.2	6.6	11.3	9.3	29.1	7.2	7.6	6.3	15.4	5.5	4.2	4.7	4.3	7.6	5.2	16.8	4.6	22.3	8.4	4.3	7.3	3.4	24.3	12.8	5.0	3.3	6.9	24.1	13.8	9.8	3.8	9.5	12.1	10.9	5.6	7.0	6.0	3.5	5.8	1.3	9.4	5.0	8.7	5.3	5.7	6.3	3.7	10.8	2.9	2.0	4.1	3.1	6.2	1.9	3.5	4.1	2.3	4.1	13.9	3.9	5.8	3.9	12.0	23.8	7.9	18.1	15.0	10.7	33.1	9.0	20.7	24.9	35.7	20.7	7.5	38.4	43.6	5.5	13.7	0.0	5.3	9.1	19.2	0.0	74.8	1.7	32.6	43.7	16.1	18.8	0.0	31.5	139.1	23.8	25.4	6.9	10.6	34.3	7.9	11.5	18.4	14.6	86.5	16.4	21.1	8.5	30.7	10.2	4.1	47.3	13.3	17.0	3.8	3.6	19.4	15.1	6.0	11.5	36.9	41.9	13.8	12.7	45.7
TMEM205	"MBC3205, UNQ501"	ENSG00000105518	"Transmembrane protein 205"	Q6UW68	19	11342776-11346518	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 396.4;Hepatocytes: 417.5;Late spermatids: 488.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nucleoplasm, Nuclear membrane"	"HPA041504: AB_10795595"	"unprognostic (2.54e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.56e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	15.8	40.5	25.7	10.6	29.4	14.5	19.3	16.2	36.3	30.3	19.2	19.8	34.6	18.7	15.5	29.7	14.6	25.9	27.8	31.7	24.5	23.6	36.1	90.8	19.4	22.9	25.2	21.9	21.7	50.5	52.4	21.7	17.5	20.6	24.3	11.3	31.8	28.6	28.4	30.0	15.0	18.2	16.9	21.4	14.2	17.2	23.1	13.2	11.1	46.6	15.4	13.3	21.3	13.1	21.9	43.1	11.0	71.0	10.4	14.8	32.1	19.3	48.1	5.9	20.1	11.8	14.2	11.2	7.4	17.1	16.2	12.7	14.6	6.2	17.4	44.9	14.9	16.1	19.9	8.5	22.2	10.9	20.4	8.1	4.6	16.7	23.9	29.8	7.8	14.9	13.4	22.7	10.4	17.4	16.3	19.5	16.7	14.0	74.6	10.0	49.0	11.7	21.9	10.6	25.3	36.9	11.1	9.2	46.0	39.4	35.1	10.7	16.3	7.8	32.1	18.0	7.4	27.9	22.8	11.4	20.4	7.8	22.2	16.4	44.5	44.3	10.3	19.7	35.1	15.6	5.2	71.0	7.1	14.6	29.8	14.8	21.9	12.2	12.8	43.1	18.4	9.8	11.8	11.0	10.4	17.5	31.0	14.6	32.1	25.7	29.4	16.2	36.3	24.5	23.6	25.2	21.9	20.6	13.2	62.5	59.8	25.2	116.9	45.7	27.8	62.3	178.3	58.9	89.9	144.8	11.8	101.4	51.4	137.3	396.4	66.1	62.3	0.0	143.8	66.1	80.7	116.5	28.8	417.5	85.9	25.4	113.0	63.3	78.3	488.1	74.8	50.9	91.1	31.5	72.5	72.5	99.5	66.6	64.0	180.1	27.1	45.3	59.3	30.7	14.9	47.2	80.9	37.9	73.4	104.8
TMEM212	FLJ23172	ENSG00000186329	"Transmembrane protein 212"	A6NML5	3	171843349-171938715	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.2;lung: 10.0;ovary: 12.8"	"Cell type enhanced"	"Detected in some"	30	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 22.8;Ciliated cells: 167.3;Club cells: 46.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045736			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA045736: AB_2679436"	"unprognostic (3.39e-2)"			"unprognostic (1.78e-2)"	"unprognostic (3.05e-1)"			"unprognostic (5.54e-2)"		"unprognostic (3.06e-1)"				"unprognostic (2.87e-1)"				0.4	0.4	0.5	0.6	0.8	2.2	0.4	0.4	0.5	1.6	0.8	0.9	0.4	0.2	1.3	2.5	0.8	19.2	0.4	0.4	0.6	0.7	0.4	3.3	10.0	0.6	0.4	0.4	12.8	0.4	0.0	0.4	0.4	0.7	0.4	0.8	0.4	0.4	2.1	1.1	1.5	0.5	0.4	0.4	0.4	0.4	1.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	4.1	3.2	6.3	2.1	3.8	2.7	0.5	4.1	2.5	2.8	3.1	0.8	0.4	5.5	3.0	0.9	1.2	1.2	2.0	3.3	5.4	3.6	1.4	3.1	2.9	1.7	1.3	2.6	7.1	2.8	6.4	6.5	2.7	0.5	3.7	5.4	1.1	1.5	1.4	1.2	1.8	1.3	3.4	4.4	8.6	0.9	2.7	3.2	4.1	4.9	2.1	2.7	2.7	4.4	4.5	1.1	3.2	3.4	3.3	4.1	3.1	2.3	3.3	3.6	3.3	6.6	4.6	5.0	7.2	3.2	5.1	4.0	3.6	2.3	3.4	2.4	6.3	2.1	1.8	2.7	1.8	2.1	1.9	2.0	1.8	1.1	4.1	2.3	2.5	5.0	3.8	2.0	3.2	1.3	0.5	0.5	0.8	0.4	0.4	0.6	0.7	0.4	0.4	0.7	0.4	32.8	22.8	0.0	0.0	0.0	0.0	0.0	0.0	167.3	46.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0
TMEM214	FLJ20254	ENSG00000119777	"Transmembrane protein 214"	Q6NUQ4	2	27032910-27041695	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034551			Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Endoplasmic reticulum, Golgi apparatus, Cytosol"		"HPA034551: AB_10602481"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (2.39e-10)"	"unprognostic (1.54e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.92e-2)"	21.8	20.8	9.9	16.3	13.2	9.4	21.0	10.4	13.6	23.2	19.8	11.6	34.5	13.7	23.0	33.4	15.8	18.2	22.6	22.3	8.7	9.7	22.1	47.5	18.9	10.5	10.8	9.4	24.0	57.7	29.1	31.8	30.8	12.7	19.1	20.4	16.9	56.0	36.8	16.9	18.0	20.2	21.7	8.5	19.4	19.4	13.5	11.7	11.4	23.3	10.8	21.1	22.5	16.9	4.1	7.6	8.7	5.7	8.7	8.1	3.1	24.6	16.4	9.9	21.1	32.5	33.5	21.7	32.5	44.1	23.8	26.9	15.7	20.6	11.4	16.5	47.6	18.8	17.7	12.0	23.0	19.3	10.8	13.7	14.9	13.0	32.3	41.0	13.6	25.4	29.0	16.4	20.6	35.4	18.2	25.6	7.5	13.5	23.3	26.6	17.6	6.9	10.1	7.1	33.2	13.3	9.3	18.4	27.2	17.9	17.3	8.6	10.1	15.1	25.9	11.7	10.2	14.2	8.2	22.0	17.3	16.9	17.5	18.1	31.4	21.2	17.8	22.4	17.0	24.0	8.7	5.1	3.9	6.3	5.7	8.1	4.1	4.9	4.4	4.3	3.8	2.4	3.6	0.9	8.7	3.2	7.6	3.6	3.1	9.9	13.2	10.4	13.6	8.7	9.7	10.8	9.4	12.7	11.7	3.0	16.1	5.2	8.2	6.8	9.2	5.9	28.1	12.0	13.6	14.0	9.8	37.7	1.7	21.0	4.9	15.5	25.3	46.7	30.1	52.9	20.9	18.0	13.9	27.6	24.1	6.4	17.1	32.5	18.0	6.8	30.2	11.5	5.0	12.6	24.8	7.0	20.2	17.0	19.1	9.0	8.4	25.8	12.3	13.9	10.7	8.2	60.0	12.1	21.0	8.9
TMEM215		ENSG00000188133	"Transmembrane protein 215"	Q68D42	9	32783499-32787399	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 8.0;retina: 6.5;testis: 17.9"	"Cell type enhanced"	"Detected in some"	32	"Bipolar cells: 564.3;Early spermatids: 108.6;Late spermatids: 188.4"	"Cancer enriched"	"Detected in single"	14	"thyroid cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NTERA-2: 6.6;SH-SY5Y: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052804, HPA063207"			Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA052804: AB_2681957, HPA063207: AB_2732697"	"unprognostic (1.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.38e-3)"		"unprognostic (2.17e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"		"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-2)"		0.1	0.0	1.8	0.4	1.5	0.0	0.1	0.1	0.9	1.9	0.0	0.0	0.0	0.0	8.0	0.9	0.1	0.1	0.0	0.9	0.9	1.5	0.0	0.0	0.1	0.0	1.7	0.2	0.7	0.0	0.0	0.1	0.0	0.6	0.1	0.0	6.5	0.1	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	17.9	0.0	0.0	3.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.1	0.8	0.9	1.5	1.7	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	564.3	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	108.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	188.4	2.6	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.7	0.0	21.9	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.0
TMEM230	"C20orf30, HSPC274"	ENSG00000089063	"Transmembrane protein 230"	Q96A57	20	5068232-5113103	"Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA009078, HPA061421"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA009078: AB_1078345, HPA061421: AB_2684513"	"unprognostic (1.39e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.34e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.55e-2)"	40.0	40.4	34.3	17.1	27.9	15.6	80.9	20.2	44.8	35.7	29.9	23.2	33.3	18.7	30.2	39.0	26.0	27.4	31.4	49.7	32.7	36.1	44.6	81.0	32.9	49.2	41.1	23.1	31.5	53.5	22.4	31.5	21.8	25.8	33.8	27.9	27.4	26.8	31.0	32.4	10.6	29.4	28.1	44.3	20.6	25.8	24.0	16.4	18.8	42.5	24.9	22.2	31.5	18.9	45.6	44.7	30.5	49.2	39.1	48.2	78.3	33.3	23.5	30.9	23.2	70.0	62.5	23.6	27.1	40.8	26.8	29.7	18.5	33.4	16.0	22.3	39.1	30.6	27.8	22.9	40.4	38.9	17.8	26.3	28.3	7.3	56.8	44.8	32.7	11.8	43.1	45.2	20.5	41.3	37.5	35.2	35.8	26.4	44.4	43.8	9.5	32.9	30.6	23.5	64.2	33.6	21.4	20.7	34.3	40.2	17.2	26.1	31.7	16.3	34.3	56.3	34.8	27.4	31.3	29.5	34.9	20.4	33.4	29.0	29.7	58.9	31.3	14.0	28.3	36.5	28.4	48.1	30.5	39.3	49.2	48.2	45.6	43.1	41.9	44.7	37.9	45.0	44.3	15.6	39.1	46.1	43.8	38.6	78.3	34.3	27.9	20.2	44.8	32.7	36.1	41.1	23.1	25.8	16.4	53.6	61.3	129.3	107.8	62.5	93.4	47.8	94.3	64.3	48.9	146.5	60.9	146.0	426.1	129.1	144.0	103.4	53.5	46.7	97.3	172.4	154.3	157.7	111.9	118.4	189.6	58.8	91.9	120.3	153.8	67.6	196.5	153.1	189.0	263.3	96.8	65.8	86.4	119.7	207.2	284.9	89.9	84.1	143.4	110.9	90.6	52.9	123.8	145.1	112.1	128.5
TMEM259	"ASBABP1, C19orf6, MBRL, MGC4022"	ENSG00000182087	"Transmembrane protein 259"	Q4ZIN3	19	1009648-1021179	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042669, HPA054801"	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nuclear speckles"	"HPA042669: AB_10794916, HPA054801: AB_2682604"	"unprognostic (1.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.12e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.81e-2)"	"prognostic favorable (8.92e-6)"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.10e-3)"	39.5	39.2	35.7	42.3	39.2	46.4	36.9	54.8	44.3	35.4	41.0	46.1	33.9	43.7	39.6	27.4	37.0	34.8	38.6	43.9	34.8	26.1	37.1	59.2	40.5	44.6	44.1	30.0	38.4	59.0	43.5	55.7	47.9	40.1	41.1	23.3	47.8	49.0	36.2	39.3	62.3	42.9	30.1	27.5	61.8	48.5	36.0	40.2	38.0	47.6	24.9	45.4	37.9	37.0	3.8	6.7	2.5	5.2	2.5	5.5	3.0	36.1	23.3	16.2	18.4	20.0	19.4	28.6	30.8	26.8	25.5	27.5	21.4	20.4	25.1	30.3	23.2	12.0	41.4	16.3	30.2	11.3	32.0	27.5	14.7	28.8	23.5	35.5	28.2	37.4	25.9	30.9	20.4	25.6	24.3	22.1	25.6	24.8	50.8	16.9	15.8	30.9	25.9	24.0	18.4	19.2	35.2	12.3	31.7	20.1	34.1	22.5	23.6	19.5	24.8	21.1	13.7	24.3	36.7	25.6	25.5	14.6	35.6	32.0	72.1	27.0	27.8	30.0	23.2	25.2	0.9	3.9	2.2	5.5	3.5	4.1	3.8	3.2	5.5	6.0	3.4	3.5	3.9	2.5	2.5	5.2	6.7	3.2	3.0	35.7	39.2	54.8	44.3	34.8	26.1	44.1	30.0	40.1	40.2	29.8	50.0	37.4	47.9	55.4	118.9	11.8	33.1	5.3	18.2	62.8	92.3	47.3	10.0	22.9	16.0	38.2	90.7	0.0	29.5	40.4	37.6	50.4	15.0	43.3	44.1	98.5	38.6	31.3	21.9	8.9	39.4	40.7	42.2	27.9	67.4	75.8	34.5	56.2	32.2	18.2	165.0	32.3	46.0	45.3	38.1	56.8	68.9	41.5	49.9	59.1
TMEM45A	"DERP7, FLJ10134"	ENSG00000181458	"Transmembrane protein 45A"	Q9NWC5	3	100492619-100577444	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 118.9"	"Cell type enhanced"	"Detected in many"	9	"Club cells: 118.3;Early spermatids: 138.9;Hepatocytes: 109.4;Suprabasal keratinocytes: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.3;myeloid DC: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 94.3;ASC TERT1: 27.6;HSkMC: 29.0"					"Low region specificity"	"Detected in all"			HPA062101	Uncertain		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"HPA062101: AB_2684682"	"unprognostic (5.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.43e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.18e-11)"	"unprognostic (1.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-5)"	"unprognostic (2.68e-2)"	5.3	5.2	1.6	3.0	7.3	0.6	12.5	0.3	1.9	8.6	2.7	1.9	2.5	1.0	8.5	5.7	4.4	5.2	5.7	5.7	1.3	0.9	1.4	45.2	5.8	5.2	4.4	0.7	6.4	20.2	0.3	25.1	20.2	2.1	5.9	1.8	3.1	23.9	2.2	2.4	118.9	1.7	6.6	2.2	2.2	2.0	5.4	4.4	0.0	6.5	3.7	12.2	7.7	18.5	0.5	2.9	0.9	3.3	0.0	0.5	2.0	6.1	0.4	0.6	2.1	94.3	27.6	0.0	14.8	13.8	2.1	19.4	0.5	0.1	0.0	7.4	9.7	5.6	7.0	0.5	2.8	5.3	1.5	1.8	5.2	2.3	1.7	5.9	0.0	0.3	29.0	1.6	3.8	5.8	8.9	0.8	0.0	0.1	0.7	5.0	0.0	0.0	0.1	0.7	0.0	3.7	0.0	5.3	0.0	0.1	0.2	0.6	4.4	3.6	1.9	1.5	4.3	0.2	2.9	2.0	14.4	10.1	0.1	3.3	12.2	6.9	0.0	11.3	0.4	9.5	0.0	3.3	0.9	0.3	0.0	0.0	0.5	0.2	0.3	2.9	0.0	0.1	0.5	0.4	0.0	0.5	1.6	0.0	2.0	1.6	7.3	0.3	1.9	1.3	0.9	4.4	0.7	2.1	4.4	56.6	52.0	7.0	4.3	84.0	3.3	1.9	0.0	97.7	118.3	0.0	0.0	2.2	0.0	7.1	138.9	3.8	0.0	0.0	13.5	42.5	64.8	3.2	60.4	109.4	5.6	7.9	1.2	12.3	6.1	11.8	15.0	5.0	21.9	1.8	1.7	1.4	8.9	0.3	26.2	0.0	0.8	6.5	16.4	1.2	1.9	222.8	6.3	3.2	0.0	4.1
TMEM97	MAC30	ENSG00000109084	"Transmembrane protein 97"	Q5BJF2	17	28319095-28328685	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 228.7"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 94.3;Exocrine glandular cells: 170.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044795, HPA076689"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044795: AB_10959306, HPA076689: "	"unprognostic (1.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-2)"	2.0	11.5	3.1	2.8	3.3	1.7	3.4	2.9	4.9	2.6	4.2	2.2	1.2	4.7	2.9	1.9	3.1	4.0	8.1	1.6	2.4	3.0	2.2	33.7	12.5	3.4	2.4	2.7	8.2	228.7	1.7	0.6	2.0	7.7	6.9	3.8	3.2	1.5	2.8	5.7	3.6	3.2	3.4	4.0	1.7	13.2	31.5	1.3	4.6	1.3	3.9	2.5	12.5	6.0	9.0	13.8	1.7	2.3	8.2	10.0	4.6	9.9	25.0	48.1	23.7	6.4	9.2	15.8	9.6	6.2	15.3	20.5	70.9	7.6	27.2	10.5	3.7	31.7	10.7	30.5	16.4	12.1	12.8	21.4	10.2	13.1	30.2	5.8	16.2	8.2	18.7	2.1	14.9	6.2	1.8	4.6	17.6	21.3	20.5	5.1	16.8	25.3	15.3	21.1	40.1	6.5	20.4	52.8	24.6	18.8	45.4	34.7	15.2	15.4	12.2	7.8	28.1	21.6	7.5	3.0	16.5	13.0	14.1	17.6	16.6	32.7	24.9	3.3	11.7	9.7	0.4	2.0	1.7	7.3	2.3	8.5	9.0	6.2	8.8	13.8	5.1	10.0	9.3	0.9	8.2	0.8	8.0	5.8	4.6	3.1	3.3	2.9	4.2	2.4	3.0	2.4	2.7	7.7	1.3	8.9	43.3	13.7	5.6	12.9	11.4	6.8	94.3	16.0	17.0	14.0	15.7	19.3	13.3	16.0	18.3	4.7	3.4	23.3	170.2	63.4	9.1	12.3	1.1	86.2	17.6	3.2	37.2	8.0	6.2	38.1	12.4	8.5	15.1	18.0	13.5	7.8	60.6	0.0	10.6	4.3	8.4	6.5	6.1	87.2	53.0	9.8	8.9	7.1	27.0	7.0
TMX1	"PDIA11, TMX, TXNDC, TXNDC1"	ENSG00000139921	"Thioredoxin related transmembrane protein 1"	Q9H3N1	14	51240162-51257546	"Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003085	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		740000	"Endoplasmic reticulum"	Nucleoli	"HPA003085: AB_1080424"	"unprognostic (1.83e-1)"	"unprognostic (7.42e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (3.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.44e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.21e-3)"	21.8	24.2	13.6	18.5	18.3	15.5	19.7	14.1	12.3	14.4	20.7	17.2	27.0	17.7	17.5	19.2	25.0	13.3	15.0	11.3	13.5	11.9	24.9	29.2	20.0	25.3	22.6	9.2	15.5	23.9	18.4	19.0	21.9	16.3	14.2	21.2	13.3	21.0	27.9	12.5	16.7	23.4	17.0	24.9	29.1	18.1	12.9	17.9	37.5	23.5	17.6	17.4	20.2	19.9	9.4	17.0	9.6	17.5	12.6	12.5	13.3	13.7	12.7	17.7	9.5	14.1	11.1	19.0	17.4	14.1	17.6	22.6	12.9	25.4	19.7	16.3	11.6	8.3	13.6	31.2	11.4	32.1	19.8	10.7	14.4	11.1	12.6	12.3	33.0	14.6	13.3	10.5	11.8	8.7	12.7	15.5	16.3	11.8	13.6	16.7	17.0	14.7	17.8	20.1	21.5	16.0	15.6	32.0	11.9	17.0	18.0	11.2	8.3	13.9	9.3	12.4	12.2	13.6	14.7	10.0	18.6	17.3	13.1	15.8	12.0	12.0	16.2	8.2	18.8	17.4	9.6	15.4	7.2	10.2	17.5	12.5	9.4	10.9	10.5	16.2	7.4	10.8	12.0	5.7	12.6	12.6	17.0	12.1	13.3	13.6	18.3	14.1	12.3	13.5	11.9	22.6	9.2	16.3	17.9	35.7	23.2	35.8	51.8	96.5	10.8	6.7	48.4	37.5	36.4	33.2	11.8	67.4	8.3	51.3	2.1	45.4	23.8	0.0	59.1	119.6	52.3	42.1	41.7	33.6	66.6	9.5	16.7	39.3	52.2	3.1	23.0	71.7	52.3	61.3	31.4	24.3	42.4	52.6	26.9	27.4	31.6	58.2	50.9	43.2	74.1	85.1	48.3	58.6	44.9	56.5
TOR1AIP2	"IFRG15, LULL1, NET9"	ENSG00000169905	"Torsin 1A interacting protein 2"	"Q8NFQ8, Q9H496"	1	179839967-179877803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051849, HPA058348, HPA070542"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA051849: AB_2681637, HPA058348: AB_2683687, HPA070542: AB_2686278"	"unprognostic (1.22e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.64e-3)"	"unprognostic (3.06e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.99e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.36e-1)"	13.3	16.4	11.2	7.3	13.1	30.4	17.5	12.1	11.6	9.1	19.8	10.0	26.9	15.2	11.4	18.7	15.9	8.5	10.1	11.2	11.1	10.0	11.7	37.9	13.2	9.5	9.7	10.4	13.5	16.4	17.4	19.3	41.3	11.0	9.3	8.3	10.0	9.9	16.9	23.0	12.0	30.7	11.6	12.0	9.0	12.2	8.8	11.2	6.7	17.4	10.5	9.5	10.4	13.4	6.9	9.2	17.7	8.7	4.9	7.4	2.5	12.8	12.9	10.3	21.1	25.4	14.2	40.5	17.0	20.9	13.9	14.2	19.1	22.4	10.4	21.7	18.5	7.7	19.4	17.7	17.7	18.8	11.7	9.6	12.7	21.1	15.8	18.6	13.4	14.7	22.3	13.8	18.7	20.4	12.3	19.5	10.0	24.4	11.2	16.7	7.5	9.6	9.3	24.4	14.4	3.2	10.7	14.4	14.8	10.7	22.3	8.6	21.8	19.3	21.6	16.6	20.8	21.5	9.8	25.1	20.2	18.6	11.2	13.4	17.8	25.3	20.9	11.1	9.8	19.0	17.7	6.6	7.7	7.1	8.7	6.8	6.9	6.8	6.1	4.4	6.9	7.4	7.2	13.4	4.9	7.9	9.2	5.7	2.5	11.2	13.1	12.1	11.2	11.1	10.0	9.7	10.4	11.0	11.2	142.9	48.3	19.0	58.0	222.7	27.1	30.5	122.3	32.1	64.8	73.3	35.3	86.6	21.6	52.0	23.9	50.1	79.9	46.7	55.0	166.0	51.6	49.3	18.5	210.0	37.5	30.2	21.1	42.4	43.5	15.3	54.1	35.3	45.5	47.7	44.5	44.6	76.2	32.8	80.2	38.5	31.3	51.8	41.2	27.2	29.1	218.2	150.8	44.9	38.5	99.9
TP53I11	PIG11	ENSG00000175274	"Tumor protein p53 inducible protein 11"	O14683	11	44885903-44951306	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 23.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 85.0;T-47d: 47.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059727, HPA061276"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"		"HPA059727: AB_2684113, HPA061276: AB_2684461"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.87e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (6.55e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	33.3	8.0	20.0	13.3	10.7	19.0	27.6	36.0	26.2	14.7	21.1	8.6	17.6	13.6	16.8	10.4	15.6	21.5	28.5	33.1	8.4	12.3	12.5	7.8	21.4	12.8	5.8	8.6	18.2	18.5	3.0	9.5	16.6	14.1	20.6	19.4	17.6	18.9	11.9	12.6	14.5	21.1	23.5	7.4	28.2	18.4	9.9	5.5	6.7	18.9	12.7	14.9	15.1	19.1	5.2	14.1	23.7	11.1	4.6	4.4	2.1	0.0	17.7	6.0	8.6	6.5	0.5	0.1	5.7	11.1	2.0	2.6	1.0	0.1	3.0	4.9	1.5	4.8	3.4	3.4	0.1	0.7	6.5	3.5	0.2	0.2	0.0	12.0	0.1	23.9	27.7	0.4	2.8	1.2	0.4	6.6	6.9	0.4	0.0	2.5	15.1	0.3	27.8	11.1	11.0	5.9	13.5	3.7	1.4	0.0	1.1	85.0	3.1	9.9	21.6	0.0	7.7	47.9	1.7	1.6	13.3	9.4	20.4	0.0	0.1	0.0	0.0	0.0	1.7	3.7	0.0	3.1	0.0	3.1	3.2	4.4	4.9	0.6	3.2	2.6	5.2	0.0	1.1	23.7	4.6	11.1	14.1	0.5	2.1	20.0	10.7	36.0	26.2	8.4	12.3	5.8	8.6	14.1	5.5	20.8	25.7	5.4	31.5	9.6	0.6	6.7	22.9	9.4	14.8	40.1	0.0	47.0	1.7	26.0	74.9	13.5	12.7	0.0	18.6	15.1	11.8	25.6	0.0	0.9	32.0	0.0	34.5	80.4	10.5	322.1	11.2	9.6	10.1	13.6	24.2	0.5	28.8	7.0	7.1	0.0	0.9	12.9	12.6	2.1	6.0	3.9	57.1	4.4	45.7	36.0
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	69	"testis: 78.6"	"Group enriched"	"Detected in some"	14	"Spermatocytes: 282.4;Spermatogonia: 73.0"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.4;K-562: 8.6;Karpas-707: 7.0;MCF7: 5.1;PC-3: 5.2;RPMI-8226: 9.5;SuSa: 8.9;U-2 OS: 4.6;U-266/70: 8.5"									"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA049690: AB_2680850, HPA068342: AB_2685976"															"unprognostic (3.63e-2)"			0.1	0.0	0.0	0.7	0.2	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0		0.1	0.8	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.4	0.0	0.9	0.0	78.6	0.0	0.4	0.1	0.4	0.8	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	7.0	0.0	5.1	0.0	0.0	1.2	0.0	5.2	0.0	0.0	9.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	8.9	0.0	0.0	0.0	2.0	4.6	2.4	0.0	8.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.6	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	12.9	0.0	282.4	73.0	0.0	0.9	0.0	0.0	0.0
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 12.3"	"Cell type enhanced"	"Detected in some"	23	"Collecting duct cells: 1.8;Early spermatids: 3.5;Spermatocytes: 9.3;Spermatogonia: 2.5"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 10.1;Karpas-707: 2.9"									HPA068342			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA068342: AB_2685976"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.0	0.1	0.4	0.2	1.0	0.0	0.1	0.7	0.8	0.0	0.1			0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.4		0.0	0.0	0.0	0.1	0.1		0.0	0.1		0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.2	12.3			0.0		0.6	0.0	0.0	0.5	0.4	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	10.1	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	2.9	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.4	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	9.3	2.5	0.1	0.1	0.0	0.0	0.0
TRAK1	"KIAA1042, MILT1, OIP106"	ENSG00000182606	"Trafficking kinesin protein 1"	Q9UPV9	3	42013802-42225889	"Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 71.9;skeletal muscle: 101.1"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 240.0;Rod photoreceptor cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005853, HPA011367"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA005853: AB_1854778, HPA011367: AB_2668495"	"unprognostic (5.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.56e-3)"	"prognostic favorable (4.84e-8)"	"unprognostic (3.65e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.61e-3)"	11.3	5.9	14.7	8.3	15.7	7.6	8.6	20.5	20.1	7.1	23.5	15.4	4.2	15.5	6.1	8.0	14.9	9.6	21.9	71.9	15.1	12.4	9.5	7.7	11.0	9.8	14.3	15.6	4.1	6.5	16.8	11.0	9.7	16.2	7.8	11.9	23.8	22.9	7.7	101.1	21.6	23.7	7.9	11.7	12.2	26.9	7.0	10.6	4.9	14.4	31.9	14.2	19.1	10.5	7.1	4.8	1.6	4.3	1.7	1.8	1.1	7.5	6.6	13.1	5.6	9.2	9.0	17.2	10.2	11.5	6.7	7.3	4.3	10.7	14.8	5.4	25.3	7.3	3.6	9.1	23.5	7.3	13.4	6.5	10.2	6.7	12.1	4.6	11.6	8.1	7.7	10.1	14.8	13.6	9.7	13.4	4.0	5.2	11.9	8.5	3.1	1.2	6.1	5.7	20.6	5.1	5.4	4.9	12.4	9.2	57.0	8.5	9.9	3.9	5.7	5.4	11.4	5.1	9.8	13.7	5.8	6.9	34.8	5.9	8.9	7.5	13.4	6.4	10.2	5.6	1.6	2.5	1.0	1.2	4.3	1.1	5.0	1.8	1.5	2.8	7.1	0.8	1.8	1.1	1.7	2.4	4.8	0.8	1.1	14.7	15.7	20.5	20.1	15.1	12.4	14.3	15.6	16.2	10.6	29.8	26.7	25.6	13.5	33.8	21.5	240.0	28.1	84.3	35.2	14.0	94.2	20.3	1.7	9.5	1.0	20.2	61.3	0.0	10.9	15.7	10.1	17.2	10.4	8.5	13.4	31.8	21.9	4.3	13.9	2.7	1.7	23.7	23.6	4.6	35.6	32.5	17.2	36.5	2.5	7.9	131.7	32.3	18.4	0.7	3.6	37.8	13.2	5.3	28.1	23.2
TRAPPC2	"hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L"	ENSG00000196459	"Trafficking protein particle complex 2"	"P0DI81, P0DI82"	X	13712244-13734635	"Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004665, HPA063308"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"CAB004665: AB_425678, HPA063308: AB_2684982"	"unprognostic (1.97e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (2.13e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.35e-4)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.89e-5)"	6.5	6.4	15.6	9.5	13.7	9.5	9.4	24.1	16.1	10.5	9.4	10.1	8.8	8.2	16.4	8.7	8.5	9.4	7.6	6.4	14.4	14.2	10.1	10.1	7.8	16.1	10.4	13.0	11.7	11.2	8.9	19.5	7.2	11.5	8.9	9.1	10.2	8.1	8.3	4.9	10.3	8.8	16.0	11.5	11.1	10.7	4.3	11.1	4.3	8.8	4.2	16.4	8.1	9.4	11.2	10.7	13.7	6.6	18.5	16.1	9.0	6.8	5.3	8.2	20.9	6.3	4.8	3.3	6.4	5.5	5.1	5.5	4.5	8.5	11.6	10.3	5.3	6.7	9.0	10.8	9.2	7.0	11.7	16.2	8.6	12.5	3.6	4.8	11.8	16.6	6.3	5.2	10.9	14.9	10.3	4.5	8.5	10.8	20.0	5.2	11.3	11.6	15.6	7.9	5.7	9.5	11.4	10.8	11.3	8.0	5.1	8.7	11.6	11.8	9.5	8.2	13.0	11.8	7.9	5.9	5.2	4.6	9.2	4.0	10.3	10.1	14.5	4.8	8.4	5.2	13.7	4.9	8.6	16.1	6.6	16.0	11.2	12.8	15.8	4.3	11.1	10.8	15.5	10.0	18.5	5.4	10.7	15.3	9.0	15.6	13.7	24.1	16.1	14.4	14.2	10.4	13.0	11.5	11.1	8.9	6.2	22.8	8.2	13.5	14.5	9.8	20.4	4.0	11.4	8.7	11.8	12.7	18.3	9.2	12.6	7.7	9.1	0.0	11.8	15.8	11.6	9.3	9.2	11.3	10.0	19.1	11.6	11.1	9.5	3.8	11.8	9.5	8.5	9.0	14.7	8.3	15.9	17.6	10.6	20.2	13.6	6.5	11.4	4.5	3.3	15.4	15.0	27.7	13.4	10.5
TRAPPC2B	"MIP-2A, SEDLP, SEDLP1, TRAPPC2P1"	ENSG00000256060	"Trafficking protein particle complex 2B"	P0DI82	19	57363511-57365353	"Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 32.7;Syncytiotrophoblasts: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA063308			Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"HPA063308: AB_2684982"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.26e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.39e-2)"	14.6	23.3	13.4	9.9	17.1	11.6	17.2	23.8	16.7	11.5	12.5	6.7	12.1	7.0	12.2	15.1	15.4	11.4	13.7	26.5	18.0	14.0	12.9	14.5	12.4	15.0	11.6	14.5	15.8	9.7	12.2	16.4	16.9	18.1	14.3	7.9	9.0	11.4	10.4	28.8	11.5	8.6	12.7	15.1	14.3	10.2	31.2	9.6	12.7	17.6	16.8	13.7	15.4	9.5	26.7	21.5	32.2	13.2	22.8	15.5	13.4	9.2	7.6	10.4	6.6	9.7	10.9	9.5	6.2	14.6	9.6	29.1	3.6	7.1	7.1	9.0	8.5	16.6	3.3	5.2	10.5	10.3	3.4	36.4	7.4	12.4	8.0	10.2	7.8	11.4	11.8	13.2	7.6	5.3	11.2	7.0	8.1	2.2	0.1	11.3	2.6	11.4	6.8	3.5	0.6	15.0	5.7	9.9	10.6	10.7	14.5	11.1	8.6	6.6	6.7	5.7	9.4	10.6	10.1	7.5	8.9	7.8	4.4	10.3	11.4	14.5	14.2	12.8	4.8	9.1	32.2	13.2	16.3	7.5	11.6	14.7	25.0	15.5	12.3	14.8	26.7	15.0	12.0	15.3	22.8	10.3	21.5	13.4	13.4	13.4	17.1	23.8	16.7	18.0	14.0	11.6	14.5	18.1	9.6	8.9	12.5	0.0	0.0	0.0	0.0	20.1	0.0	24.1	18.2	17.4	0.0	32.7	21.6	26.8	0.0	0.0	0.0	0.0	19.3	17.8	10.3	0.0	19.8	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	20.8	0.0	0.0	21.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	76.9	0.0	0.0	0.0
TRAPPC6B		ENSG00000182400	"Trafficking protein particle complex 6B"	Q86SZ2	14	39147811-39170532	"Predicted intracellular proteins"	Neurogenesis		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047928	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA047928: AB_2680214"	"unprognostic (3.89e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.18e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (2.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	13.7	19.0	23.9	12.3	26.0	5.0	17.4	38.9	33.5	14.3	11.5	11.0	12.5	12.7	14.3	14.9	15.2	8.7	11.3	15.6	23.7	20.5	16.5	27.9	12.0	12.7	17.5	23.7	11.9	10.4	17.5	19.7	14.7	21.6	15.7	12.5	13.1	10.8	16.4	15.7	13.1	10.0	13.9	14.8	14.0	10.5	14.3	14.9	14.0	18.7	9.7	13.7	14.2	11.2	5.0	7.2	8.9	9.8	11.2	6.3	3.5	10.8	4.7	8.4	8.1	12.1	13.7	6.7	14.2	12.3	12.8	12.7	8.0	20.9	6.8	10.0	12.9	6.4	8.5	12.4	8.9	15.8	12.7	6.1	9.2	6.9	23.3	17.3	12.9	12.7	13.0	15.3	10.9	14.8	20.5	11.1	12.6	10.3	14.5	13.3	13.4	9.7	9.4	7.1	8.4	19.2	7.5	15.7	6.5	14.1	21.7	8.3	6.7	16.9	10.3	14.9	9.3	19.5	8.3	15.9	11.8	6.1	10.0	7.6	13.9	19.2	10.4	5.8	7.6	11.3	8.9	4.9	7.6	4.5	9.8	4.0	5.0	6.3	5.1	7.0	3.0	5.3	5.3	4.9	11.2	9.6	7.2	5.3	3.5	23.9	26.0	38.9	30.8	23.7	20.5	17.5	23.7	21.6	14.9	20.8	14.2	7.7	15.1	20.0	23.9	22.2	15.3	6.7	11.4	17.4	33.4	11.7	46.4	12.2	22.3	17.6	8.4	23.3	15.1	11.1	16.0	15.6	28.8	19.7	13.8	22.3	16.0	25.2	10.8	10.6	15.0	19.0	16.9	10.0	11.4	14.7	17.3	11.8	16.6	16.2	39.0	25.8	20.8	67.4	27.7	22.0	18.9	17.5	8.8	25.8
TRIM61	RNF35	ENSG00000183439	"Tripartite motif containing 61"	Q5EBN2	4	164954446-164977668	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 16.1;thyroid gland: 15.5"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 14.4;Late spermatids: 9.0;Spermatocytes: 18.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HHSteC: 9.7;HSkMC: 6.5;hTERT-RPE1: 5.2;SuSa: 6.9;U-266/70: 12.9;U-266/84: 6.5"									HPA049109	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA049109: AB_2680636"	"unprognostic (2.05e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.32e-2)"	2.4	5.4	1.8	3.0	2.5	3.3	1.6	1.3	2.1	2.6	1.4	1.1	7.2	2.2	2.8	1.9	0.8	3.5	3.1	5.9	2.4	3.0	1.0	1.1	2.1	2.9	2.7	1.3	5.8	0.9	1.5	6.8	1.8	3.8	2.1	1.1	2.9	0.9	1.9	1.2	1.1	1.7	2.1	4.2	4.7	1.5	16.1	1.6	2.7	15.5	0.7	2.8	3.0	5.2	5.5	5.1	3.6	1.3	7.8	4.1	1.5	0.2	0.4	0.9	0.8	0.6	0.6	0.6	2.4	0.8	0.0	0.0	0.3	0.3	0.7	0.2	3.5	0.2	0.3	0.6	0.6	0.4	0.4	0.5	0.2	0.5	0.7	9.7	0.5	0.6	6.5	0.5	2.1	0.2	5.2	0.2	0.3	0.5	1.4	0.3	0.4	0.3	0.7	3.8	0.0	0.0	0.5	0.2	1.0	0.3	0.9	0.8	0.5	0.1	0.3	0.4	6.9	0.3	0.3	0.7	1.2	0.4	0.1	0.2	12.9	6.5	0.4	0.3	0.2	0.3	3.6	1.3	0.1	3.3	1.1	3.4	3.6	1.6	3.3	1.5	5.5	4.1	4.0	0.5	7.8	0.8	5.1	0.4	1.5	1.8	2.5	1.3	2.1	2.4	3.0	2.7	1.3	3.8	1.6	0.0	3.5	2.2	0.6	0.2	0.7	1.7	0.0	0.0	0.0	3.5	3.9	0.1	0.0	0.3	14.4	0.3	0.0	0.0	0.6	0.0	0.7	0.3	0.0	0.4	1.0	1.6	0.0	0.0	0.6	9.0	1.1	0.3	0.0	2.8	0.0	2.8	0.1	0.0	1.4	2.5	0.3	0.0	0.3	18.1	3.4	0.0	0.2	2.9	0.0	0.5
TSN	"BCLF-1, REHF-1, TRSLN"	ENSG00000211460	Translin	Q15631	2	121737103-121767853	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059561	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		320000	"Nucleoplasm, Endoplasmic reticulum"		"HPA059561: AB_2684063"	"unprognostic (3.15e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (7.13e-3)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (2.32e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.18e-1)"	14.9	18.7	23.1	13.0	24.6	43.0	25.6	17.8	27.7	18.6	23.1	23.7	11.8	17.2	17.9	19.1	18.2	15.2	16.3	18.7	20.6	23.0	24.7	22.0	15.0	22.6	22.8	20.1	17.5	20.7	19.3	17.9	13.8	23.3	15.0	18.9	16.5	16.3	18.2	29.4	18.9	16.4	14.3	22.0	17.5	15.4	33.9	17.6	28.3	17.2	18.7	17.4	13.9	14.2	22.1	22.7	22.0	24.4	19.6	23.1	20.7	21.4	9.8	14.4	12.1	13.4	10.6	8.0	18.4	16.7	19.4	19.2	27.2	11.9	30.0	21.7	16.6	11.5	10.1	21.0	16.9	26.9	16.6	17.2	17.7	14.0	24.3	15.0	24.7	12.6	9.0	18.8	21.9	14.5	8.5	15.8	14.6	26.7	14.4	17.5	11.1	15.0	27.7	17.5	11.4	18.6	25.3	16.2	22.1	23.4	14.2	18.9	11.8	12.0	17.4	20.7	11.6	11.6	18.4	11.8	14.0	23.8	9.2	17.4	13.3	37.9	33.6	16.2	16.7	16.9	17.2	24.4	22.0	19.6	22.2	22.7	22.1	20.4	17.0	22.7	18.0	23.1	20.1	7.9	19.6	19.0	16.5	20.2	20.7	23.1	24.6	17.8	27.7	20.6	23.0	22.8	20.1	23.3	17.6	29.8	26.1	37.9	30.5	34.8	31.1	31.9	35.7	21.4	25.0	40.1	21.6	29.5	36.5	47.5	50.8	37.3	18.6	23.3	52.8	29.2	29.4	23.8	39.3	39.9	31.5	15.9	19.1	60.8	29.8	10.8	33.6	31.9	64.1	36.9	25.3	80.9	38.3	21.0	29.4	48.2	26.8	25.8	37.1	109.7	104.5	38.3	23.8	36.3	34.9	22.0
TTC39B	"C9orf52, FLJ33868"	ENSG00000155158	"Tetratricopeptide repeat domain 39B"	Q5VTQ0	9	15163622-15307360	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 2.0;gdT-cell: 4.1;MAIT T-cell: 5.4;memory CD4 T-cell: 5.6;memory CD8 T-cell: 6.3;naive CD4 T-cell: 6.7;naive CD8 T-cell: 4.1;NK-cell: 7.6;T-reg: 4.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.0;NK-cells: 7.6;T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"HEL: 27.2;RT4: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063162			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA063162: AB_2684952"	"unprognostic (1.64e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (9.64e-6)"	"unprognostic (5.99e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.89e-2)"	"prognostic favorable (4.08e-7)"	"unprognostic (3.31e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.48e-1)"	7.3	4.9	3.6	7.2	7.9	2.3	7.7	35.9	12.9	8.2	10.5	1.7	1.8	9.0	10.0	4.4	14.2	6.1	11.2	3.0	3.6	5.6	14.6	8.5	8.6	8.9	5.3	6.4	6.6	6.3	3.7	13.5	2.2	20.8	4.6	9.3	3.8	6.3	3.4	3.7	15.1	15.2	6.9	5.9	6.8	8.8	8.5	2.9	1.3	4.7	4.7	9.3	6.2	8.1	1.0	0.6	2.0	0.9	7.6	6.7	3.4	2.6	0.5	0.8	3.9	3.8	7.0	0.8	3.4	6.2	2.7	6.5	0.5	1.1	0.0	0.4	4.2	3.2	2.3	0.6	4.2	2.3	2.9	0.5	27.2	1.2	4.9	6.2	0.0	0.6	6.8	3.3	5.6	6.3	1.9	3.8	2.3	0.1	6.2	6.8	0.8	1.4	0.1	1.0	8.2	0.8	0.3	2.1	1.2	5.8	15.5	2.0	0.4	0.8	2.0	0.6	1.3	8.7	1.7	2.8	1.5	1.3	2.1	0.9	0.1	0.0	0.0	1.4	0.3	0.7	2.0	0.9	1.2	4.1	0.7	5.4	0.3	5.6	6.3	0.6	1.0	6.7	4.1	0.7	7.6	0.9	0.1	4.9	3.4	3.6	7.9	35.9	12.9	3.6	5.6	5.3	6.4	20.8	2.9	11.9	17.5	2.7	6.0	15.3	23.4	2.7	7.6	16.0	9.1	7.0	0.0	2.7	14.9	5.3	30.6	6.3	28.8	0.0	19.0	0.9	8.9	7.4	27.8	10.4	4.2	12.7	12.2	6.2	3.7	25.3	6.6	5.6	6.8	2.8	14.3	16.0	10.1	44.2	12.0	32.1	3.9	0.0	10.3	2.3	1.9	18.7	3.4	20.1	12.6	13.2
TXNDC5	"EndoPDI, ERp46, FLJ21353, FLJ90810, Hcc-2, MGC3178, PDIA15"	ENSG00000239264	"Thioredoxin domain containing 5"	Q8NBS9	6	7881517-7910814	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 23.3;Mucus-secreting cells: 19.0;Pancreatic endocrine cells: 10.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.6;plasmacytoid DC: 17.5"	"Group enriched"	"Detected in many"	21	"B-cells: 9.6;dendritic cells: 17.5"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 162.2;U-266/84: 344.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034677, HPA034678"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		14000000	"Endoplasmic reticulum"		"HPA034677: AB_2674275, HPA034678: AB_2674276"	"unprognostic (3.15e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	20.2	15.7	3.7	42.1	6.3	6.0	61.9	4.6	6.8	28.8	69.8	7.5	18.3	35.0	28.3	20.9	25.3	21.5	30.2	28.6	4.4	5.2	23.2	96.2	24.5	117.9	5.9	4.3	26.1	63.3	7.9	10.6	22.4	7.2	17.6	29.0	10.9	71.5	29.1	10.1	9.9	33.6	16.3	7.5	84.2	36.8	12.3	5.2	6.4	18.0	19.8	48.2	35.8	21.7	9.6	17.5	0.0	0.5	0.0	0.6	0.3	9.5	9.4	6.5	22.0	56.8	24.3	10.7	21.5	21.0	15.0	16.3	14.0	7.1	10.1	38.0	33.0	16.6	7.6	11.6	10.6	17.1	8.6	9.9	15.5	8.2	25.2	16.6	17.5	15.5	16.6	15.6	14.3	15.8	33.2	80.3	6.4	9.6	73.9	10.2	8.5	4.1	10.6	8.6	15.1	20.5	7.3	9.5	162.2	12.1	8.7	10.2	5.5	27.7	16.9	12.1	32.5	8.6	7.7	22.0	17.2	12.0	14.7	22.7	86.2	344.1	17.9	8.8	11.1	23.5	0.0	0.2	0.0	0.6	0.5	0.5	9.6	0.1	0.4	0.7	3.3	0.1	0.3	0.0	0.0	0.0	17.5	0.5	0.3	3.7	6.3	4.6	6.8	4.4	5.2	5.9	4.3	7.2	5.2	0.0	4.5	0.0	0.0	0.8	0.0	0.2	0.0	2.7	3.4	0.0	0.0	0.8	0.0	8.2	0.1	0.7	1.0	23.3	9.2	1.2	1.7	0.4	1.1	2.4	1.3	0.0	4.7	5.5	1.5	0.0	0.0	0.3	3.3	1.0	19.0	0.0	10.3	0.0	0.4	0.2	0.2	6.5	0.4	0.0	0.1	0.1	1.0	0.0	7.0	0.1
UBA52	"CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40"	ENSG00000221983	"Ubiquitin A-52 residue ribosomal protein fusion product 1"	P62987	19	18571730-18577550	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 9484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041344, HPA049132, HPA056624"	Supported		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA056624: AB_2683196"	"unprognostic (1.98e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (9.35e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.23e-1)"	84.7	73.8	71.1	76.4	76.5	167.0	101.5	32.8	71.1	83.2	73.0	48.7	67.8	47.7	79.0	93.2	102.7	78.8	82.0	85.9	58.2	50.2	74.1	135.5	67.7	182.7	64.0	59.0	150.3	225.2	56.5	62.8	71.6	55.5	75.8	74.0	51.6	96.0	75.2	191.4	104.6	68.0	91.9	72.0	101.1	75.5	89.5	52.1	121.2	97.6	131.7	145.1	99.9	161.7	200.5	157.0	75.1	132.4	109.7	205.0	246.6	104.4	83.5	62.7	104.6	163.0	155.1	155.6	80.7	112.1	134.1	107.1	151.2	97.9	151.5	83.5	133.0	52.8	70.9	121.3	143.5	126.9	40.6	189.4	82.9	129.9	170.4	118.7	179.8	106.3	179.4	196.4	91.9	133.7	117.4	134.3	97.0	131.1	210.1	114.3	174.9	143.6	161.4	140.3	199.6	180.9	118.8	62.6	173.5	129.2	158.9	81.8	99.0	58.6	142.1	139.9	97.9	63.0	232.8	99.7	67.3	56.3	141.7	142.6	129.4	171.7	149.9	91.6	204.3	91.1	50.7	132.4	69.8	119.4	107.2	162.2	200.5	178.5	142.6	147.6	199.1	205.0	165.6	75.1	109.7	96.1	157.0	138.5	246.6	71.1	76.5	32.8	71.1	58.2	50.2	64.0	59.0	55.5	52.1	431.7	622.2	2582.1	1573.2	1686.3	110.3	294.0	1008.9	451.1	705.2	621.1	64.8	1723.9	1331.3	1227.6	2621.0	1327.6	1318.3	1448.3	1974.2	2396.3	1301.0	1468.3	776.0	1485.4	2254.1	98.5	1063.9	1146.6	2650.9	9484.0	1736.3	2494.7	1186.1	2394.1	1524.2	239.6	1703.1	1730.2	972.7	1715.5	163.6	685.6	1317.8	523.4	597.0	1957.5	1909.1	1690.5	1603.6	1847.3
UBXN4	"KIAA0242, UBXD2, UBXDC1"	ENSG00000144224	"UBX domain protein 4"	Q92575	2	135741619-135785055	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036325	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA036325: AB_10669788"	"unprognostic (1.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.14e-3)"	32.5	37.8	24.3	27.0	28.4	24.5	29.5	28.6	27.6	35.5	29.2	26.6	35.0	31.7	32.7	33.2	29.4	26.5	27.7	25.5	25.7	21.2	34.3	64.7	27.8	24.1	30.0	28.8	34.7	38.8	42.1	39.7	33.5	33.0	30.5	27.6	23.0	38.0	38.2	52.0	29.7	33.8	26.2	38.3	25.4	29.7	32.1	29.8	47.3	39.9	25.0	25.1	35.5	36.3	24.8	27.3	33.6	23.4	27.2	24.8	16.7	40.6	11.9	24.2	19.8	32.1	35.5	27.1	35.1	35.2	30.2	27.1	19.9	30.3	26.2	45.7	30.9	14.2	29.2	14.8	20.8	32.0	32.6	18.1	23.6	17.6	26.4	29.5	26.2	23.0	27.0	17.8	28.5	26.4	33.1	35.5	19.0	22.4	37.6	27.2	20.2	31.0	13.9	18.9	18.3	20.7	26.2	33.1	44.0	29.0	30.4	23.7	14.5	31.5	19.6	18.9	20.8	22.3	21.6	33.1	26.4	12.7	26.4	17.6	33.0	19.7	22.5	33.1	17.5	24.6	26.0	18.5	27.1	23.7	20.3	22.8	24.8	22.6	22.9	17.7	22.2	23.2	22.1	33.6	27.2	23.4	27.3	24.8	16.7	24.3	28.4	28.6	27.6	25.7	21.2	30.0	28.8	33.0	29.8	193.5	142.1	145.9	214.6	155.6	174.0	125.9	124.9	278.4	224.1	120.4	210.1	200.1	76.3	215.2	577.7	126.2	161.9	23.3	170.5	181.5	166.3	295.4	166.9	183.2	124.1	92.2	178.9	103.7	85.0	224.8	159.9	131.8	87.7	162.3	136.0	168.8	182.9	133.3	135.1	127.3	321.9	103.5	125.7	404.1	239.3	160.5	317.3	126.7	136.2	247.3
UBXN8	"D8S2298E, REP8, UBXD6"	ENSG00000104691	"UBX domain protein 8"	O00124	8	30732247-30767006	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 30.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 162.1;Hepatocytes: 56.2;Late spermatids: 132.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017725, HPA077538"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"	"Nucleoplasm, Nucleoli"	"HPA017725: AB_1847462, HPA077538: AB_2686844"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.13e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.25e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-2)"	5.0	5.3	3.9	1.4	4.8	1.4	4.3	1.5	9.2	3.0	3.5	4.0	6.7	3.1	3.8	14.3	4.1	3.6	3.8	2.8	5.7		8.2	21.5	2.1	3.9	7.6	4.0	30.6	10.3	6.2	3.5	6.2	6.2	4.8	4.7	1.6	1.8	6.1	1.7	4.1	2.9	2.9	7.1	5.7	3.3	11.5	6.1	0.9	9.1	2.8	2.3	2.9	3.7	6.0	8.2	1.0	6.1	3.3	8.4	3.4	7.6	7.7	5.6	5.8	9.1	12.2	6.3	13.7	8.0	7.5	9.2	12.2	2.8	12.2	11.3	11.1	12.4	6.8	1.1	7.6	11.6	6.4	12.5	34.3	6.3	14.9	13.7	7.8	19.4	9.6	7.9	12.0	5.9	6.4	6.5	5.6	33.5	9.2	16.5	7.2	7.9	6.0	10.8	22.8	5.8	9.5	5.4	8.5	12.8	10.0	3.2	8.1	3.8	11.3	24.7	7.0	8.4	13.6	8.3	8.5	3.7	3.8	12.7	4.0	12.5	9.2	7.6	12.6	12.1	0.0	6.0	0.7	8.4	6.1	7.3	6.0	4.5	8.0	6.7	2.9	4.4	7.4	1.0	3.3	3.0	8.2	4.3	3.4											3.0	8.0	3.0	4.1	0.0	1.9	3.2	15.3	1.4	5.7	14.0	19.6	20.6	6.6	7.1	162.1	6.2	6.3	0.0	4.5	16.0	9.4	4.1	13.9	56.2	19.0	11.1	8.2	27.0	14.2	132.0	13.3	6.9	0.0	10.0	6.4	6.6	3.9	3.5	9.2	22.0	1.8	6.5	3.9	14.1	20.4	0.0	12.7	7.2	10.0	2.4
UCKL1	"FLJ20517, URKL1"	ENSG00000198276	"Uridine-cytidine kinase 1 like 1"	Q9NWZ5	20	63939829-63956415	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 78.5;Rod photoreceptor cells: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004722, HPA004769"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA004722: AB_1080455, HPA004769: AB_1080453"	"unprognostic (1.03e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.87e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.26e-3)"	17.4	18.1	16.5	16.0	18.3	21.1	19.8	50.4	20.7	18.5	21.9	21.6	17.3	32.0	18.0	17.7	19.7	17.9	12.0	21.0	17.1	9.4	21.3	20.6	15.6	18.3	20.3	11.5	31.7	22.6	14.1	22.1	17.5	15.7	19.4	9.1	31.0	28.9	24.4	52.3	27.9	29.8	18.1	11.8	26.7	20.1	11.5	19.7	16.7	24.1	33.1	20.1	16.2	21.2	22.2	8.9	6.3	14.0	5.3	14.8	7.9	11.5	12.3	10.6	14.1	7.8	6.7	17.1	9.3	6.4	19.3	9.7	29.3	9.0	11.7	15.7	6.0	13.2	19.0	8.2	12.8	3.8	4.9	13.8	8.9	24.6	42.8	8.6	15.1	17.0	9.3	11.5	7.7	6.4	7.7	8.9	11.6	12.5	12.5	6.0	14.9	17.7	26.4	7.8	9.2	28.8	18.1	8.0	20.1	7.9	16.8	25.2	14.7	13.4	13.2	14.2	5.5	13.8	13.7	9.8	20.5	7.7	13.3	12.0	13.1	7.0	5.4	10.5	10.8	7.7	4.2	7.7	6.3	13.2	12.9	14.8	22.2	12.8	11.2	8.9	12.7	7.5	9.0	1.2	5.3	14.0	5.1	13.5	7.9	16.5	18.3	50.4	20.7	17.1	9.4	20.3	11.5	15.7	19.7	23.8	8.8	20.2	17.9	16.8	27.5	18.2	22.9	8.1	11.4	8.7	78.5	27.3	19.9	17.0	1.9	16.5	26.3	0.0	9.6	20.5	15.0	11.6	12.7	10.5	16.0	19.1	20.6	10.4	9.1	2.2	16.4	13.4	10.1	22.6	20.8	17.1	16.9	23.0	19.4	12.3	130.6	25.8	18.7	10.7	14.0	16.7	27.9	9.6	21.7	17.1
UCN	"UI, UROC"	ENSG00000163794	Urocortin	P55089	2	27307400-27308445	"Predicted secreted proteins"	Hearing	Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 8.5"	"Cell type enhanced"	"Detected in some"	5	"Exocrine glandular cells: 3.2;Rod photoreceptor cells: 3.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"NK-cell: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 20.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB010911	Approved		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	133000		"Endoplasmic reticulum"		"CAB010911: AB_261834"	"unprognostic (7.35e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.42e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.84e-7)"	"unprognostic (4.84e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	1.1	2.8	4.6	1.3	5.5	2.4	1.0	3.1	4.5	0.9	0.7			0.8	1.9	1.4	0.6	1.9	2.0	4.2	4.7	3.8	0.7	3.2	1.6	1.6	3.1		2.3	1.8	0.0	2.2	2.4		1.2	0.0		1.3	0.9	8.5	0.8	1.2	1.0	2.8	3.0	0.5	1.5			1.5		0.4	0.5	0.4	0.0	0.0	0.0	0.7	2.9	0.9	0.2	1.2	2.7	0.4	0.8	1.2	1.1	5.3	0.4	1.1	0.4	0.4	0.2	2.1	1.0	0.6	0.4	1.2	0.4	0.5	0.3	0.0	3.3	4.5	2.4	1.7	2.1	3.1	0.2	2.7	1.6	2.1	0.2	2.5	2.7	0.0	2.0	2.3	1.9	0.1	2.0	1.3	7.1	4.5	0.1	2.9	3.4	2.4	1.5	0.1	0.5	0.8	2.3	1.1	0.1	5.8	0.3	1.1	3.2	0.2	0.9	5.0	1.5	1.9	20.1	2.1	0.7	3.9	5.7	1.4	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	2.9	0.4	0.0	0.6	0.2											0.0	0.3	0.0	0.2	0.5	2.7	0.4	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.5	0.0	3.2	0.6	0.5	0.7	0.0	0.8	0.7	1.6	0.0	1.3	1.9	0.0	1.4	1.3	0.0	0.0	0.2	2.0	0.9	0.0	0.7	0.3	3.3	0.0	0.1	0.9	0.6	0.0	0.7	1.0	0.6	0.1
UFL1	"KIAA0776, Maxer, NLBP, RCAD"	ENSG00000014123	"UFM1 specific ligase 1"	O94874	6	96521595-96555276	"Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030558, HPA030559, HPA030560"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		6900	"Endoplasmic reticulum"		"HPA030558: AB_10600663, HPA030559: AB_10600537, HPA030560: AB_10602000"	"unprognostic (5.40e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.46e-1)"	20.2	26.3	19.8	21.9	24.0	14.6	20.9	16.4	23.6	22.1	17.9	19.4	32.1	21.5	20.5	28.5	23.6	18.6	20.2	22.1	21.6	17.8	21.6	32.7	15.8	21.5	31.1	20.0	24.8	35.7	28.8	32.4	25.6	28.0	24.6	19.2	14.2	23.9	30.7	33.0	19.3	28.4	18.5	33.0	18.8	20.6	13.4	27.3	29.2	27.6	23.1	20.1	24.0	18.8	11.2	12.6	10.1	11.7	14.7	14.7	7.9	8.9	4.7	10.1	16.9	14.6	22.4	15.1	12.6	12.9	8.1	7.6	5.9	10.5	21.7	16.1	12.6	9.0	17.5	8.2	11.9	11.9	11.6	7.4	9.5	7.5	10.8	19.5	17.8	14.2	16.0	11.2	9.6	26.8	15.1	13.2	14.0	12.6	24.1	15.3	8.6	6.5	11.1	3.6	7.7	5.4	8.3	11.9	17.1	14.6	16.4	7.1	7.0	10.4	12.3	11.7	9.4	29.9	15.3	12.9	11.4	6.2	11.5	13.2	14.3	7.3	16.7	17.5	12.0	10.4	7.8	9.2	10.1	10.9	11.7	12.5	11.2	11.5	11.6	11.8	11.0	14.7	11.5	2.0	14.7	11.2	12.6	12.7	7.9	19.8	24.0	16.4	23.6	21.6	17.8	31.1	20.0	28.0	27.3	53.6	39.1	26.8	27.8	17.3	47.7	56.2	30.6	76.3	54.6	43.6	43.2	53.5	16.6	35.6	46.2	28.1	32.8	0.0	44.3	29.6	25.7	28.2	29.0	62.7	31.5	41.3	19.0	33.7	30.2	36.5	46.3	26.2	13.5	31.5	45.7	31.7	33.7	37.9	47.4	28.0	67.4	19.4	28.6	88.5	29.6	16.8	76.1	30.9	32.0	23.0
UTP15	"FLJ12787, FLJ23637, NET21"	ENSG00000164338	"UTP15, small subunit processome component"	Q8TED0	5	73565443-73583377	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044697			Approved	"Nucleoli,Endoplasmic reticulum"		No	No			"Nucleoli, Endoplasmic reticulum"		"HPA044697: AB_2679050"	"unprognostic (8.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.87e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.22e-1)"	17.1	11.8	6.5	9.4	11.7	38.6	13.2	8.7	12.5	7.5	8.6	10.4	9.3	7.0	11.3	8.7	13.6	10.4	6.7	8.8	12.9	5.6	9.3	12.9	10.2	12.1	11.0	8.0	11.0	9.7	11.8	16.4	8.8	12.5	10.1	10.9	7.5	10.9	6.6	14.5	18.3	10.7	9.9	10.3	11.4	11.9	10.1	10.0	11.4	10.3	13.2	12.8	9.5	9.4	8.3	9.0	4.6	8.0	8.8	10.8	5.4	10.7	11.6	7.9	23.7	6.9	8.2	15.0	12.8	7.4	14.5	16.1	13.0	14.4	24.2	13.0	8.6	16.8	9.0	13.5	23.8	22.5	11.8	9.8	11.1	12.3	10.6	8.5	10.1	9.1	8.3	10.8	16.4	18.5	4.3	10.0	10.5	17.0	13.4	12.3	13.5	15.3	7.2	10.7	3.8	6.7	12.3	12.1	23.4	8.7	14.7	8.1	8.7	11.5	9.5	13.4	7.0	12.1	7.5	8.1	8.6	11.9	10.1	24.9	9.8	13.0	31.2	13.6	17.4	12.5	2.5	7.0	4.6	9.7	8.0	9.7	8.3	9.8	10.6	9.0	7.2	10.5	10.8	3.8	8.8	7.3	6.5	7.9	5.4	6.5	11.7	8.7	12.5	12.9	5.6	11.0	8.0	12.5	10.0	0.0	5.3	2.9	10.8	13.1	3.9	6.4	2.5	0.0	4.5	5.2	5.9	6.8	3.3	8.1	3.5	4.9	2.3	0.0	6.8	7.3	4.9	5.6	6.9	6.7	6.0	1.6	2.4	3.1	7.3	2.2	2.8	4.3	6.8	1.8	3.6	3.5	5.7	3.5	4.9	4.9	4.4	6.5	8.5	6.3	13.6	14.9	5.5	4.4	6.0	9.0
VAPA	"hVAP-33, VAP-A"	ENSG00000101558	"VAMP associated protein A"	Q9P0L0	18	9914002-9960021	"Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009174	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		5300000	"Endoplasmic reticulum"		"HPA009174: AB_1080549"	"unprognostic (4.03e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-2)"	27.5	64.8	28.8	21.0	35.5	73.5	27.4	32.9	39.4	24.9	34.3	30.7	19.3	27.8	30.8	23.8	42.3	27.9	29.4	39.9	28.0	30.2	32.7	33.2	35.1	24.6	33.4	28.8	40.6	36.5	25.0	19.4	35.2	48.1	25.2	32.7	18.0	27.9	21.8	55.4	27.6	32.3	28.5	39.1	27.7	34.0	25.2	28.8	36.3	36.4	28.3	22.9	36.0	30.2	24.5	30.6	62.5	37.3	22.2	24.6	39.7	17.3	10.5	12.7	8.3	15.0	16.3	17.8	21.5	17.9	19.6	21.6	14.1	17.3	17.1	20.1	18.8	17.0	12.2	12.3	20.5	22.5	10.6	15.4	27.8	11.2	21.7	35.7	37.5	53.4	15.3	20.8	18.5	22.1	15.4	19.8	14.0	28.0	17.9	17.1	9.3	28.8	21.8	8.2	59.8	16.8	15.1	17.3	23.1	19.1	17.5	18.0	9.8	24.9	15.2	15.4	12.2	14.2	19.4	21.1	32.0	23.8	33.1	26.1	32.1	26.0	20.4	18.1	16.2	21.9	26.1	37.3	62.5	19.3	32.4	22.7	24.5	20.3	20.7	30.6	22.7	22.2	20.4	59.2	22.2	26.4	21.8	24.6	39.7	28.8	35.5	32.9	39.4	28.0	30.2	33.4	28.8	48.1	28.8	119.1	156.9	129.2	289.0	598.2	103.5	201.2	160.5	211.5	124.0	197.1	58.9	238.9	388.0	249.4	7.6	182.0	272.4	70.0	315.1	261.3	247.0	278.9	222.5	128.2	255.8	128.7	138.8	187.9	265.3	9.5	168.5	232.2	264.9	418.4	154.5	119.8	283.7	174.6	203.3	294.2	76.5	187.5	270.9	168.9	212.6	544.1	378.5	153.4	155.5	360.2
VAPB	"ALS8, VAP-B, VAP-C"	ENSG00000124164	"VAMP associated protein B and C"	O95292	20	58389122-58451101	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013144, CAB013722"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		220000	"Endoplasmic reticulum"		"CAB013722: , HPA013144: AB_1858717"	"unprognostic (3.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (1.08e-8)"	"unprognostic (1.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.99e-2)"	17.4	31.1	21.8	12.6	24.3	4.8	13.2	16.5	31.8	11.7	16.1	17.0	13.3	22.5	13.0	13.1	14.8	13.7	12.7	24.5	21.4	22.1	21.8	23.5	13.6	10.4	23.2	25.1	17.7	15.5	28.5	16.3	11.1	31.6	15.0	12.1	11.4	17.9	15.7	46.8	15.3	20.6	15.2	24.9	11.4	14.7	9.4	15.8	6.7	26.7	18.8	9.4	11.6	18.5	5.6	4.3	6.8	5.2	6.6	9.5	4.6	10.9	11.0	12.4	6.6	11.4	4.8	11.0	9.8	4.1	15.2	7.5	44.3	10.6	9.7	14.1	6.6	12.1	21.0	9.8	14.1	9.1	4.5	7.4	5.8	12.2	13.9	11.5	5.4	7.4	10.9	16.4	8.4	7.0	7.4	7.5	9.7	13.7	5.5	7.3	34.4	8.5	10.8	6.5	21.5	14.6	8.6	11.5	6.3	11.6	14.7	17.5	12.1	16.2	43.2	16.9	7.1	17.7	8.3	10.3	24.6	12.0	12.3	13.1	7.4	7.9	11.1	20.8	6.0	12.4	3.9	4.4	5.2	7.8	4.4	9.1	5.6	9.0	6.2	4.3	4.7	6.7	9.5	6.8	6.6	5.2	4.3	5.0	4.6	21.8	24.3	16.5	31.8	21.4	22.1	23.2	25.1	31.6	15.8	41.7	23.2	11.7	12.1	10.4	26.4	43.1	25.5	18.7	13.6	29.6	27.5	28.5	29.9	29.7	4.2	20.4	30.7	0.0	26.6	42.2	18.8	15.2	9.2	32.1	14.0	33.4	20.8	14.7	14.0	5.1	17.3	13.9	13.5	24.4	22.3	34.0	29.0	19.2	23.7	31.6	29.2	12.9	20.5	20.4	28.3	9.3	37.2	18.7	24.2	13.6
VIP		ENSG00000146469	"Vasoactive intestinal peptide"	P01282	6	152750798-152759765	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.5;lymphoid tissue: 64.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.7;Melanocytes: 27.0"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 2.2;SH-SY5Y: 7.0;TIME: 4.9;U-2 OS: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017324, CAB018649, HPA072701, CAB079780"	Supported	Supported	Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	122000		"Endoplasmic reticulum"		"CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550"	"unprognostic (9.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.90e-2)"	1.2	5.7	9.7	64.7	8.3	0.3	0.9	1.5	20.1	0.6	31.5	0.5	0.3	7.5	0.7	0.4	13.1	0.5	4.2	1.1	12.4	7.7	0.9	0.6	1.7	0.4	2.7	8.3	0.4	3.8	0.5	0.4	0.5	1.6	6.3	28.3	3.2	0.4	6.9	0.8	0.4	32.5	18.0	0.4	5.2	13.2	0.5	0.1	0.0	1.3	0.5	0.4	9.1	4.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.4	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	2.0	0.2	0.2	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.7	8.3	1.5	20.1	12.4	7.7	2.7	8.3	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.3	4.2	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
VKORC1	VKCFD2	ENSG00000167397	"Vitamin K epoxide reductase complex subunit 1"	Q9BQB6	16	31090842-31095980	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 173.3"	"Cell type enhanced"	"Detected in all"	8	"Hepatocytes: 682.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 98.9"					"Low region specificity"	"Detected in all"			HPA042720	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (5.99e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.09e-10)"	"unprognostic (1.11e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.66e-2)"	21.3	23.0	9.3	11.5	11.0	12.9	28.1	9.4	14.5	24.3	19.3	17.1	16.5	12.6	24.0	27.4	18.5	17.8	22.6	20.1	9.8	10.2	29.9	173.3	16.4	17.5	13.7	9.1	25.5	55.5	14.0	25.0	22.5	13.3	22.3	12.6	20.8	34.8	21.4	11.4	15.9	26.8	27.7	12.5	15.4	17.5	18.2	10.6	15.8	25.6	13.8	14.6	28.4	18.7	32.3	49.9	59.6	40.6	24.7	43.7	33.6	10.5	27.1	8.9	25.5	98.9	58.9	9.9	39.1	34.0	19.3	32.8	11.2	12.1	8.3	21.2	48.9	13.6	9.8	12.3	15.3	22.0	11.7	29.9	7.5	37.5	53.9	15.6	14.6	11.3	34.0	8.2	26.6	22.9	52.3	20.8	11.8	9.8	19.8	37.6	38.2	10.7	30.0	16.1	14.6	26.1	19.4	23.7	41.2	19.0	9.2	18.2	22.1	17.1	12.5	19.0	15.0	20.6	17.8	18.1	25.9	9.3	23.7	14.7	12.0	11.1	7.3	67.4	25.3	13.3	21.5	40.6	59.6	40.3	28.1	39.7	29.9	40.5	40.7	39.6	32.3	36.4	35.4	34.2	24.7	28.3	49.9	43.7	33.6	9.3	11.0	9.4	14.5	9.8	10.2	13.7	9.1	13.3	10.6	53.6	38.2	37.9	58.4	75.2	11.2	20.0	119.8	32.1	40.9	102.9	7.9	64.0	53.0	183.3	4.8	87.9	36.0	46.7	112.2	211.1	138.5	58.9	55.3	682.4	166.1	9.5	64.4	119.7	79.0	8.3	146.4	85.1	109.6	129.8	41.2	64.7	107.2	24.6	161.9	160.1	16.9	58.2	95.7	23.7	24.7	97.9	33.1	47.3	51.3	46.5
VKORC1L1		ENSG00000196715	"Vitamin K epoxide reductase complex subunit 1 like 1"	Q8N0U8	7	65873267-65959563	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA053954	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053954: AB_2682319"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (4.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.15e-3)"	"unprognostic (1.30e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.12e-2)"	"unprognostic (5.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.30e-1)"	"unprognostic (5.06e-2)"	38.2	9.2	10.5	8.3	16.7	3.0	23.7	9.0	19.7	10.4	11.1	14.2	9.2	8.6	10.1	8.8	10.0	8.8	8.0	9.3	10.3	11.4	8.2	17.8	14.3	6.2	12.0	12.1	14.4	11.7	28.5	8.0	9.7	14.1	9.9	10.0	8.0	9.0	10.5	14.9	11.4	9.7	9.3	13.2	5.7	9.9	9.4	7.6	9.1	11.1	4.5	6.6	9.7	9.3	2.8	7.5	5.6	4.2	6.5	3.4	1.8	22.4	14.5	11.7	14.7	37.4	14.9	21.3	24.4	15.8	14.6	14.8	14.0	22.2	19.6	19.8	17.5	22.2	15.5	16.7	9.9	24.5	12.2	16.5	13.3	13.3	11.9	18.3	18.4	10.3	11.9	12.8	14.8	20.7	11.4	14.5	11.2	28.0	15.0	17.4	8.8	15.1	21.5	28.1	21.3	10.9	16.6	17.1	24.4	14.1	9.0	14.1	20.2	18.9	34.3	10.7	17.4	17.2	14.3	16.4	23.7	16.2	14.8	24.7	13.6	22.1	22.5	14.5	21.0	20.6	3.8	2.7	5.6	2.9	2.5	2.4	2.8	3.4	3.2	2.8	2.5	2.3	2.3	3.1	6.5	4.2	7.5	3.1	1.8	10.5	16.7	9.0	19.7	10.3	11.4	12.0	12.1	14.1	7.6	68.5	29.5	0.8	14.6	22.0	20.5	21.3	30.6	8.1	26.1	15.7	11.8	10.0	5.0	15.9	28.9	15.9	16.9	23.3	21.7	18.4	16.7	23.4	4.7	44.5	14.4	28.6	13.3	8.6	7.0	5.5	16.4	9.0	6.8	4.6	23.5	8.5	24.2	2.9	17.3	10.2	17.4	6.5	13.4	17.9	6.6	28.0	7.3	5.2	18.7	16.9
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 193.2"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 872.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 193.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 193.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: AB_2685348"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	22.0	37.8	20.4	21.9	24.9	13.0	18.6	20.0	28.7	18.2	32.0	27.8	16.7	40.5	18.3	15.4	22.9	14.4	25.2	19.6	21.7	22.3	22.9	43.0	22.4	20.1	23.1	15.6	16.5	22.9	19.0	20.1	27.9	29.8	17.3	29.3	20.0	17.8	13.9	19.8	19.2	39.7	14.3	26.4	36.6	19.0	17.6	16.2	14.4	18.1	12.5	16.8	19.5	17.6	3.3	10.9	193.2	39.9	3.8	4.1	24.7	20.3	41.0	13.3	20.5	28.5	17.5	21.4	32.4	23.1	20.2	27.2	26.8	29.3	11.7	48.4	21.9	22.1	25.3	15.4	18.6	25.2	30.0	19.3	15.0	23.5	28.2	27.8	17.0	18.4	26.8	15.9	26.0	22.1	16.2	21.4	10.0	19.6	20.7	20.9	56.0	15.8	8.9	15.0	42.3	21.1	8.7	23.4	24.1	25.0	23.8	9.6	21.7	18.5	15.7	21.5	19.1	32.5	14.6	30.2	27.2	26.0	21.6	26.7	32.2	36.9	16.3	30.0	10.4	27.4	7.0	35.1	4.4	3.8	24.4	4.0	3.3	3.7	4.0	10.9	2.8	3.5	3.8	193.2	3.8	39.9	3.6	4.1	24.7	20.4	24.9	20.0	28.7	21.7	22.3	23.1	15.6	29.8	16.2	83.4	125.2	71.3	872.7	143.1	32.8	26.9	112.1	278.4	247.9	261.7	55.0	83.1	19.9	167.6	5.2	128.4	394.9	0.0	118.5	105.1	178.7	606.4	129.6	93.2	107.6	27.0	298.1	52.2	269.6	8.8	33.1	306.0	123.2	55.9	173.1	46.7	132.9	326.1	33.2	57.2	44.2	90.5	178.6	63.8	38.3	113.3	147.0	90.6	149.1	526.3
VRK2		ENSG00000028116	"Vaccinia related kinase 2"	Q86Y07	2	57907651-58159920	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046459, HPA047503"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB046459: AB_1858773, HPA047503: AB_2680071"	"unprognostic (1.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (3.90e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.56e-1)"	18.7	17.7	10.9	21.9	28.3	14.9	16.1	2.4	15.1	15.6	13.5	27.3	16.3	9.9	18.4	16.7	26.8	13.2	10.9	21.6	14.4	8.9	12.4	15.2	15.6	19.5	29.2	13.5	14.2	20.0	16.1	18.7	16.1	18.7	15.7	15.6	9.3	20.5	17.6	21.5	12.8	12.9	20.1	19.0	20.1	13.5	12.5	31.2	13.6	17.4	16.7	23.0	18.1	19.4	19.7	17.0	21.6	21.3	11.3	12.2	9.2	14.2	9.5	1.1	6.3	7.1	13.1	19.7	13.2	13.2	9.1	9.3	19.4	15.1	17.4	17.4	11.6	15.0	10.9	13.8	14.4	13.7	31.2	9.3	19.6	7.7	13.8	11.3	16.6	11.7	7.2	17.2	14.6	21.1	10.9	26.2	2.4	19.2	11.2	15.2	8.2	0.1	12.7	12.0	22.6	4.8	19.0	4.8	11.8	15.1	11.7	3.8	0.1	20.9	12.5	10.5	10.9	8.8	10.2	14.6	0.2	30.3	8.2	0.2	16.5	13.0	9.3	7.4	20.6	15.0	13.7	16.8	21.6	10.1	21.3	12.2	19.7	9.8	11.8	16.6	19.0	7.4	9.5	6.0	11.3	20.6	17.0	11.5	9.2	10.9	28.3	2.4	15.1	14.4	8.9	29.2	13.5	18.7	31.2	20.8	9.1	14.1	11.3	8.8	1.0	17.1	10.2	30.8	15.9	17.4	0.0	19.7	13.3	22.0	16.8	15.0	2.9	46.7	22.8	18.5	8.5	8.1	16.3	6.8	17.1	0.0	6.3	4.9	17.7	6.5	5.5	21.4	10.1	49.5	4.3	4.6	21.8	7.8	5.6	7.1	3.6	6.5	13.7	8.3	12.6	7.3	16.2	12.7	7.1	12.2
VSTM5	"C11orf90, LOC387804"	ENSG00000214376	"V-set and transmembrane domain containing 5"	A8MXK1	11	93818232-93850531	"Predicted membrane proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 9.9;placenta: 10.7"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 16.9;Syncytiotrophoblasts: 4.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.3;OE19: 6.8;PC-3: 10.0;SH-SY5Y: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029525, HPA063591"	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029525: AB_10600789, HPA063591: AB_2732704"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-4)"	"unprognostic (2.45e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	0.5	0.6	3.1	0.4	2.9	0.1	1.1	2.2	8.2	2.8	3.0	0.4	0.6	0.5	0.9	3.2	0.5	0.5	1.5	0.8	3.2	9.9	2.1	0.1	0.3	0.2	4.7	3.5	0.3	1.3	0.1	1.2	10.7	4.9	1.6	4.4	0.3	1.4	1.3	0.2	0.3	1.3	1.9	1.3	0.1	4.9	0.4	0.0	0.0	0.4	0.0	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.9	0.2	1.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	10.0	0.0	0.0	0.3	0.0	0.3	0.2	4.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.9	2.2	8.2	3.2	9.9	4.7	3.5	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.3	0.0	0.0	0.5	0.0	2.7	0.3	0.2	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.8	2.5	0.4	1.0	0.3	0.0	0.0	0.0	0.0	0.1	4.9	0.0	1.6	0.0
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367276-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"liver: 321.7"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 4765.6"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"					"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	11	"CACO-2: 168.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB016695, CAB016765, HPA060933, HPA068011"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	606000000000	32000000000	"Endoplasmic reticulum, Vesicles"		"CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: "	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	3.6	2.2	0.0	0.0	0.0	321.7	0.0	0.0	0.0		0.0	0.6	0.0	0.0	2.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4			0.0		0.0	0.0	0.0	0.3	0.2	0.6	0.2	0.7	2.1	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.1	168.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.7	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	15.5	0.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	1.0	0.0	0.9	0.0	0.9	0.9	0.1	0.3	0.6	2.1	0.6	0.7	0.0	0.2	0.0	0.1											0.0	0.6	55.9	0.0	0.0	10.7	14.7	1151.5	0.0	0.0	0.0	72.6	2.6	3.3	14.8	0.0	0.7	0.0	233.6	17.1	1.6	7.6	0.0	0.0	4765.6	4.3	36.5	0.0	116.0	117.8	0.0	0.0	0.0	0.0	35.1	0.0	4.8	38.2	0.0	1.4	2.2	24.6	0.0	2.0	0.3	0.4	0.0	8.0	0.7	0.0	0.0
WDR83OS	"C19orf56, PTD008"	ENSG00000105583	"WD repeat domain 83 opposite strand"	Q9Y284	19	12668071-12671356	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065685	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA065685: AB_2685531"	"unprognostic (1.73e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (4.17e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	43.7	59.8	39.3	29.4	39.4	48.7	64.6	25.3	42.7	51.2	52.0	37.1	53.0	29.7	43.3	84.9	60.6	68.2	66.6	53.2	35.1	35.9	54.2	70.2	49.5	47.7	38.6	29.1	69.6	104.0	33.0	45.8	64.6	27.4	60.0	45.4	35.4	69.7	55.7	56.3	46.7	53.3	51.3	42.2	40.9	41.2	43.3	30.1	30.7	84.8	60.3	49.0	45.1	61.8	87.0	94.2	99.3	101.3	84.2	77.9	107.6	29.6	28.6	36.1	40.7	47.1	38.9	15.6	22.0	28.2	25.9	22.5	24.7	25.9	11.8	51.5	50.3	23.4	23.7	32.8	33.9	22.2	27.8	48.0	15.4	28.3	39.8	36.6	26.8	24.9	39.5	43.9	28.0	33.3	49.8	33.7	25.5	27.3	30.7	33.0	95.1	20.1	64.9	30.2	39.0	83.6	17.1	18.1	47.0	31.7	33.6	29.4	46.1	24.3	26.1	30.5	24.8	32.0	47.8	23.6	46.8	13.1	51.2	32.1	55.4	62.6	18.5	40.3	46.4	30.2	98.0	101.3	96.1	70.3	92.3	65.9	87.0	67.4	71.9	94.2	79.1	62.0	68.8	99.3	84.2	95.4	64.6	77.9	107.6	39.3	39.4	25.3	42.7	35.1	35.9	38.6	29.1	27.4	30.1	74.5	37.5	152.6	167.3	152.5	39.0	119.0	183.4	42.8	61.4	324.5	25.5	375.2	339.8	234.8	5.0	170.5	280.3	46.7	221.1	281.1	204.6	188.6	147.4	250.1	254.1	47.7	187.6	164.5	230.9	14.5	157.9	197.6	281.7	241.7	209.3	164.9	220.3	245.4	136.2	435.1	44.1	97.0	189.6	99.3	110.7	193.5	338.8	153.0	222.7	198.5
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls"	ENSG00000116729	"Wntless Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 160.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 10.0;neutrophil: 29.1"	"Group enriched"	"Detected in many"	46	"granulocytes: 29.1;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"AF22: 70.0;ASC TERT1: 54.2;SuSa: 66.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA069520: AB_2686144"	"prognostic favorable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favorable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.51e-4)"	13.7	17.2	33.5	14.3	39.0	1.5	14.5	6.8	26.6	20.0	28.3	25.8	51.6	9.1	19.5	55.1	26.7	19.9	37.1	24.1	23.1	25.4	36.8	8.9	20.3	6.9	27.0	18.6	31.4	34.7	12.1	9.8	29.2	44.5	29.0	22.8	37.8	14.5	47.4	5.3	19.3	14.1	46.2	30.5	10.8	24.4	12.2	22.3	1.9	8.9	13.5	8.2	29.6	17.0	0.0	0.4	29.1	10.0	0.0	0.0	1.9	1.9	2.9	70.0	0.0	38.8	54.2	40.6	9.7	23.9	13.5	18.8	4.2	4.6	0.0	9.8	2.7	12.6	20.3	15.7	15.9	11.5	0.1	11.7	0.0	8.4	0.0	33.9	0.0	0.1	38.7	10.7	33.1	10.9	13.7	31.7	3.7	0.0	0.1	19.9	0.3	0.0	0.2	3.1	4.2	4.7	0.0	14.7	0.0	2.3	10.5	3.9	8.2	8.9	0.4	11.6	66.2	1.9	0.2	36.7	13.0	10.4	20.8	13.1	4.7	0.1	0.0	29.9	0.3	23.7	0.0	10.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.1	0.0	0.3	0.1	0.0	1.9	33.5	39.0	6.8	23.8	23.1	25.4	27.0	18.6	44.5	22.3	44.7	28.8	2.4	56.2	37.7	7.2	27.1	35.7	115.1	44.3	26.2	131.6	119.4	8.3	69.5	13.0	20.8	38.0	0.0	52.3	3.0	31.4	26.5	5.7	10.2	20.8	12.7	9.2	34.4	10.2	7.0	30.2	10.7	18.6	12.6	24.7	7.3	63.3	28.8	51.9	30.0	160.2	38.8	20.8	0.5	0.7	26.2	46.1	1.8	33.6	39.6
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470881	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 92.3;Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.2;ASC TERT1: 11.9;U-2197: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA		30000	"Plasma membrane"	"Endoplasmic reticulum"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	5.7	5.9	6.3	21.6	3.1	5.9	7.0	3.8	6.7	8.0	7.4	1.4	0.9	3.9	7.4	3.0	4.9	3.2	4.4	3.8	6.3	4.2	1.9	0.9	2.9	7.5	4.3	2.2	5.5	2.6	0.2	1.8	5.4	2.6	4.4	4.9	3.4	2.6	4.3	1.3	4.1	4.7	5.1	3.9	6.3	3.2	3.0	2.1	4.6	2.7	6.7	6.6	4.7	4.2	1.2	0.8	1.2	3.6	0.9	0.7	0.5	0.0	0.1	2.7	0.0	19.2	11.9	3.3	8.5	4.3	1.0	0.4	0.2	0.2	2.1	0.0	10.3	0.3	0.2	0.0	1.7	1.5	4.1	0.2	2.6	0.0	0.0	0.2	3.7	3.5	4.4	0.2	5.5	0.8	1.6	0.0	0.2	0.3	8.0	1.0	0.3	0.0	4.0	2.9	1.4	0.0	1.2	0.0	0.4	0.0	3.9	0.7	5.2	0.6	2.6	0.5	2.1	0.7	2.3	0.0	9.0	1.0	19.7	0.0	9.0	0.5	3.9	10.0	4.2	7.6	0.6	0.6	1.2	0.6	2.5	0.7	1.2	0.5	0.3	0.8	1.2	0.5	0.4	0.3	0.9	3.6	0.2	0.7	0.5	6.3	3.1	3.8	5.3	6.3	4.2	4.3	2.2	2.6	2.1	3.0	4.5	7.5	1.5	7.0	13.3	2.7	0.0	0.0	1.2	0.0	92.3	9.8	0.0	1.2	0.4	2.2	5.1	0.0	1.4	16.8	16.2	3.4	2.3	0.0	3.3	0.0	12.1	2.5	8.5	0.4	11.8	8.0	3.3	2.8	3.8	1.3	2.6	7.0	47.0	0.2	4.1	6.5	5.7	0.2	2.5	16.2	11.0	4.4	6.5	4.2
YIPF5	"FinGER5, SMAP-5"	ENSG00000145817	"Yip1 domain family member 5"	Q969M3	5	144158159-144170714	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 64.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042338, HPA073622"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Endoplasmic reticulum, Golgi apparatus, Vesicles"	Nucleoplasm	"HPA042338: AB_2677953, HPA073622: AB_2686618"	"prognostic unfavorable (7.83e-5)"	"unprognostic (1.13e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.12e-5)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.49e-2)"	26.6	26.6	18.4	14.7	21.2	15.8	22.5	19.2	22.6	23.9	22.2	17.2	22.5	26.5	25.7	22.0	27.2	18.9	19.0	18.3	15.1	18.5	23.0	27.8	20.4	21.0	16.2	20.5	19.6	41.7	21.5	45.3	37.1	21.8	16.8	23.4	18.9	32.7	18.3	11.9	24.5	30.5	25.2	19.7	18.8	23.8	20.7	16.2	14.0	20.2	21.2	20.1	24.1	19.9	22.3	27.2	28.8	28.1	23.7	36.7	23.4	11.5	7.7	10.1	8.0	24.2	26.2	9.2	39.5	26.9	17.8	28.8	12.3	12.2	6.3	19.1	42.8	20.5	10.7	9.6	19.4	24.1	8.8	8.3	4.7	13.5	12.5	19.6	10.4	7.8	19.8	18.2	15.9	13.1	30.8	16.9	7.0	4.9	10.7	24.0	6.0	5.1	5.9	6.5	7.4	8.5	5.4	15.0	10.5	11.1	10.3	6.9	8.5	13.7	7.4	17.5	10.7	15.3	6.9	64.9	21.0	10.2	20.3	15.5	9.7	16.1	8.0	20.1	10.0	15.3	25.6	21.0	28.8	30.3	28.1	34.3	22.3	31.0	33.6	25.0	21.5	32.8	30.8	15.6	23.7	25.4	27.2	36.7	23.4	18.4	21.2	19.2	22.6	15.1	18.5	16.2	20.5	21.8	16.2	35.7	24.3	40.2	21.0	26.2	39.5	19.3	22.9	49.5	26.1	19.2	31.4	48.9	26.6	36.5	8.3	38.7	36.0	46.7	60.0	68.2	45.1	27.2	35.8	30.5	33.0	31.8	14.3	33.2	27.9	5.3	32.8	24.3	28.7	34.3	44.6	54.8	46.2	31.9	31.8	30.4	43.2	38.8	28.8	78.4	48.5	22.7	56.4	34.5	25.2	18.5
ZC3H12B	"CXorf32, MCPIP2"	ENSG00000102053	"Zinc finger CCCH-type containing 12B"	Q5HYM0	X	65366638-65507887	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 6.1"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 6.0;Bipolar cells: 3.8;Intestinal endocrine cells: 4.1;Peritubular cells: 3.9"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA000836	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Endoplasmic reticulum"	"Golgi apparatus, Vesicles"	"HPA000836: AB_2217374"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.44e-3)"	"unprognostic (7.86e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.71e-2)"	0.3	0.9	2.6	0.5	3.9	0.1	0.5	2.8	6.1	1.9	1.1			0.9	2.6	0.8	0.4	2.0	1.1	0.5	2.8	2.5	1.2	0.5	0.6	0.7	1.7		3.3	0.1	2.7	2.7	0.0		1.8	1.1		0.3	2.4	0.0	0.3	0.9	1.8	1.5	0.4	1.3	0.0			1.5		0.2	1.0	0.7	1.3	0.8	0.7	0.4	0.8	1.8	0.2	0.3	0.4	5.1	0.7	0.0	0.0	0.6	1.2	2.7	0.0	0.8	0.7	0.5	0.8	0.3	1.4	0.0	0.8	1.3	0.0	0.1	0.7	3.7	1.7	2.3	0.7	0.1	1.5	0.4	0.2	0.0	0.1	0.0	1.1	0.0	4.1	0.9	4.1	0.1	0.0	2.1	0.6	2.1	2.8	1.0	2.4	0.2	1.0	0.1	0.2	0.2	2.4	0.0	0.1	0.2	3.0	0.1	1.2	0.0	0.1	1.0	1.7	0.5	0.9	1.0	1.7	3.2	2.2	0.0	0.6	0.4	0.1	0.6	0.2	0.5	0.9	0.8	0.8	0.2	1.3	1.8	0.8	0.7	0.8	0.2	0.8	0.4	0.2											6.0	0.3	1.5	0.2	0.0	3.8	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.2	0.1	0.4	0.3	0.0	0.4	0.1	1.6	4.1	0.6	0.0	0.0	2.3	0.0	0.0	0.0	1.3	0.8	0.2	0.0	3.9	0.3	1.4	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.9	0.1
ZDHHC9	"CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type containing 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavorable (9.77e-5)"	"prognostic unfavorable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	18.2	7.3	16.7	6.7	24.7	3.2	14.2	7.8	33.9	14.1	14.7	78.3	5.1	21.1	8.4	8.4	9.8	7.9	10.4	7.4	24.1	15.2	25.4	27.0	15.6	3.0	24.9	13.9	8.0	17.4	19.6	7.1	11.5	28.4	13.4	17.3	3.8	13.2	8.3	7.4	19.7	22.2	10.4	32.7	2.4	12.8	2.8	25.3	1.2	9.6	5.7	4.3	10.8	9.4	4.6	7.8	2.6	6.8	3.4	7.6	3.3	15.0	7.9	11.4	23.0	39.4	31.1	9.3	14.9	17.1	7.2	9.0	12.5	19.7	0.5	25.5	15.9	18.6	10.2	12.8	15.0	10.4	0.8	8.0	3.0	8.3	16.4	15.6	2.0	5.4	33.7	24.4	11.7	17.4	12.6	13.5	5.0	3.2	6.1	11.5	13.1	2.8	3.7	6.1	33.8	13.7	2.7	7.3	8.8	10.4	8.4	9.0	7.6	4.2	22.1	6.9	14.0	9.4	3.3	10.9	7.3	2.5	17.1	12.0	5.7	4.0	1.8	13.1	8.3	3.6	0.0	3.3	2.6	4.8	2.9	6.1	4.6	5.8	4.7	3.7	2.7	7.6	4.3	0.0	3.4	6.8	7.8	2.5	3.3	16.7	24.7	7.8	33.9	24.1	15.2	24.9	13.9	28.4	25.3	20.8	28.7	3.0	9.8	16.6	9.1	3.5	28.1	5.3	17.0	43.6	2.0	5.0	3.3	16.9	1.1	10.3	26.8	0.0	17.0	17.3	20.5	23.0	2.3	41.5	4.4	1.6	17.3	6.7	2.1	1.3	11.2	4.6	10.1	0.0	24.9	1.2	26.6	10.5	7.1	24.6	2.4	0.0	13.7	6.1	6.0	16.8	8.6	2.5	25.5	13.6
ZFYVE1	"DFCP1, KIAA1589, PPP1R172, TAFF1, ZNFN2A1"	ENSG00000165861	"Zinc finger FYVE-type containing 1"	Q9HBF4	14	72969451-73027212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 37.8;Late spermatids: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002898	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA002898: AB_1080653"	"unprognostic (2.19e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.07e-12)"	"unprognostic (4.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.48e-2)"	19.0	24.3	16.6	12.8	17.3	19.0	15.7	18.2	20.5	15.0	17.1	17.1	7.9	16.4	16.5	13.0	23.7	13.4	14.8	16.1	15.0	13.7	22.0	18.2	14.8	11.2	17.7	14.7	18.1	13.5	20.4	16.6	18.1	17.9	14.1	12.3	16.4	14.4	16.4	26.0	21.2	16.8	17.0	16.4	15.9	13.2	25.6	17.5	20.2	22.5	10.5	14.2	19.2	22.4	4.0	7.6	13.5	8.5	4.2	8.6	5.9	5.3	7.6	7.2	7.1	19.4	13.2	4.9	7.8	12.3	8.7	13.5	5.3	4.7	2.6	5.8	10.0	10.1	3.8	5.1	4.8	9.0	10.4	2.8	3.4	3.5	3.8	16.2	1.2	13.2	17.1	12.9	8.3	7.2	13.1	13.5	7.2	3.1	7.4	11.2	6.3	5.4	3.8	3.4	4.2	7.0	7.3	4.9	3.4	7.9	5.6	3.9	6.7	7.0	7.3	8.1	10.7	9.8	4.8	14.8	16.0	6.4	4.4	2.5	10.6	10.3	3.9	8.9	2.7	7.3	2.8	8.5	10.8	8.6	7.6	6.0	3.8	4.4	5.9	7.6	4.0	4.8	5.8	13.5	4.2	7.0	4.4	6.8	5.9	16.6	17.3	18.2	20.5	15.0	13.7	17.7	14.7	17.9	17.5	11.9	5.6	2.7	1.9	5.8	6.9	7.6	0.0	1.4	2.3	8.7	3.9	2.8	1.7	6.8	37.8	4.5	9.7	0.0	4.5	4.0	4.2	3.0	8.1	8.1	4.6	15.9	6.9	5.5	6.7	82.5	8.1	3.3	11.8	6.4	6.2	5.8	5.4	6.8	8.5	6.4	5.1	0.0	5.1	3.9	2.7	4.6	7.8	5.0	3.2	2.6
ZMYM2	"FIM, MYM, RAMP, ZNF198"	ENSG00000121741	"Zinc finger MYM-type containing 2"	Q9UBW7	13	19958670-20091829	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031765	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"		"HPA031765: AB_10601927"	"unprognostic (2.96e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.80e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.05e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.07e-4)"	15.0	17.3	15.9	18.1	23.3	22.2	16.1	23.9	26.8	18.3	16.8	14.0	13.7	13.3	20.0	14.0	18.5	16.1	15.7	17.1	14.4	12.0	17.3	13.7	15.4	14.2	12.9	20.2	21.7	16.2	17.1	32.1	14.0	23.2	19.4	13.8	13.8	18.2	17.6	19.7	18.3	14.5	15.3	16.2	16.3	16.0	44.5	16.5	38.0	24.3	10.4	19.7	19.5	17.2	5.5	6.3	7.4	5.9	5.4	7.9	3.5	6.4	5.8	22.3	9.6	9.9	10.6	10.6	6.7	10.8	8.7	10.4	8.9	13.3	15.4	6.2	9.4	8.3	10.3	16.4	7.2	11.8	6.1	4.6	27.2	8.7	4.4	9.9	22.9	8.3	10.5	13.5	6.9	7.1	13.8	14.7	15.9	10.3	11.0	11.9	9.1	22.1	6.5	20.6	19.5	3.6	24.7	24.3	7.2	6.7	9.4	26.1	26.0	13.0	9.3	12.2	15.7	12.3	16.4	8.6	4.3	6.9	5.2	3.5	8.7	6.8	15.9	3.7	5.4	10.3	0.2	5.2	4.0	5.5	5.9	6.7	5.5	7.5	5.6	6.1	4.5	7.9	6.9	7.4	5.4	4.9	6.3	5.4	3.5	15.9	23.3	23.9	26.8	14.4	12.0	12.9	20.2	23.2	16.5	41.7	35.3	47.7	40.3	48.9	111.9	33.0	28.1	36.1	46.6	48.8	106.0	13.1	5.0	20.1	90.8	35.1	23.6	0.0	15.4	10.5	38.8	45.9	45.1	28.4	19.1	68.3	53.6	43.6	57.0	140.1	51.8	45.1	32.1	20.8	31.0	48.9	25.9	31.6	38.5	13.7	112.6	32.3	39.3	94.3	48.9	39.0	9.5	45.9	27.6	70.2
ZNF33A	"FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK"	ENSG00000189180	"Zinc finger protein 33A"	Q06730	10	38010650-38065088	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 112.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA005538, HPA056638"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"	Vesicles	"HPA005538: , HPA056638: AB_2683199"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.69e-3)"	"unprognostic (7.96e-3)"	"unprognostic (4.89e-3)"	"unprognostic (6.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.39e-3)"	11.7	13.9	10.6	18.5	13.2	10.9	19.4	34.6	15.9	17.1	14.4	8.9	31.3	13.7	16.1	17.9	14.1	16.2	12.4	11.5	13.5	10.9	16.8	16.9	12.0	14.2	18.2	13.5	16.3	21.8	24.1	49.7	12.0	18.8	17.7	17.0	9.7	18.9	27.7	16.7	14.4	16.9	17.8	17.3	17.4	17.1	6.4	16.4	12.8	18.9	11.0	16.7	16.1	15.9	7.0	6.8	17.2	6.5	4.8	6.8	3.2	10.9	6.2	11.6	9.7	5.5	7.3	9.0	5.0	5.0	6.5	7.2	6.6	10.0	21.4	5.5	6.7	3.7	7.2	13.7	8.8	6.0	12.8	15.2	17.0	12.2	9.0	5.8	24.0	14.2	6.2	16.1	4.8	7.4	12.0	5.4	12.2	8.9	11.5	6.4	7.1	9.9	5.5	11.7	5.5	7.3	8.6	7.8	9.9	9.2	10.2	8.8	13.9	7.7	8.6	4.4	8.2	10.5	6.4	4.9	5.7	8.4	6.3	3.9	9.1	11.1	12.9	5.3	13.4	2.6	9.6	3.8	6.3	6.2	5.4	5.5	7.0	5.5	4.1	3.6	7.0	6.8	5.3	17.2	4.8	6.5	6.8	3.7	3.2	10.6	13.2	34.6	15.9	13.5	10.9	18.2	13.5	18.8	16.4	56.6	54.0	38.9	30.3	10.5	35.0	62.5	22.9	112.4	63.7	26.2	31.4	24.2	21.6	27.2	3.1	25.0	16.5	0.0	25.3	16.4	10.8	34.2	32.4	34.5	16.9	28.6	32.7	14.1	20.0	5.3	22.2	27.9	10.1	32.5	29.4	19.9	26.6	31.6	22.6	31.4	29.8	25.8	15.9	16.5	17.2	11.2	29.7	25.5	25.2	35.9
ZNF33B	"KOX2, KOX31, ZNF11B"	ENSG00000196693	"Zinc finger protein 33B"	Q06732	10	42574185-42638568	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 74.5;Ciliated cells: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA005538, HPA056638"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"	Vesicles	"HPA005538: , HPA056638: AB_2683199"	"unprognostic (3.01e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.34e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.61e-2)"	6.6	8.0	6.1	8.0	6.3	1.9	16.1	19.1	8.0	10.2	9.8	2.2	16.5	6.8	9.3	8.6	8.6	15.0	6.6	4.6	5.6	8.1	16.7	8.2	6.9	8.3	5.1	8.5	19.4	31.8	16.6	29.9	8.1	9.3	14.1	8.2	5.2	16.4	13.9	4.8	9.5	11.4	7.8	5.0	10.9	11.0	3.8	2.8	10.8	20.8	4.1	6.6	11.0	10.2	14.8	8.6	11.3	6.1	6.1	16.9	8.5	9.7	2.5	6.6	6.7	2.4	0.3	8.2	6.4	4.7	3.9	5.5	5.4	11.3	14.7	3.8	2.3	6.0	8.3	12.6	4.2	4.4	8.7	9.4	5.9	9.1	8.8	2.8	13.8	4.8	4.0	15.6	2.4	13.3	10.4	3.3	8.2	7.9	11.3	2.4	4.1	5.4	3.3	7.2	4.8	5.9	5.9	6.5	6.2	10.5	13.8	11.9	11.6	3.8	8.1	3.7	6.2	10.3	4.2	4.0	2.1	9.7	3.5	6.5	7.3	11.1	4.6	1.4	10.4	1.8	11.3	6.1	5.3	9.0	5.0	12.8	14.8	13.2	9.1	5.3	12.6	16.9	11.9	1.9	6.1	3.9	8.6	10.3	8.5	6.1	6.3	19.1	8.0	5.6	8.1	5.1	8.5	9.3	2.8	74.5	28.6	15.9	16.2	4.2	16.4	29.4	33.1	73.6	47.8	19.2	9.8	15.2	18.3	21.8	2.1	9.5	6.8	0.0	31.3	14.1	4.7	12.3	8.1	9.8	7.0	9.5	24.3	12.3	11.3	1.9	19.0	6.4	6.8	13.6	16.8	10.3	25.6	25.1	11.0	19.2	9.0	0.0	4.2	7.1	10.0	3.4	9.6	12.5	20.8	9.8
ZNF501	"MGC21738, ZNF52"	ENSG00000186446	"Zinc finger protein 501"	Q96CX3	3	44729596-44737083	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 9.5;Spermatogonia: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 6.7"					"Low region specificity"	"Detected in all"			HPA044161	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044161: AB_2678841"	"unprognostic (8.89e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.02e-2)"	5.6	2.8	6.8	3.6	8.3	1.3	8.5	11.7	8.0	7.0	6.2	7.5	4.7	2.6	7.5	4.0	4.7	7.3	4.5	5.6	7.3	4.8	5.0	2.3	4.7	6.8	5.9	6.7	10.0	5.3	2.7	5.7	5.9	4.9	8.1	4.1	3.6	4.9	7.3	5.3	4.4	3.6	8.0	6.3	4.9	4.4	6.7	9.8	4.2	6.6	3.4	4.3	7.2	7.2	3.4	1.1	2.9	1.1	2.7	3.5	1.2	0.0	0.0	2.1	0.0	3.9	6.7	0.8	2.4	2.2	2.6	3.0	0.9	0.9	1.8	0.0	1.1	1.9	0.7	0.0	0.9	2.5	0.0	1.2	0.0	0.2	1.7	5.4	0.0	0.0	3.9	2.5	2.9	0.2	0.8	1.6	0.0	0.0	0.0	0.8	0.0	0.8	0.1	4.9	1.1	0.0	1.3	0.0	1.0	2.2	1.4	2.6	1.7	1.4	1.5	1.0	4.1	0.1	0.1	1.0	0.1	2.3	2.4	1.9	4.2	2.6	0.0	0.1	0.0	3.1	2.0	0.7	2.9	2.4	0.9	3.3	2.9	2.3	2.6	1.1	3.4	3.5	2.4	1.1	2.7	1.1	1.0	2.3	1.2	6.8	8.3	11.7	8.0	7.3	4.8	5.9	6.7	4.9	9.8	0.0	0.3	0.0	1.7	0.8	2.9	2.0	0.0	1.4	2.3	3.5	2.0	1.5	0.0	2.1	0.6	2.1	0.5	0.0	1.7	1.5	2.5	0.9	0.0	0.8	1.4	9.5	1.2	1.8	1.8	1.3	1.4	0.8	0.0	1.0	0.7	7.0	1.7	0.0	1.4	1.0	3.2	6.5	1.9	4.8	10.2	1.4	0.2	1.7	0.9	0.7
ZNF804A	C2orf10	ENSG00000170396	"Zinc finger protein 804A"	Q7Z570	2	184598366-184939492	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 31.6;lymphoid tissue: 9.6"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 31.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Region enriched"	"Detected in many"	4	"cerebellum: 31.6"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 20.8;RH-30: 14.3;THP-1: 10.5;U-698: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029195	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029195: AB_10603011"	"unprognostic (1.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.98e-4)"	"unprognostic (6.21e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.93e-2)"	0.4	1.0	4.3	9.6	7.2	1.8	0.4	31.6	10.7	0.6	0.8	0.1	0.8	1.5	0.4	0.3	0.6	0.4	4.8	0.3	5.2	7.3	1.8	0.6	1.2	2.7	2.2	3.0	0.8	0.3	0.2	0.4	0.5	5.4	4.1	1.1	2.4	1.1	4.4	0.3	0.3	3.3	0.5	1.5	1.8	1.2	0.9	0.4	0.0	4.4	0.0	2.9	1.8	2.1	2.0	1.2	1.0	1.7	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	4.9	1.6	1.5	0.0	0.0	20.8	0.0	0.0	2.1	0.0	0.3	0.0	3.7	0.1	0.0	5.5	0.8	0.1	8.2	5.2	0.0	2.5	0.0	0.0	1.3	2.5	3.9	0.0	0.0	0.9	0.0	0.0	0.0	4.9	0.0	0.0	3.3	0.0	14.3	0.8	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.1	0.0	10.5	0.0	5.3	0.1	0.2	2.1	2.2	0.0	15.5	6.1	1.5	1.7	0.0	1.1	0.0	0.0	1.7	0.0	2.0	0.0	0.0	1.2	0.3	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.3	4.3	7.2	31.6	7.5	5.2	7.3	2.2	3.0	5.4	0.4	0.0	1.1	3.4	0.0	0.0	31.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.2	0.0	0.0	2.7	0.4	0.3	3.2	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	2.6	6.5	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0
ZSCAN21	"DKFZp434L134, NY-REN-21, Zipro1, ZNF38"	ENSG00000166529	"Zinc finger and SCAN domain containing 21"	Q9Y5A6	7	100049774-100065038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016948, HPA023591"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA016948: , HPA023591: AB_1859037"	"unprognostic (2.44e-3)"	"unprognostic (3.77e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.42e-3)"	"unprognostic (8.59e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (6.09e-2)"	10.6	12.2	10.9	10.8	11.1	8.1	12.5	15.2	14.8	13.6	12.3	16.3	10.7	7.3	15.9	14.9	10.9	13.9	12.7	8.3	10.8	9.9	14.9	14.8	9.4	8.5	12.0	15.5	13.7	20.3	12.1	10.7	12.0	11.1	13.1	8.4	14.9	16.3	11.9	16.1	9.7	9.6	12.2	11.5	9.1	10.6	26.0	13.3	10.5	12.6	5.7	7.3	11.2	9.7	7.7	6.5	13.5	6.4	10.2	12.0	5.1	4.5	7.6	12.6	14.5	11.8	7.7	10.3	5.2	7.9	10.2	10.3	6.0	5.1	4.8	6.5	6.1	17.4	4.1	11.1	7.4	10.2	6.4	9.2	4.4	6.1	5.5	12.8	6.1	1.8	9.0	13.1	9.9	16.7	8.5	8.1	10.0	10.3	4.3	7.5	11.3	10.4	10.3	15.5	6.2	5.7	7.2	10.1	5.8	8.5	7.0	6.5	16.4	7.0	15.3	9.9	18.6	6.1	5.4	3.8	9.3	11.5	8.1	7.1	8.4	7.8	10.8	4.4	4.0	12.4	13.5	6.4	12.7	11.1	6.3	12.0	7.7	6.9	10.2	6.5	7.1	7.6	8.6	0.8	10.2	3.9	6.2	7.5	5.1	10.9	11.1	15.2	14.8	10.8	9.9	12.0	15.5	11.1	13.3	3.0	3.2	3.7	2.9	1.3	5.2	1.2	5.1	2.7	5.7	3.5	2.0	14.7	6.6	6.1	1.7	4.2	2.6	0.0	3.5	5.4	4.3	3.4	2.3	4.7	4.4	9.5	1.7	1.8	2.6	0.0	5.5	2.2	3.3	3.6	2.5	15.4	4.2	3.4	9.2	8.4	5.3	0.0	4.1	10.4	17.7	3.3	14.8	1.8	2.9	1.4
ZW10	KNTC1AP	ENSG00000086827	"Zw10 kinetochore protein"	O43264	11	113733187-113773811	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011565, HPA051253, HPA055410"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809"	"unprognostic (4.33e-3)"	"unprognostic (6.65e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (3.12e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (7.44e-2)"	"unprognostic (8.01e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.57e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.17e-3)"	11.8	11.4	9.0	10.4	13.5	10.7	15.2	19.8	15.2	12.5	11.4	11.2	8.6	7.8	14.0	10.5	17.2	8.9	8.0	10.3	9.9	7.6	12.2	19.6	9.6	11.7	10.3	9.9	11.9	16.8	14.9	14.4	10.4	17.0	11.4	14.3	7.9	15.2	11.0	24.1	22.9	10.7	12.2	12.5	11.7	12.0	25.0	10.9	18.6	9.4	12.4	15.8	11.8	13.1	8.3	12.3	8.6	13.2	7.3	11.8	7.2	12.2	7.8	16.0	11.3	10.4	10.8	9.3	13.8	11.7	17.5	17.7	20.2	22.7	15.3	18.2	13.8	15.9	17.1	20.2	17.2	25.0	10.5	8.3	16.2	6.9	12.3	11.0	15.7	10.0	9.2	11.3	18.6	15.1	7.9	18.0	18.2	18.6	5.7	18.3	6.3	15.2	10.8	10.1	15.9	15.6	14.2	16.7	17.3	11.5	11.8	6.4	7.6	15.6	12.9	5.7	13.3	24.0	9.3	10.1	14.6	23.5	8.1	15.2	3.4	5.6	16.2	4.8	20.3	17.0	7.4	9.5	8.6	8.8	13.2	11.8	8.3	8.3	7.6	12.3	7.2	7.9	9.4	2.7	7.3	11.1	3.6	7.3	7.2	9.0	13.5	19.8	15.2	9.9	7.6	10.3	9.9	17.0	10.9	0.0	4.5	1.5	6.9	10.8	3.0	6.5	7.6	4.0	6.8	0.0	0.0	8.2	8.3	8.1	4.8	5.5	4.0	0.0	10.5	8.6	5.6	4.7	3.5	7.4	7.9	3.2	3.5	4.3	4.9	5.9	4.6	5.0	3.3	8.2	4.1	6.4	7.8	3.5	5.3	6.2	4.1	19.4	6.6	45.9	6.1	10.9	8.8	6.9	5.6	4.7